-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GpKIaBXKtTg4cJmPcapha/FgTe/VzVSiE1NKlZWYJlZahb5FRR96fQtMN9sDujc1 qpngY+xFNcojsI+t7+uhCw== 0001122304-10-000046.txt : 20100429 0001122304-10-000046.hdr.sgml : 20100429 20100429160613 ACCESSION NUMBER: 0001122304-10-000046 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 19 CONFORMED PERIOD OF REPORT: 20100331 FILED AS OF DATE: 20100429 DATE AS OF CHANGE: 20100429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AETNA INC /PA/ CENTRAL INDEX KEY: 0001122304 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 232229683 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-16095 FILM NUMBER: 10781749 BUSINESS ADDRESS: STREET 1: 151 FARMINGTON AVENUE CITY: HARTFORD STATE: CT ZIP: 06156 BUSINESS PHONE: 8602730123 MAIL ADDRESS: STREET 1: 151 FARMINGTON AVENUE CITY: HARTFORD STATE: CT ZIP: 06156 FORMER COMPANY: FORMER CONFORMED NAME: AETNA U S HEALTHCARE INC DATE OF NAME CHANGE: 20000822 10-Q 1 form10q.htm FORM 10-Q form10q.htm  
 

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 10-Q

(Mark One)

þ  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
       1934

For the quarterly period ended March 31, 2010

or

¨  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
      1934



For the transition period from _________ to_________

Commission File Number:  1-16095


Aetna Inc.
(Exact name of registrant as specified in its charter)

 
Pennsylvania
(State or other jurisdiction of incorporation or organization)
23-2229683
(I.R.S. Employer Identification No.)
   
151 Farmington Avenue, Hartford, CT
(Address of principal executive offices)
06156
(Zip Code)
   
Registrant’s telephone number, including area code
(860) 273-0123

(Former name, former address and former fiscal year, if changed since last report)          N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90 days.                             þ Yes  ¨  No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulations S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
                                                                    þ Yes  ¨  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  þ
  
Accelerated filer                  ¨
Non-accelerated filer ¨ (Do not check if a smaller reporting company)
Smaller reporting company ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).                ¨ Yes  þ No
 
There were 424.9 million shares of the registrant's voting common stock with a par value of $.01 per share outstanding at March 31, 2010.
 

 
 
 
 
 
 
Aetna Inc.
Form 10-Q
For the Quarterly Period Ended March 31, 2010

Unless the context otherwise requires, references to the terms “we,” “our” or “us” used throughout this Quarterly Report on Form 10-Q (except the Report of Independent Registered Public Accounting Firm on page 22), refer to Aetna Inc. (a Pennsylvania corporation) (“Aetna”) and its subsidiaries (collectively, the “Company”).

 Table of Contents
Page

Part I
Financial Information
  
     
Item 1.
Financial Statements
    1
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
   23
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
   39
Item 4.
Controls and Procedures
   39
     
Part II
Other Information
  
     
Item 1.
Legal Proceedings
   40
Item 1A.
Risk Factors
   40
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
   40
Item 6.
Exhibits
   41
     
Signatures
     42
Index to Exhibits
     43
 
 
 

 
 
 

Part I
Financial Information

Item 1.
Financial Statements

Consolidated Statements of Income
(Unaudited)


 
For the Three Months
 
Ended March 31,
(Millions, except per common share data)
 2010
 2009
Revenue:
    
   Health care premiums
 $      6,895.1
 $      6,992.2
   Other premiums
 474.7
 485.1
   Fees and other revenue (1)
 899.8
 893.0
   Net investment income
 275.2
 249.2
   Net realized capital gains (losses)
 76.7
 (4.8)
Total revenue
 8,621.5
 8,614.7
Benefits and expenses:
    
   Health care costs (2)
 5,691.0
 5,804.2
   Current and future benefits
 527.0
 503.3
   Operating expenses:
    
      Selling expenses
 321.5
 322.5
      General and administrative expenses
 1,195.7
 1,229.8
   Total operating expenses
 1,517.2
 1,552.3
   Interest expense
 60.9
 61.5
   Amortization of other acquired intangible assets
 24.4
 24.5
Total benefits and expenses
 7,820.5
 7,945.8
Income before income taxes
 801.0
 668.9
Income taxes:
    
   Current
 216.1
 208.3
   Deferred
 22.3
 22.8
Total income taxes
 238.4
 231.1
Net income
 $         562.6
 $        437.8
Earnings per common share:
    
   Basic
 $           1.30
$            .97
   Diluted
 $           1.28
 $            .95
(1)
Fees and other revenue include administrative services contract member co-payments and plan sponsor reimbursements related to our mail order and specialty pharmacy operations of $20.4 million and $14.8 million (net of pharmaceutical and processing costs of $353.6 million and $397.9 million) for the three months ended March 31, 2010 and 2009, respectively.
(2)
Health care costs have been reduced by Insured member co-payments related to our mail order and specialty pharmacy operations of $31.2 million and $30.0 million for the three months ended March 31, 2010 and 2009, respectively.

Refer to accompanying Condensed Notes to Consolidated Financial Statements (Unaudited).


 
Page 1
 


Consolidated Balance Sheets


   
(Unaudited)
    
   
At March 31,
  
At December 31,
(Millions)
  
 2010
  
 2009
Assets:
        
Current assets:
        
   Cash and cash equivalents
  
 $       1,570.4
  
 $        1,203.6
   Investments
  
 2,851.9
  
 2,922.7
   Premiums receivable, net
  
 758.8
  
 630.4
   Other receivables, net
  
 634.0
  
 626.7
   Accrued investment income
  
 216.0
  
 209.2
   Collateral received under securities loan agreements
  
 422.4
  
 210.0
   Income taxes receivable
  
 - 
 
 89.5
   Deferred income taxes
  
 284.7
  
 383.4
   Other current assets
  
 688.2
  
 551.4
Total current assets
  
 7,426.4
  
 6,826.9
Long-term investments
  
 17,809.5
  
 17,051.1
Reinsurance recoverables
  
 978.0
  
 986.9
Goodwill
  
 5,145.7
  
 5,146.2
Other acquired intangible assets, net
  
 566.3
  
 590.7
Property and equipment, net
  
 556.3
  
 551.0
Deferred income taxes
  
 350.5
  
 333.4
Other long-term assets
  
 770.6
  
 781.1
Separate Accounts assets
  
 5,369.5
  
 6,283.1
Total assets
  
 $      38,972.8
  
 $       38,550.4
Liabilities and shareholders' equity:
        
Current liabilities:
        
   Health care costs payable
  
 $        2,965.4
  
 $         2,895.3
   Future policy benefits
  
 736.0
  
 739.6
   Unpaid claims
  
 579.0
  
 559.5
   Unearned premiums
  
 411.2
  
 306.4
   Policyholders' funds
  
 831.9
  
 788.3
   Collateral payable under securities loan agreements
  
 422.4
  
 210.0
   Short-term debt
  
 479.6
  
 480.8
   Current portion of long-term debt
  
 449.7
  
 - 
   Income taxes payable
  
 117.3
  
 - 
   Accrued expenses and other current liabilities
  
 2,851.9
  
 2,484.3
Total current liabilities
  
 9,844.4
  
 8,464.2
Future policy benefits
  
 6,433.2
  
 6,470.1
Unpaid claims
  
 1,470.8
  
 1,453.0
Policyholders' funds
  
 1,307.1
  
 1,294.1
Long-term debt
  
 3,190.1
  
 3,639.5
Other long-term liabilities
  
 1,433.8
  
 1,442.6
Separate Accounts liabilities
  
 5,369.5
  
 6,283.1
Total liabilities
  
 29,048.9
  
 29,046.6
Commitments and contingencies (Note 12)
        
Shareholders' equity:
        
   Common stock ($.01 par value; 2.7 billion shares authorized; 424.9 million and 430.8 million
      
   shares issued and outstanding in 2010 and 2009, respectively) and additional paid-in capital
  
 499.2
  
 470.1
   Retained earnings
  
 10,567.4
  
 10,256.7
   Accumulated other comprehensive loss
  
 (1,142.7)
  
 (1,223.0)
Total shareholders' equity
  
 9,923.9
  
 9,503.8
Total liabilities and shareholders' equity
  
 $        38,972.8
  
 $        38,550.4

Refer to accompanying Condensed Notes to Consolidated Financial Statements (Unaudited).



 
Page 2
 


Consolidated Statements of Shareholders’ Equity
(Unaudited)



   
Common
            
 
Number of
Stock and
  
Accumulated
      
 
Common
Additional
  
Other
Total
  
 
Shares
Paid-in
Retained
  
Comprehensive
  
Shareholders'
  
Comprehensive
(Millions)
Outstanding
Capital
Earnings
Loss
Equity
Income
Three Months Ended March 31, 2010
                  
Balance at December 31, 2009
 430.8
 $    470.1
 $    10,256.7
  
 $     (1,223.0)
  
 $      9,503.8
    
Comprehensive income:
                  
  Net income
 - 
 - 
 562.6
  
 - 
 
 562.6
  
 $      562.6
  Other comprehensive income (Note 6):
                  
    Net unrealized gains on securities
 - 
 - 
 - 
 
 52.4
  
 52.4
    
    Net foreign currency and derivative losses
 - 
 - 
 - 
 
 (4.6)
  
 (4.6)
    
    Pension and OPEB plans
 - 
 - 
 - 
 
 32.5
  
 32.5
    
  Other comprehensive income
 - 
 - 
 - 
 
 80.3
  
 80.3
  
 80.3
Total comprehensive income
                
 $      642.9
Common shares issued for benefit plans,
                  
  including tax benefits
 1.3
 29.2
 - 
 
 - 
 
 29.2
    
Repurchases of common shares
 (7.2)
 (.1)
 (251.9)
  
 - 
 
 (252.0)
    
Balance at March 31, 2010
 424.9
 $    499.2
 $    10,567.4
  
 $     (1,142.7)
  
 $      9,923.9
    
                   
Three Months Ended March 31, 2009
                  
Balance at December 31, 2008
 456.3
 $    351.2
 $      9,716.5
  
 $     (1,881.3)
  
 $      8,186.4
    
Comprehensive income:
                  
  Net income
 - 
 - 
 437.8
  
 - 
 
 437.8
  
 $      437.8
  Other comprehensive loss (Note 6):
                  
    Net unrealized losses on securities
 - 
 - 
 - 
 
 (65.3)
  
 (65.3)
    
    Net foreign currency and derivative gains
 - 
 - 
 - 
 
 2.4
  
 2.4
    
    Pension and OPEB plans
 - 
 - 
 - 
 
 34.7
  
 34.7
    
  Other comprehensive loss
 - 
 - 
 - 
 
 (28.2)
  
 (28.2)
  
 (28.2)
Total comprehensive income
                
 $      409.6
Common shares issued for benefit plans,
                  
  including tax benefits
 1.0
 44.9
 - 
 
 - 
 
 44.9
    
Repurchases of common shares
 (10.4)
 (.1)
 (276.9)
  
 - 
 
 (277.0)
    
Balance at March 31, 2009
 446.9
 $    396.0
 $      9,877.4
  
 $     (1,909.5)
  
 $      8,363.9
    

Refer to accompanying Condensed Notes to Consolidated Financial Statements (Unaudited).

 

 
Page 3
 


Consolidated Statements of Cash Flows
(Unaudited)


 
Three Months Ended
 
 March 31,
(Millions)
 2010
 2009
Cash flows from operating activities:
    
Net income
 $           562.6
 $           437.8
  Adjustments to reconcile net income to net cash provided by operating activities:
    
    Net realized capital (gains) losses
 (76.7)
 4.8
    Depreciation and amortization
 102.3
 97.0
    Equity in earnings of affiliates, net
 (11.4)
 10.2
    Stock-based compensation expense
 27.6
 37.2
    Accretion of net investment discount
 (11.6)
 (16.5)
    Changes in assets and liabilities:
    
       Accrued investment income
 (6.8)
 4.0
       Premiums due and other receivables
 (93.3)
 (256.9)
       Income taxes
 235.6
 216.7
       Other assets and other liabilities
 (66.1)
 (68.7)
       Health care and insurance liabilities
 174.7
 361.7
    Other, net
 .4
(1.0)
Net cash provided by operating activities
 837.3
 826.3
Cash flows from investing activities:
    
    Proceeds from sales and maturities of investments
 2,462.2
 2,490.7
    Cost of investments
 (2,686.4)
 (2,287.3)
    Increase in property, equipment and software
 (74.5)
 (88.6)
    Cash used for acquisition, net of cash acquired
 (.1)
 - 
Net cash (used for) provided by investing activities
 (298.8)
 114.8
Cash flows from financing activities:
    
    Net repayment of short-term debt
 (1.3)
 (114.8)
    Deposits and interest credited for investment contracts
 1.6
 1.9
    Withdrawals of investment contracts
 (3.7)
 (3.9)
    Common shares issued under benefit plans
 3.6
 3.7
    Stock-based compensation tax benefits
 (1.0)
 3.6
    Common shares repurchased
 (162.0)
 (263.8)
    Collateral on interest rate swaps
 (8.9)
 - 
Net cash used for financing activities
 (171.7)
 (373.3)
Net increase in cash and cash equivalents
 366.8
 567.8
Cash and cash equivalents, beginning of period
 1,203.6
 1,179.5
Cash and cash equivalents, end of period
 $         1,570.4
 $         1,747.3
Supplemental cash flow information:
    
   Interest paid
 $              35.0
 $             36.8
   Income taxes paid
 3.7
 10.9


Refer to accompanying Condensed Notes to Consolidated Financial Statements (Unaudited).
 


 
Page 4
 


Condensed Notes to Consolidated Financial Statements
(Unaudited)

1.
Organization

We conduct our operations in three business segments:

·  
Health Care consists of medical, pharmacy benefits management, dental and vision plans offered on both an Insured basis (where we assume all or a majority of the risk for medical and dental care costs) and an employer-funded basis (where the plan sponsor under an administrative services contract (“ASC”) assumes all or a majority of this risk).  Medical products include point-of-service (“POS”), preferred provider organization (“PPO”), health maintenance organization (“HMO”) and indemnity benefit plans.  Medical products also include health savings accounts (“HSAs”) and Aetna HealthFund®, consumer-directed health plans that combine trad itional POS or PPO and/or dental coverage, subject to a deductible, with an accumulating benefit account (which may be funded by the plan sponsor and/or the member in the case of HSAs).  We also offer Medicare and Medicaid products and services and specialty products, such as medical management and data analytics services, behavioral health plans and stop loss insurance, as well as products that provide access to our provider network in select markets.

·  
Group Insurance primarily includes group life insurance products offered on an Insured basis, including basic and supplemental group term life, group universal life, supplemental or voluntary programs and accidental death and dismemberment coverage.  Group Insurance also includes (i) group disability products offered to employers on both an Insured and an ASC basis which consist primarily of short-term and long-term disability insurance, (ii) absence management services offered to employers, which include short-term and long-term disability administration and leave management, and (iii) long-term care products that were offered primarily on an Insured basis, which provide benefits covering the cost of care in private home settings, adult day care, assisted living or nursing facilities.& #160; We no longer solicit or accept new long-term care customers, and we are working with our customers on an orderly transition of this product to other carriers.

·  
Large Case Pensions manages a variety of retirement products (including pension and annuity products) primarily for tax qualified pension plans.  These products provide a variety of funding and benefit payment distribution options and other services.  Large Case Pensions also includes certain discontinued products (refer to Note 14 beginning on page 20 or additional information).


2.
Summary of Significant Accounting Policies

Interim Financial Statements
These interim financial statements necessarily rely on estimates, including assumptions as to annualized tax rates.  In the opinion of management, all adjustments necessary for a fair statement of results for the interim periods have been made.  All such adjustments are of a normal, recurring nature.  The accompanying unaudited consolidated financial statements and related notes should be read in conjunction with the consolidated financial statements and related notes presented in our 2009 Annual Report on Form 10-K (our “2009 Annual Report”).  Certain financial information that is normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), but that is not required for interim reporting purposes, has bee n condensed or omitted.  We have omitted certain footnote disclosures that would substantially duplicate the disclosures in our 2009 Annual Report, unless the information contained in those disclosures materially changed or is required by GAAP.  We have evaluated subsequent events from the balance sheet date through the date the financials were issued and determined there were no other items to disclose.

Principles of Consolidation
These unaudited consolidated financial statements have been prepared in accordance with GAAP and include the accounts of Aetna and the subsidiaries that we control.  All significant intercompany balances have been eliminated in consolidation.
 
 
 
 
Page 5
 
 
 
New Accounting Standards
Variable Interest Entities
In June 2009, the Financial Accounting Standards Board (“FASB”) released revised accounting guidance for variable interest entities (“VIEs”).  This accounting guidance removes the quantitative-based risks-and-rewards calculation previously used to assess whether a company must consolidate a VIE and, instead, requires a variable interest holder to qualitatively assess whether it has a controlling financial interest in the VIE.  This accounting guidance was effective on January 1, 2010.  The adoption of this new accounting guidance did not impact our financial position or results of operations.  Refer to Note 5 beginning on page 7 for additional information.

Recognition and Presentation of Other-Than-Temporary Impairments
Effective April 1, 2009, we adopted new accounting guidance issued by the FASB for other-than-temporary impairments (“OTTI”) of debt securities. This guidance establishes new criteria for the recognition of OTTI on debt securities and also requires additional financial statement disclosure. The new criteria require OTTI to be recognized if either we determine a credit-related loss has occurred or we have the intention to sell a security that is in an unrealized capital loss position. Refer to Note 5 beginning on page 7 for additional information.
 
 
3.
Earnings Per Common Share

Basic earnings per share (“EPS”) is computed by dividing net income (i.e., the numerator) by the weighted average number of common shares outstanding (i.e., the denominator) during the reporting period.  Diluted EPS is computed in a similar manner, except that the weighted average number of common shares outstanding is adjusted for the dilutive effects of stock options and stock appreciation rights (“SARs”), but only if the effect is dilutive.

The computations of basic and diluted EPS for the three months ended March 31, 2010 and 2009 are as follows:


(Millions, except per common share data)
2010
  
2009
Net income
 $          562.6
  
 $          437.8
Weighted average shares used to compute basic EPS
 431.4
  
 452.7
Dilutive effect of outstanding stock-based compensation awards (1)
 8.2
  
 8.9
Weighted average shares used to compute diluted EPS
 439.6
  
 461.6
Basic EPS
 $            1.30
  
 $             .97
Diluted EPS
 $            1.28
  
 $             .95
(1)
Approximately 18.9 and 19.5 million SARs (with exercise prices ranging from $32.11 to $59.76) and 5.8 and 6.2 million stock options (with exercise prices ranging from $33.38 to $42.35 and $35.34 to $42.35) were not included in the calculation of diluted EPS for the three months ended March 31, 2010 and 2009, respectively, as their exercise prices were greater than the average market price of Aetna common shares during such periods.
 
 
4.
Operating Expenses

For the three months ended March 31, 2010 and 2009, selling expenses (which include broker commissions, the variable component of our internal sales force compensation and premium taxes) and general and administrative expenses were as follows:

(Millions)
 2010
  
 2009
Selling expenses
 $            321.5
  
 $            322.5
General and administrative expenses:
      
  Salaries and related benefits
 767.8
  
 750.2
  Other general and administrative expenses
 427.9
(1)
 479.6
Total general and administrative expenses
 1,195.7
  
 1,229.8
Total operating expenses
 $          1,517.2
  
 $          1,552.3
(1)
Includes litigation-related insurance proceeds of $70.0 million for 2010.  Refer to the reconciliation of operating earnings to net income in Note 13 beginning on page 19 for additional information.



 
Page 6
 

 
5.
Investments

Total investments at March 31, 2010 and December 31, 2009 were as follows:

 
March 31, 2010
  
December 31, 2009
(Millions)
Current
  
Long-term
  
Total
  
Current
  
Long-term
  
Total
Debt and equity securities available for sale
 $      2,750.7
  
 $     15,098.1
  
 $     17,848.8
  
 $      2,834.8
  
 $     14,324.9
  
 $     17,159.7
Mortgage loans
 98.4
  
 1,457.6
  
 1,556.0
  
 86.1
  
 1,507.9
  
 1,594.0
Other investments
 2.8
  
 1,253.8
  
 1,256.6
  
 1.8
  
 1,218.3
  
 1,220.1
Total investments
 $      2,851.9
  
 $     17,809.5
  
 $     20,661.4
  
 $      2,922.7
  
 $     17,051.1
  
 $     19,973.8


Debt and Equity Securities
Debt and equity securities available for sale at March 31, 2010 and December 31, 2009 were as follows:

   
Gross
Gross
    
 
Amortized
Unrealized
Unrealized
  
Fair
(Millions)
Cost
Gains
Losses
  
Value
March 31, 2010
          
Debt securities:
          
    U.S. government securities
 $         1,947.6
 $           56.3
 $              (.9)
  
 $       2,003.0
    States, municipalities and political subdivisions
 2,159.9
 80.6
 (20.5)
  
 2,220.0
    U.S. corporate securities
 6,866.9
 484.5
 (32.1)
  
 7,319.3
    Foreign securities
 2,690.7
 210.7
 (15.4)
  
 2,886.0
    Residential mortgage-backed securities
 1,337.0
 54.8
 (3.3)
 (1)
 1,388.5
    Commercial mortgage-backed securities
 1,146.0
 68.4
 (59.8)
 (1)
 1,154.6
    Other asset-backed securities
 475.0
 25.5
 (5.7)
 (1)
 494.8
    Redeemable preferred securities
 347.5
 21.5
 (26.2)
  
 342.8
Total debt securities
 16,970.6
 1,002.3
 (163.9)
  
 17,809.0
Equity securities
 35.3
 7.3
 (2.8)
  
 39.8
Total debt and equity securities (2)
 $       17,005.9
 $      1,009.6
 $      (166.7)
  
 $      17,848.8
           
December 31, 2009
          
Debt securities:
          
    U.S. government securities
 $           1,801.3
 $             50.7
 $           (5.2)
  
 $1,846.8
    States, municipalities and political subdivisions
 2,022.2
 80.7
 (27.5)
  
 2,075.4
    U.S. corporate securities
 6,741.9
 497.1
 (54.4)
  
 7,184.6
    Foreign securities
 2,554.5
 210.9
 (20.9)
  
 2,744.5
    Residential mortgage-backed securities
 1,375.8
 49.4
 (5.0)
 (1)
 1,420.2
    Commercial mortgage-backed securities
 1,109.8
 37.6
 (104.0)
 (1)
 1,043.4
    Other asset-backed securities
 419.6
 25.0
 (8.2)
 (1)
 436.4
    Redeemable preferred securities
 381.9
 27.8
 (41.0)
  
 368.7
Total debt securities
 16,407.0
 979.2
 (266.2)
  
 17,120.0
Equity securities
 35.3
 7.9
 (3.5)
  
 39.7
Total debt and equity securities (2)
 $         16,442.3
 $          987.1
 $       (269.7)
  
 $       17,159.7
(1)
At March 31, 2010 and December 31, 2009, we held securities for which we had recognized a credit-related impairment in the past.  For the three months ended March 31, 2010, we recognized $6.0 million of non-credit-related impairments in other comprehensive loss related to these securities (as of March 31, 2010 and December 31, 2009, these securities had a net unrealized capital loss of $12.0 million and $17.2 million, respectively).
(2)
Investment risks associated with our experience-rated and discontinued products generally do not impact our results of operations (refer to Note 14 beginning on page 20 for additional information on our accounting for discontinued products).  At March 31, 2010, investments with a fair value of $4.0 billion, gross unrealized capital gains of $303.5 million and gross unrealized capital losses of $50.0 million and, at December 31, 2009, investments with a fair value of $4.0 billion, gross unrealized capital gains of $285.6 million and gross unrealized capital losses of $78.2 million were included in total debt and equity securities, but support our experience-rated and discontinued products.  Changes in net unrealized capital gains ( losses) on these securities are not reflected in accumulated other comprehensive loss.


 
 
Page 7
 

 
The fair value of debt securities at March 31, 2010 is shown below by contractual maturity.  Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid.
     
Fair
(Millions)
    
Value
Due to mature:
      
    Less than one year
    
 $          721.1
    One year through five years
    
 3,614.2
    After five years through ten years
    
 5,351.7
    Greater than ten years
    
 5,084.1
    Residential mortgage-backed securities
    
 1,388.5
    Commercial mortgage-backed securities
    
 1,154.6
    Other asset-backed securities
    
 494.8
Total
    
 $     17,809.0

The maturity dates for debt securities in an unrealized capital loss position at March 31, 2010 were as follows:

 
Supporting discontinued
  
Supporting remaining
    
 
and experience-rated products
  
products
  
Total
 
Fair
  
Unrealized
  
Fair
  
Unrealized
  
Fair
  
Unrealized
(Millions)
Value
  
Losses
  
Value
  
Losses
  
Value
  
Losses
Due to mature:
                      
  Less than one year
 $           1.2
  
 $           - 
 
 $         32.1
  
 $         1.3
  
 $         33.3
  
 $         1.3
  One year through five years
 22.6
  
 .4
  
 460.1
  
 5.7
  
 482.7
  
 6.1
  After five years through ten years
 160.2
  
 2.2
  
 622.1
  
 8.3
  
 782.3
  
 10.5
  Greater than ten years
 490.8
  
 34.7
  
 881.2
  
 42.5
  
 1,372.0
  
 77.2
  Residential mortgage-backed securities
 - 
 
 - 
 
 363.2
  
 3.3
  
 363.2
  
 3.3
  Commercial mortgage-backed securities
 63.6
  
 9.4
  
 207.1
  
 50.4
  
 270.7
  
 59.8
  Other asset-backed securities
 18.2
  
 .5
  
 73.2
  
 5.2
  
 91.4
  
 5.7
Total
 $      756.6
  
 $      47.2
  
 $    2,639.0
  
 $     116.7
  
 $     3,395.6
  
 $     163.9

Mortgage-Backed and Other Asset-Backed Securities
All of our residential mortgage-backed securities at March 31, 2010 were agency (e.g., Government National Mortgage Association, Federal National Mortgage Association and Federal Home Loan Mortgage Corporation) issued and carry agency guarantees and explicit or implicit guarantees by the U.S. Government.  At March 31, 2010, our residential mortgage-backed securities had an average quality rating of AAA and a weighted average duration of 3.1 years.

Our commercial mortgage-backed securities have underlying loans that are dispersed throughout the United States.  Significant market observable inputs used to value these securities include probability of default and loss severity.  At March 31, 2010, these securities had an average quality rating of AA+ and a weighted average duration of 3.4 years.

Our other asset-backed securities have a variety of underlying collateral (e.g., automobile loans, credit card receivables, home equity loans, etc.).  Significant market observable inputs used to value these securities include the unemployment rate, loss severity and probability of default.  At March 31, 2010, these securities had an average quality rating of AA- and a weighted average duration of 2.1 years.

Unrealized Capital and Net Realized Capital Gains (Losses)
When a debt or equity security is in an unrealized capital loss position, we monitor the duration and severity of the loss to determine if sufficient market recovery can occur within a reasonable period of time. As described in Note 2 beginning on page 5, effective April 1, 2009, we recognize an OTTI when we intend to sell a security that is in an unrealized capital loss position or if we determine a credit-related loss has occurred. Prior to April 1, 2009, we would recognize an OTTI on a security in an unrealized capital loss position if we did not have the intention and ability to hold the security until it recovered its value.
 
 
 
Page 8
 
 
 
Summarized below are the debt and equity securities we held at March 31, 2010, and December 31, 2009, that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:

 
Less than 12 months
  
Greater than 12 months
  
Total (1)
 
Fair
Unrealized
  
Fair
  
Unrealized
  
Fair
Unrealized
(Millions)
Value
Losses
  
Value
  
Losses
  
Value
Losses
March 31, 2010
                  
Debt securities:
                  
    U.S. government securities
 $          103.0
 $          .3
 
 $           24.2
 
 $            .6
 
 $          127.2
 $              .9
    States, municipalities and political subdivisions
 300.0
 6.4
  
 213.5
  
 14.1
  
 513.5
 20.5
    U.S. corporate securities
 754.9
 12.0
  
 543.5
  
 20.1
  
 1,298.4
 32.1
    Foreign securities
 403.3
 5.7
  
 105.5
  
 9.7
  
 508.8
 15.4
    Residential mortgage-backed securites
 355.0
 3.0
  
 8.2
  
 .3
  
 363.2
 3.3
    Commercial mortgage-backed securities
 18.6
 .4
  
 252.1
  
 59.4
  
 270.7
 59.8
    Other asset-backed securities
 76.8
 5.3
  
 14.6
  
 .4
  
 91.4
 5.7
    Redeemable preferred securities
 39.3
 3.6
  
 183.1
  
 22.6
  
 222.4
 26.2
Total debt securities
 2,050.9
 36.7
  
 1,344.7
  
 127.2
  
 3,395.6
 163.9
Equity securities
 .6
 .2
  
 23.4
  
 2.6
  
 24.0
 2.8
Total debt and equity securities (1)
 $        2,051.5
 $       36.9
  
 $       1,368.1
  
 $       129.8
  
 $       3,419.6
 $       166.7
                   
December 31, 2009
                  
Debt securities:
                  
    U.S. government securities
 $        1,062.5
 $          4.8
 
 $            19.3
 
 $             .4
 
 $      1,081.8
 $           5.2
    States, municipalities and political subdivisions
 292.2
 10.6
  
 216.7
  
 16.9
  
 508.9
 27.5
    U.S. corporate securities
 730.2
 16.8
  
 681.4
  
 37.6
  
 1,411.6
 54.4
    Foreign securities
 418.1
 9.0
  
 110.4
  
 11.9
  
 528.5
 20.9
    Residential mortgage-backed securites
 383.0
 4.7
  
 8.2
  
 .3
  
 391.2
 5.0
    Commercial mortgage-backed securities
 129.7
 3.1
  
 401.6
  
 100.9
  
 531.3
 104.0
    Other asset-backed securities
 46.6
 7.5
  
 16.7
  
 .7
  
 63.3
 8.2
    Redeemable preferred securities
 49.1
 8.8
  
 198.5
  
 32.2
  
 247.6
 41.0
Total debt securities
 3,111.4
 65.3
  
 1,652.8
  
 200.9
 
 4,764.2
 266.2
Equity securities
 3.9
 1.6
  
 18.8
  
 1.9
  
 22.7
 3.5
Total debt and equity securities (1)
 $        3,115.3
 $        66.9
  
 $       1,671.6
  
 $       202.8
  
 $      4,786.9
 $       269.7
(1)
At March 31, 2010 and December 31, 2009, debt and equity securities in an unrealized capital loss position of $50.0 million and $78.2 million, respectively, and with related fair value of $780.2 million and $1.0 billion, respectively, related to discontinued and experience-rated products.

We reviewed the securities in the tables above and concluded that these are performing assets generating investment income to support the needs of our business.  In performing this review, we considered factors such as the quality of the investment security based on research performed by external rating agencies and our internal credit analysts and the prospects of realizing the carrying value of the security based on the investment’s current prospects for recovery.  Unrealized capital losses at March 31, 2010 and December 31, 2009 were generally caused by the widening of credit spreads on these particular securities relative to the interest rates on U.S. Treasury securities.  As of March 31, 2010, we did not have an intention to sell the securities that were in an unrealized capital loss position.

Net realized capital gains (losses) for the three months ended March 31, 2010 and 2009, excluding amounts related to experience-rated contract holders and discontinued products, were as follows:
 
Three Months Ended
 
March 31,
(Millions)
2010
2009
OTTI losses on securities
 $     (19.8)
 $      (42.9)
Portion of OTTI losses recognized in other comprehensive income
 6.0
 - 
Net OTTI losses on securities recognized in earnings
 (13.8)
 (42.9)
Net realized capital gains, excluding OTTI losses on securities
 90.5
 38.1
Net realized capital gains (losses)
 $       76.7
 $        (4.8)

 
 
 
Page 9
 
 
 

The decrease in OTTI recognized in earnings in 2010 compared to 2009 was primarily related to a change in the accounting guidance for the recognition of OTTI of debt securities.  Prior to the adoption of new accounting guidance for OTTI of debt securities on April 1, 2009, both yield- and credit-related OTTI were recognized in earnings if we could not assert our intention to hold the security until recovery.  In contrast, after April 1, 2009, only credit-related impairments are recognized in earnings unless we have the intention to sell the security in an unrealized capital loss position, in which case the yield-related OTTI is also recognized in earnings.  Refer to Note 2 beginning on page 5 for more information.  
 
Excluding amounts related to experience-rated and discontinued products, proceeds from the sale of debt securities and the related gross realized capital gains and losses for three months ended March 31, 2010 and 2009 were as follows:
 
 
For the Three Months Ended March 31,
(Millions)
  
2010
    
2009
Proceeds on sales
$
 2,365.4
  
$
2,430.9
Gross realized capital gains
  
 108.7
    
54.6
Gross realized capital losses
  
 (8.2)
    
(18.9)


Variable Interest Entities (“VIEs”)
We have relationships with certain real estate and hedge fund partnerships that are considered VIEs.  We record the amount of our investment in these partnerships as long-term investments on our balance sheets and recognize our share of partnership income or losses in earnings.  Our maximum exposure to loss as a result of our investment in these partnerships is our investment balance at March 31, 2010 and December 31, 2009 of approximately $116 million and $125 million, respectively, and the risk of recapture of tax credits related to the real estate partnerships previously recognized, which we do not believe to be significant.  We do not have a future obligation to fund losses or debt on behalf of these investments; however, we may voluntarily contribute funds.  The real estate partnerships constru ct, own and manage low-income housing developments and had total assets of approximately $5.0 billion and $5.1 billion at March 31, 2010 and December 31, 2009, respectively.  The hedge fund partnerships had total assets of approximately $6.6 billion and $5.7 billion at March 31, 2010 and December 31, 2009, respectively.

Credit Default Swaps
We sell credit protection via credit default swap contracts to improve the return and diversification profile of our investment portfolio.  Our contracts are limited to credit exposure on individual entities or investment-grade indices and have terms no longer than five years.  We would have to pay under these contracts based on certain defined triggering events such as bankruptcy and failure to pay interest or principal on the underlying obligation.  The fair value and maximum amount of future payments for these credit default swaps at March 31, 2010 were $0 and $9 million, respectively, and at December 31, 2009 were $.1 million and $18 million, respectively.  At March 31, 2010, we were not required to make any payments to our counterparties for risks covered by these credit default swaps.

Non-controlling Interests
Certain of our investment holdings are partially-owned by third parties.  At March 31, 2010 and December 31, 2009, $79 million and $77 million, respectively, of our investment holdings were partially owned by third parties.  The non-controlling entities’ share of these investments was included in accrued expenses and other current liabilities.  Net investment gains (losses) related to these interests were $1.6 million and $(.3) million for the three months ended March 31, 2010 and 2009, respectively.  These non-controlling interests did not have a material impact on our financial position or results of operations.
 
 

 
Page 10
 

Net Investment Income
Sources of net investment income for the three months ended March 31, 2010 and 2009 were as follows:

(Millions)
2010
2009
Debt securities
 $       236.4
 $       223.6
Mortgage loans
 26.7
 29.2
Other
 18.6
 3.5
Gross investment income
 281.7
 256.3
Less:  investment expenses
 (6.5)
 (7.1)
Net investment income (1)
 $       275.2
 $       249.2
(1)
Investment risks associated with our experience-rated and discontinued products generally do not impact our results of operations (refer to Note 14 beginning on page 20 for additional information on our accounting for discontinued products).  Net investment income includes $89.5 million and $80.5 million for the three months ended March 31, 2010 and 2009, respectively, related to investments supporting our experience-rated and discontinued products.

The increase in net investment income in 2010 from 2009 is primarily due to higher average asset levels and higher returns on alternative investments, partially offset by lower average yields.


6.
Other Comprehensive (Loss) Income

Shareholders’ equity included the following activity in accumulated other comprehensive loss (excluding amounts related to experience-rated contract holders and discontinued products) for the three months ended March 31, 2010 and 2009:

 
Net Unrealized Gains (Losses)
  
Pension and OPEB Plans
Total
 
Securities
Foreign
      
Accumulated
     
Currency
  
Unrecognized
Unrecognized
Other
 
Previously
  
and
  
Net Actuarial
Prior Service
Comprehensive
(Millions)
Impaired (1)
All Other
Derivatives
  
Losses
Cost
Income (Loss)
Three months ended March 31, 2010
              
Balance at December 31, 2009
 $     100.3
 $      235.7
 $     25.3
  
 $    (1,623.8)
 $     39.5
 $   (1,223.0)
Net unrealized gains (losses) ($226.6 pretax)
 33.6
 118.4
 (4.7)
  
 - 
 - 
 147.3
Reclassification to earnings ($43.2 pretax)
 (51.1)
 (48.5)
 .1
  
 33.4
 (.9)
 (67.0)
Other comprehensive (loss) income
 (17.5)
 69.9
 (4.6)
  
 33.4
 (.9)
 80.3
Balance at March 31, 2010
 $       82.8
 $      305.6
 $     20.7
  
 $    (1,590.4)
 $     38.6
 $   (1,142.7)
(1)
Represents the non-credit-related component of previously impaired debt securities that we do not intend to sell and subsequent appreciation in the fair value of securities that we intend to sell.
 
   
Net Unrealized
Gains (Losses)
  
Pension and OPEB Plans
  
Total Accumulated Other Comprehensive (Loss) Income
(Millions)
  
Securities
Foreign
Currency and
Derivatives
  
Unrecognized
Net Actuarial
Losses
  
Unrecognized Prior Service Cost
  
Three months ended March 31, 2009
                
Balance at December 31, 2008
 $    (229.3)
 $    (8.7)
  
 $   (1,686.6)
  
 $    43.3
  
 $   (1,881.3)
Net unrealized losses ($(79.1) pretax)
 (60.9)
 9.5
  
 - 
 
 - 
 
 (51.4)
Reclassification to earnings ($41.9 pretax)
 (4.4)
 (7.1)
  
 35.7
  
 (1.0)
  
 23.2
Other comprehensive (loss) income
 (65.3)
 2.4
  
 35.7
  
 (1.0)
  
 (28.2)
Balance at March 31, 2009
 $    (294.6)
 $    (6.3)
  
 $   (1,650.9)
  
  $    42.3
  
 $   (1,909.5)



7.
Financial Instruments

The preparation of our consolidated financial statements in accordance with GAAP requires certain of our assets and liabilities to be reflected at their fair value, and others on another basis, such as an adjusted historical cost basis.  In this note, we provide details on the fair values of financial assets and liabilities and how we determine those fair values.  We present this information for those instruments that are reported at fair value for which the
 
 
 
 
Page 11
 
 
change in fair value impacts net income or other comprehensive income separately from other financial assets and liabilities.
 
Financial Instruments Measured at Fair Value in our Balance Sheets
Certain of our financial instruments are measured at fair value in our balance sheet.  The fair values of these instruments are based on valuations that include inputs that can be classified within one of three levels of a hierarchy established by GAAP.  The following are the levels of the hierarchy and a brief description of the type of valuation information (“inputs”) that qualifies a financial asset or liability for each level:
 
o
Level 1 – Unadjusted quoted prices for identical assets or liabilities in active markets.
 
o
Level 2 – Inputs other than Level 1 that are based on observable market data.  These include:  quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, inputs that are observable that are not prices (such as interest rates, credit risks, etc.) and inputs that are derived from or corroborated by observable markets.
 
o
Level 3 – Developed from unobservable data, reflecting our own assumptions.

Financial assets and liabilities are classified based upon the lowest level of input that is significant to the valuation.  When quoted prices in active markets for identical assets and liabilities are available, we use these quoted market prices to determine the fair value of financial assets and liabilities and classify these assets and liabilities as Level 1.  In other cases where a quoted market price for identical assets and liabilities in an active market is either not available or not observable, we estimate fair value using valuation methodologies based on available and observable market information or by using a matrix pricing model.  These financial assets and liabilities would then be classified as Level 2.  If quoted market prices are not available, we determine fair value using broker q uotes or an internal analysis of each investment’s financial performance and cash flow projections.  Thus, financial assets and liabilities may be classified in Level 3 even though there may be some significant inputs that may be readily available.

The following is a description of the valuation methodologies used for our financial assets and liabilities that are measured at fair value, including the general classification of such assets and liabilities pursuant to the valuation hierarchy.

Debt Securities – Where quoted prices are available in an active market, our debt securities are classified in Level 1 of the fair value hierarchy.  Our Level 1 debt securities are comprised primarily of U.S. Treasury securities.  If Level 1 valuations are not available, the fair value is determined using models such as matrix pricing, which uses quoted market prices of debt securities with similar characteristics or discounted cash flows to estimate fair value.  We obtained one price for each of our Level 2 debt securities and did not adjust any of these prices at March 31, 2010 or December 31, 2009.

We also value a certain amount of debt securities using Level 3 inputs.  For Level 3 debt securities, fair values are determined by outside brokers or, in the case of certain private placement securities, are priced by our internal staff.  Outside brokers determine the value of these debt securities through a combination of their knowledge of the current pricing environment and market flows.  We obtained one non-binding broker quote for each of these Level 3 debt securities and did not adjust any of these quotes at March 31, 2010 or December 31, 2009.  The total fair value of our broker quoted securities was approximately $398 million at March 31, 2010 and $364 million at December 31, 2009.  Examples of these Level 3 debt securities include certain U.S. and foreign corporate securities and certain of our residential and commercial mortgage-backed securities as well as other asset-backed securities.  For some of our private placement securities, our internal staff determine the value of these debt securities by analyzing spreads of corporate and sector indices as well as interest spreads of comparable public bonds.  Examples of these Level 3 debt securities include certain U.S. and foreign securities and certain tax-exempt municipal securities.

Equity Securities – We currently have two classifications of equity securities:  those that are publicly traded and those that are privately held.  Our publicly-traded securities are classified as Level 1 because quoted prices are available for these securities in an active market.  For privately-held equity securities, there is no active market; therefore, we classify these securities as Level 3 because we must price these securities through an internal analysis of each investment’s financial statements and cash flow projections.
 
 
 
 
Page 12
 
 
 
Derivatives – Our derivative instruments are valued using models that primarily use market observable inputs and therefore are classified as Level 2 because they are traded in markets where quoted market prices are not readily available.

Our financial assets and liabilities with changes in fair value that are measured on a recurring basis in our balance sheets at March 31, 2010 and December 31, 2009 were as follows:

(Millions)
Level 1
  
Level 2
  
Level 3
  
Total
March 31, 2010
              
Assets:
              
Debt securities:
              
    U.S. government securities
 $      1,686.8
  
 $         316.2
  
 $               -
  
 $         2,003.0
    States, municipalities and political subdivisions
 - 
 
 2,208.2
  
 11.8
  
 2,220.0
    U.S. corporate securities
 - 
 
 7,197.5
  
 121.8
  
 7,319.3
    Foreign securities
 - 
 
 2,648.6
  
 237.4
  
 2,886.0
    Residential mortgage-backed securities
 - 
 
 1,388.5
  
 - 
 
 1,388.5
    Commercial mortgage-backed securities
 - 
 
 1,081.8
  
 72.8
  
 1,154.6
    Other asset-backed securities
 - 
 
 490.5
  
 4.3
  
 494.8
    Redeemable preferred securities
 - 
 
 317.1
  
 25.7
  
 342.8
Total debt securities
 1,686.8
  
 15,648.4
  
 473.8
  
 17,809.0
Equity securities
 1.6
  
 -
  
 38.2
  
 39.8
Derivatives
 - 
 
 37.3
  
 - 
 
 37.3
Total investments
 $      1,688.4
  
 $    15,685.7
  
 $       512.0
  
 $       17,886.1
Liabilities:
              
  Derivatives
 $                - 
 
 $             1.5
  
 $             - 
 
 $                1.5
 
 
December 31, 2009
              
Debt securities:
              
    U.S. government securities
 $        1,529.4
  
 $            317.4
  
 $                - 
 
  $        1,846.8
    States, municipalities and political subdivisions
 - 
 
 2,062.7
  
 12.7
  
 2,075.4
    U.S. corporate securities
 - 
 
 7,056.5
  
 128.1
  
 7,184.6
    Foreign securities
 - 
 
 2,545.5
  
 199.0
  
 2,744.5
    Residential mortgage-backed securities
   - 
 
 1,420.2
  
 - 
 
 1,420.2
    Commercial mortgage-backed securities
 - 
 
 971.6
  
 71.8
  
 1,043.4
    Other asset-backed securities
 - 
 
 425.4
  
 11.0
  
 436.4
    Redeemable preferred securities
 - 
 
 345.8
  
 22.9
  
 368.7
Total debt securities
 1,529.4
  
 15,145.1
  
 445.5
  
 17,120.0
Equity securities
 1.7
  
 - 
 
 38.0
  
 39.7
Derivatives
 - 
 
 44.0
  
 - 
 
 44.0
Total investments
 $         1,531.1
  
 $       15,189.1
  
 $         483.5
  
 $      17,203.7



 
Page 13
 

 
The changes in the balances of Level 3 financial assets for the three months ended March 31, 2010 and 2009 were as follows:

   
Three Months Ended
  
Three Months Ended
   
March 31, 2010
  
March 31, 2009
  U.S. Corporate  Foreign       Debt Equity  
(Millions)
 Securities
Securities
Other
Total
 
Securities
 Securities
Total
Beginning balance
 $     128.1
 $     199.0
 $     156.4
 $     483.5
 
 $      455.7
 $      29.3
 $      485.0
Net realized and unrealized gains (losses):
                
 
Included in earnings
 (.2)
 5.0
 1.1
 5.9
 
 1.0
 -   
 1.0
 
Included in other comprehensive income
 (.6)
 2.4
 8.2
 10.0
 
 1.2
 1.3
 2.5
 
Other (1)
 .2
 .9
 .3
 1.4
 
 (1.0)
 (2.4)
 (3.4)
Purchases, sales and maturities
 (5.7)
 14.3
 (.5)
 8.1
 
 (17.1)
 -   
 (17.1)
Transfers into (out of) Level 3 (2)
 -   
 15.8
 (12.7)
 3.1
 
 (17.2)
 -   
 (17.2)
Ending Balance
 $     121.8
 $     237.4
  $     152.8
 $     512.0
 
 $      422.6
 $      28.2
 $     450.8
Amount of Level 3 net unrealized losses included in net income
 $          -   
 $         -   
 $           .2
 $           .2
 
 $       (2.4)
 $         -   
 $      (2.4)
(1)
Reflects realized and unrealized capital gains and losses on investments supporting our experience-rated and discontinued products, which do not impact our results of operations.
(2)
At January 1, 2010, we changed our practice for reporting transfers into (out of) Level 3.  Effective January 1, 2010, we use the fair value of these assets at the end of the reporting period for all financial asset transfers.  Prior to January 1, 2010, for financial assets that were transferred into (out of) Level 3, we used the fair value of the assets at the end (beginning) of the reporting period.

Financial Instruments Not Measured at Fair Value in our Balance Sheets
The following is a description of the valuation methodologies used for estimating the fair value of our financial assets and liabilities that are measured at adjusted cost or contract value.

Mortgage loans: Fair values are estimated by discounting expected mortgage loan cash flows at market rates that reflect the rates at which similar loans would be made to similar borrowers.  These rates reflect our assessment of the credit quality and the remaining duration of the loans.  The fair value estimates of mortgage loans of lower credit quality, including problem and restructured loans, are based on the estimated fair value of the underlying collateral.

Investment contract liabilities:
 
•
With a fixed maturity:  Fair value is estimated by discounting cash flows at interest rates currently being offered by, or available to, us for similar contracts.

 
•
Without a fixed maturity:  Fair value is estimated as the amount payable to the contract holder upon demand.  However, we have the right under such contracts to delay payment of withdrawals that may ultimately result in paying an amount different than that determined to be payable on demand.

Long-term debt: Fair values are based on quoted market prices for the same or similar issued debt or, if no quoted market prices are available, on the current rates estimated to be available to us for debt of similar terms and remaining maturities.

The carrying value and estimated fair value of certain of our financial instruments at March 31, 2010 and December 31, 2009 were as follows:

 
2010
  
2009
   
Estimated
    
Estimated
 
Carrying
Fair
  
Carrying
Fair
(Millions)
Value
Value
  
Value
Value
Assets:
          
    Mortgage loans
 $     1,556.0
 $     1,521.0
 
 $     1,594.0
 $     1,506.5
Liabilities:
          
    Investment contract liabilities:
          
      With a fixed maturity
 31.9
 33.0
  
 32.4
 33.5
      Without a fixed maturity
 525.0
 498.6
  
 530.6
 503.7
    Long-term debt
 3,639.8
 3,899.5
  
 3,639.5
 3,865.9

 
 
 
Page 14
 
 
 
Separate Accounts Measured at Fair Value in our Balance Sheets
Separate Account assets represent funds maintained to meet specific objectives of contract holders.  Since contract holders bear the investment risk of these assets, a corresponding Separate Account liability has been established equal to the assets.  These assets and liabilities are carried at fair value.  Net investment income and capital gains and losses accrue directly to such contract holders.  The assets of each account are legally segregated and are not subject to claims arising from our other businesses.  Deposits, withdrawals, net investment income and realized and unrealized capital gains and losses on Separate Account assets are not reflected in our statements of income, shareholders’ equity or cash flows.

Separate Account assets include debt and equity securities and derivative instruments.  The valuation methodologies used for these assets are similar to the methodologies described beginning on page 12.  Separate Account assets also include investments in common/collective trusts and real estate that are carried at fair value.  The following are descriptions of the valuation methodologies used to price these investments, including the general classification pursuant to the valuation hierarchy.

Common/Collective Trusts – Common trusts invest in other collective investment funds otherwise known as the underlying funds.  The Separate Accounts’ interests in the common trust funds are based on the fair values of the investments of the underlying funds and therefore are classified as Level 2.  The underlying assets primarily consist of foreign equity securities.  Investments in common trust funds are valued at their respective net asset value per share/unit on the valuation date.

Real Estate – The values of the underlying real estate investments are estimated using generally accepted valuation techniques and give consideration to the investment structure.  An appraisal of the underlying real estate for each of these investments is performed annually.  In the quarters in which an investment is not appraised or its valuation is not updated, fair value is based on available market information.  The valuation of a real estate investment is adjusted only if there has been a significant change in economic circumstances related to the investment since acquisition or the most recent independent valuation and upon the appraiser’s review and concurrence with the valuation.  Further, these valuations have be en prepared giving consideration to the income, cost and sales comparison approaches of estimating property value.  These valuations do not necessarily represent the prices at which the real estate investments would sell, since market prices of real estate investments can only be determined by negotiation between a willing buyer and seller.  Therefore, these investment values are classified as Level 3.

Separate Account financial assets at March 31, 2010 and December 31, 2009 were as follows:

 
March 31, 2010
  
December 31, 2009
(Millions)
Level 1
  
Level 2
  
Level 3
  
Total
  
Level 1
  
Level 2
  
Level 3
  
Total
  Debt securities
 $      937.0
  
 $    2,460.6
  
 $    101.1
  
 $    3,498.7
  
 $      752.3
  
 $    2,508.0
  
 $      97.3
  
 $    3,357.6
  Equity securities
 1,259.0
  
 .4
  
 - 
 
 1,259.4
  
 1,215.1
  
 .9
  
 - 
 
 1,216.0
  Derivatives
 - 
 
 1.1
  
 - 
   
 1.1
  
 - 
 
 1.2
  
 - 
 
 1.2
  Common/Collective trusts
 - 
 
 .1
  
 - 
 
 .1
  
 - 
 
 1,152.6
  
 - 
 
 1,152.6
  Real estate
 - 
 
 - 
 
 70.3
  
 70.3
  
 - 
   
 - 
 
 71.4
  
 71.4
Total (1)
 $   2,196.0
  
 $    2,462.2
  
 $    171.4
  
 $   4,829.6
  
 $   1,967.4
  
 $    3,662.7
  
 $    168.7
  
 $    5,798.8
(1)
Excludes $539.9 million and $484.3 million of cash and cash equivalents and other receivables at March 31, 2010 and December 31, 2009, respectively.


 
 
Page 15
 

The changes in the balances of Level 3 Separate Account financial assets for the three months ended March 31, 2010 and 2009 were as follows:

 
Three Months Ended
March 31, 2010
  
Three Months Ended
March 31, 2009
(Millions)
Debt Securities
  
Real Estate
  
Total
 
Debt Securities
  
Real Estate
  
Total
Beginning balance
 $     97.3
 
 $   71.4
 
 $   168.7
 
 $    365.1
 
 $    86.7
 
   $    451.8
Total gains (losses) accrued to contract holders
 (14.7)
  
 (1.1)
  
 (15.8)
  
 (77.0)
  
 (6.9)
  
 (83.9)
Purchases, sales and maturities
 18.9
 
 -  
  
 18.9
 
 32.3
    -    
 32.3
Transfers (out of) into Level 3 (1)
 (.4)
  
 -  
  
 (.4)
  
 5.0
 
 -  
  
 5.0
Ending Balance
 $   101.1
 
 $   70.3
 
 $   171.4
 
 $    325.4
 
 $    79.8
 
 $    405.2
(1)
At January 1, 2010, we changed our practice for reporting transfers into (out of) Level 3.  Effective January 1, 2010, we use the fair value of these assets at the end of the reporting period for all financial asset transfers.  Prior to January 1, 2010, for financial assets that were transferred into (out of) Level 3, we used the fair value of the assets at the end (beginning) of the reporting period.


8.
Defined Benefit Retirement Plans

Components of the net periodic benefit cost of our noncontributory defined benefit pension plans and other postretirement benefit (“OPEB”) plans for the three months ended March 31, 2010 and 2009 were as follows:

 
Pension Plans
  
OPEB Plans
(Millions)
2010
  
2009
  
2010
  
2009
Operating component:
              
   Service cost
 $   15.3
  
 $   12.0
  
 $     .1
  
 $      .1
   Amortization of prior service cost
 (.5)
  
 (.5)
  
 (.9)
  
 (1.0)
Total operating component (1)
 14.8
  
 11.5
  
 (.8)
  
 (.9)
               
Financing component:
              
   Interest cost
 76.6
  
 79.1
  
 4.5
  
 5.5
   Expected return on plan assets
 (88.3)
  
 (79.7)
  
 (.9)
 
 (1.0)
   Recognized net actuarial loss
 50.3
  
 54.1
  
 1.1
  
 .8
Total financing component (1)
 38.6
  
 53.5
  
 4.7
  
 5.3
               
Net periodic benefit cost
 $   53.4
  
 $   65.0
  
 $   3.9
  
 $    4.4
(1)
The operating component of this expense is allocated to our business segments and the financing component is allocated to our Corporate Financing segment.  Our Corporate Financing segment is not a business segment.  It is added to our business segments to reconcile to our consolidated results.  Refer to Note 13 beginning on page 19 for additional information on our business segments.


9.
Debt

The carrying value of our long-term debt at March 31, 2010 and December 31, 2009 was as follows:

 
March 31,
  
December 31,
(Millions)
 2010
  
 2009
Senior notes, 5.75%, due 2011
 $          449.9
  
 $          449.9
Senior notes, 7.875%, due 2011
 449.7
  
 449.5
Senior notes, 6.0%, due 2016
 747.2
  
 747.1
Senior notes, 6.5%, due 2018
 498.8
  
 498.8
Senior notes, 6.625%, due 2036
 798.6
  
 798.6
Senior notes, 6.75%, due 2037
 695.6
  
 695.6
Total long-term debt
 3,639.8
  
 3,639.5
Less current portion of long-term debt (1)
 449.7
  
  - 
Long-term debt, less current portion
 $       3,190.1
  
 $        3,639.5
(1)
At March 31, 2010, the 7.875% senior notes due March 2011 have been classified as current in the accompanying consolidated balance sheet at March 31, 2010.

 

 
Page 16
 
 
 
At March 31, 2010 and December 31, 2009, we had approximately $480 million and $481 million, respectively, of commercial paper outstanding with a weighted average interest rate of .32% and .38%, respectively.
 
At March 31, 2010, we had an unsecured $1.5 billion revolving credit agreement (the “Facility”) with several financial institutions which terminates in March 2013.  The Facility provides for the issuance of up to $200 million of letters of credit at our request, which count as usage of the available commitments under the Facility.  Upon our agreement with one or more financial institutions, we may expand the aggregate commitments under the Facility to a maximum of $2.0 billion. Various interest rate options are available under the Facility.  Any revolving borrowings mature on the termination date of the Facility.  We pay facility fees on the Facility ranging from .045% to .175% per annum, depending upon our long-term senior uns ecured debt rating.  The facility fee was .06% at March 31, 2010.  The Facility contains a financial covenant that requires us to maintain a ratio of total debt to consolidated capitalization as of the end of each fiscal quarter at or below .5 to 1.0.  For this purpose, consolidated capitalization equals total shareholders’ equity, excluding any overfunded or underfunded status of our pension and OPEB plans and any net unrealized capital gains and losses, and total debt (as defined in the Facility).  We met this requirement at March 31, 2010. There were no amounts outstanding under the Facility at March 31, 2010.

During 2010 and 2009, we entered into five interest rate swaps with a notional value of $100 million each.  We entered into these swaps to hedge interest rate exposure in anticipation of future issuance of long-term debt.  At March 31, 2010 and December 31, 2009, the interest rate swaps had an aggregate fair value of $34.6 million and $42.2 million, respectively.  We also recorded a $7.6 million unrealized capital loss and $3.5 million unrealized capital gain related to these interest rate swaps in other comprehensive income for the three months ended March 31, 2010 and 2009, respectively.

 
10.
Capital Stock

On February 27, 2009, our Board of Directors (the “Board”) authorized a share repurchase program for the repurchase of up to $750 million of our common stock.  During the three months ended March 31, 2010, we repurchased approximately 7 million shares of common stock at a cost of approximately $252 million (approximately $90 million of these repurchases were settled in early April).  At March 31, 2010, we had remaining authorization to repurchase an aggregate of up to approximately $339 million of common stock under the February 27, 2009 Board authorization.

On February 8, 2010, approximately .8 million performance stock units (“PSUs”), 1.6 million market stock units (“MSUs”) and 1.1 million restricted stock units (“RSUs”) were granted to certain employees.  The number of vested PSUs (which could range from zero to 200% of the original number of units granted) is dependent upon the degree to which we achieve performance goals during the performance period as determined by the Board’s Committee on Compensation and Organization. The performance period for the PSUs ends on December 31, 2010, and the vesting period ends on February 8, 2012.   The number of vested MSUs (which could range from zero to 150% of the original number of units granted) is based on the weighted average closing price of our common stock for the thirty tradi ng days prior to the vesting date.  The MSUs have a two-year vesting period.  For each vested RSU, employees receive one share of common stock, net of taxes, at the end of the vesting period.  The RSUs will become 100% vested approximately three years from the grant date, with one-third vesting each December.


11.
Dividend Restrictions and Statutory Surplus

Under regulatory requirements at March 31, 2010, the amount of dividends that may be paid to Aetna through the end of 2010 by our insurance and HMO subsidiaries without prior approval by regulatory authorities is approximately $1.1 billion in the aggregate.  There are no such restrictions on distributions from Aetna to its shareholders.

The combined statutory capital and surplus of our insurance and HMO subsidiaries was $7.0 billion and $6.8 billion at March 31, 2010 and December 31, 2009, respectively.

 

 
Page 17
 

 
12.
Commitments and Contingencies

Litigation and Regulatory Proceedings
Out-of-Network Benefit Proceedings
We are named as a defendant in several purported class actions and individual lawsuits arising out of our practices related to the payment of claims for services rendered to our members by health care providers with whom we do not have a contract (“out-of-network providers”).  Other major health insurers are also the subject of similar litigation or have settled similar litigation.  Among other things, these lawsuits allege that we paid too little to our health plan members and/or providers for these services, among other reasons, because of our use of data provided by Ingenix, Inc., a subsidiary of one of our competitors (“Ingenix”).

Various plaintiffs who are health care providers or medical associations seek to represent nationwide classes of out-of-network providers who provided services to our members during the period from 2001 to the present.  Various plaintiffs who are members in our health plans seek to represent nationwide classes of our members who received services from out-of-network providers during the period from 2001 to the present.  Taken together, these lawsuits allege that we violated state law, the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), the Racketeer Influenced and Corrupt Organizations Act and federal antitrust laws, either acting alone or in concert with our competitors.  The purported classes seek reimbursement of all unpaid benefits, recalculation and repayment of deducti ble and coinsurance amounts, unspecified damages and treble damages, statutory penalties, injunctive and declaratory relief, plus interest, costs and attorneys’ fees, and seek to disqualify us from acting as a fiduciary of any benefit plan that is subject to ERISA.  Individual lawsuits that generally contain similar allegations and seek similar relief have been brought by a health plan member and by out-of-network providers.

The first class action case was commenced on July 30, 2007.  The federal Judicial Panel on Multi-District Litigation (the “MDL Panel”) has consolidated these class action cases in federal district court in New Jersey under the caption In re: Aetna UCR Litigation, MDL No. 2020 (“MDL 2020”).   In addition, the MDL Panel has transferred the individual lawsuits to MDL 2020.  Discovery has commenced in MDL 2020, and the court has not set a trial date.  We intend to vigorously defend ourselves against the claims brought in these cases.

On January 15, 2009, Aetna and the New York Attorney General announced an agreement relating to an industry-wide investigation into certain payment practices with respect to out-of-network providers.  In October 2009, pursuant to that agreement, we contributed $20 million towards the establishment of an independent database system to provide fee information regarding out-of-network reimbursement rates.  When the new database is operational, we will cease using databases owned by Ingenix and will use the new database for a period of at least five years in connection with out-of-network reimbursements in those benefit plans that employ a reasonable and customary standard for out-of-network reimbursements.  During 2009, we also agreed to pay approximately $7.5 million in claims and administrative penalties in co nnection with our out-of-network benefit payment practices as a result of agreements with state attorneys general and a state insurance department.

We also have received subpoenas and/or requests for documents and other information from attorneys general and other state and/or federal regulators, legislators and agencies relating to our out-of-network benefit payment practices.  It is reasonably possible that others could initiate additional litigation or additional regulatory action against us with respect to our out-of-network benefit payment practices.

CMS Actions
In April 2010, CMS imposed intermediate sanctions on us suspending the enrollment of and marketing to new members of all Aetna Medicare Advantage and Standalone Prescription Drug Plan Contracts, effective April 21, 2010. The sanctions relate to compliance with certain Medicare Part D requirements, primarily those relating to changes in the drugs covered by certain plans from 2009 to 2010.  The suspension does not affect our current Medicare enrollees who stay in their existing plans.  Also in April 2010, CMS granted us a limited waiver of these sanctions to allow us to continue to enroll eligible members into existing, contracted group Aetna Medicare Advantage Plans and Standalone Prescription Drug Plans through July 21, 2010.
 
Securities Class Action Litigation
Two purported class action lawsuits were pending in the United States District Court for the Eastern District of Pennsylvania (the “Pennsylvania Federal Court”) against Aetna and certain of its current or former officers and/or directors.  On October 24, 2007, the Southeastern Pennsylvania Transportation Authority filed suit on behalf of all
 
 
 
 
Page 18
 
 
 
purchasers of Aetna common stock between October 27, 2005 and April 27, 2006.  The second lawsuit was filed on November 27, 2007, by the Plumbers and Pipefitters Local 51 Pension Fund on behalf of all purchasers of our common stock between July 28, 2005 and July 27, 2006.  On June 3, 2008, plaintiffs in these two lawsuits filed a consolidated complaint in the Pennsylvania Federal Court on behalf of all purchasers of our common stock between October 27, 2005 and July 27, 2006.  The consolidated complaint (the “Securities Class Action Litigation”) supersedes and replaces the two previous complaints.  The plaintiffs allege that Aetna and four of its current or former officers and/or directors, John W. Rowe, M.D., Ronald A. Williams, Alan M. Bennett and Craig R. Callen (collectively, the  220;Defendants”), violated federal securities laws. The plaintiffs allege misrepresentations and omissions regarding, among other things, our medical benefit ratios and health plan pricing practices, as well as insider trading by Dr. Rowe and Messrs. Bennett and Callen.  The plaintiffs seek compensatory damages plus interest and attorneys’ fees, among other remedies.  On June 9, 2009, the Pennsylvania Federal Court granted Aetna’s motion to dismiss the consolidated complaint.  On July 7, 2009, the plaintiffs filed a notice of appeal to the Pennsylvania Federal Court’s order dismissing the consolidated complaint.  On February 11, 2010, the Third Circuit Court of Appeals conducted oral arguments on the plaintiff's appeal.  The Defendants intend to vigorously defend themselves against the claims brought in the Securities Class Action Litigation.
 
Other Litigation and Regulatory Proceedings
We are involved in numerous other lawsuits arising, for the most part, in the ordinary course of our business operations, including employment litigation and claims of bad faith, medical malpractice, non-compliance with state and federal regulatory regimes, marketing misconduct, failure to timely or appropriately pay medical and/or group insurance claims (including post-payment audit and collection practices), rescission of insurance coverage, improper disclosure of personal information, patent infringement and other intellectual property litigation and other litigation in our Health Care and Group Insurance businesses. Some of these other lawsuits are or are purported to be class actions.  We intend to vigorously defend ourselves against the claims brought in these matters.
 
In addition, our current and past business practices are subject to audit and review by, and from time to time we receive subpoenas and other requests for information from, various state insurance and health care regulatory authorities and attorneys general, the Office of the Inspector General, and other state and federal authorities.  These audits, reviews, subpoenas, and other requests include inquiries by, and testimony before, certain members, committees and subcommittees of the U.S. Congress regarding certain of our business practices, including our overall claims processing and payment practices, our business practices with respect to our small business or individual customers (such as rating information, premium increases and medical benefit ratios), executive compensation matters and travel and entertainment expense s, in connection with their consideration of health care reform measures, as well as the investigations by, and subpoenas and requests from, attorneys general and others described above under “Out-of-Network Benefit Proceedings.”  There also continues to be heightened review by regulatory authorities of and increased litigation regarding the health care benefits industry’s business and reporting practices, including premium rate increases, utilization management, complaint and grievance processing, information privacy, provider network structure (including the use of performance-based networks), delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices and claim payment practices (including payments to out-of-network providers).  As a leading national health care benefits company, we regularly are the subject of such reviews.  These reviews may result, and have resul ted, in changes to or clarifications of our business practices, as well as fines, penalties or other sanctions, including the actions taken by CMS that are described above under “CMS Actions.”
 
We are unable to predict at this time the ultimate outcome of the matters described above, and it is reasonably possible that their outcome could be material to us.


13.
Segment Information

Our operations are conducted in three business segments:  Health Care, Group Insurance and Large Case Pensions.  Our Corporate Financing segment is not a business segment.  It is added to our business segments in order to reconcile to our consolidated results.  The Corporate Financing segment includes interest expense on our outstanding debt and the financing components of our pension and other post-retirement benefit plan expense (the service cost components of this expense are allocated to our business segments).
 
 
 
 
Page 19
 
 
 
Summarized financial information of our segments for the three months ended March 31, 2010 and 2009 was as follows:

 
Health
Group
Large Case
Corporate
Total
(Millions)
Care
Insurance
Pensions
Financing
Company
2010
          
Revenue from external customers
 $   7,765.4
 $   458.9
 $   45.3
 $       -  
 $   8,269.6
Operating earnings (loss) (1)
 460.1
 28.5
 9.7
 (67.7)
 430.6
2009
          
Revenue from external customers
 $   7,854.6
 $   463.1
 $   52.6
 $       -  
 $   8,370.3
Operating earnings (loss) (1)
 469.4
 42.1
 9.2
 (78.1)
 442.6
(1)
Operating earnings (loss) excludes net realized capital gains or losses and the other item described in the reconciliation below.

A reconciliation of operating earnings to net income for the three months ended March 31, 2010 and 2009 was as follows:

(Millions)
 2010
 2009
Operating earnings
 $   430.6
 $   442.6
Litigation-related insurance proceeds (1)
 45.5
 -  
Net realized capital gains (losses) (2)
 86.5
 (4.8)
Net income
 $   562.6
 $   437.8
(1)
In addition to net realized capital gains (losses) the following other item is excluded from first quarter 2010 operating earnings because we believe it neither relates to the ordinary course of our business nor reflects our underlying business performance:
 
· Following a Pennsylvania Supreme Court ruling in June 2009, we received $45.5 million ($70.0 million pretax) in April 2010 from one of our liability insurers related to certain litigation we settled in 2003.  We are continuing to litigate similar claims against certain of our other liability insurers.
  
(2)
At March 31, 2010, we released a $9.8 million valuation allowance previously established on our deferred tax assets related to realized capital gains (losses).
  

 
14.
Discontinued Products

Prior to 1993, we sold single-premium annuities (“SPAs”) and guaranteed investment contracts (“GICs”), primarily to employer sponsored pension plans.  In 1993, we discontinued selling these products, and now we refer to these products as discontinued products.

We discontinued selling these products because they were generating losses for us and we projected that they would continue to generate losses over their life (which is greater than 30 years); so we established a reserve for anticipated future losses at the time of discontinuance.  This reserve represents the present value (at the risk-free rate of return at the time of discontinuance, consistent with the duration of the liabilities) of the difference between the expected cash flows from the assets supporting these products and the cash flows expected to be required to meet the obligations of the outstanding contracts.  Because we projected anticipated cash shortfalls in our discontinued products, at the time of discontinuance we established a receivable from Large Case Pensions’ continuing products (which is e liminated in consolidation).

Key assumptions in setting this reserve include future investment results, payments to retirees, mortality and retirement rates and the cost of asset management and customer service.  In 1997, we began the use of a bond default assumption to reflect historical default experience.  In 1995, we modified the mortality tables used in order to reflect a more up-to-date 1994 Uninsured Pensioner’s Mortality table.  Other than these changes, since 1993 there have been no significant changes to the assumptions underlying the reserve.

We review the adequacy of this reserve quarterly based on actual experience.  As long as our expectation of future losses remains consistent with prior projections, the results of the discontinued products are applied to the reserve and do not affect net income.  However, if actual or expected future losses are greater than we currently estimate, we may have to increase the reserve, which could adversely impact net income.  If actual or expected future losses are less than we currently estimate, we may have to decrease the reserve, which could favorably impact net income.  The current reserve reflects management’s best estimate of anticipated future losses.  The reserve for anticipated future losses is included in future policy benefits on our balance sheet.
 
 
 
 
Page 20
 
 
 
The activity in the reserve for anticipated future losses on discontinued products for the three months ended March 31, 2010 and 2009 was as follows (pretax):

(Millions)
2010
  
2009
Reserve, beginning of period
 $    789.2
  
 $    790.4
Operating income (loss)
 3.0
  
 (13.9)
Net realized capital gains (losses)
 16.1
  
 (9.4)
Reserve, end of period
 $    808.3
  
 $    767.1

During the three months ended March 31, 2010, our discontinued products reflected operating income and net realized capital gains, both primarily attributable to the favorable investment conditions that existed from the latter half of 2009 through the first quarter of 2010.  We have evaluated the operating income in 2010 against our expectations of future cash flows assumed in estimating the reserve and do not believe an adjustment to the reserve is required at March 31, 2010.

Assets and liabilities supporting discontinued products at March 31, 2010 and December 31, 2009 were as follows: (1)

(Millions)
 2010
  
 2009
Assets:
      
   Debt and equity securities available for sale
 $     2,554.0
  
 $     2,507.7
   Mortgage loans
 528.7
  
 543.9
   Other investments
 652.0
  
 630.2
   Total investments
 3,734.7
  
 3,681.8
   Other assets
 75.0
  
 118.6
   Collateral received under securities loan agreements
 88.7
  
 33.4
   Current and deferred income taxes
 53.3
  
 51.5
   Receivable from continuing products (2)
 470.5
  
 463.4
Total assets
 $     4,422.2
  
 $     4,348.7
       
Liabilities:
      
   Future policy benefits
 $     3,256.8
  
 $     3,301.0
   Policyholders' funds
 11.7
  
 12.1
   Reserve for anticipated future losses on discontinued products
 808.3
  
 789.2
   Collateral payable under securities loan agreements
 88.7
  
 33.4
   Other liabilities (3)
 256.7
  
 213.0
Total liabilities
 $     4,422.2
  
 $     4,348.7
(1)
Assets supporting the discontinued products are distinguished from assets supporting continuing products.
(2)
(3)
The receivable from continuing products is eliminated in consolidation.
Net unrealized capital gains and losses on the available-for-sale debt securities are included in other liabilities and are not reflected in consolidated shareholders’ equity.

Distributions on discontinued products for the three months ended March 31, 2010 and 2009 were as follows:

(Millions)
 2010
 2009
Scheduled contract maturities, settlements and benefit payments
 $     107.2
 $      113.2
Participant-directed withdrawals
 -  
 -  

Cash required to fund these distributions was provided by earnings and scheduled payments on, and sales of, invested assets.
 


 
Page 21
 




 

 
 
Report of Independent Registered Public Accounting Firm
 

 
The Board of Directors and Shareholders
Aetna Inc.:
 
We have reviewed the consolidated balance sheet of Aetna Inc. and subsidiaries as of March 31, 2010, the related consolidated statements of income for the three-month periods ended March 31, 2010 and 2009, and the related consolidated statements of shareholders’ equity and cash flows for the three-month periods ended March 31, 2010 and 2009.  These consolidated financial statements are the responsibility of the Company’s management.
 
We conducted our review in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.
 
Based on our review, we are not aware of any material modifications that should be made to the consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.
 
We have previously audited, in accordance with standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of Aetna Inc. and subsidiaries as of December 31, 2009, and the related consolidated statements of income, shareholders’ equity and comprehensive income, and cash flows for the year then ended (not presented herein); and in our report dated February 26, 2010, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying consolidated balance sheet as of December 31, 2009, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.
 

  /s/ KPMG LLP

Hartford, Connecticut
 
April 29, 2010
 








 
Page 22
 

 
Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”)

OVERVIEW

We are one of the nation’s leading diversified health care benefits companies, serving approximately 36.1 million people with information and resources to help them make better informed decisions about their health care.  We offer a broad range of traditional and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities and health care management services for Medicaid plans.  Our customers include employer groups, individuals, college students, part-time and hourly workers, health plans, governmental units, government-sponsored plans, labor groups and expatriates.  Our operations are conducted in three business segments:  Health Care, Group Insurance and Large Case P ensions.

The following MD&A provides a review of our financial condition at March 31, 2010 and December 31, 2009 and results of operations for the three months ended March 31, 2010 and 2009.  This Overview should be read in conjunction with the entire MD&A, which contains detailed information that is important to understanding our results of operations and financial condition, the consolidated financial statements and other data presented in this Quarterly Report on Form 10-Q as well as the MD&A contained in our 2009 Annual Report on Form 10-K (the “2009 Annual Report”).  This Overview is qualified in its entirety by the full MD&A.

Summarized Results for the Three Months Ended March 31, 2010 and 2009:

(Millions)
 2010
 2009
Revenue:
    
   Health Care
 $    7,918.6
 $    7,946.5
   Group Insurance
 556.1
 531.2
   Large Case Pensions
 146.8
 137.0
Total revenue
 8,621.5
 8,614.7
Net income
 562.6
 437.8
Operating earnings: (1)
    
   Health Care
 460.1
 469.4
   Group Insurance
 28.5
 42.1
   Large Case Pensions
 9.7
 9.2
Cash flows from operations
 837.3
 826.3
(1)
Our discussion of operating results for our reportable business segments is based on operating earnings, which is a non-GAAP measure of net income (the term “GAAP” refers to U.S. generally accepted accounting principles).  Refer to Segment Results and Use of Non-GAAP Measures on page 25 for a discussion of non-GAAP measures.  Refer to pages 26, 29 and 30 for a reconciliation of operating earnings to net income for Health Care, Group Insurance and Large Case Pensions, respectively.

Our business segments’ operating earnings declined in 2010 compared to 2009, primarily due to lower underwriting margins in our Health Care and Group Insurance segments largely offset by favorable prior period reserve development in our Health Care Segment.

Underwriting margins in our Health Care segment reflect approximately $143 million of favorable development of prior period health care cost estimates in 2010 including approximately $92 million of favorable development in our Commercial products.  Excluding this reserve development, the Commercial underwriting margin was lower in 2010 than 2009 due to lower membership and higher per member health care costs.  In addition, our Group Insurance underwriting margins were lower in 2010 than 2009.

In our Health Care segment, we experienced lower Insured membership (where we assume all or a majority of the risk for medical and dental care costs) and slightly higher membership in our administrative services contract (“ASC”) (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) products.  At March 31, 2010, we served approximately 18.7 million medical members (consisting of approximately 32% Insured members and 68% ASC members), 14.0 million dental members and 10.4 million pharmacy members.  At March 31, 2009, we served approximately 19.1 million medical members (consisting of approximately 33% Insured members and 67% ASC members), 14.5 million dental members, and 11.2 million pharmacy members.
 
 
 
 
Page 23
 
 
 
We continued to generate strong cash flows from operations in 2010 and 2009, generating $901 million and $876 million of cash flows from operations in our Health Care and Group Insurance businesses during the three months ended March 31, 2010 and 2009, respectively.  These cash flows funded ordinary course operating activities and the repurchase of approximately 7 million and 10 million shares of our common stock under our share repurchase programs at a cost of approximately $252 million and $277 million for the three months ended March 31, 2010 and 2009, respectively.

Health Care Reform Legislation
In March 2010, President Obama signed into law the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, “Health Care Reform”) legislating broad-based changes to the U.S. health care system which will significantly affect the U.S. economy.  Health Care Reform will significantly impact our business operations and financial results, including our medical benefit ratios.  Components of the legislation will be phased in over the next eight years.  We will be required to dedicate material resources and incur material expenses during that time to implement Health Care Reform.  Many significant parts of the legislation require further guidance and clarification in the form of regulations.  As a result, many of the impact s of Health Care Reform will not be known until those regulations are enacted, which we expect to occur over the next several years.

The expansion of health care coverage contemplated in Health Care Reform will be funded in part by material additional fees and taxes on us and other health insurers and health plans and reductions to the reimbursements we are paid by the government for our Medicare members, among other sources.  While not all-inclusive, we are evaluating the impact of the following key provisions of Health Care Reform to determine the impact that Health Care Reform will have on our business operations and financial results:

·  
Requirements beginning in 2010 for health plans to submit and justify rates, provide dependent coverage up to age 26 and eliminate lifetime maximums on the dollar value of coverage.
·  
Requirement for minimum medical benefit ratios of 85% for the large group market and 80% for the individual and small group markets beginning in 2011, with rebates issued to our enrollees for the amount under the minimum.
·  
Freezing 2011 Medicare Advantage payment rates to us based on 2010 levels, with additional reductions over a multi-year period beginning in 2012 based on regionally-adjusted benchmarks.
·  
Significant annual taxes on health insurance providers beginning in 2014.
·  
Multiple insurance reforms beginning in 2014, including rating limits and benefit requirements, guaranteed issue and renewability.
·  
Establishment of a health insurance exchange for the individual and small group markets by 2014.
·  
Expansion of state-based Medicaid coverages beginning in 2014.
·  
Establishment of individual and employer mandates for insurance coverage beginning in 2014.
·  
Significant excise taxes on employer-sponsored health benefits above a certain threshold beginning in 2018.

Health Care Reform presents us with new business opportunities and new financial and other challenges.  At this time, the impact of Health Care Reform on our business is uncertain because, among other things, additional regulations will need to be enacted in order to clarify significant parts of the legislation; however, it is reasonably possible that Health Care Reform, in the aggregate, could have a material adverse effect on our business operations and financial results.  For additional information on health care reform, refer to Regulatory Environment beginning on page 35 and Forward-Looking Information/Risk Factors beginning on page 37.

TRICARE Managed Care Support Contract
In July 2009, we were awarded the TRICARE managed care support contract for the North Region by the United States Department of Defense.  Under this administrative services contract, which was to commence in 2010, we were to support health care delivery to approximately 2.8 million eligible beneficiaries who are active duty service members, retirees, and family members based in the 21 states of TRICARE’s North Region.  The contract consists of five one-year option periods.
 
 
 
 
Page 24
 
 
 
The contract award was protested by an unsuccessful bidder. The United States Government Accountability Office (the “GAO”) sustained the protest in November 2009.  Based upon procurement protocol, the United States Department of Defense will review the recommendations issued by the GAO and determine how to proceed with the procurement.  We cannot predict how the United States Department of Defense will implement the GAO’s recommendations or their timing.  The United States Department of Defense has notified us that the incumbent’s contract has been extended through March 31, 2011 to ensure continuity of beneficiary care while the protest process continues.

Segment Results and Use of Non-GAAP Measures in this Document
The discussion of our results of operations that follows is presented based on our reportable segments in accordance with the accounting guidance for segment reporting and consistent with our segment disclosure included in Note 13 of Condensed Notes to Consolidated Financial Statements beginning on page 19.  Each segment’s discussion of results is based on operating earnings.  Our operations are conducted in three business segments:  Health Care, Group Insurance and Large Case Pensions.  Our Corporate Financing segment is not a business segment.  It is added to our business segments to reconcile our consolidated results.  The Corporate Financing segment includes interest expense for our outstanding debt and the financing components of our pension and other post-retirement b enefit plans (“OPEB”) expense (the service cost and prior service cost components of this expense are allocated to our business segments).

Our discussion of the results of operations of each business segment is based on operating earnings, which is the measure reported to our Chief Executive Officer for purposes of assessing the segment’s financial performance and making operating decisions, such as allocating resources to the segment.  Operating earnings exclude net realized capital gains and losses as well as other items, if any, from net income reported in accordance with GAAP.  We believe excluding realized capital gains and losses from net income to arrive at operating earnings provides more meaningful information about our underlying business performance.  Net realized capital gains and losses arise from various types of transactions, primarily in the course of managing a portfolio of assets that support the payment of liabilities; h owever, these transactions do not directly relate to the underwriting or servicing of products for our customers and are not directly related to the core performance of our business operations.  We also may exclude other items that do not relate to the ordinary course of our business from net income to arrive at operating earnings.  In each segment discussion in this MD&A, we present a table that reconciles operating earnings to net income reported in accordance with GAAP.  Each table details the net realized capital gains and losses and any other items excluded from net income, and the footnotes to each table describe the nature of each other item and why we believe it is appropriate to exclude that item from net income.

HEALTH CARE

Health Care consists of medical, pharmacy benefits management, dental, behavioral health and vision plans offered on both an Insured basis and an ASC basis.  Medical products include point-of-service (“POS”), preferred provider organization (“PPO”), health maintenance organization (“HMO”) and indemnity benefit plans.  Medical products also include health savings accounts and Aetna HealthFund®, consumer-directed health plans that combine traditional POS or PPO and/or dental coverage, subject to a deductible, with an accumulating benefit account.  We also offer Medicare and Medicaid products and services, as well as specialty products, such as medical management and data analytics services, stop loss insurance, and products that provide access to our provider network in select markets.  We separately track premiums and health care costs for Medicare and Medicaid products; all other medical, dental and other insured products are referred to as Commercial.
 


 
Page 25
 
 

 
Operating Summary for the Three Months Ended March 31, 2010 and 2009:

(Millions)
 2010
  
 2009
Premiums:
      
   Commerical
 $      5,143.4
  
 $      5,322.0
   Medicare
 1,519.3
  
 1,461.1
   Medicaid
 232.4
  
 209.1
Total premiums
 6,895.1
  
 6,992.2
Fees and other revenue
 870.3
  
 862.4
Net investment income
 107.8
  
 97.7
Net realized capital gains (losses)
 45.4
  
 (5.8)
   Total revenue
 7,918.6
  
 7,946.5
Health care costs
 5,691.0
  
 5,804.2
Operating expenses:
      
   Selling expenses
 298.2
  
 299.1
   General and administrative expenses
 1,083.4
  
 1,101.7
Total operating expenses
 1,381.6
  
 1,400.8
Amortization of other acquired intangible assets
 22.7
  
 22.8
   Total benefits and expenses
 7,095.3
  
 7,227.8
Income before income taxes
 823.3
  
 718.7
Income taxes
 261.4
  
 255.1
Net income
 $         561.9
  
 $         463.6


The table presented below reconciles net income, in accordance with GAAP, to operating earnings for the three months ended March 31, 2010 and 2009:

(Millions)
 2010
  
 2009
Net income
 $    561.9
  
 $    463.6
Litigation-related insurance proceeds (1)
 (45.5)
  
 -  
Net realized capital (gains) losses (2)
 (56.3)
  
 5.8
Operating earnings
 $    460.1
  
 $    469.4
(1)
In addition to net realized capital gains (losses), the following other item is excluded from first quarter 2010 operating earnings because we believe it neither relates to the ordinary course of our business nor reflects our underlying business performance:
 
· Following a Pennsylvania Supreme Court ruling in June 2009, we received $45.5 million ($70.0 million pretax) in April 2010 from one of our liability insurers related to certain litigation we settled in 2003.  We are continuing to litigate similar claims against certain of our other liability insurers.
(2)
At March 31, 2010, we released a $10.9 million valuation allowance previously established on our deferred tax assets related to realized capital gains (losses).

Operating earnings for the three months ended March 31, 2010 decreased marginally when compared to the corresponding period in 2009, primarily due to lower Commercial underwriting margins and lower Insured membership largely offset by favorable development of prior period health care cost estimates.

We calculate our medical benefit ratio (“MBR”) by dividing health care costs by premiums.  For the three months ended March 31, 2010 and 2009, our MBRs by product were as follows:

 
2010
  
2009
Commercial
81.1%
  
81.7%
Medicare
87.0%
  
86.8%
Medicaid
85.9%
  
90.7%
Total
82.5%
  
83.0%

Refer to our discussion of Commercial and Medicare results that follows for an explanation of the changes in our MBR.
 
 

 
Page 26
 
 

 
The operating results of our Commercial products reflect lower underwriting margins in the three months ended March 31, 2010 and lower membership.
Commercial premiums decreased approximately $179 million for the three months ended March 31, 2010, when compared to the corresponding period in 2009, reflecting a decline in Insured membership levels in 2010 partially offset by higher premium rates.

Our Commercial MBR for the first quarter of 2010 was 81.1%, compared to 81.7% for the corresponding period in 2009.  Included in these amounts were approximately $92 million of favorable and $38 million of unfavorable development of prior period health care cost estimates for the three months ended March 31, 2010 and 2009, respectively.   The 2010 development was primarily due to lower-than-expected flu costs in the fourth quarter of 2009 and a lower-than-projected medical cost trend for the month of December 2009 and the partial release of a previously disclosed provision for certain provider costs related to prior years.  The 2009 development was driven by unusually high paid claims activity in the first quarter of 2009.  Excluding this development, the Commercial MBR was higher in 2010 than 2009, reflecting a percentage increase in per member health care costs that exceeded the percentage increase in per member premiums.  The higher per member health care costs were attributable to higher flu and Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) participation in 2010.  Refer to Critical Accounting Estimates – Health Care Costs Payable in our 2009 Annual Report for a discussion of Health Care Costs Payable at December 31, 2009.

Medicare results for the first quarter 2010 reflect growth from the corresponding period in 2009.
Medicare premiums increased approximately $58 million for the three months ended March 31, 2010, compared to the corresponding period in 2009.  This increase is primarily a reflection of the increase in Medicare membership in 2010.

Our Medicare MBR for the first quarter of 2010 was 87.0%, compared to 86.8% for the corresponding period in 2009.  For the three months ended March 31, 2010, we had approximately $38 million of favorable development of prior period Medicare health care cost estimates.  For the three months ended March 31, 2009, we had a small amount of unfavorable development of prior period health care cost estimates.  Excluding this development, the Medicare MBR for the three months ended March 31, 2010 was higher than the corresponding period in 2009, reflecting a percentage increase in per member health care costs that outpaced the percentage increase in per member premiums.

Other Sources of Revenue
Net realized capital gains (losses) for 2010 increased by approximately $51 million when compared to the corresponding period in 2009.  This increase primarily reflects net gains from the sales of debt securities and lower impairments of invested assets.
 
 

 
Page 27
 
 

 
Membership
Health Care’s membership at March 31, 2010 and 2009 was as follows:

 
2010
  
2009
(Thousands)
Insured
ASC
Total
  
Insured
ASC
Total
Medical:
              
   Commercial
 5,198
 11,978
 17,176
  
 5,656
 12,060
 17,716
   Medicare
 451
 - 
 451
  
 419
 - 
 419
   Medicaid
 315
 746
 1,061
  
 284
 647
 931
Total Medical Membership
 5,964
 12,724
 18,688
  
 6,359
 12,707
 19,066
               
Consumer-Directed Health Plans (1)
    
 2,206
      
 1,795
               
Dental:
              
   Commercial
 5,042
 7,339
 12,381
  
 5,214
 7,640
 12,854
   Medicare and Medicaid
 137
 435
 572
  
 245
 381
 626
   Network Access  (2)
 - 
 1,000
 1,000
  
 - 
 1,056
 1,056
Total Dental Membership
 5,179
 8,774
 13,953
  
 5,459
 9,077
 14,536
               
Pharmacy:
              
   Commercial
    
 8,921
      
 9,997
   Medicare PDP (stand-alone)
    
 601
      
 322
   Medicare Advantage PDP
    
 233
      
 223
   Medicaid
    
 30
      
 26
Total Pharmacy Benefit Management Services
    
 9,785
      
 10,568
   Mail Order (3)
    
 625
      
 672
Total Pharmacy Membership
    
 10,410
      
 11,240
(1)
Represents members in consumer-directed health plans who also are included in Commercial medical membership above.
(2)
Represents members in products that allow these members access to our dental provider network for a nominal fee.
(3)
Represents members who purchased medications through our mail order pharmacy operations during the first quarter of 2010 and 2009, respectively, and are included in pharmacy membership above.

Total medical membership at March 31, 2010 decreased compared to March 31, 2009, reflecting a reduction in Commercial membership due primarily to lapsed customers that was partially offset by growth in Medicare and Medicaid membership.

Total dental membership decreased in 2010 primarily due to lapses exceeding new sales and membership declines from existing customers.

Total pharmacy membership decreased in 2010 compared to 2009 primarily due to lower cross-selling of our Commercial pharmacy benefit management services, partially offset by growth in Medicare PDP membership.


GROUP INSURANCE

Group Insurance primarily includes group life insurance products offered on an Insured basis, including basic and supplemental group term life insurance, group universal life, supplemental or voluntary programs, and accidental death and dismemberment coverage.  Group Insurance also includes (i) group disability products offered to employers on both an Insured and an ASC basis, which consist primarily of short-term and long-term disability insurance (and products which combine both), (ii) absence management services offered to employers, which include short-term and long-term disability administration and leave management, and (iii) long-term care products that were offered primarily on an Insured basis, which provide benefits covering the cost of care in private home settings, adult day care, assisted living or nursing facili ties.  We no longer solicit or accept new long-term care customers, and we are working with our customers on an orderly transition of this product to other carriers.
 


 
Page 28
 
 

 
Operating Summary for the Three Months Ended March 31, 2010 and 2009:

(Millions)
 2010
  
 2009
Premiums:
      
  Life
 $     278.9
  
 $     276.8
  Disability
 139.2
  
 140.4
  Long-term care
 14.0
  
 18.2
Total premiums
 432.1
  
 435.4
Fees and other revenue
 26.8
  
 27.7
Net investment income
 71.0
  
 64.1
Net realized capital gains
 26.2
  
 4.0
    Total revenue
 556.1
  
 531.2
Current and future benefits
 399.5
  
 375.6
Operating expenses:
      
  Selling expenses
 23.3
  
 23.4
  General and administrative expenses
 67.2
  
 68.4
Total operating expenses
 90.5
  
 91.8
Amortization of other acquired intangible assets
 1.7
  
 1.7
    Total benefits and expenses
 491.7
  
 469.1
Income before income taxes
 64.4
  
 62.1
Income taxes
 11.0
  
 16.0
Net income
 $      53.4
  
 $       46.1

The table presented below reconciles net income, in accordance with GAAP, to operating earnings for the three months ended March 31, 2010 and 2009:

(Millions)
 2010
 2009
Net income
 $     53.4
 $     46.1
Net realized capital gains
 (24.9)
 (4.0)
Operating earnings
 $     28.5
 $     42.1


Operating earnings decreased in the three months ended March 31, 2010 compared to the corresponding period in 2009, primarily due to lower gains on long-term care reserve transfers and unfavorable group life claim experience, partially offset by higher net investment income.

The group benefit ratio was 92.5% for the three months ended March 31, 2010, compared to 86.3% for the corresponding period in 2009.  The increase in the group benefit ratio for the three months ended March 31, 2010 compared to the corresponding period in 2009 was primarily due to the lower long-term care transfer gains and the unfavorable life experience in 2010.

Net realized capital gains for 2010 increased by approximately $22 million when compared to the corresponding period in 2009.  This increase primarily reflects net gains from the sales of debt securities.
 
 
LARGE CASE PENSIONS

Large Case Pensions manages a variety of retirement products (including pension and annuity products) primarily for tax qualified pension plans.  These products provide a variety of funding and benefit payment distribution options and other services.  The Large Case Pensions segment includes certain discontinued products.
 


 
Page 29
 
 

 
Operating Summary for the Three Months Ended March 31, 2010 and 2009:

(Millions)
 2010
 2009
Premiums
 $    42.6
 $    49.7
Net investment income
 96.4
 87.4
Other revenue
 2.7
 2.9
Net realized capital gains (losses)
 5.1
 (3.0)
  Total revenue
 146.8
 137.0
Current and future benefits
 127.5
 127.7
General and administrative expenses
 1.8
 .9
  Total benefits and expenses
 129.3
 128.6
Income before income taxes
 17.5
 8.4
Income taxes
 2.5
 2.2
Net income
 $    15.0
 $     6.2


The table presented below reconciles net income, in accordance with GAAP, to operating earnings for the three months ended March 31, 2010 and 2009:

(Millions)
 2010
 2009
Net income
 $   15.0
 $    6.2
Net realized capital (gains) losses (1)
 (5.3)
 3.0
Operating earnings
 $     9.7
 $    9.2
(1)
At March 31, 2010, we released a $.2 million valuation allowance previously established on our deferred tax assets related to realized capital gains (losses).

Discontinued Products
Prior to 1993, we sold single-premium annuities (“SPAs”) and guaranteed investment contracts (“GICs”), primarily to employer sponsored pension plans.  In 1993, we discontinued selling these products, and now we refer to these products as discontinued products.

We discontinued selling these products because they were generating losses for us, and we projected that they would continue to generate future losses over their life (which is greater than 30 years); so we established a reserve for anticipated future losses at the time of discontinuance.  We provide additional information on this reserve, including key assumptions and other important information, in Note 14 of Condensed Notes to Consolidated Financial Statements beginning on page 20.  Please refer to this note for additional information.

The operating summary for Large Case Pensions above includes revenues and expenses related to our discontinued products, with the exception of net realized capital gains and losses which are recorded as part of current and future benefits.  Since we established a reserve for future losses on discontinued products, as long as our expected future losses remain consistent with prior projections, the operating results of our discontinued products are applied against the reserve and do not impact operating earnings or net income for Large Case Pensions.  However, if actual or expected future losses are greater than we currently estimate, we may have to increase the reserve, which could adversely impact net income.  If actual or expected future losses are less than we currently estimate, we may have to decrease the reserve, which could favorably impact net income.  In those cases, we disclose such adjustment separately in the operating summary. Management reviews the adequacy of the discontinued products reserve quarterly.  The current reserve reflects management's best estimate of anticipated future losses.
 
 

 
Page 30
 


The activity in the reserve for anticipated future losses on discontinued products for the three months ended March 31, 2010 and 2009 was as follows (pretax):

(Millions)
2010
2009
Reserve, beginning of period
 $    789.2
 $    790.4
Operating income (loss)
 3.0
(13.9)
Net realized capital gains (losses)
 16.1
(9.4)
Reserve, end of period
 $    808.3
 $    767.1

During the three months ended March 31, 2010, our discontinued products reflected operating income and net realized capital gains, both primarily attributable to the favorable investment conditions that existed from the latter half of 2009 through the first quarter of 2010.  We have evaluated the operating income in 2010 against our expectations of future cash flows assumed in estimating the reserve and do not believe an adjustment to the reserve is required at March 31, 2010.

Assets Managed by Large Case Pensions
At March 31, 2010 and 2009, Large Case Pensions assets under management consisted of the following:

(Millions)
  
2010
2009
Assets under management: (1)
      
   Fully-guaranteed discontinued products
  
 $     3,645.8
 $     3,694.4
   Experience-rated
  
 4,088.1
 4,239.8
   Non-guaranteed
  
 2,611.5
 2,514.7
   Total assets under management
  
 $   10,345.4
 $   10,448.9
(1)
Excludes net unrealized capital gains (losses) of $252.4 million and $(266.7) million at March 31, 2010 and 2009, respectively.

Assets supporting experience-rated products (where the contract holder, not us, assumes investment and other risks subject to, among other things, certain minimum guarantees) may be subject to contract holder or participant withdrawals.  Experience-rated contract holder and participant withdrawals for the three months ended March 31, 2010 and 2009 were as follows:

(Millions)
 2010
 2009
Scheduled contract maturities and benefit payments (1)
 $    65.6
 $    66.8
Contract holder withdrawals other than scheduled contract maturities and benefit payments
 3.2
 .4
Participant-directed withdrawals
 .5
 .9
(1)
Includes payments made upon contract maturity and other amounts distributed in accordance with contract schedules.


INVESTMENTS

At March 31, 2010 and December 31, 2009 our investment portfolio consisted of the following:

 
March 31,
December 31,
(Millions)
 2010
 2009
Debt and equity securities available for sale
 $    17,848.8
 $    17,159.7
Mortgage loans
 1,556.0
 1,594.0
Other investments
 1,256.6
 1,220.1
Total investments
 $    20,661.4
 $    19,973.8


The risks associated with investments supporting experience-rated pension and annuity products in our Large Case Pensions business are assumed by the contract holders and not by us (subject to, among other things, certain minimum guarantees).  Anticipated future losses associated with investments supporting discontinued fully-guaranteed Large Case Pensions products are provided for in the reserve for anticipated future losses on discontinued products.
 
 
 
 
Page 31
 
 
 
As a result of the foregoing, investment risks associated with our experience-rated and discontinued products generally do not impact our results of operations.  Our total investments supported the following products at March 31, 2010 and December 31, 2009:

 
March 31,
December 31,
(Millions)
 2010
 2009
Supporting experience-rated products
 $      1,707.2
 $     1,681.1
Supporting discontinued products
 3,734.7
 3,681.8
Supporting remaining products
 15,219.5
 14,610.9
Total investments
 $    20,661.4
 $   19,973.8


Debt and Equity Securities
The debt securities in our portfolio had an average credit quality rating of A+ at both March 31, 2010 and December 31, 2009, with approximately $5.2 billion and $4.9 billion, respectively, rated AAA.  Total debt securities that were rated below investment grade (that is, having a quality rating below BBB-/Baa3) were $1.3 billion at both March 31, 2010 and December 31, 2009 (of which 15%, in both periods, supported our discontinued and experience-rated products).

At March 31, 2010 and December 31, 2009, we held approximately $806 million and $486 million, respectively, of municipal debt securities and $29 million and $34 million, respectively, of structured product debt securities that were guaranteed by third parties, collectively representing approximately 4% and 3%, respectively, of our total investments.  These securities had an average credit quality rating of A+ at both March 31, 2010 and December 31, 2009 with the guarantee.  Without the guarantee, the average credit quality rating of the municipal debt securities was A and A+ on each respective date.  The structured product debt securities are not rated by the rating agencies on a standalone basis.  We do not have any significant concentration of investments with third party guarantors (either direct or indirect).

We classify our debt and equity securities as available for sale, carrying them at fair value on our balance sheet.  Approximately 3% of our debt and equity securities at both March 31, 2010 and December 31, 2009 were valued using inputs that reflect our own assumptions (categorized as Level 3 inputs in accordance with GAAP).  Refer to Note 7 of Condensed Notes to Consolidated Financial Statements beginning on page 11 for additional information on the methodologies and key assumptions we use to determine the fair value of investments.

At March 31, 2010 and December 31, 2009, our debt and equity securities had net unrealized capital gains of $843 million and $717 million, respectively, of which $254 million and $207 million, respectively, related to our experience-rated and discontinued products.

Refer to Note 5 of Condensed Notes to Consolidated Financial Statements beginning on page 7 for details of net unrealized capital gains and losses by major security type, as well as details on our debt securities with unrealized capital losses at March 31, 2010 and December 31, 2009.  We regularly review our debt securities to determine if a decline in fair value below the carrying value is other-than-temporary.  If we determine a decline in fair value is other-than-temporary, the carrying value of the security is written down.  The amount of the credit-related impairment is included in our results of operations and the non-credit component is included in other comprehensive income if we do not intend to sell the security.  Accounting for other-than-temporary impairments ("OTTI") of our debt securit ies is considered a critical accounting estimate.  Refer to Critical Accounting Estimates - Other-Than-Temporary Impairment of Debt Securities in our 2009 Annual Report for more information.  

Net Realized Capital Gains and Losses
For the three months ended March 31, 2010, net realized capital gains were $77 million ($87 million after tax) compared to net realized capital losses of $5 million ($5 million after tax) for the corresponding period in 2009.  Included in these amounts were $14 million and $43 million of OTTI losses on debt and equity securities for the three months ended March 31, 2010 and 2009, respectively. There were no significant investment write-downs from other-than-temporary impairments during the first quarter of 2010 or 2009.  We had no individually material realized losses on debt or equity securities that materially impacted our results of operations during the three months ended March 31, 2010 or 2009.
 
 
 
 
Page 32
 
 
 
The decrease in OTTI recognized in earnings in 2010 compared to 2009 was primarily related to a change in the accounting guidance for the recognition of OTTI of debt securities.  Prior to the adoption of new accounting guidance for OTTI of debt securities on April 1, 2009, both yield- and credit-related OTTI were recognized in earnings if we could not assert our intention to hold the security until recovery.  In contrast, after April 1, 2009, only credit-related impairments are recognized in earnings unless we have the intention to sell the security in an unrealized capital loss position, in which case the yield-related OTTI is also recognized in earnings.  Refer to Note 2 of Condensed Notes to Consolidated Financial Statements beginning on page 5 and Critical Accounting Estimates - Other-Than-Temporary Impai rment of Debt Securities in our 2009 Annual Report for more information.  

Mortgage Loans
Our mortgage loan portfolio (which is secured by commercial real estate) represented 8% of our total invested assets at both March 31, 2010 and December 31, 2009.  At March 31, 2010, approximately 99% of our mortgage loans continued to be performing assets. In accordance with our accounting policies, there were no material impairment reserves on these loans at March 31, 2010 or December 31, 2009.

Risk Management and Market-Sensitive Instruments
We manage interest rate risk by seeking to maintain a tight match between the durations of our assets and liabilities where appropriate.  We manage credit risk by seeking to maintain high average quality ratings and diversified sector exposure within our debt securities portfolio.  In connection with our investment and risk management objectives, we also use derivative financial instruments whose market value is at least partially determined by, among other things, levels of or changes in interest rates (short-term or long-term), duration, prepayment rates, equity markets or credit ratings/spreads.  Our use of these derivatives is generally limited to hedging purposes and has principally consisted of using interest rate swap agreements, warrants, forward contracts, futures contracts and credit default swap s.  These instruments, viewed separately, subject us to varying degrees of interest rate, equity price and credit risk.  However, when used for hedging, we expect these instruments to reduce overall risk.

We regularly evaluate our risk from market-sensitive instruments by examining, among other things, levels of or changes in interest rates (short-term or long-term), duration, prepayment rates, equity markets or credit ratings/ spreads.  We also regularly evaluate the appropriateness of investments relative to our management-approved investment guidelines (and operate within those guidelines) and the business objectives of our portfolios.

On a quarterly basis, we review the impact of hypothetical net losses in our investment portfolio to our consolidated near-term financial position, results of operations and cash flows assuming the occurrence of certain reasonably possible changes in near-term market rates and prices.  Based on our overall exposure to interest rate risk and equity price risk, we believe that these changes in market rates and prices would not materially affect our consolidated near-term financial position, results of operations or cash flows at March 31, 2010.  Refer to the MD&A in our 2009 Annual Report for a more complete discussion of risk management and market-sensitive instruments.

LIQUIDITY AND CAPITAL RESOURCES

Cash Flows
Generally, we meet our operating cash requirements by maintaining appropriate levels of liquidity in our investment portfolio and using overall cash flows from premiums, deposits and income received on investments.  We monitor the duration of our portfolio of debt securities (which is highly marketable) and mortgage loans, and execute purchases and sales of these investments with the objective of having adequate funds available to satisfy our maturing liabilities.  Overall cash flows are used primarily for claim and benefit payments, contract withdrawals, operating expenses and share repurchases.
 
 

 
Page 33
 

Presented below is a condensed statement of cash flows for the three months ended March 31, 2010 and 2009.  We present net cash flows used for operating activities and net cash flows provided by investing activities separately for our Large Case Pensions segment because changes in the insurance reserves for the Large Case Pensions segment (which are reported as cash used for operating activities) are funded from the sale of investments (which are reported as cash provided by investing activities).  Refer to the Consolidated Statements of Cash Flows on page 4 for additional information.

(Millions)
  
2010
2009
Cash flows from operating activities
      
Health Care and Group Insurance (including Corporate Financing)
  
 $      901.1
 $     875.7
Large Case Pensions
  
 (63.8)
 (49.4)
Net cash provided by operating activities
  
 837.3
 826.3
       
Cash flows from investing activities
      
Health Care and Group Insurance
  
 (364.3)
 (180.3)
Large Case Pensions
  
 65.5
 295.1
Net cash (used for) provided by investing activities
  
 (298.8)
 114.8
       
Net cash used for financing activities
  
 (171.7)
 (373.3)
Net increase in cash and cash equivalents
  
 $     366.8
 $     567.8


Cash Flow Analysis
Cash flows provided by operating activities for Health Care and Group Insurance were approximately $901 million in the three months ended March 31, 2010 and $876 million in the three months ended March 31, 2009.

We repurchased approximately 7 million shares of common stock at a cost of approximately $252 million during the three months ended March 31, 2010 and 10 million shares of common stock at a cost of approximately $277 million during the three months ended March 31, 2009.  At March 31, 2010, the capacity remaining under our share repurchase program was approximately $339 million.  Refer to Note 10 of Condensed Notes to Consolidated Financial Statements on page 17 for more information.

Other Liquidity Information
While our Board reviews our common stock dividend annually, we currently intend to maintain an annual dividend of $.04 per common share.  Among the factors considered by our Board in determining the amount of each dividend are our results of operations and the capital requirements, growth and other characteristics of our businesses.

We use short-term commercial paper borrowings from time to time to address timing differences between cash receipts and disbursements.  The maximum amount of commercial paper borrowings outstanding during the three months ended March 31, 2010 was $575 million.

Our committed short-term borrowing capacity consists of a $1.5 billion revolving credit facility which terminates in March 2013 (the “Facility”).  The Facility also provides for the issuance of letters of credit at our request, up to $200 million, which count as usage of the available commitments under the Facility.  The Facility permits the aggregate commitments under the Facility to be expanded to a maximum of $2.0 billion upon our agreement with one or more financial institutions.  There were no amounts outstanding under the Facility at any time during the period ending March 31, 2010.

Our total debt to capital ratio (total debt divided by shareholders’ equity plus total debt) was approximately 29% at March 31, 2010.  We continually monitor existing and alternative financing sources to support our capital and liquidity needs, including, but not limited to, debt issuance, preferred or common stock issuance and pledging or selling of assets.

Interest expense was $61 million for the three months ended March 31, 2010, compared to $62 million for the corresponding period in 2009.

Refer to Note 9 of Condensed Notes to Consolidated Financial Statements beginning on page 16 for additional information on our short-term and long-term debt.
 
 
 
 
Page 34
 
 
 
Other Common Stock Transactions
On February 8, 2010, approximately .8 million performance stock units ("PSUs"), 1.6 million market stock units ("MSUs") and 1.1 million restricted stock units ("RSUs") were granted to certain employees.  Refer to Note 10 of Condensed Notes to Consolidated Financial Statements on page 17 for additional information.

Ratings
At April 28, 2010, the ratings of Aetna Inc. and Aetna Life Insurance Company (“ALIC”) from the respective nationally recognized statistical rating organizations were as follows:

     
Moody's Investors
Standard
 
A.M. Best
Fitch
Service
& Poor's
Aetna Inc. (senior debt) (1)
bbb+
A-
A3
A-
         
Aetna Inc. (commercial paper)
AMB-2
F1
P-2
A-2
         
ALIC (financial strength) (1)
A
AA-
Aa3
A+
(1)
Aetna’s senior debt and ALIC’s financial strength have a stable outlook from A.M. Best and a negative outlook from Fitch and Standard & Poor’s.  Moody’s Investors Service has Aetna’s senior debt and ALIC’s financial strength ratings under review for possible downgrade.


CRITICAL ACCOUNTING ESTIMATES

Refer to Critical Accounting Estimates in our 2009 Annual Report for information on accounting policies that we consider critical in preparing our Consolidated Financial Statements.  These policies include significant estimates we make using information available at the time the estimates are made.  However, these estimates could change materially if different information or assumptions were used.


REGULATORY ENVIRONMENT

In March 2010, President Obama signed into law the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively “Health Care Reform”) legislating broad-based changes to the U.S. health care system which will significantly affect the U.S. economy.   Health Care Reform will significantly impact our business operations and financial results, including our medical benefit ratios.  Components of the legislation will be phased in over the next eight years.  We will be required to dedicate material resources and incur material expenses during that time to implement Health Care Reform.   Many significant parts of the legislation require further guidance and clarification in the form of regulations.  As a result, m any of the impacts of Health Care Reform will not be known until those regulations are enacted, which we expect to occur over the next several years.

Beginning in 2010, the gap in coverage for Medicare Part D prescription drug coverage (the so-called “donut hole”) will incrementally close until the coverage gap is eliminated by 2020.  Some of the changes effective for plan years beginning on or after September 23, 2010 include:  restrictions on pre-existing condition exclusions for enrollees under age 19, elimination of lifetime maximums on the dollar value of coverage, restricted annual limits on the dollar value of coverage, a requirement to provide dependent coverage until age 26, elimination of  payments by members for covered preventive services, a prohibition on eligibility waiting periods beyond 90 days and new claim appeal requirements.  Effective January 1, 2011, insured health plans are required to provide rebates to enrollees if medical loss ratios are less than 85% in the large group market and less than 80% in the small group and individual markets.  Medicare Advantage regionally-adjusted benchmarks will begin to phase in during 2012.  Beginning in 2014, the legislation requires:  guaranteed issue of coverage in the individual and small group markets, rating limits and minimum benefit requirements, an individual mandate to purchase insurance, federal assistance to purchase health coverage for individuals meeting certain criteria, creation of state-based insurance exchanges for the delivery of coverage, elimination of pre-existing condition exclusions for all enrollees, elimination of annual limits on the dollar value of coverage and detailed public reporting and disclosure requirements.  In 2018, the law imposes a 40% excise tax on employer-sponsored health benefits above a certain threshold (the so-called “Cadillac Tax”).  Some provisions may not apply to certain grandfathered plans in effect on the date of enactment, and many provisions apply to both fully-insured and self-funded health plans.
 
 
 
 
Page 35
 
 

The law also specifies required benefit designs, limits rating and pricing practices, encourages additional competition (including potential incentives for new market entrants) and expands eligibility for Medicaid programs.  In addition, the law has created a new federal Health Insurance Rate Authority that will significantly increase federal oversight of health plan premium rates beginning in 2010 and could adversely affect our ability to appropriately increase health plan premiums.  Financing for these reforms will come, in part, from material additional fees and taxes on us and other health insurers, health plans and individuals beginning in 2014, as well as reductions in certain levels of payments to us and other health plans under Medicare which are described below.

At the state level, forty-four states and the District of Columbia will be holding regular legislative sessions in 2010.  We expect state legislatures to focus on the impact of federal health care reform legislation and state budget deficits in 2010.  Health care reform will significantly alter the federal structure that shapes the state regulation of health insurance, and states will be required to significantly amend numerous existing statutes and regulations.  Independent of federal efforts, we expect many states to consider legislation to extend coverage to the uninsured through health insurance exchanges, increase the limiting age for dependent eligibility, restrict health plan rescission of individual coverage, mandate minimum medical benefit ratios, implement rating reforms and enact an autism benefit mandate.  We cannot predict whether additional health care reforms will be enacted at the state level, and if they are, what provisions they will contain in any state or what effect they will have on our business operations or financial results, but the effect could be materially adverse.
 
We will need to dedicate material resources and incur material expenses over the next several years to implement Health Care Reform at both the state and federal level, including implementing the future regulations that will provide guidance and clarification on significant parts of the legislation; however, it is reasonably possible that Health Care Reform, in the aggregate, could have a material adverse effect on our business operations and financial results.
 
In addition to the health care reform measures discussed above, the federal and state governments continue to enact and seriously consider many broad-based legislative and regulatory proposals that have or could materially impact various aspects of the health care system.  For example:

·  
On February 17, 2009, the American Recovery and Reinvestment Act of 2009 (“ARRA”) was enacted into law.  Under ARRA, as amended, if an individual is involuntarily terminated from employment (for reasons other than gross misconduct) before May 31, 2010, the individual may elect COBRA coverage and, for a period of up to fifteen months, receive a subsidy from his or her employer equal to 65% of the otherwise applicable COBRA premium charged to the employee.  The employer is entitled to apply the amount of premium assistance it pays as an offset against its payroll taxes.  Congress may further extend the end date of this subsidy or make additional changes to the benefits.  During 2009, the availability of this subsidy caused more people to elect COBRA coverage from us than we assumed, which caused unexpe cted increases in our medical costs.  Any further changes to COBRA may cause unexpected increases in our medical costs.

·  
ARRA also expands and strengthens the privacy and security provisions of the federal Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and imposes additional limits on the use and disclosure of Protected Health Information (“PHI”).  Among other things, ARRA requires us and other covered entities to report any unauthorized release of, use of, or access to PHI to any impacted individuals and to the U.S. Department of Health and Human Services in those instances where the unauthorized activity poses a significant risk of financial, reputational or other harm to the individuals, and to notify the media in any states where 500 or more people are impacted by any unauthorized release or use of or access to PHI.  Business associates (e.g., entities that provide services to health plans, such as e lectronic claims clearinghouses, print and fulfillment vendors, consultants, and us for the administrative services we provide to our ASC customers) must also comply with certain HIPAA provisions.  In addition, ARRA establishes greater civil and criminal penalties for covered entities and business associates who fail to comply with HIPAA’s provisions and requires the U.S. Department of Health and Human Services to issue regulations implementing its privacy and security enhancements.  We will continue to assess the impact of these regulations on our business operations as they are issued.
 
 
 
 
Page 36
 
 

 
·  
In 2008, the U.S. Congress reduced funding for Medicare Advantage plans beginning in 2010 and imposed new marketing requirements on Medicare Advantage and PDP plans beginning in 2009.  The federal health reform legislation contains significant reductions in reimbursements we receive for our Medicare Advantage members, including freezing 2011 rates based on 2010 levels, with additional reductions in future years based on regionally-adjusted benchmarks.

There also continues to be a heightened review by federal and state regulators of the health care insurance industry’s business and reporting practices.  In April 2010, the Centers for Medicare & Medicaid Services (“CMS”) imposed intermediate sanctions on us suspending the enrollment of and marketing to new members of all Aetna Medicare Advantage and Standalone Prescription Drug Plan Contracts, effective April 21, 2010.  The sanctions relate to compliance with certain Medicare Part D requirements, primarily those relating to changes in the drugs covered by certain plans from 2009 to 2010.  The suspension does not affect our current Medicare enrollees who stay in their existing plans.  Also in April 2010, CMS granted us a limited waiver of these sanctions to allow us to continue to enroll eligible members into existing, contracted group Aetna Medicare Advantage Plans and Standalone Prescription Drug Plans through July 21, 2010.

Refer to Regulatory Environment in our 2009 Annual Report for additional information on the regulation of our business and the health care system.


FORWARD-LOOKING INFORMATION/RISK FACTORS

Certain information in this MD&A is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements are subject to uncertainties that are outside our control and could cause actual future results to differ materially from those statements.  You should not place undue reliance on forward-looking statements, and we disclaim any intention or obligation to update or revise forward-looking statements.

The following risk factors supplement the Forward-Looking Information/Risk Factors portion of our 2009 Annual Report.  You should read that section of our 2009 Annual Report and the information below carefully because each of them contains a discussion of important risk factors that could adversely affect our business as well as the market price for our common stock.

The federal and state governments continue to enact and seriously consider many broad-based legislative and regulatory measures that have and will continue to materially impact various aspects of the health care system and our business.
In March 2010, President Obama signed the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act legislating broad-based changes to the U.S. health care system.   Components of the legislation will be phased in over the next eight years and there are many parts of the legislation that will require further guidance in the form of regulations.  In addition, at the state level, forty-four states and the District of Columbia will be holding regular legislative sessions in 2010.  We expect state legislatures to focus on the impact of federal health care reform legislation and state budget deficits in 2010.  For more information on these matters, refer to Regulatory Environment beginning on page 35.

We will need to dedicate material resources and incur material expenses to implement health care reform at both the state and federal level, including implementing the future regulations that will provide guidance and clarification on significant parts of the legislation.  In addition, we cannot predict whether additional health care reforms will be enacted at the state level, and if they are, what provisions they will contain in any state or what effect they will have on our business or operations.  While health care reform at the state and federal level presents us with new business opportunities and new financial and other challenges and may, for example, cause membership in our health plans to increase or decrease, it is reasonably possible that our business operations and financial results could be materially adve rsely affected by such reform. 
 
 
 
 
Page 37
 
 
 
Our business activities are highly regulated; new laws or regulations or changes in existing laws or regulations or their enforcement could also materially adversely affect our business and profitability.
Our business is subject to extensive regulation and oversight by state, federal and international governmental authorities.  The laws and regulations governing our operations change frequently and generally are designed to benefit and protect members and providers rather than our investors.  The federal and many state governments have enacted and continue to consider legislative and regulatory changes related to health products and changes in the interpretation and/or enforcement of existing laws and regulations, and the likelihood of adverse changes is increasing due to state and federal budgetary pressures.  We must monitor these changes and promptly implement any revisions to our business processes that these changes require.  At this time, we are unable to predict the impact of future changes, a lthough we anticipate that some of these measures, if enacted, could materially adversely affect our health care operations and/or operating results including:

· 
Reducing our ability to obtain adequate premium rates (including regulatory approval for and implementation of those rates),
·    
Restricting our ability to price for the risk we assume and/or reflect reasonable costs or profits in our pricing, including mandating minimum medical benefit ratios,
·    
Reducing our ability to manage health care costs,
·    
Increasing health care costs and operating expenses,
·    
Increasing our exposure to lawsuits and other adverse legal proceedings,
·    
Regulating levels and permitted lines of business,
·    
Restricting our ability to underwrite and operate our individual health business,
·    
Imposing new or increasing taxes and financial assessments, and/or
·    
Regulating business practices.
 
For example, premium rates generally must be filed with state insurance regulators and are subject to their approval, either before or after rates take effect.  The new federal health legislation will require review of unreasonable premium rate increases by the Department of Health and Human Services in conjunction with state regulators.  Regulators or legislatures in a number of states have implemented or are considering limits on premium rate increases, either enforcing existing legal requirements more stringently or proposing different regulatory standards.  We anticipate additional regulatory or legislative action with respect to regulation of premium rates in our Insured business, some of which could materially and adversely affect our ability to earn adequate returns on Insured business in one or more s tates.

Decisions by health plans to rescind coverage and decline payment to treating providers after a member has received medical services also have generated public attention, particularly in California.  As a result, there has been both legislative and regulatory action in connection with this issue.  On September 30, 2008, the state of California enacted legislation requiring health care service plans and health insurers that have rescinded an individual policy to reinstate coverage, on a guarantee issue basis, for the individual(s) whose information in the application for coverage and related communications did not lead to the rescission.  In 2009, California enacted legislation that limits the time period in which health plans and health insurers can rescind an individual policy to 0;two years.  In addition, in 2009 Illinois issued a bulletin requiring a health carrier who is seeking to rescind an individual policy to provide the state with a complete copy of its underwriting guidelines so the state can determine whether the false information provided in the individual policy application materially affected the acceptance of the risk assumed by the health carrier.

In addition, our Medicare, Medicaid and specialty and mail order pharmacy products are more highly regulated than our Commercial products.  In April 2010, CMS imposed intermediate sanctions on us suspending the enrollment of and marketing to new members of all Aetna Medicare Advantage and Standalone Prescription Drug Plan Contracts, effective April 21, 2010.  The sanctions relate to compliance with certain Medicare Part D requirements, primarily those relating to changes in the drugs covered by certain plans from 2009 to 2010.  The suspension does not affect our current Medicare enrollees who stay in their existing plans.  Also in April 2010, CMS granted us a limited waiver of these sanctions to allow us to continue to enroll eligible members into existing, contracted group Aetna Medicare Advantage Plans and Standalone Prescription Drug Plans through July 21, 2010.  We are cooperating fully with CMS on its review and are working to resolve the issues CMS has raised as soon as possible.  Any failure of our prevention, detection or control systems related to regulatory compliance and/or compliance with our internal policies could adversely affect our reputation and also expose us to litigation
 
 
 
 
Page 38
 
 
 
and other proceedings, fines, sanctions and/or penalties, any of which could adversely affect our business, operating results or financial condition.
 
There continues to be a heightened review by federal and state regulators of the health care insurance industry’s business and reporting practices, including utilization management, payment of providers with whom the payor does not have contracts and other claim payment practices, as well as heightened review of the general insurance industry’s brokerage practices.  As one of the largest national health and related benefits providers, we are regularly the subject of regulatory market conduct and other reviews, audits and investigations by state insurance and health and welfare departments and attorneys general, CMS, the Office of the Inspector General, the Office of Personnel Management, the U.S. Department of Justice and U.S. Attorneys.  Several such reviews, audits and investigations currently are pending , some of which may be resolved during 2010.  These regulatory reviews, audits and investigations could result in changes to or clarifications of our business practices, and also could result in significant or material fines, penalties, civil liabilities, criminal liabilities or other sanctions, including exclusion from participation in government programs.  For example, in January 2009, Aetna and the New York Attorney General announced an agreement relating to an industry-wide investigation into certain payment practices with respect to out-of-network providers.  As a result of that 2009 agreement, Aetna contributed $20 million towards the establishment of an independent database system to provide fee information regarding out-of-network reimbursement rates.  Our business also may be adversely impacted by judicial and regulatory decisions that change and/or expand the interpretations of existing statutes and regulations, impose medical or bad faith liability, increase our responsibilities under ERISA, or reduce the scope of ERISA pre-emption of state law claims.

For more information regarding these matters, refer to Regulatory Environment beginning on page 35 and Litigation and Regulatory Proceedings in Note 12 of Condensed Notes to Consolidated Financial Statements beginning on page 18.


Item 3.
Quantitative and Qualitative Disclosures About Market Risk

Refer to the information contained in the MD&A – Investments beginning on page 31 for a discussion of our exposures to market risk.


Item 4.
Controls and Procedures

Disclosure Controls and Procedures
We maintain disclosure controls and procedures, which are designed to ensure that information that we are required to disclose in the reports we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

An evaluation of the effectiveness of our disclosure controls and procedures as of March 31, 2010 was conducted under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer.  Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures as of March 31, 2010 were effective and designed to ensure that material information relating to Aetna Inc. and its consolidated subsidiaries would be made known to the Chief Executive Officer and Chief Financial Officer by others within those entities, particularly during the periods when periodic reports under the Exchange Act are being prepared.  Refer to the Certifications by our Chief Executive Officer and Chief Financial Officer filed as Exhibits 31.1 and 31.2 to this report.

 

 
Page 39
 
 

 
Changes in Internal Control over Financial Reporting
There has been no change in our internal control over financial reporting, identified in connection with the evaluation of such control, that occurred during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.


Part II.
Other Information

Item 1.
Legal Proceedings

The information contained in Note 12 of Condensed Notes to Consolidated Financial Statements, beginning on page 18 is incorporated herein by reference.


Item 1A.
Risk Factors

The information contained under the heading “Forward-Looking Information/Risk Factors” in the MD&A beginning on page 37 is incorporated herein by reference.


Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information about our monthly share repurchases for the three months ended March 31, 2010:

Issuer Purchases Of Equity Securities
       
Total Number of
  
Approximate Dollar
       
Shares Purchased
  
Value of Shares
       
as Part of Publicly
  
That May Yet Be
 
Total Number of
  
Average Price
Announced
  
Purchased Under the
(Millions, except per share amounts)
Shares Purchased
  
Paid Per Share
Plans or Programs
  
Plans or Programs
January 1, 2010 - January 31, 2010
 -  
 
 $        -   
 -  
 
 $   591.2
February 1, 2010 - February 28, 2010
 -  
 
 -   
 -  
 
 591.2
March 1, 2010 - March 31, 2010
 7.2
  
 34.78
 7.2
  
 339.2
Total
 7.2
  
 $   34.78
 7.2
  
N/A

On February 27, 2009, we announced that our Board authorized a share repurchase program for the repurchase of up to $750 million of our common stock.  During the three months ended March 31, 2010, we repurchased approximately 7 million shares of common stock at a cost of approximately $252 million.  At March 31, 2010, we had remaining authorization to repurchase an aggregate of up to approximately $339 million of common stock remaining under the February 27, 2009 Board authorization.
 
 

 
Page 40
 
 
 
 
Item 6.
Exhibits

Exhibits to this Form 10-Q are as follows:
 
10
Material Contracts
 
10.1
 
Form of Aetna Inc. 2000 Stock Incentive Plan – Market Stock Unit Terms of Award.
 
 
10.2
 
Form of Aetna Inc. 2000 Stock Incentive Plan – Performance Stock Unit Terms of Award.
 
 
10.3
 
Form of Aetna Inc. 2000 Stock Incentive Plan – Restricted Stock Unit Terms of Award (2010, with retirement vesting).
 
 
10.4
 
Form of Aetna Inc. 2000 Stock Incentive Plan – Restricted Stock Unit Terms of Award (2010, without retirement vesting).
 
 
10.5
 
Amended and Restated Aetna Inc. 2001 Annual Incentive Plan.

11
Statements re: computation of per share earnings
   
11.1
Computation of per share earnings is incorporated herein by reference to Note 3 of Condensed Notes to Consolidated Financial Statements, beginning on page 6 in this Form 10-Q.
   
12
Statements re: computation of ratios
   
12.1
Computation of ratio of earnings to fixed charges.
   
15
Letter re: unaudited interim financial information
   
15.1
Letter from KPMG LLP acknowledging awareness of the use of a report dated April 29, 2010 related to their review of interim financial information.

31
Rule 13a-14(a)/15d-14(a) Certifications
   
31.1
Certification.
   
31.2
Certification.
   
32
Section 1350 Certifications
   
32.1
Certification.
   
32.2
Certification.
   
101
XBRL Documents
   
101.INS
XBRL Instance Document.
   
101.SCH
XBRL Taxonomy Extension Schema.
   
101.CAL
XBRL Taxonomy Extension Calculation Linkbase.
   
101.DEF
XBRL Taxonomy Extension Definition Linkbase.
   
101.LAB
XBRL Taxonomy Extension Label Linkbase.
   
101.PRE
XBRL Taxonomy Extension Presentation Linkbase.
   
 

 
 
Page 41
 

 
 
SIGNATURES




Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



 
Aetna Inc.
 
Registrant



 
 
Date:  April 29, 2010
By    /s/ Rajan Parmeswar
 
        Rajan Parmeswar
 
        Vice President, Controller and
 
        Chief Accounting Officer


 
 
Page 42
 
 
 

INDEX TO EXHIBITS



Exhibit
  
Filing
Number
Description
Method
 
10
Material Contracts
  
     
10.1
Form of Aetna Inc. 2000 Stock Incentive Plan – Market Stock Unit Terms of Award.
Electronic
     
10.2
Form of Aetna Inc. 2000 Stock Incentive Plan – Performance Stock Unit Terms of Award.
Electronic
     
10.3
Form of Aetna Inc. 2000 Stock Incentive Plan – Restricted Stock Unit Terms of Award (2010, with retirement vesting).
Electronic
     
10.4
Form of Aetna Inc. 2000 Stock Incentive Plan – Restricted Stock Unit Terms of Award (2010, without retirement vesting).
Electronic
     
10.5
Amended and Restated Aetna Inc. 2001 Annual Incentive Plan.
Electronic
 
12
Statements re: computation of ratios
  
     
12.1
Computation of ratio of earnings to fixed charges.
Electronic
 
    
15
Letter re: unaudited interim financial information
  
     
15.1
Letter from KPMG LLP acknowledging awareness of the use of a report dated April 29, 2010 related to their review of interim financial information.
Electronic
     
31
Rule 13a-14(a)/15d-14(a) Certifications
  
     
31.1
Certification.
Electronic
     
31.2
Certification.
Electronic
     
32
Section 1350 Certifications
  
     
32.1
Certification.
Electronic
     
32.2
Certification.
Electronic
     
101
XBRL Documents
Electronic
     
101.INS
XBRL Instance Document.
Electronic
     
101.SCH
XBRL Taxonomy Extension Schema.
Electronic
     
101.CAL
XBRL Taxonomy Extension Calculation Linkbase.
Electronic
     
101.DEF
XBRL Taxonomy Extension Definition Linkbase.
Electronic
     
101.LAB
XBRL Taxonomy Extension Label Linkbase.
Electronic
     
101.PRE
XBRL Taxonomy Extension Presentation Linkbase.
Electronic
     

 

 
Page 43
 


 

 
 
 
 
 

 
EX-10.1 2 exhibit10-1.htm EXHIBIT 10.1 exhibit10-1.htm  
 
Exhibit 10.1  

 

AETNA INC.
2000 STOCK INCENTIVE PLAN

MARKET STOCK UNIT TERMS OF AWARD

Pursuant to its 2000 Stock Incentive Plan (the "Plan"), Aetna Inc. (the "Company") hereby grants Market Stock Units on the terms and conditions hereinafter set forth.  The number of Market Stock Units awarded is included in the website of the designated broker, currently UBS Financial Services, Inc., and in the Notice of the Market Stock Unit Grant Acknowledgement and Acceptance Form.  All capitalized terms used herein which are not otherwise defined herein shall have the meaning specified in the Plan.

ARTICLE I

DEFINITIONS

(a)
“Affiliate" means an entity at least a majority of the total voting power of the then-outstanding voting securities of which is held, directly or indirectly, by the Company and/or one or more other Affiliates.

(b)
    "Board" means the Board of Directors of Aetna Inc.

(c)         "Change in Control" means the happening of any of the following:

(i)  
When any "person" as defined in Section 3(a)(9) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and as used in Sections 13(d) and 14(d) thereof, including a "group" as defined in Section 13(d) of the Exchange Act but excluding the Company and any Subsidiary thereof and any employee benefit plan sponsored or maintained by the Company or any Subsidiary (including any trustee of such plan acting as trustee), directly or indirectly, becomes the "beneficial owner" (as defined in Rule 13d-3 under the Exchange Act, as amended from time to time), of securities of the Company representing 20 percent or more of the combined voting power of the Company's then outstanding securities;

(ii)  
When, during any period of 24 consecutive months, the individuals who, at the beginning of such period, constitute the Board (the "Incumbent Directors") cease for any reason other than death to constitute at least a majority thereof, provided that a director who was not a director at the beginning of such 24-month period shall be deemed to have satisfied such 24-month requirement (and be an Incumbent Director) if such director was elected by, or on the recommendation of or with the approval of, at least two-thirds of the directors who then qualified as Incumbent Directors either actually (because they were directors at the beginning of such 24-month period) or by prior operation of this paragraph (ii); or

 
      (iii)
The occurrence of a transaction requiring stockholder approval for the acquisition of the Company by an entity other than the Company or a Subsidiary through purchase of assets, or by merger, or otherwise.
 
 
 
Notwithstanding the foregoing, in no event shall a “Change in Control” be deemed to have occurred (i) as a result of the formation of a Holding Company, or (ii) with respect to Grantee, if Grantee is part of a “group,” within the meaning of Section 13(d)(3) of the Exchange Act as
 
 
 
 
1
 
 

 
 
in effect on the effective date, which consummates the Change in Control transaction.  In addition, for purposes of the definition of “Change in Control” a person engaged in business as an underwriter of securities shall not be deemed to be the “Beneficial Owner” of, or to “beneficially own,” any securities acquired through such person’s participation in good faith in a firm commitment underwriting until the expiration of forty days after the date of such acquisition.
 
(d)
"Committee" means the Board's Committee on Compensation and Organization or any successor thereto.

(e)
"Common Stock" means the Company's Common Shares, $.01 par value per share.

(f)
"Company" means Aetna Inc.

(g)
"Effective Date" means the date of grant of this award of Market Stock Units.

(h)
“Fair Market Value" means the closing price of the Common Stock as reported by the Consolidated Tape of the New York Stock Exchange Listed Shares on the date such value is to be determined, or, if no shares were traded on such date, on the next day on which the Common Stock is traded.

(i)
“Fundamental Corporate Event” shall mean any stock dividend, extraordinary cash dividend, recapitalization, reorganization, merger, consolidation, split-up, spin-off, combination, exchange of shares, warrants or rights offering to purchase Common Stock at a price substantially below fair market value, or similar event.

(j)
"Grantee" means the person to whom this award has been granted.

(k)
“Holding Company” means an entity that becomes a holding company for the Company or its businesses as a part of any reorganization, merger, consolidation or other transaction, provided that the outstanding shares of common stock of such entity and the combined voting power of the then outstanding voting securities of such entity entitled to vote generally in the election of directors is, immediately after such reorganization, merger, consolidation or other transaction, beneficially owned, directly or indirectly, by all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the voting stock outstanding immediately prior to such reorganization, merger, consolidation or other transaction in substantially the same proportions as their ownership, immediately prior to such reorganization, merger, consolidation or other transaction, of such outstanding voting stoc k.

(l)
"Long Term Disability" means long-term disability as defined under the terms of the Company's applicable long-term disability plans or policies.

(m)
“Net Shares” means the number of shares of Common Stock which will be deposited in a brokerage account in the Grantee’s name at the Company’s designated broker after shares have been withheld to satisfy applicable tax and withholding requirements upon vesting of the Market Stock Units.
 
 

 
2
 
 
 
(n)
“Performance Period” means the two-year period following the Effective Date.

(o)
“Market Stock Units” means the number of units awarded that will convert to a number of shares of Common Stock based on the operation of Article II of this Agreement, or such other amount as may result by operation of Article III of this Agreement.

(p)
“Plan” means the Aetna Inc. 2000 Stock Incentive Plan.

(q)
"Retirement" means the termination of employment of a Grantee from active service with the Company, a Subsidiary or Affiliate provided the Grantee’s age and completed years of service total 65 or more points at termination of employment.

(r)
“Section 162(m)” means Section 162(m) of the Internal Revenue Code of 1986, as amended, and the regulation issued thereunder, as may be amended from time to time.

(s)
“Section 409A” means Section 409A of the Internal Revenue Code of 1986, as amended, and the regulation issued thereunder, as may be amended from time to time.

(t)
“Shares of Stock” or “Stock” means the Common Stock.

(u)
"Subsidiary" means an entity of which, at the time such subsidiary status is to be determined, at least 50% of the total combined voting power of all classes of stock of such entity is held by the Company and/or one or more other subsidiaries.

(v)
"Successor" means the legal representative of the estate of a deceased Grantee or the person or persons who shall acquire the right to the Market Stock Units by bequest or inheritance or by reason of the death of the Grantee.

(w)
“Vest Date” means the date on which this award of Market Stock Units shall vest in accordance with the terms of this Agreement and in the Notice of Market Stock Unit Grant.

(x)
“Vest Date Fair Market Value” means the average closing price of the Common Stock as reported by the Consolidated Tape of the New York Stock Exchange Listed Shares for the 29 trading days prior to the Vest Date and the Vest Date, or, if no shares were traded on such Vest Date, for the 30 trading days prior to the Vest Date.
 

 
ARTICLE II

PERFORMANCE PERIOD & AWARD CONVERSION

Subject to the terms of this Agreement, the Market Stock Units will vest, as of the Vest Date, in accordance with the terms of the Plan and this Terms of Award Agreement, or on such earlier date as provided in Article IV.   On the Vest Date the Grantee shall vest in a number of shares of Common Stock for each vested Market Stock Unit based on the formula below, net of applicable taxes and withholding.  Such Net Shares will be delivered to the Company’s designated broker, in a brokerage account established in the Grantee’s name after the Vest Date.  To the extent Section 162(m) is applicable to a Grantee, for shares to vest the Committee must also determine that the performance goal set forth on Exhibit A is met.  If the Committee determines that the performance goal is not met at th e minimum level, as applicable, no shares will vest.
 
 
 
 
3
 

 
The number of shares of Common Stock that each Market Stock Unit will convert and be awarded to you on the Vest Date, net of applicable taxes, shall be determined in accordance with the following formula:

(Number of Market Stock Units granted)

Multiplied by

((the Vest Date Fair Market Value) divided by (the Grant Date Fair Market Value))

Up to a maximum of 1.5 shares of Common Stock per Market Stock Unit.

Any social security calculation or other adjustments discovered after the payment of Net Shares will be settled in cash, not in Common Stock.
 

 
ARTICLE III

CAPITAL CHANGES

In the event that the Committee shall determine that any Fundamental Corporate Event affects the Common Stock such that an adjustment is required to preserve, or to prevent enlargement of, the benefits or potential benefits made available under this Plan, then the Committee shall, in such manner as the Committee may deem equitable, adjust the number and kind of shares subject to the award of Market Stock Units.  Additionally, the Committee may make provision for cash payment to a Grantee or the Successor of the Grantee to the extent permitted under Section 409A.  However, the number of Market Stock Units shall always be a whole number.
 

 
ARTICLE IV

CHANGE IN CONTROL

Notwithstanding any other provision of this Agreement to the contrary, upon the occurrence of a Change in Control, the Market Stock Units not previously forfeited pursuant to this Terms of Award Agreement shall become immediately vested and convert to a number of shares of Common Stock based on the formula in Article II but such formula shall use the Fair Market Value on the date on which the Change in Control occurs rather than the Vest Date Fair Market Value.  Net Shares will be payable on the Vest Date, provided however, if within the 24 month period following the Change in Control the Company terminates Grantee’s employment without cause, the Net Shares will become payable as of such termination of employment date.  If an award is considered deferred compensation subject to Section 409A, the award w ill vest but the Change in Control will not accelerate the payment of the Market Stock Units unless the Change in Control also meets the definition of change in control set forth in Treasury Regulation Section 1.409A-3(i)(5).
 


 
4
 
 

 
ARTICLE V

TERMINATION OF EMPLOYMENT
 
(a)  Except a provided in (c) below, if, during the Performance Period, Grantee shall cease to be employed by the Company, its Subsidiaries or Affiliates, for reason of death, Long-term Disability, Retirement or involuntary termination of employment by the Company, the portion of the Market Stock Units that may vest on the Vest Date, if any, shall be calculated in accordance with the following formula:  (i) the number of completed months employed commencing on the first day of the Performance Period divided by the number of months in the Performance Period; multiplied by (ii) the number of Market Stock Units that otherwise would have vested under the t erm of this Agreement had the Grantee remained actively employed through the Vest Date.
 
(b)     Except as provided in (a) above, any Market Stock Unit not vested as of the date Grantee terminates employment shall be forfeited at the time of cessation of employment; provided, however, that if Grantee's employment is terminated by the Company other than for cause and Grantee has not previously, or does not subsequently, vest to any portion of the Market Stock Unit in accordance with its terms, then upon the forfeiture of the entire Market Stock Unit, the Company will pay Grantee an amount equal to the value of a single share of Common Stock, whether or not the forfeited Market Stock Unit related to more than a single share of Common Stock, calculated as of the cessation of employment, if requested by Grantee, within 30 days of such cessation of employment.
 
(c)     No Market Stock Unit will vest after the Company has terminated the employment of the Grantee for cause, unless the Committee, in its sole discretion, deems a payment to be warranted under the particular circumstances. In addition, the Market Stock Units will not vest if Grantee has willfully engaged in gross misconduct or other serious impropriety which the Company determines is likely to be damaging or detrimental to the Company, any Subsidiary or Affiliate.
 
(d)     Employment for purposes of determining the vesting rights of the Grantee and the expiration of the grant under this Article V shall mean continuous active full-time salaried employment with the Company, a Subsidiary or an Affiliate, except that the period during which the Grantee is on vacation, sick leave, or other pre-approved leave of absence (provided there is no actual termination of employment), shall not interrupt the continuous employment of the Grantee.  Employment shall also include service with Aetna Foundation, Inc.  Notwithstanding any period during which Grantee receives salary continuation or severance shall not be considered as part of t he continuous employment of the Grantee.
 
 

ARTICLE VI

EMPLOYEE COVENANTS

 (a)
As consideration for this grant of Market Stock Units, without prior written consent of the Company:

 
 
(i)
Grantee will not (except to the extent required by an order of a court having competent jurisdiction or under subpoena from an appropriate government agency) use or disclose to any third person, whether during or subsequent to Grantee’s employment, any trade secrets, confidential information and proprietary materials, which may include, but are not limited to, the following categories of information and materials: customer lists and identities; provider lists and identities; employee lists and identities; product development and related information; marketing
 
 
 
 
5
 
 
 
   
 
plans and related information; sales plans and related information; premium or other pricing information; operating policies and manuals; research; payment rates; methodologies; procedures; contractual forms; business plans; financial records; computer programs; database; or other financial, commercial, business or technical information related to the Company or any Subsidiary or Affiliate unless such information has been previously disclosed to the public by the Company or has become public knowledge other than by a breach of this Agreement; provided, however, that this limitation shall not apply to any such use or disclosure made while Grantee is employed by the Company, any Subsidiary or Affiliate if such disclosure occurred in connection with the performance of Grantee’s job as an employee of the Company, any Subsidiary or Affiliate;
 
 
 
(ii)
Grantee will not, during and for a period of 12 months or 24 months for executive tier employees (the executive tier status determined as of the effective date of this grant) following Grantee’s termination of Employment, directly or indirectly induce or attempt to induce any employee to be employed or perform services elsewhere;
 
 
 
 
(iii)
Grantee will not, during and for a period of 12 months or 24 months for executive tier employees (the executive tier status determined as of the effective date of this grant) following Grantee's termination of Employment, directly or indirectly, induce or attempt to induce any agent or agency, broker, supplier or health care provider of the Company or any Subsidiary to cease or curtail providing services to the Company or any Subsidiary; and

 
 
(iv)
Grantee will not, during and for a period of 12 months or 24 months for executive tier employees (the executive tier status determined as of the effective date of this grant) following Grantee’s termination of Employment, directly or indirectly solicit or attempt to solicit the trade of any individual or entity which, at the time of such solicitation, is a customer of the Company, any Subsidiary or Affiliate, or which the Company, any Subsidiary or Affiliate is undertaking reasonable steps to procure as a customer at the time of or immediately preceding termination of Employment; provided, however, that this limitation shall only apply to any product or service which is in competition with a product or service of the Company, any Subsidiary or Affiliate and shall apply only with respect to a customer or prospective customer with whom the Grantee has been directly or indirectly involved.

 
In addition:

 
(v)    
Following the termination of Grantee’s Employment, Grantee shall provide assistance to and shall cooperate with the Company or a Subsidiary or Affiliate, upon its reasonable request and without additional compensation, with respect to matters within the scope of Grantee’s duties and responsibilities during Employment, provided that any reasonable out-of-pocket expenses Grantee incurs in connection with any assistance Grantee has been requested to provide under this provision for items including, but not limited to, transportation, meals, lodging and telephone, shall be reimbursed by the Company.  The Company agrees and acknowledges that it shall, to the maximum extent possible under the then prevailing circumstances, coordinate, or cause a Subsidiary or Affiliate to coordinate, any such request with Grantee’s other commitme nts and responsibilities to minimize the degree to which such request interferes with such commitments and responsibilities; and

 
 (vi)
Grantee shall promptly notify the Company’s General Counsel if Grantee is contacted by a regulatory or self-regulatory agency with respect to matters pertaining to the Company or by an
 

 
 
6
 
 
 

 
 
attorney or other individual who informs the Grantee that he/she has filed, intends to file, or is considering filing a claim or complaint against the Company.
 
 
 (vii)
Grantee acknowledges that all original works of authorship that are created by Grantee (solely or jointly with others) within the scope of Grantee’s employment which are protectable by copyright are “works made for hire” as that term is defined in the United States Copyright Act (17 U.S.C., Section 101).  Grantee further acknowledges that while employed by the Company, Grantee may develop ideas, inventions, discoveries, innovations, procedures, methods, know-how or other works which relate to the Company’s current or are reasonably expected to relate to the Company’s future business that may be patentable or subject to trade secret protection.  Grantee agrees that all such works of authorship, ideas, inventions, discoveries, innovations, procedures, methods, know-how and other works shall belong exclusively to the Company, and the Grantee hereby assigns all right, t itle, and interest therein to the Company.
 
 
 
To the extent any of the foregoing works may be patentable, Grantee agrees that the Company may file and prosecute any application for patents for such works and that the Grantee will, on request, execute assignments to the Company relating to (and take all such further steps as may be reasonably necessary to perfect the Company’s sole and exclusive ownership of) any such application and any patents resulting therefrom.
 
(b)
If any provision of Article VI (a) is determined by a court of competent jurisdiction not to be enforceable in the manner set forth herein, the Company and Grantee agree that it is the intention of the parties that such provision should be enforceable to the maximum extent possible under applicable law and that such court shall reform such provision to make it enforceable in accordance with the intent of the parties.

(c)       
Grantee acknowledges that a material part of the inducement for the Company to grant the Market Stock Units is Grantee’s covenants set forth in Article VI (a) and that the covenants and obligations of Grantee with respect to nondisclosure, non-solicitation and cooperation relate to special, unique and extraordinary matters and that a violation of any of the terms of such covenants and obligations will cause the Company irreparable injury for which adequate remedies are not available at law.  Therefore, Grantee agrees that, if Grantee shall breach any of those covenants or obligations, Grantee shall not be entitled to vest in the Market Stock or be entitled to retain any income therefrom and the Company shall be entitled to an injunction, restraining order or such other equitable relief (without the requirement to post bond) restraining Grantee from committing any violation of the covenants and obligations contained in Article VI.  The remedies in the preceding sentence are cumulative and are in addition to any other rights and remedies the Company may have at law or in equity as a court or arbitrator shall reasonably determine.

(d)
Employment Dispute Arbitration Program - Mandatory Binding Arbitration of Employment Disputes.

(i)    
Except as otherwise specified in this Agreement, the Grantee and the Company agree that all employment-related legal disputes between them will be submitted to and resolved by binding arbitration, and neither the Grantee nor the Company will file or participate as an individual party or member of a class in a lawsuit in any court against the other with respect to such matters.  This shall apply to claims brought on or after the date the Grantee accepts this Agreement, even if the facts and circumstances relating to the claim occurred prior to that date and regardless of whether the Grantee or the Company previously filed a complaint/charge with a government agency concerning the claim.
 
 
 
 
7
 

 
For purposes of Article VI (d) of this Agreement, “the Company” includes Aetna Inc., its Subsidiaries and Affiliates, their predecessors, successors and assigns, and those acting as representatives or agents of those entities.  THE GRANTEE UNDERSTANDS THAT, WITH RESPECT TO CLAIMS SUBJECT TO THE ARBITRATION REQUIREMENT, ARBITRATION REPLACES THE RIGHT OF THE GRANTEE AND THE COMPANY TO SUE OR PARTICIPATE IN A LAWSUIT.  THE GRANTEE ALSO UNDERSTANDS THAT IN ARBITRATION, A DISPUTE IS RESOLVED BY AN ARBITRATOR INSTEAD OF A JUDGE OR JURY, AND THE DECISION OF THE ARBITRATOR IS FINAL AND BINDING.

 
(ii)
THE GRANTEE UNDERSTANDS THAT THE ARBITRATION PROVISIONS OF THIS AGREEMENT AFFECT THE LEGAL RIGHTS OF THE GRANTEE AND THE COMPANY AND ACKNOWLEDGES THAT THE GRANTEE HAS BEEN ADVISED TO, AND HAS BEEN GIVEN THE OPPORTUNITY TO, OBTAIN LEGAL ADVICE BEFORE SIGNING THIS AGREEMENT.

 
(iii)
Article VI (d) of this Agreement does not apply to workers’ compensation claims, unemployment compensation claims, and claims under the Employee Retirement Income Security Act of 1974 (“ERISA”) for employee benefits.  A dispute as to whether Article VI (d) of this Agreement applies must be submitted to the binding arbitration process set forth in this Agreement.

 
(iv)
The Grantee and/or the Company may seek emergency or temporary injunctive relief from a court (including with respect to claims arising out of Article VI (a) in accordance with applicable law).  However, except as provided in Article VI (c) of this Agreement, after the court has issued a ruling concerning the emergency or temporary injunctive relief, the Grantee and the Company shall be required to submit the dispute to binding arbitration pursuant to this Agreement.

 
(v)
Unless otherwise agreed, the arbitration will be administered by the American Arbitration Association (the “AAA”) and will be conducted pursuant to the AAA’s Employment Arbitration Rules and Mediation Procedures (the “Rules”), as modified in this Agreement, in effect at the time the request for arbitration is filed.  The AAA’s Rules are available on the AAA’s website at www.adr.org. THE GRANTEE ACKNOWLEDGES THAT THE COMPANY HAS ENCOURAGED THE GRANTEE TO READ THESE RULES PROMPTLY AND CAREFULLY AND THAT THE GRANTEE HAS BEEN AFFORDED SUFFICIENT OPPORTUNITY TO DO SO.

 
(vi)
If the Company initiates a request for arbitration, the Company will pay all of the administrative fees and costs charged by the AAA, including the arbitrator’s compensation and charges for hearing room rentals, etc.  If the Grantee initiates a request for arbitration or submits a counterclaim to the Company’s request for arbitration, the Grantee shall be required to contribute One Hundred Dollars ($100.00) to those administrative fees and costs, payable to the AAA at the time the Grantee's request for arbitration or counterclaim is submitted.  The Company may increase the contribution amount in the future without amending this Agreement, but not to exceed the maximum permitted under the AAA rules then in effect. In all cases, the Grantee and the Company shall be responsible for payment of any fees assessed by the arbitrator as a result of that party’s delay, request for postpo nement, failure to comply with the arbitrator’s rulings and for other similar reasons.
 
 
 
 
8
 

 
 
(vii)
The Grantee and the Company may choose to be represented by legal counsel in the arbitration process and shall be responsible for their own legal fees, expenses and costs.  However, the arbitrator shall have the same authority as a court to order the Grantee or the Company to pay some or all of the other’s legal fees, expenses and costs, in accordance with applicable law.

 
(viii)
Unless otherwise agreed, there shall be a single arbitrator, selected by the Grantee and the Company from a list of qualified neutrals furnished by the AAA.  If the Grantee and the Company cannot agree on an arbitrator, one will be selected by the AAA.

 
(ix)
Unless otherwise agreed, the arbitration hearing will take place in the city where the Grantee works or last worked for the Company.  If the Grantee and the Company disagree as to the proper locale, the AAA will decide.

 
(x)
The Grantee and the Company shall be entitled to conduct limited pre-hearing discovery.  Each may take the deposition of one person and anyone designated by the other as an expert witness.  The party taking the deposition shall be responsible for all associated costs, such as the cost of a court reporter and the cost of an original transcript.  Each party also has the right to submit one set of ten written questions (including subparts) to the other party, which must be answered under oath, and to request and obtain all documents on which the other party relies in support of its answers to the written questions.  Additional discovery may be permitted by the arbitrator upon a showing that it is necessary for that party to have a fair opportunity to present a claim or defense.

 
(xi)
The arbitrator shall apply the same substantive law that would apply if the matter were heard by a court and shall have the authority to order the same remedies (but no others) as would be available in a court proceeding.  The time limits for requesting arbitration or submitting a counterclaim and the administrative prerequisites for filing an arbitration claim or counterclaim are the same as they would be in a court proceeding.  The arbitrator shall consider and decide any dispositive motions (motions seeking a decision on some or all of the claims or counterclaims without an arbitration hearing) filed by any party.

 
(xii)
All proceedings, including the arbitration hearing and decision, are private and confidential, unless otherwise required by law.  Arbitration decisions may not be published or publicized without the consent of both the Grantee and the Company.

 
(xiii)    Unless otherwise agreed, the arbitrator’s decision will be in writing with a brief summary of the arbitrator’s opinion.

 
(xiv)
The arbitrator’s decision is final and binding on the Grantee and the Company.  After the arbitrator’s decision is issued, the Grantee or the Company may obtain an order of judgment from a court and may obtain a court order enforcing the decision.  The arbitrator’s decision may be appealed to the courts only under the limited circumstances provided by law.

 
(xv)
If the Grantee previously signed an agreement, including but not limited to an employment agreement, containing arbitration provisions, those provisions are superseded by the arbitration provisions of this Agreement.

 
(xvi)
If any provision of Article VI (d) is found to be void or otherwise unenforceable, in whole or in part, this shall not affect the validity of the remainder of Article VI (d) and the remainder of the Agreement.  All other provisions shall remain in full force and effect.

 
 
9
 
 
For purposes of this Article VI, the term “Employment” shall refer to active employment with the Company, any Subsidiary or Affiliate, and shall not include salary continuation or severance periods.


ARTICLE VII

OTHER TERMS

(a)
Nothing in this Agreement shall interfere with or limit in any way the right of the Company or any Subsidiary or Affiliate to terminate the Grantee’s employment at any time.  Neither the execution and delivery hereof nor the granting of the Award shall constitute or be evidence of any agreement or understanding, express or implied, on the part of the Company or any of its Subsidiaries to employ or continue the employment of the Grantee for any period.

(b)
Until the Market Stock Units have become vested, Grantee shall not have any rights as a stockholder (including the right to payment of dividends) by virtue of this grant of Market Stock Units.

(c)
During the Performance Period, the Market Stock Units shall be nontransferable and non-assignable except by will or the laws of descent and distribution.

(d)
The award, when vested, will be settled on a net basis.  Prior to issuing any Common Shares, the Company will withhold an amount sufficient to satisfy federal, state, local, social security and Medicare withholding tax requirements relating to award.  Any social security calculation or other adjustments discovered after net share payment will be settled in cash, not in Shares of Common Stock.  Vesting will result in taxable compensation reportable on the Grantee’s W-2 in year of vesting.

(e)
The Company may from time to time adopt stock ownership requirements applicable to Grantees who are senior managers of the Company.  In connection with and for the purpose of implementing those ownership requirements, the Company may adopt certain restrictions on the ability of a Grantee to sell shares issued under this Agreement when such ownership requirements have not been satisfied.  Any such restriction on sale will be communicated generally to affected Grantees and the restriction may be modified by the Company from time to time, at its discretion.  Neither the Company nor its Board of Directors shall have any obligation or liability to a Grantee in connection with any such restriction.

(f)
This Market Stock Unit is an unfunded obligation of the Company and nothing in this Agreement shall be construed to create any claim against particular assets or require the Company to segregate or otherwise set aside any assets or create any fund to meet its obligations hereunder.

(g)
Anything herein to the contrary notwithstanding, a Grantee whose Market Stock Units have been forfeited as a result of termination of employment due to U.S. Military Service and who is later re-employed (in a full-time active status) after discharge within the time period set in 38 U.S.C. Section 4312 will be eligible to have the forfeited Market Stock Units reinstated as follows: (i) if such Grantee is re-employed during the Performance Period, all forfeited Market Stock Units shall be reinstated; or (ii) if such Grantee is re-employed after the Performance Period, a cash payment will be 
 
 
 
 
10
 
 
 

 
 made to the Grantee, minus applicable taxes, for the value of the forfeited Market Stock Units on the Vest Date pursuant to procedures established by the Company for this purpose.
 
(h)
It is the intention of the Company and Grantee that this Agreement not result in unfavorable tax consequences to Grantee under Section 409A and the Agreement shall be interpreted as to so comply.  Notwithstanding anything to the contrary herein, the Company and Grantee agree to the provisions set forth below in order to comply with the requirements of Section 409A.

 
(i)
If Grantee is a “specified employee” (within the meaning of Section 409A) with respect to the Company, any non-qualified deferred compensation otherwise payable to or in respect of Grantee in connection with Grantee’s termination of employment shall be delayed until the earliest date upon which such amounts may be paid without being subject to taxation under Section 409A.  Any amount, the payment or benefit of which is delayed by application of the preceding sentence, shall be paid as soon as possible following the expiration of such period.

 
(ii)
Unless deferred pursuant to this agreement, all payments shall be paid to Grantee, to the extent earned, in no event later than the last day of the “applicable 2 ½ month period,” as such term is defined in Treasury Regulation Section 1.409A-1(b)(4)(i)(A) with respect to such payment’s treatment as a “short-term deferral” for purposes of Section 409A.

 
(iii)
The Company and Grantee agree to cooperate in good faith in an effort to comply with Section 409A.  Under no circumstances shall the Company be responsible for any taxes, penalties, interest or other losses or expenses incurred by the Grantee due to any failure to comply with Section 409A.

(i)
This Agreement is subject to the 2000 Stock Incentive Plan heretofore adopted by the Company and approved by its shareholders.  The terms and provisions of the Plan (including any subsequent amendments thereto) are hereby incorporated herein by reference.  In the event of a conflict between any term or provision contained herein and a term or provision of the Plan, the applicable terms and provisions of the Plan will govern and prevail.

(j)         At such times and upon such terms and conditions as the Company shall determine, the Company may permit eligible Grantees to elect to defer the distribution of an Award otherwise payable to the
      Grantee under this Agreement until termination of the Grantee’s Employment or such other date the Company shall permit.
 
 
 

 
11
 

EX-10.2 3 exhibit10-2.htm EXHIBIT 10.2 exhibit10-2.htm  
 
Exhibit 10.2  
 

 
AETNA INC.
2000 STOCK INCENTIVE PLAN

PERFORMANCE STOCK UNIT TERMS OF AWARD

Vesting Period – 24 month period following the Effective Date
Performance Period January 1, 2010 through December 31, 2010

Pursuant to its 2000 Stock Incentive Plan (the "Plan"), Aetna Inc. (the "Company") hereby grants Performance Stock Units on the terms and conditions hereinafter set forth.  The number of Performance Stock Units awarded is included in the website of the designated broker, currently UBS Financial Services, Inc., and in the Notice of the Performance Stock Unit Grant Acknowledgement and Acceptance Form.  All capitalized terms used herein which are not otherwise defined herein shall have the meaning specified in the Plan.

ARTICLE I

DEFINITIONS

(a)
“Affiliate" means an entity at least a majority of the total voting power of the then-outstanding voting securities of which is held, directly or indirectly, by the Company and/or one or more other Affiliates.

(b)
"Board" means the Board of Directors of Aetna Inc.

(c)           "Change in Control" means the happening of any of the following:

(i)  
When any "person" as defined in Section 3(a)(9) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and as used in Sections 13(d) and 14(d) thereof, including a "group" as defined in Section 13(d) of the Exchange Act but excluding the Company and any Subsidiary thereof and any employee benefit plan sponsored or maintained by the Company or any Subsidiary (including any trustee of such plan acting as trustee), directly or indirectly, becomes the "beneficial owner" (as defined in Rule 13d-3 under the Exchange Act, as amended from time to time), of securities of the Company representing 20 percent or more of the combined voting power of the Company's then outstanding securities;

(ii)  
When, during any period of 24 consecutive months, the individuals who, at the beginning of such period, constitute the Board (the "Incumbent Directors") cease for any reason other than death to constitute at least a majority thereof, provided that a director who was not a director at the beginning of such 24-month period shall be deemed to have satisfied such 24-month requirement (and be an Incumbent Director) if such director was elected by, or on the recommendation of or with the approval of, at least two-thirds of the directors who then qualified as Incumbent Directors either actually (because they were directors at the beginning of such 24-month period) or by prior operation of this paragraph (ii); or

 
(iii)
The occurrence of a transaction requiring stockholder approval for the acquisition of the Company by an entity other than the Company or a Subsidiary through purchase of assets, or by merger, or otherwise.
 
 
 
Notwithstanding the foregoing, in no event shall a “Change in Control” be deemed to have occurred (i) as a result of the formation of a Holding Company, or (ii) with respect to Grantee, if Grantee is part of a “group,” within the meaning of Section 13(d)(3) of the Exchange Act as in effect on the effective date, which consummates the Change in Control transaction.  In addition,
 
 
 
 
1
 
 

 
 
for purposes of the definition of “Change in Control” a person engaged in business as an underwriter of securities shall not be deemed to be the “Beneficial Owner” of, or to “beneficially own,” any securities acquired through such person’s participation in good faith in a firm commitment underwriting until the expiration of forty days after the date of such acquisition.
 
(d)
"Committee" means the Board's Committee on Compensation and Organization or any successor thereto.

(e)
"Common Stock" means the Company's Common Shares, $.01 par value per share.

(f)
"Company" means Aetna Inc.

(g)
"Effective Date" means the date of grant of this award of Performance Stock Units.

(h)
“Fair Market Value" means the closing price of the Common Stock as reported by the Consolidated Tape of the New York Stock Exchange Listed Shares on the date such value is to be determined, or, if no shares were traded on such date, on the next day on which the Common Stock is traded.

(i)
“Fundamental Corporate Event” shall mean any stock dividend, extraordinary cash dividend, recapitalization, reorganization, merger, consolidation, split-up, spin-off, combination, exchange of shares, warrants or rights offering to purchase Common Stock at a price substantially below fair market value, or similar event.

(j)
"Grantee" means the person to whom this award has been granted.

(k)
“Holding Company” means an entity that becomes a holding company for the Company or its businesses as a part of any reorganization, merger, consolidation or other transaction, provided that the outstanding shares of common stock of such entity and the combined voting power of the then outstanding voting securities of such entity entitled to vote generally in the election of directors is, immediately after such reorganization, merger, consolidation or other transaction, beneficially owned, directly or indirectly, by all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the voting stock outstanding immediately prior to such reorganization, merger, consolidation or other transaction in substantially the same proportions as their ownership, immediately prior to such reorganization, merger, consolidation or other transaction, of such outstanding voting stoc k.
 
(l)
"Long Term Disability" means long-term disability as defined under the terms of the Company's applicable long-term disability plans or policies.

(m)
“Net Shares” means the number of shares of Common Stock which will be deposited in a brokerage account in the Grantee’s name at the Company’s designated broker after shares have been withheld to satisfy applicable tax and withholding requirements upon vesting of the Performance Stock Units.

(n)
“Performance Period” means the one-year period ending December 31, 2010.

(o)
“Performance Stock Units” means the number of shares of Common Stock represented by the number of units awarded or such other amount as may result by operation of Article III of this Agreement.

(p)
“Plan” means the Aetna Inc. 2000 Stock Incentive Plan.

(q)
"Retirement" means the termination of employment of a Grantee from active service with the Company, a Subsidiary or Affiliate provided the Grantee’s age and completed years of service total 65 or more points at termination of employment.
 
 
 
 
2
 
 

 
(r)
“Section 409A” means Section 409A of the Internal Revenue Code of 1986, as amended, and the regulation issued thereunder, as may be amended from time to time.

(s)
“Shares of Stock” or “Stock” means the Common Stock.

(t)
"Subsidiary" means an entity of which, at the time such subsidiary status is to be determined, at least 50% of the total combined voting power of all classes of stock of such entity is held by the Company and/or one or more other subsidiaries.

(u)
"Successor" means the legal representative of the estate of a deceased Grantee or the person or persons who shall acquire the right to the Performance Stock Units by bequest or inheritance or by reason of the death of the Grantee.

(v)
“Vest Date” means the last day of the Vesting Period and is the date on which this award of Performance Stock Units shall vest in accordance with the terms of this Agreement and in the Notice of Performance Stock Unit Grant, if at all.

(w)
“Vesting Period” means the period beginning on the Effective Date and ending twenty-four months thereafter (e.g., the second anniversary of the Effective Date).


ARTICLE II

VESTING PERIOD

Subject to the terms of this Agreement, the Performance Stock Units will vest, as of the Vest Date, in accordance with the terms of the Plan and this Terms of Award Agreement, or on such earlier date as provided in Article IV.  If the Committee determines that the performance goal set forth on Exhibit A is met, on the Vest Date the Grantee shall vest to one share of Common Stock for each vested Performance Stock Unit net of applicable taxes and withholding (or such greater or lessor amount based on performance, as set forth on Exhibit A).  Such Net Shares will be delivered to the Company’s designated broker, in a brokerage account established in the Grantee’s name after the Vest Date.  If the Committee determines that the performance goal set forth on Exhibit A is not met at the minimum level, no shares will vest.

Any social security calculation or other adjustments discovered after the payment of Net Shares will be settled in cash not in Common Stock.

ARTICLE III

CAPITAL CHANGES

In the event that the Committee shall determine that any Fundamental Corporate Event affects the Common Stock such that an adjustment is required to preserve, or to prevent enlargement of, the benefits or potential benefits made available under this Plan, then the Committee shall, in such manner as the Committee may deem equitable, adjust the number and kind of shares subject to the award of Performance Stock Units.  Additionally, the Committee may make provision for cash payment to a Grantee or the Successor of the Grantee.  However, the number of Performance Stock Units shall always be a whole number.
 
 
 
 
3
 

 
ARTICLE IV

CHANGE IN CONTROL

Notwithstanding any other provision of this Agreement to the contrary, upon the occurrence of a Change in Control, the Performance Stock Units not previously forfeited pursuant to this Terms of Award Agreement shall become immediately vested at a level which equals the greater of the number of Performance Stock Units that would have vested (x) at target-level 100% vesting, or (y) based on the Company’s actual performance level using the date on which the Change in Control occurs as the end of the Vesting Period.  Net Shares will be payable on the Vest Date, provided however, if within the 24 month period following the Change in Control the Company terminates Grantee’s employment without cause, the Net Shares will become payable as of such te rmination of employment date.  If an award is considered deferred compensation subject to Section 409A, the award will vest but the Change in Control will not accelerate the payment of the deferred Performance Stock Units unless the Change in Control also meets the definition of change in control set forth in Treasury Regulation Section 1.409A-3(i)(5).


ARTICLE V

TERMINATION OF EMPLOYMENT

(a)
Except as provided in (c) below, if, during the Vesting Period, Grantee shall cease to be employed by the Company, its Subsidiaries or Affiliates, for reason of death, Long-term Disability, Retirement or involuntary termination of employment by the Company, the portion of the Performance Stock Units that may vest on the Vest Date, if any, shall be calculated in accordance with the following formula:  (i) the number of completed months employed commencing on the first day of the Vesting Period divided by the number of months in the Vesting Period; multiplied by (ii) the number of Performance Stock Units, that otherwise would have vested.

(b)
Except as provided in (a) above, any Performance Stock Unit not vested as of the date Grantee terminates employment shall be forfeited at the time of cessation of employment; provided, however, that if Grantee’s employment is terminated by the Company other than for cause and Grantee has not previously, or does not subsequently, vest to any portion of the Performance Stock Unit in accordance with its terms, then upon the forfeiture of the entire Performance Stock Unit, the Company will pay Grantee an amount equal to the value of a single share of Common Stock, whether or not the forfeited Performance Stock Unit related to more than a single share of Common Stock, calculated as of the cessation of employment, if requested by Grantee, within 30 days of such cessation of employment.

(c) 
 No Performance Stock Unit will vest after the Company has terminated the employment of the Grantee for cause, unless the Committee, in its sole discretion, deems a payment to be warranted under the particular circumstances.  In addition, the Performance Stock Units will not vest if Grantee has willfully engaged in gross misconduct or other serious impropriety which the Company determines is likely to be damaging or detrimental to the Company, any Subsidiary or Affiliate.
 
 
(d)
Employment for purposes of determining the vesting rights of the Grantee and the expiration of the grant under this Article V shall mean continuous active full-time salaried employment with the Company, a Subsidiary or an Affiliate, except that the period during which the Grantee is on vacation, sick leave, or other pre-approved leave of absence (provided there is no actual termination of employment), shall not interrupt the continuous employment of the Grantee.  Employment shall also include service with Aetna Foundation, Inc.  Notwithstanding any period during which Grantee receives salary continuation or severance shall not be considered as part of the continuous employment of the Grantee.
 

 
 
4
 


ARTICLE VI

EMPLOYEE COVENANTS

(a)
As consideration for this grant of Performance Stock Units, without prior written consent of the Company:

 
 
(i)
Grantee will not (except to the extent required by an order of a court having competent jurisdiction or under subpoena from an appropriate government agency) use or disclose to any third person, whether during or subsequent to Grantee’s employment, any trade secrets, confidential information and proprietary materials, which may include, but are not limited to, the following categories of information and materials: customer lists and identities; provider lists and identities; employee lists and identities; product development and related information; marketing plans and related information; sales plans and related information; premium or other pricing information; operating policies and manuals; research; payment rates; methodologies; procedures; contractual forms; business plans; financial records; computer programs; database; or other financial, commercial, business or technical information related to the Co mpany or any Subsidiary or Affiliate unless such information has been previously disclosed to the public by the Company or has become public knowledge other than by a breach of this Agreement; provided, however, that this limitation shall not apply to any such use or disclosure made while Grantee is employed by the Company, any Subsidiary or Affiliate if such disclosure occurred in connection with the performance of Grantee’s job as an employee of the Company, any Subsidiary or Affiliate;

 
 
(ii)
Grantee will not, during and for a period of 12 months or 24 months for executive tier employees (the executive tier status determined as of the effective date of this grant) following Grantee’s termination of Employment, directly or indirectly induce or attempt to induce any employee to be employed or perform services elsewhere;
 
 
 
 
(iii)
Grantee will not, during and for a period of 12 months or 24 months for executive tier employees (the executive tier status determined as of the effective date of this grant) following Grantee's termination of Employment, directly or indirectly, induce or attempt to induce any agent or agency, broker, supplier or health care provider of the Company or any Subsidiary to cease or curtail providing services to the Company or any Subsidiary; and

 
 
(iv)
Grantee will not, during and for a period of 12 months or 24 months for executive tier employees (the executive tier status determined as of the effective date of this grant) following Grantee’s termination of Employment, directly or indirectly solicit or attempt to solicit the trade of any individual or entity which, at the time of such solicitation, is a customer of the Company, any Subsidiary or Affiliate, or which the Company, any Subsidiary or Affiliate is undertaking reasonable steps to procure as a customer at the time of or immediately preceding termination of Employment; provided, however, that this limitation shall only apply to any product or service which is in competition with a product or service of the Company, any Subsidiary or Affiliate and shall apply only with respect to a customer or prospective customer with whom the Grantee has been directly or indirectly involved.
 
 
 
 
5
 
 

 
 
In addition:

(v)  
Following the termination of Grantee’s Employment, Grantee shall provide assistance to and shall cooperate with the Company or a Subsidiary or Affiliate, upon its reasonable request and without additional compensation, with respect to matters within the scope of Grantee’s duties and responsibilities during Employment, provided that any reasonable out-of-pocket expenses Grantee incurs in connection with any assistance Grantee has been requested to provide under this provision for items including, but not limited to, transportation, meals, lodging and telephone, shall be reimbursed by the Company.  The Company agrees and acknowledges that it shall, to the maximum extent possible under the then prevailing circumstances, coordinate, or cause a Subsidiary or Affiliate to coordinate, any such request with Grantee’s other commitme nts and responsibilities to minimize the degree to which such request interferes with such commitments and responsibilities; and

 
(vi)
Grantee shall promptly notify the Company’s General Counsel if Grantee is contacted by a regulatory or self-regulatory agency with respect to matters pertaining to the Company or by an attorney or other individual who informs the Grantee that he/she has filed, intends to file, or is considering filing a claim or complaint against the Company.

 
(vii)
Grantee acknowledges that all original works of authorship that are created by Grantee (solely or jointly with others) within the scope of Grantee’s employment which are protectable by copyright are “works made for hire” as that term is defined in the United States Copyright Act (17 U.S.C. Section 101).  Grantee further acknowledges that while employed by the Company, Grantee may develop ideas, inventions, discoveries, innovations, procedures, methods, know-how or other works which relate to the Company’s current or are reasonably expected to relate to the Company’s future business that may be patentable or subject to trade secret protection.  Grantee agrees that all such works of authorship, ideas, inventions, discoveries, innovations, procedures, methods, know-how and other works shall belong exclusively to the Company, and the Grantee hereby assigns all right, ti tle, and interest therein to the Company.

To the extent any of the foregoing works may be patentable, Grantee agrees that the Company may file and prosecute any application for patents for such works and that the Grantee will, on request, execute assignments to the Company relating to (and take all such further steps as may be reasonably necessary to perfect the Company’s sole and exclusive ownership of) any such application and any patents resulting there from.
 
(b)
If any provision of Article VI (a) is determined by a court of competent jurisdiction not to be enforceable in the manner set forth herein, the Company and Grantee agree that it is the intention of the parties that such provision should be enforceable to the maximum extent possible under applicable law and that such court shall reform such provision to make it enforceable in accordance with the intent of the parties.

(c)    
Grantee acknowledges that a material part of the inducement for the Company to grant the Performance Stock Units is Grantee’s covenants set forth in Article VI (a) and that the covenants and obligations of Grantee with respect to nondisclosure, non-solicitation and cooperation relate to special, unique and extraordinary matters and that a violation of any of the terms of such covenants and obligations will cause the Company irreparable injury for which adequate remedies are not available at law.  Therefore, Grantee agrees that, if Grantee shall breach any of those covenants or obligations, Grantee shall not be entitled to vest in the Performance Stock or be entitled to retain any income therefrom and the Company shall be entitled to an injunction, restraining order or such other equitable relief (without the requirement to post bond) r estraining Grantee from committing any violation of the covenants and obligations contained in Article VI.  The remedies in the preceding sentence are cumulative and are in addition to any other rights and remedies the Company may have at law or in equity as a court or arbitrator shall reasonably determine.
 
 
 
 
6
 
 

 
(d)
Employment Dispute Arbitration Program - Mandatory Binding Arbitration of Employment Disputes.

(i)   
Except as otherwise specified in this Agreement, the Grantee and the Company agree that all employment-related legal disputes between them will be submitted to and resolved by binding arbitration, and neither the Grantee nor the Company will file or participate as an individual party or member of a class in a lawsuit in any court against the other with respect to such matters.  This shall apply to claims brought on or after the date the Grantee accepts this Agreement, even if the facts and circumstances relating to the claim occurred prior to that date and regardless of whether the Grantee or the Company previously filed a complaint/charge with a government agency concerning the claim.

For purposes of Article VI (d) of this Agreement, “the Company” includes Aetna Inc., its Subsidiaries and Affiliates, their predecessors, successors and assigns, and those acting as representatives or agents of those entities.  THE GRANTEE UNDERSTANDS THAT, WITH RESPECT TO CLAIMS SUBJECT TO THE ARBITRATION REQUIREMENT, ARBITRATION REPLACES THE RIGHT OF THE GRANTEE AND THE COMPANY TO SUE OR PARTICIPATE IN A LAWSUIT.  THE GRANTEE ALSO UNDERSTANDS THAT IN ARBITRATION, A DISPUTE IS RESOLVED BY AN ARBITRATOR INSTEAD OF A JUDGE OR JURY, AND THE DECISION OF THE ARBITRATOR IS FINAL AND BINDING.

 
(ii)
THE GRANTEE UNDERSTANDS THAT THE ARBITRATION PROVISIONS OF THIS AGREEMENT AFFECT THE LEGAL RIGHTS OF THE GRANTEE AND THE COMPANY AND ACKNOWLEDGES THAT THE GRANTEE HAS BEEN ADVISED TO, AND HAS BEEN GIVEN THE OPPORTUNITY TO, OBTAIN LEGAL ADVICE BEFORE SIGNING THIS AGREEMENT.

 
(iii)
Article VI (d) of this Agreement does not apply to workers’ compensation claims, unemployment compensation claims, and claims under the Employee Retirement Income Security Act of 1974 (“ERISA”) for employee benefits.  A dispute as to whether Article VI (d) of this Agreement applies must be submitted to the binding arbitration process set forth in this Agreement.

 
(iv)
The Grantee and/or the Company may seek emergency or temporary injunctive relief from a court (including with respect to claims arising out of Article VI (a) in accordance with applicable law).  However, except as provided in Article VI (c) of this Agreement, after the court has issued a ruling concerning the emergency or temporary injunctive relief, the Grantee and the Company shall be required to submit the dispute to binding arbitration pursuant to this Agreement.

 
(v)
Unless otherwise agreed, the arbitration will be administered by the American Arbitration Association (the “AAA”) and will be conducted pursuant to the AAA’s Employment Arbitration Rules and Mediation Procedures (the “Rules”), as modified in this Agreement, in effect at the time the request for arbitration is filed.  The AAA’s Rules are available on the AAA’s website at www.adr.org. THE GRANTEE ACKNOWLEDGES THAT THE COMPANY HAS ENCOURAGED THE GRANTEE TO READ THESE RULES PROMPTLY AND CAREFULLY AND THAT THE GRANTEE HAS BEEN AFFORDED SUFFICIENT OPPORTUNITY TO DO SO.

 
(vi)
If the Company initiates a request for arbitration, the Company will pay all of the administrative fees and costs charged by the AAA, including the arbitrator’s compensation and charges for hearing room rentals, etc.  If the Grantee initiates a request for arbitration or submits a counterclaim to the Company’s request for arbitration, the Grantee shall be required to contribute One Hundred Dollars ($100.00) to those administrative fees and costs, payable to the AAA at the time the Grantee's request for arbitration or counterclaim is submitted.  The Company may increase the contribution amount in the future without amending this Agreement, but not to exceed the maximum permitted under the AAA rules then in effect. In all cases, the Grantee and the Company shall be responsible for payment
 
 
 
 
7
 
 

 
 
 
 of any fees assessed by the arbitrator as a result of that party’s delay, request for postponement, failure to comply with the arbitrator’s rulings and for other similar reasons.
 
 
(vii)
The Grantee and the Company may choose to be represented by legal counsel in the arbitration process and shall be responsible for their own legal fees, expenses and costs.  However, the arbitrator shall have the same authority as a court to order the Grantee or the Company to pay some or all of the other’s legal fees, expenses and costs, in accordance with applicable law.

 
(viii)
Unless otherwise agreed, there shall be a single arbitrator, selected by the Grantee and the Company from a list of qualified neutrals furnished by the AAA.  If the Grantee and the Company cannot agree on an arbitrator, one will be selected by the AAA.

 
(ix)
Unless otherwise agreed, the arbitration hearing will take place in the city where the Grantee works or last worked for the Company.  If the Grantee and the Company disagree as to the proper locale, the AAA will decide.

 
(x)
The Grantee and the Company shall be entitled to conduct limited pre-hearing discovery.  Each may take the deposition of one person and anyone designated by the other as an expert witness.  The party taking the deposition shall be responsible for all associated costs, such as the cost of a court reporter and the cost of an original transcript.  Each party also has the right to submit one set of ten written questions (including subparts) to the other party, which must be answered under oath, and to request and obtain all documents on which the other party relies in support of its answers to the written questions.  Additional discovery may be permitted by the arbitrator upon a showing that it is necessary for that party to have a fair opportunity to present a claim or defense.

 
(xi)
The arbitrator shall apply the same substantive law that would apply if the matter were heard by a court and shall have the authority to order the same remedies (but no others) as would be available in a court proceeding.  The time limits for requesting arbitration or submitting a counterclaim and the administrative prerequisites for filing an arbitration claim or counterclaim are the same as they would be in a court proceeding.  The arbitrator shall consider and decide any dispositive motions (motions seeking a decision on some or all of the claims or counterclaims without an arbitration hearing) filed by any party.

 
(xii)
All proceedings, including the arbitration hearing and decision, are private and confidential, unless otherwise required by law.  Arbitration decisions may not be published or publicized without the consent of both the Grantee and the Company.

            (xiii)
 Unless otherwise agreed, the arbitrator’s decision will be in writing with a brief summary of the arbitrator’s opinion.

 
(xiv)
The arbitrator’s decision is final and binding on the Grantee and the Company.  After the arbitrator’s decision is issued, the Grantee or the Company may obtain an order of judgment from a court and may obtain a court order enforcing the decision.  The arbitrator’s decision may be appealed to the courts only under the limited circumstances provided by law.

 
(xv)
If the Grantee previously signed an agreement, including but not limited to an employment agreement, containing arbitration provisions, those provisions are superseded by the arbitration provisions of this Agreement.

 
(xvi)
If any provision of Article VI (d) is found to be void or otherwise unenforceable, in whole or in part, this shall not affect the validity of the remainder of Article VI (d) and the remainder of the Agreement.  All other provisions shall remain in full force and effect.
 
 
 
 
8
 
 
 
For purposes of this Article VI, the term “Employment” shall refer to active employment with the Company, any Subsidiary or Affiliate, and shall not include salary continuation or severance periods.

ARTICLE VII

OTHER TERMS

(a)
Nothing in this Agreement shall interfere with or limit in any way the right of the Company or any Subsidiary or Affiliate to terminate the Grantee’s employment at any time.  Neither the execution and delivery hereof nor the granting of the Award shall constitute or be evidence of any agreement or understanding, express or implied, on the part of the Company or any of its Subsidiaries to employ or continue the employment of the Grantee for any period.

(b)
Until the Performance Stock Units have become vested, Grantee shall not have any rights as a stockholder (including the right to payment of dividends) by virtue of this grant of Performance Stock Units.

(c)
During the Vesting Period, the Performance Stock Units shall be nontransferable and non-assignable except by will or the laws of descent and distribution.

(d)
The award, when vested, will be settled on a net basis.  Prior to issuing any Common Shares, the Company will withhold an amount sufficient to satisfy federal, state, local, social security and Medicare withholding tax requirements relating to award.  Any social security calculation or other adjustments discovered after net share payment will be settled in cash, not in Shares of Common Stock.  Vesting will result in taxable compensation reportable on the Grantee’s W-2 in year of vesting.

(e)
The Company may from time to time adopt stock ownership requirements applicable to Grantees who are senior managers of the Company.  In connection with and for the purpose of implementing those ownership requirements, the Company may adopt certain restrictions on the ability of a Grantee to sell shares issued under this Agreement when such ownership requirements have not been satisfied.  Any such restriction on sale will be communicated generally to affected Grantees and the restriction may be modified by the Company from time to time, at its discretion.  Neither the Company nor its Board of Directors shall have any obligation or liability to a Grantee in connection with any such restriction.

(f)
This Performance Stock Unit is an unfunded obligation of the Company and nothing in this Agreement shall be construed to create any claim against particular assets or require the Company to segregate or otherwise set aside any assets or create any fund to meet its obligations hereunder.

(g)
Anything herein to the contrary notwithstanding, a Grantee whose Performance Stock Units have been forfeited as a result of termination of employment due to U.S. Military Service and who is later re-employed (in a full-time active status) after discharge within the time period set in 38 U.S.C. Section 4312 will be eligible to have the forfeited Performance Stock Units reinstated as follows: (i) if such Grantee is re-employed during the Vesting Period, all forfeited Performance Stock Units shall be reinstated; or (ii) if such Grantee is re-employed after the Vesting Period, a cash payment will be made to the Grantee, minus applicable taxes, for the value of the forfeited Performance Stock Units on the Vest Date pursuant to procedures established by the Company for this purpose.

(h)
It is the intention of the Company and Grantee that this Agreement not result in unfavorable tax consequences to Grantee under Section 409A and the Agreement shall be interpreted as to so comply.  Notwithstanding anything to the contrary herein, the Company and Grantee agree to the provisions set forth below in order to comply with the requirements of Section 409A.
 
 
 
 
9
 

 
 
(i)
If Grantee is a “specified employee” (within the meaning of Section 409A) with respect to the Company, any non-qualified deferred compensation otherwise payable to or in respect of Grantee in connection with Grantee’s termination of employment shall be delayed until the earliest date upon which such amounts may be paid without being subject to taxation under Section 409A.  Any amount, the payment or benefit of which is delayed by application of the preceding sentence, shall be paid as soon as possible following the expiration of such period.

 
(ii)
Unless deferred pursuant to this agreement, all payments shall be paid to Grantee, to the extent earned, in no event later than the last day of the “applicable 2 ½ month period,” as such term is defined in Treasury Regulation Section 1.409A-1(b)(4)(i)(A) with respect to such payment’s treatment as a “short-term deferral” for purposes of Section 409A.

 
(iii)
The Company and Grantee agree to cooperate in good faith in an effort to comply with Section 409A.  Under no circumstances shall the Company be responsible for any taxes, penalties, interest or other losses or expenses incurred by the Grantee due to any failure to comply with Section 409A.

(i)
This Agreement is subject to the 2000 Stock Incentive Plan heretofore adopted by the Company and approved by its shareholders.  The terms and provisions of the Plan (including any subsequent amendments thereto) are hereby incorporated herein by reference.  In the event of a conflict between any term or provision contained herein and a term or provision of the Plan, the applicable terms and provisions of the Plan will govern and prevail.

(j)
At such times and upon such terms and conditions as the Company shall determine, the Company may permit eligible Grantees to elect to defer the distribution of an Award otherwise payable to the Grantee under this Agreement until termination of the Grantee’s Employment or such other date Company shall permit.
 
 

 
10
 

EX-10.3 4 exhibit10-3.htm EXHIBIT 10.3 exhibit10-3.htm  
 
Exhibit 10.3  
 

AETNA INC.
2000 STOCK INCENTIVE PLAN

RESTRICTED STOCK UNIT TERMS OF AWARD

Pursuant to its 2000 Stock Incentive Plan (the "Plan"), Aetna Inc. (the "Company") hereby grants Restricted Stock Units on the terms and conditions hereinafter set forth.  The number of Restricted Stock Units awarded and vesting information are included in the website of the designated broker, currently UBS Financial Services, Inc., and in the Notice of the Restricted Stock Unit Acknowledgement and Acceptance Form, if applicable.  All capitalized terms used herein which are not otherwise defined herein shall have the meaning specified in the Plan.
 

ARTICLE I

DEFINITIONS

(a)
“Affiliate" means an entity at least a majority of the total voting power of the then-outstanding voting securities of which is held, directly or indirectly, by the Company and/or one or more other Affiliates.

(b)
"Board" means the Board of Directors of Aetna Inc.

(c)           "Change in Control" means the happening of any of the following:

(i)  
When any "person" as defined in Section 3(a)(9) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and as used in Sections 13(d) and 14(d) thereof, including a "group" as defined in Section 13(d) of the Exchange Act but excluding the Company and any Subsidiary thereof and any employee benefit plan sponsored or maintained by the Company or any Subsidiary (including any trustee of such plan acting as trustee), directly or indirectly, becomes the "beneficial owner" (as defined in Rule 13d-3 under the Exchange Act, as amended from time to time), of securities of the Company representing 20 percent or more of the combined voting power of the Company's then outstanding securities;

(ii)  
When, during any period of 24 consecutive months, the individuals who, at the beginning of such period, constitute the Board (the "Incumbent Directors") cease for any reason other than death to constitute at least a majority thereof, provided that a director who was not a director at the beginning of such 24-month period shall be deemed to have satisfied such 24-month requirement (and be an Incumbent Director) if such director was elected by, or on the recommendation of or with the approval of, at least two-thirds of the directors who then qualified as Incumbent Directors either actually (because they were directors at the beginning of such 24-month period) or by prior operation of this paragraph (ii); or

 
(iii)
The occurrence of a transaction requiring stockholder approval for the acquisition of the Company by an entity other than the Company or a Subsidiary through purchase of assets, or by merger, or otherwise.
 
 
 
Notwithstanding the foregoing, in no event shall a “Change in Control” be deemed to have occurred (i) as a result of the formation of a Holding Company, or (ii) with respect to Grantee, if Grantee is part of a “group,” within the meaning of Section 13(d)(3) of the Exchange Act as in effect on the effective date, which consummates the Change in Control transaction.  In addition, for purposes of the definition of “Change in Control” a person engaged in business as an underwriter of securities shall not be deemed to be the “Beneficial Owner” of, or to “beneficially
 
 
 
 
1
 
 
 
 
own,” any securities acquired through such person’s participation in good faith in a firm commitment underwriting until the expiration of forty days after the date of such acquisition.
 
(d)
"Committee" means the Board's Committee on Compensation and Organization or any successor thereto.

(e)
"Common Stock" means the Company's Common Shares, $.01 par value per share.

(f)
"Company" means Aetna Inc.

(g)
"Effective Date" means the date of grant of this award of Restricted Stock Units.

(h)
“Fair Market Value" means the closing price of the Common Stock as reported by the Consolidated Tape of the New York Stock Exchange Listed Shares on the date such value is to be determined, or, if no shares were traded on such date, on the next day on which the Common Stock is traded.

(i)
“Fundamental Corporate Event” shall mean any stock dividend, extraordinary cash dividend, recapitalization, reorganization, merger, consolidation, split-up, spin-off, combination, exchange of shares, warrants or rights offering to purchase Common Stock at a price substantially below fair market value, or similar event.

(j)
"Grantee" means the person to whom this award has been granted.

(k)
“Holding Company” means an entity that becomes a holding company for the Company or its businesses as a part of any reorganization, merger, consolidation or other transaction, provided that the outstanding shares of common stock of such entity and the combined voting power of the then outstanding voting securities of such entity entitled to vote generally in the election of directors is, immediately after such reorganization, merger, consolidation or other transaction, beneficially owned, directly or indirectly, by all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the voting stock outstanding immediately prior to such reorganization, merger, consolidation or other transaction in substantially the same proportions as their ownership, immediately prior to such reorganization, merger, consolidation or other transaction, of such outstanding voting stoc k.

(l)
"Long Term Disability" means long-term disability as defined under the terms of the Company's applicable long-term disability plans or policies.

(m)
“Net Shares” means the number of shares of Common Stock which will be deposited in a brokerage account in the Grantee’s name at the Company’s designated broker after shares have been withheld to satisfy applicable tax and withholding requirements upon vesting of the Restricted Stock Units.

(n)
“Plan” means the Aetna Inc. 2000 Stock Incentive Plan.

(o)
“Restricted Period” means the period during which this award of Restricted Stock Units is not vested.

(p)
“Restricted Stock Units” means the number of shares of Common Stock represented by the number of units awarded or such other amount as may result by operation of Article III of this Agreement.

(q)
"Retirement" means the termination of employment of a Grantee from active service with the Company, a Subsidiary or Affiliate provided the Grantee’s age and completed years of service total 65 or more points at termination of employment.

(r)
“Section 409A” means Section 409A of the Internal Revenue Code of 1986, as amended, and the regulation issued thereunder, as may be amended from time to time.
 
 
 
 
2
 
 
 
(s)
“Shares of Stock” or “Stock” means the Common Stock.

(t)
"Subsidiary" means an entity of which, at the time such subsidiary status is to be determined, at least 50% of the total combined voting power of all classes of stock of such entity is held by the Company and/or one or more other subsidiaries.

(u)
"Successor" means the legal representative of the estate of a deceased Grantee or the person or persons who shall acquire the right to the Restricted Stock Units by bequest or inheritance or by reason of the death of the Grantee.

(v)
“Vest Date” means the date on which this award of Restricted Stock Units shall vest in accordance with the terms of this Agreement and as set forth on the website of the designated broker and in the Notice of Restricted Stock Unit Grant, if applicable.

ARTICLE II

RESTRICTED PERIOD

Subject to the terms of this Agreement, the Restricted Stock Units will vest in installments on the Vest Date in accordance with the terms of the Plan and this Terms of Award Agreement, or on such date as provided in Article IV or V.  On the Vest Date, the Grantee shall vest to one share of Common Stock for each vested Restricted Stock Unit net of applicable taxes and withholding. Such Net Shares will be delivered to the Company’s designated broker, in a brokerage account established in the Grantee’s name.



ARTICLE III

CAPITAL CHANGES

In the event that the Committee shall determine that any Fundamental Corporate Event affects the Common Stock such that an adjustment is required to preserve, or to prevent enlargement of, the benefits or potential benefits made available under this Plan, then the Committee shall, in such manner as the Committee may deem equitable, adjust the number and kind of shares subject to the award of Restricted Stock Units.  Additionally, the Committee may make provision for cash payment to a Grantee or the Successor of the Grantee to the extent permitted under Section 409A.  However, the number of Restricted Stock Units shall always be a whole number.

ARTICLE IV

CHANGE IN CONTROL

Upon the occurrence of (i) a Change in Control, and (ii) within 24 months thereafter the Company terminates Grantee’s Employment without cause, all RSUs, whether or not vested, shall become immediately vested and become payable, provided, however, that, as set forth in the Plan, to the extent the RSUs are considered deferred compensation subject to Section 409A, unless the Change in Control also satisfies the definition of “change in control” under Section 409A, payment shall not be so accelerated but shall occur upon the scheduled Vest Date(s) under Article II.
 
 
 
 
3
 

 
ARTICLE V

TERMINATION OF EMPLOYMENT

(a)  
Except as provided in (f) below, if the Grantee shall die during the Restricted Period, the unvested Restricted Stock Units shall become immediately vested and Net Shares, if any, will be deposited with the Company’s designated broker in a brokerage account established in Grantee’s name.

(b)
Except as provided in (f) below, if the Grantee shall begin to receive Long Term Disability benefits during the Restricted Period, the unvested Restricted Stock Units shall continue to vest and Net Shares, if any, will be deposited with the Company’s designated broker in a brokerage account established in Grantee’s name on the scheduled Vest Date(s) under Article II.
 
 
(c)
Except as provided in (f) below, if, during the restricted period, Grantee shall cease to be employed by the Company, its Subsidiaries or Affiliates during the Restricted Period, for reason of Retirement or involuntary termination of employment by the Company, a portion of the Restricted Stock Units shall vest in accordance with the following formula:  (i) the number of completed months employed after the Effective Date divided by the number of full months in the restricted period; multiplied by (ii) number of Restricted Stock Units, minus any vested Restricted Stock Units.   For purposes of this calculation, a month is complete on the day in the following month that corresponds to the Effective Date (e.g., February 13 to March 13).  Net shares, if any, will be deposited with the Company’s designated broker in a brokerage account established in Grantee’s name on the ne xt scheduled Vest Date under Article II and, applicable taxes and withholding will be applied based on the Fair Market Value on that date.

(d)
Except as provided in (e) and (f) below, if the Grantee shall, for a reason other than death, Long-Term Disability, Retirement or involuntary termination of employment by the Company, cease to be employed by the Company, its Subsidiaries or Affiliates during the Restricted Period, any unvested Restricted Stock Units shall be forfeited at the time of cessation of employment.
 
 
(e) 
Except as provided in (a) or (b) or (c) above, any Restricted Stock Unit not vested as of the date Grantee terminates employment shall be forfeited at the time of cessation of employment; provided, however, that if Grantee’s employment is terminated by the Company other than for cause and Grantee has not previously, or does not subsequently, vest to any portion of the Restricted Stock Unit in accordance with its terms, then upon the forfeiture of the entire Restricted Stock Unit, the Company will pay Grantee an amount equal to the value of a single share of Common Stock, whether or not the forfeited Restricted Stock Unit related to more than a single share of Common Stock, calculated as of the cessation of employment, if requested by Grantee, within 30 days of such cessation of employment.
 
 
(f)
 No Restricted Stock Unit will vest after the Company has terminated the employment of the Grantee for cause, unless the Committee, in its sole discretion, deems a payment to be warranted under the particular circumstances. In addition, the Restricted Stock Units will not vest if Grantee has willfully engaged in gross misconduct or other serious impropriety which the Company determines is likely to be damaging or detrimental to the Company, any Subsidiary or Affiliate.
 
 
(g)
Employment for purposes of determining the vesting rights of the Grantee and the expiration of the grant under this Article V shall mean continuous full-time salaried employment with the Company, a Subsidiary or an Affiliate, except that the period during which the Grantee is on vacation, sick leave, or other pre-approved leave of absence (provided there is no actual termination of employment), or in receipt of salary continuation or severance pay shall not interrupt the continuous employment of the Grantee.  Employment shall also include service with Aetna Foundation, Inc.
 
 
 
 
4
 

 
ARTICLE VI

EMPLOYEE COVENANTS

(a)
As consideration for this grant of Restricted Stock Units, without prior written consent of the Company:

 
 
(i)
Grantee will not (except to the extent required by an order of a court having competent jurisdiction or under subpoena from an appropriate government agency) use or disclose to any third person, whether during or subsequent to Grantee’s employment, any trade secrets, confidential information and proprietary materials, which may include, but are not limited to, the following categories of information and materials: customer lists and identities; provider lists and identities; employee lists and identities; product development and related information; marketing plans and related information; sales plans and related information; premium or other pricing information; operating policies and manuals; research; payment rates; methodologies; procedures; contractual forms; business plans; financial records; computer programs; database; or other financial, comm ercial, business or technical information related to the Company or any Subsidiary or Affiliate unless such information has been previously disclosed to the public by the Company or has become public knowledge other than by a breach of this Agreement; provided, however, that this limitation shall not apply to any such use or disclosure made while Grantee is employed by the Company, any Subsidiary or Affiliate if such disclosure occurred in connection with the performance of Grantee’s job as an employee of the Company, any Subsidiary or Affiliate;

 
 
(ii)
Grantee will not, during and for a period of 12 months or 24 months for executive tier employees (the executive tier status determined as of the effective date of this grant) following Grantee’s termination of Employment, directly or indirectly induce or attempt to induce any employee to be employed or perform services elsewhere;
 
 
 
 
(iii)
Grantee will not, during and for a period of 12 months or 24 months for executive tier employees (the executive tier status determined as of the effective date of this grant) following Grantee's termination of Employment, directly or indirectly, induce or attempt to induce any agent or agency, broker, supplier or health care provider of the Company or any Subsidiary to cease or curtail providing services to the Company or any Subsidiary; and

 
 
(iv)
Grantee will not, during and for a period of 12 months or 24 months for executive tier employees (the executive tier status determined as of the effective date of this grant) following Grantee’s termination of Employment, directly or indirectly solicit or attempt to solicit the trade of any individual or entity which, at the time of such solicitation, is a customer of the Company, any Subsidiary or Affiliate, or which the Company, any Subsidiary or Affiliate is undertaking reasonable steps to procure as a customer at the time of or immediately preceding termination of Employment; provided, however, that this limitation shall only apply to any product or service which is in competition with a product or service of the Company, any Subsidiary or Affiliate and shall apply only with respect to a customer or prospective customer with whom the Grantee has been directly or indirectly involved.

 
In addition:

(v)  
Following the termination of Grantee’s Employment, Grantee shall provide assistance to and shall cooperate with the Company or a Subsidiary or Affiliate, upon its reasonable request and without additional compensation, with respect to matters within the scope of Grantee’s duties and responsibilities during Employment, provided that any reasonable out-of-pocket expenses Grantee incurs in connection with any assistance Grantee has been requested to provide under this provision for items including, but not limited to, transportation, meals, lodging and telephone, shall be reimbursed by the Company.  The Company agrees and acknowledges that it shall, to the maximum extent possible under the then prevailing circumstances, coordinate, or cause a Subsidiary or Affiliate to coord inate,
 
 
 
 
5
 
 

 
any such request with Grantee’s other commitments and responsibilities to minimize the degree to which such request interferes with such commitments and responsibilities; and
 
 
(vi)
Grantee shall promptly notify the Company’s General Counsel if Grantee is contacted by a regulatory or self-regulatory agency with respect to matters pertaining to the Company or by an attorney or other individual who informs the Grantee that he/she has filed, intends to file, or is considering filing a claim or complaint against the Company.


 
(vii)
Grantee acknowledges that all original works of authorship that are created by Grantee (solely or jointly with others) within the scope of Grantee’s employment which are protectable by copyright are “works made for hire” as that term is defined in the United States Copyright Act (17 U.S.C. Section 101).  Grantee further acknowledges that while employed by the Company, Grantee may develop ideas, inventions, discoveries, innovations, procedures, methods, know-how or other works which relate to the Company’s current or are reasonably expected to relate to the Company’s future business that may be patentable or subject to trade secret protection.  Grantee agrees that all such works of authorship, ideas, inventions, discoveries, innovations, procedures, methods, know-how and other works shall belong exclusively to the Company, and the Grantee hereby assigns all right, ti tle, and interest therein to the Company.

To the extent any of the foregoing works may be patentable, Grantee agrees that the Company may file and prosecute any application for patents for such works and that the Grantee will, on request, execute assignments to the Company relating to (and take all such further steps as may be reasonably necessary to perfect the Company’s sole and exclusive ownership of) any such application and any patents resulting therefrom.

(b)
If any provision of Article VI (a) is determined by a court of competent jurisdiction not to be enforceable in the manner set forth herein, the Company and Grantee agree that it is the intention of the parties that such provision should be enforceable to the maximum extent possible under applicable law and that such court shall reform such provision to make it enforceable in accordance with the intent of the parties.

(c)    
Grantee acknowledges that a material part of the inducement for the Company to grant the Restricted Stock Units is Grantee’s covenants set forth in Article VI (a) and that the covenants and obligations of Grantee with respect to nondisclosure, non-solicitation and cooperation relate to special, unique and extraordinary matters and that a violation of any of the terms of such covenants and obligations will cause the Company irreparable injury for which adequate remedies are not available at law.  Therefore, Grantee agrees that, if Grantee shall breach any of those covenants or obligations, Grantee shall not be entitled to vest in the Restricted Stock or be entitled to retain any income therefrom and the Company shall be entitled to an injunction, restraining order or such other equitable relief (without the requirement to post bond) res training Grantee from committing any violation of the covenants and obligations contained in Article VI.  The remedies in the preceding sentence are cumulative and are in addition to any other rights and remedies the Company may have at law or in equity as a court or arbitrator shall reasonably determine.

(d)
Employment Dispute Arbitration Program - Mandatory Binding Arbitration of Employment Disputes.

(i)  
Except as otherwise specified in this Agreement, the Grantee and the Company agree that all employment-related legal disputes between them will be submitted to and resolved by binding arbitration, and neither the Grantee nor the Company will file or participate as an individual party or member of a class in a lawsuit in any court against the other with respect to such matters.  This shall apply to claims brought on or after the date the Grantee accepts this Agreement, even if the facts and circumstances relating to the claim occurred prior to that date and regardless of whether the Grantee or the Company previously filed a complaint/charge with a government agency concerning the claim.
 
 
 
 
6
 
 
 
For purposes of Article VI (d) of this Agreement, “the Company” includes Aetna Inc., its Subsidiaries and Affiliates, their predecessors, successors and assigns, and those acting as representatives or agents of those entities.  THE GRANTEE UNDERSTANDS THAT, WITH RESPECT TO CLAIMS SUBJECT TO THE ARBITRATION REQUIREMENT, ARBITRATION REPLACES THE RIGHT OF THE GRANTEE AND THE COMPANY TO SUE OR PARTICIPATE IN A LAWSUIT.  THE GRANTEE ALSO UNDERSTANDS THAT IN ARBITRATION, A DISPUTE IS RESOLVED BY AN ARBITRATOR INSTEAD OF A JUDGE OR JURY, AND THE DECISION OF THE ARBITRATOR IS FINAL AND BINDING.

 
(ii)
THE GRANTEE UNDERSTANDS THAT THE ARBITRATION PROVISIONS OF THIS AGREEMENT AFFECT THE LEGAL RIGHTS OF THE GRANTEE AND THE COMPANY AND ACKNOWLEDGES THAT THE GRANTEE HAS BEEN ADVISED TO, AND HAS BEEN GIVEN THE OPPORTUNITY TO, OBTAIN LEGAL ADVICE BEFORE SIGNING THIS AGREEMENT.

 
(iii)
Article VI (d) of this Agreement does not apply to workers’ compensation claims, unemployment compensation claims, and claims under the Employee Retirement Income Security Act of 1974 (“ERISA”) for employee benefits.  A dispute as to whether Article VI (d) of this Agreement applies must be submitted to the binding arbitration process set forth in this Agreement.

 
(iv)
The Grantee and/or the Company may seek emergency or temporary injunctive relief from a court (including with respect to claims arising out of Article VI (a) in accordance with applicable law).  However, except as provided in Article VI (c) of this Agreement, after the court has issued a ruling concerning the emergency or temporary injunctive relief, the Grantee and the Company shall be required to submit the dispute to binding arbitration pursuant to this Agreement.

 
(v)
Unless otherwise agreed, the arbitration will be administered by the American Arbitration Association (the “AAA”) and will be conducted pursuant to the AAA’s Employment Arbitration Rules and Mediation Procedures (the “Rules”), as modified in this Agreement, in effect at the time the request for arbitration is filed.  The AAA’s Rules are available on the AAA’s website at www.adr.org. THE GRANTEE ACKNOWLEDGES THAT THE COMPANY HAS ENCOURAGED THE GRANTEE TO READ THESE RULES PROMPTLY AND CAREFULLY AND THAT THE GRANTEE HAS BEEN AFFORDED SUFFICIENT OPPORTUNITY TO DO SO.

 
(vi)
If the Company initiates a request for arbitration, the Company will pay all of the administrative fees and costs charged by the AAA, including the arbitrator’s compensation and charges for hearing room rentals, etc.  If the Grantee initiates a request for arbitration or submits a counterclaim to the Company’s request for arbitration, the Grantee shall be required to contribute One Hundred Dollars ($100.00) to those administrative fees and costs, payable to the AAA at the time the Grantee's request for arbitration or counterclaim is submitted.  The Company may increase the contribution amount in the future without amending this Agreement, but not to exceed the maximum permitted under the AAA rules then in effect. In all cases, the Grantee and the Company shall be responsible for payment of any fees assessed by the arbitrator as a result of that party’s delay, request for postpo nement, failure to comply with the arbitrator’s rulings and for other similar reasons.

 
(vii)
The Grantee and the Company may choose to be represented by legal counsel in the arbitration process and shall be responsible for their own legal fees, expenses and costs.  However, the arbitrator shall have the same authority as a court to order the Grantee or the Company to pay some or all of the other’s legal fees, expenses and costs, in accordance with applicable law.

 
(viii)
Unless otherwise agreed, there shall be a single arbitrator, selected by the Grantee and the Company from a list of qualified neutrals furnished by the AAA.  If the Grantee and the Company cannot agree on an arbitrator, one will be selected by the AAA.
 
 
 
 
7
 
 
 
 
(ix)
Unless otherwise agreed, the arbitration hearing will take place in the city where the Grantee works or last worked for the Company.  If the Grantee and the Company disagree as to the proper locale, the AAA will decide.

 
(x)
The Grantee and the Company shall be entitled to conduct limited pre-hearing discovery.  Each may take the deposition of one person and anyone designated by the other as an expert witness.  The party taking the deposition shall be responsible for all associated costs, such as the cost of a court reporter and the cost of an original transcript.  Each party also has the right to submit one set of ten written questions (including subparts) to the other party, which must be answered under oath, and to request and obtain all documents on which the other party relies in support of its answers to the written questions.  Additional discovery may be permitted by the arbitrator upon a showing that it is necessary for that party to have a fair opportunity to present a claim or defense.

 
(xi)
The arbitrator shall apply the same substantive law that would apply if the matter were heard by a court and shall have the authority to order the same remedies (but no others) as would be available in a court proceeding.  The time limits for requesting arbitration or submitting a counterclaim and the administrative prerequisites for filing an arbitration claim or counterclaim are the same as they would be in a court proceeding.  The arbitrator shall consider and decide any dispositive motions (motions seeking a decision on some or all of the claims or counterclaims without an arbitration hearing) filed by any party.

 
(xii)
All proceedings, including the arbitration hearing and decision, are private and confidential, unless otherwise required by law.  Arbitration decisions may not be published or publicized without the consent of both the Grantee and the Company.

             (xiii)
Unless otherwise agreed, the arbitrator’s decision will be in writing with a brief summary of the arbitrator’s opinion.

 
(xiv)
The arbitrator’s decision is final and binding on the Grantee and the Company.  After the arbitrator’s decision is issued, the Grantee or the Company may obtain an order of judgment from a court and may obtain a court order enforcing the decision.  The arbitrator’s decision may be appealed to the courts only under the limited circumstances provided by law.

 
(xv)
If the Grantee previously signed an agreement, including but not limited to an employment agreement, containing arbitration provisions, those provisions are superseded by the arbitration provisions of this Agreement.

 
(xvi)
If any provision of Article VI (d) is found to be void or otherwise unenforceable, in whole or in part, this shall not affect the validity of the remainder of Article VI (d) and the remainder of the Agreement.  All other provisions shall remain in full force and effect.

For purposes of this Article VI, the term “Employment” shall refer to active employment with the Company, any Subsidiary or Affiliate, and shall not include salary continuation or severance periods.

 
ARTICLE VII

OTHER TERMS

(a)
Nothing in this Agreement shall interfere with or limit in any way the right of the Company or any Subsidiary or Affiliate to terminate the Grantee’s employment at any time.  Neither the execution and delivery hereof nor the granting of the Award shall constitute or be evidence of any agreement or
 
 
 
 
8
 
 
 
 
understanding, express or implied, on the part of the Company or any of its Subsidiaries to employ or continue the employment of the Grantee for any period.
 
(b)
Until the Restricted Stock Units have become vested, Grantee shall not have any rights as a stockholder (including the right to payment of dividends) by virtue of this grant of Restricted Stock Units.

(c)
During the Restricted Period, the Restricted Stock Units shall be nontransferable and non-assignable except by will or the laws of descent and distribution.

(d)
The award will be settled on a net basis.  Prior to issuing any Common Shares, the Company will withhold an amount sufficient to satisfy federal, state, local, social security and Medicare withholding tax requirements relating to award.  Any social security calculation or other adjustments discovered after net share payment will be settled in cash, not in Shares of Common Stock.  Vesting will result in taxable compensation reportable on the Grantee’s W-2 in year of vesting.

(e)
The Company may from time to time adopt stock ownership requirements applicable to Grantees who are senior managers of the Company.  In connection with and for the purpose of implementing those ownership requirements, the Company may adopt certain restrictions on the ability of a Grantee to sell shares issued under this Agreement when such ownership requirements have not been satisfied.  Any such restriction on sale will be communicated generally to affected Grantees and the restriction may be modified by the Company from time to time, at its discretion.  Neither the Company nor its Board of Directors shall have any obligation or liability to a Grantee in connection with any such restriction.

(f)
This Restricted Stock Unit is an unfunded obligation of the Company and nothing in this Agreement shall be construed to create any claim against particular assets or require the Company to segregate or otherwise set aside any assets or create any fund to meet its obligations hereunder.

(g)
Anything herein to the contrary notwithstanding, a Grantee whose Restricted Stock Units have been forfeited as a result of termination of employment due to U.S. Military Service and who is later re-employed (in a full-time active status) after discharge within the time period set in 38 U.S.C. Section 4312 will be eligible to have the forfeited Restricted Stock Units reinstated as follows: (i) if such Grantee is re-employed during the Restricted Period, all forfeited Restricted Stock Units shall be reinstated; or (ii) if such Grantee is re-employed after the Restricted Period, a cash payment will be made to the Grantee, minus applicable taxes, for the value of the forfeited Restricted Stock Units on the Vest Date pursuant to procedures established by the Company for this purpose.

(h)
If any provision of this Agreement would cause Grantee to incur any additional tax or interest under Section 409A, the Company may reform such provision (including an amendment retroactive to the Effective Date to the extent permissible) to comply with Section 409A.

(i)
If the Company reasonably anticipates that the Company’s tax deduction with respect to the payment upon vesting of the Restricted Stock Units would be limited or eliminated by application of Section 162(m) of the Internal Revenue Code, the Company may elect, in accordance with Section 409A, to delay the payment of such Restricted Stock Units to the earliest date in which the Company anticipates that its tax deduction for such payment will not be limited or eliminated.

(j)
This Agreement is subject to the 2000 Stock Incentive Plan heretofore adopted by the Company and approved by its shareholders.  The terms and provisions of the Plan (including any subsequent amendments thereto) are hereby incorporated herein by reference.  In the event of a conflict between any term or provision contained herein and a term or provision of the Plan, the applicable terms and provisions of the Plan will govern and prevail.
 
 
 
 
9
 
 
 
(k)
Voluntary Deferral.  At such times and upon such terms and conditions as the Company shall determine in accordance with the terms of the Plan and Section 409A, the Company may permit eligible Grantees to elect to defer the distribution of an Award otherwise payable to the Grantee under this Agreement until termination of the Grantee’s Employment or such other date Company shall permit.

 
I have read the Restricted Stock Unit Agreement. I accept the Restricted Stock Unit award and agree to be bound by all of its terms and conditions, including mandatory binding arbitration of employment related disputes and, if applicable, any other provisions of Article VI.
 
 
 
 
 
 
 
 
 
 
 

 
10
 

EX-10.4 5 exhibit10-4.htm EXHIBIT 10.4 exhibit10-4.htm  
 
Exhibit 10.4  
 

 
AETNA INC.
2000 STOCK INCENTIVE PLAN

RESTRICTED STOCK UNIT TERMS OF AWARD

Pursuant to its 2000 Stock Incentive Plan (the "Plan"), Aetna Inc. (the "Company") hereby grants Restricted Stock Units on the terms and conditions hereinafter set forth.  The number of Restricted Stock Units awarded and vesting information are included in the website of the designated broker, currently UBS Financial Services, Inc., and in the Notice of the Restricted Stock Unit Acknowledgement and Acceptance Form, if applicable.  All capitalized terms used herein which are not otherwise defined herein shall have the meaning specified in the Plan.


ARTICLE I

DEFINITIONS

(a)
“Affiliate" means an entity at least a majority of the total voting power of the then-outstanding voting securities of which is held, directly or indirectly, by the Company and/or one or more other Affiliates.

(b)
"Board" means the Board of Directors of Aetna Inc.

(c)        "Change in Control" means the happening of any of the following:

(i)  
When any "person" as defined in Section 3(a)(9) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and as used in Sections 13(d) and 14(d) thereof, including a "group" as defined in Section 13(d) of the Exchange Act but excluding the Company and any Subsidiary thereof and any employee benefit plan sponsored or maintained by the Company or any Subsidiary (including any trustee of such plan acting as trustee), directly or indirectly, becomes the "beneficial owner" (as defined in Rule 13d-3 under the Exchange Act, as amended from time to time), of securities of the Company representing 20 percent or more of the combined voting power of the Company's then outstanding securities;

(ii)  
When, during any period of 24 consecutive months, the individuals who, at the beginning of such period, constitute the Board (the "Incumbent Directors") cease for any reason other than death to constitute at least a majority thereof, provided that a director who was not a director at the beginning of such 24-month period shall be deemed to have satisfied such 24-month requirement (and be an Incumbent Director) if such director was elected by, or on the recommendation of or with the approval of, at least two-thirds of the directors who then qualified as Incumbent Directors either actually (because they were directors at the beginning of such 24-month period) or by prior operation of this paragraph (ii); or

 
      (iii)
The occurrence of a transaction requiring stockholder approval for the acquisition of the Company by an entity other than the Company or a Subsidiary through purchase of assets, or by merger, or otherwise.
 
 
 
Notwithstanding the foregoing, in no event shall a “Change in Control” be deemed to have occurred (i) as a result of the formation of a Holding Company, or (ii) with respect to Grantee, if Grantee is part of a “group,” within the meaning of Section 13(d)(3) of the Exchange Act as in effect on the effective date, which consummates the Change in Control transaction.  In addition, for purposes of the definition of “Change in Control” a person engaged in business as an underwriter of securities shall not be deemed to be the “Beneficial Owner” of, or to “beneficially
 
 
 
 
 
1
 
 
 
 
own,” any securities acquired through such person’s participation in good faith in a firm commitment underwriting until the expiration of forty days after the date of such acquisition.
 
(d)
"Committee" means the Board's Committee on Compensation and Organization or any successor thereto.

(e)
"Common Stock" means the Company's Common Shares, $.01 par value per share.

(f)
"Company" means Aetna Inc.

(g)
"Effective Date" means the date of grant of this award of Restricted Stock Units.

(h)
“Fair Market Value" means the closing price of the Common Stock as reported by the Consolidated Tape of the New York Stock Exchange Listed Shares on the date such value is to be determined, or, if no shares were traded on such date, on the next day on which the Common Stock is traded.

(i)
“Fundamental Corporate Event” shall mean any stock dividend, extraordinary cash dividend, recapitalization, reorganization, merger, consolidation, split-up, spin-off, combination, exchange of shares, warrants or rights offering to purchase Common Stock at a price substantially below fair market value, or similar event.

(j)
"Grantee" means the person to whom this award has been granted.

(k)
“Holding Company” means an entity that becomes a holding company for the Company or its businesses as a part of any reorganization, merger, consolidation or other transaction, provided that the outstanding shares of common stock of such entity and the combined voting power of the then outstanding voting securities of such entity entitled to vote generally in the election of directors is, immediately after such reorganization, merger, consolidation or other transaction, beneficially owned, directly or indirectly, by all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the voting stock outstanding immediately prior to such reorganization, merger, consolidation or other transaction in substantially the same proportions as their ownership, immediately prior to such reorganization, merger, consolidation or other transaction, of such outstanding voting stoc k.

(l)
"Long Term Disability" means long-term disability as defined under the terms of the Company's applicable long-term disability plans or policies.


(m)
“Net Shares” means the number of shares of Common Stock which will be deposited in a brokerage account in the Grantee’s name at the Company’s designated broker after shares have been withheld to satisfy applicable tax and withholding requirements upon vesting of the Restricted Stock Units.

(n)
“Plan” means the Aetna Inc. 2000 Stock Incentive Plan.

(o)
“Restricted Period” means the period during which this award of Restricted Stock Units is not vested.

(p)
“Restricted Stock Units” means the number of shares of Common Stock represented by the number of units awarded or such other amount as may result by operation of Article III of this Agreement.

(q)
“Section 409A” means Section 409A of the Internal Revenue Code of 1986, as amended, and the regulation issued thereunder, as may be amended from time to time.

(r)
“Shares of Stock” or “Stock” means the Common Stock.
 
 
 
 
2
 

 
(s)
"Subsidiary" means an entity of which, at the time such subsidiary status is to be determined, at least 50% of the total combined voting power of all classes of stock of such entity is held by the Company and/or one or more other subsidiaries.

(t)
"Successor" means the legal representative of the estate of a deceased Grantee or the person or persons who shall acquire the right to the Restricted Stock Units by bequest or inheritance or by reason of the death of the Grantee.

(u)
“Vest Date” means the date on which this award of Restricted Stock Units shall vest in accordance with the terms of this Agreement and as set forth on the website of the designated broker and in the Notice of Restricted Stock Unit Grant, if applicable.


ARTICLE II

RESTRICTED PERIOD

Subject to the terms of this Agreement, the Restricted Stock Units will vest in installments on the Vest Date in accordance with the terms of the Plan and this Terms of Award Agreement, or on such date as provided in Article IV or V.  On the Vest Date, the Grantee shall vest to one share of Common Stock for each vested Restricted Stock Unit net of applicable taxes and withholding. Such Net Shares will be delivered to the Company’s designated broker, in a brokerage account established in the Grantee’s name.


ARTICLE III

CAPITAL CHANGES

In the event that the Committee shall determine that any Fundamental Corporate Event affects the Common Stock such that an adjustment is required to preserve, or to prevent enlargement of, the benefits or potential benefits made available under this Plan, then the Committee shall, in such manner as the Committee may deem equitable, adjust the number and kind of shares subject to the award of Restricted Stock Units.  Additionally, the Committee may make provision for cash payment to a Grantee or the Successor of the Grantee to the extent permitted under Section 409A.  However, the number of Restricted Stock Units shall always be a whole number.


ARTICLE IV

CHANGE IN CONTROL

Upon the occurrence of (i) a Change in Control, and (ii) within 24 months thereafter the Company terminates Grantee’s Employment without cause, all RSUs, whether or not vested, shall become immediately vested and become payable, provided, however, that, as set forth in the Plan, to the extent the RSUs are considered deferred compensation subject to Section 409A, unless the Change in Control also satisfies the definition of “change in control” under Section 409A, payment shall not be so accelerated but shall occur upon the scheduled Vest Date(s) under Article II.
 
 

 
3
 
 
 
ARTICLE V

TERMINATION OF EMPLOYMENT

(a) 
Except as provided in (f) below, if the Grantee shall die during the Restricted Period, the unvested Restricted Stock Units shall become immediately vested and Net Shares, if any, will be deposited with the Company’s designated broker in a brokerage account established in Grantee’s name.

(b)
Except as provided in (f) below, if the Grantee shall begin to receive Long Term Disability benefits during the Restricted Period, the unvested Restricted Stock Units shall continue to vest and Net Shares, if any, will be deposited with the Company’s designated broker in a brokerage account established in Grantee’s name on the scheduled Vest Date(s) under Article II.
 
 
(c)
Except as provided in (f) below, if, during the restricted period, Grantee shall cease to be employed by the Company, its Subsidiaries or Affiliates during the Restricted Period, for reason of involuntary termination of employment by the Company, a portion of the Restricted Stock Units shall vest in accordance with the following formula:  (i) the number of completed months employed after the Effective Date divided by the number of full months in the restricted period; multiplied by (ii) number of Restricted Stock Units, minus any vested Restricted Stock Units.   For purposes of this calculation, a month is complete on the day in the following month that corresponds to the Effective Date (e.g., February 13 to March 13).  Net shares, if any, will be deposited with the Company’s designated broker in a brokerage account established in Grantee’s name on the next scheduled V est Date under Article II and, applicable taxes and withholding will be applied based on the Fair Market Value on that date.

(d)
Except as provided in (e) and (f) below, if the Grantee shall, for a reason other than death, Long-Term Disability, or involuntary termination of employment by the Company, cease to be employed by the Company, its Subsidiaries or Affiliates during the Restricted Period, any unvested Restricted Stock Units shall be forfeited at the time of cessation of employment.
 
 
(e)
Except as provided in (a) or (b) or (c) above, any Restricted Stock Unit not vested as of the date Grantee terminates employment shall be forfeited at the time of cessation of employment; provided, however, that if Grantee’s employment is terminated by the Company other than for cause and Grantee has not previously, or does not subsequently, vest to any portion of the Restricted Stock Unit in accordance with its terms, then upon the forfeiture of the entire Restricted Stock Unit, the Company will pay Grantee an amount equal to the value of a single share of Common Stock, whether or not the forfeited Restricted Stock Unit related to more than a single share of Common Stock, calculated as of the cessation of employment, if requested by Grantee, within 30 days of such cessation of employment.
 
 
(f)
No Restricted Stock Unit will vest after the Company has terminated the employment of the Grantee for cause, unless the Committee, in its sole discretion, deems a payment to be warranted under the particular circumstances. In addition, the Restricted Stock Units will not vest if Grantee has willfully engaged in gross misconduct or other serious impropriety which the Company determines is likely to be damaging or detrimental to the Company, any Subsidiary or Affiliate.
 
 
(g)
 Employment for purposes of determining the vesting rights of the Grantee and the expiration of the grant under this Article V shall mean continuous full-time salaried employment with the Company, a Subsidiary or an Affiliate, except that the period during which the Grantee is on vacation, sick leave, or other pre-approved leave of absence (provided there is no actual termination of employment), or in receipt of salary continuation or severance pay shall not interrupt the continuous employment of the Grantee.  Employment shall also include service with Aetna Foundation, Inc.
 

 
 
4
 
 

 
 
ARTICLE VI

EMPLOYEE COVENANTS

(a)
As consideration for this grant of Restricted Stock Units, without prior written consent of the Company:

 
 
(i)
Grantee will not (except to the extent required by an order of a court having competent jurisdiction or under subpoena from an appropriate government agency) use or disclose to any third person, whether during or subsequent to Grantee’s employment, any trade secrets, confidential information and proprietary materials, which may include, but are not limited to, the following categories of information and materials: customer lists and identities; provider lists and identities; employee lists and identities; product development and related information; marketing plans and related information; sales plans and related information; premium or other pricing information; operating policies and manuals; research; payment rates; methodologies; procedures; contractual forms; business plans; financial records; computer programs; database; or other financial, commercial, business or technical information related to the Co mpany or any Subsidiary or Affiliate unless such information has been previously disclosed to the public by the Company or has become public knowledge other than by a breach of this Agreement; provided, however, that this limitation shall not apply to any such use or disclosure made while Grantee is employed by the Company, any Subsidiary or Affiliate if such disclosure occurred in connection with the performance of Grantee’s job as an employee of the Company, any Subsidiary or Affiliate;

 
 
(ii)
Grantee will not, during and for a period of 12 months or 24 months for executive tier employees (the executive tier status determined as of the effective date of this grant) following Grantee’s termination of Employment, directly or indirectly induce or attempt to induce any employee to be employed or perform services elsewhere;
 
 
 
 
(iii)
Grantee will not, during and for a period of 12 months or 24 months for executive tier employees (the executive tier status determined as of the effective date of this grant) following Grantee's termination of Employment, directly or indirectly, induce or attempt to induce any agent or agency, broker, supplier or health care provider of the Company or any Subsidiary to cease or curtail providing services to the Company or any Subsidiary; and

 
 
(iv)
Grantee will not, during and for a period of 12 months or 24 months for executive tier employees (the executive tier status determined as of the effective date of this grant) following Grantee’s termination of Employment, directly or indirectly solicit or attempt to solicit the trade of any individual or entity which, at the time of such solicitation, is a customer of the Company, any Subsidiary or Affiliate, or which the Company, any Subsidiary or Affiliate is undertaking reasonable steps to procure as a customer at the time of or immediately preceding termination of Employment; provided, however, that this limitation shall only apply to any product or service which is in competition with a product or service of the Company, any Subsidiary or Affiliate and shall apply only with respect to a customer or prospective customer with whom the Grantee has been directly or indirectly involved.

 
In addition:

(v)   
Following the termination of Grantee’s Employment, Grantee shall provide assistance to and shall cooperate with the Company or a Subsidiary or Affiliate, upon its reasonable request and without additional compensation, with respect to matters within the scope of Grantee’s duties and responsibilities during Employment, provided that any reasonable out-of-pocket expenses Grantee incurs in connection with any assistance Grantee has been requested to provide under this provision for items including, but not limited to, transportation, meals, lodging and telephone, shall be reimbursed by the Company.  The Company agrees and acknowledges that it shall, to the maximum extent possible under the then prevailing circumstances, coordinate, or cause a Subsidiary or Affiliate to coordinate,
 
 
 
 
5
 


 
any such request with Grantee’s other commitments and responsibilities to minimize the degree to which such request interferes with such commitments and responsibilities; and
 
 
(vi)
Grantee shall promptly notify the Company’s General Counsel if Grantee is contacted by a regulatory or self-regulatory agency with respect to matters pertaining to the Company or by an attorney or other individual who informs the Grantee that he/she has filed, intends to file, or is considering filing a claim or complaint against the Company.

 
(vii)
Grantee acknowledges that all original works of authorship that are created by Grantee (solely or jointly with others) within the scope of Grantee’s employment which are protectable by copyright are “works made for hire” as that term is defined in the United States Copyright Act (17 U.S.C. Section 101).  Grantee further acknowledges that while employed by the Company, Grantee may develop ideas, inventions, discoveries, innovations, procedures, methods, know-how or other works which relate to the Company’s current or are reasonably expected to relate to the Company’s future business that may be patentable or subject to trade secret protection.  Grantee agrees that all such works of authorship, ideas, inventions, discoveries, innovations, procedures, methods, know-how and other works shall belong exclusively to the Company, and the Grantee hereby assigns all right, ti tle, and interest therein to the Company.

To the extent any of the foregoing works may be patentable, Grantee agrees that the Company may file and prosecute any application for patents for such works and that the Grantee will, on request, execute assignments to the Company relating to (and take all such further steps as may be reasonably necessary to perfect the Company’s sole and exclusive ownership of) any such application and any patents resulting therefrom.

(b)
If any provision of Article VI (a) is determined by a court of competent jurisdiction not to be enforceable in the manner set forth herein, the Company and Grantee agree that it is the intention of the parties that such provision should be enforceable to the maximum extent possible under applicable law and that such court shall reform such provision to make it enforceable in accordance with the intent of the parties.

(c)       
Grantee acknowledges that a material part of the inducement for the Company to grant the Restricted Stock Units is Grantee’s covenants set forth in Article VI (a) and that the covenants and obligations of Grantee with respect to nondisclosure, non-solicitation and cooperation relate to special, unique and extraordinary matters and that a violation of any of the terms of such covenants and obligations will cause the Company irreparable injury for which adequate remedies are not available at law.  Therefore, Grantee agrees that, if Grantee shall breach any of those covenants or obligations, Grantee shall not be entitled to vest in the Restricted Stock or be entitled to retain any income therefrom and the Company shall be entitled to an injunction, restraining order or such other equitable relief (without the requirement to post bond) res training Grantee from committing any violation of the covenants and obligations contained in Article VI.  The remedies in the preceding sentence are cumulative and are in addition to any other rights and remedies the Company may have at law or in equity as a court or arbitrator shall reasonably determine.

(d)
Employment Dispute Arbitration Program - Mandatory Binding Arbitration of Employment Disputes.

(i)   
Except as otherwise specified in this Agreement, the Grantee and the Company agree that all employment-related legal disputes between them will be submitted to and resolved by binding arbitration, and neither the Grantee nor the Company will file or participate as an individual party or member of a class in a lawsuit in any court against the other with respect to such matters.  This shall apply to claims brought on or after the date the Grantee accepts this Agreement, even if the facts and circumstances relating to the claim occurred prior to that date and regardless of whether the Grantee or the Company previously filed a complaint/charge with a government agency concerning the claim.
 
 

 
6
 



For purposes of Article VI (d) of this Agreement, “the Company” includes Aetna Inc., its Subsidiaries and Affiliates, their predecessors, successors and assigns, and those acting as representatives or agents of those entities.  THE GRANTEE UNDERSTANDS THAT, WITH RESPECT TO CLAIMS SUBJECT TO THE ARBITRATION REQUIREMENT, ARBITRATION REPLACES THE RIGHT OF THE GRANTEE AND THE COMPANY TO SUE OR PARTICIPATE IN A LAWSUIT.  THE GRANTEE ALSO UNDERSTANDS THAT IN ARBITRATION, A DISPUTE IS RESOLVED BY AN ARBITRATOR INSTEAD OF A JUDGE OR JURY, AND THE DECISION OF THE ARBITRATOR IS FINAL AND BINDING.

 
(ii)
THE GRANTEE UNDERSTANDS THAT THE ARBITRATION PROVISIONS OF THIS AGREEMENT AFFECT THE LEGAL RIGHTS OF THE GRANTEE AND THE COMPANY AND ACKNOWLEDGES THAT THE GRANTEE HAS BEEN ADVISED TO, AND HAS BEEN GIVEN THE OPPORTUNITY TO, OBTAIN LEGAL ADVICE BEFORE SIGNING THIS AGREEMENT.

 
(iii)
Article VI (d) of this Agreement does not apply to workers’ compensation claims, unemployment compensation claims, and claims under the Employee Retirement Income Security Act of 1974 (“ERISA”) for employee benefits.  A dispute as to whether Article VI (d) of this Agreement applies must be submitted to the binding arbitration process set forth in this Agreement.

 
(iv)
The Grantee and/or the Company may seek emergency or temporary injunctive relief from a court (including with respect to claims arising out of Article VI (a) in accordance with applicable law).  However, except as provided in Article VI (c) of this Agreement, after the court has issued a ruling concerning the emergency or temporary injunctive relief, the Grantee and the Company shall be required to submit the dispute to binding arbitration pursuant to this Agreement.

 
(v)
Unless otherwise agreed, the arbitration will be administered by the American Arbitration Association (the “AAA”) and will be conducted pursuant to the AAA’s Employment Arbitration Rules and Mediation Procedures (the “Rules”), as modified in this Agreement, in effect at the time the request for arbitration is filed.  The AAA’s Rules are available on the AAA’s website at www.adr.org. THE GRANTEE ACKNOWLEDGES THAT THE COMPANY HAS ENCOURAGED THE GRANTEE TO READ THESE RULES PROMPTLY AND CAREFULLY AND THAT THE GRANTEE HAS BEEN AFFORDED SUFFICIENT OPPORTUNITY TO DO SO.

 
(vi)
If the Company initiates a request for arbitration, the Company will pay all of the administrative fees and costs charged by the AAA, including the arbitrator’s compensation and charges for hearing room rentals, etc.  If the Grantee initiates a request for arbitration or submits a counterclaim to the Company’s request for arbitration, the Grantee shall be required to contribute One Hundred Dollars ($100.00) to those administrative fees and costs, payable to the AAA at the time the Grantee's request for arbitration or counterclaim is submitted.  The Company may increase the contribution amount in the future without amending this Agreement, but not to exceed the maximum permitted under the AAA rules then in effect. In all cases, the Grantee and the Company shall be responsible for payment of any fees assessed by the arbitrator as a result of that party’s delay, request for postpo nement, failure to comply with the arbitrator’s rulings and for other similar reasons.

 
(vii)
The Grantee and the Company may choose to be represented by legal counsel in the arbitration process and shall be responsible for their own legal fees, expenses and costs.  However, the arbitrator shall have the same authority as a court to order the Grantee or the Company to pay some or all of the other’s legal fees, expenses and costs, in accordance with applicable law.

 
(viii)
Unless otherwise agreed, there shall be a single arbitrator, selected by the Grantee and the Company from a list of qualified neutrals furnished by the AAA.  If the Grantee and the Company cannot agree on an arbitrator, one will be selected by the AAA.
 
 
 
 
7
 

 
 
(ix)
Unless otherwise agreed, the arbitration hearing will take place in the city where the Grantee works or last worked for the Company.  If the Grantee and the Company disagree as to the proper locale, the AAA will decide.

 
(x)
The Grantee and the Company shall be entitled to conduct limited pre-hearing discovery.  Each may take the deposition of one person and anyone designated by the other as an expert witness.  The party taking the deposition shall be responsible for all associated costs, such as the cost of a court reporter and the cost of an original transcript.  Each party also has the right to submit one set of ten written questions (including subparts) to the other party, which must be answered under oath, and to request and obtain all documents on which the other party relies in support of its answers to the written questions.  Additional discovery may be permitted by the arbitrator upon a showing that it is necessary for that party to have a fair opportunity to present a claim or defense.

 
(xi)
The arbitrator shall apply the same substantive law that would apply if the matter were heard by a court and shall have the authority to order the same remedies (but no others) as would be available in a court proceeding.  The time limits for requesting arbitration or submitting a counterclaim and the administrative prerequisites for filing an arbitration claim or counterclaim are the same as they would be in a court proceeding.  The arbitrator shall consider and decide any dispositive motions (motions seeking a decision on some or all of the claims or counterclaims without an arbitration hearing) filed by any party.

 
(xii)
All proceedings, including the arbitration hearing and decision, are private and confidential, unless otherwise required by law.  Arbitration decisions may not be published or publicized without the consent of both the Grantee and the Company.

                        (xiii)
 Unless otherwise agreed, the arbitrator’s decision will be in writing with a brief summary of the arbitrator’s opinion.

 
(xiv)
The arbitrator’s decision is final and binding on the Grantee and the Company.  After the arbitrator’s decision is issued, the Grantee or the Company may obtain an order of judgment from a court and may obtain a court order enforcing the decision.  The arbitrator’s decision may be appealed to the courts only under the limited circumstances provided by law.

 
(xv)
If the Grantee previously signed an agreement, including but not limited to an employment agreement, containing arbitration provisions, those provisions are superseded by the arbitration provisions of this Agreement.

 
(xvi)
If any provision of Article VI (d) is found to be void or otherwise unenforceable, in whole or in part, this shall not affect the validity of the remainder of Article VI (d) and the remainder of the Agreement.  All other provisions shall remain in full force and effect.

For purposes of this Article VI, the term “Employment” shall refer to active employment with the Company, any Subsidiary or Affiliate, and shall not include salary continuation or severance periods.


ARTICLE VII

OTHER TERMS

(a)
Nothing in this Agreement shall interfere with or limit in any way the right of the Company or any Subsidiary or Affiliate to terminate the Grantee’s employment at any time.  Neither the execution and delivery hereof nor the granting of the Award shall constitute or be evidence of any agreement or
 
 
 
 
8
 
 
 
understanding, express or implied, on the part of the Company or any of its Subsidiaries to employ or continue the employment of the Grantee for any period.
 
(b)
Until the Restricted Stock Units have become vested, Grantee shall not have any rights as a stockholder (including the right to payment of dividends) by virtue of this grant of Restricted Stock Units.

(c)
During the Restricted Period, the Restricted Stock Units shall be nontransferable and non-assignable except by will or the laws of descent and distribution.

(d)
The award will be settled on a net basis.  Prior to issuing any Common Shares, the Company will withhold an amount sufficient to satisfy federal, state, local, social security and Medicare withholding tax requirements relating to award.  Any social security calculation or other adjustments discovered after net share payment will be settled in cash, not in Shares of Common Stock.  Vesting will result in taxable compensation reportable on the Grantee’s W-2 in year of vesting.

(e)
The Company may from time to time adopt stock ownership requirements applicable to Grantees who are senior managers of the Company.  In connection with and for the purpose of implementing those ownership requirements, the Company may adopt certain restrictions on the ability of a Grantee to sell shares issued under this Agreement when such ownership requirements have not been satisfied.  Any such restriction on sale will be communicated generally to affected Grantees and the restriction may be modified by the Company from time to time, at its discretion.  Neither the Company nor its Board of Directors shall have any obligation or liability to a Grantee in connection with any such restriction.

(f)
This Restricted Stock Unit is an unfunded obligation of the Company and nothing in this Agreement shall be construed to create any claim against particular assets or require the Company to segregate or otherwise set aside any assets or create any fund to meet its obligations hereunder.

(g)
Anything herein to the contrary notwithstanding, a Grantee whose Restricted Stock Units have been forfeited as a result of termination of employment due to U.S. Military Service and who is later re-employed (in a full-time active status) after discharge within the time period set in 38 U.S.C. Section 4312 will be eligible to have the forfeited Restricted Stock Units reinstated as follows: (i) if such Grantee is re-employed during the Restricted Period, all forfeited Restricted Stock Units shall be reinstated; or (ii) if such Grantee is re-employed after the Restricted Period, a cash payment will be made to the Grantee, minus applicable taxes, for the value of the forfeited Restricted Stock Units on the Vest Date pursuant to procedures established by the Company for this purpose.

(h)
If any provision of this Agreement would cause Grantee to incur any additional tax or interest under Section 409A, the Company may reform such provision (including an amendment retroactive to the Effective Date to the extent permissible) to comply with Section 409A.

(i)
If the Company reasonably anticipates that the Company’s tax deduction with respect to the payment upon vesting of the Restricted Stock Units would be limited or eliminated by application of Section 162(m) of the Internal Revenue Code, the Company may elect, in accordance with Section 409A, to delay the payment of such Restricted Stock Units to the earliest date in which the Company anticipates that its tax deduction for such payment will not be limited or eliminated.

(j)
This Agreement is subject to the 2000 Stock Incentive Plan heretofore adopted by the Company and approved by its shareholders.  The terms and provisions of the Plan (including any subsequent amendments thereto) are hereby incorporated herein by reference.  In the event of a conflict between any term or provision contained herein and a term or provision of the Plan, the applicable terms and provisions of the Plan will govern and prevail.
 
(k)
Voluntary Deferral.  At such times and upon such terms and conditions as the Company shall determine in accordance with the terms of the Plan and Section 409A, the Company may permit eligible Grantees to

 
 
 
9
 

 
 
 
elect to defer the distribution of an Award otherwise payable to the Grantee under this Agreement until termination of the Grantee’s Employment or such other date Company shall permit.

 
I have read the Restricted Stock Unit Agreement. I accept the Restricted Stock Unit award and agree to be bound by all of its terms and conditions, including mandatory binding arbitration of employment related disputes and, if applicable, any other provisions of Article VI.
 
 
 
 
 
 
 
 
 
 
 
 

 
10
 

EX-10.5 6 exhibit10-5.htm EXHIBIT 10.5 exhibit10-5.htm  
Amended 12/5/08
Exhibit 10.5  

AETNA INC.
2001 ANNUAL INCENTIVE PLAN
(EFFECTIVE AS OF JANUARY 1, 2001)


SECTION 1.   PURPOSE.
 
The purpose of this Plan is to provide a general incentive for designated key executive employees of the Companies in order to improve operating results of the Companies and to reward such employees for the accomplishment of financial and strategic objectives of the Companies.
 
SECTION 2.   DEFINITIONS.
 
Unless the context requires otherwise, the following words as used in the Plan shall have the meanings ascribed to each below, it being understood that masculine, feminine and neuter pronouns are used interchangeably and that each comprehends the others.
 
 
(a)
“Aetna” means Aetna Inc., a Pennsylvania corporation.
 
 
(b)
“Board” means the Board of Directors of Aetna.
 
 
(c)
“Change in Control” means the happening of any of the following:
 
 
(i)
When any “person” as defined in Section 3(a)(9) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and as used in Sections 13(d) and 14 (d) thereof, including a “group” as defined in Section 13 (d) of the Exchange Act but excluding Aetna and any subsidiary thereof and any employee benefit plan sponsored or maintained by Aetna or any subsidiary (including any trustee of such plan acting as trustee), directly or indirectly, becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act, as amended from time to time), of securities of Aetna representing 20 percent or more of the combined voting power of Aetna’s then outstanding securities;
 
 
(ii)
When, during any period of 24 consecutive months, the individuals who, at the beginning of such period, constitute the Board (the “Incumbent Directors”) cease for any reason other than death to constitute at least a majority thereof, provided that a director who was not a director at the beginning of such 24-month period shall be deemed to have satisfied such 24-month requirement (and be an Incumbent Director) if such director was elected by, or on the recommendation of or with the approval of, at least two-thirds of the directors who then qualified as Incumbent Directors either actually (because they were directors at the beginning of such 24-month period) or by prior operation of this paragraph (ii); or
 
 
(iii)
The occurrence of a transaction requiring stockholder approval for the acquisition of Aetna by an entity other than Aetna or a Subsidiary through purchase of assets, or by merger, or otherwise.
 
 
(d)
“Committee” means the Committee on Compensation and Organization of the Board (or such other committee of the Board that the Board shall designate from time to time) or any subcommittee thereof consisting of two or more directors each of whom is an “outside director” within the meaning of Section 162 (m) and a “non-employee director” within the meaning of Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
 
 
 
 
3B-1
 
 
 
 
(e)
“Common Stock” means the common stock, $.01 par value, of Aetna.
 
 
(f)
“Companies” means one or more of Aetna, any of Aetna’s affiliated companies, and any other entity as to which (i) Aetna or any of Aetna’s affiliated companies holds or is seeking to acquire an ownership interest, and (ii) has been included in the Plan by the Committee.
 
 
(g)
“Covered Employee” shall have the meaning set forth in Section 162(m).
 
 
(h)
“Deferral Period” means the period of time during which payment of any amount otherwise payable under the Plan is deferred (i) at the direction of the Committee pursuant to Section 6(b) or (ii) at the election of a Participant pursuant to Section 6(c).
 
 
(i)
“Disability” means the occurrence of an event that would entitle a Participant to the payment of disability income under a specific long-term disability income plan approved by the Companies and under which the Participant is enrolled, as such plan may be amended from time to time, or if such Participant is not enrolled in a specific plan, as defined in a plan covering similarly situated executive officers of Aetna.
 
 
(j)
“Fair Market Value” means on any date, with respect to a share of Common Stock, the closing price of a share of Common Stock as reported by the Consolidated Tape of New York Stock Exchange Listed Shares on such date, or, if no shares were traded on such Exchange on such date, on the next date on which the Common Stock is traded.
 
 
(k)
“Participant” means (i) each Covered Employee and (ii) each other executive officer of Aetna as defined in Rule 3b-7 of the Securities Exchange Act of 1934 whom Aetna designates as a participant under the Plan.
 
 
(1)
“Performance Period” means the calendar year or such other period as may be designated by the Committee.
 
      (m)
“Plan” means the Aetna Inc. 2001 Annual Incentive Plan, as set forth herein and as may be amended from time to time.
 
 
(n)
“Retirement” means the retirement of a Participant from active service with the Companies at or after the age at which full pension benefits are provided under a specific retirement plan maintained or contributed to by any of the Companies and under which the Participant has an accrued benefit, as such plan may be amended from time to time, or if such Participant does not have an accrued benefit under any such plan, the age at which full pension benefits are provided under a retirement plan covering similarly situated executive officers of Aetna.
 
 
(o)
“Section 162(m)” means Section 162 (m) of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder.
 
 
(p)
“Section 409A” means Section 409A of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder.
 
 
(q)
“Share” means a share of Common Stock.
 
(r)   “Stock Unit” means a unit representing the contractual right to receive the value of one Share.
 
 
(s)
“Stock Unit Account” means, with respect to any Participant who has elected to have deferred amounts deemed invested in Stock Units, a bookkeeping account established to record such Participant’s interest under the Plan related to such Stock Units.
 
 
(t)
“Subsidiary” means any entity of which the Company possesses directly or indirectly fifty percent (50%) or more of the total combined voting power of all classes of stock of such entity.
 
 
 
 
3B-2
 
 
 
SECTION 3.   ADMINISTRATION.
 
The Plan shall be administered by the Committee.  The Committee shall have the responsibility of construing and interpreting the Plan, provided that, in no event shall the Plan be interpreted in a manner which would cause any award to a Covered Employee to fail to qualify as performance-based compensation under Section 162(m). The Committee shall establish the performance objectives for any Performance Period in accordance with Section 5 and certify whether such performance objectives have been obtained. Any determination made or decision or action taken or to be taken by the Committee, arising out of or in connection with the construction, administration, interpretation and effect of the Plan and of its rules and regulations, shall, to the fullest extent permitted by law (but subject to the limitations on the discretion of the Committee applicable to awards intended to be qualified as performance-based compensation under Section 162(m)), be within the Committee’s absolute discretion and shall be conclusive and binding on any and all Participants, any person claiming under or through a Participant and each of the Companies. The Committee may employ such legal counsel, consultants and agents (including counsel or agents who are employees of any Company) as it may deem desirable for the administration of the Plan and may rely upon any opinion received from any such counsel or consultant or agent and any computation received from such consultant or agent. All expenses incurred in the administration of the Plan, including, without limitation, for the engagement of any counsel, consultant or agent, shall be paid by the Companies. No member or former member of the Board or the Committee shall be liable for any act, omission, interpretation, construction or determination made in connection with the Plan other than as a result of su ch individual’s willful misconduct.
 
SECTION 4.   DETERMINATION OF PARTICIPANTS.
 
In addition to the Covered Employees, the Committee may designate as a Participant in the Plan any executive officer of Aetna as defined in Rule 3b-7 of the Securities Exchange Act of 1934. Members of the Board who are not employees of any of the Companies shall not be eligible to participate in the Plan.
 
SECTION 5.   BONUSES.
 
(a)      Performance Criteria.  On or before the end of the first 90 days of each Performance Period (or such other date as may be required or permitted under Section 162(m)), the Committee shall establish the performance objective or objectives that must be satisfied in order for a Participant to receive a bonus for such Performance Period. Any such performance objectives will be based upon the relative or comparative achievement of one or more of the following criteria, as determined by the Committee: (i) net income, (ii) earnings before income taxes, (iii) earnings per share, (iv) return on shareholders equity, (v) expense management, (vi) profitability of an identifiable business unit or product, (vii) ratio of claims to revenues, (viii) revenue growth, (ix) earnings growth, (x) total shareholder return, (xi) cash flow, (xii) return on assets, (xiii) pretax operating income, (xiv) net economic profit (operating earnings minus a charge for capital), (xv) customer satisfaction, (xvi) provider satisfaction, (xvii) employee satisfaction, (xviii) quality of networks, (xix) strategic innovation or (xx) any combination of the foregoing.
 
(b)      Maximum Amount Payable.  If the Committee certifies in writing that any one of the performance objectives established for the relevant Performance Period under Section 5(a) has been satisfied, each Participant who is employed by the Companies on the last day of the Performance Period for which the bonus is payable shall be entitled to receive a bonus in an amount not to exceed $3,000,000.
 
(c)      Negative Discretion.  Notwithstanding anything else contained in Section 5(b) to the contrary, the Committee shall have the right, in its discretion, (i) to reduce or eliminate the amount otherwise payable to any Participant under Section 5(b) and (ii) to establish rules or procedures that have the effect of limiting the amount payable to each Participant to an amount that is less than the maximum amount otherwise authorized under Section 5(b).
 
 
 
 
3B-3
 
 
 
(d)      Affirmative Discretion.  Notwithstanding any other provision in the Plan to the contrary, (i) the Committee shall have the right, in its discretion, to pay to any Participant who is not a Covered Employee a bonus for a Performance Period in an amount up to the maximum bonus payable under Section 5(b), based on individual performance or any other criteria that the Committee, in its discretion, deems to warrant the payment of such a bonus, and (ii) in connection with the hiring of any person who is or becomes a Covered Employee, the Committee may provide for a minimum bonus amount for such Covered Employee with respect to the Performance Period in which such Covered Employee is hired and/or for the next following Performance Period, wh ich would be payable to such Covered Employee regardless of whether the relevant performance objectives are attained with respect to the relevant Performance Period.
 
(e)      Methodology for Determinations.  In making any determination under Section 5(c) or 5(d), the Committee shall give consideration to such factors as it deems appropriate, including, without limitation, the degree to which the established performance objectives have been obtained and whether the Participant has materially contributed to the overall results of the Companies. To assist it in making its determination under such Sections, the Chairman of Aetna will furnish the Committee with specific recommendations (except with respect to the Chairman’s own award) and the Committee may request such other advice and recommendations as it deems appropriate.
 
SECTION 6.   PAYMENT OF AWARDS.
 
(a)      General Rule.   Except as otherwise expressly provided hereunder, payment of any bonus amount determined under Section 5 shall be made to each Participant as soon as practicable after the Committee certifies that one or more of the applicable performance objectives have been attained (or, in the case of any bonus payable under the provisions of Section 5(d), after the Committee determines the amount of any such bonus), provided, however, that payment shall be made during the first 2½ months of the calendar year following the end of the Performance period.  Any such payments shall be made in cash or, at the discretion of the Committee in awards under the Aetna Inc. 2001 Stock Incentive Plan.
 
(b)      Mandatory Deferral.  Notwithstanding Section 6(a), the Committee may specify that a percentage of the bonus payable with respect to any Participant, all Participants or any class of Participants for any Performance Period be mandatorily deferred for a Deferral Period specified by the Committee. The percentage to be so deferred shall be determined by the Committee in its discretion. Unless otherwise determined by the Committee at or after the date of such deferral, any amount payable in respect of an amount mandatorily deferred pursuant to this Section 6(b) shall be forfeited by the Participant if
 
 
(i)
the Participant’s employment with each of the Companies is terminated for cause (as determined in the discretion of the Committee under the generally applicable practices and policies of whichever of the Companies employs the Participant);
 
 
(ii)
the Participant voluntarily terminates employment, other than by reason of death, Disability or Retirement, prior to the end of the Deferral Period specified by the Committee with respect to such mandatorily deferred amount; or
 
 
(iii)
the Participant engages in any activity or conduct which, in the reasonable opinion of the Committee, is inimical to the best interest of the Companies.
 
(c)      Voluntary Deferral.  Notwithstanding Section 6(a), the Committee may permit a Participant to defer payment of any portion of an award that is not mandatorily deferred pursuant to Section 6(b) or to defer payment of an amount mandatorily deferred to a date or event later than that specified by the Committee. Any such election shall be made in the calendar year prior to the start of the Performance period during which it will be earned or, if permitted under Section 409A, at least six months prior to the end of such Performance Period.
 
 
 
3B-4
 

 
(d)      Accounting for Deferrals. Any amount deferred under this Section 6 shall be credited to one or more bookkeeping accounts for the benefit of such Participant on the books and records of whichever of the Companies employs the Participant. Unless a Participant otherwise elects to have such amounts deemed invested in Stock Units in accordance with Section 6(e), such amounts shall be deemed held in cash and shall be credited with such rate of interest or such deemed rate of earnings as the Committee shall specify from time to time; provided that, unless the Committee otherwise determines, no interest or earnings shall be credited during the Deferral Period specified by the Committee in respect of amounts mandatorily deferred.
 
(e)      Stock Units.  The Committee may permit any Participant, all Participants or any class of Participants to elect that any or all amounts deferred under the Plan (including amounts mandatorily deferred pursuant to Section 6(b)) be deemed invested, in whole or in part, in a number of whole or fractional Stock Units. Any such Stock Units shall be credited to a Stock Unit Account for the benefit of such Participant. The number of whole and fractional Stock Units credited to a Stock Unit Account in respect of any amount deferred under this Section 6 shall be equal to the quotient of (i) the amount deferred divided by (ii) the Fair Market Value of a Share on the date such amount would have been paid under the Plan but for such deferral. When ever a dividend other than a dividend payable in the form of Shares is declared with respect to the Shares, the number of Stock Units in the Participant’s Stock Unit Account shall be increased by the number of Stock Units determined by dividing (i) the product of (A) the number of Stock Units in the Participant’s Stock Unit Account on the related dividend record date and (B) the amount of any cash dividend declared by the Company on a Share (or, in the case of any dividend distributable in property other than Shares, the per share value of such dividend, as determined by the Company for purposes of income tax reporting) by (ii) the Fair Market Value of a Share on the related dividend payment date. In the case of any dividend declared on Shares which is payable in Shares, each Participant’s Stock Unit Account shall be increased by the number of Stock Units equal to the product of (i) the number of Units credited to the Participant’s Stock Unit Account on the related dividend record dat e and (ii) the number of Shares (including any fraction thereof) distributable as a dividend on a Share. In the event of any stock split, recapitalization, reorganization or other corporate transaction affecting the capital structure of Aetna, the Committee shall make such adjustments to the number of Stock Units credited to each Participant’s Stock Unit Account as the Committee shall deem necessary or appropriate to prevent the dilution or enlargement of such Participant’s rights.
 
(f)      Payment of Deferred Amounts.  Payment of any amounts deferred under Section 6(b) or 6(c) shall be made in a lump sum on the date the Participant experiences a “separation from service” within the meaning of Section 409A unless another time and form of payment is elected or otherwise established at the time of the mandatory or elective deferral, consistent with the requirements of Section 409A.  The Participant may elect payment in a lump sum or in five, ten or such other number of annual installments as shall be permitted by the Committee.  The Committee may, in its discretion, accelerate the payment of all or any portion of any Participant’ ;s deferred amounts (regardless of whether the applicable Deferral Period or period have terminated) in the event of an “unforeseeable emergency” within the meaning of Section 409A.
 
Any payment to be made in respect of deferred amounts shall be made in cash. For purposes of any cash distribution in respect of a Participant’s Stock Units, the cash payable shall equal the product of (i) the number of whole and fractional Stock Units being distributed and (ii) the Fair Market Value of a Share on the date as of which the distribution is to be made.
 
 (g)     Change in Control.  Upon the occurrence of a Change in Control, all performance objectives for the then current Performance Period shall be deemed to have been achieved at target levels of performance and the Committee shall cause each Participant to be paid an amount in cash based on such assumed performance for the entire Performance Period as soon as practicable but in no event later than 10 business days following the occurrence of such Change in Control.
 
 
 
 
3B-5
 
 
 
SECTION 7.  AMENDMENT AND TERMINATION.
 
Notwithstanding Section 8(a), the Board or the Committee may at any time amend, suspend, discontinue or terminate the Plan; provided, however, that no such action shall be effective without approval by the shareholders of Aetna to the extent necessary to continue to qualify the amounts payable to Covered Employees as performance-based compensation under Section 162(m). Notwithstanding the foregoing, no amendment, suspension, discontinuance or termination of the Plan shall adversely affect the rights of any Participant or beneficiary in respect of any award that the Committee has determined to be payable to a Participant in accordance with the terms hereof or as to any amounts awarded, but payment of which has been deferred, in accordance with Section 6.
 
SECTION 8. GENERAL PROVISIONS.
 
(a)      Effectiveness of the Plan.  Subject to the approval of Aetna’s shareholders and the shareholders of Aetna Inc., a Connecticut corporation, the Plan shall be effective with respect to calendar years beginning on or after January 1, 2001 and ending on or before December 31, 2020, unless the term hereof is extended by action of the Board or the Committee.
 
(b)      Designation of Beneficiary.  Each Participant may designate a beneficiary or beneficiaries (which beneficiary may be an entity other than a natural person) to receive any payments which may be made following the Participant’s death. Such designation may be changed or canceled at any time without the consent of any such beneficiary. Any such designation, change or cancellation must be made in a form approved by the Committee and shall not be effective until received by the Committee. If no beneficiary has been named, or the designated beneficiary or beneficiaries shall have predeceased the Participant, the beneficiary shall be the Participant’s spouse or, if no spouse survives the Participant, the Participant’s estat e. If a Participant designates more than one beneficiary, the rights of such beneficiaries shall be payable in equal shares, unless the Participant has designated otherwise.
 
(c)      No Right of Continued Employment.  Nothing contained in this Plan shall create any rights of employment in any Participant or in any way affect the right and power of any of the Companies to discharge any Participant or otherwise terminate the Participant’s employment at any time with or without cause or to change the terms of employment in any way.
 
(d)      No Limitation on Corporate Actions.  Nothing contained in the Plan shall be construed to prevent any of the Companies from taking any corporate action (including, without limitation, making provision for the payment of other incentive compensation, whether payable in cash or otherwise, or whether pursuant to a plan or otherwise) which is deemed by it to be appropriate or in its best interest, whether or not such action would have an adverse effect on any awards made under the Plan.  No employee, beneficiary or other person shall have any claim against any of the Companies as a result of any such action.
 
(e)      No Right to Specific Assets.  Nothing contained in the Plan (including, without limitation, the provisions of Section 6 hereof) shall be construed to create in any Participant or beneficiary any claim against, right to or lien on any particular assets of any of the Companies or to require any of the Companies to segregate or otherwise set aside any assets or create any fund to meet any of its obligations hereunder.
 
(f)      No Contractual Right to Bonus.  Nothing in this Plan shall be construed to give any Participant any right, whether contractual or otherwise, to receive any bonus with respect to any Performance Period unless and until the Committee shall have expressly determined that such a Participant is entitled to receive such an award pursuant to the terms of the Plan.
 
(g)      Nonalienation of Benefits.  Except as expressly provided herein, no Participant or beneficiary shall have the power or right to transfer, anticipate, or otherwise encumber the Participant’s interest under the Plan.
 
 
 
3B-6
 
 
 
(h)      Withholding.  Any amount payable to a Participant or a beneficiary under this Plan shall be subject to any applicable Federal, state and local income and employment taxes and any other amounts that any of the Companies is required at law to deduct and withhold from such payment.
 
(i)      Severability.  If any provision of this Plan is held unenforceable, the remainder of the Plan shall continue in full force and effect without regard to such unenforceable provision and shall be applied as though the unenforceable provision were not contained in the Plan.
 
(j)      Governing Law.  The Plan shall be construed in accordance with and governed by the laws of the State of Connecticut, without reference to the principles of conflict of laws.
 
(k)      Headings.  Headings are inserted in this Plan for convenience of reference only and are to be ignored in a construction of the provisions of the Plan.
 
(l)      Compliance with Section 409A.  The payment of bonuses under this Plan is intended to be exempt from the requirements of Section 409A as short-term deferrals.  To the extent not exempt (i.e., in the case of deferrals permitted under Section 6(b) and (c)), payment is intended to satisfy the requirements of Section 409A.  The provisions of this Plan shall be construed in a manner consistent with such intent.  The Company will not pay or accelerate the payment of any deferred compensation in violation of Section 409A.  To the extent an amount that constitutes “deferred compensation” within the meaning of Section 409A would otherwise vest and become payable upon a Change in Control, such amount shall vest as so provided but payment shall not be accelerated unless the Change in Control also satisfies the broadest definition of change in control permitted under Section 409A.
 
Any amount that constitutes “deferred compensation” within the meaning of Section 409A and is payable under this Plan solely by reason of a Participant’s termination of employment or separation from service shall be payable as soon as, and no later than, the Participant experiences a “separation from service” within the meaning of Section 409A, provided that if the Participant is a “specified employee” within the meaning of Section 409A at the time of such separation from service, as determined by the Company in accordance with Section 409A, no payments shall be made before the six-month anniversary of the Participant’s separation from service, at which time all payments that would otherwise have been made during such six-month period shall be paid to the Participant in a lump sum.
 

 
Last amended February 25, 2010
 

 
 
3B-7
 

EX-12.1 7 exhibit12-1.htm EXHIBIT 12.1 exhibit12-1.htm  
 
Exhibit 12.1  
 

Computation of Ratios

The computation of the ratio of earnings to fixed charges for the three months ended March 31, 2010 and the years ended December 31, 2009, 2008, 2007, 2006 and 2005 are as follows:

Three Months Ended
  
Years Ended December 31,
(Millions)
March 31, 2010
  
2009
  
2008
  
2007
  
2006
  
2005
Pretax income from continuing operations
 $    801.0
  
 $   1,901.2
  
 $   2,174.2
  
 $   2,796.4
  
 $   2,586.6
  
 $   2,453.3
Add back fixed charges
 74.8
  
 302.9
  
 297.9
  
 234.3
  
 199.5
  
 177.5
Income, as adjusted
 $    875.8
  
 $   2,204.1
  
 $   2,472.1
  
 $   3,030.7
  
 $   2,786.1
  
 $   2,630.8
                       
Fixed charges:
                      
Interest on indebtedness
 $      60.9
  
 $      243.4
 
 $     236.4
  
 $      180.6
  
 $     148.3
  
 $      122.8
Portion of rents representative
                      
  of interest factor
 13.9
  
 59.5
  
 61.5
  
 53.7
  
 51.2
  
 54.7
Total fixed charges
 $      74.8
  
 $      302.9
 
 $     297.9
  
 $      234.3
  
 $     199.5
  
 $      177.5
                       
Ratio of earnings to fixed charges
 11.71
  
 7.28
  
 8.30
  
 12.94
  
 13.97
  
 14.82

 
 

 
 
 

 
 EX-15.1 8 exhibit15-1.htm EXHIBIT 15.1 exhibit15-1.htm  
 
 
Exhibit 15.1  
 






Aetna Inc.
Hartford, Connecticut
 
 
Re: Registration Statements No. 333-52124, 52122, 52120, 73052, 87722, 87726, 124619, 124620, 136176, 136177 and 155961
 
With respect to the subject registration statements, we acknowledge our awareness of the use therein of our report dated April 29, 2010 related to our review of interim financial information.
 
Pursuant to Rule 436 under the Securities Act of 1933 (the “Act”), such report is not considered part of a registration statement prepared or certified by an independent registered public accounting firm, or a report prepared or certified by an independent registered public accounting firm within the meaning of Sections 7 and 11 of the Act.
 
 
 
 
/s/ KPMG LLP
 
 
Hartford, Connecticut
April 29, 2010
 
 

 

 
 
 

EX-31.1 9 exhibit31-1.htm EXHIBIT 31.1 exhibit31-1.htm  
 
Exhibit 31.1  
 
 

 
Certification

I, Ronald A. Williams, certify that:

1.  
I have reviewed this quarterly report on Form 10-Q of Aetna Inc.;

2.  
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.  
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)  
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)  
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)  
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.  
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)  
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)  
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:   April 29, 2010
 /s/ Ronald A. Williams
 
 Ronald A. Williams
 
 Chairman and Chief Executive Officer
 
 


 
 
 

EX-31.2 10 exhibit31-2.htm EXHIBIT 31.2 exhibit31-2.htm  
 
 
Exhibit 31.2  
 

 
Certification

I, Joseph M. Zubretsky, certify that:

1.  
I have reviewed this quarterly report on Form 10-Q of Aetna Inc.;

2.  
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.  
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)  
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)  
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)  
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.  
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)  
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)  
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date:   April 29, 2010
 /s/ Joseph M. Zubretsky
 
 Joseph M. Zubretsky
 
 Executive Vice President and Chief Financial Officer
 
 
 


 
 
 

EX-32.1 11 exhibit32-1.htm EXHIBIT 32.1 exhibit32-1.htm  

Exhibit 32.1    
 
 
 
Certification


The certification set forth below is being submitted to the Securities and Exchange Commission in connection with the Quarterly Report on Form 10-Q of Aetna Inc. for the period ended March 31, 2010 (the “Report”) solely for the purpose of complying with Rule 13a-14(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code.

Ronald A. Williams, Chairman and Chief Executive Officer of Aetna Inc., certifies that, to the best of his knowledge:

1. 
the Report fully complies with the requirements of Section 13(a) of the Exchange Act; and
   
2. 
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Aetna Inc.



Date:   April 29, 2010
 /s/ Ronald A. Williams
 
 Ronald A. Williams
 
 Chairman and Chief Executive Officer

 
 
 
 
 
 

 
 
 

EX-32.2 12 exhibit32-2.htm EXHIBIT 32.2 exhibit32-2.htm  
 
 
Exhibit 32.2  
 

 
Certification


The certification set forth below is being submitted to the Securities and Exchange Commission in connection with the Quarterly Report on Form 10-Q of Aetna Inc. for the period ended March 31, 2010 (the “Report”) solely for the purpose of complying with Rule 13a-14(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code.

Joseph M. Zubretsky, Executive Vice President and Chief Financial Officer of Aetna Inc., certifies that, to the best of his knowledge:

1. 
the Report fully complies with the requirements of Section 13(a) of the Exchange Act; and
   
2. 
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Aetna Inc.



Date:   April 29, 2010
 /s/ Joseph M. Zubretsky
 
 Joseph M. Zubretsky
 
 Executive Vice President and Chief Financial Officer
 
 
 
 
 

 

 
 
 

EX-101.INS 13 aet-20100331.xml XBRL INSTANCE DOCUMENT 0001122304 2009-01-01 2009-12-31 0001122304 aet:CommonStockOutstandingMember 2008-12-31 0001122304 aet:CommonStockAndAdditionalPaidInCapitalMember 2008-12-31 0001122304 us-gaap:RetainedEarningsMember 2008-12-31 0001122304 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2008-12-31 0001122304 2008-12-31 0001122304 2009-12-31 0001122304 aet:CommonStockOutstandingMember 2009-12-31 0001122304 aet:CommonStockAndAdditionalPaidInCapitalMember 2009-12-31 0001122304 us-gaap:RetainedEarningsMember 2009-12-31 0001122304 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2009-12-31 0001122304 2009-01-01 2009-03-31 0001122304 us-gaap:RetainedEarningsMember 2009-01-01 2009-03-31 0001122304 us-gaap:ComprehensiveIncomeMember 2009-01-01 2009-03-31 0001122304 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2009-01-01 2009-03-31 0001122304 aet:CommonStockOutstandingMember 2009-01-01 2009-03-31 0001122304 aet:CommonStockAndAdditionalPaidInCapitalMember 2009-01-01 2009-03-31 0001122304 aet:CommonStockOutstandingMember 2009-03-31 0001122304 aet:CommonStockAndAdditionalPaidInCapitalMember 2009-03-31 0001122304 us-gaap:RetainedEarningsMember 2009-03-31 0001122304 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2009-03-31 0001122304 2009-03-31 0001122304 2010-01-01 2010-03-31 0001122304 us-gaap:RetainedEarningsMember 2010-01-01 2010-03-31 0001122304 us-gaap:ComprehensiveIncomeMember 2010-01-01 2010-03-31 0001122304 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-01-01 2010-03-31 0001122304 aet:CommonStockOutstandingMember 2010-01-01 2010-03-31 0001122304 aet:CommonStockAndAdditionalPaidInCapitalMember 2010-01-01 2010-03-31 0001122304 2010-03-31 0001122304 aet:CommonStockOutstandingMember 2010-03-31 0001122304 aet:CommonStockAndAdditionalPaidInCapitalMember 2010-03-31 0001122304 us-gaap:RetainedEarningsMember 2010-03-31 0001122304 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares Q1 <div><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">10.</font></div></td><td valign="top" align="left" width="85%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Capital Stock</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">On February 27, 2009, our Board of Directors (the &#8220;Board&#8221;) authorized a sh are repurchase program for the repurchase of up to $750 million of our common stock.&#160;&#160;During the three months ended March 31, 2010, we repurchased approximately 7 million shares of common stock at a cost of approximately $252 million (approximately $90 million of these repurchases were settled in early April).&#160;&#160;At March 31, 2010, we had remaining authorization to repurchase an aggregate of up to approximately $339 million of common stock under the February 27, 2009 Board authorization.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">On February 8, 2010, approximately .8 million performance stock units (&#8220;PSUs&#8221;), 1.6 million market stock units (&#8220;MSUs&#8221;) and 1.1 million restricted stock units (&#8220; RSUs&#8221;) were granted to certain employees.&#160;&#160;The number of vested PSUs (which could range from zero to 200% of the original number of units granted) is dependent upon the degree to which we achieve performance goals during the performance period as determined by the Board&#8217;s Committee on Compensation and Organization. The performance period for the PSUs ends on December 31, 2010, and the vesting period ends on February 8, 2012.&#160;&#160;&#160;The number of vested MSUs (which could range from zero to 150% of the original number of units granted) is based on the weighted average closing price of our common stock for the thirty trading days prior to the vesting date.&#160;&#160;The MSUs have a two-year vesting period.&#160;&#160;For each vested RSU, employees receive one share of common stock, net of taxes, at the end of the vesting period.&#160;&#160;The RSUs will become 100% vested approximately three years from the grant date, with one- third vesting each December.</font></div> No 899800000 893000000 366800000 567800000 -1300000 -114800000 2462200000 2490700000 -66100000 -68700000 27600000 37200000 634000000 626700000 474700000 485100000 false 80300000 -28200000 80300000 -28200000 80300000 -28200000 556300000 551000000 1.28 0.95 216100000 208300000 6895100000 6992200000 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">9.</font></div></td><td valign="top" align="left" width="85%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Debt</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The carrying value of our long-term debt at March 31, 2010 and December 31, 2009 was as follows:</font><br /></d iv><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="56%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">March 31,</font></div></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">December 31,</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td s tyle="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2009</font></div></td></tr><tr><td valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Senior notes, 5.75%, due 2011</font></div></td><td valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; 449.9</font> ;</div></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 449.9</font></div></td></tr><tr><td valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Senior notes, 7.875%, due 2011</font></div></td><td valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align= "right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;449.7</font></div></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;449.5</font></div></td></tr><tr><td valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Senior notes, 6.0%, due 2016</font></div></td><td valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt ; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;747.2</font></div></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;747.1</font></div></td></tr><tr><td valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Senior notes, 6.5%, due 2018</font></div></td><td valign="bottom" align="right" width="12%">&l t;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;498.8</font></div></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;498.8</font></div></td></tr><tr><td valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Senior notes, 6.625%, due 2036</font></div></td><td valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;798.6</font></div></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;798.6</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times n ew roman">Senior notes, 6.75%, due 2037</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;695.6</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;695.6</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total long-term debt</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3,639.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="ri ght"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3,639.5</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Less current portion of long-term debt <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;449.7</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="l eft" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; -&#160; </font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Long-term debt, less current portion</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0p t" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; &#160;3,190.1</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; &#160;&#160;&#160; 3,639.5</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT- ALIGN: center" valign="top" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="84%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">At March 31, 2010, the 7.875% senior notes due March 2011 have been classified as current in the accompanying consolidated balance sheet at March 31, 2010.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div><div><font style="DISPLAY: inline; FONT- SIZE: 11pt; FONT-FAMILY: Times New Roman">At March 31, 2010 and December 31, 2009, we had approximately $480 million and $481 million, respectively, of commercial paper outstanding with a weighted average interest rate of .32% and .38%, respectively.</font></div><div>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 2.7pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">At March 31, 2010, we had an unsecured $1.5 billion revolving credit agreement (the &#8220;Facility&#8221;) with several financial institutions which terminates in March 2013.&#160;&#160;The Facility provides for the issuance of up to $200 million of letters of credit at our request, which count as usage of the available commitments under the Facility.&#160;&#160;Upon our agreement with one or more financial institutions, we may expand the aggregate commitments under the Facility to a maximum of $2.0 billion.<font style="DISPLAY: inline; FONT-SIZE: 14pt">&#160;</font>Various interest rate options are available under the Facility.&#160;&#160;Any revolving borrowings mature on the termination date of the Facility.&#160;&#160;We pay facility fees on the Facility ranging from .045% to .175% per annum, depending upon our long-term senior unsecured debt rating.&#160;&#160;The facility fee was .06% at March 31, 2010.&#160;&#160;The Facility contains a financial covenant that requires us to maintain a ratio of total debt to consolidated capitalization as of the end of each fiscal quarter at or below .5 to 1.0.&#160;&#160;For this purpose, consolidated capitalization equals total shareholders&#8217; equity, excluding any overfunded or underfunded status of our pension and OPEB plans and any net unrealized capital gains and losses, and total debt (as defined in the Facility).&#160;&#160;We met this requirement at March 31, 2010. There were no amounts outstanding under the Facility at March 31, 2010.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">During 2010 and 2009, we entered into five interest rate swaps with a notional value of $100 million each.&#160;&#160;We entered into these swaps to hedge interest rate exposure in anticipation of future issuance of long-term debt.&#160;&#160;At March 31, 2010 and December 31, 2009, the interest rate swaps had an aggregate fair value of $34.6 million and $42.2 million, respectively.&#160;&#160;We also recorded a $7.6 million unrealized capital loss and $3.5 million unrealized capital gain related to these interest rate swaps in other comprehensive income for the three months ended March 31, 2010 and 2009, respectively.</font></div>< div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div> <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">1.</font></div></td><td valign="top" align="left" width="85%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Organization</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We conduct our operations in three business segm ents:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr valign="top"><td style="WIDTH: 36pt" align="right"><div><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Symbol, serif">&#183;&#160;&#160;</font></div></td><td><div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Health Care</font> consists of medical, pharmacy benefits management, dental and vision plans offered on both an Insured basis (where we assume all or a majority of the risk for medical and dental care costs) and an employer-funded basis (where the plan sponsor under an administrative services contract (&#8220;ASC&#82 21;) assumes all or a majority of this risk).&#160;&#160;Medical products include point-of-service (&#8220;POS&#8221;), preferred provider organization (&#8220;PPO&#8221;), health maintenance organization (&#8220;HMO&#8221;) and indemnity benefit plans.&#160;&#160;Medical products also include health savings accounts (&#8220;HSAs&#8221;) and Aetna HealthFund<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, consumer-directed health plans that combine traditional POS or PPO and/or dental coverage, subject to a deductible, with an accumulating benefit account (which may be funded by the plan sponsor and/or the member in the case of HSAs).&#160;&#160;We also offer Medicare and Medicaid products and services and specialty products, such as medical management and data analytics services, behavioral health plans and stop loss insurance, as well as products that provide access to our provider network in selec t markets.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr valign="top"><td style="WIDTH: 36pt" align="right"><div><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Symbol, serif">&#183;&#160;&#160;</font></div></td><td><div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Group Insurance</font> primarily includes group life insurance products offered on an Insured basis, including basic and supplemental group term life, group universal life, supplemental or voluntary programs and accidental death and dismemberment coverage.&#160;&#16 0;Group Insurance also includes (i) group disability products offered to employers on both an Insured and an ASC basis which consist primarily of short-term and long-term disability insurance, (ii) absence management services offered to employers, which include short-term and long-term disability administration and leave management, and (iii) long-term care products that were offered primarily on an Insured basis, which provide benefits covering the cost of care in private home settings, adult day care, assisted living or nursing facilities.&#160;&#160;We no longer solicit or accept new long-term care customers, and we are working with our customers on an orderly transition of this product to other carriers.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr valign="top">< td style="WIDTH: 36pt" align="right"><div><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Symbol, serif">&#183;&#160;&#160;</font></div></td><td><div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Large Case Pensions</font> manages a variety of retirement products (including pension and annuity products) primarily for tax qualified pension plans.&#160;&#160;These products provide a variety of funding and benefit payment distribution options and other services.&#160;&#160;Large Case Pensions also includes certain discontinued products (refer to Note 14 beginning on page&#160;20 or additional information).</font></div></td></tr></table></div> Yes 162000000 263800000 1600000 1900000 74500000 88600000 102300000 97000000 -76700000 4800000 2965400000 2895300000 24400000 24500000 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="2%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">5.</font></div></td><td valign="top" align="left" width="82%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Investments</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Total investments at March 31, 2010 and December 31, 2009 were as follows:</font><br /></div>&l t;div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="32%" colspan="5"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">March 31, 2010</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" colspan="5"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-R IGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">December 31, 2009</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Current</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FON T-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Long-term</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" w idth="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Current</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Long-term</font></div></td><td st yle="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total</font></div></td></tr><tr><td valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Debt and equity securities available for sale</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&g t;<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 2,750.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 15,098.1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right">& lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 17,848.8</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 2,834.8</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY : inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 14,324.9</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 17,159.7</font></div></td></tr><tr><td valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Mortgage loans</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;98.4</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,457.6</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLA Y: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,556.0</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;86.1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,507.9</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,594.0</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Other investments</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,253.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="r ight"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,256.6</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MA RGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,218.3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,220.1</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times ne w roman">Total investments</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 2,851.9</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 17 ,809.5</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 20,661.4</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt " align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 2,922.7</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 17,051.1</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: bl ack 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 19,973.8</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Debt and Equity Securities</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -252pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Debt and equity securities available for sale at M arch 31, 2010 and December 31, 2009 were as follows:</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="59%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Gross</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDEN T: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Gross</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" width="59%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Amortized</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Unrealized</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Unrealized</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Fair</font></ div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Cost</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, s erif">Gains</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Losses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Value</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPL AY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">March 31, 2010</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr&g t;<tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Debt securities:</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY : times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;U.S. government securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,947.6</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT - -SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 56.3</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (.9)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif ">&#160;$&#160;&#160;&#160;&#160;&#160; 2,003.0</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2,159.9</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;80.6</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(20.5)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2,220.0</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDE NT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;U.S. corporate securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;6,866.9</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;484.5</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right">& lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(32.1)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;7,319.3</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Foreign securities</font></div></td><td valign="bottom" align="right " width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2,690.7</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;210.7</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(15.4)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new r oman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2,886.0</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;1,337.0< /font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;54.8</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(3.3)</font></div></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;(1)</fon t></font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;1,388.5</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;1,146.0</fon t></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;68.4</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(59.8)</font></div></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;(1)</font&g t;</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;1,154.6</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Other asset-backed securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;475.0</font></div ></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;25.5</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(5.7)</font></div></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;(1)</font></font> ;</div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;494.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Redeemable preferred securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;347.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;21.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(26.2)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px soli d" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;342.8</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Total debt securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;16,970.6</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY : block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;1,002.3</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(163.9)</font></div></td><td valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;17,809.0</font>&l t;/div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Equity securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;35.3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;7.3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(2.8)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;39.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: bl ack 4px double" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Total debt and equity securities <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160; 17,005.9</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right">< ;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; 1,009.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; (166.7)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLA Y: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160; 17,848.8</font></div></td></tr><tr><td valign="bottom" width="59%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DI SPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">December 31, 2009</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">& ;#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Debt securities:</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISP LAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;U.S. government securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,801.3</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 50.7</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (5.2)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div s tyle="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$1,846.8</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2,022.2</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0p t; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;80.7</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(27.5)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2,075.4</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><di v style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;U.S. corporate securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;6,741.9</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;497.1</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" alig n="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(54.4)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;7,184.6</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Foreign securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2,554.5</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;210.9</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(20.9)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2,744.5</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;1,375.8</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARG IN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;49.4</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(5.0)</font></div></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;(1)</font></font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt ; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;1,420.2</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;1,109.8</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font sty le="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;37.6</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(104.0)</font></div></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;(1)</font></font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SI ZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;1,043.4</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Other asset-backed securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;419.6</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160; 25.0</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(8.2)</font></div></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;(1)</font></font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;436.4</font></div> </td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Redeemable preferred securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;381.9</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;27.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(41.0)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;368.7</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Total debt securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;16,407.0</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;979.2</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(266.2)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;17,120.0</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Equity securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style ="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;35.3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;7.9</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(3.5)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;39.7</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Total debt and equity securities <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0 pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 16,442.3</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160; 987.1</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&a mp;#160;&#160;&#160;(269.7)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;17,159.7</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="2%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="96%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -5.4pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">At March 31, 2010 and December 31, 2009, we held securities for which we had recognized a credit-related impairment in the past.&#160;&#160;For the three months ended March 31, 2010, we recognized $6.0 million of non-credit-related impairments in other comprehensive loss related to these securities (as of March 31, 2010 and December 31, 2009, these securities had a net unrealized capital loss of $12.0 million and $17.2 million, respectively).</font></div></td></tr><tr><td style="TEXT-ALIGN: center" valign="top" width="2%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; F ONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div></td><td valign="top" align="left" width="96%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -5.4pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Investment risks associated with our experience-rated and discontinued products generally do not impact our results of operations (refer to Note 14 beginning on page&#160;20 for additional information on our accounting for discontinued products).&#160;&#160;At </font><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">March 31, 2010, investments with a fair value of $4.0 billion, gross unrealized capital gains of $303.5 million and gross unrealized capital losses of $50.0 million and, at December 31, 2009, investments with a fair value of $4.0 billion, gro ss unrealized capital gains of $285.6 million and gross unrealized capital losses of $78.2 million were included in total debt and equity securities, but support our experience-rated and discontinued products.&#160;&#160;Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive loss.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 4.5pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The fair value of debt securities at March 31, 2010 is shown below by contractual maturity.&#160;&#160;Actual maturities may differ from contractual maturities because securities may be restruct ured, called or prepaid.</font><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="51%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Fair</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" vali gn="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></di v></td></tr><tr><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Due to mature:</font></div></td><td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: ti mes new roman">&#160;&#160;&#160; Less than one year</font></div></td><td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 721.1</font></div></td></tr><tr><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-S IZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160; One year through five years</font></div></td><td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3,614.2</font></div></td></tr><tr><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&am p;#160;&#160; After five years through ten years</font></div></td><td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5,351.7</font></div></td></tr><tr><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160; Greater than ten years</font ></div></td><td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5,084.1</font></div></td></tr><tr><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160; Residential mortgage-backed securities</font></div></td><td valign="bot tom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,388.5</font></div></td></tr><tr><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160; Commercial mortgage-backed securities</font></div></td><td valign="bottom" width="12%"><font style="DISPLAY: i nline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,154.6</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160; Other asset-backed securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%">&l t;font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;494.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total</font></div></td><td style="BORDER-BOTTOM: blac k 4px double" valign="bottom" align="left" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 17,809.0</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -1.8pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The maturity dates for debt securities in an unrealized capital loss position at March 31, 2010 were as follows:</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="22%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Supporting discontinued</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font>< ;/td><td valign="bottom" width="19%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Supporting remaining</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="17%" colspan="3"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style ="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">and experience-rated products</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="19%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">products</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="17%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total</font></div></td></tr><tr><td valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Fair</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrealized</font></div ></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Fair</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrealized</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Fair</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrealized</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font s tyle="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Losses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times n ew roman">Losses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: in line; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Losses</font></div></td></tr><tr><td valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Due to mature:</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </fo nt></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9 pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;Less than one year</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160; 1.2</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><d iv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160; -&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; &#160;&#160;&#160;&#160;&#160; 32.1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </f ont></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1.3</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 33.3</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZ E: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1.3</font></div></td></tr><tr><td valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;One year through five years</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;22.6</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.4</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;460.1</font></div></td><td valign="bottom " width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;482.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#1 60; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;6.1</font></div></td></tr><tr><td valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;After five years through ten years</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;160.2</font></div></td><td valign="bottom" width="2%">& lt;font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2.2</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;622.1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font> ;</td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;8.3</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;782.3</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT : 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;10.5</font></div></td></tr><tr><td valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;Greater than ten years</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;490.8</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="b ottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;34.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;881.2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; M ARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;42.5</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,372.0</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;77.2</font></div></td></tr><tr><td valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;Residential mortgage-backed securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LE FT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;363.2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inl ine; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3.3</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;363.2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3.3</font></d iv></td></tr><tr><td valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;Commercial mortgage-backed securities</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;63.6</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIG HT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;9.4</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;207.1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;50.4</font></div></td ><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;270.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;59.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" widt h="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;Other asset-backed securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;18.2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&g t;<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;73.2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: bl ock; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;91.4</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px s olid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.7</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 756.6</font></di v></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 47.2</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right">& lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 2,639.0</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 116.7</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4 px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 3,395.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 163.9</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-I NDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Mortgage-Backed and Other Asset-Backed Securities</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">All of our residential mortgage-backed securities at March 31, 2010 were agency (e.g., Government National Mortgage Association, Federal National Mortgage Association and Federal Home Loan Mortgage Corporation) issued and carry agency guarantees and explicit or implicit guarantees by the U.S. Government.&#160;&#160;At March 31, 2010, our residential mortgage-backed securities had an average quality rating of AAA and a weighted average duration of 3.1 years.</font></div><div style="DISPLAY: bl ock; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Our commercial mortgage-backed securities have underlying loans that are dispersed throughout the United States.&#160;&#160;Significant market observable inputs used to value these securities include probability of default and loss severity.&#160;&#160;At March 31, 2010, these securities had an average quality rating of AA+ and a weighted average duration of 3.4 years.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Our other asset-backed securities have a variety of underlying collateral (e.g., automobile loans, credit card rece ivables, home equity loans, etc.).&#160;&#160;Significant market observable inputs used to value these securities include the unemployment rate, loss severity and probability of default.&#160;&#160;At March 31, 2010, these securities had an average quality rating of AA- and a weighted average duration of 2.1 years.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Unrealized Capital and Net Realized Capital Gains (Losses)</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">When a debt or equity security is in an unrealized capital loss position, we monitor the duration and severity of the loss to determine if sufficient market recovery can occur within a reasonable period of time. As described in Note 2 beginning on page 5, effective April 1, 2009, we recognize an OTTI when we intend to sell a security that is in an unrealized capital loss position or if we determine a credit-related loss has occurred. Prior to April 1, 2009, we would recognize an OTTI on a security in an unrealized capital loss position if we did not have the intention and ability to hold the security until it recovered its value.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Summarized below are the debt and equity securities we held at March 31, 2 010, and December 31, 2009, that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="19%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Less than 12 months</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; &l t;/font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="21%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Greater than 12 months</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="18%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td></tr><tr><td valign="bottom" width="40%"><fo nt style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Fair</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrealized</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><fo nt style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Fair</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrealized</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Fair</font></di v></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrealized</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td><td styl e="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Losses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: ti mes new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Losses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%">&l t;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Losses</font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">March 31, 2010</font></div></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font>&l t;/td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DI SPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Debt securities:</font></div></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9% "><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;U.S. government securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 103.0</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160; .3 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 24.2 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160; .6 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div styl e="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; &#160;&#160; &#160;&#160;&#160; 127.2 </font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; .9 </font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&am p;#160;&#160;&#160;States, municipalities and political subdivisions</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;300.0</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;6.4</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="r ight"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;213.5</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;14.1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roma n">&#160;513.5</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;20.5</font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;U.S. corporate securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;754.9</font></div></td&g t;<td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;12.0</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;543.5</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;20.1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,298.4</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;32.1</font></div></td></tr><tr><td valign="bottom" align=" left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Foreign securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;403.3</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roma n">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;105.5</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;9.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div styl e="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;508.8</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;15.4</font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Residential mortgage-backed securites</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-I NDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;355.0</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3.0</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;8.2</font></div></td><td valign="bottom" width="1%"><font style="DISPLA Y: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.3</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;363.2</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font st yle="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3.3</font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;18.6</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FON T-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.4</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;252.1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;59.4</font></div></td><td va lign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;270.7</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;59.8</font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;& amp;#160;&#160;&#160;Other asset-backed securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;76.8</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.3</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font s tyle="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;14.6</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.4</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;91.4&l t;/font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.7</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Redeemable preferred securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;39.3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3.6</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;183.1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" alig n="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;22.6</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;222.4</font></div> ;</td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;26.2</font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total debt securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2,050.9</font></div></td><td valign="bottom" align="right" width="10 %"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;36.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,344.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="ri ght"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;127.2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3,395.6</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;163.9</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Equity securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.6</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;23.4</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2.6</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;24.0</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt ; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total debt and equity securities <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160; 2,051.5</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;& ;#160;&#160;&#160;&#160; &#160;36.9</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160; &#160;&#160;&#160;&#160; 1,368.1</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block ; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 129.8</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; &#160; 3,419.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGI N-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 166.7 </font></div></td></tr><tr><td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: ti mes new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: i nline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">December 31, 2009</font></div></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">& ;#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Debt securities:</font></div></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inlin e; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td vali gn="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;U.S. government securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,062.5 </font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><f ont style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 4.8 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 19.3 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0 pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; .4 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 1,081.8</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: t imes new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 5.2 </font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;292.2</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inli ne; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;10.6</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;216.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;16.9</font></div></td><td valign="bottom" width="1%">& lt;font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;508.9</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;27.5 </font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;U.S. corporate securities</font> ;</div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;730.2</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;16.8</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;681.4</font></d iv></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;37.6</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,411.6</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGI N-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;54.4 </font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Foreign securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;418.1</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;9.0</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;110.4</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;11.9</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SI ZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;528.5</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;20.9 </font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Residential mortgage-backed securites</font></div></td>< ;td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;383.0</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;4.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;8.2</font></div></td><td valign ="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.3</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;391.2</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right">< ;font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.0</font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;129.7</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&a mp;#160;3.1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;401.6</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;100.9</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FA MILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;531.3</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;104.0 </font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Other asset-backed securities</font></div></td><td valign="bottom" ali gn="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;46.6</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;7.5</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;16.7</font></div></td><td valign="bottom" width="1%"> ;<font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;63.3</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: in line; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;8.2 </font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Redeemable preferred securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;49.1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"& gt;<font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;8.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;198.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT : 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;32.2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;247.6</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;41.0 </font></div>& lt;/td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total debt securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3,111.4</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;65.3</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">& #160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,652.8</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;200.9</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"></font>&#160;</ div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;4,764.2</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;266.2</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Equity securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width ="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3.9</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1.6</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-F AMILY: times new roman">&#160;18.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1.9</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="D ISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;22.7</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3.5</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total debt and equity securities <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MAR GIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3,115.3</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; &#160;&#160;&#160;&#160; 66.9</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDE NT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 1,671.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; &#160;&#160;&#160; 202.8</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font&g t;</td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 4,786.9</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 269.7</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="3%"><div st yle="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="97%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -5.4pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">At March 31, 2010 and December 31, 2009, debt and equity securities in an unrealized capital loss position of $50.0 million and $78.2 million, respectively, and with related fair value of $780.2 million and $1.0 billion, respectively, related to discontinued and experience-rated products.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We reviewed the securities in the tables above and concluded that these are performing assets generating investment income to support the needs of our business.&#160;&#160;In performing this review, we considered factors such as the quality of the investment security based on research performed by external rating agencies and our internal credit analysts and the prospects of realizing the carrying value of the security based on the investment&#8217;s current prospects for recovery.&#160;&#160;Unrealized capital losses at March 31, 2010 and December 31, 2009 were generally caused by the widening of credit spreads on these particular securities relative to the interest rates on U.S. Treasury securities.&#160;&#160;As of March 31, 2010, we did not have an intention to sell the securities that were in an unrealized capital loss position.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"&g t;<br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Net realized capital gains (losses) for the three months ended March 31, 2010 and 2009, excluding amounts related to experience-rated contract holders and discontinued products, were as follows:</font><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="62%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="16%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Three Months Ended</font></div ></td></tr><tr><td valign="bottom" width="62%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="16%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">March 31,</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="62%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2009</font></div></td></tr><tr><td valign="bottom" align="left" width="62%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">OTTI losses on securities</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="D ISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; (19.8)</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; (42.9)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="62%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Portion of OTTI losses recognized in other comprehensive income</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLA Y: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;6.0</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td></tr><tr><td valign="bottom" align="left" width="62%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net OTTI losses on securities recognized in earnings</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT - -INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(13.8)</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(42.9)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="62%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net realized capital gains, excluding OTTI losses on securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;90.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;38.1</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="62%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net realized capital gains (losses)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MAR GIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 76.7</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160; (4.8)</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; F ONT-FAMILY: Times New Roman">The decrease in OTTI recognized in earnings in 2010 compared to 2009 was primarily related to a change in the accounting guidance for the recognition of OTTI of debt securities.&#160;&#160;Prior to the adoption of new accounting guidance for OTTI of debt securities on April 1, 2009, both yield- and credit-related OTTI were recognized in earnings if we could not assert our intention to hold the security until recovery.&#160;&#160;In contrast, after April 1, 2009, only credit-related impairments are recognized in earnings unless we have the intention to sell the security in an unrealized capital loss position, in which case the yield-related OTTI is also recognized in earnings.&#160;&#160;Refer to Note 2 beginning on page&#160;5 for more information.&#160;&#160;</font></div><div>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Excluding amounts related to experience-rated and discontinued products, proceeds from the sale of debt securities and the related gross realized capital gains and losses for three months ended March 31, 2010 and 2009 were as follows:</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="74%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="26%" colspan="5"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">F or the Three Months Ended March 31,</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" wid th="7%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2009</font></div></td></tr><tr><td valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Proceeds on sales</font></div></td><td valign="bottom" align="left" width="1%"><div s tyle="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2,365.4</font></div></td><td valign="bottom" align="left" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="8% "><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2,430.9</font></div></td></tr><tr><td valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Gross realized capital gains</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;108.7</font></div></td><td val ign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">54.6</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Gross realized capital losses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(8.2)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDEN T: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(18.9)</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Variable Interest Entities (&#8220;VIEs&#8221;)</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We have relationships with certain real estate and hedge fund partnerships that are considered VIEs.&#160;&#160;We record the amount of our investment in these partnerships as long-term inv estments on our balance sheets and recognize our share of partnership income or losses in earnings.&#160;&#160;Our maximum exposure to loss as a result of our investment in these partnerships is our investment balance at March 31, 2010 and December 31, 2009 of approximately $116 million and $125 million, respectively, and the risk of recapture of tax credits related to the real estate partnerships previously recognized, which we do not believe to be significant.&#160;&#160;We do not have a future obligation to fund losses or debt on behalf of these investments; however, we may voluntarily contribute funds.&#160;&#160;The real estate partnerships construct, own and manage low-income housing developments and had total assets of approximately $5.0 billion and $5.1 billion at March 31, 2010 and December 31, 2009, respectively.&#160;&#160;The hedge fund partnerships had total assets of approximately $6.6 billion and $5.7 billion at March 31, 2010 and December 31, 2009, respectively .</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Credit Default Swaps</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We sell credit protection via credit default swap contracts to improve the return and diversification profile of our investment portfolio.&#160;&#160;Our contracts are limited to credit exposure on individual entities or investment-grade indices and have terms no longer than five years.&#160;&#160;We would have to pay under these contracts based on certain defined triggering events such as bankruptcy and failure to pay interest or principal on the underlying obligati on.&#160;&#160;The fair value and maximum amount of future payments for these credit default swaps at March 31, 2010 were $0 and $9 million, respectively, and at December 31, 2009 were $.1 million and $18 million, respectively.&#160;&#160;At March 31, 2010, we were not required to make any payments to our counterparties for risks covered by these credit default swaps.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Non-controlling Interests</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Certain of our investment holdings are partially-owned by third parties.&#160;&#160;At Ma rch 31, 2010 and December 31, 2009, $79 million and $77 million, respectively, of our investment holdings were partially owned by third parties.&#160;&#160;The non-controlling entities&#8217; share of these investments was included in accrued expenses and other current liabilities.&#160;&#160;Net investment gains (losses) related to these interests were $1.6 million and $(.3) million for the three months ended March 31, 2010 and 2009, respectively.&#160;&#160;These non-controlling interests did not have a material impact on our financial position or results of operations.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Net Investment Income</font></div><div style="DIS PLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Sources of net investment income for the three months ended March 31, 2010 and 2009 were as follows:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="80%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align=" right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2009</font></div></td></tr><tr><td valign="bottom" align="left" width="80%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Debt securities</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FA MILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 236.4</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 223.6</font></div></td></tr><tr><td valign="bottom" align="left" width="80%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Mortgage loans</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT- FAMILY: times new roman">&#160;26.7</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;29.2</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="80%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Other</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;18.6</font> </div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3.5</font></div></td></tr><tr><td valign="bottom" align="left" width="80%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Gross investment income</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;281.7</font></div></td><td valign="bottom" align="right" width="10%">& lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;256.3</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="80%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Less:&#160;&#160;investment expenses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(6.5)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align ="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(7.1)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="80%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net investment income <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#16 0;&#160;&#160;&#160;&#160;&#160; 275.2</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 249.2</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="2%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="81%"><div sty le="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Investment risks associated with our experience-rated and discontinued products generally do not impact our results of operations (refer to Note 14 beginning on page&#160;20 for additional information on our accounting for discontinued products).&#160;&#160;Net investment income includes $89.5 million and $80.5 million for the three months ended March 31, 2010 and 2009, respectively, related to investments supporting our experience-rated and discontinued products.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The increase in net investment incom e in 2010 from 2009 is primarily due to higher average asset levels and higher returns on alternative investments, partially offset by lower average yields.</font></div> 10-Q 14900000000 1203600000 1179500000 1570400000 1747300000 -6800000 4000000 642900000 409600000 5369500000 6283100000 5369500000 6283100000 978000000 986900000 2851900000 2922700000 No 0001122304 -171700000 -373300000 -1000000 3600000 3600000 3700000 3700000 3900000 117300000 0 284700000 383400000 422400000 210000000 AETNA INC /PA/ --12-31 9923900000 9503800000 8186400000 8363900000 470100000 499200000 351200000 396000000 10256700000 10567400000 9716500000 9877400000 -1223000000 -1142700000 -1881300000 -1909500000 29048900000 29046600000 479600000 480800000 1195700000 1229800000 76700000 -4800000 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">14.</font></div></td><td valign="top" align="left" width="81%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Discontinued Products</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 4.5pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Prior to 1993, we sold single-premium annuities (&#8220;SPAs&#8221;) and guaranteed investment contracts (&#8220;GICs&#8221;), primarily to employer sponsored pension plans.&#160;&#160;In 1993, we discontinued selling these products, and now we refer to these products as discontinued products.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 4.5pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We discontinued selling these products because they were generating losses for us and we projected that they would continue to generate losses over their life (which is greater than 30 years); so we established a reserve for anticipated future losses at the time of discontinuance.&#160;&#160;This reserve represents the present value (at the risk-free rate of return at the time of discontinuance, consistent with the duration of the liabilities) of the difference between the expected cash flows fr om the assets supporting these products and the cash flows expected to be required to meet the obligations of the outstanding contracts.&#160;&#160;Because we projected anticipated cash shortfalls in our discontinued products, at the time of discontinuance we established a receivable from Large Case Pensions&#8217; continuing products (which is eliminated in consolidation).</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 4.5pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Key assumptions in setting this reserve include future investment results, payments to retirees, mortality and retirement rates and the cost of asset management and customer service.&#160;&#160;In 1997, we began the use of a bond default assumption to reflect historical default experience.&#160;&#160;In 1995, we modified the mort ality tables used in order to reflect a more up-to-date 1994 Uninsured Pensioner&#8217;s Mortality table.&#160;&#160;Other than these changes, since 1993 there have been no significant changes to the assumptions underlying the reserve.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We review the adequacy of this reserve quarterly based on actual experience.&#160;&#160;As long as our expectation of future losses remains consistent with prior projections, the results of the discontinued products are applied to the reserve and do not affect net income.&#160;&#160;However, if actual or expected future losses are greater than we currently estimate, we may have to increase the reserve, which could adversely impact net income.&#160;&#160;If actua l or expected future losses are less than we currently estimate, we may have to decrease the reserve, which could favorably impact net income.&#160;&#160;The current reserve reflects management&#8217;s best estimate of anticipated future losses.&#160;&#160;The reserve for anticipated future losses is included in future policy benefits on our balance sheet.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -1.8pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The activity in the reserve for anticipated future losses on discontinued products for the three months ended March 31, 2010 and 2009 was as follows (pretax):</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing=" 0" cellpadding="0" width="100%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLA Y: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2009</font></div></td></tr><tr><td valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Reserve, beginning of period</font></div></td><td valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 789.2</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font&g t;</td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; &#160;790.4</font></div></td></tr><tr><td valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Operating income (loss)</font></div></td><td valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3.0</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; F ONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(13.9)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net realized capital gains (losses)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new r oman">&#160;16.1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(9.4)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Reserve, end of period</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" w idth="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 808.3</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; &#160;767.1</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">During the three months ended March 31, 2010, our discontinued products reflected operating income and net realized capital gains, both primarily attributable to the favorable investment conditions that existed from the latter half of 2009 through the first quarter of 2010.&#160;&#160;We have evaluated the operating income in 2010 against our expectations of future cash flows assumed in estimating the reserve and do not believe an adjustment to the reserve is required at March 31, 2010.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Assets and liabilities supporting discontinued products at March 31, 2010 and December 31, 2009 were as </font><font style="DISPLAY: inli ne; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">follows: <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY : times new roman, serif">&#160;2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2009</font></div></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Assets:</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZ E: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Debt and equity securities available for sale</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160 ;$&#160;&#160;&#160;&#160; 2,554.0</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; 2,507.7</font></div></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160; &#160;Mortgage loans</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-IND ENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;528.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;543.9</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Other investments</font></div>&l t;/td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;652.0</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;630.2</font></div></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Total investments</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;3,734.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;3,681.8</font></div></td></tr><tr><td valign="b ottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Other assets</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;75.0</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;118.6 </font></div></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Collateral received under securities loan agreements</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;88.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="ri ght"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;33.4</font></div></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Current and deferred income taxes</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;53.3</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%">&l t;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;51.5</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Receivable from continuing products <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;470.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;463.4</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Total assets</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align= "right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; 4,422.2</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; 4,348.7</font></div></td></tr><tr><td valign="bottom" width="77%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Liabilities:</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" w idth="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Future policy benefits</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; 3,256.8</font></div></td><td valign="bottom" width="3%"> <font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; 3,301.0</font></div></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Policyholders' funds</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FO NT-FAMILY: times new roman, serif">&#160;11.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;12.1</font></div></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160; &#160;Reserve for anticipated future losses on discontinued products</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEX T-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;808.3</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;789.2</font></div></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Collateral payable under securities loan agreements</font></div>&l t;/td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;88.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;33.4</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-S IZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Other liabilities <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(3)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;256.7</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;213.0</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Total liabilities</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; 4,422.2</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">& ;#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; 4,348.7</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="2%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="83%"><div align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Assets supporting the discontinued products are distinguished from assets supporting continuing products.</font></div></td></tr><tr><td style="TEXT-ALIGN: center" valign="top" width="2%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(3)</font></font></div></td><td valign="top" align="left" width="83%"><div align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">The receivable from continuing products is eliminated in consolidation.</font></div><div align="left"><font style=" DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net unrealized capital gains and losses on the available-for-sale debt securities are included in other liabilities and are not reflected in consolidated shareholders&#8217; equity.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 4.5pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Distributions on discontinued products for the three months ended March 31, 2010 and 2009 were as follows:</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59% "><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2009</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Scheduled contract maturities, settlements and benefit payments</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; 107.2</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160; 113.2</font></div></td></tr>& lt;tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Participant-directed withdrawals</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;- &#160; </font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;- &# 160; </font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Cash required to fund these distributions was provided by earnings and scheduled payments on, and sales of, invested assets.</font><br /></div> <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">12.</font></div></td><td valign="top" align="left" width="85%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Commitments and Contingencies</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Litigation and Regulatory Proceedings</fon t></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Out-of-Network Benefit Proceedings</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We are named as a defendant in several purported class actions and individual lawsuits arising out of our practices related to the payment of claims for services rendered to our members by health care providers with whom we do not have a contract (&#8220;out-of-network providers&#8221;).&#160;&#160;Other major health insurers are also the subject of similar litigation or have settled similar litigation.&#160;&#160;Among other things, these lawsuits allege that we paid too little to our health plan members and/or providers for t hese services, among other reasons, because of our use of data provided by Ingenix, Inc., a subsidiary of one of our competitors (&#8220;Ingenix&#8221;).</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Various plaintiffs who are health care providers or medical associations seek to represent nationwide classes of out-of-network providers who provided services to our members during the period from 2001 to the present.&#160;&#160;Various plaintiffs who are members in our health plans seek to represent nationwide classes of our members who received services from out-of-network providers during the period from 2001 to the present.&#160;&#160;Taken together, these lawsuits allege that we violated state law, the Employee Retirement Income Security Act of 197 4, as amended (&#8220;ERISA&#8221;), the Racketeer Influenced and Corrupt Organizations Act and federal antitrust laws, either acting alone or in concert with our competitors.&#160;&#160;The purported classes seek reimbursement of all unpaid benefits, recalculation and repayment of deductible and coinsurance amounts, unspecified damages and treble damages, statutory penalties, injunctive and declaratory relief, plus interest, costs and attorneys&#8217; fees, and seek to disqualify us from acting as a fiduciary of any benefit plan that is subject to ERISA.&#160;&#160;Individual lawsuits that generally contain similar allegations and seek similar relief have been brought by a health plan member and by out-of-network providers.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAM ILY: Times New Roman">The first class action case was commenced on July 30, 2007.&#160;&#160;The federal Judicial Panel on Multi-District Litigation (the &#8220;MDL Panel&#8221;) has consolidated these class action cases in federal district court in New Jersey under the caption <font style="DISPLAY: inline; FONT-STYLE: italic">In re: Aetna UCR Litigation, </font>MDL No. 2020 (&#8220;MDL 2020&#8221;).&#160;&#160; In addition, the MDL Panel has transferred the individual lawsuits to MDL 2020.&#160;&#160;Discovery has commenced in MDL 2020, and the court has not set a trial date.&#160;&#160;We intend to vigorously defend ourselves against the claims brought in these cases.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman" >On January 15, 2009, Aetna and the New York Attorney General announced an agreement relating to an industry-wide investigation into certain payment practices with respect to out-of-network providers.&#160;&#160;In October 2009, pursuant to that agreement, we contributed $20 million towards the establishment of an independent database system to provide fee information regarding out-of-network reimbursement rates.&#160;&#160;When the new database is operational, we will cease using databases owned by Ingenix and will use the new database for a period of at least five years in connection with out-of-network reimbursements in those benefit plans that employ a reasonable and customary standard for out-of-network reimbursements.&#160;&#160;During 2009, we also agreed to pay approximately $7.5 million in claims and administrative penalties in connection with our out-of-network benefit payment practices as a result of agreements with state attorneys general and a state insurance departmen t.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We also have received subpoenas and/or requests for documents and other information from attorneys general and other state and/or federal regulators, legislators and agencies relating to our out-of-network benefit payment practices.&#160;&#160;It is reasonably possible that others could initiate additional litigation or additional regulatory action against us with respect to our out-of-network benefit payment practices.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"&g t;CMS Actions</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">In April 2010, CMS imposed intermediate sanctions on us suspending the enrollment of and marketing to new members of all Aetna Medicare Advantage and Standalone Prescription Drug Plan Contracts, effective April 21, 2010. The sanctions relate to compliance with certain Medicare Part D requirements, primarily those relating to changes in the drugs covered by certain plans from 2009 to 2010.&#160; The suspension does not affect our current Medicare enrollees who stay in their existing plans.&#160; Also in April 2010, CMS granted us a limited waiver of these sanctions to allow us to continue to enroll&#160;eligible members into existing, contracted group Aetna Medicare Advantage Plans and Standalone Prescription Drug Plans through July 21, 2010.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Securities Class Action Litigation</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Two purported class action lawsuits were pending in the United States District Court for the Eastern District of Pennsylvania (the &#8220;Pennsylvania Federal Court&#8221;) against Aetna and certain of its current or former officers and/or directors.&#160;&#160;On October 24, 2007, the Southeastern Pennsylvania Transportation Authority filed suit on behalf of all </font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMIL Y: Times New Roman">purchasers of Aetna common stock between October 27, 2005 and April 27, 2006.&#160;&#160;The second lawsuit was filed on November 27, 2007, by the Plumbers and Pipefitters Local 51 Pension Fund on behalf of all purchasers of our common stock between July 28, 2005 and July 27, 2006.&#160;&#160;On June 3, 2008, plaintiffs in these two lawsuits filed a consolidated complaint in the Pennsylvania Federal Court on behalf of all purchasers of our common stock between October 27, 2005 and July 27, 2006.&#160;&#160;The consolidated complaint (the &#8220;Securities Class Action Litigation&#8221;) supersedes and replaces the two previous complaints.&#160;&#160;The plaintiffs allege that Aetna and four of its current or former officers and/or directors, John W. Rowe, M.D., Ronald A. Williams, Alan M. Bennett and Craig R. Callen (collectively, the &#8220;Defendants&#8221;), violated federal securities laws. The plaintiffs allege misrepresentations and omissions regarding, among other things, our medical benefit ratios and health plan pricing practices, as well as insider trading by Dr. Rowe and Messrs. Bennett and Callen.&#160;&#160;The plaintiffs seek compensatory damages plus interest and attorneys&#8217; fees, among other remedies.&#160;&#160;On June 9, 2009, the Pennsylvania Federal Court granted Aetna&#8217;s motion to dismiss the consolidated complaint.&#160;&#160;On July 7, 2009, the plaintiffs filed a notice of appeal to the Pennsylvania Federal Court&#8217;s order dismissing the consolidated complaint.&#160;&#160;On February 11, 2010, the Third Circuit Court of Appeals conducted oral arguments on the plaintiff's appeal.&#160; The Defendants intend to vigorously defend themselves against the claims brought in the Securities Class Action Litigation.</font></div></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style= "DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Other Litigation and Regulatory Proceedings</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We are involved in numerous other lawsuits arising, for the most part, in the ordinary course of our business operations, including employment litigation and claims of bad faith, medical malpractice, non-compliance with state and federal regulatory regimes, marketing misconduct, failure to timely or appropriately pay medical and/or group insurance claims (including post-payment audit and collection practices), rescission of insurance coverage, improper discl osure of personal information, patent infringement and other intellectual property litigation and other litigation in our Health Care and Group Insurance businesses. Some of these other lawsuits are or are purported to be class actions.&#160;&#160;We intend to vigorously defend ourselves against the claims brought in these matters.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">In addition, our current and past business practices are subject to audit and review by, and from time to time we receive subpoenas and other requests for information from, various state insurance and health care regulatory authorities and attorneys gen eral, the Office of the Inspector General, and other state and federal authorities.&#160;&#160;These audits, reviews, subpoenas, and other requests include inquiries by, and testimony before, certain members, committees and subcommittees of the U.S. Congress regarding certain of our business practices, including our overall claims processing and payment practices,&#160;our business practices with respect to our small business or individual customers (such as rating information, premium increases and medical benefit ratios), executive compensation matters and travel and entertainment expenses, in connection with their consideration of health care reform measures, as well as the investigations by, and subpoenas and requests from, attorneys general and others described above under &#8220;Out-of-Network Benefit Proceedings.&#8221;&#160;&#160;There also continues to be heightened review by regulatory authorities of and increased litigation regarding the health care benefits industry&am p;#8217;s business and reporting practices, including premium rate increases, utilization management, complaint and grievance processing, information privacy, provider network structure (including the use of performance-based networks), delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices and claim payment practices (including payments to out-of-network providers).&#160;&#160;As a leading national health care benefits company, we regularly are the subject of such reviews.&#160;&#160;These reviews may result, and have resulted, in changes to or clarifications of our business practices, as well as fines, penalties or other sanctions, including the actions taken by CMS that are described above under &#8220;CMS Actions.&#8221;</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-S IZE: 11pt; FONT-FAMILY: Times New Roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We are unable to predict at this time the ultimate outcome of the matters described above, and it is reasonably possible that their outcome could be material to us.</font><br /></div> <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">7.</font></div></td><td valign="top" align="left" width="85%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -1.8pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Financial Instruments</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The preparat ion of our consolidated financial statements in accordance with GAAP requires certain of our assets and liabilities to be reflected at their fair value, and others on another basis, such as an adjusted historical cost basis.&#160;&#160;In this note, we provide details on the fair values of financial assets and liabilities and how we determine those fair values.&#160;&#160;We present this information for those instruments that are reported at fair value for which the </font><font size="3">change in fair value impacts net income or other comprehensive income separately from other financial assets and liabilities.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Financial Instruments Me asured at Fair Value in our Balance Sheets</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Certain of our financial instruments are measured at fair value in our balance sheet.&#160;&#160;The fair values of these instruments are based on valuations that include inputs that can be classified within one of three levels of a hierarchy established by GAAP.&#160;&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#8220;inputs&#8221;) that qualifies a financial asset or liability for each level:</font></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"><tr valign="top"><td style="WIDTH: 18pt"><div><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">&#160; </font></div></td><td style="WIDTH: 18pt"><div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">o</font></div></td><td><div align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Level 1</font> &#8211; Unadjusted quoted prices for identical assets or liabilities in active markets.</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"><tr valign="top"><td style="WIDTH: 18pt"><div><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">&#160; </font></div></td><td style="WID TH: 18pt"><div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">o</font></div></td><td><div align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Level 2</font> &#8211; Inputs other than Level 1 that are based on observable market data.&#160;&#160;These include:&#160;&#160;quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, inputs that are observable that are not prices (such as interest rates, credit risks, etc.) and inputs that are derived from or corroborated by observable markets.</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> ;<tr valign="top"><td style="WIDTH: 18pt"><div><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">&#160; </font></div></td><td style="WIDTH: 18pt"><div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">o</font></div></td><td><div align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Level 3</font> &#8211; Developed from unobservable data, reflecting our own assumptions.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Fi nancial assets and liabilities are classified based upon the lowest level of input that is significant to the valuation.&#160;&#160;When quoted prices in active markets for identical assets and liabilities are available, we use these quoted market prices to determine the fair value of financial assets and liabilities and classify these assets and liabilities as Level 1.&#160;&#160;In other cases where a quoted market price for identical assets and liabilities in an active market is either not available or not observable, we estimate fair value using valuation methodologies based on available and observable market information or by using a matrix pricing model.&#160;&#160;These financial assets and liabilities would then be classified as Level 2.&#160;&#160;If quoted market prices are not available, we determine fair value using broker quotes or an internal analysis of each investment&#8217;s financial performance and cash flow projections.&#160;&#160;Thus, financia l assets and liabilities may be classified in Level 3 even though there may be some significant inputs that may be readily available.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The following is a description of the valuation methodologies used for our financial assets and liabilities that are measured at fair value, including the general classification of such assets and liabilities pursuant to the valuation hierarchy.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -1.8pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Debt Securitie s&#160;&#8211;&#160;</font>Where quoted prices are available in an active market, our debt securities are classified in Level 1 of the fair value hierarchy.&#160;&#160;Our Level 1 debt securities are comprised primarily of U.S. Treasury securities.&#160;&#160;If Level 1 valuations are not available, the fair value is determined using models such as matrix pricing, which uses quoted market prices of debt securities with similar characteristics or discounted cash flows to estimate fair value.&#160;&#160;We obtained one price for each of our Level 2 debt securities and did not adjust any of these prices at March 31, 2010 or December 31, 2009.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -1.8pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We also value a certain amount of debt secur ities using Level 3 inputs.&#160;&#160;For Level 3 debt securities, fair values are determined by outside brokers or, in the case of certain private placement securities, are priced by our internal staff.&#160;&#160;Outside brokers determine the value of these debt securities through a combination of their knowledge of the current pricing environment and market flows.&#160;&#160;We obtained one non-binding broker quote for each of these Level 3 debt securities and did not adjust any of these quotes at March 31, 2010 or December 31, 2009.&#160;&#160;The total fair value of our broker quoted securities was approximately $398 million at March 31, 2010 and $364 million at December 31, 2009.&#160;&#160;Examples of these Level 3 debt securities include certain U.S. and foreign corporate securities and certain of our residential and commercial mortgage-backed securities as well as other asset-backed securities.&#160;&#160;For some of our private placement securities, our internal staff determine the value of these debt securities by analyzing spreads of corporate and sector indices as well as interest spreads of comparable public bonds.&#160;&#160;Examples of these Level 3 debt securities include certain U.S. and foreign securities and certain tax-exempt municipal securities.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Equity Securities &#8211; </font>We currently have two classifications of equity securities:&#160;&#160;those that are publicly traded and those that are privately held.&#160;&#160;Our publicly-traded securities are classified as Level 1 because quoted prices are available for these securities in an active market.&#160;&#16 0;For privately-held equity securities, there is no active market; therefore, we classify these securities as Level 3 because we must price these securities through an internal analysis of each investment&#8217;s financial statements and cash flow projections.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Derivatives&#160;&#8211;&#160;</font>Our derivative instruments are valued using models that primarily use market observable inputs and therefore are classified as Level 2 because they are traded in markets where quoted market prices are not readily available.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LE FT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Our financial assets and liabilities with changes in fair value that are measured on a recurring basis in our balance sheets at March 31, 2010 and December 31, 2009 were as follows:</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY : block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Level 1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Level 2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" v align="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Level 3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="D ISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">March 31, 2010</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"> ;&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Assets:</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style= "DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Debt securities:</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td ><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;U.S. government securities</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 1,686.8</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 316.2</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT : 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 2,003.0</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3% "><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2,208.2</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;11.8</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; < /font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2,220.0</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;U.S. corporate securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;7,197.5</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;121.8</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;7,319.3</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Foreign securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div> ;</td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2,648.6</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;237.4</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FON T-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2,886.0</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#1 60;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,388.5</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" wid th="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,388.5</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,081.8</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;72.8</font></div> </td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,154.6</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Other asset-backed securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="D ISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;490.5</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;4. 3</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;494.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Redeemable preferred securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: bloc k; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;317.1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM : black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;25.7</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;342.8</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0p t" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total debt securities</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,686.8</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;15,648.4</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FA MILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;473.8</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;17,809.0</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DIS PLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Equity securities</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1.6</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;38.2</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;39.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPL AY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Derivatives</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;37.3</font></div></td><td style="B ORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman" >&#160;37.3</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total investments</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 1,688.4</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style ="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;15,685.7</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; &#160;&#160; 512.0</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 17,886.1</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Liabilities:</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">& amp;#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td style="BORDER-BOTTOM: black 4px doubl e" valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;Derivatives</font></div></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -&#160; </font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td>&l t;td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1.5</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#1 60;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -&#160; </font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1.5</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div><div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</ div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">December 31, 2009</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman ">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Debt securities:</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPL AY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;U.S. government securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; &#160;&#160;&#160;1,529.4</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160 ;&#160;&#160;&#160;&#160;&#160; 317.4</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><f ont style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; $&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,846.8</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#16 0; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2,062.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;12.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2,075.4</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;U.S. corporate securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" a lign="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;7,056.5</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;128.1</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;7,184.6</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Foreign securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2,545.5</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;199.0</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: time s new roman">&#160;2,744.5</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160; -&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-IN DENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,420.2</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,420.2</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MAR GIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;971.6</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;71.8</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,043.4</font& gt;</div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Other asset-backed securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style=" DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;425.4</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;11.0</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;436.4</font></div></td></tr><tr>< td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Redeemable preferred securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><di v style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;345.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;22.9</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bo ttom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;368.7</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total debt securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,529.4</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td ><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;15,145.1</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;445.5</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0p t" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;17,120.0</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Equity securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-I NDENT: 9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;38.0</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"> &#160;39.7</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Derivatives</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%">< div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;44.0</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" a lign="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;44.0</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total investments</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,531.1</font></div></td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; &#160;15,189.1</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY : inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 483.5</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; &#160;17,203.7</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"></font>&#160;</div><div style="DISPLAY: block; TEXT - -INDENT: 0pt">&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The changes in the balances of Level 3 financial assets for the three months ended March 31, 2010 and 2009 were as follows:</font></div><div>&#160;</div><div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="29%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="15%" colspan="4"><div style=" DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three Months Ended</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="17%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three Months Ended</font></div></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="29%"> ;<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="15%" colspan="4"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31, 2010</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="17%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31, 2009</font></div></td></tr><tr><td style="BORDE R-BOTTOM: black 2px solid" valign="top" align="left" width="31%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">U.S.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Corporate</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"& gt;<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Foreign</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; M ARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div></td><td style="BORDER-BOTTOM: bla ck 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Debt</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign ="top" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Equity</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FO NT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" align="left" width="31%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Beginning balance</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 128.1</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 199.0</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 156.4</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align=" right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 483.5</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 455.7</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font s tyle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 29.3</font></div></td><td valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 485.0</font></div></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" align="left" width="31%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net realized and unrealized gains (losses):</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td&g t;<td style="PADDING-BOTTOM: 2px" valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMI LY: times new roman">&#160; </font></td><td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="left" width="29%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Included in earnings</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(.2)</font ></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.0</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.1</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.9</font></div></td><td style="PADDING-BOTTOM: 2px" v align="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.0</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.0</font></div></td></t r><tr><td style="PADDING-BOTTOM: 2px" valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="left" width="29%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Included in other comprehensive income</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(.6)</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="rig ht"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.4</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.2</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.0</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align= "right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.2</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.3</font></div></td><td valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.5</font></div></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>& lt;td style="PADDING-BOTTOM: 2px" valign="top" align="left" width="29%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">.2</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">.9</font></div> </td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">.3</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.4</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style ="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1.0)</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2.4)</font></div></td><td valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3.4)</font></div></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" align="left" width="31%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Purchases, sales and maturities</font& gt;</div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(5.7)</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14.3</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(.5)</font></div></td><td style="PADDING-BOTTOM: 2px " valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.1</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(17.1)</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(17.1)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="left" width="31%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Transfers into (out of) Level 3 <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGH T: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(12.7)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FO NT-FAMILY: times new roman">3.1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(17.2)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; T EXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(17.2)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="top" align="left" width="31%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ending Balance</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160; 121.8</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARG IN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160; 237.4</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 152.8</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160; 512.0</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 422.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 28.2</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; M ARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160; 450.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="left" width="31%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount of Level 3 net unrealized losses </font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">included in net income</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inli ne; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160;&#1 60;&#160;&#160;&#160;&#160;&#160;&#160; .2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; .2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;& ;#160;&#160;&#160; (2.4)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160;&#160;(2.4)</font></div></td></tr></table></div></div></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100% "><tr><td style="TEXT-ALIGN: center" valign="top" width="3%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="TEXT-ALIGN: left" valign="top" width="82%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Reflects realized and unrealized capital gains and losses on investments supporting our experience-rated and discontinued products, which do not impact our results of operations.</font></div></td></tr><tr><td style="TEXT-ALIGN: center" valign="top" width="3%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div></td><td valign="top" align="left" width="82%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">At January 1, 2010, we changed our practice for reporting transfers into (out of)&#160;Level 3.&#160;&#160;Effective January 1, 2010, we use the fair value of these assets at the end of the reporting period for all financial asset transfers.&#160;&#160;Prior to January 1, 2010, for financial assets that were transferred into (out of) Level 3, we used the fair value of the assets at the end (beginning) of the reporting period.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="le ft"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Financial Instruments Not Measured at Fair Value in our Balance Sheets</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 9pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The following is a description of the valuation methodologies used for estimating the fair value of our financial assets and liabilities that are measured at adjusted cost or contract value.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Mortgage loans:</font><font style="DISPLAY: inline; FONT-STYLE: italic">&#160;</fon t>Fair values are estimated by discounting expected mortgage loan cash flows at market rates that reflect the rates at which similar loans would be made to similar borrowers.&#160;&#160;These rates reflect our assessment of the credit quality and the remaining duration of the loans.&#160;&#160;The fair value estimates of mortgage loans of lower credit quality, including problem and restructured loans, are based on the estimated fair value of the underlying collateral.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Investment contract liabilities:</font></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"><tr valign="top"&g t;<td style="WIDTH: 36pt"><div><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">&#160; </font></div></td><td style="WIDTH: 18pt"><div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">&#8226;</font></div></td><td><div align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">With a fixed maturity</font>:&#160;&#160;Fair value is estimated by discounting cash flows at interest rates currently being offered by, or available to, us for similar contracts.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding=" 0" width="100%" align="center" border="0"><tr valign="top"><td style="WIDTH: 36pt"><div><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">&#160; </font></div></td><td style="WIDTH: 18pt"><div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">&#8226;</font></div></td><td><div align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Without a fixed maturity</font>:&#160;&#160;Fair value is estimated as the amount payable to the contract holder upon demand.&#160;&#160;However, we have the right under such contracts to delay payment of withdrawals that may ultimately result in paying an amount different than that determined to be payable on demand.</font></div></td>&l t;/tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Long-term debt: </font>Fair values are based on quoted market prices for the same or similar issued debt or, if no quoted market prices are available, on the current rates estimated to be available to us for debt of similar terms and remaining maturities.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The carrying value and estimated fair value of certain of our financial instruments at March 31, 2010 and December 31, 2009 were as follows:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="47%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="22%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="21%" colspan="2" ><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2009</font></div></td></tr><tr><td valign="bottom" width="47%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Estimated</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </f ont></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Estimated</font></div></td></tr><tr><td valign="bottom" width="47%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Carrying</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLA Y: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Fair</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Carrying</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Fair</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="47%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td><td style="BORDER-BOTTOM: black 2px s olid" valign="bottom" align="left" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td></tr><tr><td valign="bottom" align="left" width="47%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font s tyle="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Assets:</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="47%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160; Mortgage loans</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 1,556.0 </font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 1,521.0 </font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman ">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 1,594.0</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 1,506.5</font></div></td></tr><tr><td valign="bottom" align="left" width="47%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Liabilities:</font></div></td><td valign=" bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="47%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#1 60;&#160;&#160; Investment contract liabilities:</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="47%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt " align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;&#160; With a fixed maturity</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;31.9</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;33.0</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%" ><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;32.4</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;33.5</font></div></td></tr><tr><td valign="bottom" align="left" width="47%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;&#160; Without a fixed maturity</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGH T: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;525.0</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;498.6</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;530.6</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;503.7</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="47%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160; Long-term debt</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3,639.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="D ISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3,899.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3,639.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FON T-FAMILY: times new roman">&#160;3,865.9</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 9pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Separate Accounts Measured at Fair Value in our Balance Sheets</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 4.5pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Separate Account assets represent funds maintained to meet specific objectives of contract holders.&#160;&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Account liability has been established equal to the assets.&#1 60;&#160;These assets and liabilities are carried at fair value.&#160;&#160;Net investment income and capital gains and losses accrue directly to such contract holders.&#160;&#160;The assets of each account are legally segregated and are not subject to claims arising from our other businesses.&#160;&#160;Deposits, withdrawals, net investment income and realized and unrealized capital gains and losses on Separate Account assets are not reflected in our statements of income, shareholders&#8217; equity or cash flows.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Separate Account assets include debt and equity securities and derivative instruments.&#160;&#160;The valuation methodologies used for these assets are similar to the methodologi es described beginning on page 12.&#160;&#160;Separate Account assets also include investments in common/collective trusts and real estate that are carried at fair value.&#160;&#160;The following are descriptions of the valuation methodologies used to price these investments, including the general classification pursuant to the valuation hierarchy.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Common/Collective Trusts </font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8211;&#160;</font>Common trusts invest in other collective investment funds otherwise known as the underlying funds.&#160;&#160;The Separate Accounts&#8217; interests in the common trust funds a re based on the fair values of the investments of the underlying funds and therefore are classified as Level 2.&#160;&#160;The underlying assets primarily consist of foreign equity securities.&#160;&#160;Investments in common trust funds are valued at their respective net asset value per share/unit on the valuation date.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Real Estate&#160;&#8211;&#160;</font>The values of the underlying real estate investments are estimated using generally accepted valuation techniques and give consideration to the investment structure.&#160;&#160;An appraisal of the underlying real estate for each of these investments is performed annually.&#160 ;&#160;In the quarters in which an investment is not appraised or its valuation is not updated, fair value is based on available market information.&#160;&#160;The valuation of a real estate investment is adjusted only if there has been a significant change in economic circumstances related to the investment since acquisition or the most recent independent valuation and upon the appraiser&#8217;s review and concurrence with the valuation.&#160;&#160;Further, these valuations have been prepared giving consideration to the income, cost and sales comparison approaches of estimating property value.&#160;&#160;These valuations do not necessarily represent the prices at which the real estate investments would sell, since market prices of real estate investments can only be determined by negotiation between a willing buyer and seller.&#160;&#160;Therefore, these investment values are classified as Level 3.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0p t"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Separate Account financial assets at March 31, 2010 and December 31, 2009 were as follows:</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div><div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="PADDING-BOTTOM: 2px" valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="16%" colspan="7"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-IND ENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31, 2010</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="16%" colspan="7"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31, 2009</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="left" width="20%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times n ew roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Level 1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Level 2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font s tyle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Level 3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Total</font></div></td><td style="BORDER-BOTTOM: black 2 px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Level 1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Level 2</font></div&g t;</td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Level 3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new r oman">&#160;Total</font></div></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" align="left" width="20%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;Debt securities</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160;&#160;&#160; 937.0</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top " align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 2,460.6</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 101.1</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; < ;/font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 3,498.7</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 752.3</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 2,508.0</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 97.3</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPL AY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 3,357.6</font></div></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" align="left" width="20%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;Equity securities</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT - -FAMILY: times new roman">1,259.0</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">.4</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new r oman">-</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,259.4</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,215.1</font></div> ;</td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">.9</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" widt h="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,216.0</font></div></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" align="left" width="20%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;Derivatives</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times ne w roman">-</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.1</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font> ;</div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.1</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td style="PADDIN G-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.2</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPL AY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.2</font></div></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" align="left" width="20%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;Common/Collective trusts</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font ></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">.1</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td> ;<td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">.1</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td style="PADDING-BOTTOM: 2px" valign="t op" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,152.6</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZ E: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,152.6</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="left" width="20%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;Real estate</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font>< ;/div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> 70.3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">70.3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" >-</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71.4</font> </div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71.4</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="top" align="left" width="20%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align= "right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160; 2,196.0</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160; 2,462.2</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">& ;#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 171.4</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 4,829.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160; 1,967.4</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 3,662.7</font></div></td& gt;<td style="BORDER-BOTTOM: black 4px double" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160; 168.7</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;& ;#160;&#160; 5,798.8</font></div></td></tr></table></div></div></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="3%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="97%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Excludes $539.9 million and $484.3 million of cash and cash equivalents and other receivables at March 31, 2010 and December 31, 2009, respectively.</font></div></td></tr></table></div><di v style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The changes in the balances of Level 3 Separate Account financial assets for the three months ended March 31, 2010 and 2009 were as follows:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="37%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" colspan="5"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style ="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Three Months Ended</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">March 31, 2010</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="31%" colspan="5"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Three Months Ended</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGH T: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">March 31, 2009</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Debt Securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td>&l t;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Real Estate</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total </font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FO NT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Debt Securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Real Estate</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total </font></div></td></tr><tr><td valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Beginning balance</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMIL Y: times new roman">&#160;$&#160;&#160;&#160;&#160; 97.3 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 71.4 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$& ;#160;&#160; 168.7 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 365.1 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 86.7 </font></div></td><td valign=" bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160; $&#160;&#160;&#160; 451.8 </font></div></td></tr><tr><td valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total gains (losses) accrued to contract holders</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-S IZE: 9pt; FONT-FAMILY: times new roman">&#160;(14.7)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(1.1)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(15.8)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(77.0)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(6.9)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font>& lt;/td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(83.9)</font></div></td></tr><tr><td valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Purchases, sales and maturities</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;18.9 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMI LY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160;&#160;</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;18.9 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td val ign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;32.3 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; -&#160;&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"&g t;&#160;32.3 </font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Transfers (out of) into Level 3 <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(.4)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160;&#160;</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(.4)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font styl e="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.0 </font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160;&#160;</font></div></td><td style="BORDER-BOTTOM: black 2px solid" v align="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.0 </font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Ending Balance</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font st yle="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 101.1 </font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 70.3 </font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 171.4 </font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 325.4 </font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 79.8 </font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 405.2 </font></div></td></tr></table></div><div>< ;table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="3%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="85%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">At January 1, 2010, we changed our practice for reporting transfers into (out of) Level 3.&#160;&#160;Effective January 1, 2010, we use the fair value of these assets at the end of the reporting period for all financial asset transfers.&#160;&#160;Prior to January 1, 2010, for financial assets that were transferred into (out of) Level 3, we use d the fair value of the assets at the end (beginning) of the reporting period.</font></div></td></tr></table></div> <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="2%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">4.</font></div></td><td valign="top" align="left" width="82%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Operating Expenses</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">For the three months ended March 31, 2010 and 2009, selling expenses (which include broker commissions, the variable component of our internal sales force compensation and premium taxes) and general and administrative expenses were as follows:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: t imes new roman">&#160;2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="14%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2009</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Selling expenses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bo ttom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 321.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="14%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 322.5</font> ;</div></td></tr><tr><td valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">General and administrative expenses:</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="14%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;Salaries and related benefits</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;767.8</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="14%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;750.2</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="74%"><div style="DISPLAY: block ; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;Other general and administrative expenses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;427.9</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td>& lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="14%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;479.6</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total general and administrative expenses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,195.7</font> </div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="14%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,229.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total operating expenses</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DI SPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,517.2</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="14%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,552.3</font></div></td></tr></table></div><div><table styl e="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="2%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="83%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Includes litigation-related insurance proceeds of $70.0 million for 2010.&#160;&#160;Refer to the reconciliation of operating earnings to net income in Note 13 beginning on page&#160;19 for additional information.</font></div></td></tr></table></div> 3700000 10900000 35000000 36800000 400000 -1000000 5145700000 5146200000 22300000 22800000 801000000 668900000 837300000 826300000 -7200000 -10400000 1433800000 1442600000 3190100000 3639500000 1307100000 1294100000 422400000 210000000 579000000 559500000 7426400000 6826900000 216000000 209200000 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="2%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">6.</font></div></td><td valign="top" align="left" width="80%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Other Comprehensive (Loss) Income</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -1.8pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Shareholders&#8217; equity included the following activity in accumu lated other comprehensive loss (excluding amounts related to experience-rated contract holders and discontinued products) for the three months ended March 31, 2010 and 2009:</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="37%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net Unrealized Gains (Losses)</font></div></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT- FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="19%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Pension and OPEB Plans</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total</font></div></td></tr><tr><td valign="bottom" width="37%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="21%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0p t; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Foreign</font></div></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><d iv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Accumulated</font></div></td></tr><tr><td valign="bottom" width="37%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Currency</font></div>< ;/td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrecognized</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrecognized</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"&g t;Other</font></div></td></tr><tr><td valign="bottom" width="37%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Previously</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">and</font></div></td><td valign="bottom" width="4%"><font style=" DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net Actuarial</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Prior Service</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Comprehensive</font></div></td></tr& gt;<tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Impaired <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGH T: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">All Other</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Derivatives</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Losses</font></div></td><td style="BORDER-BOTTOM: black 2 px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Cost</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Income (Loss)</font></div></td></tr><tr><td valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Three months ended March 31, 2010</font></div></td><td valign="bottom" width="11%"> ;<font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; &l t;/font></td></tr><tr><td valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Balance at December 31, 2009</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 100.3</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 235.7</font ></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;25.3</font></div></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; (1,623.8)</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align= "right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 39.5</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; (1,223.0)</font></div></td></tr><tr><td valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net unrealized gains (losses) ($226.6 pretax)</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="righ t"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;33.6</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;118.4</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(4.7)</font></div></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARG IN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;147.3</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Reclassification to earnings ($43.2 pretax)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(51.1)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(48.5)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISP LAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;33.4</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(.9)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(67.0)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Other comprehensive (loss) income</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font styl e="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(17.5)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;69.9</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(4.6)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;33.4</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(.9)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;80.3</font></div> </td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Balance at March 31, 2010</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 82.8</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 305.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;20.7</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FO NT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; (1,590.4)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 38.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; (1,142.7)</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" ce llpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="2%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="85%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -5.4pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Represents the non-credit-related component of previously impaired debt securities that we do not intend to sell and subsequent appreciation in the fair value of securities that we intend to sell.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cell padding="0" width="100%"><tr><td valign="bottom" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="31%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="19%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net Unrealized</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Gains (Losses)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; F ONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Pension and OPEB Plans</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%" rowspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total Accumulated Other Comprehensive (Loss) Income</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="15%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="31%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt " align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Foreign</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Currency and</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Derivatives</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="ri ght"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrecognized</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net Actuarial</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Losses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right">< ;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrecognized Prior Service Cost</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="46%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Three months ended March 31, 2009</font></div></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="46%" colspan="2"><div style ="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Balance at December 31, 2008</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; (229.3)</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; (8.7)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font>< /td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; (1,686.6)</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 43.3</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; (1,881.3)</font></div></td></tr><tr><td valign="bottom" align="left" width="46%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net unrealized losses ($(79.1) pretax)</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(60.9)</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;9.5</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#16 0; </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(51.4)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="46%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Reclassification to earnings ($41.9 pretax)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt ; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(4.4)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(7.1)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;35.7</font></div>< /td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(1.0)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&a mp;#160;23.2</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="46%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Other comprehensive (loss) income</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(65.3)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman" >&#160;2.4</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;35.7</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-S IZE: 9pt; FONT-FAMILY: times new roman">&#160;(1.0)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(28.2)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="46%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Balance at March 31, 2009</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; (294.6)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; (6.3)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div st yle="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; (1,650.9)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; $&#160;&#160;&#160; 42.3</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td&g t;<td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; (1,909.5)</font></div></td></tr></table></div> <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">3.</font></div></td><td valign="top" align="left" width="85%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Earnings Per Common Share</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Basic earnings per share (&#8220;EPS&#8221;) is computed by dividing net income (i .e., the numerator) by the weighted average number of common shares outstanding (i.e., the denominator) during the reporting period.&#160;&#160;Diluted EPS is computed in a similar manner, except that the weighted average number of common shares outstanding is adjusted for the dilutive effects of stock options and stock appreciation rights (&#8220;SARs&#8221;), but only if the effect is dilutive.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The computations of basic and diluted EPS for the three months ended March 31, 2010 and 2009 are as follows:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE : 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="68%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">(Millions, except per common share data)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td>&l t;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="15%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">2009</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="68%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Net income</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#1 60;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 562.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="15%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 437.8</font></div></td></tr><tr><td valign="bottom" align="left" width="68%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Weighted average shares used to compute basic EPS</font></div></td><td valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;431.4</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="15%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;452.7</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="68%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARG IN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Dilutive effect of outstanding stock-based compensation awards <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;8.2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="15%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT : 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;8.9</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="68%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Weighted average shares used to compute diluted EPS</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;439.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><f ont style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="15%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;461.6</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="68%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Basic EPS</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline ; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1.30</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="15%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; .97</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="68%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Diluted EPS</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1.28</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="15%"><div style="DISPLAY: blo ck; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; .95</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="2%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="83%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -5.4pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FON T-FAMILY: times new roman">Approximately 18.9 and 19.5 million SARs (with exercise prices ranging from $32.11 to $59.76) and 5.8 and 6.2 million stock options (with exercise prices ranging from $33.38 to $42.35 and $35.34 to $42.35) were not included in the calculation of diluted EPS for the three months ended March 31, 2010 and 2009, respectively, as their exercise prices were greater than the average market price of Aetna common shares during such periods.</font></div></td></tr></table></div> 424900000 430800000 174700000 361700000 -93300000 -256900000 -4600000 2400000 -4600000 2400000 499200000 470100000 6433200000 6470100000 736000000 739600000 1.3 0.97 7820500000 7945800000 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">13.</font></div></td><td valign="top" align="left" width="75%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Segment Information</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 2.7pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Our operations are conducted in three business segments:&#160;&#160;Health Care, Group Insurance and Large Case Pensions.&#160;&#160;Our Corporate Financing segment is not a business segment.&#160;&#160;It is added to our business segments in order to reconcile to our consolidated results.&#160;&#160;The Corporate Financing segment includes interest expense on our outstanding debt and the financing components of our pension and other post-retirement benefit plan expense (the service cost components of this expense are allocated to our business segments).</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 2.7pt" align="left">&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 2.7pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Summarized financial information of our segments for the three months ended March 31, 2010 and 2009 was as follows:</font></div><div style="DISPLAY: block; TEXT- INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="56%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Health</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Group</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEX T-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Large Case</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Corporate</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style=" DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Care</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Insurance</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: i nline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Pensions</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Financing</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Company</font></div></td></tr><tr><td style="TEXT-ALIGN: left" valign="bottom" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT - -WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIG HT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Revenue from external customers</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 7,765.4</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 458.9</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT - -WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 45.3</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; &#160;&#160;- &#160;</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 8,269.6</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT- INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Operating earnings (loss) <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;460.1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;28.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" va lign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;9.7</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(67.7)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;430.6</font></div></td></tr><tr><td style="TE XT-ALIGN: left" valign="bottom" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2009</font></div></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new rom an">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Revenue from external customers</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 7,854.6</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 463.1</font></div></td><td valign="bottom" align="right" w idth="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 52.6</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; &#160; - &#160; </font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 8,370.3</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bo ttom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Operating earnings (loss) <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;469.4</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;42.1</font></div></td&g t;<td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;9.2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(78.1)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;442.6</font></div></td></tr></table></div><div ><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="97%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Operating earnings (loss) excludes net realized capital gains or losses and the other item described in the reconciliation below.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><di v style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">A reconciliation of operating earnings to net income for the three months ended March 31, 2010 and 2009 was as follows:</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TE XT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2009</font></div></td></tr><tr><td valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Operating earnings</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font sty le="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 430.6</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 442.6</font></div></td></tr><tr><td valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Litigation-related insurance proceeds<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"> (1)</font></font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIG HT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;45.5</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;- &#160; </font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net realized capital gains (losses) <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="righ t" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;86.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(4.8)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net income</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width=" 9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 562.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 437.8</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="3%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SI ZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="82%" colspan="2"><div align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">In addition to net realized capital gains (losses) the following other item is excluded from first quarter 2010 operating earnings because we believe it neither relates to the ordinary course of our business nor reflects our underlying business performance:</font></div></td></tr><tr><td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="top" width="81%"><div style="MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: symbol, serif">&#183;</font><font style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Following a Pennsylvania Supreme Court ruling in June 2009, we received $45.5 million ($70.0 million pretax) in April 2010 from one of our liability insurers related to certain litigation we settled in 2003.&#160;&#160;We are continuing to litigate similar claims against certain of our other liability insurers.</font></div></td><td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td style="TEXT-ALIGN: center" valign="top" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div></td><td valign="top" align="left" width="81%"><div style=" DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">At March 31, 2010, we released a $9.8 million valuation allowance previously established on our deferred tax assets related to realized capital gains (losses).</font></div></td><td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr></table></div> <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">11.</font></div></td><td valign="top" align="left" width="85%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Dividend Restrictions and Statutory Surplus</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Under regulatory requirements at March 31, 2010, the amount of dividends that may be paid to Aetna through the end of 2010 by our insurance and HMO subsidiaries without prior approval by regulatory authorities is approximately $1.1 billion in the aggregate.&#160;&#160;There are no such restrictions on distributions from Aetna to its shareholders.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The combined statutory capital and surplus of our insurance and HMO subsidiaries was $7.0 billion and $6.8 billion at March 31, 2010 and December 31, 2009, respectively.</font></div> 2010-03-31 -298800000 114800000 449700000 0 1517200000 1552300000 8621500000 8614700000 275200000 249200000 100000 0 29200000 44900000 29200000 44900000 430800000 424900000 456300000 446900000 2851900000 2484300000 770600000 781100000 350500000 333400000 0 89500000 2010 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">2.</font></div></td><td valign="top" align="left" width="82%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Summary of Significant Accounting Policies</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Interim Financial Statements</fon t></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">These interim financial statements necessarily rely on estimates, including assumptions as to annualized tax rates.&#160;&#160;In the opinion of management, all adjustments necessary for a fair statement of results for the interim periods have been made.&#160;&#160;All such adjustments are of a normal, recurring nature.&#160;&#160;The accompanying unaudited consolidated financial statements and related notes should be read in conjunction with the consolidated financial statements and related notes presented in our 2009 Annual Report on Form 10-K (our &#8220;2009 Annual Report&#8221;).&#160;&#160;Certain financial information that is normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP& amp;#8221;), but that is not required for interim reporting purposes, has been condensed or omitted.&#160;&#160;We have omitted certain footnote disclosures that would substantially duplicate the disclosures in our 2009 Annual Report, unless the information contained in those disclosures materially changed or is required by GAAP.&#160;&#160;We have evaluated subsequent events from the balance sheet date through the date the financials were issued and determined there were no other items to disclose.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Principles of Consolidation</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">These unaudited consolidated financial statements have been prepared in accordance with GAAP and include the accounts of Aetna and the subsidiaries that we control.&#160;&#160;All significant intercompany balances have been eliminated in consolidation.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">New Accounting Standards</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Variable Interest Entities</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style ="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">In June 2009, the Financial Accounting Standards Board (&#8220;FASB&#8221;) released revised accounting guidance for variable interest entities (&#8220;VIEs&#8221;).&#160;&#160;This accounting guidance removes the quantitative-based risks-and-rewards calculation previously used to assess whether a company must consolidate a VIE and, instead, requires a variable interest holder to qualitatively assess whether it has a controlling financial interest in the VIE.&#160;&#160;This accounting guidance was effective on January 1, 2010.&#160;&#160;The adoption of this new accounting guidance did not impact our financial position or results of operations.&#160;&#160;Refer to Note 5 beginning on page 7 for additional information.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIG HT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Recognition and Presentation of Other-Than-Temporary Impairments</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Effective April 1, 2009, we adopted new accounting guidance issued by the FASB for other-than-temporary impairments (&#8220;OTTI&#8221;) of debt securities. This guidance establishes new criteria for the recognition of OTTI on debt securities and also requires additional financial statement disclosure. The new criteria require OTTI to be recognized if either we determine a credit-related loss has occurred or we have the intention to sell a security that is in an unrealized capital loss position. Refer to Note 5 beginning on page&#160;7 for additional information.</font></div> 2700000000 2700000000 0.01 0.01 -8900000 0 1300000 1000000 10567400000 10256700000 17809500000 17051100000 758800000 630400000 60900000 61500000 -11400000 10200000 562600000 437800000 562600000 437800000 562600000 437800000 527000000 503300000 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="2%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">8.</font></div></td><td valign="top" align="left" width="83%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -1.8pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Defined Benefit Retirement Plans</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 3.6pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FO NT-FAMILY: Times New Roman">Components of the net periodic benefit cost of our noncontributory defined benefit pension plans and other postretirement benefit (&#8220;OPEB&#8221;) plans for the three months ended March 31, 2010 and 2009 were as follows:</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="59%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="20%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Pension Plans</font></div></td><td valign="bo ttom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="17%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">OPEB Plans</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="ri ght"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN- LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2009</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Operating component:& lt;/font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="7%"><font style="DISPLAY: i nline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;Service cost</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 15.3</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt ; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 12.0</font></div></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; .1</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; .1</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;Amortization of prior service cost</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(.5)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(.5)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(.9)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%"><font style="D ISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(1.0)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total operating component<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"> (1)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-I NDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;14.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;11.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"& gt;<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(.8)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(.9)</font></div></td></tr><tr><td valign="bottom" width="59%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPL AY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td>< ;/tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Financing component:</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY : times new roman">&#160; </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;Interest cost</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;76.6</font></div></td><td valign="bo ttom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;79.1</font></div></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;4.5</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font> ;</td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.5</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;Expected return on plan assets</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(88.3)</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inli ne; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(79.7)</font></div></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(.9)</font></div></td><td valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; F ONT-SIZE: 9pt; FONT-FAMILY: times new roman"></font>&#160;</div></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(1.0)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;Recognized net actuarial loss</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-S IZE: 9pt; FONT-FAMILY: times new roman">&#160;50.3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;54.1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1.1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total financing component<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"> (1)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;38.6</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;53.5</font></div></td><td style="BORDER-BOTTOM: black 2px s olid" valign="bottom" align="left" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;4.7</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.3</font></di v></td></tr><tr><td valign="bottom" width="59%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="2%"><font style="DISPLAY : inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net periodic benefit cost</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 53.4</font></div></td><td style="BORDER-BOTTOM: black 4px double" val ign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 65.0</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$& #160;&#160; 3.9</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 4.4</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: ti mes new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="82%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">The operating component of this expense is allocated to our business segments and the financing component is allocated to our Corporate Financing segment.&#160;&#160;Our Corporate Financing segment is not a business segment.&#160;&#160;It is added to our business segments to reconcile to our consolidated results.&#160;&#160;Refer to Note 13 beginning on page&#160;19 for additional information on our business segments.</font></div></td></tr></table></div> -- -- 235600000 216700000 831900000 788300000 38972800000 38550400000 5691000000 5804200000 -100000 -100000 -251900000 -276900000 -252000000 -277000000 38972800000 38550400000 1470800000 1453000000 411200000 306400000 566300000 590700000 688200000 551400000 321500000 322500000 Large Accelerated Filer 424900000 2686400000 2287300000 -11600000 -16500000 32500000 34700000 32500000 34700000 52400000 -65300000 52400000 -65300000 -1142700000 -1223000000 9844400000 8464200000 238400000 231100000 Fees and other revenue include administrative services contract member co-payments and plan sponsor reimbursements related to our mail order and specialty pharmacy operations of $20.4 million and $14.8 million (net of pharmaceutical and processing costs of $353.6 million and $397.9 million) for the three months ended March 31, 2010 and 2009, respectively. Health care costs have been reduced by Insured member co-payments related to our mail order and specialty pharmacy operations of $31.2 million and $30.0 million for the three months ended March 31, 2010 and 2009, respectively. EX-101.SCH 14 aet-20100331.xsd XBRL TAXONOMY EXTENSION SCHEMA 002000 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 001000 - Statement - Consolidated Statements of Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 003000 - Statement - Consolidated Statements of Shareholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 004000 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 006010 - Disclosure - Organization link:presentationLink link:calculationLink link:definitionLink 006020 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 006030 - Disclosure - Earnings Per Common Share link:presentationLink link:calculationLink link:definitionLink 006040 - Disclosure - Operating Expenses link:presentationLink link:calculationLink link:definitionLink 006050 - Disclosure - Investments link:presentationLink link:calculationLink link:definitionLink 006060 - Disclosure - Other Comprehensive (Loss) Income link:presentationLink link:calculationLink link:definitionLink 006080 - Disclosure - Defined Benefit Retirement Plans link:presentationLink link:calculationLink link:definitionLink 006090 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 006100 - Disclosure - Capital Stock link:presentationLink link:calculationLink link:definitionLink 006110 - Disclosure - Dividend Restrictions and Statutory Surplus link:presentationLink link:calculationLink link:definitionLink 006070 - Disclosure - Financial Instruments link:presentationLink link:calculationLink link:definitionLink 006120 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 006130 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 006140 - Disclosure - Discontinued Products link:presentationLink link:calculationLink link:definitionLink 020010 - Disclosure - Audit Opinion link:presentationLink link:calculationLink link:definitionLink 002010 - Statement - Parenthetical to Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 020020 - Disclosure - Acquisition link:presentationLink link:calculationLink link:definitionLink 020030 - Disclosure - Subsequent Event link:presentationLink link:calculationLink link:definitionLink 020040 - Disclosure - Reinsurance link:presentationLink link:calculationLink link:definitionLink 020050 - Disclosure - Goodwill and Other Acquired Intangible Assets link:presentationLink link:calculationLink link:definitionLink 020060 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 020070 - Disclosure - Stock-based Employee Incentive Plans link:presentationLink link:calculationLink link:definitionLink 020080 - Disclosure - Health Care Costs Payable link:presentationLink link:calculationLink link:definitionLink 021000 - Schedule - Schedule I: Financial Information of Aetna Inc. (Parent Company Only) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 15 aet-20100331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 16 aet-20100331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 17 aet-20100331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Accretion of net investment discount Accumulated other comprehensive loss Cash used for acquisition, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Deposits and interest credited for investment contracts Stock-based compensation expense Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash and cash equivalents Interest paid Health care and insurance liabilities Increase (Decrease) in Health Care Insurance Liabilities Income taxes Premiums due and other receivables Net repayment of short-term debt Collateral received under securities loan agreements Commitment and Contingencies Commitments and Contingencies Disclosure [Text Block] Common Stock, shares authorized Total comprehensive income Comprehensive Income, Net of Tax, Attributable to Parent Other Comprehensive Income Comprehensive Income Note [Text Block] Current Current liabilities: Total current liabilities Total current liabilities Deferred Collateral payable under securities loan agreements Depreciation and amortization Diluted Earnings Per Share, Diluted Equity in earnings of affiliates, net Income (Loss) from Equity Method Investments Health care costs (2) Current and future benefits General and administrative expenses Consolidated Statements of Income Income from continuing operations Income from continuing operations Income (Loss) from Continuing Operations, Per Basic Share Income from continuing operations Income (Loss) from Continuing Operations Attributable to Parent Income from discontinued operations Income from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Per Basic Share Income from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Discontinued operations Income taxes refunded Income taxes receivable Accrued investment income Increase (Decrease) in Accrued Investment Income Receivable Other acquired intangible assets, net Interest expense Liabilities and shareholders' equity: Total liabilities and shareholders' equity Total liabilities and shareholders' equity Total liabilities Total liabilities Long-term investments Net cash used for financing activities Net cash used for financing activities Cash Flows From Investing Activities Net cash (used for) provided by investing activities Net cash (used for) provided by investing activities Cash Flows From Operating Activities Net cash provided by operating activities Net cash provided by operating activities Net income Net Income (Loss) Net income Net investment income Health care premiums Other premiums Revenue: Total revenue Total revenue Organization Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Other assets and other liabilities Pension and OPEB plans Other comprehensive income (loss) (Note 6): Other comprehensive income (losses) Other Comprehensive Income (Loss), Net of Tax Other current assets Other receivables, net Dividends paid to shareholders Dividends paid to shareholders Employee Benefit Plan Pension and Other Postretirement Benefits Disclosure [Text Block] Premiums receivable, net Common shares issued under benefit plans Proceeds from issuance of long-term debt, net of issuance costs Proceeds from sales and maturities of investments Property and equipment, net Cost of investments Payments to Acquire Investments Additions of property, equipment and software Increase in property, equipment and software Reinsurance recoverables Repayment of long-term debt Repayment of long-term debt Common shares repurchased Common shares repurchased Cumulative effect of adopting new accounting standard at April 1, 2009 (Note 2) Retained earnings Capital Stock Schedule of Capital Units [Text Block] Segment Information Segment Reporting Disclosure [Text Block] Selling expenses Separate Accounts assets Separate Accounts liabilities Short-term debt Consolidated Statements of Cash Flows Consolidated Statements of Shareholders' Equity Shareholders' equity: Income taxes paid Current assets: Total current assets Total current assets Withdrawals of investment contracts Withdrawals of investment contracts Dividends declared, per share Total assets Total assets Accrued investment income Accrued expenses and other current liabilities Other long-term liabilities Deferred income taxes Deferred Tax Assets, Net, Noncurrent Deferred income taxes Deferred income taxes Deferred Tax Liabilities, Noncurrent Assets Common stock ($.01 par value; 2.7 billion shares authorized; 424.9 million and 430.8 million shares issued and outstanding in 2010 and 2009, respectively) and additional paid-in capital Basic Earnings Per Share, Basic Stock-based compensation tax benefits Other long-term assets Operating Expenses [Abstract] Operating expenses Total operating expenses Total operating expenses Earnings Per Share, Basic Earnings Per Share, Basic [Abstract] Earnings Per Share, Diluted Earnings Per Share, Diluted [Abstract] Earnings per common share: Unearned premiums Common Stock, par value Total shareholders' equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Total income taxes Total income taxes Net realized capital (gains) losses Comprehensive income: Fees and other revenue (1) Retained Earnings [Member] Accumulated Other Comprehensive Loss Net realized capital gains (losses) Operating Expense Selling, General and Administrative Expenses, Policy [Text Block] Repurchases of common shares Repurchases of common shares (in shares) Comprehensive Income [Member] Dividends declared ($.04 per share) Beginning balance (in shares) Ending balance (in shares) Shares, Issued Commitments and contingencies (Note 12) Other, net Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities, Other Cumulative Effect Of Initial Adoption Of S F A S 158 Beginning balance at January 1, 2007, as adjusted Health care costs payable Health Care Costs Payable represents the company's estimated obligation for health care services that have been rendered on behalf of insured customers but for which claims have not yet been received or processed as of the balance sheet date, and for liabilities for physician, hospital and other medical cost disputes as of the balance sheet date. Short Term Health Care Costs Payable Future policy benefits The sum of the known and estimated amounts currently payable as of the balance sheet date to policyholders pertaining to insured events for long-duration contracts, which can be viewed as either (a) the present value of future benefits to be paid to or on behalf of policyholders and expenses less the present value of future net premiums payable under the insurance contracts or (b) the accumulated amount of net premiums already collected less the accumulated amount of benefits and expenses already paid to or on behalf of policyholders. Short Term Future Policy Benefits Unpaid claims Current liability as of the balance sheet date for the estimated ultimate cost of settling claims and claim adjustment expense relating to insured events that have occurred on or before the balance sheet date for those liabilities owed to another party as a result of assuming another insurer's primary obligation. Short Term Unpaid Claims Policyholders' funds The total liability as of the balance sheet date of current amounts due to policy holders, excluding future policy benefits and claims, including unpaid policy dividends, retrospective refunds, and undistributed earnings on participating business. Future policy benefits The sum of the known and estimated noncurrent amounts payable as of the balance sheet date to policyholders pertaining to insured events for long-duration contracts, which can be viewed as either (a) the present value of future benefits to be paid to or on behalf of policyholders and expenses less the present value of future net premiums payable under the insurance contracts or (b) the accumulated amount of net premiums already collected less the accumulated amount of benefits and expenses already paid to or on behalf of policyholders. Long Term Furture Policy Benefits Unpaid claims Noncurrent liability as of the balance sheet date for the estimated ultimate cost of settling claims and claim adjustment expense relating to insured events that have occurred on or before the balance sheet date for those liabilities owed to another party as a result of assuming another insurer's primary obligation. Long Term Unpaid Claims Policyholders' funds The total liability as of the balance sheet date of noncurrent amounts due policy holders, excluding future policy benefits and claims, including unpaid policy dividends, retrospective refunds, and undistributed earnings on participating business. Long Term Policyholders Funds Common Stock, shares issued and outstanding Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury; and Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Excludes common shares repurchased by the entity and held as Treasury shares. Shares outstanding equals shares issued minus shares held in trea sury. Does not include common shares that have been repurchased. Reduction of reserve for anticipated future losses on discontinued products The amount of reduction taken against our reserve for anticipated future losses related to our discontinued products during the period. Physician class action settlement insurance-related charge Common Stock And Additional Paid In Capital [Member] Benefits and expenses: Total benefits and expenses Total benefits and expenses Total amount of benefit and other expenses incurred during the period. Sum of income before income taxes. Income before income tax Income before income taxes Income before income taxes Health care and insurance liabilities The net change during the reporting period of Health Care and Other Insurance Liabilities balances; shall be classified as cash flows from operating activities. Other, net Transactions that result in no cash inflows or outflows in the period in which they occur, but affect net income and thus are removed when calculating net cash flow from financing activities using the indirect method. This element is used when there is not a more specific and appropriate element. Other Net Financing Common shares issued for benefit plans, including tax benefits (in shares) Number of stock issued during the period as a result of stock-based compensation plans and employee stock purchase plans. Common Shares Issued For Benefit Plans Including Tax Benefit Shares Common Stock Outstanding [Member] Summary Of Significant Accounting Policies This element may be used to describe all significant accounting policies of the reporting entity. For a new accounting pronouncement that has been issued but not yet adopted, an entity's disclosure should (1) describe the new pronouncement, the date that adoption is required and the date that the entity plans to adopt, if earlier; (2) discuss the methods of adoption allowed by the pronouncement and the method expected to be utilized by the entity, if determined; (3) discuss the impact that adoption of the pronouncement is expected to have on the financial statements of the entity, unless such impact is not known or reasonably estimable (in which case, a statement to that effect should be made) and; (4) disclose the potential impact of other significant matters that the entity believes might result from the adoption of the pronouncement (for example, technical violations of debt covenant agreements and planned or intended changes in business practices.) Summary of Significant Accounting Policies [Text Block] Investments [Text Block] This item represents the entire disclosure related to Investments in Certain Debt and Equity Securities (and certain other trading assets) which include all debt and equity securities (other than those equity securities accounted for under the equity or cost methods of accounting) with readily determinable fair values. Other trading assets include assets that are carried on the balance sheet at fair value and held for trading purposes. A debt security represents a creditor relationship with an enterprise that is in the form of a security. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownershi p interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities (and other trading assets). Secondly, contains a description of noncontrolling interest which might include background information, terms of the ownership arrangement, and type and terms of equity interest owned by the noncontrolling interest holders. Thirdly, a description of the variable interest entity. In general, a VIE is a corporation, partnership, trust, or any other legal structure used for business purposes that either (a) does not have equity investors with voting rights or (b) has equity investors that do not provide sufficient financial resources fo r the entity to support its activities. A VIE often holds financial assets, including loans or receivables, real estate or other property. A VIE may be essentially passive or it may engage in research and development or other activities on behalf of another company. Fourth, credit default swaps are also included. These are a type of swap transaction used as a credit derivative in which one party makes periodic payments to the other and receives the promise of a pay-off if a third party defaults. Finally, net investment income is also disclosed. This is the income earned from investments in securities and property, equipment and other capital assets. It includes rent from property and equipment, dividends from shares in corporations, and interest from bonds, loans, mortgages, derivatives, commercial paper, bank accounts, certificates of deposits, treasuries, and other financial securities. It does not include realized gains and losses on investments. Investments Debt [Text Block] Debt Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancings and noncompliance with debt covenants. Also contains a description of forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payment s based on a market interest rate (index rate) over a specified period. Fair Value Measurements [Text Block] Financial Instruments This item represents the complete disclosure regarding the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments, assets, and liabilities. Also, provides general information items required or determined to be disclosed with respect to the Companys fair value estimates for financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined). Dividend Restrictions Dividend Restrictions And Statutory Surplus [Text Block] Disclosure of statutory restrictions on the payment of dividends as prescribed by the National Association of Insurance Commissioners or state regulatory authorities, amounts not available for future dividend payments, and amount of dividends paid. Amount of statutory capital and surplus computed using prescribed or permitted statutory accounting practice. Collateral on interest rate swaps This item represents the change in cash that serves as collateral for our interest rate swaps. Collateral on interest rate swaps Net foreign currency and derivative gains (losses) This item represents the adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into functional currency of the reporting entity and also the accumulated pretax change in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Net Foreign Currency and derivative Gains Common shares issued for benefit plans, including tax benefits Value of stock issued during the period as a result of stock-based compensation plans and employee stock purchase plans. Common Shares Issued For Benefit Plans Including Tax Benefit Values Earnings Per Share [Text Block] Earnings Per Share Statement [Table] Statement [Line Items] Statement of Financial Position [Abstract] Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Goodwill Income taxes payable Taxes Payable Proceeds from Dividends Received Cash Flows From Financing Activities Net increase in cash and cash equivalents Statement, Equity Components [Axis] Equity Component [Domain] Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Well Known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Public Float Entity Common Stock Shares Outstanding Amortization of other acquired intangible assets Investments Short Term Investments Long-term debt Long Term Debt Noncurrent Net unrealized gains (losses) on securities Notes to Financial Statements [Abstract] Income Tax Expense Benefit [Abstract] Income taxes: Subsequent Event, Description Subsequent Event Prior to 1993, we sold single-premium annuities ("SPAs") and guaranteed investment contracts ("GICs"), primarily to employer sponsored pension plans. In 1993, we discontinued selling these products, and now we refer to these products as discontinued products. Discontinued Products [Text Block] Discontinued Products The paragraph of the combined report that expresses an unqualified opinion, a qualified opinion, or a disclaimer of an opinion that the financial statements are in conformity with the basis of accounting (US GAAP, IFRS, etc.) on which they were prepared, and an opinion on the effectiveness of the system of internal controls over financial reporting. Audit Opinion [Text Block] Audit Opinion Document Type Document Period End Date Amendment Flag Amendment Description Reinsurance Acquisition Goodwill and Other Acquired Intangible Assets Income Taxes Employee Incentive Plans Health Care Costs Payable [Text Block] Health Care Costs Payable Disclosures of the year over year change in health care costs payable consist principally of unpaid fee-for-service medical, dental and pharmacy claims, capitation costs and other amounts due to health care providers pursuant to related risk-sharing arrangements. Schedule to Financial Statements [Abstract] Schedule I: Financial Information of Aetna Inc. (Parent Company Only) Document Information [Text Block] Entity [Text Block] Total Stockholders' Equity [Member] Beginning balance at January 1, 2007, as adjusted Beg Bal at Jan 1, 2007, as adjusted Beginning balance as of January 1, 2007, as adjusted Total of all Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity which are attributable to the parent. Shareholders' equity has been adjusted as a result of the cumulative effect of adopting new accounting standards. Beginning balance as of January 1, 2007, as adjusted (in shares) Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Cumulative effect of initial adoption of Statement of Financial Accounting Standard 158 (FAS No. 158), Employers' Accounting for Defined Benefit Pension and Other Postretirement Plans on beginning retained earnings, net of tax. Beginning balance at January 1, 2007, as adjusted (in shares) Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Cumulative effect of initial adoption of Statement of Financial Accounting Standard 158 (FAS No. 158), Employers' Accounting for Defined Benefit Pension and Other Postretirement Plans on beginning retained earnings, net of tax. Cumulative effect of adopting new accounting standards (Note 2) Cumulative effect of initial adoption of new accounting principle on beginning retained earnings, net of tax. This element can be used, generally, for the adjustment to retained earnings of a new accounting principle. Adjustments to Reconcile Net Income To Net Cash Provided By Operating Activities Changes In Assets And Liabilities Supplemental Cash Flow Information Document Fiscal Year Focus Document Fiscal Period Focus Current portion of long-term debt Cash Flows From Financing Activities Net increase (decrease) in cash and cash equivalents Earnings Per Share Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Cumulative effect of initial adoption of Statement of Financial Accounting Standard 158 (FAS No. 158), Employers' Accounting for Defined Benefit Pension and Other Postretirement Plans on beginning retained earnings, net of tax. EX-101.PRE 18 aet-20100331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 19 logo1.jpg AETNA LOGO begin 644 logo1.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`! M````/@```!L!!0`!````1@```"@!`P`!`````@`!`3$!`@`0````3@`````` M``!@`````0```&`````!````4&%I;G0N3D54('8T+C`P`/_;`$,``@$!`0$! M`@$!`0("`@("!`,"`@("!00$`P0&!08&!@4&!@8'"0@&!PD'!@8("P@)"@H* M"@H&"`L,"PH,"0H*"O_;`$,!`@("`@("!0,#!0H'!@<*"@H*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"O_``!$(`#8` MG@,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_ MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-CH.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($ M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B M7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X MN;K"P\3%QL?(RKR\_3U]O?X^?K_V@`,`P$` M`A$#$0`_`/W6N]>NO$^EVU]\/M1L+^TO(V:/4H+I980HP`5*9#YYZ9'%5K?X M:Z?(&N-;N9;V=N6DD<@`^P!X'XUY!\4_^"=7PQGLY_%G[)VMW?P.\+?LL?\%8_&/ACXO>,?V)O^"C MOA#3_"?Q;\":)=:Q;:KH3$:5XQTNWA>=KRR$A!20PQM(8B<$))]PQO&GA8S@ MK+\[K2Q%9.I;[+Z>:0+'U,,E'8^OD\)^.)HUL6UJ&UMD&V-806;:.`"<`]/> MF77@/4K.W>ZF\<7$2QJ6DDD8A5`&222W`Q7RW\)?^"ROPE\2?#GQ9XV\801Z ME/I?B*VTKPJG@:"2\M?$]Y1;@=-2NEX+2R@Q(X_WD MU/#')H^]B>;RU?X&2SV52K[.BDWU/5?#>A>*-)NW75-9%S;E,("GS!L]>GIG MO6Q/-1DMQXD\46'A_2%BB+M-?7DOEPI@=!G))[*I/:NM!R,TG%VU0KI MNP4444QA1110`4444`.C[TZFQ]Z=0!"0.I/UK\R/^"\OP+%G^T%\`/VU=(UJ M7PV?AQJE[<>)O$EI;*TTUK#);7%K8(&&V2::;SHHXVRNVXG=P8XY,?IP,CC% M?E[_`,'(OB&-O#?PL\#A;F:2YU:_NOLT.J1HK;$@C&ZWVEW8^8P60$*F7&&+ MC'O<,4W7SJE#H]_2Q\WQ3C98#)JE:*O+IZFM_P`$JO#,/[:/[2OB?]M'X^>( MK+5/$?A0Q6?A3PAID+OIOA6WF60HJ2!/(>8(&^2-F9"[/)B1P$_2OY57"G`7 MKBOR9_X(,_$WQIX6_:K^(W[.OCL0Z));Z*/)\*0Q8AM)[*Y$,JQ-EOF'G$N= MS-*3O9G*[J_6;&>5''I6O%5'ZOFTJECCX)KQQ.4JK+XW>]^XI(45^' M?_!3I4Y3^\&UDW4P M8<>6V>G-?K5^W+\?_P#AEO\`9(\>_':&:%;W0O#\QT9;E@$EU*7$%E&Q/`#W M,L*'_>KYWT?XW?\`!,Z']A&#]AKQ!^U/X5N]&E^'I\,ZG>"Z+/'_\`!JQ^U@?BA^Q_ MXB_9?U[4EDU+X::\9M,BD?G^R[\O,@&>3LN5NLXX`>,<9&?T[\;^./!_PU\( MZE\0/'_B2QT;1-'LY+O5-4U&Y6&"U@0%GD=V("J`,Y-?S2?\$+/VB;G]B?\` MX*JZ#X.\1:]#_8WBN_N?!6NW%O(3!,T\H6UF4G`*_:XK?#G&$=O4U]I?\'9' M[8/BK0M+\!?L5^$-8EM=/URUD\2>+H8I"IO(8YC#90MCK&)8[B0J>"\<1ZI7 MO9UD/VBO@QKOQ?^`UEXG\67WAB\2R\2_#_`$S12OB/2[MI?+,$]C,Z%&4AR6W; M"(I-K-L('G/[%?\`P4)_X)_?#']C[X7?#BX_:0\+:;+HGP\T>QGL&N2K0RQV M4*.K`+]X,#D]SDU^2_@S]JOQ%^SS_P`%_->_:%^`IOK[P'XP^)YLM;N=,M)3 M9ZGI6H3QK<2G"@/MDG_!7/XM?'W_@J+\%/V??^&;/&GA?0?AE\4]'UB\\%:A!`VOZQ?N8WA9H$ ME,2,+:<^5$)3N\]BSC<`GZU>'_VN[G7/`>O^.&_9=^+ED=!:T']CWWA%([[4 M?/D9,VL0G(E$>W=)EEVJ0>8?#8>CAE3C;F@F_5DX*I5G.;;V9\.^"_P#@OG^R%XY_:OT?]C/2 M/A[\1K/QMJ7B1M$O+;5]`M[:'2[I"PD%PS7)9=I1@0JMS^=>D:Y_P4C3Q1<7 M\O[*G[*7Q*^,6D:9/)#=>+/"=O86FCS21L5D2UNM0NH!?%6!4M;+)&2"`Y(Q M7X9^(/A9HWQN_P"#B#Q#\)/$6J7]II>O_'K5;/5)--NF@GDM7N)O.A612&02 M1[XR000KG'-?TJ>'/#/A[P9X9LO"/A;1K33M+TVSCM=/TZR@6*&V@C0*D<:* M`%55```X`%+-\OP66JBX)MSBFT_,K"XBMB.>^R9\^?L(_P#!5;]E[_@H#JFN M>"/AA(O`7C'3UL]5L@DGE2/L5W21%D^1BCDHQ4.$+*#V?[6? M[=/[/_[&MIHUO\5==O[O7_%%Y]C\(^"_#>FO?ZQKMQD#RK6UC^9N64%V*H"R M@L"P!_#K]DWQ/J_@?_@Y]UE_#=VULM_\;_%MC>QQG"S03F_#HPZ$9(;G^)5/ M4"OK/_@J'_P30_X*=?&C_@KKX,_:V_9?ND_X1^QCTF+2_%`\0V]N/"Z0,1-JRI.RNT['VGX_ M_P""B7Q-^#?@2\^,GQH_X)W_`!>T'P3IMJ;O5-:BO/#]_<:;:@9:XN+.UU.2 M=(T7+.4#E%!+`8-=/+^W[\%OB+^R=-^U3^S#XLTWQKI$DL5M8RQ2M&L-R\B( M8[B-@LD,B;P?)<([DH@*^8K5U_[6NN>'+']F?Q[8Z_J]E#]H\$:H@BN;A$\W M-I*-H#'G.<8K\=/^#3&<>*O%_P`259;A- MQC;*Y*O@G'.U?[HQRX;+Z>(R^KBK6]FUIW3-*F(G3K1I[\Q^O/[)O[0?BGXW MZ-JMMXVT:UM=4TB?][+8V\L$'4<'4;BK+L=T4XQ2;N1E,D<].*_.S]J;P/X:_:Q_X+4_#GX.>) M$:ZTCX=^"QKVIVT>,-OT)0Y0'/;K7S]_P41_9; M\8_M0_!W1[3X6W-C;>,/"?C'3/$/ABYU&8Q1+/;S`.&=58J#$\A&`P M^/M1\?Z#X'O-3^&OA&QU_7H8E_L_2-2UDZ?!X$,QB`4L<^6V2`,#.0 M8S$?6Z-)M^\E;Y+;\Q97@I8#%5H*-H-W7ZGBO[43CXN?M8?!;]F>W/FV=AJ= MW\0_%L2M]VUTE4AT^-^PWZE>6LR]S]@?'0FOHGR8L;!&".@XKXD^%_A;_@J? MX7_:M^('[2OCC]EWX3ZN/%NBZ3HN@:9;?%V\@ET+3K%KJ3R?-;2'%P99KN25 MV"1I>9C[US'_!=;X@:M^UIX;_9Q_P""@UM#YFG>/OA#'HNHR0+^[MM9TZ]N M6OH./NXENG"YQN$9('!Q^FO_``6@_84_;G_X*;?#[3O@WX)^`_PYT*V\+^,Y M-1T/QGJ?Q*N);JYLQ'-#Y9M5TQ1`9E>*1U\V3:T2KEOO5Y'^RS_P18_;)TS] MC'6?^"=W[87P\\!^(_!&K^+%UOP_XQT/Q]<1ZGX.NGC6.2XMH)-/9;D#!;RC M)$'\V92W[S+5]7%JWX:'B5L)4E7G&*=GK\S]+/V* M?)F_8X^%,L.V16^'&AD,.A'V"#FMGX_?&KP=^SG\*M5^+WC73;V[L].>WABT M_2H4DN[ZYN)X[>WMH$=T5Y99I8XT4LH+.,D=:^9_V2[?_@HU^Q7\&M%_9:^( M?[,5E\6M-\&:='IOA;Q[X*\9V%@U]IT(V6T5W9ZD\+0S1Q!$)C>52%')();O M_"?P:_:+_:2^*N@?&+]KSPYH_A/PYX/OQJ?@[X5Z+J_]I.VJ*K)'J.J7@1(Y M9(0S&&VA5HXW82&21TCV?#U8+V[GS75[[[GKP?N*-M3\A/VM/F_X.K-,RO\` MS57P9S_W"]+K^@HG$9;VK\J_^"E/_!'K]J;7?^"E/AC_`(*??L::=HWBW4;/ M7]%U7Q%X&U?6$TZ::XT\01*89Y!Y7ER06Z(VXAD;+`/NPOU4=6_X*3_%_P`1 MZ7\3-7^`>D>`-+\'.]U8?#B;XH*UUXPOY$-N!?7MG;2Q6MC!%-+,L(69IYXX M=XC5.?6S:K1QM'#.G)>[!)Z[-'+@XSHSFI+=Z'XV?#L!?^#G2Y!_Z.%U3'_? MZXK^CUMNPD#^#O\`2OQ3\-_\$6?^"HF@_P#!3)O^"BW_``A_PLFF?XCW/BD^ M$CX]NU4)-,[FU%S_`&<>0K[?-\OJ-VS^&OULO_%W[1L?P0B\4Z?\$?#D_CYE M42^#Y/'4B6"$S;6QJ7V`L<1?/_Q[#+?)Q]ZM.(*U'$O#^SDGRP2=GU08&$Z? M/S*UW<_`C]GQ]O\`P<\:@[=OC_XF)_[[OJ]R^,'_``4<_:;_`."IO_!6K2O^ M"=?PD^-&N_#?X4)XPO\`2+Z3PC?-9:CK5OIT5Q->3272?O%\U+698XP0BJZ% MT=@:V_AY_P`$8?\`@J%X$_X*8R?\%&7\&_"RZEG^(>H^)9/"/_"?7:*$NY)B MUL+G^SSRJS$"3R^2H.SG%,^(O_!%7_@HE^S7^WQHG_!0O]B?P3X4U6[N?$4O MB#4/`=QXJ13I%U=>9]NL!4WM[M;$Y36<7.<7*-) M1B[JREKN<<88F#:2=G*[]#[_`/B]_P`$S_V!?AE^S)XUD\._LD>`YKZR\&ZC M)%KFM^'8-1U)I4M9"LCWEVLEP[@@'=FM=-'WV.JK3D\33G%.R/V&4@`YIR@@8-+/$=M:`:SX@.FQ6:WEP26=D@B&V*,$[47E@BKN9VRQZ@#(SMSGWKY-KEEW M/73NAV!C&.****H84444`&!G..:***``@'J`:,#T%%%`!1110`8`Z"BBB@`H 1HHH`****`"BBB@`HHHH`_]D_ ` end XML 20 R19.xml IDEA: Discontinued Products 2.0.0.10 false Discontinued Products 006140 - Disclosure - Discontinued Products true false false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 2 0 aet_NotesToFinancialStatementsAbstract aet false na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false No definition available. false 3 1 aet_DiscontinuedProductsTextBlock aet false na duration string Prior to 1993, we sold single-premium annuities ("SPAs") and guaranteed investment contracts ("GICs"), primarily to employer... false false false false false false false false false false false terselabel false 1 false false false false 0 0 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">14.</font></div></td><td valign="top" align="left" width="81%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Discontinued Products</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 4.5pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Prior to 1993, we sold single-premium annuities (&#8220;SPAs&#8221;) and guaranteed investment contracts (&#8 220;GICs&#8221;), primarily to employer sponsored pension plans.&#160;&#160;In 1993, we discontinued selling these products, and now we refer to these products as discontinued products.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 4.5pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We discontinued selling these products because they were generating losses for us and we projected that they would continue to generate losses over their life (which is greater than 30 years); so we established a reserve for anticipated future losses at the time of discontinuance.&#160;&#160;This reserve represents the present value (at the risk-free rate of return at the time of discontinuance, consistent with the duration of the liabilities) of the difference between the expected cash flows from the assets supporting these products and the cash flows expected to be required to meet the obligations of the outstanding contracts.&#160;&#160;Because we projected anticipated cash shortfalls in our discontinued products, at the time of discontinuance we established a receivable from Large Case Pensions&#8217; continuing products (which is eliminated in consolidation).</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 4.5pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Key assumptions in setting this reserve include future investment results, payments to retirees, mortality and retirement rates and the cost of asset management and customer service.&#160;&#160;In 1997, we began the use of a bond default assumption to reflect historical default experience.&#160;&#160;In 1995, we modified the mortality tables used in order to reflect a more up-to-date 1994 Uninsured Pensioner&#8217;s Mortality table.&#160;&#160;Other than these changes, since 1993 there have been no significant changes to the assumptions underlying the reserve.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We review the adequacy of this reserve quarterly based on actual experience.&#160;&#160;As long as our expectation of future losses remains consistent with prior projections, the results of the discontinued products are applied to the reserve and do not affect net income.&#160;&#160;However, if actual or expected future losses are greater than we currently estimate, we may have to increase the reserve, which could adversely impact net income.&#160;&#160;If actual or expected future losses ar e less than we currently estimate, we may have to decrease the reserve, which could favorably impact net income.&#160;&#160;The current reserve reflects management&#8217;s best estimate of anticipated future losses.&#160;&#160;The reserve for anticipated future losses is included in future policy benefits on our balance sheet.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -1.8pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The activity in the reserve for anticipated future losses on discontinued products for the three months ended March 31, 2010 and 2009 was as follows (pretax):</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100% "><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TE XT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2009</font></div></td></tr><tr><td valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Reserve, beginning of period</font></div></td><td valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 789.2</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bo ttom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; &#160;790.4</font></div></td></tr><tr><td valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Operating income (loss)</font></div></td><td valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3.0</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: ti mes new roman">&#160; </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(13.9)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net realized capital gains (losses)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;16.1</fo nt></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(9.4)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Reserve, end of period</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="16%"><div style="D ISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 808.3</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; &#160;767.1</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPL AY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">During the three months ended March 31, 2010, our discontinued products reflected operating income and net realized capital gains, both primarily attributable to the favorable investment conditions that existed from the latter half of 2009 through the first quarter of 2010.&#160;&#160;We have evaluated the operating income in 2010 against our expectations of future cash flows assumed in estimating the reserve and do not believe an adjustment to the reserve is required at March 31, 2010.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Assets and liabilities supporting discontinued products at March 31, 2010 and December 31, 2009 were as </font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMI LY: Times New Roman">follows: <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">& amp;#160;2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2009</font></div></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Assets:</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Debt and equity securities available for sale</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#16 0;&#160; 2,554.0</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; 2,507.7</font></div></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160; &#160;Mortgage loans</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" a lign="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;528.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;543.9</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Other investments</font></div></td><td style="BORDER- BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;652.0</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;630.2</font></div></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGH T: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Total investments</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;3,734.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;3,681.8</font></div></td></tr><tr><td valign="bottom" align="left" width="77% "><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Other assets</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;75.0</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;118.6</font></div></ td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Collateral received under securities loan agreements</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;88.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLA Y: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;33.4</font></div></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Current and deferred income taxes</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;53.3</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; M ARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;51.5</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Receivable from continuing products <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;470.5< /font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;463.4</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Total assets</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; 4,422.2</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; 4,348.7</font></div></td></tr><tr><td valign="bottom" width="77%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman" >&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Liabilities:</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="D ISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Future policy benefits</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; 3,256.8</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inlin e; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; 3,301.0</font></div></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Policyholders' funds</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, se rif">&#160;11.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;12.1</font></div></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160; &#160;Reserve for anticipated future losses on discontinued products</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0 pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;808.3</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;789.2</font></div></td></tr><tr><td valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Collateral payable under securities loan agreements</font></div></td><td valign="bottom " align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;88.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;33.4</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160; Other liabilities <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(3)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;256.7</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;213.0</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="77%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Total liabilities</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; 4,422.2</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td> ;<td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; 4,348.7</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="2%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="83%"><div align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Assets su pporting the discontinued products are distinguished from assets supporting continuing products.</font></div></td></tr><tr><td style="TEXT-ALIGN: center" valign="top" width="2%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(3)</font></font></div></td><td valign="top" align="left" width="83%"><div align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">The receivable from continuing products is eliminated in consolidation.</font></div><div align="left"><font style="DISPLAY: inline; FONT-SIZE: 9p t; FONT-FAMILY: times new roman">Net unrealized capital gains and losses on the available-for-sale debt securities are included in other liabilities and are not reflected in consolidated shareholders&#8217; equity.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 4.5pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Distributions on discontinued products for the three months ended March 31, 2010 and 2009 were as follows:</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: b lock; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2009</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style= "DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Scheduled contract maturities, settlements and benefit payments</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; 107.2</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160; 113.2</font></div></td></tr><tr><td style="BORDER- BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Participant-directed withdrawals</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;- &#160; </font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;- &#160; </font></div> </td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Cash required to fund these distributions was provided by earnings and scheduled payments on, and sales of, invested assets.</font><br /></div> 14.Discontinued ProductsPrior to 1993, we sold single-premium annuities (&#8220;SPAs&#8221;) and guaranteed investment contracts (&#8220;GICs&#8221;), false false false Prior to 1993, we sold single-premium annuities ("SPAs") and guaranteed investment contracts ("GICs"), primarily to employer sponsored pension plans. In 1993, we discontinued selling these products, and now we refer to these products as discontinued products. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 21 R11.xml IDEA: Other Comprehensive (Loss) Income 2.0.0.10 false Other Comprehensive (Loss) Income 006060 - Disclosure - Other Comprehensive (Loss) Income true false false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 2 0 aet_NotesToFinancialStatementsAbstract aet false na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false No definition available. false 3 1 us-gaap_ComprehensiveIncomeNoteTextBlock us-gaap true na duration string No definition available. false false false false false false false false false false false terselabel false 1 false false false false 0 0 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="2%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">6.</font></div></td><td valign="top" align="left" width="80%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Other Comprehensive (Loss) Income</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -1.8pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Shareholders&#8217; equity included the following activity in accumulated other comprehensive loss (exclu ding amounts related to experience-rated contract holders and discontinued products) for the three months ended March 31, 2010 and 2009:</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="37%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net Unrealized Gains (Losses)</font></div></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160 ; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="19%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Pension and OPEB Plans</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total</font></div></td></tr><tr><td valign="bottom" width="37%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="21%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0p t" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Foreign</font></div></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT : 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Accumulated</font></div></td></tr><tr><td valign="bottom" width="37%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Currency</font></div></td><td valign="bottom" width= "4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrecognized</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrecognized</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Other</font></div></ td></tr><tr><td valign="bottom" width="37%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Previously</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">and</font></div></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT - -FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net Actuarial</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Prior Service</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Comprehensive</font></div></td></tr><tr><td style="BORDER-BOT TOM: black 2px solid" valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Impaired <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">All Other</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Derivatives</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Losses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="righ t" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Cost</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Income (Loss)</font></div></td></tr><tr><td valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Three months ended March 31, 2010</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FON T-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr>< tr><td valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Balance at December 31, 2009</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 100.3</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 235.7</font></div></td><td val ign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;25.3</font></div></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; (1,623.8)</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: i nline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 39.5</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; (1,223.0)</font></div></td></tr><tr><td valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net unrealized gains (losses) ($226.6 pretax)</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline ; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;33.6</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;118.4</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(4.7)</font></div></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGI N-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;147.3</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Reclassification to earnings ($43.2 pretax)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(51.1)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(48.5)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-IN DENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;33.4</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: ti mes new roman">&#160;(.9)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(67.0)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Other comprehensive (loss) income</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold ; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(17.5)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;69.9</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(4.6)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2p x solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;33.4</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(.9)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;80.3</font></div></td></tr><tr><t d style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Balance at March 31, 2010</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 82.8</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FO NT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 305.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;20.7</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; (1,590.4)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 38.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; (1,142.7)</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr& gt;<td style="TEXT-ALIGN: center" valign="top" width="2%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="85%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -5.4pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Represents the non-credit-related component of previously impaired debt securities that we do not intend to sell and subsequent appreciation in the fair value of securities that we intend to sell.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr> ;<td valign="bottom" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="31%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="19%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net Unrealized</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Gains (Losses)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">& #160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Pension and OPEB Plans</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%" rowspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total Accumulated Other Comprehensive (Loss) Income</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign=" bottom" width="15%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="31%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DI SPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Foreign</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Currency and</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Derivatives</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inli ne; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrecognized</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net Actuarial</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Losses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WE IGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrecognized Prior Service Cost</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="46%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Three months ended March 31, 2009</font></div></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="46%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; T EXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Balance at December 31, 2008</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; (229.3)</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; (8.7)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align=" right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; (1,686.6)</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 43.3</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; (1,881.3)</font></div></td></tr><tr><td valign="bottom" align="left" width="46%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net unrealized losses ($(79.1) pretax)</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(60.9)</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT - -SIZE: 9pt; FONT-FAMILY: times new roman">&#160;9.5</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td&g t;<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(51.4)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="46%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Reclassification to earnings ($41.9 pretax)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"> ;<font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(4.4)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(7.1)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;35.7</font></div></td><td style="BORDER-BOTTOM: b lack 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(1.0)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;23.2</font></div> </td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="46%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Other comprehensive (loss) income</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(65.3)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2.4</font></di v></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;35.7</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roma n">&#160;(1.0)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(28.2)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="46%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Balance at March 31, 2009</font></div></td><td style="BORDER-BOTTOM: black 4px doubl e" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; (294.6)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; (6.3)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt ; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; (1,650.9)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; $&#160;&#160;&#160; 42.3</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; (1,909.5)</font></div></td></tr></table></div> 6.Other Comprehensive (Loss) IncomeShareholders&#8217; equity included the following activity in accumulated other comprehensive loss (excluding amounts false false false This label may include the following: 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income. Components of comprehensive income include: (1) foreign currency translation adjustments; (2) gains and losses on foreign currency transactions that are designated as, and are effective as, economic hedges of a net investment in a foreign entity; (3) gains and losses on intercompany foreign currency transactions that are of a long-term-investment nature, when the entities to the transaction are consolidated, combined, or accounted for by the equity method in the reporting enterprise's financial statements; (4) change in the market value of a futures contract that qualifies as a hedge of an asset reported at fair value; (5) unrealize d holding gains and losses on available-for-sale securities and that resulting from transfers of debt securities from the held-to-maturity category to the available-for-sale category; (6) a net loss recognized as an additional pension liability not yet recognized as net periodic pension cost; and (7) the net gain or loss and net prior service cost or credit for pension plans and other postretirement benefit plans. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 14-26 false false 1 2 false UnKnown UnKnown UnKnown false true XML 22 R10.xml IDEA: Investments 2.0.0.10 false Investments 006050 - Disclosure - Investments true false false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 2 0 aet_NotesToFinancialStatementsAbstract aet false na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false No definition available. false 3 1 aet_InvestmentsTextBlock aet false na duration string This item represents the entire disclosure related to Investments in Certain Debt and Equity Securities (and certain other... false false false false false false false false false false false terselabel false 1 false false false false 0 0 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="2%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">5.</font></div></td><td valign="top" align="left" width="82%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Investments</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Total investments at March 31, 2010 and December 31, 2009 were as follows:</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="32%" colspan="5"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">March 31, 2010</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" colspan="5"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="cen ter"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">December 31, 2009</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Current</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new r oman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Long-term</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Current</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Long-term</font></div></td><td style="BORDER-BOTTOM: b lack 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total</font></div></td></tr><tr><td valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Debt and equity securities available for sale</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DIS PLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 2,750.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 15,098.1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLA Y: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 17,848.8</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 2,834.8</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 14,324.9</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 17,159.7</font></div></td></tr><tr><td valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Mortgage loans</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0 pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;98.4</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,457.6</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGH T: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,556.0</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;86.1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,507.9</font></div></td><td valign="bottom" width ="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,594.0</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Other investments</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt ; FONT-FAMILY: times new roman">&#160;2.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,253.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font sty le="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,256.6</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT- INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,218.3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,220.1</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total inv estments</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 2,851.9</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 17,809.5</font>&l t;/div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 20,661.4</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right">&l t;font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 2,922.7</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 17,051.1</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valig n="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 19,973.8</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Debt and Equity Securities</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -252pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Debt and equity securities available for sale at March 31, 2010 and Dec ember 31, 2009 were as follows:</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="59%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Gross</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Gross</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" width="59%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Amortized</font></div></td><td valign="bottom" align="right" width="10%"><d iv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Unrealized</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Unrealized</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Fair</font></div></td>< ;/tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Cost</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Gains</fo nt></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Losses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Value</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEF T: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">March 31, 2010</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td va lign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Debt securities:</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"> ;&#160; </font></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;U.S. government securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,947.6</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAM ILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 56.3</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (.9)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$& #160;&#160;&#160;&#160;&#160; 2,003.0</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2,159.9</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT - -FAMILY: times new roman, serif">&#160;80.6</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(20.5)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2,220.0</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT : 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;U.S. corporate securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;6,866.9</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;484.5</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLA Y: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(32.1)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;7,319.3</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Foreign securities</font></div></td><td valign="bottom" align="right" width="11%">< div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2,690.7</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;210.7</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(15.4)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; & lt;/font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2,886.0</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;1,337.0</font></div> </td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;54.8</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(3.3)</font></div></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;(1)</font></font>< ;/div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;1,388.5</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;1,146.0</font></div>< /td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;68.4</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(59.8)</font></div></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;(1)</font></font></d iv></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;1,154.6</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Other asset-backed securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;475.0</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;25.5</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(5.7)</font></div></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;(1)</font></font></div></td& gt;<td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;494.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Redeemable preferred securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, ser if">&#160;347.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;21.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(26.2)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" al ign="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;342.8</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Total debt securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;16,970.6</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;1,002.3</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(163.9)</font></div></td><td valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;17,809.0</font></div></td> </tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Equity securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;35.3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;7 .3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(2.8)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;39.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valig n="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Total debt and equity securities <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160; 17,005.9</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; 1,009.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160; (166.7)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGH T: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160; 17,848.8</font></div></td></tr><tr><td valign="bottom" width="59%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-S IZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">December 31, 2009</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font>& lt;/td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Debt securities:</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZ E: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;U.S. government securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,801.3</font></div></td><td valign="bottom" alig n="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 50.7</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (5.2)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$1,846.8</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2,022.2</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;80.7</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(27.5)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2,075.4</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: blo ck; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;U.S. corporate securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;6,741.9</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;497.1</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(54.4)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;7,184.6</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Foreign securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: bloc k; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2,554.5</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;210.9</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(20.9)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;2,744.5</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;1,375.8</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-IN DENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;49.4</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(5.0)</font></div></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;(1)</font></font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;1,420.2</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;1,109.8</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;37.6</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(104.0)</font></div></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;(1)</font></font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY : times new roman, serif">&#160;1,043.4</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Other asset-backed securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;419.6</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;25.0</font>< /div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(8.2)</font></div></td><td valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;(1)</font></font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;436.4</font></div></td></tr> ;<tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;&#160;&#160;&#160;Redeemable preferred securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;381.9</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">& ;#160;27.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(41.0)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;368.7</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block ; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Total debt securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;16,407.0</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;979.2</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FON T-FAMILY: times new roman, serif">&#160;(266.2)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;17,120.0</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Equity securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MAR GIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;35.3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;7.9</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;(3.5)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times ne w roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;39.7</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Total debt and equity securities <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt " align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 16,442.3</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160; 987.1</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&am p;#160;(269.7)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;17,159.7</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="2%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><fon t style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="96%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -5.4pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">At March 31, 2010 and December 31, 2009, we held securities for which we had recognized a credit-related impairment in the past.&#160;&#160;For the three months ended March 31, 2010, we recognized $6.0 million of non-credit-related impairments in other comprehensive loss related to these securities (as of March 31, 2010 and December 31, 2009, these securities had a net unrealized capital loss of $12.0 million and $17.2 million, respectively).</font></div></td></tr><tr><td style="TEXT-ALIGN: center" valign="top" width="2%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-F AMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div></td><td valign="top" align="left" width="96%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -5.4pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Investment risks associated with our experience-rated and discontinued products generally do not impact our results of operations (refer to Note 14 beginning on page&#160;20 for additional information on our accounting for discontinued products).&#160;&#160;At </font><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">March 31, 2010, investments with a fair value of $4.0 billion, gross unrealized capital gains of $303.5 million and gross unrealized capital losses of $50.0 million and, at December 31, 2009, investments with a fair value of $4.0 billion, gross unrealized capital gains of $285.6 million and gross unrealized capital losses of $78.2 million were included in total debt and equity securities, but support our experience-rated and discontinued products.&#160;&#160;Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive loss.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 4.5pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The fair value of debt securities at March 31, 2010 is shown below by contractual maturity.&#160;&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepa id.</font><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="51%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Fair</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="le ft" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td></ tr><tr><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Due to mature:</font></div></td><td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&am p;#160;&#160;&#160; Less than one year</font></div></td><td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 721.1</font></div></td></tr><tr><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY : times new roman">&#160;&#160;&#160; One year through five years</font></div></td><td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3,614.2</font></div></td></tr><tr><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160; Aft er five years through ten years</font></div></td><td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5,351.7</font></div></td></tr><tr><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160; Greater than ten years</font></div></ td><td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5,084.1</font></div></td></tr><tr><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160; Residential mortgage-backed securities</font></div></td><td valign="bottom" width="12%">& lt;font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,388.5</font></div></td></tr><tr><td valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160; Commercial mortgage-backed securities</font></div></td><td valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 9pt ; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,154.6</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160; Other asset-backed securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%"><font style="DISPLAY : inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;494.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="51%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign= "bottom" align="left" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 17,809.0</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -1.8pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FON T-FAMILY: Times New Roman">The maturity dates for debt securities in an unrealized capital loss position at March 31, 2010 were as follows:</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="22%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Supporting discontinued</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign ="bottom" width="19%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Supporting remaining</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="17%" colspan="3"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FO NT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">and experience-rated products</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="19%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">products</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="17%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; F ONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total</font></div></td></tr><tr><td valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Fair</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrealized</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Fair</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrealized</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&# 160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Fair</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrealized</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline ; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Losses</font></div></td><td style="BORDER-BOTTOM : black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Losses&l t;/font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bo ld; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Losses</font></div></td></tr><tr><td valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Due to mature:</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td>< td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: time s new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;Less than one year</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160; 1.2</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: bl ock; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160; -&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; &#160;&#160;&#160;&#160;&#160; 32.1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td>< ;td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1.3</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 33.3</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1.3</font></div></td></tr><tr><td valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;One year through five years</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times n ew roman">&#160;22.6</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.4</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;460.1</font></div></td><td valign="bottom" width="1%"><f ont style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;482.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font>< /td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;6.1</font></div></td></tr><tr><td valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;After five years through ten years</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;160.2</font></div></td><td valign="bottom" width="2%"><font style="DISPLA Y: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2.2</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;622.1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td va lign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;8.3</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;782.3</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0 pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;10.5</font></div></td></tr><tr><td valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;Greater than ten years</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;490.8</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;34.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;881.2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" ali gn="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;42.5</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,372.0</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times n ew roman">&#160;77.2</font></div></td></tr><tr><td valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;Residential mortgage-backed securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;363.2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bol d; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3.3</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;363.2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3.3</font></div></td>< /tr><tr><td valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;Commercial mortgage-backed securities</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;63.6</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;9.4</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;207.1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;50.4</font></div></td><td valign="bo ttom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;270.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;59.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="35%"><div st yle="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;Other asset-backed securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;18.2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DIS PLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;73.2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt ; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;91.4</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.7</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="35%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 756.6</font></div></td><t d style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 47.2</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLA Y: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 2,639.0</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 116.7</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bo ttom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 3,395.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 163.9</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Mortgage-Backed and Other Asset-Backed Securities</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">All of our residential mortgage-backed securities at March 31, 2010 were agency (e.g., Government National Mortgage Association, Federal National Mortgage Association and Federal Home Loan Mortgage Corporation) issued and carry agency guarantees and explicit or implicit guarantees by the U.S. Government.&#160;&#160;At March 31, 2010, our residential mortgage-backed securities had an average quality rating of AAA and a weighted average duration of 3.1 years.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt "><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Our commercial mortgage-backed securities have underlying loans that are dispersed throughout the United States.&#160;&#160;Significant market observable inputs used to value these securities include probability of default and loss severity.&#160;&#160;At March 31, 2010, these securities had an average quality rating of AA+ and a weighted average duration of 3.4 years.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Our other asset-backed securities have a variety of underlying collateral (e.g., automobile loans, credit card receivables, home equity loans, etc.).&#160;&#160;Significant market observable inputs used to value these securities include the unemployment rate, loss severity and probability of default.&#160;&#160;At March 31, 2010, these securities had an average quality rating of AA- and a weighted average duration of 2.1 years.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Unrealized Capital and Net Realized Capital Gains (Losses)</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">When a debt or equity security is in an unrealized capital loss position, we monitor the duration and severity of the loss to determine if sufficient market recovery can occur within a reasonable period of time. As described in Note 2 beginning on page 5, effective April 1, 2009, we recognize an OTTI when we intend to sell a security that is in an unrealized capital loss position or if we determine a credit-related loss has occurred. Prior to April 1, 2009, we would recognize an OTTI on a security in an unrealized capital loss position if we did not have the intention and ability to hold the security until it recovered its value.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Summarized below are the debt and equity securities we held at March 31, 2010, and December 31, 2009, that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="19%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Less than 12 months</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td> ;<td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="21%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Greater than 12 months</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="18%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td></tr><tr><td valign="bottom" width="40%"><font style="DISPLAY: in line; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Fair</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrealized</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: in line; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Fair</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrealized</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Fair</font></div></td><t d valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Unrealized</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td><td style="BORDER-BOTTOM: bla ck 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Losses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&am p;#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Losses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Losses</font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">March 31, 2010</font></div></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valig n="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN- LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Debt securities:</font></div></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style=" DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;U.S. government securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TE XT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 103.0</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160; .3 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inlin e; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 24.2 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160; .6 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MA RGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; &#160;&#160; &#160;&#160;&#160; 127.2 </font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; .9 </font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;& ;#160;States, municipalities and political subdivisions</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;300.0</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;6.4</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font sty le="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;213.5</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;14.1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;513.5 </font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;20.5</font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;U.S. corporate securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;754.9</font></div></td><td valign="bott om" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;12.0</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;543.5</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MAR GIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;20.1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,298.4</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;32.1</font></div></td></tr><tr><td valign="bottom" align="left" width="40%"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Foreign securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;403.3</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; < /font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;105.5</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;9.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MA RGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;508.8</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;15.4</font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Residential mortgage-backed securites</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RI GHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;355.0</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3.0</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;8.2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.3</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;363.2</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3.3</font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;18.6</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAM ILY: times new roman">&#160;.4</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;252.1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;59.4</font></div></td><td valign="bottom" width=" 1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;270.7</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;59.8</font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&a mp;#160;Other asset-backed securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;76.8</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.3</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline ; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;14.6</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.4</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;91.4</font></div&g t;</td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.7</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Redeemable preferred securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; 39.3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3.6</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;183.1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"&g t;<font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;22.6</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;222.4</font></div></td><td st yle="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;26.2</font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total debt securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2,050.9</font></div></td><td valign="bottom" align="right" width="10%"><div style=" DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;36.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,344.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font styl e="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;127.2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3,395.6</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;163.9</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="40%"><d iv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Equity securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.6</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inlin e; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;23.4</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2.6</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="b ottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;24.0</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total debt and equity securities <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160; 2,051.5</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;& #160;&#160; &#160;36.9</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160; &#160;&#160;&#160;&#160; 1,368.1</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; T EXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 129.8</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; &#160; 3,419.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-IND ENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 166.7 </font></div></td></tr><tr><td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&am p;#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: b old; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">December 31, 2009</font></div></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font>& lt;/td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Debt securities:</font></div></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FO NT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9% "><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;U.S. government securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,062.5 </font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: i nline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 4.8 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 19.3 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; .4 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 1,081.8</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&a mp;#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 5.2 </font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;292.2</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; F ONT-FAMILY: times new roman">&#160;10.6</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;216.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;16.9</font></div></td><td valign="bottom" width="1%"><font style="DISPLA Y: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;508.9</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;27.5 </font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;U.S. corporate securities</font></div></td& gt;<td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;730.2</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;16.8</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;681.4</font></div></td>< td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;37.6</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,411.6</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align=" right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;54.4 </font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Foreign securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;418.1</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&# 160;9.0</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;110.4</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;11.9</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;528.5</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;20.9 </font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Residential mortgage-backed securites</font></div></td><td valign="bottom" a lign="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;383.0</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;4.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;8.2</font></div></td><td valign="bottom" width="1%"& gt;<font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.3</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;391.2</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.0</font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;129.7</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3.1</font& gt;</div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;401.6</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;100.9</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman ">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;531.3</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;104.0 </font></div></td></tr><tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Other asset-backed securities</font></div></td><td valign="bottom" align="right" width="9%" ><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;46.6</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;7.5</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;16.7</font></div></td><td valign="bottom" width="1%"><font style="DISP LAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.7</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;63.3</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;8.2 </font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Redeemable preferred securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;49.1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DI SPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;8.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;198.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;32.2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;247.6</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;41.0 </font></div></td></tr> <tr><td valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total debt securities</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3,111.4</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;65.3</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font>&l t;/td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,652.8</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;200.9</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"></font>&#160;</div></td>< ;td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;4,764.2</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;266.2</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Equity securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div styl e="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3.9</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1.6</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roma n">&#160;18.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1.9</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT- SIZE: 9pt; FONT-FAMILY: times new roman">&#160;22.7</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3.5</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="40%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total debt and equity securities <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-I NDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160; 3,115.3</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; &#160;&#160;&#160;&#160; 66.9</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT : 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 1,671.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; &#160;&#160;&#160; 202.8</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td s tyle="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 4,786.9</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 269.7</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="3%"><div style="TEXT-ALIGN: cent er"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="97%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -5.4pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">At March 31, 2010 and December 31, 2009, debt and equity securities in an unrealized capital loss position of $50.0 million and $78.2 million, respectively, and with related fair value of $780.2 million and $1.0 billion, respectively, related to discontinued and experience-rated products.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inli ne; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We reviewed the securities in the tables above and concluded that these are performing assets generating investment income to support the needs of our business.&#160;&#160;In performing this review, we considered factors such as the quality of the investment security based on research performed by external rating agencies and our internal credit analysts and the prospects of realizing the carrying value of the security based on the investment&#8217;s current prospects for recovery.&#160;&#160;Unrealized capital losses at March 31, 2010 and December 31, 2009 were generally caused by the widening of credit spreads on these particular securities relative to the interest rates on U.S. Treasury securities.&#160;&#160;As of March 31, 2010, we did not have an intention to sell the securities that were in an unrealized capital loss position.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></di v><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Net realized capital gains (losses) for the three months ended March 31, 2010 and 2009, excluding amounts related to experience-rated contract holders and discontinued products, were as follows:</font><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="62%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="16%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Three Months Ended</font></div></td></t r><tr><td valign="bottom" width="62%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="16%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">March 31,</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="62%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0p t; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2009</font></div></td></tr><tr><td valign="bottom" align="left" width="62%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">OTTI losses on securities</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT- WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; (19.8)</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; (42.9)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="62%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Portion of OTTI losses recognized in other comprehensive income</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT : 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;6.0</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td></tr><tr><td valign="bottom" align="left" width="62%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net OTTI losses on securities recognized in earnings</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN- RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(13.8)</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(42.9)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="62%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net realized capital gains, excluding OTTI losses on securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MA RGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;90.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;38.1</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="62%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net realized capital gains (losses)</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-I NDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 76.7</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160; (4.8)</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The decrease in OTTI recognized in earnings in 2010 compared to 2009 was primarily related to a change in the accounting guidance for the recognition of OTTI of debt securities.&#160;&#160;Prior to the adoption of new accounting guidance for OTTI of debt securities on April 1, 2009, both yield- and credit-related OTTI were recognized in earnings if we could not assert our intention to hold the security until recovery.&#160;&#160;In contrast, after April 1, 2009, only credit-related impairments are recognized in earnings unless we have the intention to sell the security in an unrealized capital loss position, in which case the yield-related OTTI is also recognized in earnings.&#160;&#160;Refer to Note 2 beginning on page&#160;5 for more information.&#160;&#160;</font></div><div>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11 pt; FONT-FAMILY: Times New Roman">Excluding amounts related to experience-rated and discontinued products, proceeds from the sale of debt securities and the related gross realized capital gains and losses for three months ended March 31, 2010 and 2009 were as follows:</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="74%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="26%" colspan="5"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">For the Three Months E nded March 31,</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%"><font s tyle="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2009</font></div></td></tr><tr><td valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Proceeds on sales</font></div></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2,365.4</font></div></td><td valign="bottom" align="left" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="left" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">$</font></div></td><td valign="bottom" align="right" width="8%"><div style="D ISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2,430.9</font></div></td></tr><tr><td valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Gross realized capital gains</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;108.7</font></div></td><td valign="bottom" width="7 %"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">54.6</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Gross realized capital losses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPL AY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(8.2)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(18.9)</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Variable Interest Entities (&#8220;VIEs&#8221;)</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We have relationships with certain real estate and hedge fund partnerships that are considered VIEs.&#160;&#160;We record the amount of our investment in these partnerships as long-term investments on our balan ce sheets and recognize our share of partnership income or losses in earnings.&#160;&#160;Our maximum exposure to loss as a result of our investment in these partnerships is our investment balance at March 31, 2010 and December 31, 2009 of approximately $116 million and $125 million, respectively, and the risk of recapture of tax credits related to the real estate partnerships previously recognized, which we do not believe to be significant.&#160;&#160;We do not have a future obligation to fund losses or debt on behalf of these investments; however, we may voluntarily contribute funds.&#160;&#160;The real estate partnerships construct, own and manage low-income housing developments and had total assets of approximately $5.0 billion and $5.1 billion at March 31, 2010 and December 31, 2009, respectively.&#160;&#160;The hedge fund partnerships had total assets of approximately $6.6 billion and $5.7 billion at March 31, 2010 and December 31, 2009, respectively.</font></di v><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Credit Default Swaps</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We sell credit protection via credit default swap contracts to improve the return and diversification profile of our investment portfolio.&#160;&#160;Our contracts are limited to credit exposure on individual entities or investment-grade indices and have terms no longer than five years.&#160;&#160;We would have to pay under these contracts based on certain defined triggering events such as bankruptcy and failure to pay interest or principal on the underlying obligation.&#160;&#16 0;The fair value and maximum amount of future payments for these credit default swaps at March 31, 2010 were $0 and $9 million, respectively, and at December 31, 2009 were $.1 million and $18 million, respectively.&#160;&#160;At March 31, 2010, we were not required to make any payments to our counterparties for risks covered by these credit default swaps.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Non-controlling Interests</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Certain of our investment holdings are partially-owned by third parties.&#160;&#160;At March 31, 2010 and Dece mber 31, 2009, $79 million and $77 million, respectively, of our investment holdings were partially owned by third parties.&#160;&#160;The non-controlling entities&#8217; share of these investments was included in accrued expenses and other current liabilities.&#160;&#160;Net investment gains (losses) related to these interests were $1.6 million and $(.3) million for the three months ended March 31, 2010 and 2009, respectively.&#160;&#160;These non-controlling interests did not have a material impact on our financial position or results of operations.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Net Investment Income</font></div><div style="DISPLAY: block; MARGIN-L EFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Sources of net investment income for the three months ended March 31, 2010 and 2009 were as follows:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="80%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font st yle="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2009</font></div></td></tr><tr><td valign="bottom" align="left" width="80%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Debt securities</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman ">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 236.4</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 223.6</font></div></td></tr><tr><td valign="bottom" align="left" width="80%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Mortgage loans</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new rom an">&#160;26.7</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;29.2</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="80%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Other</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;18.6</font></div></td&g t;<td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3.5</font></div></td></tr><tr><td valign="bottom" align="left" width="80%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Gross investment income</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;281.7</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY : block; MARGIN-LEFT: 9pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;256.3</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="80%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Less:&#160;&#160;investment expenses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(6.5)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"& gt;<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(7.1)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="80%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net investment income <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160 ;&#160;&#160;&#160; 275.2</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 249.2</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="2%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="81%"><div style="DISPLAY: block; M ARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Investment risks associated with our experience-rated and discontinued products generally do not impact our results of operations (refer to Note 14 beginning on page&#160;20 for additional information on our accounting for discontinued products).&#160;&#160;Net investment income includes $89.5 million and $80.5 million for the three months ended March 31, 2010 and 2009, respectively, related to investments supporting our experience-rated and discontinued products.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The increase in net investment income in 2010 from 2009 i s primarily due to higher average asset levels and higher returns on alternative investments, partially offset by lower average yields.</font></div> 5.InvestmentsTotal investments at March 31, 2010 and December 31, 2009 were as follows:&#160; March 31, 2010&#160; December 31, 2009(Millions)Current&#160; false false false This item represents the entire disclosure related to Investments in Certain Debt and Equity Securities (and certain other trading assets) which include all debt and equity securities (other than those equity securities accounted for under the equity or cost methods of accounting) with readily determinable fair values. Other trading assets include assets that are carried on the balance sheet at fair value and held for trading purposes. A debt security represents a creditor relationship with an enterprise that is in the form of a security. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certai n preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities (and other trading assets). Secondly, contains a description of noncontrolling interest which might include background information, terms of the ownership arrangement, and type and terms of equity interest owned by the noncontrolling interest holders. Thirdly, a description of the variable interest entity. In general, a VIE is a corporation, partnership, trust, or any other legal structure used for business purposes that either (a) does not have equity investors with voting rights or (b) has equity investors that do not provide sufficient financial resources for the entity to support its activities. A VIE often holds financial assets, including loans or receivables, real estate or other property. A VIE may be essentially passive or it may engage in research and development or other activities on behalf of another company. Fourth, credit default swaps are also included. These are a type of swap transaction used as a credit derivative in which one party makes periodic payments to the other and receives the promise of a pay-off if a third party defaults. Finally, net investment income is also disclosed. This is the income earned from investments in securities and property, equipment and other capital assets. It includes rent from property and equipment, dividends from shares in corporations, and interest from bonds, loans, mortgages, derivatives, commercial paper, bank accounts, certificates of deposits, treasuries, and other financial securities. It does not include realized gains and losses on investments. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 23 R8.xml IDEA: Earnings Per Common Share 2.0.0.10 false Earnings Per Common Share 006030 - Disclosure - Earnings Per Common Share true false false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 2 0 aet_NotesToFinancialStatementsAbstract aet false na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false No definition available. false 3 1 us-gaap_EarningsPerShareTextBlock us-gaap true na duration string No definition available. false false false false false false false false false false false terselabel false 1 false false false false 0 0 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">3.</font></div></td><td valign="top" align="left" width="85%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Earnings Per Common Share</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Basic earnings per share (&#8220;EPS&#8221;) is computed by dividing net income (i.e., the numerator) by the wei ghted average number of common shares outstanding (i.e., the denominator) during the reporting period.&#160;&#160;Diluted EPS is computed in a similar manner, except that the weighted average number of common shares outstanding is adjusted for the dilutive effects of stock options and stock appreciation rights (&#8220;SARs&#8221;), but only if the effect is dilutive.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The computations of basic and diluted EPS for the three months ended March 31, 2010 and 2009 are as follows:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="68%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">(Millions, except per common share data)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: bla ck 2px solid" valign="bottom" align="right" width="15%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">2009</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="68%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Net income</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#1 60;&#160;&#160;&#160;&#160; 562.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="15%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 437.8</font></div></td></tr><tr><td valign="bottom" align="left" width="68%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Weighted average shares used to compute basic EPS</font></div></td><td valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;431.4</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="15%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;452.7</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="68%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> ;<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Dilutive effect of outstanding stock-based compensation awards <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;8.2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="15%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" alig n="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;8.9</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="68%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Weighted average shares used to compute diluted EPS</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;439.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FO NT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="15%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;461.6</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="68%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Basic EPS</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE : 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1.30</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="15%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; .97</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="68%"><div style="DISPLAY: block; MARGIN- LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">Diluted EPS</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="16%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1.28</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="15%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-IND ENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman, serif">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; .95</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="2%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="83%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -5.4pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"> Approximately 18.9 and 19.5 million SARs (with exercise prices ranging from $32.11 to $59.76) and 5.8 and 6.2 million stock options (with exercise prices ranging from $33.38 to $42.35 and $35.34 to $42.35) were not included in the calculation of diluted EPS for the three months ended March 31, 2010 and 2009, respectively, as their exercise prices were greater than the average market price of Aetna common shares during such periods.</font></div></td></tr></table></div> 3.Earnings Per Common ShareBasic earnings per share (&#8220;EPS&#8221;) is computed by dividing net income (i.e., the numerator) by the weighted average number false false false This element may be used to capture the complete disclosure pertaining to an entity's earnings per share. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 40 false false 1 2 false UnKnown UnKnown UnKnown false true XML 24 R18.xml IDEA: Segment Information 2.0.0.10 false Segment Information 006130 - Disclosure - Segment Information true false false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 2 0 aet_NotesToFinancialStatementsAbstract aet false na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false No definition available. false 3 1 us-gaap_SegmentReportingDisclosureTextBlock us-gaap true na duration string No definition available. false false false false false false false false false false false terselabel false 1 false false false false 0 0 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">13.</font></div></td><td valign="top" align="left" width="75%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Segment Information</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 2.7pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Our operations are conducted in three business segments:&#160;&#160;Health Care, Group Insurance and Large Case Pen sions.&#160;&#160;Our Corporate Financing segment is not a business segment.&#160;&#160;It is added to our business segments in order to reconcile to our consolidated results.&#160;&#160;The Corporate Financing segment includes interest expense on our outstanding debt and the financing components of our pension and other post-retirement benefit plan expense (the service cost components of this expense are allocated to our business segments).</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 2.7pt" align="left">&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 2.7pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Summarized financial information of our segments for the three months ended March 31, 2010 and 2009 was as follows:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div> <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="56%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Health</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Group</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align= "right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Large Case</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Corporate</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT - -SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Care</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Insurance</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt ; FONT-FAMILY: times new roman">Pensions</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Financing</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Company</font></div></td></tr><tr><td style="TEXT-ALIGN: left" valign="bottom" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMI LY: times new roman">2010</font></div></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style= "DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Revenue from external customers</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 7,765.4</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 458.9</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMI LY: times new roman">&#160;$&#160;&#160; 45.3</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; &#160;&#160;- &#160;</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 8,269.6</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="l eft"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Operating earnings (loss) <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;460.1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;28.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"&g t;<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;9.7</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(67.7)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;430.6</font></div></td></tr><tr><td style="TEXT-ALIGN: left" valign="bottom" width="5 6%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2009</font></div></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td&g t;</tr><tr><td valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Revenue from external customers</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 7,854.6</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 463.1</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: blo ck; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 52.6</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; &#160; - &#160; </font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 8,370.3</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="56%"><di v style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Operating earnings (loss) <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;469.4</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;42.1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;9.2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(78.1)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;442.6</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FON T-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="97%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Operating earnings (loss) excludes net realized capital gains or losses and the other item described in the reconciliation below.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0p t; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">A reconciliation of operating earnings to net income for the three months ended March 31, 2010 and 2009 was as follows:</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align ="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2009</font></div></td></tr><tr><td valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Operating earnings</font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 430.6</font></div></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 442.6</font></div></td></tr><tr><td valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Litigation-related insurance proceeds<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"> (1)</font></font></div></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style ="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;45.5</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;- &#160; </font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net realized capital gains (losses) <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;86.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(4.8)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="61%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net income</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MA RGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 562.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 437.8</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="3%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1 )</font></font></div></td><td valign="top" align="left" width="82%" colspan="2"><div align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">In addition to net realized capital gains (losses) the following other item is excluded from first quarter 2010 operating earnings because we believe it neither relates to the ordinary course of our business nor reflects our underlying business performance:</font></div></td></tr><tr><td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="top" width="81%"><div style="MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: symbol, serif">&#183;</font><font style="COLOR: black; LETTER-SPACING: 9pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Following a Pennsylvania Supreme Court ruling in June 2009, we received $45.5 million ($70.0 million pretax) in April 2010 from one of our liability insurers related to certain litigation we settled in 2003.&#160;&#160;We are continuing to litigate similar claims against certain of our other liability insurers.</font></div></td><td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td style="TEXT-ALIGN: center" valign="top" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div></td><td valign="top" align="left" width="81%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-I NDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">At March 31, 2010, we released a $9.8 million valuation allowance previously established on our deferred tax assets related to realized capital gains (losses).</font></div></td><td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr></table></div> 13.Segment InformationOur operations are conducted in three business segments:&#160;&#160;Health Care, Group Insurance and Large Case Pensions.&#160;&#160;Our false false false This element may be used to capture the complete disclosure of reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10% or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 131 false false 1 2 false UnKnown UnKnown UnKnown false true ZIP 25 0001122304-10-000046-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001122304-10-000046-xbrl.zip M4$L#!!0````(`-&`G3R7[W''8+0``!4H"P`0`!P`865T+3(P,3`P,S,Q+GAM M;%54"0`#R>;92\GFV4MU>`L``00E#@``!#D!``#L/=MRV[B2[UNU_X#C36:3 M6MVHNQPGIY38SKA.''MMS\PYN[4/$`E)F*%(#D':UGS]=@/@590MR;(E*\I+ M+!*7OJ,;`+N/_GX_LKRK=Q4\&+&L*P1O6?Y]^NS3&;T'(>'IR>+P$_ M3#0BNE.H*E1JS7KW?2H5M(P/62[JEY&3;EPFW6C\Q`(JD74(13E$:5> M=O!05/5S[-,KUXQRPXAA9L$\F!M)*XOQF3'A67J\3__^;X0<(=$/A23G%1L2 MR83#8.JQCP>"3SP;:26?C7TV_'@`,Y:CN2KWPCJHJF%,UPG8?4"X]?'`K.$_ M-3Z\`DGDP53_@M_!GZ)_S\7!)V#Q(3R;N,YUX)I_7(0!*@T:'S7D4;5PI@2V M:A:XQ_BDE#)`\GLOF7Q`(:@]B7EUIGSA7H\H/:KX$;C ME7,C:G;%`LH=9IU0WP%-$*^"^,T=(7[?!()9VN-)\:SQFL/J%[6#&R*2[L2:+V8?=@4H_9! MV2MEW/-';[L5&VR*3\\?E.YT$+$IMNU#[R?XMYK\3_!O]Z'W-G%C'WIOCOCU M?>B]7?S8?.B]9H2>/Z)>9I$W:@LM\MCLJ8M\?5>BU)??2WA)+NU*B+J1D/0E M&?7:0]*-KU2;8MR.Q:@ONI?PDGS:L:!TDWL)+\FVYP]F%_<8$X2>X#&^]GAP MWZA5 MB#;21!KQ:-)8[D'GK-!F%T/=[!<`7]S`C)]M:%XX_4]V\`%0_FD4?,`_`SJP M&1'!U`;=/;WX?E.^/ON?DT-BU+S@`Y$/3OOG9]_^=4@"4#Q!''9'?'="G0-B M,ML6'C7E-THU]=NCEA7]ON-6,/YX8-1J;P_B^?SX+XO<4IN/0(\#USL@^F^; M#8.X:R/I"#!GFD3/AX!C!/_QV?7EMSZ`RAT;K*R&_[>3LZ\_WQR2@6M;^I'& MT7@41YP%V(`357&F:-9JBH35P%H&IVYK&Y#*R-6BZ%43[E6EX!2U1YSRH`]0 M'#^0FY-_WI3/OA^??`?(0W: MA^2OX]`'/99C!F.?,0+-@[$@$*(!).<4)B$-`[$S:B5REYX9`/4`KGL^@:76 MGI)./+FRS@A#>GY"`T#-=$6`;[)]W]1;];C[N]R[7@8M`%6DP1``%1!+L""P M`2;N$$9]Z-;W?&Z_+T2Z'Q1A-J86##L!QPTI$O&#HB^-Y$V1G#J$CD8^&P&` M"?US4#<:O338&4J$0%W%R!D1TM*3F?YAP[37Q)0F=B.&9KE1Z<:\``\,M&@B MOZ>-N`'+*7F74L_+ZU]$6CM+Q*BTXQ$FU/^#!7,[G^O=>6-0,@XFP,%>(&PF\S'$(&SBV>Z4,5$HZ#<@84XH_6D0P5N8%WHC M>+,,IH+]!5\6IV"\ MJTO?-1FSQ"E8A*NHG[@87F.W&^AU#)V6YU;9:.2P66BB;4(#N5(VC&:>+[ANX@$>>J[_1B>"Y]00R2KYD9 MC;;DG"HJL73M2"Y56OW39RJ"T^W1;B)/6PW"+1]XHH$CF1B=O!AX!]$([+>CNHG(( MZ=@6>B]72:,E*=@]^-1N-`M=E]2@+PH3)BAHU]MYF7P$)L]G$QY.9C1'OKU4 M+Z^4`[B2YC<[S4*(9H9^0;A0K)K=5MXB/0)7'Q8&2YV*V'24C@CB-_BBD`I# M@(6I8"#3.(>TF3Z70X\0?>LR21W?$=4P.V!9H?#&\H?=K<ZK/O^;->_N`'H>5Z-V_1GYM!-ZX\\<%= MC[%K6Q!]_R=1)^8/$WQ^OXT)>'T3`KX[])..V\L+8%8#U=C%3\G_JBL7__

>C)%#JS45-TT0.(6T^B MULN[D>!LMUKM@LV;N1-L%F#TQ%O:O5P6X&-NA[!RYX&+KLT!?Z0YU):MV\*BP(X,^,VL&8F'CX,R^^TO&/0&XP"R03W$EY M:Q$$5O=?FJ3M;F\FV'I\GHV"C81N]WH%6Y`+@]VKD./4KC!>2\;?:[FDUMO? M4=,W'7H[>$4-Q61_,VV=]V'P6!KLAS_%PV.0@C`^R+==9Y0"A=_8>E'0< MP!BZMNW>B<,9;JU`O54XL4UV8N`&@3N).[3:;Y?FYN/@RA'C MVP9D5DL*]3T"3?_T\89'@ED]J_//(MQJRC68D,5(%,OP"L8QQ\?7PL;N[G$Q M;7966`\R6JKA_'QQ=7QR5?Y\<7-S<8Y4H>"(U+U[(ER;6P?S2)U9)-.:O2VK MP1,I_>Y<7404[Y=0F*>1=/>-4*+@N)"^&&$SLKH%UFN=8K*#1BXM);7>4\W< M:[5?RU#LFCEXI]1Q`SQ';E4ZK;[7H.\=B`+#PB*4L)Q=ZV1;:M4^GNC=O*`HU"U]E;HM=GB9!QK;VU M6-9:M"NUQ%:T][9B&9'K-#N5^MY6O#Y;@8Q;>%W5BRU//6Z ME:>0;&\K-N57+,.XO:U(;$6[GEB+QMZS6&Z!`J%["LGVUF)3GL4RC/M!CYV> M8E12.QN-9<+T_;'3HA+<[K66,CW[JCU*6?6)1_86U=Z8/8,Q M:Y3:C=Y2<=?>G.V^.5-2\>3-XKU!BVG[C0E!3'6AGGBN'^AL=;F+HLM,W*F] M_4!^/;FZ.?O2_U;N?SO[^AWF9O=!&2\BXZ3OC(*+1WL+NMGSL!_0?FI.:A'5 MPC$G(G]&(UH$QK/3K_P@+==G3YM`;,L-!S;[00QJQG"6B%U@8->DE0N0]D"O<:"%IU\+HU18_6UJSU&^YQ5Q:TG;'Y7Q$J@IOQ:5>K^ZQ/OA]4\RW#7X) MHV=-KUTF&#GF)S(BOSS3`S5?:@'50"PK&`M^K;8UGO#C7_<](\5?8B4M2-*- M^5+5+3DB4OO+1/J%,)#.@MDH//6:LX"NYA3_"W*;/%8O'2FS6?".SYJ\39_A:_-%AG)(] MEU:]V4VRP6-'>!!GUBYA:FV/F0&_A;:E*.)1#W,B)P6J5+Y=.IL$ MF:,%82(@OD[P7FG4W\K9*HWNV^PLC^9F?Y3.Z]/,>J7S0I^8SL^@3QT2.@)3 M-`)!WQB5%AG$:<]O7?M6*AN\XZ!8F!Y ME#1X&!19ZP`Z@TZ&$\3C3;U2B[A<64K8FL5V*-*F7ZG/W5#D]=%3O,8,"0GY M%B19WYFF!''@^KY[AWDX5')4%N5%CR0(>6QI(_#HV+\QL#%3,HSH-,3,TGK` MF'B8PAVGEKE9*[4FK&5`SXJ!BQK:)^HXX:2DT^ECPS!B_1,_D)IW* MNCE7QM-@R2^Z*[7VVZ+%[3$=P4P.E",#4L)ENK?,P4SFP9@&4O0YE@`!Y@%V M6%-#5BN@$DA74E,>I4C`L9Q!>ODU5>+0J/8&%1'U=79VF0]]J(HU_1E2/T"R M!2CQ`V:[=P1L#B;&KQ3CZK.F2I1<'GRF7C@?:B4 MKSB,(Q/R^`QA2N`C(\4":(0IFV0*>]3CA*KO9,V$H2R8P+-"6%P5!<1WP@)% M&\U`:5)F101K)_A,U:1PP!A,T+2)S-):8#:6]*-^^#0.NC1/["+%7I$,<"17 M0A`81A*\YI>3K-G#(L5ZIGG*\JENH`(VB-)EK8AY7Z* M%(UFJJZ+*N(>8XJLZD#$H*Y%4RI5MF$LVE MWGV)33G\Z#O6)>`!8BQ_7@Q/H^4JKB0ICF$9L:74[E,5K;>M>XW##H<*S15Z.2J'/+HY4O7!>W6(!0P.)A.792U(`_1+N8>RNC&[/;K M;V?'-S\?DD9[[L[X>G9RKJ<3T)H2$-_GP[0=[S:*#UD65OX"ACU-3G\/(\LLZPLE, M)VNZ`8!$>+@\ZUA(^F461-F`/"K[+=9P]&^YR51]*9^",4C7Q.M??\F6U9,H MB'DX8!0#2!3'.N<:*\]WT>B@F<'0#>!TP;\JN\.RAB5;%O#B.EL5$'PMH#C2 M5V\<@>E*K1'9SI<7V9U_/K_(XNZ@6VZQB8/X:B%14K`8 MOM)IC9#6D`AZ*[="<&-_IB`:_T\Q:$Q6P M8_'HLB4+K`+Y-09*#>06!'B^`YA2U:?3(1#P#R4%.('05^'/2*)=M?,+]BT< M_`Y#JCTND&0@%@>+KVNSH?E_I$FO*985*P/-]8&X'=K79C.:H">'I]/ M5"RC0W13EW1%PZ.'_,82265I[D(ZXP@/QY<9(I%,."^Y<_P^DD6`VLD>5X!1;?1*S=QGV M+L.37(:OOAMZ:@5'_;^@I,>0 M)@T>F$J%0\^SI1G`O0@YMMRMP0E*^D'HP+KM"]S5D$\S?<#`W<:E)74%:[VO MJ?,(R[U*&JCR?Q87RA9*RQ.9Y$(;F*-,9C6#98N_U^#!D*I:UG26#F!D(J]% M%'E,VK,!KT-[,]$QCG374O3/UL93.[+QSE8"0,H.ON,`(1T(AK"GK&ULJ8M@ MC,Z1HD5[D3G3_I7>X+(9GHZGO4E\"A`!2,D8.OUTVD;+W=X(L!3V1>*D((VL M>NS#2IY&57ZC0N!R*K#L,.0M[FB-<82F*3X]E>=RHF28&;@1B!7(@.\A*M`.JSAP42>4*IS;LJ.]SZ+I? MR?8KV>ZN9-^H/V(0^X)O>ZE.NT1V-5/V"(\4;\&L,!7#^2R(SJ!B4_0N6:G2 MYV9X:IJV\N]3%DIN?]-[/"JTU5V@J.?\>.E&;K7'L\;^:1H\=._569^51&"Z M7JJ%1I@,-KUF7(LCTZS>=!EO8]V M8Z;<[^*@'S//%5S'O?%!F;J6`W*`EB`I>QOO,LW4U^AK=1`W[A?=YF=UZH^; M'"O4]S7RY4[C"X`^&;)V\W;M^4 MUQ/FUAA:GD.=9FN.V#T^VU8CA]SJ=O/RMP)R((H^[AW%D02=X.RZ<;] M5#L8N6^:N+"[SDH55HU:/5\/:,&YM@@1Y$FODS?1R^*A*K3G[@R\D_>"WNM+ M07ELOL)++(!VX6!][8OA65(#?(4RUYV9\KL/C+\58*M:N"L`G:[*)$\^T--# M1R==\"BN/Z]:XU'/%VQ[J9HN7P>NWFNWFAK:!2;8(+18!*[>[;4:*T";EG5Y M)TX5/E=V2:YZ>&4205+%T&<6MU1_Y%[4O*]*IR]?$ZW9S$G(PS-L)2+2EYI9 MTQ9$I%4A*25("TWJ\>[;MK==W74;EH>&I97#A M4EZXB[NOY?50\KU&:[N_QGT@&T.$`6@_6&6D#KQL/?]G@$M_<[FNBE]DR6([ M\PCVZCE>VW&.SUBR%1:4YTH"U&AMWY>VK[Y$6&T+4P@\D:BZ.E4B0K"`08&T$,W]`#[`A(BT+X,&9HA8\S$%X].5ONYJ[/_J.O$T-4>;O6D MH-OS=9)C#G73UG8-:^3G&*%OB9C_)P%$:1O^]!`!9/N&%4=U#\EQ$>N)X+?H.C2LAO9GN$ZGHB1XL!EB;D<&K;/T9Y> MYT#C8UDU,]HP,"^3@KF,8M0V19@W01Q#3Q\D43LDL`W/#T7,5AP+.V4T#`*Y MZ?N!J4;EQGB!MA\]H@#"[3'RC>B<%8)K/5+6Q1X[7&I:\\1#V\]=;7[&7Z`, MV]`<>HK%N<8!`W;( M*A&&8T>F"U(!4O%8*AR.28ZG&&HZ]F#IV7%#02K'/\%41G-VYL*GR+>YDCHB M!5MR$.27+Z6#+K[B&HMC;BF(U>B,ZQFDRK&,(+"YMF2%6F'%I$I*8WA*RQ<[ M#E?)+T#4N"#J!%;.(L[3N8:^@P@I($*Q$8<]I"2:/X_7"RLX-&*R%]A(#G`)Y/3ZE6/?TQ%-`$G:B M_74_;1FH=F*JR0O"HXEJ!;'S79)5/0+78Y64^J<@M;!0DXO2YV^GI[`!I$W% MST56A<&>ML6'JFCQ=+WN1AP>;&@`@VB]-VI4!@)P?0%@+!_XR MOYIH1L=A%^O)WTQ;T)#Z?H':/0K(=M=S&+$WK,N(=O&L<";L9(P?:<$B7'(UM362![]2/.9?I@0=5B MJM,=109K>*P`.BVK95D1LPCQ\T!B!T84!&#U^A'/BSRNH[)`N@>SYSJF#69/ M+::&AFO'[.D:,'OL9N]=66&R)K!W@SVS(!XV+TACT'9L(%U?>V?[I@?V3BVF M.D84<30S!WO';N^^X#J;XJ+)DAPMUI,P+B=)^C>>@@T<2'G;<-UP4`]^C8'< M'S:*2F/*7;BF.\0"[B:=PI3C`.'0^NTU^O[VR[?#[FY?@V^&8._!WH^9)0\(&G.D_#1MEW+XJOJZ!=!8 MA9*<3SF[E0T\=- M$R`^[Y5-"HPXA-,SO7-QEN7``>&^-6F!.^ST[BZ,D\``@F6[UX_5/"^9!LBK M8@/?/AVJ`('H,5TT_X3S7G4T!B'0]\AA*-\6N$#$E<`B0TC*BW?Q<7/.O#/+ M5+':6Y'K[LE(8K=B+G9EGH8#@.+S;4_9N(;.`K3\4PY2UM'Z<0S6(^R(N=(A MP(XCLN/"#@*^O7R15D=RST6)29FG%JYNQK@7B4^X2SR;"GH"*[HT:5=V;B50 M;9=,$$H^&Z0$4ZQ[#X,.<`?$4 M=PS+<4P'#`#+!`&PDRQE1"&,"Q@U!PDDA#Y[)QFP8)PAJ[:S`88.`@@]6Y-! M`$//@X>F#71B:`+A0J1]L.=OT M-9A?.F8..L1OY<`$L%'L-@IZ\`LBLVVX).37HVW\T-A*DQZ[@_OK6=!?CX-R M'#R!_GK'A4*/N%S,&R)@KMG--?3-%R6BML5Q^E9C,^2&FO0M&MIGQ_+`7H.] M'J/LVH;EN;!;>0Q[#S1?D"T1<";:?14J' M>B;:#2+V\G8(HG7N,#^XG;QGZ3+#')+70\UUH,3^$S@)MHLMW"K,G.>4QG!#>'>C6/CBZVT=AZ-8.W=K' MK2'"^[L@&NEZ?+._Q#))/:MVJ'-S#R[%$=]A66#12?2(Q/0QM'57N:V[%&)& M\PY^/]_H]X9NJ.ZZ?NN_W34;.G!)"TIQGM?+),V*V1^_6*N_E\ETNOG['D*V M,&27O];Q<.U,I+AH4/>5C=A7#?J85.E\W>7;MCKO]5GO;P/=8C3'^7:Q`+HI*W0[S\B/Z9?) M%%4X+6=%]B^>H@2E%9YFS66%\Z0A'V2+99)577O.K$#-'*-E4C?F"P?.NPN: M>84Q6I#WG=<(%U-RE\=K[5:U]=!?`]-"BRS/L[)`Y0TJRN+RQ674=!UE5]B8 MEHMEA>>XJ+,?&.5E7:/-]4U)EU)O=VA!%TE-[\Y&MV>_IH1*"!<:U!85)ARF M*T^394;CA^[9Y-Z_VL[6J]!;_VJ'IK/YQ"#KJYFN!95A3$_"&B',MDAK<*1:P.EJAUI+\F*I45Y(-%=R]Z M.7U.DJ9E2UN=!7.Z&)P.4S^1!+[Z<(E]W3OU[1.T$W!,&H[+6X@PJ/ M(,5D@PNSBB+(#F29)5FQ@A;7"=^O4[D MFP'W>L/H`2Z)F:@P65F:M]2(4/MS(%MCH$E+F-HNEV75<(KX3L%Y,T^*&>YL MS@O0OWKAB]4KO**B^LQT).0MJ,H0A<@)^*]>A0ASNVA7UNHE<];'0.SU:E]" MLJ>X=0]*DPK]?L!#9@X4[&>*]*U3I$]$D;X\LA(/K_S`$O:7X8=ES_0'9QW9 MWNX;\8\>Z]63`A2JGD\\E*Q&];R\+0A^YN4MFMPA*KP50=^6'L1,&OK3N]VX M]^@:>OM%0A`\NZ'(?$/0:]>MZ&43G";M8RFFOYQ0OZUN*J(O+7'0#*(%>4X% MN*)UJ<1%FSX76081.F>0]=*,+PDR""_MU3C2+NW%U%`25[]1+ M&8HJ8X4+'D+]29PY$NEV'A06,3%+`E4?CXU_KH!G69G."G!@D_8:D\B_(<$T M"9`QNL,)LZ\".@)^<#\*'7'@#PH=F[WH`'#A13I^7J,!W30JV]DR?J%*>V&E_=-#2A>*^[]^K\/G MKPL][#QRC.D..0L""^Z3>))#!^_[2`XDW"<+E482YBU`9(=&9,6]^A>=K.): MX#D4VXQ.6/&\J5%&TZ19'T![6O9,*^*+%X]6+RHSJZ.R.0T)OF>7E; M/Z^]Z4'0(>7P$M8RN_[Y,>N%I3G$.J"TI*]-OG2/#T7<)]P&8M'7U5D4>F9I M^]3)\$C=E9:G=JP/3RN\2#)ZI$UIAH:[&2IUD9U$V#(KN3?$^/Z6U. MY2FA5P.3+ZKC*?#Z(-0JPVNN5,0(L7Z\7:-.>/YL3SP`'#P;!_^Z#[Z5`.+1 M]M620A$E//ZL"P-UU$,%L]!ZZ:&"#.37PQ.4.VS[N+)L18[^7+V"SAS7R6W! M])3`B0?QV$_)ZZY=U"GJ@YP0/"1P>D`[`#BCC`^P`Z3@S=@PY M#R)CH'36CD+6^95C/$E_^8DF@264M]1^/,DTZ6DFKYR=N]W7&.7LW#33V:+O MJCL7VA=-F^Q5GP+_'DV^[$'#N^5Q;M:/W![TL981!K='M,RL+WJT#OD$IX>X M;/WX^H"*ZW!-*QR/AP$R,;RMI,TU;'3D>*%@>NN8LN&Z M(H1C+,`!PG$LX(`0[#'MCM."5L-8S''8&\-('2\!+U^;GCY^B-(^JA=8$&\H MPDN?O;OM^+52:0?0BQP1O!R+5BK-R^`T'6M5=+V/VC9>0Z^-_%-DRP*8^=H1 MP\=B<+SE9J;KZ91G4]M;BX34\(W%QBO-2\]AM_'C5TNUW37##1WV7MOC5TRE MN1F&IYFAJJ+S+7Q0&]1Z/R>WV')L"9QT8/*QF3P6-T%IC\\-7/#>5>$EY,U5 MX:1>6JDV+Z%LO*_G?NR!K!HF7@FP0`&Y(KR,H8)<$4XZ5@C5*XKPTK=T4DNE M73^O%QYQTKT&-\\"G/\\Y1U]`#M".N-(%`^94@`@`Q83YIRK.I M+Q+DU!(2I=W6D"_C*%!*)'"/0$J8C\>>24@4@Q*E7>W8YHJ``4JTE!*.D_9] MXC&/T'I:MI,VL@2KU@"MEVP+5K`NBD:03`+E*NX<;^ MV?PIU7`*A&J%4X%KQCU"T-^;A-!ZU_5[J/F4=O>DF53H=\Y[G2$&M>U[-GS] M]G_7Y).,A)M9^H0UWSK6?"*L^7+/FH^;RKW_6FT))L44K78*K[J=PO7'7]EV M"J4ERSX27.4Y*F]0V5:H8CJ,A)(&?4RJ=(Y+GU35LNRZBY]A;*Z;M?,3).JNMLL;=8F55(TF+X#^0[_7!(IR1I45BA; MK/^_=01]%W^:0G;FSM$7Z>8 M4>9<75UU*TX(I2EVT9=;7SQM5V]-+W-->]6\P>PKINH@P3Z1_TQ8D[*4[Q+. M_,"H+8C8Y7>4%SD1NFY>3X,2(O+3K%[BJB:_63>N*]MF)3-%1IGTM4D:7.^4 MF*_D+;.;+"6RAA9)]3%PE$1&\$F$#I16>$K@C M^#@E,)7BK!,\\L6<@BO^IZ4,7E^+F]1\=70IIGK3%I@`<7G7V0TB-]AX+,&= MD.T6]V,*]R6+<#OZHN^+#C*CO/]55)@\^5]"V3?)DGIO'<$_$7'Z\O2+]TE& M(/AB-4CVE7K^V/_.,1%&(M63SC%9:^):7N^(;T/N3>6U?:!9NB9-IRK+LLY6 MCM4M)J:-&**RZG3K7E8I:>\5B@@N_;+[*='1*2:XL2!+1]D-JML;HML9?E!N M@A34$;HCCR0RGY(UD;BMF=,5D>^2FOAO5/&)43(C>NTRB9D MM>3B3V6#D8,F>)851:=E!5I2??()V-S46K<4:AI<="A38^+0)@\$ZXPU,]4Z7_"&WO&!$LD:+"\K3&%U M;53G2;VB`/G.1/]#7KBBCW^^Z-NRS:<[EDXYL<57MN6MUY9-45$V*RM`V=>] M_CUS-^!(EC,G&ME=GQ&SV8"!7>[6N[ M('K92N:8R,2S(,[H?O`G<046$^)XN/U!*T*=>)BD!M3]^L59_+Y/I=//W_:[AUK;AWN.4 MZQ]X$@RB[ED]LGGE^+=?J&=*J$.^=(Z?Y4N):.'J=&F^AU&NMD,-;S,?!@46K^]1M_??OGVXSN>6'O"&D$GLZ7R)SHNFW]+LE@R#<#G1Z2`DJ`*1L?;?7X.%#> M1\9!!0%+1T54D(W'L#L*DHE?VD]P(ML[A7T7E?1GH_/%QRS/L[(XD,.'LW`< M-/U.D[AG(J>*+NAJD^EEFJJ`S_G@K>'B8'Y\??1@ZX(A MT9^TG.FAAFE_3=`HN`GV">S3N5ELGUA/]78G"6X5Y)F. M1B(#\-X36;8Q)@"!45A@=@K'`8E!MA,.PQ$@_AG^A\R8F6<0IARFYZIKA8$6 M;9&EV9(>A\_6+5.6)?TC37)4MQ-"@ZRF%5R@,!RT=RT+(@P^D@4BAE:-Q52K M'0XXMLLU\&/DS%0:R6P/Y@(JPDI_H%KJ1S''8B<8.)V,N?%TW<4/0VJ\YZ`D MWV-O&PK.96?%G$'N^,BLF-K>I>^!=ZD*+XF!!>]2#5;:AA-'@V)X_6CF.NSB M#_[E8?_R75EALA9P+/L1U[-'//9O7!P*@\[E5\.S_<`/Y,O[/%]V!WG)!GD+U5A9<0U.77DK%0: MQP8%R\!(>1CI!NX@I=208NRR#S[F81_S#6Q*K(NFJMD?K'C[OJ=+M6@DY?*90A[DE4>>PDI8.:0SSU%TD9-R5`:AT^2\P6Y M&)]<>%S'?8&NS/HVN)QX'ZT]0NMIV4YRK(>OOI4,IG,#\%/7'?$\,K1^>XV^ MO_WR[<.;J^O+J^L/[S^1I^*?S653+KO'7=BOGG-ON(8P<$TC%1$TZ@/1-+?- MU4])*(_4#C1Z,`D]2J;S;#^(1#S)G1!^,5,Z;OEUI_@!F(&8\=A(Y!J>'0L+SX$A`O4^",Q0^"RX'2&9+!N1D@S_WK-Y M*R_1)`#JEU8F\=*D79G$.B#MRN2EV;E7IEHAYT`#_2=.\6*"*^3:!G(L:TB- MHB0-3G[\Y*ZIWD]\QH".GE M-0SC*0^03BAVZVELNAI)"@#U<)$Q/1`8/02&6O'(UF,NG,1:B'S3$;X1KW-@ M\+5)&EP;:-$669HMR<*Z,FI:7+TLZ1]IDJ.ZG1`:9'56%A`OO%SJ'SOB1_HH MY.3;EDX]?!5RQ!U;JUXHZB"2S5=V#WR3A&]T`K'P=DWJD,<).;)IX`0R9H?3 MLEJ6%?$&(3G,,HW#M<#9VV]ZAL3*(S,]"CE[032LK?_(.*<.(KFA3N&5.GRS M#<^V]6B!UM,;]CC2[.#N'7;WWI45)FL!/X^!DI[-=[)8-S\OYFH;,W*CHY"; M9]L6N'GC9!SD],;(-]^)N'K3:$8>QS)CP MX/$=]OC>E(L%KM(]#A]D^O:.E8D'^32J>WQ\,T5';H,4\O@\:]CNTL@XIQ`@ M6<.&]@'CSN77N/8@?UUQ\MB69UJ0ZQ/H^7UNYKA"25WC!CP^#LL8B"^[4,CA M"P?M5XS,^BCD\,%IC7'R#;@V1JX%+OAZ>[<;!GMZZV7!J%)VA_`+GF*\2"8Y M1LL*W^"JZNL2#B.^JF+MQ<+&C2@QS[0O.(@:IL$)`Q)82:$BH9#O&O-528%0 MJ`^V+E];!1`)]47"\?@..P$5=Y]M@#PL$\FVIHY"7I4!L`W;'G:(5'7/-_!U M*NA2R3\U`I]CI//X>:<.*CD#M],/.(ACM&N/J?&01P)CMN4D&6'@017G'KT* M`G;R0([W(&7?/IUI#W'.X,I%45.LCX?-,"M>*1=[*Y]+&YWCIQXWXGED:/WV&GU_^^7; MAS=7UY=7UQ_>?R)/Q3^;RZ9<=H^[L%\]Y]YP=6#@FJKZ(&HT$\U4\Z5BA3)$ MH?!@)T<0,R,"OD[5(L%,$48GM79`_)T*'7`<]]\*JGYO:%GUKNNW_MM=LWEGKE=$*<[S M>IFD63'[XQ=K]?'OX.#W?+ MH0#OO^F$Z-K20'?:M%V7+&T77K,M8D_)ZUZ[U28+PS3Q!QSM]0#O@XA?&L2A M[I+JGO%,S56#O?!B>'/XV=0\&'BJ&0YNBT_9:(-A._J8#X?Y:^/LT8)!/)M, M#%<'-!J6#W^S17U?4L>@EDZ;#GMIZ=@37_?<5MGR8!.1I$DBW.^Q0]X6'.L, M419%62.W)T9N7X#.!0`CLVM9T%2$%^S]DE,VI1V#[\Q;">J>NQQM:&I=L+BMON^LNE M[;`Q@`WHQ$4JLGV'C'T7%N3";F?HA7LK/I4W-URQA@9YH0@>5E5T&'7JGNVX M,`WPD^:R:?[R`:O`+C`1_AD#2RQ]1<::"Q\#`0.Y4L:+8CKX=;P"T@11:P$W MB95IL$H]:,B'P!N6>$$'(`QD4LU%?X1, M%=N5&&A)V#ENAJHR^-$E\*J#ZXEF`=AA&AU;BZ\R,?IKMJC`->431X!X(`"^ MW::Y@E%\EV,+`7W!*I>X*%B.P(F[A!EQORU!0$O-\0S=-S4G3H-,1("X0&+A M2P;4PJ(1]Y1]S?KB/,%@KN_$A6#F.F\9QI,+8D0S,2;$LCTRUQB1LWDL)B21 M2D&]IYF#D3Y;=#YANUUL7;T8^D(]LH;`F698+KGAE/B&43$32'.'4K(``.8N MH18*H@P2Y4J2?D=1Q;AT8?N6Y\:5SIJ.017D@,P@<]L$"<(9-J&:`BW4X'NO M(6^9IOWB_K"VOUOVIPHFZ(:3#"_LP)^P,2]J$'2A7>Y#T/$:^%%D*)=LPSQ8+G]W&RJ8J6.1#- M-Y^Y:^)F^*0G.?\>5C#42&V74&A:1FA>+W-,=.]QTU=8H-TZO5.,7V8X'VPDBG7'Y@+&0 MF<5\3?#>;5:93[<72X?.J>5BN(&'J*06*U_"]`NU[,B%5K%R<=@@<+G!<3@B M;K/`.+:4:6YUN*25D,8:!=OP(U5\^1R= M'3F.1W_+\`ZDBL_;;[1]POI0UO.\5]@OK*B?"$J22:+9SN546B M/7U$(=,C'A2KDUS[;3GO58R;;@';KDKY-]=QB/XTIV1"=FL//PWDBA^:2I6,L-,X+^IZER9*1H/CH&#\'0/;6(O@T&0N#?-N6$"-/5N83$F";/F M@./G9&50<]+DR4PL':49K),-Q([V-^%MRG.,?),GC&"BD^.%:3]AS@AF$"13 M=Q!N=-/BVA`%TF.KYA560$[8OM M4:*2,9T9%L\CLLA2F]'HU1XC@X7-\G$P54OC23=9\FR;_`K^N;'.SD4*A@^% MLF"V)+W`OW26IC<%-<.)13-I%N<%J6[!1#,':6:#`88O"^>,2Y"\"3Z[LW!. MO'?;Z":T4ZJ7]3/H7GI"B)I(".G5+R'DHU"MZTE"I(JY(G&*JHK,O*!P2,-7%DD,]Z;F*$8(+23>JHGXHE%D06,)XF@`V<`FGA%6O6GH@ M9;TN^U"PAMHD5I*IT>GWRJC/G>2Z\\O?"R7^LU)Z%?5,(:72Z'8*%':^9KWR MRY8XR0%D51W[2XIVI3TLHXUD!67YA5'9I8O57C=_Y:0K#?F4('IY8/KX/OX. M0Z@._G*MQ?K-L*6>[A99U>]OFF.P0\;[ MH%S&!\OCY[(W0:D0M?WC;_UP5W!2M;L.2'7@9$=MRY\;2Y16, M=.IXX%0Q?4\`19K'J]O,Z61&R=2'?V))$HLZ_"-6\`/3*V+U91"!F3D&O_,L M#(>?@?-#]Z"T3:(03JSX23B3YH+-8(C,PD[9<.C8`!=MEKLAK1>FGRDVIO6W%JUA*@N'^R0OO M@(GG^1Q5GO9=Y-4DDB-X"D-$(8D%+;'JD.V[+$\JR&IIB%P8+"ICLQ2A,34- MRDO8C&'7@.B-J:%KEK>)=,1WO!8-D"*'<0SLH@7).HP^@WQVAV=?P),QG6OF M5%0-Y% MA<3X5O=:2O1#WJII<9+8N,A-,B`'E/U6/PWEX%`H]Q3+5ZO^[GB)J?=TJJ%\ M>GS1EMO]MZHLO*AN8RE[HJ`64*&')`-D]FQHP:\3@0,7_I-!`:"#]H23!9;:8S,5UPKEEDBG=X M5Z#>-JKG%Y;!R4>P@Y&4$>%EP+[`7`*&P8+`-L;I@/I1D(,Y1C M096YL6;]Z?A+3U\Q**>:80K5B=.$%6L&91T8W!8++Z;Y&\WRBF M8L47N;CERCHR-X3J@&FYI!7IN;C`=?+(JO7&TNM>K1-L6K>IJ)PKT%, M)U7T,'N@[(IM:9B8^F(#HXYTL/BE2%]>:'\B(E;1>N%'F]&ACTAG%>9$BB': M`*BSGID=Q\O4;4"+E+]%)=,7VVHR#K)AEX&4`R^DAD+X3DB%=?&(">`L[YI5 MQD32P\*(3;"-`H(S'&Y>;"Q6F-=:>#T8I4JX#C:QZA8X&4^%@)("@*(LLE)[ M'@CQ6&7*R"]9,T[9K0,C*"N*>>>Z[F#J,28G6VY06Y,7:A#E+4UP<0US\T4" MO/`56V>JFQG>CRI("$:^55LJSN&EUWH2_[%.+,(_IZ:YC,@(L6:22H,D) M?K[)+@#H7N`>@GH"IPI_CPK].L)7X_55EZPF*]CK>XNV4Z1+5T(8'"P*@0CO M(R*\WUU6I"HK+[3,1R`\M,K8-1V/K-?Z+@$(/PMVU<[A&3K7(`$^VXXWXV<%VD%YCI=#C^5EBAK MHY9Z*`O6W!0O5&878S#21CQ&6O"PM#Z8IT!L1=F]A"[K?AI]?/W[=;ZMZ=F/U$7?>'+$++F8"^R9-W M))2Q2&YRR>OAJ-5+9A8-V[%?#LTL2K35CJ=8B5[+#"6%]D-VW"Z]2B]00UBE M-SMA)JC/RPIMLGP8(UZ7=^*SA.(YJ$.@>^T9.&%&^:T$8N+E"I$AS9_S_&YV M@4@S66]JCSK]$`D#]PD$Z#O< MCI__\S\(^>F_FLWWMNZS53ZMEK39Y+]/J/%#\`!_9]G7\.DW.OW'*[W=;JOJ MJY^5=O/__>EM^M5P8':_;44>P%XQ=/+1M#4O/CQ_S)^RA\2W##Z!#Q.\PK+) M@%K3Y8HQ/?\0YN^.VN)_'(RU(4-8[C1WSFL+XS\P01DT`$=R3"I-L:FX84_( M?Y,M'U!,>PQ>#5;DN\V9IBU_P.]NK0G^YT/TT:UW)WJ(_\92PS>NM-E;7VJ[ M#TM5VYV^6&FAJ>J!@1Y@0!F,>E>+`4;NO4&[>[T84``#@^Z@*1A>>)GVECL<;OQ>0QK@X.7@ MW4_BU55Q`=_K]-=4W,;ASPHMFB1]==A12H"67]O=`>@MO]M[#)3RH<\!8$XL MI@#\1@W+]1UV25]TKD!9N09@[+UOL=>*XW`T&*9E^8:QSP,CHG$T[*<%Y"X8 M8T[1VM[.P2E_HLXB]DYQO*G#GI(&*FODTT"$6%)'JCHH`I%PX>[$]:YO-(A6 M/'J:Y[OK[IQX,WR1OY=I_'RQXTY;]H=K@%"\`VR"$IG0[^3_T%4&!/P5]@:\ MD#DU,U%4M=/N)D!(?AG.C<$C9O_Z>.T88T'B.A?V[L`(3Z:DA:_0)GUP[&=C M0B?O5K^Z:.I\##Z]#;_S=MSFM5!&.4N']Q98^AL_Q-(V+GI#O(2`6#A9FIJUMOJ@;CC.>@]? MHZ&Q*60O,9(Q[6KC0XLD)SWL\JG)8["0"+`U0\!(,Q$URU$S[ M(DP==M.DN67\,P&*&.P,.^F@8QY`[VP33[S06'-8/"<48K&&9'BSA&@SA]), MHQ?5?C3.1]MY9SN._4(GC]$0A1'?5=6L(.J.>:J]+F;;"WMBSW4)`_L;G1DN MR!.@E"_:@JZ;U]$+^#Q3YMY^>/IR2^Z_W)&W#[=OXQ9V\N,(IX(V/QJN#GC] M'ZHYV$6+O`?`XQ"(]_AK^!:\A.]DVU=-16UV%#[]IB]3D3*F<^=^(H8N[\2-U396L MCWLM&&%!@UZ[DP[`7S%&>J]^'BK#?EHZ7B]&\,AIV.D7X9HMBQ[Q`#G:]MP< MQW.UVRCAY4$S)DW#(G>\QGGJY=OUE\E]^'(\0K\!=TK[]/-G[?L947":+2B= M+]%H&;37@L22""41GHP(.VT@0K`@)!%*(CR?),2`3D^11"B)\'Q$J`PQ)-=/ M^]K[$^$WBM4JZ81\$)7?,W[*2U`'C)5%'"6!5GR9I4N.$6:KJKW^VNFGW+8* M;UL'<_[:L&L%?%*Y;6??MG8'DT:4_EKBC=RU"N^:,L(TFD&)O':KZ_["YQ=? M6(V:5"K@)]MU\[VU8TN/-5'6?I]B425CKW1*:6/Z`N;/2%*1I+)=@[-,%Z6[ MGG8F24622M)JZ"*I#(=*.I%`DHHDE=3!#%-`H_9Z:O>NLZHMJ?&?HD=[I'., MVMUA^IPH-N()P.`)ONUN/YUZE@4&R_KEW>RP3]G&=&.>,<#LSN*9%H.UVQ<9 MXYX,),1/=]A>._#=`M(O_-([;Z8S61@6RUY@]W2#FDYI,,4GM];D-O'!!_Y^ M\0PV11GUTLISQR25@1_3U\!.'*5QGA=^3%!>Z_V<;!JR?J.`OQYEL_^"[W_B M;?D*8W^P%C':.D%%(&>IU-TTUO-!KG1;Y'V\Y,"#*#D0P(L7RN,O!,_#F^69 MB*Q0R92=M3\ZR=(?Q^]2DE7``_;AF/5,SK.H3,*ZCE(6W5;O1,4L'AS#9G57 ME-&HPUJSN;!=!)M\FK0)IMG"P(YTEN6OMQ]^?+A-M!]FJF/F:YBS1Y-WBZ-^ M?/$!?KF_2PS0B!7(`)#H8FG:*\R67-J6:V,F*XI\UM40D]HSJ[?<6]%2$M50 ML-%.6%??H'U5F1'&SKS#]D'2&#R7`;Q2@T;+3[S!M$ M&@X8U5-*;GBG7\,E,]"_7M!\LM/FK2??_`C,@+-AN]RQ:;ASK+*#Q7JH\\Q; M(@&E&]@`$B$1S1K%7!PJ)MCP0D"$!G2A-G0/,]QP<((C@@*^^$[TY\1]1/8NW=XE['F^"W MB3$%!L&20[!EW@NEO.DEFH=L+]C]L"DV>^)E;UCO;'[7-5:\*,U;)2%RCT2.)FH?B<(+D%)\;UDP+AH[4\UL""P MF@_67,J4`HWMZ,XBH+!2`D/3)\V942R?02/ETP[YA'<^@4#]Q9(3$F`0J%50:8P;1?&O@,5CBDV4,VLD M>I8"%P*]4OAU`12DL2OSO,L[_LZ_@QV+T;[MLGZOO/X3;[O-7F/E5'S7LQ?L MTH#S;&P0'ESM#9C:&].9)MK1NHP@-;#!L#B8Z(H:K9@#.S6!`0BLU[,=`Y/J M@Q>C$F-;YNSQ?N0V"`>#\N5$J_;$%6V7DZ?M3+B"#2;5\%V`<]GT[.8$A1B, MV"6_6NPZ-MI]G"&H$^,(EWQ.3I#=P)C%EYA`%[UAX9\SW!0P;G0V40>?P/2L M'^,8Q9EEQ_N[!Y\$C>3CI!+K],L[,#-*N5"..V'+:X<^&_`;0^<$!+NFK[C\ MCK$;_.IXB-VH>S.(CM%WKJLBS0:;$&)/-T+U5I200,C,A<[K0R7S"(6 M:@&WNA%L<%"WD*O"K,*'V!Y56RY-(VQ,&JZ)5>?CU1`UT*)`^[QN'-[,RES+ M/^T7"O9*@QC38/6V$ZG&E+6!-E/\ZIVBILFQV6L8M! M"B\QW:(S]W`".3K)OLOXU3YK,>C60WW:`/.*AV8)?@8G90ZG(L MXO)@7E"O9`ETF@:O3:4U/&'U1E&O`'NY)WAT^YX`MK.Y?I_>J)H;:XU*;L"^ M][3O;]9[I.XA_F6_U%>#;O4*\EY\O]1^!VSM2/31GI7QVB-VV\I)T/LIO0[W+9A>YB_<6[)=%QQB5>8DNHC\G;ZA/U!?C59I03'C6.5?';S MWG>"\_:=9RV-S0D[P3$?GBRGO4N6#;C12FR`Z.!'Q")+4?,\QQC[_-A$G/@& M!Y&)/!&`@E>?<'G&&OV.9\Z3*$_*A*&H0^::.47IS4Z)8)&V/^/Y65/#<;W@ M9)R_H;0S3QE_%PD-%)/%>",Y3(Y*KS1H4*:QE7GI`W,W=F(>2\UB*1#\4%*< M@Z8R(.('W6-J&I3]1+3)'[Y`1>I@G)W[BP2OM>M2,I]B*T.(1A*(\EB^7CS9 M;D.>PMJU-!QB_582Q/5_>*`IQ")9=VV:"]"[D- M3*PSIA4Y93U%*]G2[.9BR(UW<#W%N>L%6L=%R65T'=1RHF/9"LJU?3#'K8+U M7*+"$?^X,*I*R+\Z?+P!LM&9(9,]/[,<\5Z?4=<++89:J/7ZU[3J605-?4)-[L]:`VD#M\'S;$`(5Y[F6$G M=^P9DOLJM!11<73VU&%^2I1BIWIBI]?MM`YV!VH>#2G-9N*7Z*(X=A&A(\,B M11'?[ZF%3"(9%[D>L=?OM/-G`DL+:H,\XQ75]I-G4E!%^:2-0:= M1G^HM(92HI1B(?$J)U*8[(/,04_&@2Y9DBC*L-67*.P.VOEY20:SKTK,=OLEV'"E7OZKB:#E M\>W"T:ARK_Y=A7C+G_W2;715M5`5%WD=\)J$81%*ZG0+!"_R.K\9,K`J;H=, M1):)R)>LCV/MM&0^OF2#:V6#3&WV,;.HL8P['M>&Z#347C__N?]%<;PT&-H7^G4Q]:R(%U9[)`O+P]9)ECZ+N5:)&BI/X/9YO M!_4;D()GKZR/@B6YI.2IF.0I5`I;BIX-EDPLS6RIK=CAJ\PRDUEF4MP<(\M, M9H(4R:&/5S`K`D".O(^.S/LX7;6>7K^0Y)-Y']KH%9_V]1.'(?V7/V%@W%;:)N MJW>B*O;O00FP+@J\[4"9;;9%_?J@OOS:SLD"\/O$67JGL,.OM`!\%5VH1SDBO0HAD#_TH;0'!W7!OAQ!<"*,QG&K=`Y/JZBY;;'/KCQH#D_LLKSF MQ'"XH_%B>/.)H[UH9NF%5`4"A`,L2'WWE8BR49P%QJG(OTFVAJ5/A]]CBI:+ M0W"5O.!3-2J\PX9Y85<[SV89X^B\NCSD&7F[+^"=@H?[;*`;.UX1JCD6N'3< MS'!#JR0P-,`[;O!'FHFAD6E#%#/%YGDL<+H>GK]\#[F9S\(-_N) M?O?>(;9^_L__(.2G_VHV%;5%[NS%PO`B`^B.?3:CE@[V4;/)W_7=YDS3EC_$ M7KZU)HE7<4;3=GV'AO,PBPO^^$:G_WBEM]MM57WUW%]@YWZ&2X>5-B^AQUFL>OL$OUM0Z?8"-;D#6MYBUBA]?`]&-Q8\!@P MWIT0;V/F,G\=QUFP[J4NJM$YU4QO3G1<@5"O\`#-;_(RMQ?DA08]:EFK7"UR M^V^"@+_:_M'FVVZ);0\'"E]1?GR3V8*7)S0NM#\`7`&*8:'6<_@A!=C_?(6N M/_X#7`-T"Z9) M9Y2W(GY!1!N(11M']G@G8T2H`'UI:E:(7-C7M[830ZH(R[LTW!BP4&(0.%1S M;=8ZF>J:#Z^)71?_G&B>EK"`[E'`&]\;\`^]!4,ACEQC8F@@>/!3*QQ!MQ=+ MZAD@DMS$MHD1DKNT)W]>K/0OQ.N_`5?:OHL[;8"*G4Y=9!-&JMF<9".W30R= M%QNR=4/TC'8I_1.IQZ%+[.\,0%KL"9@5E`L(9K6239S%I@VI(>3T%(-/HC[@ M2W!3;)$YH+;;2B@Z^/29_+%EM<$,>'B89(`B:XL@Q7'# MM#^I!2_.*++?+LY_-FPN4@MKWP(EA8OB>EP=]Y`>N M*W++!9F#18=*AIEX MCN,O/?+5F6F6\6]!5C@3/IW2"5,Z>&G.HT*O;>H<9B[#LN#902X)+X%A.>0?F"!FZW9NIH*@66 M$Q!,I,@`0>!F&>C/X#/=9HI!`RA1:OH6#N%;[I+JQM0`"";:0IN)DVO/H?B= M^*G!]LQG%MF26D"I+%9M6'_X%LP0M&*GL`:'VVT.]F,'EW%I^DCB'BA/UVL` M#*XPL#4/WK/H*G'J/:5,I*/3*3@`7-B_0*D;TQ5(<9&U(U"/=L(45+X>R&O- M6D7A*AXM0]_Q:/]J([-*O;)5KR`S30T'^#1N'((R`8F$ MD0]@Q@7G??CU7S[L9J?-6L\/-O)F(`+^Y8/Z,>`?#YI%3?S^LP\O`613#!`P@='Z$-\,1R!G6RYHF(T/LVR\H&I@_DRYV"1)W`@5@+K M`1D`_H+ON,AAR&.HQ1?18`=C&%@5D([8AWW*'/]WRN2;Q7R#9V-F`YN[0%[< MA4%%X%+S&<4J2S?R^#S-00Y!IL M(W[P/R@];X66(;]P(0YO6*#YN`D073SEWB`SA6Q\`'0&&M]9-9G!Q<.>`8?# M9ML$%3UJ@D#;1GXET_Z@[)9"X6P6YYDZB'S5/1NU`5\6F`>NCVXPL\9`&84@ M-]"D8JXD!GAA/:^!"1<\HP3>?M&H87@6O:\&7[H"VV.;SMY'-V]M<%;X(+!N8$NYU?;I0ES0Y@+E)FS,"?W1K70_`** M`AH&JH4-L2:`2`;;UHFR!1HWVCF!O`@/G]$%$T%`DD1;PA9^-V#;*$BBUX-6 M+R0-7"L7/LP*FRP,"_6*QJRXT+;+1LD:M*GDA!@;,.L,V``4)<-Z>,6;C\5= M@-`&#&PL#I-X&EFK0*R:PX*S4C3N#*0A-3"C,W(&_?'2AIT-(RIX7$1=D>.BNVZS/EA;,E@1?WOFZC[P>1@4`OC@]UHBP?#8@^<*!HM3+-` MD_M9XK[(,JZ>F(M&Q^\^/Z*'CA[72IC%[*./ZZ)&#\(YU')LTXQ4_H2`ZOF3!MR&*C(('(GH M`K>@/K-0FT/)[>09[`[L`(X?/S*5Q8(=#T#MNF-P)^.]X\_(`SJQ=R*JC2&2 MZ93RJ(!8B4B6;A'TJB+`>0@>P<%(B6DP6<\8*C"O0F@PQ86\#\ZYF;@"X\@! M#0<3K(0RCHL3?:Y9,RHT-6@0@!.9_YD%\<%X"`TXIKB#J-<(/V6@QGP4!C3# MKHM+GMB4>P<:6R:/](@6-R&\'/V4\K`<2,B5@,1P"/W.;R+QN>,SW:+L-M8) M8`9J$$T\'Y4JWK1@"3X:8-C!W1,A\1"O:,-B$CJ^SY#+S]WQWQRN:$H*;,QD M9!2-Q+<$A(WPK`+FFX&OLMQ,)0\,D;EH!0TEYOAP/SPDCW+%8:0B2A"LM1&@ MC]$5ECL6;>#2-.;DU^]X\>G%WG!V&$41V/6-0(`*H?&KQ1CM$>T;EX31GCL6 M(PBNB'P`7X(Z5O08&/*!6I:[,H$U#&TM(I1X^%&82VS,1(@HL#$BQS8063`! M0AS('#2ZP%ACHF`*9D5T<,9S`3=%G[_&?,TNCX3Q$,PCV"]S*I:5@/8)PS&( M1FXFW<)[-@O/3PUV9@B81&TTIG/-G`9Z98V>2MY=V%D0]J[09!Q=&.4!0,#A MTM'^\EXP_AJN=L!6VV-(%:*6_]3?&`IT*4C"24`N+*#(UPRS?`&MLH@-#/\_ M7C%,/IA^>)))'HPEFH$>_OW)QN.LGH+H94KE(R9MK:$NN31QI+"^,"Y%A[%5 M\5^V+0J#*#Y(Z`Y[9]B(GU"%T2BP7R,.X>O5DG%+IKCQPX!G-E/WWLO+W+?= M*WQBX;Q,6-,LF4,HQEG3]9<8=)V(HQ*'PK#LZ'#.4;9TZ#,[]0MGW'+^$Z$] M?EP612%6;Y!_F7/+?)["SCEA3;(Y];[5@/^#0X-$'V+_([A`&T![]VB M]?:YA9DFX+'PPZ\[1S-FY%N+W"%0%KG1T9IA-IVYXE(BAK[W0;)&(ENA$1WX M!4YAO/`;D!6W!]'FH65RF%]FAL.[+7AZ*@.A'P#[<.@9&<[>/2*^H'% M2IR9'^34)I?Z=U>L+.UP1#RU]70!!EOD/5X@N\71U,"Y3"S]C*(4W@-9@N%. M/#``9<@/#/`((.\7AHG[$.*`!$#K M@NNTH%%$9HW*6*80RVX+O5'8A7'RX'_#R5F9I\R`->^0C)(S,/WZ]8LZ"O@= M@>$H52(>=$2B7.*)9BB,8L=P#HUG/T5LB2X*##]>\=P'%@!%<1"(!3Q8%`=( MR?.CT-*,'2&ECXO`]!=YC^F3O)C]S>*'\;,5$4T(:Z>DCYRXY?65>3R"R9`- ME\SA"0[X&UD'4U$R7S3')@L=V(-AB:77(8XP^2U`0",+`Z(,#/P7@],(?H!5 M#],&P#S'M#3`$`BU((8CPJT-YO%B4$`L&F:*_2(6^6OK$:]%63,'-S-8. M/P1'A_7&]?4Y.ED.C]DGQ3DX,H:_0/#Q0$\@)]NG`V5"OX-ERPX<0G<*25&( M.9'/J('ORO[)RDDAXMAJZ7?\@.-J[2KB)L8]6TY;79#X&%(?HW\TA@T5F5\Q=WSW#9)6S$_?P`;! MS8'@\,`5F@H0`JJ$8@I&*$(V<;$X>`HV<1)7KA$5(Y+B"`W26\,DG(1+%]*5 MB+R(NFV9)!]0D<-ED""E!@%2,46^+]"(I>-7W5")-Z2'#D"V"#K8462\Q`PH6*FPA@@+!A8/3FF*%&?(G4/*$LJQ0W MV'$T84RFX&@H8)`@TB'N6V(6K\]R?M8>+.<:@!/U1HOA):Y-`L,U(^$C M;@D&-TBWI#]EYP/>L@,NRJ,MED@(RJ8.W"S-6C6XHD+Z<\`XLLC@F&*3YLQ-)M M,!&(ZZS@%"].R*PF67"XQW+N@>GP8)"GA&%QPUU"(79PGN#^R[$`K\3'S^'2 M^CRIC"7JH4KT,*G-FQNNL.!0S@!98?87\I\>.26A2DS1"R=U8WL>&P8`\ MD6;,AJ0L0Q;@\7/?"=_O`G=X47S0(A_!'[=86C88@2!OV1C!_7"\'/4J>&D,VE1:P]/<;LY"4B:ERCOE9=_^6.+EI\A( MY^>)L5C_--P&YAB&F;R:KMO.)`JN_7)[^Q!D&KEI)TN4#&8U0V/%/KEQ')7Y M#,7E%(00$KY/&W$CGL6,(37'FX&@:"S2YB*;-U^.2LH2'EM,3<>\66!Y?%#X2OY891LV6 M?L#[NF:%T7!^)14%,@)E"0L6R_&:])F:/+H`$A)<7T>?KZ)K+CR_$X7X9LA9 MC5X6]Q+^8C0F"T>$H_+["&,';W).8KF,XD5OM62`A8M+2+GXE3B^S$0:"5LR MO]S*1&U:IJ!<"B3*B@D_JH'L8Z"NEQ<^;QG@@+B#PO9C=O2.KT7&;<+^BYF% M`KC?[]\__1,H?9A,NSS20<$AU=LV0!H\WD\\'$DBV/F7=[@W4=A1+Z8E>*D@ M)'^2;`PO-2"!B*QO!74$L"U;:=+-K.S$$62>:' MIWMU?ZA2$Q3)F)(Q3\F8ZF;&O.>:/LC5`UTO>#DR_$-KP1YC!1/&(IP1V87. M+>%;84[\D/7&NA@("SAP(;#&]8T\HL-`;9_^+F[.L`/_:"'A;WAY1`P/IK3?B,"4Y/C`SN^/'71-T81S'!B9G'B]6DT@C M4DHT*=&D1"L@T3J;)=I[?,%>!NSG6S%N0WG5"")"X0'\BX72PU\LQ4F,#`*6 MN,T?=T:SG(1SR;6-OQ2Q,7`)40`S_XJ?L(*HC6H(`?CLG"\HQD`CKV]SK8.D M&EG3,]F*)0OLL"41B^Z)2@?P_V("H23%/)B8'8O6Q5WUW%$_@:>5F&?3FVZ@ MQ#>%)45DC25QO/"\@BR@\V$"$9C"(>L^Q6MRL4N9`9Y0&>(/$4LRS+&,'#P8 MBZ&$5YB(?/@%]>;VQ#;M&4OF"6R2:&@6R%VS4.*N/TP^7HF!-3PBHU#QNLO"OS&^CQM?XAT'DQ4P M\2!`G;S4O[M,5QA^,WBMU[6XVB9>])$5>=64W2'XR$C.CG:F,RR"7*N`2O3P M*$D8Z9F3)"OTQ$$/HXC5(XE.__BGIJ>PT-YC5[[H6DM:0C`K+742$FS#[XS3 MD_HYH6BSE`U/O,WJ!9@E6I2`G&/R,T8461>.8/3@V\Q9\(#*<#G$HO8!S,$2 M1)\<1N6KV#>;E$`P12PFGZ$"4I`;;J01)D(/,$WFAF>723W7$(=U/JK^3+W# M:E0F5\FO-PCW7)]KK/B`@^4(=*9H6+\^G]U+"[4$,W@R%/NF8TE[C(&H8F%&5G4R//X(",E+]PF$\=]3G=\3YC^V1U(N MY"YHQ$E0"T_C>?W2+`+BA!GH=JZQ,PGAH^V$KZ4&:23.MGB8):1\7J(3$X*% M&81T&=X38O4FL8AX4%\$ M-/5#*Y\39!H]0>4-=D=^;%A:3.W"DO^T[!>33F9APEAPR2"P7:GU;#BV%5ZP M$0S-V#`7O^%UIK'!ZRS$S<@$"W+8-^S.3B849FE>)MQP2.C9V"(VZ3FQP]$8 MT).$Z-+<=.&USF@8%EY;!P?7\;K3[\9?R0??A^_P3S-^[KH)5\$Q:T"/3%7P M>^4.!?;%@.&2A0O3&$XEOCC4Y>Z9R$9GA30=9GXM;,>;:3-,9=;_3.(DEO/* M'4%F1:V_N)%#79&\R(OW;^.E=>XIQAE8EA<]EW\C9;I+-.P9?B,$\1*_[+8) M$K">7%\8P4U\N\#D$;0FEO[8-'0P7:Q)]FI+W-,-.^EIWYOT.UTLP7OQ+=8Q MS$SLP66JHU-F%N]AHWY@G9SCEZ_C(<2D31K*6W/%$\^QG$32'^%N-1\SVKO, M815Z09P"L5J6HTU$#?3T*YS#<'9J3C::J,%(33'29ELXB@^%/1FVF=SQ M!@\Q*BW`!35S`.IX:PL-GJ7+),7_DC_@]K1>:#H`EA5K`FL&BX/T% MZB%N3:Y]$6K=@\(DL;3%+5&24IGXX"RR6K#P>\K("FBED(OYE?F*P:=KJ5%, M'Z4\*<:)D6_GNV%T,19O%&$H4>R8D^Q&QE-#&H5WQ049SK5X#5&$H5_BSG!V M;%`&N@I6J+%#J-2A3%K8UVU(V MK5\_<2VCL6Q'K5YCV8WIMKMQBY.)X^4I:B58D/BK+XXDZ+V?*(V*U4AZU\LBV>&M1RM5&[3 M`<+Y:HY2(CR^SHOP&.TJC?ZPWQH>K@4K*`*N)1A^$`7LH(^.TF\5.8:I+G6( M*>/=+`5E[%:WQVVJ61]R.8C4FK4@LVL]<3FF$%(;[7:GE?LH0MI,?>!?9]<=8O][=V73X0$E[3+.L(J*VN5\QC`N7<[4VMM2&VA[6 MQ#B2NZDHU^0%U=H``<94V])<*#U$DW5A3IH%TBR0BB2.H4%#&0U:/;F;M=A- M195V05WVP, M6MWKV"C(L=)XV&T\W.6IK"=M!RF)I.V0E$3MX55%J6N]FP/UFK:RYB:"TNOF MC_Q)$V&WB?!U6RU=:1I(TT`JDSB&NJ-V38(* M)JM`@%K7JIW'.9R84+K@1>D=.J6.U3K-7E44[5U6*H]:*O3.2IR.E5CR.>CB6 M'"D[]@E'7@NA,KKDE"<40MR,LRDG+@\9J.1?8M3EXL]EXJ85=;*!:FKUH' M]G.3%Q[H#,M+&I!$=;U$13)_["EJ_C,)25W7:\@=5">=X.G7L)\_1:YNIU^' M-I`VM+%ARA9@LIV5Q%G-<5;5%F#2"=]^@Z/\W[%QZ MG]+&ZS%'"FF676`6PQ;:3J)3TW27FFY8LW^\:O._E]ID$OP=6KPQDU=&BS"% M2J>+,75(1VD0M=T>E1`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`*]S(U3!@U%;>>/-%VS M+O[PEV]XJXKIX;RMD4]-5S6YZWN>?+%C=*:5QS\GEN^5X,/.4)XB7*)>[HP. M]X_E(4*LF&S9/81.=A"05\%?D';8DS"K(XPJ%]2KA*[I=DMK>%H?*B@B'J3M M>#UT<74A_R+20;9*S'LR8%A@TGA8C;G\YH@Y2;1&IP>EEULE2J/740K%M$NE M\6H+PUJTU3H9I<7J@^-1R7`DR4J2U=$%6'?8D9TL)9WM2V=QH35HJ.W.7F&M M$GOT%4"*HJQAY8EAY0M@Y5N$E<1Z(AP<"ND^(YW!6LV)I:>B%9_29@6RL2:$.A<_A4].T7W9TC@K^N0W;AQ!;[/,J-&ST[&7X MMEI?H+,#K?3^!EMFXP["D^[QE8`. M_B!U"B!J8U_,G+A[8MSYF7/G!^3.XB9#?G1>(@D,XB30D220/]J37S9<(%U4 M29[E#5A>EVA+6AG7(=;VHH3:2[@X)>1O_5S2Z3Q#=::3K,3QKE8NIGTHU@]W MK^1RJ[OEG-+,DLDGCD>G.F7QV962X\ M,"3MR)K2_GLZ]J01>7R]6,5\$L#<%VP;=]AN*YC:*8`KGL% M:OE*7!^$ZSTO&EQB>DV-Y-ZQB*'7*U1`Z##$5M'//A)BU5&K4P"ODB@3$JI7 MVA5F::S_^(5ZQ*$PT;_IA%W>\*WPSYEF6"ZY,6W7I>Z;[3-'2L`C5'(RK M[1'8KY&SW1R*2>IMO%R)R" M#'(Z`7/Q4:>F#"3M23O21JZCC6RSGL.ZO5@Z=$XMUWBF\#/\+8^A#[.:^])J M/@2!JCS#/`A_PY8J\7>(UU&@OXPTFRNRZ05-G]-QR,6;S8H\@4WKI]QY'])P MKHOAS"X;DB(##]I_^Y'\]N';T_W=[:>@DKU'OWM-Q!*S%)4,0U%:C?MI[1.* M]%JB[RB1PJNQ&0OI2(F^=1OC*"Z?M+BK8C/=**WVZ:(B%V]SWZBM;A%T70,% M=0J@1&8S[D+G@^_H<\VE;H.XF@F/,:-QH7E[7XBLD60[.`+<:PUD"/@@>Z`K M#:H##R%ZIZ/`.B+P2!<$I45:&7M"&;2RXB_2))79$Z63S[4752Y69,#1+'=* M'6R\XMGDQO8]8D_?A#U72@["9N6XRE(@!RO0(O)"(G*;+=QK#<^!RSI:=3>* MNI=K)K&9AEGHG*KQ#OI`?. MS1Z)R\6P?2$6^>7+Q&,5!5+55O\L+'GQQGN!JE5[7<&0A+Q;QG5[[?P:14;= M"V#^=F'[EA?O;6Y1+U[CBA>WRA#*IRAT?,R5&[$[D;CF?>]`UM-3/YFU6/:_ MB`RVR"V4H?JS;"$IS?Z1.U>/_;H0O_'B9?VQ:8L434V7AS^GY61I]9QH;PHQ M0LP5?>MIX,UGOK_AW[%_LF^#=<>6.=JY2J)3$SU5W;!F_WC5YG\OM)PD7HK#N[%=&*X.T!N6#S\L'7OBP\P-\C(W]#F9V,2R MP:-?`-U[;`R'NKX)0]M38L-HFF?8EKN]`7W^B-)ULL;^"90[(VS'9(?#8DOY M,'WKD7]IEJ\Y*Z(TB-I6VD"9E.ASS9H!N2)!+AT@34.G9&HC=0;T[F4GP4;J M1T3I6EFJZ<-T"OR'];RR9O==2KPY3*@9#FZ!3Y$;X!?X70,V!.[0//8&!?[B MCV*0(0_:$P:N9IID:EB:I1O`S>S;"/!,R![@6X?`@M8`P_%28[DP,T#R0AT: M#NNP.%U&6G"PM$GVVC)6=C,.VF^]V;3*?03#9OV^A8+3]!K2X]@A;ZL<:=WL MWBIK'/+$..0+<,BWD$,^AEM^;[F>XW/!_P6$]F>JN3YN-VS91]S.W]AV8N$Z M8!N1L$(>YQ2V]71!Z='!0>E\>'E"(K9-TWY!:C2`<,F$NKIC+%%C!?2*%,Y4 M&%E0;VY/;-.>&3`6XP/D*%"EQD+C$F6-+1"/:RS'M+&AC0V3703E+*@!!RYB M^Z%-_O!=U,"Z[0(78A5!RT-!Q@??SC;G8(-._S0G#ODVMSAKL<\^@VR::3,* MUA((P_4N(SF@?/J?3P`F&E^&G@J;)(;[&!**RS9?T!'L^'C%32[?8E2%-IF. MOR_BP(&%Y\[)%*B72=R%YOR)W5-@`$%0#C<1N=!E/Z.@9S:;:RP,4W/X(LF+ M[9LP*9"?-J&H.(+'8]MQ[)=->N:):3,^NBD`E82`>2-CSREP\H M\5:,_+DF6(!QBBN<^-Q*##Y@<&V:-,YA`SE3,&X+XN[RL`6DRC`):?!X/[/H6!J`+72HJOT"_E)\49714NLJ MY7?#FX.Y,C6^T["D1+*C^`]9TC-2.6CN;%0X2SL(7"24"T,LE#!Y+-$AE[W%'=NRCKD MS8?AF\^&:6):Z!&O.5P=B[/D+8G/"\5G@N6KH"HE>52)/.JO=0OA,Z^G=2GZ MM%#&.\LBW7YP<+'!A0L`K0*R66*M,&C7+#%VW&=-)CW+@$@1A!:HU-?H]?JM M=I&D*8G?8OA5EN]O>A]TV>GB";/"H)V;9R36I*0I4])D2I_=U\BD?[H# MUQVEE3OS46*,8:QSD/-6%5%ST9NYY\ZIA5I\7)O;#80M/>GC*:J=UQ6EY-V! M[I[:.T+N],:'*JO:I[F6&*D)WDM MN0!=RCRLW`98H]\9';.3\U7C=C@:Y;=O93KDQ9'*(3QW.KJHK3H&!NOW\L>2 MJE1#)'NL9-7#"A8+/;10W2-=:EC`@]SJK'266]%ZJMU6[T1U-=(8"0J>.G3I M4!_P'+ZS,*CBF"@=E%X5\-!"M MZ5?)F&J\?$M4[YPXAOMGNA1S@VCPL0,0+FW>JGEM'<&1W(K,-1R86E@L!-C. M<.>P"(JU)8-:1WS0+24S-U2!Q4HQ6)3$X/03E2#)'.H+ZZ(6KHLW5&-C;JS\ MKNFZ`]0X,1Q`L+EBE3[C992VXO@IJN\,Z*,:?*<%FPR`FW2FF3"F2V<._#.H M'(^/+!MVUV>[BE/JIF9@Y1K8"43U%&0AXPX;<.>0L0^_4@0W$XKW=&F[!BL^ M'U5W:HB6K->SEUP1;05Y<216P8?CUJ6Z*(3$^Q=0QWC66+'V6,6> MC62^L^)SLHX[4$58E(E+@.1GO*;T&$LD!L70D MQ0$($8AN85MOL?2L*$P/"W4]-V0#)K$\&E6;SB]LDI6R\=M8H6PW5Z5L0`VK MB"60%P,^7I`7AYE1"ROGHJ!P750)?,RE[[B^9GD!DJ/9Y@:\[^CS5?6XJ!8% MU>XX9=U%E/7$*6L-W7L,'DI&95.=;#Y]0,V<<)CD90HC1N\Q#<#-#/;&BP'D M]J=EOUA!B<)8H6;VWD:27S/PXF(\*(O*F(_7.(S@%`"LU8^>QLK/":Z)L_%Z M)6DQ#J^8#8K'QN)AR+N".7CA1=Z?(5N6/"4'%)($>'$!*A@T-FA_UW!9;3D< M'8AP78IF#GR?)7_6EL\6.Q$](0S6'&8I]@NU-F]HP2NM+;&N(RK-M[YE>`'* M(CZ?P%9(%C\*BW]#_?"!Z8?T5F]CS4!;TBS2C>N<.)$G:]W[S`H4,A_($8Q* MNL0'T;Y[5)];QE^^T.8SI!U&M1/17"A0"3$!$-9RSR3=6Y`%RZ6C&2Z`N!UR MUN$!K=W0:4CH71>I%MY9,!/3\G$-&[B%S0*.@N/QEC.B%K]F)4Q7EYF8`CH4 M'`X!>S>&#?&&OT1VF#3BI0KA42AMHAJ2HAZE82&8;(P73&'?[`5X>;KAZ/X"AK9TUC[`#,I? MIO>1N7::#A()['X&&??I%M@5`QP9;N]/Z)+"_UE>;`G,XE\**1(@U(F)<)SW MV0#V85Z3;?&BG#`=^A9)V9.)L8^^@\MN"+H(7W9YR5J&"/![08=01K6\,T`F MW7*/@77Z0&"`++'2MKU8HIMD"R>I%ZP9`6L>^RO0%`Q/,"UU-JV:J\O&&MO&Z[]FZ=%.]91, MM;VQ]08W)ZZ%6A:NMH4L3[ME%2G6*F9]N'W__O[++V&P7EU^S^ZZI^YQ4%.) MYL,!)OKQ:IV#XY\ME%>H,R<:DWQ9_-@F-RE<:AOJJZ&$-7%\XER0C1TIU5,< MZI5V5I0/V:'59O:,/Q6@D!;C5IAP9L137$FKMN6.8%IU%G4.AVZ04'E"7-%*<9HC:Z_6(W,B6%7!>%*&VEM8>C M)>GC2NBCT\#K^+GO+$L*J0B%'(D?)8FACL2@-GKMH;0_)3D(9V10 M>]$@]SMA&G1Z@_S.A8ROY(VO?$C?!9$1E@-L7:6A]D922UW=OA>JFRBWO`Y; MWI0[?F4[SH6[Y/1+V_>BFZST9)2RWIMXLR$W M^'(VN.[\>P5;6(!'I6.?U[%?+^/)2VI*+U_:_U>D2PX^RI?F_[5MN63R:]MQ MR>07M^62H^7V1H>#2D^55PWKO_7 MM._[!"JZ@,V)[8]->@V1"E8-DQ09>-#^VX_DMP_?GN[O;C\U;S_=__(%AJ;? MO29B"<>\43*::QS.I;LVIOIT?N0*741M**,"=W'VQ?>%B$5)+[OII=M7]TG# ME/1RC?02KQ!9HO4EZ>9ZZ*;;&*JC?0Z$)>54DG+V)1.B-$;]@10A5T\(.\O) M]<%"V:/2K"23FI()4?I[E1Z6!%%3@L@DDEYC,!JVAGO$B=ZR-L^9[V_X=^R? M%6@1S39+1&5$*]M,TNYD$D/&UT7WN,6B.RX`UP62?XU]UAM]4)?[*G1-?<.7O$_D'_\@U`$!""RWZTO3EU MB$-U"C\#J>?N,-^`C]PEO^YDKEJE\N6634EO08CBL4/>;N/E2*;DG^P<05YE MC02>&`E\`1+X%@5YYY3H<\V:P1/#(K")9*R9FJ7#W[#GHE,6>:1+S=$\2FYU MW?8!@JEAP4N&9A+-=2G0P-1VV-?>W*&4+`#*N4NH-:&3+"K`C2ZTPIO8)VO#%[[_@RLKS& M[/D0^<2(_#,G\@](Y/O2[F6M.\G)>ZC2%*'L8417C-(52>FUI_1V[E*3)66_ M!T2697-V*FAS'HCKF\_V+7#+#GDBK:XDEQ\%$E-.OU>2[FFK:VB:W"Z;XBFZXY/)\2SB0ZS M.9KND3GH4.H4B<1RU MAE>TF97DS#VW;C!HM:]IZ^ICF]_T6Z,KVKDJ2M`]-V[8*;!SUVQ0/_B./M?` MC&X05V-)Z]:$+#2O^$GFY8C;JQX*0''&7:W MF>G%UV&W+U8[2,ZMD1C>#Q\=M2Y'D\5E[BF`SI1Z18FP.DB^6%%W`NZXTN3] M0O%G1[/<*75<'K``RUU'X]O:XG/<%]DB=W:E=@=]B[;([_UR+\TR]><%1%5$QOD M)2BY.B&V[Y`EWM@Q=,I*J#IT:3L>.O%>>-;*CEC#`U=QUMK*8K`/TRDOI)LY MJ>]25J)UJAD.8MZG6.(5?G%I4,55\]@;%`OZLDP)@U(SS70%V`C> M3,@>X%L'KRBM`8;CK563]>8`":L/&PSK`+8R$1$L;9*]MHR5W8R#P@EO-JVR MO#+$/[W5J/?#1P#K-X3J,]5;,TU;_O`(L@F>_T(M>-.\M2:WDX5A&:Z'WSW3X+,' MVS3T53@'NQL&?WRCTW^\TMOMMJJ^^KE"`G1W/[VD(-B/=3>WLUDOEYS%SMW< MA)%+N%5B3>L45[:"WB2U]RG<7"$-D+/$]L?"E;$;Q.4\3JC8$7+S,C?@5<-B M%=O)V+'_I`[P]&)AN"[6SFRP.9XUQV!,#$^6M@52!B4<:AD#S0D+)"S/

I MJ_.W8'S8?5'U?0FBR?`7Q-.^LZNE\-.,RQGV;RTA:2+HKKV2=XDI8H-N]0R> MBZ_O6D6_O+2`8,%2W"72:L4=\<)D<@K6.R.95*J.=17E7!'$/J8TM!1MYRS1 M5LZ_2$=56CTI2^LJ2R^%"-7\1'C(Y=U+%\&_[/9,MGLB^6[M5(`SJYO7M@FR M[IE!NV:^R)(JCYJI.8:XX.Y04_/HA(R!@::&5_XU]UH;)8/^('_[R(MBWKIK M\D&OW5*E#W140?.5]8',$324#M,19%-7';1R>_G'*ZU?&\068)G+N<]:'X'> M'8Q:?2G0R[O?S>N+2N%]GBHL#674*ZV!O8P_58Y2]B4+51WMU;#^:/>DZB'G M[##QH62Q5H_$X4N(XA.ET5,&^9TZF8E\+5+SR$374UN=/21RW?*8U4QZD7G, MZZE^V1G?%Z,Q[WGBF4M,PS-F+&&L&821#F&:?"L-$Q?B_2TYF#:KHOO6M3#=#A[ M0>$_Y(OM4:)T2)C:2^#;I3:C,3MJQ'.7@1MP9#``#`M^6+!YRDSX/2Q1-TP& MON>+8ZEXL!1CDDX$YB\\X?,'>$Q\R^#IO7Z[#;P^H;JQT$SW'Z^:O5>9Z;^= M01O_%T&<&O%$H"C*JY^5]B@W+"!/J.MM@(,_W!,?O?8:$-%XQX8`T=#I#_-` MP(*L#62!]/2WDS]\UV/IY5^`C31W?N_1A?MD?Q-L1;]0CZ/VD^W"[W?PRH-C M/QL3.GFW^M6EDWLKS`B^QH+?"V[T\-7//:7;2TN38+0C3=ONLVG[ZJYIWU-^?R0];?![*&F$ M1'['CT6+4[NJ=E*P[)CBM"`BQ:EJ6L#D!5'H@#$%G4D#SZZGL0H\S?"1AU>O8D_(_WZF^/G_)?]-3C+/VNTQ?#.:>?+> M=^#U!W;K34P01[NRDZ)`"C<':1F\>Q:)[7VPK?28T9`VJPJ@FULJI@W+`<-R M`?Z<-C;,3$YEKWZ*GJ-!XH.JL(JJ1K`/E&ZGD]8\F\<_)[1H5BC=KMHO#NVG M$,X)':_9GOCT"1Z^AV>'H+*CC(1VC(#+'ON$@"'6.OW.J%<,,.[[BFZ%?R=3 MWYHDE';P>>*]C_C6'B38:0\"O&T?^^3@,9I31]V"X-W9)D9@\*QVJ:U8U!"> M`\.X5!<=;(!W-(MH,X?R.\?K!N;2=@W/!?>"&L]T\M%V'L.//\&W='(+"M1Q M5B!0V`WFXHCOJFI:8!6?]I(6C=NI"@.VG$7_:F&L@>BF9BP2%/@XMQT/R82_ M<<=>V,-]&XSB]G;FJ"$;K4'$7[P/W^..#"=3P6`%4:8J M_;7(QJY9S@XX8]OV*&W+Y@>\WR+<8`$[<>G0.;C1F#1S@Y&:-^0^NPX>I&O$QT%?,^=E=$[\"*@7`0._"P<_RCZ<)I``=F'V%X\E?+H3#] MOX&X?]$,R^72D18J0[$!?^>^WG9X2?Q1G`#4^A'``TI44=7FZ\.'=^3!U"S9 MT#5OB#7@$5E_54AU+&Q[ M12KS:BZ\/3CTV;!]URQ!_DLM?KY]U*Q#Y)A4X&??0(S]WNJ>C[6P

RKIC@ M>6^&1^H\&X6:1EXM@27.7`]5Y276<*AB^U)9.[QZ]'N_6&H&-E0IHIXNI[Y1 M#27.K6F20HY#R3BMH=9[3QWCF5W$/5TUHX2TKH")*-EN.R9YOH#DN?(,)]>3 M6J$\/: MR2H':1YY3W5VB59(WOS=BJ[YT&&/@F=$:;?S%R^[YCC?0=7DB-HI5LSU6IV" M@["L]@XBY>IJ=,ED:PQUHS3Z:J]+#6CR[JS/A%'9-?U"$WKU6UW^IC7V)/^UXZX]?;(NQT\C='D/S,2H0J MPU97:I<"&+OIM@:UND\7KUTL]C%'W*#LC14O)>`XP^XVMZ)O5]P^/RJ/R"*7 MC4DIDW]4NH.]2JU?4Y)-$81MK"@1UM6]>=SLM=0]S2Z;< MY-:8/:65E2@C3T%+,$:&K=ZY4%MK,Z^EG`RK,D?F4HD$_,TBSI-DOKQBK362 M^N(HB.T/2HC22=LR59(L6=**Q?+>B`I^TJ(\!ADK@_.9/?66$/W1V=HIUUNE M=5O]$U"LM"(OCS2D%2FMR(M"[+!`-M4IFO-6T8@\$-FQ+,&]D[,/1/$U&90' M]4XE0S5_L^K2]Z76DF:?+,1.NUJ69=%)SMZ+LTEG>#[A>H4<@'2O=-4"*4>R][KLO3[L'8E1FKU6 M]U1)&TN'NMC+BK5OL&RKJ3MT8GAA$W8,NML6]LJQIYB_(4J1$2.H]8&=W^(] MLKPY>%,O%&0.#(<==CQJL083+M`M*YON^F.7_N6S5D9+&%(7+=D-BW>X@'$1 M^3[%*3-&3@Y97H?U'?N8W6PBDB;59/Y-28:]\]MMFXH-5N!:\V%QX=HW04AV MP=C*@+59<]FM/BZ>RE6UYKU>2F_U3B;MSM&WA,3JTN]NQG?, ML'VX/FKZ'Q%.=YDJC@3DY3 M9;,BZN&0VAG=_HGC?Y4J;7E0@359U>\`T*H+675!JX!&NCP>J"YDY^;..JN- MDNIO%DGBO%@K[$CI6:HZ:G7*+U=5Q7C5D3`X+*6N4`4EX.5$)4I.W.H/^\4N M?5V.)7#EXJ[;*:,(Z\7P:LVE,/+J<*@4T%_2F,JL9#44MYM]:F*=;1IT2:J(Z))\5M4DXH!4H(2CEQ' M!I.M:(0AVVU*,& M(PN7#ZNX"7F<`I.%4J0/1'==!=SN7+E1B<6@ZU%%ZTB8[I=GUQ>5'Q77-?4H M`%MVPEZO8#I&F013<8/UB@4ZV9D.J!9*!Y1BYGJU$XJ947M4H'W)SNIP/[WU MW>9,TY8_)`J_\((O7VR//M'OWCO$V\__^1^$_/1?S6:G13X$I]$/O&+,PK;( MXUQS:+/)7PLZ$]]CS<#2PCBTL:?B-3O_Q2F^WVZKZZF>Q;R%Y5*#`W,8R MB9TDJ95LARM*+GKIY"X3N$_EQ_.L:2-ME4;S.\1#=D5$^&;LD+<%QSK#P4`& MFI\8FK\`FK_%?#C7T*.TDB4@VT4LDQLN;X:JVO[QP\-C^)?RXQMBN.PLP<=R M4>,5@84;R%*P@YXX3R`W1HNV&KSNIK^@CN;9SAM\&7]YH2@\X6/M&9[,V"MX MA\J>XKBXTPP&E]B^YWJ:Q0:/C3BAEKTP+#[FQ'?P,?[NT*7M>/@7K,.P)ZTL MZ?G>,!G@L*C$0@R+:,0U%H:I.0308U&G0>AWG2X]7IQS;\AA%FWRA^_B=U/; MX4M`*/`8ADZG5/=<5@W40XEH+S'9Q^7%1-DOB3JB3.^XB>UYO/WFQO>G0<:^ M1VP+"YE.V6Q\$@0DF'>[Q+AZMG@"I''*T/ANP/:,&:O@MDQB)!1LJ+?]WKC2 M9E]B=(0@>VDN?&F:]HO[0Q5V8I^QJJ"?2PSL]H<7U`%&:>]";H.X(`.G;+*P MDEPHT);\.#@46&2B>=K9CB_[%;372T)]B?UVKOR@XHA5'L]/)/ECYJ_1L@?(:B[:26E_MB(OU^NHINX5UNCTU M?T[;"7*=ZR*`WB>C:ABUB0?B6#BM"=)'M/ZAELN#:MJ+YDQ<4@2PHW9GDMYU M48X:YK\[(-WLZQ*VPY9TKL]H[,6"Y=(+/ZY9.)*>LO24-Y)'7\E/'E(0YD?Q MNSV\62G>JA3IR8S^**U.62K]]8B5%4QM>%"2)?FG%E M0KZ[T[([1V*^9J_5/4T9DMOETK&_&PO-H^:**,/6B"5%*J-6CRQXBAK!9%9R M\V)XN.VE(4##2][HU:@_X;-E2O-63_ M[;?4<,1D6FVNH3NMSI`-C;=R>FS$UYU>J].-?GQ#7JA#B66S%!/3G_`48DP% MU353QV:Z.+D]/3!;M$$N$4!G MN*Z/T4;`2_Q,I\D1UXHP]]^DV/?OJ=X*KRX'-US;$K37Y M&AO`MPQ^?<5OMY579$)U('#3Y=(S?;ME^.KGKMH=M?%_/[W-/4G],=/N`V8Z M[>'>F/DGU4Q@;)TE5UO(BZ[OL.OIIJ&-#9.US(VO@7]P!^_#B/?!VY^BEQ/P MM^/P-WL96ZN^^ED9=`>Q!>R(X0P`$ MHHEST-\8R#;J_/L+F[P84?5@0[K]&$ODF4-NQE$V0^F^^EGMGF0OGFQ/,_E5 MP[EMPAONW\F'OWS#6Q7$[>:!CDRXZND(]^*1A6)W?\(2YA3W,&Y>M]H*66H. M^G(^^$=J:T#&@1/"32W-]^:V@XU.\,9_%QR@P$M!O(`!!/[+(OG)!NL,?(TM M?@+WAM!O1R\$,+O4C$D3OM&UI0&83FNSF*UUS[P9F.(V_/H!/KZW[OBG!8D1 M+=[12$UIM0+S263G1C8SH@<`Z.'(_NA[/ABC2]LT@&G'U*)3PTL(^4^V-7NB MSN*C[^"K#^S-=^+%XD32[W8Z:HP/MPY_'C`1O?T8?LL$\Q$HU>,#E8'-08?+ M?P'EUM'/`R4B<]`9]0M#R8[;=Q68X&?R<8#4.$#J!O^MU=D\UJ2[R%X+,`GZ[(-XI[AA,1BJ[5YLSS:-?!X($7V# M4;R4?#@A%8D%W0@^&R(P1M#:[,T>X]7DQDPE-L;1A\;3VX5-N9 MX"&`C0$L&R8$B2->AS]9.CCSY<&(]4TO&W"L@+$5<'[H@=-Y%`;R`K%.\-0# MMR)F/T_HV&-HPR.):3@6I@C;%@.:W=1PR)+C,A:"6]JNUW2H9SB4S2LT"5F: MFA5.>8/CNM1YQM,-';Y(#>W-`6W!RRS(:@(],QQL0N.;O2NDE,ZXEQQ5SE8R87%[Q;V3M% M0NQI:^:'I;ADS\[R6+Q`55")S5W8#/UV2\AJ"-GPS)`=4CVM MBEY"$11]H\_4\BF_>T"_>]3!'!+==V'%U"EB-%RK-;"K7\:@,>CW#BJ9)C$I M2B+V"E33D7C<@L=]NOW$K1F!PMV:YKA&5;7PFHGKK!^;)'6X)@.#AY#SL*'V M"Q0?NM+08:&.[3R1P9I%O5E$P_8B?;J4V6%*8>];J$2OA)M&$OK=PJY5Q)IV%9IKZY*-0A`GB[:2.)!Q@P=4K\H M8[DAQ[8\*'5Y*+&9B495!V(.1.#IAFYVZXO!F,&QE MB71#X5G>,<50)-[A^;O#KO6-JVB_E ME93=L0/GK7MP\&[FO%-]FT8RWJ%>WV+/9KO*NV$?XU[U'DB]U#O6)?J4?:5Z MPD3><*OP26?!:P5U-QU+Q&O^0\^#6GU7D.$/LQZN(?)^[&S@(ND+,D`LD+:G M_W=U+/O)\(P9+VGG4%[$.:HOOW1LG=*)6Z[_14IPP*Y72'1[^Z0UYC^;.Z)D M.,?9W%[';"Y(NG#60-3PV51)M%NYM6&NFWY`#U-\K":@N0O7W.P-R$[5\@XHAA37?-=2EXH'A09])G"<`")(5IQH>O*#C+8 MJ9,#%*LY*\"8[[@TJ!P;EO&U;/QD:E(=*P##$]^:4,=0`D]/MS>W7_YA4V4PLS6P0[?@H\AY6M8`=QR5^:S9AD:>?27 M6*J:W`'5`1/YIF@@\R_?HH0WCWFAHK,<,,AK]/;#-C0WKP?M5CO\$T;RM.]O M\//;I6.8G'<83]E62/1!C\`5C^M0QR5!H`>X1:>.!XQ+S#`,A/.[U/-,?E`+ M,'4R2X#_3H,BZL"H/BX#AA/#P`@&0*DY1#Y?X M7^\;7*EK'S)YXYQ1@-U*]L+]I%LO=4`OA(F)K2$G((I>CV)-K;`U%N=XK'?_ M(@*^]-FP?==<$>JB'6FX<_A2%.V?T"EU'!0B@9[W$K)DATE0(Z;>U<0X M1S>8J,&,TB+OC6=C0JT)^098=PQ=]*B`'QX]S?,]&TR91]]9FGZB+4[P6?RK M6VL2?B,^D1UHRNU`HY3:@698B0XT!2BP;+?UNC.T?D7/`T3G##NH(I8=^IO"9MN73L9^S9M8H# M+9HILM[2V(,&W_IN+$`S@"9YK;24L/NBR/W39C/X')YO:B_C2=. MEC#,Q,"_QS[_@=F\8K$VP4YB;JQ7Z-Z]6JZ#`K&7CVXOQO`Y6J@!MP=*'(G" MY9P?F.V[*$9SR>L!."KC6$/-UWTP/<(?TF3-7GD/7L]B#-P0-)5/-M+V[K/N00_@==H3\@%A`=(,5.V$&C\$[_!7X`U\(5.?XG*:[4ZS MH_ST=N.7B7ZZNN;.R8V/)MK4=M[@J3NN9((\9EC/L!SF2"(:$JW>`VL#QKB# M(1[$9^]6O\)0]]9]\.EM^.4>K8+5T3#HEU=\OHM8)K8%5)1N":OD/8%!5*+5 MQY-M3=N:-<&W6K`N5^DEL7;909/0]_!",$+Q+KK=T2"U@$V#GQM<[.U9!$S> M(S(6$DPUB`P'"M[8OW^ETE,&Z6;$:\.>&C!&G[V>VBD(F,/K+Z2A$649]L#. ML*\JO100P6C'G!L1,.PKW32!K\W-SPF1/X,F=/9B#09XZ3Y\YYYGO!=&A3KH MI>DD8]P3`\:[E:]UT]X&&$HX$HADD+U@>KHLS-]@07Z0"$QJLP?@^*=!?M!6 MS$Y]LF_Y&^]$\)RZ,.O7*0XOGDSVX,;40HK,5OT5LF:^!R[."!IVLXA,V$:W M240W=-;5F]E644=O\B#ZCXNFWJF7;]=?)O?AR^1_/S,3[?^2_R;GFSP>`Q'M MRUF#]GO6G_VC[8B&O@^F9KEA4_,G[;OX_3=L"E]4``Z`N4;Q'N3[SRSW[_3[ MI_29D72B_>-:\#'FA/Z=?`#F]5;;$+_YJ[-0O'I*BJ\#QE"DETYC[S23N]K> MNH,,&/CBLU]`CP6LD=?;$O?%[>#0;N?!5]ZY--# MA^@;#)5T]&8[=.^#U!)1@P+L_/7=#5X"6UD,1+U#<-CIM=/QS.U3G`]<1&JG MT^GN!^Y]#$J17(@'\FF`^6M/^-:W\*7B:(W!ESGB&#EUX+/C1 M<'7P,O^':@[Y"#^Z60>#_"5\A[VR\6@P>2B8^BJ<6VV11W^QP!1F4$"/QLPR MIH:N`3`@'_'L'W7,@VT:>DP(HL,IOOHZC7T3?1)\(3."2DV>4-W0[1+,L76:H82G3PB\P4 MI'N>IV0O#4N^T@/[#E!G4_KAZ M2_-\9V."%=&`E5E39WS7MS1`&2;R@D9@UW995F\F^M$B#])^+1NOW;ASVS?+;/T$M`'&:GLU$Q^8BY9[=L&PE/L,7M_PBK M)TJ[^7_(#;[$5SI455Z[)_E^^%#Y\4TF=N[$+84(1,-B5X'X!2A,M#-<@7!S M)>B-0\CI*WMQL)2EYHCW`/G.A#F?##V_MAY;9$8MZK`AX3%=XJ*U2-XN85-U M8VD"4FYBZ_OE]O8AOJ(&&?M>#$@OR"CD)Z`!W3E!;C)9^L[2=I%QYIK+21`V M:H+>UP0K^MD+PP-0-ET"880KW@GO=TQMV\/]PSP]D?DL,A1?&*5@OABXRI[! M5COQEZ!*,*$*J23^R<8];P#%FGA+B_-2M#MHT&@LE8UE&L+"$@.BB'#XK/I< MLV9\B88;(6F\(HC2K>\H7`E\CDF(W@B5Q$A&HL@@ONG%*/3/CRHDS, M2;#>D%9<\H)ICP8/#B`K3"BZ:FPU'DN)9"]8=NP^'9-J8H7T^C(=#]6M#Q%3 ML4A/(*"`E.JJ6HN(^D@K;1->R"^,7H4DY!F^7'(QO/+4W*`F:")9E`L%GDKI MV.9FQ1, M;VK.Y$+MSL>G__D$OV`R@J'G6/UO0*/,^V4F.)B8Y`/@P=OE]%1V_=N]C/@E M5.33R-_(H@#RSH;_)$R1C[>/[^*F2'3U#*^5N4ES9N8;7(2@5?(<(-H($$T% MHA,3_';_P=UIO3W-\09"QD0.7=C/E)L,?_EH?8"@,YYI<\QA--P_W2:LKNG0 M%[9"73-UO.$@+ML&-^-8-AGZ$IBTR;BI, MP2YB)8=E!`"NC!V3;Q&?9=B8,>\,0:+)R<4@?#9@Z7$(!T9PC"D1]3\`KZ&O MA.(0#%7#"PM:X@5D)BAMG9V,,)_O1?AR03#&"JJ;N!2#.\&:5J$KS;Q[L)[7 MKCFSX0-9U2([Y4\DJO831#RUK&"D/TJ(CAU9-_@].3>XOX>K:O*C\%9TL/_? M9/"D_/TPNP;'8>7JPX/2$93$^4(=!EEBN&E^NNN$(L=56,A>Z:89+ M7C"[$'7`@DV4<@Y>1;(BD\]A55A>M*6;S(0-7OYJ!3[--_CA$5_`" M57D;\8V*T'I0E6W]?A]_X8-X#O:(O_"9$?8>QM.-/9)TE':O/TCGO>R>Z'Q` MHSA7VBI`O3_0G\(TK>C:X!K@P:79Z'9?41&.Z!T,VVN),1DCGQ@TAL1!N[>6 M1K8--'`\%X:_B.<2L5M^:Y?ZQ'M1TL^M=Z;^V:_,Y9S@TW MXKC?::=Y*S_<8514)&NN)V[QY^*"N/F\"1=Q: M`G>L&5O+4]$^@2?YT;$7?(C/%,SYR?[V0OAE[I<1=UW=\'@6SIT#K()`Y'\[>Q?-RYZCR'* MW.GNOCM]\4M7.@5V/;CD@*'7J8\Y7Z$+LV9!8%APQ4^7A(V/-9+N6)76>YXW M/D$\%)>!080J9DCDG*PZ"T%1VFMWTA<_"B]DV")HT:-L$.^CL!!5W0CSMM86 MA#1E6S`L.RYYL%W/"3\))LVH(WGQ&=R5R'8>EIO!?:S"O4VE-3Q-+DAFC<@= M)'T=B>"=5O]$IXBH;&R+BAPJCYV->2)AV-`#T0@"P/6"RGR6;;%4`*R,B$7\ M)F++@G>77,J0)>Y7[&K=,B%NPM<39XH/'Y+)'7R,?9H%L^*.LEMP5C\[\4%O M=/[F`'LV=PK$>CO>L*)S_+K:A6N8']@_1RCL8J)O\XYW+WW#E4'--QP%X-Z* M[EAM!'NGZ$QU92W"E78%NT\=B-23=@;?9-]?F&"[F,YD!]-&_N[FY=+&Y2J] MZZ$-*3=*H8U!'6DCO]PXI,5Z%6V<0H9C6"%:#SSZW`WE-CL,<2OEW/WCTKY? M92$;5A:R"JC"B\-9=>EL4)U>55J3.LZ%3%C4]0`A?C>.XJY.Q MTFMU#E=F%>3DB['P2]U-M57$W+\<778QNWE<=LW<])9R/0Q<13?LR/N[UTY? M:>BZ/#OC=H'E=?X=7H+E[?/<_:P/&=W.NQ4WK=X)C@VJ(_3J'KZ\`"JH@+53 M=RHH43R,I'BH401[3RI06NW<9"`MH9V833="#,/<1:8:M/_V(_GMP[>G^[O; M3\W;3_>_?('9Z'>OB7F6.`VY43)V35I0Y8I(I=L:G@RQ=3[QJZ(BW9,DE%;O M/"0A;:O+$1PWK>'I,K;J+#AJ9&@5,+?S'EE5*$-:GLQ?PRES!730Q>&LNG0F M3^;/YR>*@K(R$>K\D%57=$AQ6R48<4 M3-!BSWT;E9'J4D$%=3'[5AH+=@M%)"^<`^L3$.KEWS:IN3=I;BPXIWNLJX;G M.Q81]1Q$1U^IR@M%*(?#5J=(V/K"14D5E<*>.P?:?%#"SDEU7@4V+):7DPMA M:@415@@["7QL[#1VU?:$S.0YI>'Q+6J]@I6H--WSL7,5[X!2@'UE,DYN>[E= MZ':5/%._).VY)TET"P4Q9#+.)9%$>5E\YR*2FLF-^IA*^;,ZI9V4,^-YNGZ> M760JF?%<#5G9&18ZSI'"\I(TZIY&5D=F/->6)$H\A!I(N2&-K,3Y5FYW7>8[ M7W5B5'63R2J@@2X.9]6ELZHFX&W3'UW0'Q/;'YOT.KS)+YO:.I1D7>3`YS7Y M>]FEK\#D[YX.WY=DSA4FGRH:_6622K]7J$I:F:12`>5<>U(YLJ#IM,JJMG[M MVN%6[*&;L?B5G9?HCXM^CJDFRR)@8Z5ENUZ*4D$$5W M/6P[49+)M2?#`H;H-\X`,$&_!GRQXI_$48]L4A\(!*R)J)FPJ_+`0]1&M;/AR=V7<*?1B MS3SW;+09=2FU%PO#BT@"&^[!FBD@$0CPAB-#?9-N\!G[#'N'QC]B7?$RVW]FZ?R=3WYJ$Z]"HE^AUZW[$IP51 M/7SU\["CC`2HV4.>#)IV_]7/@^&PDP\:?JK/KU&D]_:6_5H<%YWA:*"F^SCS MP8XV+ZZZ,^SUVMWM\_Z3:J8W)[KF\(JT^W59YJ/?`Y:P;+/#W`K2F.X=W7-ZN'/]^ M]+`E-(K]VTC3/FC&I&E8Y$Y;&D!HJ9=OUU\F]^'+\?[HYP8AO8_LXPBHR7O? M`9WSP`*IOVFF7Y0>!Z#1E-1V[9Q#;M#)-DCI'W.#OE%/8[V2/V@.VK!NQD\% MD%UHN&-3-DC8IMH+E;+$70&B0S-<'?2/ACNN_!_QS]`.^O"7;WBKW8C:_.VQ M*8IAI:>F=?9U8P7-=*"5P?Y8X:";AC8V3)"VE+MP;F(I-',IGZ)O0%JS&<47 M`FWE6*Z[IJG<2C;:PKE7\JNU1'VG,PLM[IQ\LJW9$W46_`5NP15'L](=M`,L M;QKU%+`@HI1NK]/.#PL%60PB>>G0A>$OUNSLX(4'\;PX;KJ*DK:?TX.>"AQ& M1^U^FHHV@L."2T33@9;`H">&Y6G6S$#/G_MY#;Q"MQY`"-[BGMH7ZGWXKIL^ M1M1_L>W)BV&:Q;'8Z_<[*;#S3%2UI>`.]$;M]2!(X:4P)\OR-GC<[!T^UIUX ML3#*^\-AFG#7ASTI5`Q[/25-OUN@>J2FB;%<$21?@T@\_R!BZ(7MAXZJ]-** M,C'D22!!G=U1U9R0?+`\U$`?#1,V[$[SZ,QV0@4VH<8/_`7V/'B0\-=!XA^P]_GKL;<3&%/B M&&MOD,MJ-["'\\T0BTZ[[/C%L)ZIR\/%:^$9;<5^?[)ON'JMF^MB>?PFWB?JJ_3]^)U M-(D"E780^IN*DHZZ[S=UY5?+C'^EGQ8D!ZY6G%8QX_GKPX=WK-(/.CDPKK_P M328ZN/X`_@/39XX?/%/RR7;=?&^!0W6"63+U6>(U?FCQGD[1SQ>AT0>$XW;R MA\_Q`KK]Z_1)^\Y=I_3Q1T'J[*'@3V_7$<"2>WGTO52ZL)?=M&5XEKW<&KC8 MXZO*X9J;;I7@F]KCFAFG)Z5K3$7W+?C-9&5>9IH!.,/@&@7WA,=Q2I97J1FQ ME`P]YI1Y-_GV63-,/#K_:#N/FDD?0W".IX]Z:J9_=A3HY):??\^WAX;+VY&RH5ID-KW)+F&=U%C:)"Q>;!^D2PL7,$"ZQ;S9!B#(I M@*!X;!%Y[DKPMV/C MGW//6_[P]NW+RTOK^]@Q6[8S>PM[UWF+C]_BBZ_89,%TIJTG9F&9Z+83#`KB MD)K_>!4`U?[_/@5/Y@XN]?\QE%=ORQU030T8O)H8U:&N[3LZW31L$:0$'\$W M"Q-&PCLHU'KU\T'/H,[5\BJ1C^A-*M,G"L`S7PSL"(.]J^U6ERP,TPS\U]?8E#7\Y0:CGO"> M^)SZGJ%C_BA"Y=@`O,OO)K@>'Z[3Z[3ZR?$ZHT%K%/STAJ7FX\T&#W:/D@4L M?>X21J;DL^;H<])1&D1M*VWV->9S-_!F`)8A!Z29J]9/;Q.;G+GSMTZ2I&#@ M8'^GCKW(I";/SJ`&P3*_&?2%?(QVG3V#07<0BWCC[10VMQD1#=L?X,-6^R!. M4-8YH5/V@-T26*N0O-G$6FN9MF2N`0^-*;6`/":^#O0S7I%["R]23+(XZ5!. MZ2@M-479[58[_*5:=*UDT[5R6KI.+0D5%/S^TUL<#?[Q_P-02P,$%`````@` MT8"=/!3SP'="$```0>```!0`'`!A970M,C`Q,#`S,S%?8V%L+GAM;%54"0`# MR>;92\GFV4MU>`L``00E#@``!#D!``#=75ESXS82?M^J_0]:YUDC>V:374_- M;$J6QQ-M>6*7Y4GRM@63L(4,!2@@Z2._?@%>XH&3I"P@+S[([@:Z^R/8:#3` M#S\^;Z+)(Z0Q(OCCT/1U-9VO%LOET8__^?O?/OQC.IU\ MAAA2D,!P!PL"1R_ M?X[1QZ-UDFS?SV9/3T]OGMZ](?1A]O;X^&3VVY?+5;"&&S!%.$X`#N#1A-&_ MC[.+ER0`2=:_&OOS'8U*`>]F55M2"O[?M"2;\DO3D[?3=R=OGN/PJ.@B@$G5 M!OL;@SCK+[AXQ&T\F MN94IB>`-O)_PWU]OEH+^\SNS!<$QB5#(?7<&(M[@:@UA$K-F,SG)RQ9^/(K1 M9AO!\MJ:PON/1TS2M+0!M]9WSG!N(DOKI?@'A]$9&GH1T4RQRQ MHTOVN&S@B+TL!([8Q=4:4+@F4\T]_I"AY&;&[`N'UK@,:E+TO_JPK4#T* M"">S$&UF!0ZGLK>;J^SQH(N2;'WV=:-.76.QJ`*$BC;*"Y M9/\WFH3/"<0A#,M&>1?MG[2LL;*YB`2-)B(^R!$J5"L!SP23#8)QKET:S])X M^@#`EBMY.H-14EWAJIY.CT^*H>V[XO+_YG%<>]HC<`>CCT?-BPE*N%K%Q9D# MW5VDE#*4"7O=NM?H?'FOJ4/-PW/:5(?!KA14(%`Q8I<8C=/-)I,V1>QI*/GO M*=ET+$O4O:[U[/TD)YPD9-)B26-&2K:<"D1'$T+9(U>\LY\@>E@G^3^'=1P? M8^0;I;X$<9)]HYIH45(XJ"C5:H8^54L0.S&MVZY\9K"#4HW M\0T,(`/D7035(X`Q?6$X/;V#@+!54HT.`VEBJ+QS"RI7R1K2G1+MI[USVT'' MRE0P\F.76>RV?[KEMGD0T!2&NZ$IG[;L%&D';:;T92"GI7<0"+9*JI%A($T, ME>_=@@H/3!8D8GI""J(+0L\(I>2)32-AD%*4H,Y#;\%1"P=U'`X"QEY1?2BH ME2<&S0]N@2;'^BUXAK%T3%'2%/82TS@(!1-EU,Z72!"[^U]NN?LY*^ M2MRUH_9B=K[$"<`/B">%RA#@TW,0I7Q=7^([&Y8JMC9@<3\=K$0@H")4UW%N:HRTVTD'A:PNK% M!'L%MX"7\9DETI$[H[Q<3[E*!WP@C/U` M5+HT@*\3F27'ZJ*\*&BJ]5B!&L.QI2ET&2AMH)9ZKJUXRTE#E85,\F$W@HIU^D M_)5Y32(4O)Q!#.^1O.A01=MVN)#6>7<;:&CC;+&X_2UHJ%W]%6\!"A<10!NI MBT4T;=((N*[2''8]I6=P2V+V#LA+E&!X0>BN M..V2`.9`=:UX?P%52MI:@*M(&FP+`Z3U:<.+18_JO9872;+>2T."+D4[(*A1 MN`H6O38VP4!=B#^K&F5US3F\D]072LE<=:M.+W/?RB5YL:J15;X6DTFQ;Q44 MA95$%*XZ7J^-@<^%0KQ8X\C1JDNO::CJ*Y6N)MJDSWS?I%OGD3=/P!WO*_PO MAYV+E&J3,4:TK3I1,:T3_FTD4BU44^94U7)>.?U2]D:1?5&1M%SI7NY%Y,$> M.9>ZXUXKUZ+TEW9.KB=L^4Y`Z*P'>T_3ZWXTGZ<[5D):CP.E54`2(F==*E;& MPIUM`5ZD7-HO>751EY)0$B^Y['MCI53^5PGQ(]G1K&:*2UW:!19:.G'I5XW. M.0"8JJ3ROT*&%\D/P31OCD/I0&!*+I\U-\F=PX2E@BIHZ$5YD3VI52Z;O"I, MR;MEX)Z\-BP55"%$+\J+A(NV.$];CJL2+\`6):"]PZP'9WFZAP7GX0"EAE!_[1O8$J/)2K@7 M=9,W,`$(P_`3H)@O,K'`*]UP*\"0#:*_P7O/>H?+L MO$MG\)Y06!UL)72VA*;AWQ;-0;?.6/B.F.G8<*Y>_,[C';&>A(:/$*>"@V6: MEZLPK[A\:(_+?$BD71?XM24D#]Q*9B^\5U;G?LIJ==E0Q$(!%.9)LWQC2,NO MY@RMPX$5#(?#0L?5I(>"4$NN'`JLD>8&2+"@LM"D4[!Y'HB:J+U5UB=Q" M@)$F4J_+N+V8KF6=;WY$I>[>UN=5:CYM?"?%*4<*^ZSV7LGBQ:::+'YL'DHL MFE^(*>JSC!:%6Z[4ZR!UJ9#5BZJ/&_:20'_6#YW^#!".>3@I"+@,:*LH3$7K MEN-M]))"0"-D?W4CPMG4+4E`5);_\2.JGK<0=SVJ(RN7>V5D#H?8AJJ9A=QR M80:OW.GAG_)Z45I-C;S:<)DO2X:[7=KM@+P?=QF=6W(?#E-:R)"AMFB@3=9< M>[>?43->!/E&6@E.(;1DLP'>8:<&HR%.,WD8##6/IA=YV@L_2%YYTOOE5*-S MWVUXZ/0QQH%`D!>3DQ6,HEVOVQ4JPIM526/CYN'\+/%UIY7HSV2YQ`RN9; M8F!([NY.LV[<=7N<5^MB/,IWQ'B1I9AO"$W0GYE^?+&]>19WNZ)#3>RVF\TT MM?6Z3NHK9R=N8)@&>5]N8`SI([P@=(X3%*`MKZS(CY#*4R=7^!S%0;ZJR8]Z M(9RUFYD:2V"5OAHLT&V]HVQ9[45$GN+#ED+S;O`<-OO%2]`?0<2[=PTI(OQ9IA#$ M\!SFO]LOV1ZLM6\2&[,>O**#=Y-%U(^(N?SLY6O,1[DJ4S1G$?JCZ)QZ>\9= M_8Q+.\1H9W]PJO&-IY:DKVA5@#RC+!KZ#T#2KF6@\`CK(1+R+<<[BED'\7 MAWNRENODJQL!&S#YW]VZ`DNNW6G"1ER^0:V?-0;`SKA!+Y:AFU%]OO'Q"TS6 M))2/:58\PFF5C,1+M>O\2(#9]X$8$XGF=+*BN8,.WR(O3J8^/9INO%&M"'3F'G M`!%ED5T?$;XA:@0[#HL)\9/76.A0+G#3?X6'29D=Y!# M'R&^(7D46PW`6DOP#<3# MK30L=+1OW(L#`;N:93L5=WH(IB^&#%)P=AC\QZ+&!J-"K]N6%P<+*IZAZL`. M\9W#J!\8.I_\@-+7*?@;";J-[_+K$F&E$T5JLP7*M^M2:D:66:ID-]MNSZB.&D2,OH&YMTW&CR*$;4H@N;?O MQNQVM+*)8)79$!S87&#*F+XPFY[>-P396F``<`R:DN#%O:6:UA.P4\T`='W9 MI<.9AMTW2`ZTSZA#FZYE"6`=6^*9A[^G12J,'R+/#+)DOHIO"9OZL?]1!!NU M'[?$T&;9P-_.IKY&6V72=:]M^?;6)":[0)@-,3WJ M)Q6,ZOI)$>-?IGY2;Y5]U$\*6W6SZ(1U/8`PS":9RSA.^?OMZK[^[;+VBJ\Q M0W6VII;!N7%6!1O2PP8F@Z6@S?Q\3GU;7A1JUA6Y@5OP4A3\5Y\'UX!-RR/` MFYS'9\B96F(DU"F:\Z*TL]Y_Q<"F(ZOV=4O(?$.4H;X#0"1OP:`>TX&MM>7G M<'@$2G!"09#\)/^PK2%U-7%14_N&)COM!X!*VY`7)9>_HF0=4O`$HG)KN@9= MY@R%B0T8?,.8M0T&P,RD+8-R30=&,7$`6?O\EU&`+Z!7QO=U>M]P9FN!T:/[ M1E->E&%^>@Y@'-^"YV)?.]=GM084GK&9D$B7F%/072%RV/T;MB%U1/8MD=!(]KJ8ZNU>DUP+$"T7Y4T$G4S/GWRRL]]8-I_`4E*4?)R=?\%T&\PX;7;*QCP:UTT]N879![,^)T;_%08 M(\,M9#(X"KK0SDP8-NW',F3Q-K\E\X`]IKRL2[8MU(2T%40)2;U#G;G>0P"F M;,6/PU?K#TD5'.:[J7:GX`E&.RFM8&3KTGJ')PO-1QJQ!,UX<09,YZ%@2FTA M35[X.1'\DZP\M-AR$MU8I664C5QR1N]PU]G3&:Q;WYG.8BM$K2WE)!G"OS_)+R&V95MVE,;P!1Q[ MM=K=Y]%*6CGY\'$9!M8#I`P1?#(8[0T'%L0>\1&^/QE\G=CNY&P\'GS\Z_?? M/OQAV]9GB"$%'/K6],GZ%/U`G$76MW\!]JW3X6C_K67;4C1`^.>Q_#,%#%JB M"\R.EPR=#.:<+XX=Y_'Q<>_Q8(_0>V=_.!PYW[Y<3KPY#(&-,.,`>W!@"?EC M%M^\)![@L7UKS9=3&F0*#IQ57Y42\I.=B=GRECW:MP]&>TOF#U(3`>2K/L0U M!GL>"47SD9`^&&524HF&*9GX8K@27A<\C#_Y/!-;EM2F`1H='1TY\=.5J&B( M:BQ8Q5!`85D)&)0$\!;.+/G_Z^U8X:9\XIP1S$B`?`GQA(N_(<2<7<\F(4'< M3%'*X58I>$9)6!MGTF#VLV7'5EF-Q8E5;$ZHX%^Z[%H,CSV"N2#W11#+B`$& M[^5%7W!,QLD9"1<$RU'D+E$E2^MDBR@K9;<)>DUF*Y`@#S-IYZ"2#['&'!?4 MFM:HL5OX"^:=Y^;8%/9:F30::IEMPERU,"A@7(LDT7-.";5*L42^0N'+1_S[ M?I\PSZ]>38!>\L\$[!$3BLA"*@%B+EI01*B0$T1846*_&R5*.QIQX[OH/R1X MPHGW\SKB[U8YAT M\W4=?64'$G5-Q046;)8+FH!WL>_Z/DHZNP'('^,SL$`=&B91JA-R[XR MH[OW6OQHI5[-DH.=SQBWD`MWH'\!*!:D9DH:U0NE,:L0ZBLYM'S2XD&5)C7D M?^X<#IN$4S"6R\M1@S%CU7 MQC-(%8\R,-OIC-H,?E&:-P"P2NGUA[/;N" MCV**)Q'F8G%X0Q'VT*)45-]83S9S=M;32P:9"DLSW3;HJ:_K?,4RX@H*Q^[` MTITR3H''BRS4;U&]4BNUZ">S6KNJP2$=G7U=PPM+$Y,O"2N>#2F?967#W+,= M8=T&35+OSSK,&FKC0F%>G=&"H$&$JW:7TNK,K1M($?'%?0H!@^XGPB=@`!.H!=1$3;(7/]'Q+A, MZ?6^:PX!`QWMB,D&J5E#='-`*`;`YB[4C0\3IF__S$A8(.R#Z!Z?191"[#VY MV#\7YCS$B]S/`G[%+*_=Y'GR;V[R*HC<(3CF*:EGQ$M+RN-C^Z'_=1E^(YO[6JGJ'C)CJWYCJ_W7/61:!_+7C0P= MTUY@.4R_#*9?_GHA.U%]7SML,6N5]S51:E2")Y_CP??L:?J&A?M$^:]C/ M6FI7QXV4Y5>JMW\V?@KO$9;O^)R"0'Y-S^5_`QP!^C027'KGIJL$*))B6LVN4DE[7,D&7F[QG=FULT2Q@5I?V(FL%$3R=4Z1D]+[_X`@*F&WN:+\ MBY5=%/5S\)L*C-;Y2N>N*BHN[W?,-66>V%S1!ES;<47DR'N\+8L]5[R?IR*^_KE0KW\N,V-9- MS9>9ZC6J.=(QO?TBCBB3GWX##9;L-IGI$Z&!-8VYJ;&G)A;U/=62ADPITLL! M)_+KP(#Z[(IPN%^!43==O8:I8W@RI$R69<\1D[^_@K#85=]0XD<>9W=PR4^# M\BHQ,[^^3?IS1DXA\"(@/^6/Y"7WY1_Y;92\GF MV4MU>`L``00E#@``!#D!``#M?>MSW#B2Y_>+N/\!UW<1+4=(MAY^J6>W-LJR M-:-=CZ6PW+.[T;'109$HB=,LHH8/R9J__I``^`9`D$05(75_Z9:+F7CE#XE$ M(I'XEW_[OH[0/4[2D,3_^L/1R\,?$(Y]$H3Q[;_^\//UP?+Z[.+BAW];_.__ M]2__Y^``_1G'./$R'*";1W2>_SW,TAS]UW]Z<8`^'!X=OT4'!T`:A?%O/\%_ M;KP4(UI%G/[T/0W_]8>[+-O\].K5P\/#RX>3ER2Y?75\>'CTZK_^^OG:O\-K M[R",T\R+??P#HO0_I>S'S\3W,M:^&OOWFR0J"CAY5=:EI(!_'11D!_#3P='Q MPSL@[Z=^R]],F:LA]1ZI.C@@H*,6A*0?Z]0R]Z?G1Z>OJ* M?2U):4&AINAR<.@8(\1'.2$1_HI7"/[_\]>+DIMQYNFK/#VX];S-*_C^*O)N M`1@M5G)9-O$;I48`%I)(.Y)YWTE, MUB%.7[:'AU9Q^@I'6?D+].OTX/"HZ)?X^=>E[R<8T+A;GZ&*8^ MR>,L7<;!58+78;Y.+^)[G&9K3'\MFL-&@C;R)AI;T*MF[Z&\1O\3G)(\\;&D M1O;G\>GI^_>OW[X?-.K`R$!*BP/%@..#GZ]_0&%`"_9N1G:%M^=77M:B+`.1 M%8IQAL*2$@6BH']Y576I.PS+I(D$+_&+3M(_>_HI*%[YA,ZO3790=)FQKQ*R MGB2THEU$*@B2!#CARO?5W-C.UWD$\_6T3RD#QT8%\R(`#?RZ^PHHIQ.P'B,H-OX M%4/O#'ZOO$@A:@QK%F8@3`&L8X% M/,/8F$8V`#/`*.!]&U6O8F(-+6@!_T)Y2F?2BB3(@]_3$!3N/EL@Z#KA`X4G M&.:=5J,`1*9(MBZBG]"0$E!&T(AZ=X;=7X_'Z'-'<$L;ORCH8:#%[ZABV4=? M.'P9P)>_,_A6PIT;P+NVKH*`:2_:UC,29XGG9W\A$5TZT_,\#J1;A!X."];3 MZ>G1R5NKUI.^S4UKZ2/>$*K24P0.A##.,&UQAJB)32X84&:R M;!M,8K2=,9BN,^+_=KF!GEQ1:7[ZOJ$FH`PN"D(;F]%W1Z=6-Z/RIC9QQV@. MP$L3,/N<4K"=',*<>GZ`Z273V4CR070&5TSKQ@'\[Q/5O?=>!#IZF9UY2?(8 MQK=_\Z*\#8I!/&+I,..9@%*C"K@8TJ,A*-[@)"3!=>8EV><>0)NUH5U@`75F M8X!Z9;8RK@K81S?X-HQC6@+8(IQ_7N`/@P`9)2+U''$(%Y_BP"8JBN(,,('I MKX9H,+?]!\EUFLEO6I7:UC\?+UX6P1*^\ ML.TG@LG?^#S5!#HYI)(]?3MJQZO2#?4&-@V?X@O:T$_S6SFR@6[8-M7H.&/; M7,1T?T(MQX^8__\B_@OVHNR.`IC^G>8)G-!]#KV;,*);!"S;UPTNPL9&[_CX MW2`[FTHFQ7VKT-">--'(::D&3;#8`0H.%%4L+J!TG,0[NS\N`@L6"!O$L7*^'EE(MW5/5UNR* M&DYO<7GF/WDTDTYM#N&VHY\.3=R=V;0#C]K=-!/B.,B!P<=;T M"K&C=OG0.FQ`L#/8K]C'U!RF'3$S&3I,-IQQI^].K#KC^IO=!%\1/(&"G)L$ M_`P]J>A=A*1*?ATW'1]>9Y!XE1`?XR`]IWW[BC?B*.5R=7U'DNP;3M8?\4TF M@8L9GPVM^/[-X2#W21\>C5K>A"2GY`#A)C1SOR M(78&D^`8.",1Q*8D7G1.D@\D2<@##JZQGR>J'94)EP4\GKP[?F\UULB@W4TT M5L1"*>(`Y3&5'4I+#A01+T;>;8+Q>GZ/E*EX%/@40^X./LEZ'?*P/G!CD3@+ MXUL<^[10B`*,"+6#\3?\/?M`6_);^XQC%'-QV#&,>=+>V2FNH;01J M'[\YMFL\J=O;-IJ`$#'*?6J_`RWR2F('[*-^.75BK_EHNF07M4/(-?<$=-06 MH/;N],W`PPZ2>5'?88>FT;]6!12@^P:_M*+_0\;D!-[ZA-7&FQA26X<7!BV8 MO"IK*M`NP4J^1>,CXE_+:%Y*L8^669:$-WD&?B!8-*[H;';AXI*IQ$V%TUE, M50R-E=-TSCN@NTBFV\49D5?[-CVY]8DD:XR=O5E?5;:MZ4]Z%ZOS:4RV0 MML84XV=K*ZZNV+:.&:A;GK*X>D:V3Y'H%,C,BN,C7F':CL#<_NKCL&&`O3TZ MLGJ-M:?-[6NLG'A^5!H*IV.#\>%SQ@8K[@5_%2$.YR2I(@4^$R_&@?XR(1^+ MP8786-S>O'EM]3+'\&XH(T8V/%#R"02,C`=`9['D\G`)V@GV0Z^=1&H9!V5R MJ2]8KD;-.&W$@;XY/;8:!VK8]DYV@)*)'6Y[-4XG,#I$DIU@4#[&S@#SDY?` M7>#T"B?L#/)C&.69])Q816GCX.[P]#=W"PKB:LM@.#]W?^U!I)6# M.&6X^YL]_A5G=R30Y\DTX[.QZ+U]\W;0%1S3&Y+]S6^N>YP(KK7A`MUDA;S5 MBNX#J267LO1G\Z-[D$`[JQ\?;(MW(W&X'MGUA1P2A?[C'=I5G$)9](YB?"$(U^UDQQLY`DS]5$,%N M/%B'<0BG;EEXC]5)[OHX;`#Q^.30*A![VMS$GR#FOI0&>9'XS@$<&LJM`S\^ MLL[`CYL;UQDUV-?Z&`(5I06#6%F]#1-85GB?T=OE69R1.*6J)V`IT\OO;,OC M0O2?3D(*:U9-*+%?.\1MB[47&+/NX_D%F)QN4B\W\#(,Y$2]PHEP.3#W0^^> MWJ0,&[[%HW>'@WR+?;IW<"^DB3;8QLXOF1$IN>?7Q:-EW?%/\K%W3#OW=.R# MEX;^)`C72K`"X,.WIUMV4/5VY'EBN"OJ+H+9X&_'867<*INN*Y-*39U8_67) MW%D5%ZK8]IDKGW%RA_[3AM`4:>O\7;V%J#Q?@U65G9G>E62P5Q(&@&"B_H;IRB'IT2B.RM^98 M&W%0-;&X23ET[S6L-!M&[/'INRWNP@;U1ZU7@UHQ#FO645CH6+9<(H[NS7J[ M.&"7-J0L*U`_.=GV?FU`EYX_V@UV<5PDVS$O1K3/IM4QK'I38V1(J3(;I<[? MV.75LR8XON,;"SP[&-%9-@.*4QD\$Y2BPPO#Q+7`RF[Q_>'QH+@(Z^K_F6M\ MY1Z2#_P<2G[W>MV:*A^OO2E?E`>P"[V"*'@2=[:@7ZC0X9D\$D5`5CS[\83A M-AH9X[7Y.`4^]W476>,,VO\!KTB"RVML$C5KJV0;::J/#@_M7I>QT[?6=1I7 M=;YEC'0R7'/I.+:_%2\7A(KH.`F1C9>F7K\YM9J"L=M,]6,2B`XDW#QTX&*& M6@2=UZ?XB+D(GNK!`3U^:G164J"?'EM^K$S24BV*"B*G<-251C>3.1LYEZ"D M>EJEB(?G_>L#VN!2K+Q4L"N[;45^S:%/8<+6>O'EG]5I% MJXV*1W3%I0DG`"0;](YCE`^3,UBIY;9:Q@%+?\_O'Z7\>J99XD4]JZW4:$8- MM)8PK:\VHS1J^D(6]3<^X480>Q=!T/[(7C3/'MW*X&@D`VGZ-3-.55(V+;):)@2-%=^[B@]O7ZSHLJ.CM]L5969:"VG0*K40WRD MMJ"'K*L<4^WRI$2A&C6E%I!.^+GG-HEOX9E;?1XI&94-+\?AZ[=6O1R2=C:W MGT#`GQ\.74H`I)%"QV?!Q\R9?>@7G,$+M5<)N0\#''QX_#D%M]]Y&'NQ'\:W M2S\+[U5KQP!F&R>X1V^'>3J,EA;S/DA6'@@%\BDWRBD36I$$K0H^Y)6,\P-T MN)0[A\%\\&VM5L,;-&TQ&U2?>JT;4,QSQ\9(,3975W/^:O$=KW3<4*U\D6@T M5./L&U'(-B:F0:.W,D'U]0Z>J+KB%L"`SB/RD"*(NT(E,5JZ,EW'`<)TVIJ4 M83)]->7T3N,!P'9V.IM;2C)F&T&9[XY/AH7?3["4)'W064I[Q7+X`FU$2>CF M4=CS3V1MU,B\$X')1;%ENTG3H%VI94OJ^'>&E)%"':N&QZA?-]6NB(2>9D7I M"MG&-#5H]%:FJ[[>P=-65US'BBJ)GX(592"@WFEK4H;)]-64TSN-!P#;V>EL M;D7)F&U846].CG?F;Y+T06=%U1=$4LZP)[`@:@3=,9WX^&_9=-(T:%>ZV)(. M_CW`8Z0DQRK<,8IV?@5;W1^3Z]#:]PEJLE$0G[2#9HZIMJQ5(E>(KMPRD(Y\ MH=3DHV5!MUF01-^QG*3\^O@W[D[KQ3!(6W<'<_!E%ZE6;I2K5;PURB>"-/78 M=51@1=+0[YAZ?MT[8ZS92R>&Y$`P(#)!KS>OCFU^VY,;[/53\5L M!._\8#.76`=[?$"=P1Z[?2.Z\Q7?XSC'\LON"D(;&'MW/&S[VH5-EMX[< M091>#AT4\2%S!D6BQ3K/9H=DTAY95>&TG;"D5+79U2%>B%\ ML'9U=F:WT:Q^&D,O'27Y%.Y.W;DMC^36B\5SW-7[0OQM;KH0IM2:8O^\7(F( M*2^J7AZ"7$,12?,$?\/?LP^TK;^U$+2MXL7H6B]^TD395F MV:)>XKQ*8&N`)MM&45,AV:ZE4FS/>T[^.NH&PS.;D'00&E-R'S5*9;/*3X6E,]EDL^>X(MY`LKCNC-O$U([5)F`T)39 M2@;-MZ\'I?/J\].8-U^:,8:E86$SGK`?G+K,-URNW928;+B=\?&P]I^1]2;! M=SA.PWN1U?,C7H4Q#L1SQ%=4TNDR^'O.'?&U%.4A/.+>'!25F]%R+3:>B7A_ M8C=[[!;ZV9PD5U"J6!$OKSY]0!LH:_Z)L448=1Z2X$)S?@;!&::^AQJ_JH5" MIYFYUCHUT:RUT0Z-(3N]>+%N^?5"Q/$IVHM8/O>]+R3#Z.T+!US(]N1:LS[M ME=FT-B>76[,OK<^G)Z-E!BS'!H59675/AUF<1N[V\7V2..C[YC3NBS2:<\TU MAT1W:3W5&Z>[6D3F7CRVM&@4P&HP-P/8ZN][/!N(64*#K>7!QK+@PG+`4Y:> MY0F\,JI2\TTB&VGH3X].K:9=Z393YACP^2?A('!D:D@ET,D^SP?,K0U+E4I9 M=KK>(;&!F[>'1U9?P&@W4H::ZLD"5S(.JT:_@QH^7,Z@YLI[9,[6R]7'$.X@ MQ$$;.!H*H;EE%),L#$V5#6FU>UWAZU6,;[T,!U(#0EZ\VC*0T2_*/]'&"P-8 M>^J)#><%I$YDQ&"0FRNRA+!::GUN':1;D#D=:SU'RJJ.AJ;+?M3;C?M1E M'/`034(W^3@+$W:@)+R5!N$H4XLI].+88J9-H(F-MQ!&,J$)FMDXMM#%I_4F M(H\8(T&%P&$]\SR=BC!B2]RM^3ZRM)I2>%*@M[:TN(1X6*0:)TK,9FZR%W/! MT>"*^>>'+KU(T]RCW;YWT\-K+''KX^M'H=JK?53>SQ#WP#DJ*0,N``P9N@";H1QHXCH03&(NSDB.5# M[#@6BV3-'_&-S&=KP&0E0]_[83=>QJ&QWNRV*N3T_*WS4'#`N4=4YM@.*!?3 MC_!S2>+35=!9E,J$VTW)]UY_FV9&F%Y[5//'P5^]+$_"[/%R]56;S$/[(4.TRDM@,?F-[+DKUVJ'\,P(6T=E4A)K?C-=8VP>7BBJ*??FRYE MI(9LFCFE1XV$VG&I&T"@Y5F7<71=[+O%B^T#%ZM88=XM\1T&2E#4WG5^-LCI M.Y6QAYVYE:MRQ9"MZN;,-LS1MV_LYFPR;WYSQ5\&00AWI9BYN1$\^]7:SQ_7 M(ZOLP4L$-VLIRJ:MU@$)4%[,H8MK@T?MGBY.1(NW1 MHTI^C58UUCX[S[(2QFF>@`?C*_;)/4Y486$J2BM/UA^>6MTA*=K:5)4U(G#* MEU3SH[U'*-VWZ-GP.;,I^HHW94VM+JF#EVV&@73 MHOS2]93."]E>01+346_GN9%3U_/>[!(;MC8\5G$!&YUGC`S5YL8>-F;:U)R3 MA+:08O".&F&Z4TISAI;W2,-@Q43N;Y!-TUA;6[])K&%O'8\F)5G@AH?`0/`= M6]<8+"T;5\W7M6WGPY=MS]/6L`7*^7>%KCY?U';PM6,5?I:O\\C+PGO\:;7" M?G:YNHC#+/2B94`V/%'-%_RP]'V2QY`8Y"H)8S_<1+(MT/BR+.R[WA\>'UE- M_S*Z-ZUXE;(8A%DY8-=XK(CX%L7X`7EE$2C-O#CPD@!Y&5INDC!"1_L()">N MWA\[<%MW,F+:6SXA.8>V?)D'N3X@>S9M?TJ[PKN,`\@"XH#/(+U@:=?^IE.K%1U9<.0 M6JQ=?=23K!S#IEBX9]%?D]K$Z>-=B)\16Y?G!;:I<,E`$30MF1ZFRHR9$SVV M#.0M0@=,XX($EO<"2(S*H3L&ME&ELI"WA:M=ZV-\"\8[-=Q)`I9,_S6Z`1R% M7C;@F#:[S)MD0S\;U::9:`;\"T&$+N(52=8.Y#X>(G8R0C"MV=7/6)MA#N#+ MF@;?/KB8)A?P*NGTD)A0 M3C\2/67!3-B:AMA`D[;';7!Q$B1H4B>R&?6+H88Y@Z%U%8/I9Y%*^E&JME2T M-OQ/AV^/K?J?E*WMPYM3V;1[Y=/Q//%Q=`=@=W29AD/E#R1)R`.XT630DE#9 MB)AZ>_3.:L24I)TM.`&!*W$%JI%50$>,ECO0*5XO@#U\>G<>D0?=.WM:\FD; M$8.&3-Q_Z&O0;#QTC(OJF0@4=QSM,W?_.^X_3*"X,6#.L[W3:E!5>#HG*;3H96%4W[7"02S^`K M2SGICE]!,31MCT*'S!E[O9'I6:,[Y723U*:VZFD:4U6T6EG*.19GC>S<#FA( M[:!5RE%/UM"+4M)*)1H)?D[02EP)6\@-__YXD$_"Z&F/9FYXU7/:KB6(-\P- MSP;,UM55:9T6582Y:GAZ4E$/H$8/*.;_S//^/\/L+DB\!R^"Q#YTQ\>4T5^X MO7:>=U.WP\@8,-FX)7_ZSNYA7G^SFT921=]*QX1\P>L`2LT%V+D+S\?7ED(Q M;XB-BSY&M:D5D`'[LQ3_0$DUU5D_7Z7CAJN('2N^,KW\E??(LIBNX6#I"B=L M'R]12ST,-BY8'!\=67UC5-_DIK*K8!=K32HW3+9E`=[?&CL6M`V36<#F_D)C+AD<&1F M<=L>GGMJ^GZ2XZ#*9\4=3%6::]FL[>6Q\AC6VS=6(T)Z6]W*$<7)Z_8/?]_2 M`?"9RJS[8A8;4V?6!9:T_W,5<-/S4)^$TL;*\>[U:_NOKG7;*H=7$47)4DF1 MQCM^3D4B]8BJL^;P0746:5]H;XW!5B.V@3=JGVT5;U5S9>_]59E/G,975T`= MB/%Q=`9B'_$*TP8'W[SO?&7_@C,MS'H8;$#MY/!PF%%H!0FH:]GJ`?4E]H>TU';,/[?OWEC=8W4M/?)*JR^@S,^ABZNCZ:& M6"^+%7/L9-@^<^@::6"9N0^Z@9;9B7Z;.7J=U#;#VDJIJL5HK90S-U?+&HVS MJV6_Q`<)1[EB2KFD:Z:1"IC%L]T;[60SS&E,?%//Y?I.P7WNV"JL:>F"0[8[ MS@K'K$G\DBIPR9&(I5J&MXO8C_(@C&^+?/9>!#&!%['(>=$"43W:<$@I%N(^ M1S3:9DSH@.KE;P*RW'M[_^_EX1':>`FZAPHP1L>'1X?L=X#" M/J+$&^Q#?K3H\07[W2O[P()9#RB/S[OA3ESK"-&W8UX'%>&,O5ND#2L.:S]X M:>BW]3I=<^5T-K("G+X[/;5^)"IMKN2$E/T^OT6CE4(G10`?,5N&J[;N:=:J MJFCUPBWG6!0_(_H[O]ZTCYZ,Z/I'N;G`2TFK==YH)NY:BWSW<9I2ZU>\9LW> M(12-PP'5C'!\Q#(5G8>Q%_N@&F&-4+U#.:T\&\_\'AV^MAK>.*E'K>O;L,0< MW``?\FN,L"$O'@&>V]:=+$.9[JODXLSRR0Z$A*^K]["N0V?E\.3MB?USNG9+ M]4=TKH2[:(71/29A`^<.DC8X\;(J09!NNZZFG60)*(NUE<%,UT>U3:!KUJ+\ MB(JOZ)?B^\P9RO22ZE@(!J/?M!.4#)6ML&N@6/3V6,9*'2F.Y`2S!(_M@V-N M32A;3SLT-K:BK]^_'O3RH]%6M--49:`N<0VATH%6[4KYX-G:E2KKM;P"#=,F M3U=2^D'MT1T:G3'WQE.V&=983GIZ^WZ4+2R,??4,=*Y4"Z2K3I9>L9DY6_3K MI9:EQ_FR`_S8LL"W!!ZPQ)7P<X6"`9FUS6)T; MBN9L0;MV:S*?(FU>Z1011.[-#,48J^>&BD$[-UI,ZMFQ2SQM2]M:!)-*XPHR MIW7N5&29ZEU;V)I9]PY0NMN9'79S%6E*-Y\-$IT*]Z']V@.-#B0OZAM(->*' M*=%^A#L"[9]C>#@-!U<)7H?Y6N;9Z9!8N79]>FCUD*3=R.;Y2/$5;<3G^9T# MJH'OWL)F(^7,J4@MJ.;*2RX3EJ,S^!M$-FFR09APV4@'?_3^U.KE7X-V2R._ M&,=^%?0U/]X&R*V3')Z/JC,0[.;(E$!"0C0!8-W2^.@,K\0%-+I\"59C`M.*MM28M:+R$)Z#1)LA$R:W.7X6WX-HS!$$`W'BW+[]$, M,_3X4QR,[F_!6_3V$X])M==55K@:8=/L8&FY0[(;BTB@5J)OM,RR)+S),TBQ M``8AU;].W-KHF:D]8]V7VUB7T]B57,;BS$3$0[7`UD,E^J^BFK3?ZZEZ\&+3 MQ;JZ!C7@53QB.7+G$EJ?Y(CA.#+[LQ?>F:7L;7'CQR6Z4"DFW\==0V\O>]>W]R8G.SIFEO8SXCZ-!?KN`V MNMJ%:L(U2:4.:-8TY6I6D5K1FO`O&D1"]3K@:1TPR)46'L+4T,<&C)5N'@&P M.8+8>C&_NI4,><G5NU9X]9W4D06;(A?#&J:"&!4SJ]O!XNU8^SRX79(&_,-166G@P6? M?F;;"0EL]/0VUO73HQ.KZ[JVQ08[++;!0GM\@^7`DF\DL8X1P$?5&=B)1^S_ MC&.<>-$R#I;!.HQ#,&,AY4,1%7Y%HM!__(:_9Q]HBWYKP69:(6*1&5G(M(#?O#)N(*6)'Q*U3BE%EU4XRG@S$;?F'G<$W>)<% MYSX2O&POV>0N+YWN(UX`^@6*0*R,F4WZ>6>$RI7MQIR8(X3D*][067<'R0\^ MY@GMPQ4[Q&8Q,:HS=BV/C4W$Z\-CJYN(WE8W#;>*DKWB5`_?=&"RVSF:! M#ZL[5INF(RP62[9C,&"R@L"W;ZP^J]3?;',(HKVP^-.!#82Y%+MX9(/L#!Y- MG2K]NW2^MMAWM*@\]S;=BKKB!YW2%,[%IN-%O"+MAG_1S-]B-NJ]9S%M1Z,Q M/.9ZY:X6+2M1E5(R&ZKWZ/5[JXN_K*%][]BQ?)6OJ\?L'-"S.K%T-"L?0V2U5LZ6@UWK-1F'N3JV<$N$4D8GRT;24ERR#2&9Q.=V M1:2/S#67S@"_A62,)_HBFB5J/`QUP@7_US[B_W88?,IA:VW8:Q2U;;A&D@0F=40/D@.SJS@R^#ON0B\@R2&7GIWD>%U^HU\Q3!$8031 M0]R(A:.C;^2,DEPE!&R6X,/CSRF<,)7.^2JC)COV;"%U)W4)=;+=NJ:]6+"+ M8;!P^K/M=FK>4]AJS3RAZ#Z*\HOB=3G9;YV#/ M=*;#J5JM`OZJ$.5'K(Y]P$]9#3S25_BP]J"J%_`9:D-%=>CF$>U!C2B,7U19 MZU!5ZSX/2?I#J]@'^//7*[O>Q_``-3C$7*VPG\$=#-HX+UH&9`-ITB]7U^?+ MZZ/JN*2VUQ_`;,-S>/C^M=5#&_/FM[8O)1_BC.ARA00K*GCAMVMTCI;TO[2$ M^;?DPR7=<3MR`4SW$S7V2,;-$BT8]FR+R8.$P^="'0]ELR0.02]#_^[%N9<\ MHJ-]>*KHW3[RZ)Z7*107_#3C0#%5?M.VO1[.#N#YI\,3HWY$D^X:3 M]5^P%V5W9UZ"STB:I5?>(UQ);\<"FE$707\]U--"G\R:8B.,K[2MDUG,!B M%X""3XA]0\5H)GA#QX$Y#ZD!Q1ZC\>+''U.$TRQ^H]KYSJ.+^`W&,2TUIDH)>&/ZPYT7K2`P(XS3''[TJ;ZFYEV2 MHIL\8V4^W(4^+3+RPG7*BXE)AA[I]D$4YV.J$VEQ"=HD!!ZE@8?L6+0'M+I8 M(=([3%D"VNI]Y@J%HJ/J,4_V[\W=8QKZH1?OHSN2\CCSZH;9&@>A3W^!68>" M,-WD&=Q`T]3T\GG-2670WY.8E:/.PG<[&T_@?(F2(*!!RHGYS%!ULEM43;=\ MSO.,ZBH>@RI2,;0C[(QHVU:/E-;.G-`UPZ;%HZC'8$I(.1?\5[3AT==NO'YF M)MLN_`V@T(:^C$4"_!T#9VL&CEWTL!0R=%U.\W6Q1/\6DP?^"FYEPGAKDH.) M(QX4BQX+@UJ[M(,4."I%+BJ(<8(+K[`KI=\*>P9NI6?&`/H?L0/W`#!H?,[-CS7K`V"%N,IX"$AJWXW+BIX8+RPQN\\">M ML&%@-1O+AJ!X_B.B-I.VBIAVNDAV6HY.#F8<8V-]9>-3=@JJW[OA#?=J5TCY M8$/1C3*]*,%>\$CYHXAN;2EAV28Y=]GI1D>*8HS&P!7CS((6Z37,'-4CMDTR MR_JC:8Z)I4A#Q@[49=7: MM+%:Y1N@N\&QX/\2.VI'\"L551>W&HFVT5HGE:!TRW+?FHDT3?A@$IUQ.Z=T M?CSJ[1RP7.!393#E$?^+.T(H9XJS+`*[1SAI6*09_"G\[]"U8I%&"8[X,6[7 M2*H<1<1GUACS$='Z;S!M!=:WD-"RZ_X<\L`#&KV8>V\V7L*[ZM$FI+0/T'(O MI<8A-*:@XBU*?J1F3D([F3S6/%RN&`PCYDJO@3#S;+%M"$R<)N M+WO7]PD8&+V>7]4M\G.ZI6@OYLJ7#7@?K#TGP?JJJFP:*B6EJ@'9(5XTANA' MNB6C@S0O"K6O36@'LHF\-E4%NNV*U?;B/$G`A9>"I5@V793A)JM8Q@OW19#7 M?!)(P&6?+KM^E+/;&2NI*ZU:K"EQ&!?$.==Y@C@HKDSMT[4S2TBZP3Z+RJ`3 M.V<_0RGT+[BH#\G)84TO,J#1)1S6WM`/-WSAO\G3,*;;^YG7T^$H5JVBXW$\ M6F]^)O$MWVPEO;YH(UK1(SWMI%EHU`P+^Z2^>M134\_II"_:3+9DD`R:X-:R M5$B?"SBV=?F6T&/HBXZII%MZ_0]G]!_.Z">E1E2KI.N*Q-(>=%L*A.Y)@:#P M12?N.:.M@DBQ6=T&B"8;81I?M(ZD97+9\['H*K5H8!D[6:0,+KFAM5+J`+;? M"2VC[()SNP+?EF$T2>I@!GVI;)P_7-!/RP4]?I[T&06SSA3+*_^T&=)8YQUR M/4^0?<]:/E[VDU?N7O=S/V%K%9<06@&LN@$65W1I)?WXE;`YZ+4V$&4'QKUB M;T&Y2]\%].X0LBT3P!I,QOJ^)6X2<'__X?O>[5SH6]0=FPV6EWE[LZ"QY#>^ MH_/GHC?[C``[6!EM$-1R`=9S7RWCX#+/TLQC""9FM;4O%F3 M4YP:5:5-=VI0PH*3\7>!]XOLO2%/6L8N:%7$LR="'8`),DIFG02I_:R-9*E. M`-"V;;(C*%;/TL8YRT+;R2D-6_H8T;:R5ZN;5Q]3JKK`F7";>''&?0.,J]#V M>]P(H:4TRV3%/&!JP7#,@RE2YHEF$R#!:R^,J1'#K*8LP5Z:)X\O7B)J7J6X M**>\T%F^HA.RUVIXKA7@7(7)^L>TV2HVP1YB9E+!WVL/3"CD11$_TXBHP4:M MI82=)`F[K1H=4;679W:XJCW13&^P,['["[E+:TYSJ,\[0SR**T ME^@CH3_#?=M"2A)@UJ_VEFV=V<#=IAY6F;V[T,2C#9RO.,A]GB7B*X:KV?B< M),M8;$UPP(,;^&M5E_'',.6I(G.(72'`VO:,V"NP?#9RKIQ<_*(L`Q1:PDMA/G"O*J?8<_,'VF`G'-3*@JOZK+"YW\6T!F)B'T?M M]S:GEEM_F_.ISS7;]J/SLZ[PE55A)TDY"S/O-[KZ>NQ)1/HI3PPG)3L(XW8H M,$DG*`K8.R0\)(=E_YYY:7=SSJJ,`K=G[?BX_2)3REGDI>F2M>H:SF`Q3+.+ M(@;K*P?8&;5O;MN:8$H18HQ'%3%)<4UI]#2S8&3-:I4TJL!%R06.\Y3NA;@& M2DO&*@#OH%`O/N.=5VM,0ANQ(?ZF7AA34J4);`#?AJ^4/=`7A%"]%UUY87`1 MGW'/@NK!IZ&<7;]I+ZC4;FH.V'9!^9Z(V2 M;!(X^RJ?AE!-Z6J8*IG$`83TUL&\@.T5(3$=[R9T5=05?G>+BF$K/XMN^;P; M<%3G4\\2'JJ5V3F`#(HUZ?=.V<7(28&1SA6F6K;3\AY3&(M`:-<<01;@I`A* ML0>GT8LF?^7@`XLZYW]_\[ZW,"BEZ>A0%=4DX/=4;0?UZDK4H%?Q+*[YSP7EXH(/&T\:!:*AU" MQ"`C2A_!KBI_("#48)C;=IH&AP%0Z`'"6!C`FD;_E!NE M?N[&$R!@L%W@`EFT9+T7WPS",9U_<4"`"9_WJTL&]6E(F[VI'^"6,((_!7\1#%^39J"R.@L6IJQL]>3J4COS"JY:)J1W')N0[)!5$-RV8&VKTHG29:J2 MSK*4AT.(P&AQR3^,44RX.@MCKM`@;C[/^-\BJ%UH4?HOGH&)_O;(DQ#LLZ>0 M//X`(BAC8::"ALWN\A2!NDWPFL`K2`]W.*9U17XNYABG`1W@&D144P#G`I@86(>V@-1C1;_GS$Q2QPA4\1<13 M(VQJMP+.22*\S5=4-.E%<5F9;O7$[YQ:'G`SH:!F_,V8@FR$XTSH@(6E?U(C M>N-UQA1;!.\T[_*L6)X:?I"S@0+JM]HS[WMU)K@7%KPOG`CIF0+0=H3/=+"+ MJ3^^O$[TSQ.:-UNZF.G.Y&$YJ*K;@BS\34R@S@EG.UD3HSZX89?QX#E,3"T^ M%O_*IAL_:E]O(O*(L2BYN!#'*=RX%3?S;.L)K_N]S3=+AIQ[\^RDBC'E4N+\ MB!:`!"5B1:"R#`0'$,4WSO7'C%''*;@U8VP$E->NODHCR+GBOES56ZU.D=!' M/6G*]Q3>;/ZTN6U:E7H:FY70C`FOWUIV(P#<5/IDE(R:<\N(M9I&9C59>P8M M7T-FR,O5=7@;@[/%B[.E[T,T%ZV,Y,AA52>]O( M82A;?T%N/CSS@\2:#UEDD&%^9"J,`*=^$HHT+&D-[UZ%]XTHM$BA4AT_\FPH M+YE9Z:$8/S38$A+3OWU>KTA7DO)L)6+3!\YU<%\_8EIA0#89Y-BJ)DSLEA?7UP$![ED8039;9KY9E@3`DS5YCJ,<4!;<=)L1;C>>'[6ZJ\0 M5[-Z@$*M2IYO.18)B)@SU:-`H&!FY*7,BW;D,7N0(KJ.XK67P5K3D3"=22&^IY!>A[=WY6D1.Z%A;TUH MAW`/G'WXN[?>1+0G&?;O8EI;A.Y#$GG\#(J`N&XRY)-['+/I=)M@,:(``$!8 MC%E"*DA0%`?\JFY\RX*^RU25M&(X)O)Q^G)F9^&N5QOEJXG/8VPI\P%[`GW)*`]'5,I:DV.SJ2\H:$A&1BN+.Z MTJFQ[]*2=7'.$H9%[5>'YH%65L1D<-L!SEW*>GSS+L1NVXZW`H#2(@^I^5.E M+4Q+\X3:NC6SMY8GJ`X<:B2<\7?&T$O.:6I2J[R.K)7143QFSS9T+[2:I=\<$1O'^O2\Y!/]Q5A MQ@Q@809"_DG6(;ZEPY97EON0RK0VJZ-H^7!ND+1*O ME5``I?OHY^M:"LJ2A?U^2\W/)&9&:_W+.H]9WJ*H\:M/:#<3V`_=$)9RP.?/97@Y^I_,%)"02P)H4!F(/OW,+O`$S^AG,[6(R]-W1+7/X`^^.` MM)*`-H7"!Y?O:F!O3WG9DX0)@=SY8K_NP23D2*P2C<30%I9./X-%B.T_8;?$ MYRSSGO(-ML?REK$+?`T%I%,4U676EL)Y"?J)XBMZ9`"#88+)P[?TY:8+7AF` M)P1)%`%O*4>NK?BFK1B1&\__[3:A&@0B^&`RLY?*TPP"=P*3P'K M(UU<^!\%@^A/E3KV(:YVY*JFER\)&=!*QL*)+3Z`CO'):LC[!BP:B([2#29[2/K`TXSJ3$_#PM. M*;>40IN)/7?UMF10Y)ME/H%R#$#DA&ZA&7SN";/C.7R+MQW!J],A9Z4+[!9@ M3//5"JS1.*OY&HI5/:W>FA()G`EEV("K";&[]%7D.=7#,#QD17?.;-S36GD< M9_7PFXB`.XGX?C6NP6!LM1_U-:Z8W`*\#V.R(9IW[*"6M1GXT7*X@4JB&R@ MT@276IYD=_MB5:&%K3QP4:0/WH9'G7I12HHY4"9#9A\XHB%D@A+#_"MB8SD: MO&JQHL4F=$"8$B@=-"3&XKFLM?<;3D4X1NC#@Y]\[C.'#2YZQ%)@P\#BXO%0 ML@Z%,@:>`[):@?_*`V69!*)LT2$J3(CABV"^\/C:0L44H;8P":"KA?>G"(H- MA>>+4_&WGKD'IZ6FZK9)')0BWF>8W90^.3'^(NL21Q&=E*6>`>=A+'Q$11FE M]MMP=5(^6,+)BA"QN#Z)A9XOIS^C%"LN0^H^Q/)F`"GZ9R6@5+;\WGCQ;X7] ME/)UAVT!,RQ\4'2JA_!%I)5F"WW5VYK'KQPDUN>@G7L:9@M;W&^YPJ9%5-EE M:P,^^TWNL;L8]9U=!_8QPRYI]EW7M;&).6GL8Y^LT!7.F.E"'^U6`E5 MQT@I@L<#?G@ZHE,M!KL6GN541F/EQY1]N;-"W@W)V3%=DAW`GDE8`_$M_Q?? M%E:[K/)A^]*0*AZ.@^1')$G(`^RAA:L(>Y22-IW9C]Q*W0=+!!?OS7?-('Z: MO,^-*+A"12NE>Q\PGF[XGP4%\U:4>Z7BD?H<[+WB?`ZDFF!:%ZH],<=[#.8F M:V3TR#:TC2YRX\Z+1-[O\D*M+\8LK4:HOC=A5?%Z8?>Y7]F%X(EA-E\$#L`$ M.LNW4>P)&GCP3MQWXW:]>,\6BP/&:I\!HX]9?VF[N$G'=AE1R+Q@;%O7.*ML M6(C%`6JXAHV8Q\>'5I>4.VO9J?$^/R#VA%.3G>NF/&]Z>0&.MY/MIG6-H3LQ ML/[5K@(ZW`\>W584D>%H1V^)B4U\6Q%L#@J=#F/S&=C8UP<)Y>("_L[]?(/#2@?N/W]Z# M!/`NY/@:I#`5AM08A3G:=#KWPN1OX,;]*]OK8.W9E!FQZ$T/\22-;]:0:>97 M;QWJE:"'=0'?$2-`=0J';#9#29-A`FGB7,]3`7\^(%DU!+>&)S`5S\L%Y:(Z M0WA.$%)9ET\`1)8-TNWAZ$1SR,H,#IRUCEEOJ1%1W$"KG0B"A5$"LG:HA?:H M=1.`.8.#%W6+KNV)9F9.]6,M31#:`^../VG,S@OJ!59A@C6ERBP0..BJ-62_ M]'@S,[PJGEM.^X79F!:G"_53$GZ&6(5%UD[#RI#$TO%:',ZR9Y@+)_`9=UBG M]3'C87^9<.G/,'PS6TZ6U87"MMJ.NACON!*^[Z^UO;*) MMQ>R&'4`.(8H\\U:MK_`2-9B_6<:"MHI" M&M>:^)6,N;USNU<+*A_?;&IAPJWWPJE^&5\(O^Q7^L,U1->T=(H1;9FJ24<[ M,;1(W1'.`IKF3C1A(F$R2!+M9!$:EGH^B'G@ M8S_OT%:`I(V<%UERX7`+,BZR@QSV3BM;S6JG:"N6`#*1P7#V%$'V<*A.]#,? M$HNLZ=K"QX*][G(2_]C_&<^>[Q(&B0,;)KI9\QX*QEGW$"A;:7\)U`4;N@>\'?%"`QR*0(R[2+J<((KD%^(&5,I/0^@^,5_G_,8>[0TD_JP,D_K'3A@UZU8C'+\Z*PDPY#1@ M?,#QC]R+PA6/0:I'V``;:QS?EU>9I^]P<#M[PO[MS6*5K?,DY[&E5`"[F;\G M?#$1A.A,L9@PXF>+/H5;9/OHVVF.:W:":"/'=;.@"3FN14$[SQW:[,!,.:[+ M1MA-'RJ*G9CC>NX-TF103LH;*@5XN?T>6]ZTK*'SSA47\EIO=<*`(?NW(ESH MC[36.Y]L-M-:/X/I-F-:Z^U.LZEIK7DQ?\P8NVFMMS=C3"Q<(0MJ?Y"8K"'N MD8DD3U_EZ<&MYVU`,J>O<)25OQS`+P>'1P?")A8___K)2V*XF7*%$]9Z5:Q: M+YT84S7=),W06_VT::\K7CVKU5R+XA.BW_C$=2B\IE^6Q'C%-_4;1.RT("C_6"0P;WZA'KY63LD%32SFIE>)<8/P`;6,OE>4Z*]S%@IJYL5>419MO)/C>^&M3S+HYI@E,IJ M1,F+5@)>\,TN@WL6^DY17Y6WC^HE[J.J3![`SHI%1;G.),^:`%M9EJW)LT!H MG4E%2K-V39]3.]93?R8D>`BCJ#5CVS^+<2M_GJ0(VH5/F].UTM33LR1:%'_- M.S!XE'F?0-C`U%**/,HI)0--4.0US M\H+5\)/14YW/\HMF\*U(034O*G4B(@:#VL2JA+""K8&LYT<$HT)6C$T$N7-VLT,%!/44:7-KYHL7/CB?/ M%43,XB`]I\-7W+U+O_+ MD@`5%//.'C,!DT&":,X;+4LU:0:A9\R1S&,116P(N1/E/+"D1LSS1&CO6!M`:^EZ#O^#YV'NO0B\"5S20BA^+:\,L[>RX`]< M%3!SJ-@8T)`ITFP%@PTHH1;^-0&O>()<=B:&UR^^A\AA91]L^H>Z>\0U<*??AZFOA?]-_:23W'PD5I)[8UV#UFQ MJ5:13=M`]U0^<;.L+EVS,58Q+8K3/OX)P3>*B0#!UYGWO7TR)*8#WMK/*JAK M>U=#6.Q*=F`8]HFWO!$R`T-P02#DZ^P(CU.Q\BK"9>D8-MEN2R+>\4HK&A&A2 M6)@'TBIMP+]=\POWX MAT6=&.[P\K>L/5^\ M!LI2<@L`EI4[/C=.'W9EM;406_OB#AAUPFI#4#&B:N`-6[1U39D8[20O61/D M)&-8L%\1_(R>I"S[A[D5R"2AK,4O&SR2^A1;!V_/*^V+U$5,P6-`^ M\I*WIW_D];4T$!`=P-._**!D[@!7+[>V&E(.K2U%I&_.-%6D+%NMC!0L3)I< M&\$75'UZ2H(U&?&F5I+35GK);$[O6#-=@G4*@7`)OL-Q&MYC?NEX6;R)>$Z2 M:R_"UYBVE]^'*-_&^(*SR]4W[[O1)83ZZ&^Q4@L:*4'GJM*RQKC;QW=[%=@J?+;Q7A;):OBLR9W%\#$$"&"ZFYJO;S MU2[U#0;:SG-^@2:@$_S3=TBVCT4":L5$,Z3.BKQ=>NJ)F;F,FC(U]U9?);KL M6GK>(I<*9&07)*C(S.[*M#*5-QDHE>:$ZF&J)ZV:#U!6DT5O$5>_'C>S]/ST MO!"DNGF]+0SMVB&GJRCQXP2DD4H#2,;R-\0+?VZS!?(R^. M<[:#1WL_7%\MTQ]>L$0.M[D'-_$P.^TMCB`05`=K'A#_^>*,$N^C31*NO22, M6&B8>&HK0>F&Q"F!PV)8,\OWN%[29;=J3U#K`$IQ%(FGOE+V."WK#T_X&I,' MH*<0XR'T31IX$JQ15/%AYK>]S+!,!F&NJ:BU+)6NGFNBV,ILM*4I`H9OG0`5 M%`X]KV,30RI+V'44#7J.K6\W$YWP3? M>KV/<.:_9$<]#W>AS]AH`3@!U9U86DN.LQLUFBQS\QPFM3!4A)JZF_J\EDR]RP M-(W`O&`?D/CBD%DQ!0,J,\(5%-@T%VQ!X:0%A2^.)%K1"ZP#79U< M6QAND';!K)7^#E&]I(T)H$'GD=>^N";]5NRO&M^F&0&R:B8:@*TB-:M]@W)1 M_A/!OV=>Y*7#3[3#UEK2ZR2UI5PGNSFPIS[SU)&TD6CMG%-7J25T\P9902!&MDON-C_*\XC-,\@;?P(`*L!2S%5]'G]M=)Z%54 M-0VXW4+5F&W3+FH_S`M2E11(S]@UH=DBJE#9(\8=`_)#GH;@Z#IC7C_FS&=:GG@&$1BR7/)0-=<,*(N`+@WEM(BN_B9,#.G25J") MZ=+PE6]C,C<_N^F`EL7-]NKJ-UHZ<+/=1,9D@#1:85YJAEJC6UR"31E@*/A^ZWF@9:V'G<]^*,I)C-S#8>$G1<4@"@MU;/JH67:[@ M_A:.4[;0?<61E^'@C*19RO*T?/!2'%QYC^Q(51>,9Z&T6KC>E-(F1YA8Z,KT M.*9IC="'ITPI>_&)A^YAF`3T4WB/T16$[,T?P6(#@L0R$+HQ,!,*;4;)6)PC MH^-H_H*]*+L[HQ6Q*L63K"H]84@MQJR/>M(\-VS*M'G<7XEZGO;Q+C@!`@K$ M2(K'@AT*'S`5.!DHEN:LZF&J9LV:5`$J3P-/@\)7 M^F,"MPDI$?3*%ZPR).X1'L)@L6_L+_^.%LXB]NXX_'R`G\_@MQ&:C8(C#=,, M[A+$?KCQHN@12LOCC1<&:(7QP8HD!RE.[D,?HS4.0M^+]E$`/>?[^`U=%->> M_XA81&&Z3VO9A'Q81%U`)?+8K2$V,$5!SKRO]69M^%NJ"6U:GJ2YQW.?)'SU M14F8_G:0TIH@KM!+$N@86X!GCNBS/H$4,3[;FD"CS93".3$D]4.,'RXH1:N' MQ:^3IG:KZ&E&1E68>H(6-(MB()Q/N]`>?:(8NR;PQ,<*8`IQ[7JW71T?7JZJ MUY8O5U<>I$4"`]Z+VVG4AS$5>V+Q.<+G$6>[#S?8GV.#\2!:#+.'I\,?,F>!ADR#B)MK:T1KRUG>LHA,X0 M@%>3O-+O94#:"L>3DEJ)RM,UPDYPGJ*&_A@]*6,5JE>?8^[L78V$VPG=,X!" M,7$T'-U`/A/<[#P[O6I>*+XV\LY;0K^BJFF`[Q;:ESZ^[A_EN>+=`;)*&J1G M#&4IWR4([1'G:)O]&\G`2J=%WI$(MEK\(>._XO5-YST^H*]O:_GF?AAP4A1G?;'XMGW7SC]S``TDTX-EH8COH44%!_P;1C'=-O^ MP8L@P&J9_;L7YU[R>$0[^VXITA?B0($_8_:)4!S:3%NH-*VW"="2"]UP-N1E M2#"BHWT$O/N0G,$3[&[`=>@@UY%KSCL]7_+0.NUGQAD+C6.&#?0!?',,$;]S M-&PGK4ZG=KK9FJ;5U`78AG!O4[>FV90U]^HVYN!^@NJM=ZRUD-9P;U'%*6L] MFG(Z8A\H1X69!CD'(H6UMA?@5>B'V0L49AC.)F*<`4."?1S>@V<\12!#^ANE MHYS[*`CI1ZH&*.8>8O8+RTE`OT>AEU5G+9AO2G@J`SC`\+(L"6_RC!VK\$Q) MD,F!TKWD+UN5C<.\<7<4P#<8QR6*&:)IV](\RLK4#_DZCSP6$\*S(+#^!F3# M,BS$^*&><($]_^0EP=RG(KN>$$,+SGLH?IFA%0U;^/PMB/>\>/KA&U90,2[-WA")+]L7HS2-:?)X\OT9E,]8=QF,$I"E\"^!%*>=@( M_Z@.6I;5PG`M%@9T].8]VCM?7J,OY"7\X\4^$M&'L##5.%8D01_IX@E9AXI, MUUC"Z9_(8X1"U"TIZ;NJ?Z)!Y`FN5H0#&;,MWLD[UU+V[56H`DOY8 MH_Y8HYR9G=M9GRK(?&*(N5PMQ7;V"WZHI%O`(84;V<>*16I<61,5S:0.V%JN M1C6BN69)YVZO:P'ML;OSQXZL6I.$49\<(PNRMWZ-:L"DD.6MXNM$`3#9XM#" MFHA%CO`0-8V^W84IPA'7\KX'G"A/(:GH+5T;$HALWF=+!JQ@7OEH&H\R;I7, M9H*R68XL"?-"_\2AI[FK)_#2;^0KAK$+(_P%9_R^Z&>2TM_/O/3NB@>9!Q\> M?TYAG;O<4&!`WZJP.47L\C:K*/(A;:.*:?F4MMCIB?F8MM,R33ZG;52XJ)4* M>J@L%\%KF<7E;\+^!66CHG#TX1&5!:.JY)E326USCI!=@+*5RFH+-=528>U@ MNN\^+T3CR=%:6\_8I:!(_5;A0,8J9X0IX]0,$@,;.#F?A'E]VNP2IL4LSMAM ML12>B>$)6-"2[J$_A]Y-&#F@7$9`A(R77BS!Z*8NYH"#NWG[I0<-L M6.?IM?O1+J&3XKU.9Q'QDNIM8KY9O"GJZUP=W(OL[BOT:N MPK\&'3NVPMA9U6<2WW[#R?HCOLG.\@1B!UM8+!\3);Z:Q<(KL*JRK9YC]/6] M%=@N?D7L+2?N.(XHTT%&N5!`V>:%M9%H:@@W'.[I!PQ\%+_@3.9,$$>QV_/4 MC:I7K?%&%+44G4.P;TEL[#DS&N:;B`/VY/#P\/CD:%!\0=]4@2[0[3C\ M#T*;[[T(_$9?U(0``QQL" M`!0`'`!A970M,C`Q,#`S,S%?<')E+GAM;%54"0`#R>;92\GFV4MU>`L``00E M#@``!#D!``#M75MWW#:2?M]S]C]HO<^R+&>S3SD4 MB9:0L(D.+Y(ZOWX`WIH$<2F`:!%L^\679J&`JOH*UT+A;W]_6L4'#RC-,$G> MO3A^^>K%`4I"$N'D[MV++S>'BYO3BXL7?_^___ZOO_W/X>'!3RA!:9"CZ.!V M_(;SK#CX]R]!$AVTBB3[\2G#[U[< MY_GZQZ.CQ\?'EX_?O23IW='K5Z^.C_[]\<-->(]6P2%.LCQ(0O3B@-+_F)4_ M?B!AD)?MZQ1_NDWCAL%W1VU=4@KVO\.&[)#]='C\^O"[XY=/6?2B;F*`\K8. M^N\D>!F2%2U^3*F_.VZH&!-`4QKRIP%]+?GQV[=OC\JO+2EEA!6L6^50'1\< M5%I.28RNT?*`_?WE^D+0?O;EZ)0D&8EQQ&QWD],_5RC)L\OE:9#=G\?D,:-M M*/GEFS5Z]R+#JW6,FM_N4[1\]X)R/&QTP;3VOWJ>1^,:>A+$3-R;>X3RL0WL M\QK9L*ZT%]1=5LBA^FJ&#IMX7:&4@8$DI9-:M%'"R*9)M#:R0>B$ MSB"6.+^BO;&-TH1L+)IS'N#TYR`NT$<49$5:=686[1'SL6C01?)`<6#;C&YI MB\HOUVQ61PW]_FF-DLRJUQGRL&E(>ARLVC>%?6]A/+,<1C$9T$>G)/4Y7S)C+^%`#?HCF'T(EF2=&5K M9`$3FZ84JU60;NC\!=\E>$DE3O)%&)*B'"VOJ,B6HV_-F&@80YI:_L!HSIK^W MAZ^.&_U%V$'KWU.\Y)MG;SNMVLZ=;C/T1T%+OW]@+&S\IL]AQ!R#]K"4`^UN MQ\XR.$863?J)D.@1Q[1X5(X&)<)3%%TD="5_AV]CM,@RN]X:S-JBV?]`09S? MG]+QX)1D>785;(+;V&8(E#"RFB"Q8?-S\&35*W=+6U1^C7!"IW?USI1IY=W2 M-KX5WJ.HB-'%.4XH#QS$G5[AN/!_JF'>3DP'V3BHPV MA:Q9H2!^<4#2"*7UL01MX!*E='S[4,%,JOA2ZSE*,U12-EW3D;!OVD6W!5Q: M?.4=FE`8F.ID/8]EZ5I,T](SZ3?&*<6F6S"N<2^\7K)5^I5[N<-I2T?!I6IE MO8"6KA983C<3SX8*:N/#"MY[X:W#W>IOCNK*46]03!G?5;$B,9T++J(53C!K M&]M+:31>#@0;Z5@^BDDSI-LQF8G_.U&1U0!O6?%>]!S=H[:OO,\0"M/1C\RW M521U@X4D,_%+@'@V7B=FNQ<^I3PH_E95K6[UW9%=YN6)L4GHGOCU*) MY6:V485[T3<(+J%]ZQ++N@#T`M M>^';PM0!7[EW2Q;<0T7)5]<`VG8IK:*=B5>:"&RW2%;RGZ?K]?*X?'.YH3!= M!-W-GM%> M%=01MK<"I80S<3VPJ'9W_>3,:Q=[/:]QLYNLX9MCNG+,CE996SEY)5]KX?BO M,_$[M5`VSC;@..4@!DX_\\V)W,ET3IN*_92.)LD&]\WG7/G@JV"CC?1QQZYQ%C.$V$^=VJS3;\XQ1 M+9BRBY"D.?S*NPBA,&)5R9P92%V+H:.>B3.:"6WC;-H:YGGF89;`>MJU7&.7 M3G*\*U*=UTB\VJ1(L[J#%)EX4#Y&*KR-LA9823M8!&-F.&`C;]WY( M->6B5L&^=OV_M./HE)&A)"F;2AW[,BV%B\JPXR8ME2`<%%BB$P.J*S$A:+0@ M(#9"\YB1U=)$=VJYR\.^O$%0V=)L4>3W),5_;H>3(7)DE$/$#"CG@Q2-D)8( M&7(5(^.U'3*$\\E!]1=95J"(798O\BP/$O:6G<[:JC(RNPO+S`T!`,%'84', M7XR*[YYEY6;^9L3.NK"$)-7_(H0';T@@_*N@,=)-#P!ILZ.A(MU=?PT5]C.M M22)<]Q,G3/EI,N<#:9\H!>E[F8IAN5G28S3%\`LU)YTD8!*]3R*Z')/954C# M&;A/,QM+JT2S,SG'43[`&J[;X\Z2?0K`+*AP$1/P/`[X\5KXK8ED[7WS'A@J M4B*4BX2WL1?"5L:&A`5=@>_<8BLW^%P^F4N\'#UA-AL.J M*=*$X>*O39IP[NMTWE2UY!K=E9EVD_Q3L.)'5!5)3QZ.9#)ODNF>@&3I.Q#' MJTQC+N3AXWRI:NDIE29ECRY%Z.E?:".TKH2F9UZ>QE_[JJ4!&GC`Q.FV@R,+ MGQ8IT](YSL(@_G\4I.))L8ZLV8Z0D?EH:J!,6FO+^?@X^ZD$^`7%\;\2\IC< MH"`C"8K*+9%4Z-H:VIZ+RVA]M+^)=$"7ES+338BF0\+/)"ZH8.GF',T>^S%@E-K2:M#^8BTG]-3M(-NC0 M+N$E!L'W'H"@A.DI'97N2"J>P0DI>B;O4_AK:94D0`-S+,1V_:L'=KTJ;F,< MGLB8K> MO@(ZH86[=/[;6"Z5H95[C!H[3W.[WO8-W^S8'E50 MS8!O' M/5GX\O2B:D74BN9[P)Q6))/H.!$SR6;6*XN+%R0/X@\[CN*`Y7K(`YR@J'E# M>!'2B4)1WN(Z0TL<8MXUX`7:C!#:`I[CREAD$YQ!F$^Q?P8!3Z>MPU!3BZ2.KG9_AC6_.2P\!R;4G/$6>O!,L@V6H,FP4.82 MDH@L_MATZOV/L[D!J!3*[M8?S])9[/#@SN^T,!'"0PB+Z>`@,2^1-+=O\'[A MK6GWWE_4 MF,H*1`R`[10!O<#]J;1@64X?4)97UW78]L96DN&.%(Q^NP>EH?<7+::R0@14F3S3^H@$B$]#^$E931"3"(B6JV3=M<"72)Y2+ MES8`RC8F0D[I+P;@\@&1H&0X1?@A!`]53G7%"E=.4&M'0."OT;72`&TMXB-9 M>.PV"!&TNW]/TOPS2E?;J0T_'8AO8S&9OZ:4-GD/]YM+N&V'%Y'U!B1^6VXH MD?Q"W0SW##^0Y$[M<0J*NBL247BXC:P71+>)+.0@V\9Y,WG44?LX"H4O>:"S M?H%':JC:^"(QE8=6A@FDL[24RQ07Z2'6;M[BX,S+_UR+W_[LH0$E3=99;%ML MB@O/L#5L_R$@.NM^_U2':TC,9U*D7>$"BGAH=@M1=9"`L9SB]C1L&YZL49IO MV.,:^2*)V%'"FHTY5(S!#KR>M-U\5Y!Z"`L#T71P4+/R=<=4M%C_1)(0O!4R M)%;LAG2(/02#D7@Z..B8R;="9[TXJV65(4A),]Q(\1LO$&%T,)'P\'7;]`91 M104Y6H0A*6@W)XK_4M(T(9!"&@]M#!%&9V,)#U^W0CO+SXMDL5SB&-/&9^SI M61SA(*7,J0@D+'^E`]T_"4[RGREYD0[6?TYXM5//,;P\Q)9+Y>@GJZ/J:K8= MIC^J^X"#6]IX=IY(FPF^#FA:K-E[@A:;39RSI2+L(J#AE#P4L1, MLEUC\S#;J)!=<:J+YIA/\OXA-P^'43#5.OB3K`$>G<8!7 M4GR(:'A<]&CF@@>%8%8XZ/-S-OGP9L?O2X*"-$%1$U_.`4;VN5;IX+/G,-&( M8X*0(2NGIXI"%Z^ZHWK:?%XDD,X,-!-J%R=[,+Y2)V87<.J>+,YR=5$BNPV//T*WDJDX;4"TB]1P# MRK8KX@&>RYK"-473UO,BU6XO@6BYD&\QK0^6A)]X&(@]XM!#78NS.P4[V'IJ MFJ[8>5*1<(CQ;M_)&"@VFU!@?$!VI"Q6L#N$A7;;0D_(041`.$N@:`4>#Q=1 M%?)%XURW,3NAFATE0:)@E>3#.%@Q^:S`9RB\/03U%4G.W9[]X&V'RV!U'"W$ M``K"6>$.++`]XE15S"0>-VN:/T@5KZ,3Q^5VZ&:%%JBX]F!1U.!K7&]'/'F@ MD#Q":%X(D(OD)+),.OJXS.WGN8HM8T>-O,PX8O3[^0?S";4B]U@E.3",>5[` M,Q3>B<-+*I*`T&9GQ9L,GV2UPM5-`99EDB3L&5B4A)0I*\$!$4C=R;VOHIX5 M#,U$MT>AMIYF[)EIUR'G3ZBOS)Z]0],9'" MAIVO2`AGA0"%'#N\4SS1PW/;Y_,NERS!Y'E,'B=_@*Z]^M2V2/\TB)1T^"3( MD'1:[V+9^VB3KE+R@*D)3S9?,I8<]G*-Z/J7/073OE\H48,]@UHY%@Q\N(XG MMSEQH!3IA;Q!M:P[MZG.UUQ$5);M&U=#K`V_;6'4^3890D98GJ@%[$/"O)X: M*%W^GMQMF:0[L^[&K+NO&8/23C6.$`NNW.&1D2_+]47T6U%?[/],6#(YNC", M4<^-/Y-Q`_@NJVC2\.^BBIEZTS.HVX7?[::9WLPR?@IPPF2X3&Z"&%TNY1E, M`91-7D0%Y73Y278)-V*B'BZ'R0[:569R5+7'UT=SSA!5#DO.PO"P(FF._ZS^ MG43LN0[$_CU,W&=8:GL1!U1J;Q%KI[;G02^X;;ZNWK;RGU-C5OM<'U%^3R)Y M#VM4IO<4AZ[,WF+81F7/@V!@R_;OMG2YOWM92L1RA+Y_6J,D&R3M4!*UNX5" MHKT%,T@ISX->65.>X?[V_2;#M.=/3N,@RUCK2'*#.8=)X/M&"RMP[A1*G/XQ*V375V_\&'V(N.VO^SZCB9[)RWD/PW6.`]BR2F! M><'M2AU:<&\=SUIYS[9F!S?/FYPBPT:;/B8]@H,4VQX_.&T!0B%TQ[U+#6^% M&)G6SU?/.:I!H#3U4XGP`O)>VIN7%ET!5Z,"MSB%OOSHQ9:]S,?:-Y_%*8@M M2NH[SD')V>,.JI0==93#6N6;[Q,?@[+%.;O_0-M="TN2_H&"D.0$+4F*6DGY M8U*W7)MC5$=<9X;NW2AS#/*=M[)"P^:MGGN%TG4'@W(;X^#Z6M-Z>EGAAE3!8R!"J"NO=J@'FIGJP$` M-FV+2_LY3?&9(7>D>MSV>;JJ]^_%3$G@;;5U,>)J%8"!^FZ"BL%+D M:I6R.E_75W!9K(%H#4#OPODA@#*"HTV0OJ(19N"4[HJ^FO'E&"IWB%!4KO%8 MM#>=,WT,M*^F1/672(=,0%$94E5%]P6YG/&6:* M2Z+V-2C%O%9**YC##FGG"E0#!;B>FPKJ:V<*QWYN`-2/O-OO2`$8J#<$5`SF MNB,%5XJ3'2EE=;Z>;<)EL0:B-0"]Z_P@@#*"HTU/J&B$&3CW?D?J(LL*=LIQ MN>PF]%,,U>H"@O%:4F"FN#56A0N\0BKU=ANIT_9KM*[GQY?+]FE(#=ZT9020 MDY?9`]1!%>(:>(IZG;TJ[\-I?U=.19^H(ZNM("6;*1*!8KL`G[RJ/5PY+Z(( M,WG8W1B2E#KXA_R],2!U>Q%133U3*)HIP04BM37ZNH+Y!>?W41H\!C'KR0$` M@Q>HU0LH,%.8&:O"!=(@E9J_G.A]+RB>Z++'!TA29CT!+4P$],IU29=^IB`U M5<3N5B6].N5AH-/B[/U3B++L<_!4/T];'M??4]NV1AXCZ<=9X3E(ZLR[2\)Z*H^Q:9P26\(53> M3J+"MH)Q($G0(\NRPNFJ^76F8!`+Y0(`+6>QT=\JC/Y\[[&?DICEADN#^#*Y M2.@_4)9?TQ]N'H,UWTF`:-LGX52T,\6*B0)<($A3GPQ7\[TY4T:G)1'[BT7U M/`0QZT&O4(I9&MG^S2(>G!9%&ZR:%/4^*F&$(LSB$0]1.?#.(@NOHS"VG3AQ038.O`LQ'/XL^M1?^.Y^FL[RA18E2 M)L[2,-[5%?TN3U^#G'KYJP2V%G[M/1*R_3HOBZLD&V%TCJW'6>FZ#15F-Y(0 MB*T_:;:B\0#0I22RQX`B[]`V98$'+T17S9[V>>BJ#6VKY+F2550]?`ZIIH[1 M>T!)(;T`(OO09=&TLWL.9]:Z%Z".-]D":(C0>+,&0G5>Q6996V:1`#-8"U+(-)V9JHEI/$B(O00`22&]X&1M?LT65[:TG M70(+][]TS5I_\=>6PJ8##=B4]34>N7P-HI\;G[.>@F)[1W)`X:4U]:+HK2KD MX>O3:-=T@,!_=I\_8.\=9RS1L6""!J!M9VTJ6B]M;R(>9'ZGY.8TVE88@%%' M1+)WR>I7)WE[*BAJ,444/B_`]!*!UV!"5LX>F?5A&79%8AQN[LM["AUI3^,` MLR?LPH))LTVRRL_8[4HWTW?#TI.!3H4H,E8+?3`*JBJG]Z95^+KQ#A)D./LW M+6:"L$E7""Z@I5LVC,&4U\_"MZFB&[$DVXM:NF:=(:7S%1]0R4"`4##;OX?5 M!\+J,*/#RG08T8-`A!0E0J0LA3BQ2?7G^^[E3]1'TB"F+K*(5CC!3/P*+^1[\-KY3$P,X\ M'Z=S5>$R^#/K5?1K81U9+:J4S-=9`E`NT"1!SFL?,FTUT4MB5Y9\Y<+`)G=F M#1K44H!`,&#AZQW:Q8JD.?ZSE(;%>N1!,!E-S*OC M*+_$ZJK#OD91$5;57],&IP_HG*2+),)MV7^*Y2PHH. MMZU=,6SWMDFA6BN=IA5K\GJJ3IQ79Q-)[OQD/D M`N_'2YCMW^JS%:[VD-IGE)&!6FH^@E5"[3^:H)(:XDK!UMG5+F_VOT[9]FYS M-#V0G`,8C+BYQ*4FGAA>>NP00WE%*)/64E[=TG#W]>SFK`8Z##-`ZN;A:PWU M'%!C)K$Q;+3L?=T>@^$%IK4YXV-'N##$@\VAC5_3HN8!]M-J`8"3N_;Y=<%3 MOL`"/7PI"_@_/S*0UW"*I.;L[K%=/P'7771NY2Y?OI(MZ,R*"D&H*3H?.!KI MP!*8NCK,\Z_Y/I$O(TT;%7`8%'[KAN.VWWQ&D4H*,$PX)NZR&_G25;&;'[0_ M9BERFN27.)1L&(!HFQ2G2EJ?<6,B)1A'&J8.7Y_QI8/1C_Q4%Z4:2H48S\"$ MI<'3L7[IR>`(PQIHAJ;21Q^FRDIADS:N,OG6PWZ@5ST]@./8@H_%W&[>V+;7 MT2B4&U7K[$JU-WCGM76&XR)'$7`B(*&63`5XZCE-!M226D\'!FPE/>K^=*F2 M4:56A/640%3>9%+0*^]-URE#'71BH-"*NM/D*@9/#OH5^KW##!X!P-BTXF0W MT,\C&>EQLX8@.'ZEF.T:X'9^VH/--<.L(9,F3+![+5XT]G M!-[C,>I?M)L[+E?%OFX6UETD;'4`6Q7,"S=BT>R1T_)SM\+DL>-!\KQ2U.H& M:<:R$.>;:1/I=3+2EN_M])HF2P1L4J:YM@,J,_&EI*:-GX/;>'`I2?B1EZ[Z MZ$,N8X!EB$8J:>YB.>_RLA+'TYMHK+9AU+,1>PJ&/_R3$_!VWA),;^N^Z0A` M#(EA2T8]"W88>+-R+<&W?2TL.BM2.HQ4SUR(\NJ#Z5L;Z^BG-_G0L,1<4`D* M6MX5$K0\&V!,GW)+U=ARW!WZ.[0``!MU@0G!`36_!BM"R7FP:.K28:>IP]O` MW>:)./G;D2J2)D171.)I[P$0!])AB-DT?<1,GQ=JA;H*-FR,7*Q(D>3-PD6& M"R4QCQ`Q\6184:*!&`K9QXV(=0\Y$I:^=A6GQ:J(JZP+RR4*H#N^R_5/I\GGI$DK>D4G-"RC:%Q$='[S.7BJ?R\W5X;O M@(]EU#X2;LW(4T0Y4PUHX3&BL@:>SYX@U!DTA4N2\8Q&0'/RU^EVJ`MOT=)1E>R5715$TPG.4(W*+%U`&T)?SMA0V&!O:V> M:].M3G]LJ6@N'!MP3$S:ZX&MK0:'KO_25:-!R3ZF>RB?1A+(S")_._&]=#I+ M?T]1D*$S5/TM2P3OC&'W9:IQ#.<";>>ZL_(`%ZW8JWX>W7J5EXYJM=/7LKP8I9R- M3LY&I7UW&V-5/J=W0!KG28HEX3X+;3M=-R-\EU09#L/-(HG.J"`/Y:%H^?0= M!WF3(MN\-?HB>P)C"_7L`K"P9G2>LYSKUH=,78N'`,JX2:(T0T*BQ3G MM"[+.55\&^^RLCV!_XZU),T;_6:."X&9YP$S7(W"Q(^OF[O.E*,H]@^65T3O#H[*LAO9'"? MKV@QED/6L=@\5O`,(9O9Y7*4,YF91A2H\R"8PTIRF,;AZ1GMC7FV\K67J M$'&HPF!$J(:"Y*XW$%`9DRA(H^P3R=%KB='L>'EN-TL%.7LAQH>9?JNI*A24 M37!)PB[D+YZP]!*PBI:_#RRDG1X8\JO!`.'`MX3%O+Q9`'#-.R.K`">01<2\7,SKF#J+VG([8>O@HWP%.<)5 M"Z\"3..+CH;#X^,1BN6!#UQ?"NF?PY*&GC[M?0^IQY8,W!Y!/;@Z>5`I MQOW]_=']\9&0*P09C@;?/E_-;:L)+392V6!$%:J^W@20X3XLI'<4JD%28=#? M]X>C?L;C,?[[EAR6)Y;D>&"J%U1!*G2!/I9[]/[]^X&M34D1B%5`,ZXTY0[D MZ5V]+7M,_'805?;0)808IU#.A:8:>X(MB@N#@/&EB$NPS(ASDJAP`TMB!3PQ MMCCM*>8'GFG=EJTE+$][:-M^8M5?`PE'*%I"(84'%>J8Z@&R*'2\%>PJ:S>! MH-(IH!3LAR`B`*D9^BLU_^"YE'*H=ZA2R.*$7HMU71RJ M$K*`]T.U,3"W*#\Q'U]OIB4AR4HR$5P)C[DFJ)Y1SPSR^1I`JQYA[FEO?W7: M7M)BYJ:/PR&J.B1],L?A9<,K?N>A2(Q%(K`/@UV$7?!0@3OC'^WW[L"-N6.2 M*LZ=T=&<<;L+EO/%I8GAG\$?J?74;#G%V=.'HE-*:*H],ZKQ3`9(Q))$D.35 M5TY#EV']3YVO:GTU7U,):^&YN/ZY^!XRO:GV6PE]M0^/#_)A'O[O)&J@\^A! M'IU0M;[TQ'U)5"PGJ_;?FX/\9U")A>V\5NJUF5Q1SOZP,D8.VBJI]L4[C(AH M_W.F'$^H4`+^R+-W=D[M/`]]G\H-!BRVXI@?.93KL>.(D&O,ZZZQ^SJX)HD\ M$-.*&MHZW[PN^"8&MH$M@R89-DG`.\^EGKN@DJ-IU#7(B?!]P>V<$'EJ3UV= M9XX+GDF`""*1""J:>SI'9*$J,/L<:*6+AP"X2D9+L;C._&^*02O!(`E(9_?4 M[E-^!TK;*36R>+Z@SM9O"[;.<7=&SCJW7ML8@DJNL0.R.[@22N4SETJ*.C>\ M*W9Y`T>V\,@K@_A3G+ATSLFF`#_PQ`;@##BVJ:\Q_XZ'0FE-G3-^+CCCW!"8 MU#Z"(3>@F8R6MQ:R\T7JBW-8Z,CV]JO.UN]+;+W0G3VSM(T&3%-OKH7S>YRA MY4MJ[#L:%NP;LQ/+WQDZZ[CLCKG`W1N<_21S3)-JS&T.'&HA-_-0!EX8QY6F MQ'7N*>9G"3+)0Q-S6I2"DQB]55=7/I'P3&7 MC%/N,!PY4XZ>";L5TN[^DN^S:-V((V$B;,(*/$N;JPCJQDDQ5\ZAV=&QA=>Y M)=O8@)4QTI0OA?1SVT@EY75.**;%,0C)H72FS\THRK&],@3W6@HW='0Z?934 MU)F_F!;G84B"TSD@=<#8["?/`FPMZ?5;)94&-Q<@"@:W["3F[PR=&OJ:2M1M MC5D1"GM.-;T4LN;T]3"6NA/9T>Z9PQ8\T:([HFTV8ISO(5,LFR;R!77CI3A) MY[@[(^?.&A8*OH>HW\4=_DD.%;8+ZXQ=,AFG",1"=!9/+7X#C*.5HFM>QMKY M@CI+%^?=''=GY-3(GX1P[YF'D=6UFY=V\$MPIZ@P7[&%!V.ETOC?F+K./<4= M[`3:Y@71/FJ"3C)X$N%W#LP=))A]Y5OZ`.E!0E90YX;B#G9\O\:R=U8N;%:C M>5!'=@(;&GDK,$-/9BFNVVYK879E!M?,6XDD0OL.:3A@D>_$.\1TE2]8]@C49'% M_.HG?$:(X_[H]2-,DBC&8672:P/^[P92'/U MO*$I++5I]4T?&QX-#S+`[N.0IHTF#*;=MX\P>?$IS1,'A@7O\M0X_QM M+]YMXO-_5:)=.5G+=?O*`\K97Z;3=G4[=8DL'E\!OPRYFU.DK*Z=6EP) MOHIZD:SJ;35D[=:MO+.5U[9;DZH^5T733JWBF[$F8[176M54J1#<,7=GH3:L MYF5KIF!#\KRN*J)[FJ:'J'0#YBC,+OIO<-DL[^!2R#'FO@X+S`(C"M;F-AVH M&=]_3F?T?0ZL'^EX%Q;E?G=#&9WK[@V=ZXU"+2C'4:?4V"HY!ZTCHFFRQ7D# MGM%SLC8OCW/!]5'N:_,;ZEUC\)GR^&[49_`7($N[?#U3 MI&&RG#IQA4\9?R$5>A)M]EBN)!P,\\(2@3>*6Z#I*47 ME$M$KZ-K@RX-[\67.>9@SC;H.Q&>26\D]69\RO$#I;_!@OD]#;:&?R792\=S M,[O@4@!C\B24$KBS0U)"\7:F030UL&KWU7TYVT^T:LJ?EVYE:2^JIY]'K#%:, MFS?O\5W9L?X7Y2$.XI&Y<#)68_>W4&GS;^2RK+PIQY-B0T-EGV%CM*"0FBT/ M-D(%3TO,4#_)A;Z]/W`'%\LE.'JV'+LB,"OV+W"?+=_G9@^)2E>9_8S7NS_*]9I[O$IWTT+'L/[A'3@)>-$`^5K.5NF^F.2.KN`?V)BF&#\&2-DKT'L MC9[HP@'^^B]02P$"'@,4````"`#1@)T\E^]QQV"T```5*`L`$``8```````! M````I($`````865T+3(P,3`P,S,Q+GAM;%54!0`#R>;92W5X"P`!!"4.```$ M.0$``%!+`0(>`Q0````(`-&`G3P4\\!W0A```$'@```4`!@```````$```"D M@:JT``!A970M,C`Q,#`S,S%?8V%L+GAM;%54!0`#R>;92W5X"P`!!"4.```$ M.0$``%!+`0(>`Q0````(`-&`G3R6*'7T7@<``(U/```4`!@```````$```"D M@3K%``!A970M,C`Q,#`S,S%?9&5F+GAM;%54!0`#R>;92W5X"P`!!"4.```$ M.0$``%!+`0(>`Q0````(`-&`G3SY8,`P`4`!@```````$```"D M@>;,``!A970M,C`Q,#`S,S%?;&%B+GAM;%54!0`#R>;92W5X"P`!!"4.```$ M.0$``%!+`0(>`Q0````(`-&`G3P>D@WG]2$``,<;`@`4`!@```````$```"D M@>8=`0!A970M,C`Q,#`S,S%?<')E+GAM;%54!0`#R>;92W5X"P`!!"4.```$ M.0$``%!+`0(>`Q0````(`-&`G3P"@@LYLPD``!55```0`!@```````$```"D M@2E``0!A970M,C`Q,#`S,S$N>'-D550%``/)YME+=7@+``$$)0X```0Y`0`` 64$L%!@`````&``8`%`(``"9*`0`````` ` end XML 26 R12.xml IDEA: Financial Instruments 2.0.0.10 false Financial Instruments 006070 - Disclosure - Financial Instruments true false false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 2 0 aet_NotesToFinancialStatementsAbstract aet false na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false No definition available. false 3 1 aet_FairValueMeasurementsTextBlock aet false na duration string This item represents the complete disclosure regarding the fair value of financial instruments (as defined), including... false false false false false false false false false false false terselabel false 1 false false false false 0 0 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">7.</font></div></td><td valign="top" align="left" width="85%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -1.8pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Financial Instruments</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The preparation of our consolidated financi al statements in accordance with GAAP requires certain of our assets and liabilities to be reflected at their fair value, and others on another basis, such as an adjusted historical cost basis.&#160;&#160;In this note, we provide details on the fair values of financial assets and liabilities and how we determine those fair values.&#160;&#160;We present this information for those instruments that are reported at fair value for which the </font><font size="3">change in fair value impacts net income or other comprehensive income separately from other financial assets and liabilities.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Financial Instruments Measured at Fair Value in our Bal ance Sheets</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Certain of our financial instruments are measured at fair value in our balance sheet.&#160;&#160;The fair values of these instruments are based on valuations that include inputs that can be classified within one of three levels of a hierarchy established by GAAP.&#160;&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#8220;inputs&#8221;) that qualifies a financial asset or liability for each level:</font></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"><tr valign="top"><td style="WIDTH: 18pt"><div><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Rom an">&#160; </font></div></td><td style="WIDTH: 18pt"><div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">o</font></div></td><td><div align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Level 1</font> &#8211; Unadjusted quoted prices for identical assets or liabilities in active markets.</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"><tr valign="top"><td style="WIDTH: 18pt"><div><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">&#160; </font></div></td><td style="WIDTH: 18pt"><div style="MAR GIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">o</font></div></td><td><div align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Level 2</font> &#8211; Inputs other than Level 1 that are based on observable market data.&#160;&#160;These include:&#160;&#160;quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, inputs that are observable that are not prices (such as interest rates, credit risks, etc.) and inputs that are derived from or corroborated by observable markets.</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"><tr valign="top"><td style="WIDTH: 18pt"><div><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">&#160; </font></div></td><td style="WIDTH: 18pt"><div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">o</font></div></td><td><div align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Level 3</font> &#8211; Developed from unobservable data, reflecting our own assumptions.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Financial assets and liabilities are classified based upon the lowest level of input that is significant to the valuation.&#160;&#160;When quoted prices in active markets for identical assets and liabilities are available, we use these quoted market prices to determine the fair value of financial assets and liabilities and classify these assets and liabilities as Level 1.&#160;&#160;In other cases where a quoted market price for identical assets and liabilities in an active market is either not available or not observable, we estimate fair value using valuation methodologies based on available and observable market information or by using a matrix pricing model.&#160;&#160;These financial assets and liabilities would then be classified as Level 2.&#160;&#160;If quoted market prices are not available, we determine fair value using broker quotes or an internal analysis of each investment&#8217;s financial performance and cash flow projections.&#160;&#160;Thus, financial assets and liabilities may be classified in Level 3 even though there may be some significant inputs that may be readily available.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The following is a description of the valuation methodologies used for our financial assets and liabilities that are measured at fair value, including the general classification of such assets and liabilities pursuant to the valuation hierarchy.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -1.8pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Debt Securities&#160;&#8211;&#160 ;</font>Where quoted prices are available in an active market, our debt securities are classified in Level 1 of the fair value hierarchy.&#160;&#160;Our Level 1 debt securities are comprised primarily of U.S. Treasury securities.&#160;&#160;If Level 1 valuations are not available, the fair value is determined using models such as matrix pricing, which uses quoted market prices of debt securities with similar characteristics or discounted cash flows to estimate fair value.&#160;&#160;We obtained one price for each of our Level 2 debt securities and did not adjust any of these prices at March 31, 2010 or December 31, 2009.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -1.8pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We also value a certain amount of debt securities using Level 3 inputs.& ;#160;&#160;For Level 3 debt securities, fair values are determined by outside brokers or, in the case of certain private placement securities, are priced by our internal staff.&#160;&#160;Outside brokers determine the value of these debt securities through a combination of their knowledge of the current pricing environment and market flows.&#160;&#160;We obtained one non-binding broker quote for each of these Level 3 debt securities and did not adjust any of these quotes at March 31, 2010 or December 31, 2009.&#160;&#160;The total fair value of our broker quoted securities was approximately $398 million at March 31, 2010 and $364 million at December 31, 2009.&#160;&#160;Examples of these Level 3 debt securities include certain U.S. and foreign corporate securities and certain of our residential and commercial mortgage-backed securities as well as other asset-backed securities.&#160;&#160;For some of our private placement securities, our internal staff determine th e value of these debt securities by analyzing spreads of corporate and sector indices as well as interest spreads of comparable public bonds.&#160;&#160;Examples of these Level 3 debt securities include certain U.S. and foreign securities and certain tax-exempt municipal securities.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Equity Securities &#8211; </font>We currently have two classifications of equity securities:&#160;&#160;those that are publicly traded and those that are privately held.&#160;&#160;Our publicly-traded securities are classified as Level 1 because quoted prices are available for these securities in an active market.&#160;&#160;For privately-held equity sec urities, there is no active market; therefore, we classify these securities as Level 3 because we must price these securities through an internal analysis of each investment&#8217;s financial statements and cash flow projections.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Derivatives&#160;&#8211;&#160;</font>Our derivative instruments are valued using models that primarily use market observable inputs and therefore are classified as Level 2 because they are traded in markets where quoted market prices are not readily available.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARG IN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Our financial assets and liabilities with changes in fair value that are measured on a recurring basis in our balance sheets at March 31, 2010 and December 31, 2009 were as follows:</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT - -INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Level 1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Level 2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" wi dth="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Level 3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bo ld; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">March 31, 2010</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></t d><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Assets:</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9p t; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Debt securities:</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" widt h="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT- INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;U.S. government securities</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 1,686.8</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160; 316.2</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align ="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 2,003.0</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: i nline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2,208.2</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;11.8</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td vali gn="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2,220.0</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;U.S. corporate securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%">& lt;font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;7,197.5</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;121.8</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font ></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;7,319.3</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Foreign securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bott om" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2,648.6</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;237.4</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">& amp;#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2,886.0</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font>< ;/div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,388.5</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISP LAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,388.5</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMI LY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,081.8</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;72.8</font></div></td><td valign="botto m" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,154.6</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Other asset-backed securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bo ld; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;490.5</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;4.3</font></div></ td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;494.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Redeemable preferred securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDEN T: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;317.1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bott om" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;25.7</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;342.8</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font sty le="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total debt securities</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,686.8</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;15,648.4</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">& #160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;473.8</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;17,809.0</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; F ONT-FAMILY: times new roman">Equity securities</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1.6</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;38.2</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;39.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FON T-FAMILY: times new roman">Derivatives</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;37.3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;37.3</font> </div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total investments</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; 1,688.4</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px doub le" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;15,685.7</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; &#160;&#160; 512.0</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align=" left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; 17,886.1</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Liabilities:</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td& gt;<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;Derivatives</font></div></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -&#160; </font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: blac k 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1.5</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#16 0;&#160;&#160;&#160;&#160;&#160;&#160; -&#160; </font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1.5</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div><div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div><div><table sty le="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">December 31, 2009</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font>&l t;/td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Debt securities:</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FON T-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style ="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;U.S. government securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; &#160;&#160;&#160;1,529.4</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; 317.4</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FON T-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; $&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,846.8</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td>< td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2,062.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;12.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align=" right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2,075.4</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;U.S. corporate securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%">< div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;7,056.5</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;128.1</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SI ZE: 9pt; FONT-FAMILY: times new roman">&#160;7,184.6</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Foreign securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2,545.5</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;199.0</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2,744 .5</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160; -&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" a lign="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,420.2</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,420.2 </font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&g t;<font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;971.6</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;71.8</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,043.4</font></div></td></ tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Other asset-backed securities</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt ; FONT-FAMILY: times new roman">&#160;425.4</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;11.0</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;436.4</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;Redeemable preferred securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN - -LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;345.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;22.9</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"& gt;<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;368.7</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total debt securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,529.4</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" alig n="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;15,145.1</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;445.5</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font st yle="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;17,120.0</font></div></td></tr><tr><td valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Equity securities</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1.7</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;38.0</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;39.7</font>< /div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Derivatives</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARG IN-LEFT: 0pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;44.0</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160; </font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="9%">< div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;44.0</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="32%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total investments</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,531.1</font></div></td><td style="BORDER-BOTTOM: bl ack 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; &#160;15,189.1</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT- FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 483.5</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; &#160;17,203.7</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"></font>&#160;</div><div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;< /div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The changes in the balances of Level 3 financial assets for the three months ended March 31, 2010 and 2009 were as follows:</font></div><div>&#160;</div><div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="29%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="15%" colspan="4"><div style="DISPLAY: block; MARGIN-LEFT: 0p t; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three Months Ended</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="17%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three Months Ended</font></div></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="29%"><font style="DISPLAY: inlin e; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="15%" colspan="4"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31, 2010</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="17%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31, 2009</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" vali gn="top" align="left" width="31%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT - -SIZE: 10pt; FONT-FAMILY: times new roman">U.S.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Corporate</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inl ine; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Foreign</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right" ><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" widt h="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Debt</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="9%" ><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Equity</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> </font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" align="left" width="31%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Beginning balance</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT : 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 128.1</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 199.0</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 156.4</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="7%"><div st yle="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 483.5</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 455.7</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZ E: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 29.3</font></div></td><td valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 485.0</font></div></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" align="left" width="31%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net realized and unrealized gains (losses):</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#1 60; </font></td><td valign="top" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="left" width="29%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Included in earnings</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(.2)</font></div></td>< td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.0</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.1</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.9</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><f ont style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.0</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.0</font></div></td></tr><tr><td style="PA DDING-BOTTOM: 2px" valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="left" width="29%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Included in other comprehensive income</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(.6)</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.4</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.2</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.0</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div s tyle="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.2</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.3</font></div></td><td valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.5</font></div></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2p x" valign="top" align="left" width="29%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">.2</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">.9</font></div></td><td style="PADDIN G-BOTTOM: 2px" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">.3</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.4</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 1 0pt; FONT-FAMILY: times new roman">(1.0)</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2.4)</font></div></td><td valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3.4)</font></div></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" align="left" width="31%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Purchases, sales and maturities</font></div></td><t d style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(5.7)</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14.3</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(.5)</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" wi dth="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.1</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(17.1)</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></di v></td><td valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(17.1)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="left" width="31%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Transfers into (out of) Level 3 <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT- FAMILY: times new roman">-</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(12.7)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> 3.1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(17.2)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(17.2)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="top" align="left" width="31%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ending Balance</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160; 121.8</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160; 237.4</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 152.8</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160; 512.0</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" width="1% "><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 422.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 28.2</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right" ><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160; 450.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="left" width="31%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount of Level 3 net unrealized losses </font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">included in net income</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZ E: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#16 0;&#160;&#160;&#160; .2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; .2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160;&#160; (2.4 )</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="9%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; -</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160;&#160;(2.4)</font></div></td></tr></table></div></div></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TE XT-ALIGN: center" valign="top" width="3%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="TEXT-ALIGN: left" valign="top" width="82%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Reflects realized and unrealized capital gains and losses on investments supporting our experience-rated and discontinued products, which do not impact our results of operations.</font></div></td></tr><tr><td style="TEXT-ALIGN: center" valign="top" width="3%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN : text-top">(2)</font></font></div></td><td valign="top" align="left" width="82%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">At January 1, 2010, we changed our practice for reporting transfers into (out of)&#160;Level 3.&#160;&#160;Effective January 1, 2010, we use the fair value of these assets at the end of the reporting period for all financial asset transfers.&#160;&#160;Prior to January 1, 2010, for financial assets that were transferred into (out of) Level 3, we used the fair value of the assets at the end (beginning) of the reporting period.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Financial Instruments Not Measured at Fair Value in our Balance Sheets</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 9pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The following is a description of the valuation methodologies used for estimating the fair value of our financial assets and liabilities that are measured at adjusted cost or contract value.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Mortgage loans:</font><font style="DISPLAY: inline; FONT-STYLE: italic">&#160;</font>Fair values are estimated by discounting expected mortgage loan cash flows at market rates that reflect the rates at which similar loans would be made to similar borrowers.&#160;&#160;These rates reflect our assessment of the credit quality and the remaining duration of the loans.&#160;&#160;The fair value estimates of mortgage loans of lower credit quality, including problem and restructured loans, are based on the estimated fair value of the underlying collateral.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Investment contract liabilities:</font></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"><tr valign="top"><td style="WIDTH: 36pt"> ;<div><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">&#160; </font></div></td><td style="WIDTH: 18pt"><div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">&#8226;</font></div></td><td><div align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">With a fixed maturity</font>:&#160;&#160;Fair value is estimated by discounting cash flows at interest rates currently being offered by, or available to, us for similar contracts.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"><tr valign="top"><td style="WIDTH: 36pt"><div><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">&#160; </font></div></td><td style="WIDTH: 18pt"><div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">&#8226;</font></div></td><td><div align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Without a fixed maturity</font>:&#160;&#160;Fair value is estimated as the amount payable to the contract holder upon demand.&#160;&#160;However, we have the right under such contracts to delay payment of withdrawals that may ultimately result in paying an amount different than that determined to be payable on demand.</font></div></td></tr></table></div ><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Long-term debt: </font>Fair values are based on quoted market prices for the same or similar issued debt or, if no quoted market prices are available, on the current rates estimated to be available to us for debt of similar terms and remaining maturities.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The carrying value and estimated fair value of certain of our financial instruments at March 31, 2010 and December 31, 2009 were as follows:</font>&l t;/div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="47%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="22%" colspan="2"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2010</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="21%" colspan="2"><div style="DISPLAY: blo ck; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2009</font></div></td></tr><tr><td valign="bottom" width="47%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Estimated</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign ="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Estimated</font></div></td></tr><tr><td valign="bottom" width="47%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Carrying</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEX T-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Fair</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Carrying</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Fair</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="botto m" align="left" width="47%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="le ft" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Value</font></div></td></tr><tr><td valign="bottom" align="left" width="47%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZ E: 9pt; FONT-FAMILY: times new roman">Assets:</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="47%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align= "left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160; Mortgage loans</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 1,556.0 </font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 1,521.0 </font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font>&l t;/td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 1,594.0</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; 1,506.5</font></div></td></tr><tr><td valign="bottom" align="left" width="47%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Liabilities:</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="47%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160; Investm ent contract liabilities:</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="47%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font styl e="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;&#160; With a fixed maturity</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;31.9</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;33.0</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: blo ck; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;32.4</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;33.5</font></div></td></tr><tr><td valign="bottom" align="left" width="47%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;&#160;&#160; Without a fixed maturity</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><fo nt style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;525.0</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;498.6</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;530.6</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-R IGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;503.7</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="47%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160; Long-term debt</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3,639.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt ; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3,899.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3,639.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">& amp;#160;3,865.9</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 9pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Separate Accounts Measured at Fair Value in our Balance Sheets</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 4.5pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Separate Account assets represent funds maintained to meet specific objectives of contract holders.&#160;&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Account liability has been established equal to the assets.&#160;&#160;These assets and l iabilities are carried at fair value.&#160;&#160;Net investment income and capital gains and losses accrue directly to such contract holders.&#160;&#160;The assets of each account are legally segregated and are not subject to claims arising from our other businesses.&#160;&#160;Deposits, withdrawals, net investment income and realized and unrealized capital gains and losses on Separate Account assets are not reflected in our statements of income, shareholders&#8217; equity or cash flows.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Separate Account assets include debt and equity securities and derivative instruments.&#160;&#160;The valuation methodologies used for these assets are similar to the methodologies described beginning on page 12.&#160;&#160;Separate Account assets also include investments in common/collective trusts and real estate that are carried at fair value.&#160;&#160;The following are descriptions of the valuation methodologies used to price these investments, including the general classification pursuant to the valuation hierarchy.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Common/Collective Trusts </font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8211;&#160;</font>Common trusts invest in other collective investment funds otherwise known as the underlying funds.&#160;&#160;The Separate Accounts&#8217; interests in the common trust funds are based on the fair values of the investments of the underlying funds and therefore are classified as Level 2.&#160;&#160;The underlying assets primarily consist of foreign equity securities.&#160;&#160;Investments in common trust funds are valued at their respective net asset value per share/unit on the valuation date.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Real Estate&#160;&#8211;&#160;</font>The values of the underlying real estate investments are estimated using generally accepted valuation techniques and give consideration to the investment structure.&#160;&#160;An appraisal of the underlying real estate for each of these investments is performed annually.&#160;&#160;In the quarters in w hich an investment is not appraised or its valuation is not updated, fair value is based on available market information.&#160;&#160;The valuation of a real estate investment is adjusted only if there has been a significant change in economic circumstances related to the investment since acquisition or the most recent independent valuation and upon the appraiser&#8217;s review and concurrence with the valuation.&#160;&#160;Further, these valuations have been prepared giving consideration to the income, cost and sales comparison approaches of estimating property value.&#160;&#160;These valuations do not necessarily represent the prices at which the real estate investments would sell, since market prices of real estate investments can only be determined by negotiation between a willing buyer and seller.&#160;&#160;Therefore, these investment values are classified as Level 3.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div>& lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Separate Account financial assets at March 31, 2010 and December 31, 2009 were as follows:</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div><div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="PADDING-BOTTOM: 2px" valign="top" width="20%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="16%" colspan="7"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" al ign="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31, 2010</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="16%" colspan="7"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31, 2009</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="left" width="20%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Millions)</fon t></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Level 1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Level 2</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZ E: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Level 3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Total</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1 %"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Level 1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Level 2</font></div></td><td style="BORD ER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Level 3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Total</fo nt></div></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" align="left" width="20%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;Debt securities</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160;&#160;&#160; 937.0</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%">& lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 2,460.6</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 101.1</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td sty le="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 3,498.7</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 752.3</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"& gt;&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 2,508.0</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 97.3</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FO NT-FAMILY: times new roman">&#160; </font></td><td valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 3,357.6</font></div></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" align="left" width="20%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;Equity securities</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1, 259.0</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">.4</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div ></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,259.4</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,215.1</font></div></td><td style="PADDI NG-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">.9</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPL AY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,216.0</font></div></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" align="left" width="20%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;Derivatives</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></ div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.1</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.1</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" wid th="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.2</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FO NT-FAMILY: times new roman">&#160; </font></td><td valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.2</font></div></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="top" align="left" width="20%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;Common/Collective trusts</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td>< td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">.1</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">.1</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font styl e="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,152.6</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,152.6</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="left" width="20%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;Real estate</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td styl e="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">70.3</font></div>&l t;/td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">70.3</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div>& lt;/td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71.4</font></div></td><td s tyle="BORDER-BOTTOM: black 2px solid" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71.4</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="top" align="left" width="20%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div s tyle="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160; 2,196.0</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160; 2,462.2</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td> <td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 171.4</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 4,829.6</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" width="1%">< ;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160; 1,967.4</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 3,662.7</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160; 168.7</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="top" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160; 5,798.8</fo nt></div></td></tr></table></div></div></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="3%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="97%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Excludes $539.9 million and $484.3 million of cash and cash equivalents and other receivables at March 31, 2010 and December 31, 2009, respectively.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-I NDENT: 0pt"><br /></div><div>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The changes in the balances of Level 3 Separate Account financial assets for the three months ended March 31, 2010 and 2009 were as follows:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="37%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" colspan="5"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Three Months Ended</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">March 31, 2010</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="31%" colspan="5"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Three Months Ended</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-F AMILY: times new roman">March 31, 2009</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Debt Securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: blac k 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Real Estate</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total </font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"> &#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Debt Securities</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Real Estate</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%">< ;font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total </font></div></td></tr><tr><td valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Beginning balance</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#16 0;$&#160;&#160;&#160;&#160; 97.3 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 71.4 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 168.7 </fon t></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 365.1 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 86.7 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160; $&#160;&#160;&#160; 451.8 </font></div></td></tr><tr><td valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total gains (losses) accrued to contract holders</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times ne w roman">&#160;(14.7)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(1.1)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(15.8)</font></div></td><td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(77.0)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(6.9)</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom " align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(83.9)</font></div></td></tr><tr><td valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Purchases, sales and maturities</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;18.9 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#1 60; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160;&#160;</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;18.9 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" widt h="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;32.3 </font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; -&#160;&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;32.3 </font>& lt;/div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Transfers (out of) into Level 3 <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(.4)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160;&#160;</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(.4)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.0 </font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;-&#160;&#160;</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%">&l t;font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.0 </font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="37%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Ending Balance</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIG HT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 101.1 </font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 70.3 </font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="D ISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 171.4 </font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 325.4 </font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font& gt;</td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 79.8 </font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 405.2 </font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; F ONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="3%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="85%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">At January 1, 2010, we changed our practice for reporting transfers into (out of) Level 3.&#160;&#160;Effective January 1, 2010, we use the fair value of these assets at the end of the reporting period for all financial asset transfers.&#160;&#160;Prior to January 1, 2010, for financial assets that were transferred into (out of) Level 3, we used the fair value of the assets at the end (beginning) of the reporting period.</font></div></td></tr></table></div> 7.Financial InstrumentsThe preparation of our consolidated financial statements in accordance with GAAP requires certain of our assets and liabilities to be false false false This item represents the complete disclosure regarding the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments, assets, and liabilities. Also, provides general information items required or determined to be disclosed with respect to the Companys fair value estimates for financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined). No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 27 R3.xml IDEA: Parenthetical to Consolidated Balance Sheets 2.0.0.10 false Parenthetical to Consolidated Balance Sheets (USD $) 002010 - Statement - Parenthetical to Consolidated Balance Sheets true false false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 false 2 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 3 1 us-gaap_StockholdersEquityAbstract us-gaap true na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false No definition available. false 4 2 us-gaap_CommonStockParOrStatedValuePerShare us-gaap true na instant decimal No definition available. false false false false false false false false false false false true 1 true true false false 0.01 0.01 false false false 2 true true false false 0.01 0.01 false false false Face amount or stated value of common stock per share; generally not indicative of the fair market value per share. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 4 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false 5 2 us-gaap_CommonStockSharesAuthorized us-gaap true na instant shares No definition available. false false false false false false false false false false false false 1 false true false false 2700000000 2700000000.00 false false false 2 false true false false 2700000000 2700000000.00 false false false The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false 6 2 aet_CommonStockSharesIssuedAndOutstanding aet false na instant shares Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were... false false false false false false false false false false false false 1 false true false false 424900000 424900000.00 false false false 2 false true false false 430800000 430800000.00 false false false Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury; and Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Excludes common shares repurchased by the entity and held as Treasury shares. Shares outstanding equals shares issued minus shares held in treasury. Does not include common shares that have been repurchased. No authoritative reference available. false false 2 4 false UnKnown NoRounding Hundreds false true XML 28 R14.xml IDEA: Debt 2.0.0.10 false Debt 006090 - Disclosure - Debt true false false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 2 0 aet_NotesToFinancialStatementsAbstract aet false na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false No definition available. false 3 1 aet_DebtTextBlock aet false na duration string Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit,... false false false false false false false false false false false terselabel false 1 false false false false 0 0 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">9.</font></div></td><td valign="top" align="left" width="85%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Debt</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The carrying value of our long-term debt at March 31, 2010 and December 31, 2009 was as follows:</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="56%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">March 31,</font></div></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SI ZE: 9pt; FONT-FAMILY: times new roman">December 31,</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-B OTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2009</font></div></td></tr><tr><td valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Senior notes, 5.75%, due 2011</font></div></td><td valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; 449.9</font></div>& lt;/td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 449.9</font></div></td></tr><tr><td valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Senior notes, 7.875%, due 2011</font></div></td><td valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right">< ;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;449.7</font></div></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;449.5</font></div></td></tr><tr><td valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Senior notes, 6.0%, due 2016</font></div></td><td valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;747.2</font></div></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;747.1</font></div></td></tr><tr><td valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Senior notes, 6.5%, due 2018</font></div></td><td valign="bottom" align="right" width="12%"><div style="D ISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;498.8</font></div></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;498.8</font></div></td></tr><tr><td valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Senior notes, 6.625%, due 2036</font></div></td><td valign="bottom " align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;798.6</font></div></td><td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;798.6</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">S enior notes, 6.75%, due 2037</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;695.6</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;695.6</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom " align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total long-term debt</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3,639.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><fo nt style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;3,639.5</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Less current portion of long-term debt <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;449.7</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="6% "><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; -&#160; </font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="56%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Long-term debt, less current portion</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="12%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="righ t"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160; &#160;3,190.1</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; &#160;&#160;&#160; 3,639.5</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="4%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="84%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">At March 31, 2010, the 7.875% senior notes due March 2011 have been classified as current in the accompanying consolidated balance sheet at March 31, 2010.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div><div><font style="DISPLAY: inline; FONT-SIZE: 11pt; FO NT-FAMILY: Times New Roman">At March 31, 2010 and December 31, 2009, we had approximately $480 million and $481 million, respectively, of commercial paper outstanding with a weighted average interest rate of .32% and .38%, respectively.</font></div><div>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 2.7pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">At March 31, 2010, we had an unsecured $1.5 billion revolving credit agreement (the &#8220;Facility&#8221;) with several financial institutions which terminates in March 2013.&#160;&#160;The Facility provides for the issuance of up to $200 million of letters of credit at our request, which count as usage of the available commitments under the Facility.&#160;&#160;Upon our agreement with one or more financial institutions, we may expand the aggregate commitments under the Facility to a maximum of $2.0 billion.& lt;font style="DISPLAY: inline; FONT-SIZE: 14pt">&#160;</font>Various interest rate options are available under the Facility.&#160;&#160;Any revolving borrowings mature on the termination date of the Facility.&#160;&#160;We pay facility fees on the Facility ranging from .045% to .175% per annum, depending upon our long-term senior unsecured debt rating.&#160;&#160;The facility fee was .06% at March 31, 2010.&#160;&#160;The Facility contains a financial covenant that requires us to maintain a ratio of total debt to consolidated capitalization as of the end of each fiscal quarter at or below .5 to 1.0.&#160;&#160;For this purpose, consolidated capitalization equals total shareholders&#8217; equity, excluding any overfunded or underfunded status of our pension and OPEB plans and any net unrealized capital gains and losses, and total debt (as defined in the Facility).&#160;&#160;We met this requirement at March 31, 2010. There were no amounts outst anding under the Facility at March 31, 2010.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">During 2010 and 2009, we entered into five interest rate swaps with a notional value of $100 million each.&#160;&#160;We entered into these swaps to hedge interest rate exposure in anticipation of future issuance of long-term debt.&#160;&#160;At March 31, 2010 and December 31, 2009, the interest rate swaps had an aggregate fair value of $34.6 million and $42.2 million, respectively.&#160;&#160;We also recorded a $7.6 million unrealized capital loss and $3.5 million unrealized capital gain related to these interest rate swaps in other comprehensive income for the three months ended March 31, 2010 and 2009, respectively.</font></div><div style="DIS PLAY: block; TEXT-INDENT: 0pt">&#160;</div> 9.DebtThe carrying value of our long-term debt at March 31, 2010 and December 31, 2009 was as follows:&#160; March 31,&#160; December false false false Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancings and noncompliance with debt covenants. Also contains a description of forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 29 R15.xml IDEA: Capital Stock 2.0.0.10 false Capital Stock 006100 - Disclosure - Capital Stock true false false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 2 0 aet_NotesToFinancialStatementsAbstract aet false na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false No definition available. false 3 1 us-gaap_ScheduleOfCapitalUnitsTextBlock us-gaap true na duration string No definition available. false false false false false false false false false false false terselabel false 1 false false false false 0 0 <div><table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">10.</font></div></td><td valign="top" align="left" width="85%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Capital Stock</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">On February 27, 2009, our Board of Directors (the &#8220;Board&#8221;) authorized a share repurchase program for the repur chase of up to $750 million of our common stock.&#160;&#160;During the three months ended March 31, 2010, we repurchased approximately 7 million shares of common stock at a cost of approximately $252 million (approximately $90 million of these repurchases were settled in early April).&#160;&#160;At March 31, 2010, we had remaining authorization to repurchase an aggregate of up to approximately $339 million of common stock under the February 27, 2009 Board authorization.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">On February 8, 2010, approximately .8 million performance stock units (&#8220;PSUs&#8221;), 1.6 million market stock units (&#8220;MSUs&#8221;) and 1.1 million restricted stock units (&#8220;RSUs&#8221;) were granted to cer tain employees.&#160;&#160;The number of vested PSUs (which could range from zero to 200% of the original number of units granted) is dependent upon the degree to which we achieve performance goals during the performance period as determined by the Board&#8217;s Committee on Compensation and Organization. The performance period for the PSUs ends on December 31, 2010, and the vesting period ends on February 8, 2012.&#160;&#160;&#160;The number of vested MSUs (which could range from zero to 150% of the original number of units granted) is based on the weighted average closing price of our common stock for the thirty trading days prior to the vesting date.&#160;&#160;The MSUs have a two-year vesting period.&#160;&#160;For each vested RSU, employees receive one share of common stock, net of taxes, at the end of the vesting period.&#160;&#160;The RSUs will become 100% vested approximately three years from the grant date, with one-third vesting each December.</fon t></div> 10.Capital StockOn February 27, 2009, our Board of Directors (the &#8220;Board&#8221;) authorized a share repurchase program for the repurchase of up to $750 false false false This element may be used to capture the complete disclosure pertaining to an entity's capital units or capital shares, including the value of capital units or capital shares, units authorized, units outstanding and other information necessary to a fair presentation. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 30 R20.xml IDEA: Document Information 2.0.0.10 false Document Information 995200 - Document - Document Information true false false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 2 0 dei_DocumentInformationTextBlock dei false na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package. false 3 1 dei_DocumentType dei false na duration na No definition available. false false false false false false false false false false false false 1 false false false false 0 0 10-Q 10-Q false false false The type of document being provided (such as 10-K, 10-Q, N-1A, etc). The document type should be limited to the same value as the supporting SEC submission type. The acceptable values are as follows: S-1, S-3, S-4, S-11, F-1, F-3, F-4, F-9, F-10, 6-K, 8-K, 10, 10-K, 10-Q, 20-F, 40-F, N-1A, 485BPOS, NCSR, N-Q, and Other. No authoritative reference available. false 4 1 dei_DocumentPeriodEndDate dei false na duration date No definition available. false false false false false false false false false false false label false 1 false false false false 0 0 2010-03-31 2010-03-31 false false false The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements this will be the filing date. The format of the date is CCYY-MM-DD. No authoritative reference available. false 5 1 dei_AmendmentFlag dei false na duration na No definition available. false false false false false false false false false false false false 1 false false false false 0 0 false false false false false If the value is true, then the document as an amendment to previously-filed/accepted document. No authoritative reference available. false false 1 4 false UnKnown UnKnown UnKnown false true XML 31 R4.xml IDEA: Consolidated Statements of Shareholders' Equity (Unaudited) 2.0.0.10 true Consolidated Statements of Shareholders' Equity (Unaudited) (USD $) 003000 - Statement - Consolidated Statements of Shareholders' Equity (Unaudited) true false In Millions false false 1 usd $ true false false false aet_CommonStockOutstandingMember us-gaap_StatementEquityComponentsAxis xbrldi http://xbrl.org/2006/xbrldi aet_CommonStockOutstandingMember us-gaap_StatementEquityComponentsAxis explicitMember u001 Standard http://www.xbrl.org/2003/instance shares xbrli 0 false 2 usd $ true false false false aet_CommonStockAndAdditionalPaidInCapitalMember us-gaap_StatementEquityComponentsAxis xbrldi http://xbrl.org/2006/xbrldi aet_CommonStockAndAdditionalPaidInCapitalMember us-gaap_StatementEquityComponentsAxis explicitMember u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 false 3 usd $ true false false false us-gaap_RetainedEarningsMember us-gaap_StatementEquityComponentsAxis xbrldi http://xbrl.org/2006/xbrldi us-gaap_RetainedEarningsMember us-gaap_StatementEquityComponentsAxis explicitMember u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 false 4 usd $ true false false false us-gaap_AccumulatedOtherComprehensiveIncomeMember us-gaap_StatementEquityComponentsAxis xbrldi http://xbrl.org/2006/xbrldi us-gaap_AccumulatedOtherComprehensiveIncomeMember us-gaap_StatementEquityComponentsAxis explicitMember u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 false 5 usd $ true false false false us-gaap_ComprehensiveIncomeMember us-gaap_StatementEquityComponentsAxis xbrldi http://xbrl.org/2006/xbrldi us-gaap_ComprehensiveIncomeMember us-gaap_StatementEquityComponentsAxis explicitMember u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 false 6 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 6 3 us-gaap_SharesIssued us-gaap true na instant shares No definition available. false false false true false false false false true false false periodstartlabel false 1 false true false false 456300000 456.3 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 false false false 6 false false false false 0 0 false false false Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. No authoritative reference available. false 5 3 us-gaap_StockholdersEquity us-gaap true credit instant monetary No definition available. false false false true false false false false true false false periodstartlabel false 1 false false false false 0 0 true false false 2 true true false false 351200000 351.2 true false false 3 true true false false 9716500000 9716.5 true false false 4 true true false false -1881300000 -1881.3 true false false 5 false false false false 0 0 false false false 6 true true false false 8186400000 8186.4 false false false Total of all Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A3 -Appendix A Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section E Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 false 7 3 us-gaap_ComprehensiveIncomeNetOfTaxAbstract us-gaap true na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false false false false 0 0 false false false No definition available. false 8 4 us-gaap_NetIncomeLoss us-gaap true credit duration monetary No definition available. false false false false false false false false false false false false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false true false false 437800000 437.8 true false false 4 false false false false 0 0 true false false 5 false true false false 437800000 437.8 true false false 6 false true false false 437800000 437.8 false false false The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph d Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A7 -Appendix A Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 10, 15 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 87-21 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28, 29, 30 false 9 4 us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract us-gaap true na duration string No definition available. false false false false false true false false false false false label false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false false false false 0 0 false false false No definition available. false 10 5 us-gaap_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease us-gaap true na duration monetary No definition available. false false false false false false false false false false false label false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false true false false -65300000 -65.3 true false false 5 false false false false 0 0 true false false 6 false true false false -65300000 -65.3 false false false Gross appreciation or the gross loss in value of the total unsold securities at the end of an accounting period, after tax. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 14, 17, 19, 22, 26 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 13 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(3) Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 24 -Subparagraph b false 11 5 aet_NetForeignCurrencyAndDerivativeGains aet false na duration monetary This item represents the adjustment that results from the process of translating subsidiary financial statements and foreign... false false false false false false false false false false false terselabel false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false true false false 2400000 2.4 true false false 5 false false false false 0 0 true false false 6 false true false false 2400000 2.4 false false false This item represents the adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into functional currency of the reporting entity and also the accumulated pretax change in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. No authoritative reference available. false 12 5 us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease us-gaap true na duration monetary No definition available. false false false false false false false false false false false false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false true false false 34700000 34.7 true false false 5 false false false false 0 0 true false false 6 false true false false 34700000 34.7 false false false Net changes to accumulated comprehensive income during the period related to benefit plans, after tax. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 158 -Paragraph 7 -Subparagraph c Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(3) Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 14, 17, 22, 26 false 13 5 us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease us-gaap true na duration monetary No definition available. false false false false false false false false false false false totallabel false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false true false false -28200000 -28.2 true false false 5 false true false false -28200000 -28.2 true false false 6 false true false false -28200000 -28.2 false false false This element represents Other Comprehensive Income (Loss), Net of Tax, for the period. Includes deferred gains (losses) on qualifying hedges, unrealized holding gains (losses) on available-for-sale securities, minimum pension liability, and cumulative translation adjustment. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(3) Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 22, 23, 24, 25 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 true 14 4 us-gaap_ComprehensiveIncomeNetOfTax us-gaap true credit duration monetary No definition available. false false false false false false false false false false false totallabel false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false true false false 409600000 409.6 true false false 6 false false false false 0 0 false false false The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A5 -Appendix A Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 30 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(3) Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 8, 9, 10, 11, 12, 13, 14 true 15 3 aet_CommonSharesIssuedForBenefitPlansIncludingTaxBenefitValues aet false na duration monetary Value of stock issued during the period as a result of stock-based compensation plans and employee stock purchase plans. false false false false false false false false false false false terselabel false 1 false false false false 0 0 true false false 2 false true false false 44900000 44.9 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false true false false 44900000 44.9 false false false Value of stock issued during the period as a result of stock-based compensation plans and employee stock purchase plans. No authoritative reference available. false 16 4 aet_CommonSharesIssuedForBenefitPlansIncludingTaxBenefitShares aet false na duration shares Number of stock issued during the period as a result of stock-based compensation plans and employee stock purchase plans. false false false false false false false false false false false terselabel false 1 false true false false 1000000 1.0 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false false false false 0 0 false false false Number of stock issued during the period as a result of stock-based compensation plans and employee stock purchase plans. No authoritative reference available. false 17 3 us-gaap_StockRepurchasedDuringPeriodValue us-gaap true debit duration monetary No definition available. false false false false false false false false false false false false 1 false false false false 0 0 true false false 2 false true false false -100000 -0.1 true false false 3 false true false false -276900000 -276.9 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false true false false -277000000 -277.0 false false false This element represents the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 43 -Chapter 1 -Section B -Paragraph 11A false 18 4 us-gaap_StockRepurchasedDuringPeriodShares us-gaap true na duration shares No definition available. false false false false false false false false false false false false 1 false true false false -10400000 -10.4 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false false false false 0 0 false false false Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 43 -Chapter 1 -Section B -Paragraph 11A false 19 3 us-gaap_StockholdersEquity us-gaap true credit instant monetary No definition available. false false false true false false false false false true false periodendlabel false 1 false false false false 0 0 true false false 2 false true false false 396000000 396.0 true false false 3 false true false false 9877400000 9877.4 true false false 4 false true false false -1909500000 -1909.5 true false false 5 false false false false 0 0 true false false 6 false true false false 8363900000 8363.9 false false false Total of all Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A3 -Appendix A Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section E Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 false 20 3 us-gaap_SharesIssued us-gaap true na instant shares No definition available. false false false true false false false false false true false periodendlabel false 1 false true false false 446900000 446.9 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false false false false 0 0 false false false Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. No authoritative reference available. false 6 3 us-gaap_SharesIssued us-gaap true na instant shares No definition available. false false false true false false false false true false false periodstartlabel false 1 false true false false 430800000 430.8 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 false false false 6 false false false false 0 0 false false false Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. No authoritative reference available. false 5 3 us-gaap_StockholdersEquity us-gaap true credit instant monetary No definition available. false false false true false false false false true false false periodstartlabel false 1 false false false false 0 0 true false false 2 false true false false 470100000 470.1 true false false 3 false true false false 10256700000 10256.7 true false false 4 false true false false -1223000000 -1223.0 true false false 5 false false false false 0 0 false false false 6 false true false false 9503800000 9503.8 false false false Total of all Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A3 -Appendix A Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section E Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 false 7 3 us-gaap_ComprehensiveIncomeNetOfTaxAbstract us-gaap true na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false false false false 0 0 false false false No definition available. false 8 4 us-gaap_NetIncomeLoss us-gaap true credit duration monetary No definition available. false false false false false false false false false false false false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false true false false 562600000 562.6 true false false 4 false false false false 0 0 true false false 5 false true false false 562600000 562.6 true false false 6 false true false false 562600000 562.6 false false false The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph d Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A7 -Appendix A Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 10, 15 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 87-21 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28, 29, 30 false 9 4 us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract us-gaap true na duration string No definition available. false false false false false true false false false false false label false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false false false false 0 0 false false false No definition available. false 10 5 us-gaap_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease us-gaap true na duration monetary No definition available. false false false false false false false false false false false label false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false true false false 52400000 52.4 true false false 5 false false false false 0 0 true false false 6 false true false false 52400000 52.4 false false false Gross appreciation or the gross loss in value of the total unsold securities at the end of an accounting period, after tax. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 14, 17, 19, 22, 26 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 13 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(3) Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 24 -Subparagraph b false 11 5 aet_NetForeignCurrencyAndDerivativeGains aet false na duration monetary This item represents the adjustment that results from the process of translating subsidiary financial statements and foreign... false false false false false false false false false false false terselabel false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false true false false -4600000 -4.6 true false false 5 false false false false 0 0 true false false 6 false true false false -4600000 -4.6 false false false This item represents the adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into functional currency of the reporting entity and also the accumulated pretax change in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. No authoritative reference available. false 12 5 us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease us-gaap true na duration monetary No definition available. false false false false false false false false false false false false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false true false false 32500000 32.5 true false false 5 false false false false 0 0 true false false 6 false true false false 32500000 32.5 false false false Net changes to accumulated comprehensive income during the period related to benefit plans, after tax. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 158 -Paragraph 7 -Subparagraph c Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(3) Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 14, 17, 22, 26 false 13 5 us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease us-gaap true na duration monetary No definition available. false false false false false false false false false false false totallabel false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false true false false 80300000 80.3 true false false 5 false true false false 80300000 80.3 true false false 6 false true false false 80300000 80.3 false false false This element represents Other Comprehensive Income (Loss), Net of Tax, for the period. Includes deferred gains (losses) on qualifying hedges, unrealized holding gains (losses) on available-for-sale securities, minimum pension liability, and cumulative translation adjustment. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(3) Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 22, 23, 24, 25 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 true 14 4 us-gaap_ComprehensiveIncomeNetOfTax us-gaap true credit duration monetary No definition available. false false false false false false false false false false false totallabel false 1 false false false false 0 0 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false true false false 642900000 642.9 true false false 6 false false false false 0 0 false false false The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A5 -Appendix A Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 30 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(3) Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 8, 9, 10, 11, 12, 13, 14 true 15 3 aet_CommonSharesIssuedForBenefitPlansIncludingTaxBenefitValues aet false na duration monetary Value of stock issued during the period as a result of stock-based compensation plans and employee stock purchase plans. false false false false false false false false false false false terselabel false 1 false false false false 0 0 true false false 2 false true false false 29200000 29.2 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false true false false 29200000 29.2 false false false Value of stock issued during the period as a result of stock-based compensation plans and employee stock purchase plans. No authoritative reference available. false 16 4 aet_CommonSharesIssuedForBenefitPlansIncludingTaxBenefitShares aet false na duration shares Number of stock issued during the period as a result of stock-based compensation plans and employee stock purchase plans. false false false false false false false false false false false terselabel false 1 false true false false 1300000 1.3 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false false false false 0 0 false false false Number of stock issued during the period as a result of stock-based compensation plans and employee stock purchase plans. No authoritative reference available. false 17 3 us-gaap_StockRepurchasedDuringPeriodValue us-gaap true debit duration monetary No definition available. false false false false false false false false false false false false 1 false false false false 0 0 true false false 2 false true false false -100000 -0.1 true false false 3 false true false false -251900000 -251.9 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false true false false -252000000 -252.0 false false false This element represents the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 43 -Chapter 1 -Section B -Paragraph 11A false 18 4 us-gaap_StockRepurchasedDuringPeriodShares us-gaap true na duration shares No definition available. false false false false false false false false false false false false 1 false true false false -7200000 -7.2 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false false false false 0 0 false false false Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 43 -Chapter 1 -Section B -Paragraph 11A false 19 3 us-gaap_StockholdersEquity us-gaap true credit instant monetary No definition available. false false false true false false false false false true false periodendlabel false 1 false false false false 0 0 true false false 2 true true false false 499200000 499.2 true false false 3 true true false false 10567400000 10567.4 true false false 4 true true false false -1142700000 -1142.7 true false false 5 false false false false 0 0 true false false 6 true true false false 9923900000 9923.9 false false false Total of all Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A3 -Appendix A Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section E Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 false 20 3 us-gaap_SharesIssued us-gaap true na instant shares No definition available. false false false true false false false false false true false periodendlabel false 1 false true false false 424900000 424.9 true false false 2 false false false false 0 0 true false false 3 false false false false 0 0 true false false 4 false false false false 0 0 true false false 5 false false false false 0 0 true false false 6 false false false false 0 0 false false false Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. No authoritative reference available. false false 6 32 false HundredThousands HundredThousands UnKnown false true XML 32 R16.xml IDEA: Dividend Restrictions and Statutory Surplus 2.0.0.10 false Dividend Restrictions and Statutory Surplus 006110 - Disclosure - Dividend Restrictions and Statutory Surplus true false false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 2 0 aet_NotesToFinancialStatementsAbstract aet false na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false No definition available. false 3 1 aet_DividendRestrictionsAndStatutorySurplusTextBlock aet false na duration string Disclosure of statutory restrictions on the payment of dividends as prescribed by the National Association of Insurance... false false false false false false false false false false false terselabel false 1 false false false false 0 0 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">11.</font></div></td><td valign="top" align="left" width="85%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Dividend Restrictions and Statutory Surplus</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Under regulatory requirements at March 31, 2010, the amount of dividends that may be paid to Aetna th rough the end of 2010 by our insurance and HMO subsidiaries without prior approval by regulatory authorities is approximately $1.1 billion in the aggregate.&#160;&#160;There are no such restrictions on distributions from Aetna to its shareholders.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The combined statutory capital and surplus of our insurance and HMO subsidiaries was $7.0 billion and $6.8 billion at March 31, 2010 and December 31, 2009, respectively.</font></div> 11.Dividend Restrictions and Statutory SurplusUnder regulatory requirements at March 31, 2010, the amount of dividends that may be paid to Aetna through the false false false Disclosure of statutory restrictions on the payment of dividends as prescribed by the National Association of Insurance Commissioners or state regulatory authorities, amounts not available for future dividend payments, and amount of dividends paid. Amount of statutory capital and surplus computed using prescribed or permitted statutory accounting practice. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 33 R9.xml IDEA: Operating Expenses 2.0.0.10 false Operating Expenses 006040 - Disclosure - Operating Expenses true false false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 2 0 aet_NotesToFinancialStatementsAbstract aet false na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false No definition available. false 3 1 us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock us-gaap true na duration string No definition available. false false false false false false false false false false false terselabel false 1 false false false false 0 0 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="2%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">4.</font></div></td><td valign="top" align="left" width="82%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Operating Expenses</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">For the three months ended March 31, 2010 and 2009, selling expenses (which include broker commissions, the variable component of our internal sales force compensation and premium taxes) and general and administrative expenses were as follows:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2010</font></div>& lt;/td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="14%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;2009</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Selling expenses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 321.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="14%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 322.5</font></div></td></tr><tr><td valign= "bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">General and administrative expenses:</font></div></td><td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="14%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; &#160;Salaries and related benefits</font></div></td><td valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;767.8</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="14%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;750.2</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" al ign="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;Other general and administrative expenses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;427.9</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="1%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom " align="right" width="14%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;479.6</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total general and administrative expenses</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,195.7</font></div></td><td style="BORDER-BOTTOM: black 2 px solid" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="14%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;1,229.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="74%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total operating expenses</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="11%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RI GHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,517.2</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="14%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,552.3</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacin g="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="2%"><div style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="83%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Includes litigation-related insurance proceeds of $70.0 million for 2010.&#160;&#160;Refer to the reconciliation of operating earnings to net income in Note 13 beginning on page&#160;19 for additional information.</font></div></td></tr></table></div> 4.Operating ExpensesFor the three months ended March 31, 2010 and 2009, selling expenses (which include broker commissions, the variable component of our false false false Describes the nature of and identifies the significant items comprising an entity's selling, general and administrative (or similar) report caption. No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 34 R6.xml IDEA: Organization 2.0.0.10 false Organization 006010 - Disclosure - Organization true false false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 2 0 aet_NotesToFinancialStatementsAbstract aet false na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false No definition available. false 3 1 us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock us-gaap true na duration string No definition available. false false false false false false false false false false false terselabel false 1 false false false false 0 0 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">1.</font></div></td><td valign="top" align="left" width="85%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Organization</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We conduct our operations in three business segments:</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt">< ;br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr valign="top"><td style="WIDTH: 36pt" align="right"><div><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Symbol, serif">&#183;&#160;&#160;</font></div></td><td><div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Health Care</font> consists of medical, pharmacy benefits management, dental and vision plans offered on both an Insured basis (where we assume all or a majority of the risk for medical and dental care costs) and an employer-funded basis (where the plan sponsor under an administrative services contract (&#8220;ASC&#8221;) assumes all or a majority of this risk).&#160;&#160;Medical products inc lude point-of-service (&#8220;POS&#8221;), preferred provider organization (&#8220;PPO&#8221;), health maintenance organization (&#8220;HMO&#8221;) and indemnity benefit plans.&#160;&#160;Medical products also include health savings accounts (&#8220;HSAs&#8221;) and Aetna HealthFund<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, consumer-directed health plans that combine traditional POS or PPO and/or dental coverage, subject to a deductible, with an accumulating benefit account (which may be funded by the plan sponsor and/or the member in the case of HSAs).&#160;&#160;We also offer Medicare and Medicaid products and services and specialty products, such as medical management and data analytics services, behavioral health plans and stop loss insurance, as well as products that provide access to our provider network in select markets.</font></div></td></tr></table></div>&l t;div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr valign="top"><td style="WIDTH: 36pt" align="right"><div><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Symbol, serif">&#183;&#160;&#160;</font></div></td><td><div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Group Insurance</font> primarily includes group life insurance products offered on an Insured basis, including basic and supplemental group term life, group universal life, supplemental or voluntary programs and accidental death and dismemberment coverage.&#160;&#160;Group Insurance also includes (i) group disability products offered to employers on both an Insured and an ASC basis which consist primarily of short-term and long-term disability insurance, (ii) absence management services offered to employers, which include short-term and long-term disability administration and leave management, and (iii) long-term care products that were offered primarily on an Insured basis, which provide benefits covering the cost of care in private home settings, adult day care, assisted living or nursing facilities.&#160;&#160;We no longer solicit or accept new long-term care customers, and we are working with our customers on an orderly transition of this product to other carriers.</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr valign="top"><td style="WIDTH: 36pt" align="right"><div><font style="DISPLAY: inline; F ONT-SIZE: 11pt; FONT-FAMILY: Symbol, serif">&#183;&#160;&#160;</font></div></td><td><div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Large Case Pensions</font> manages a variety of retirement products (including pension and annuity products) primarily for tax qualified pension plans.&#160;&#160;These products provide a variety of funding and benefit payment distribution options and other services.&#160;&#160;Large Case Pensions also includes certain discontinued products (refer to Note 14 beginning on page&#160;20 or additional information).</font></div></td></tr></table></div> 1.OrganizationWe conduct our operations in three business segments:&#183;&#160;&#160;Health Care consists of medical, pharmacy benefits management, dental and false false false Description containing the entire organization, consolidation and basis of presentation of financial statements disclosure. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Staff Position (FSP) -Number FAS140-4 and FIN46(R)-8 -Paragraph 8, C1, C7 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 2-6 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Statement of Position (SOP) -Number 94-6 -Paragraph 10 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Interpretation (FIN) -Number 46R -Paragraph 4, 14, 15 false false 1 2 false UnKnown UnKnown UnKnown false true XML 35 R5.xml IDEA: Consolidated Statements of Cash Flows (Unaudited) 2.0.0.10 false Consolidated Statements of Cash Flows (Unaudited) (USD $) 004000 - Statement - Consolidated Statements of Cash Flows (Unaudited) true false In Millions false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 false 2 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 3 1 us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract us-gaap true na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities include all transactions and events that are not defined as investing or financing activities. Operating activities generally involve producing and delivering goods and providing services. Cash flows from operating activities are generally the cash effects of transactions and other events that enter into the determination of net income. false 4 2 us-gaap_NetIncomeLoss us-gaap true credit duration monetary No definition available. false false false false false false false false false false false terselabel false 1 true true false false 562600000 562.6 false false false 2 true true false false 437800000 437.8 false false false The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph d Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A7 -Appendix A Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 10, 15 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 87-21 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28, 29, 30 false 5 2 us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract us-gaap true na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false No definition available. false 6 3 us-gaap_GainLossOnSaleOfInvestments us-gaap true credit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false -76700000 -76.7 false false false 2 false true false false 4800000 4.8 false false false The net realized gain or loss on investments sold during the period, which, for cash flow reporting, is a component of proceeds from investing activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 7 3 us-gaap_DepreciationAmortizationAndAccretionNet us-gaap true debit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false 102300000 102.3 false false false 2 false true false false 97000000 97.0 false false false The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by (used in) operations using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 8 3 us-gaap_IncomeLossFromEquityMethodInvestments us-gaap true credit duration monetary No definition available. false false false false false false false false false false false terselabel false 1 false true false false -11400000 -11.4 false false false 2 false true false false 10200000 10.2 false false false This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. Such amount typically reflects adjustments similar to those made in preparing consolidated statements, including adjustments to eliminate intercompany gains and losses, and to amortize, if appropriate, any difference between cost and underlying equity in net assets of the investee at the date of investment. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 18 -Paragraph 19 -Subparagraph c Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 11 -Article 7 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 9 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 18 -Paragraph 6 -Subparagraph b false 9 3 us-gaap_StockOptionPlanExpense us-gaap true debit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false 27600000 27.6 false false false 2 false true false false 37200000 37.2 false false false The noncash expense that accounts for the value of stock options distributed to employees as compensation. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph 64 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph i false 10 3 us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments us-gaap true credit duration monetary No definition available. false false false false false false false false false false false label false 1 false true false false -11600000 -11.6 false false false 2 false true false false -16500000 -16.5 false false false The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by (used in) operations using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 11 3 us-gaap_IncreaseDecreaseInOperatingCapitalAbstract us-gaap true na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false No definition available. false 12 4 us-gaap_IncreaseDecreaseInAccruedInvestmentIncomeReceivable us-gaap true credit duration monetary No definition available. false false false false false false false false false false false terselabel false 1 false true false false -6800000 -6.8 false false false 2 false true false false 4000000 4.0 false false false The net change during the reporting period in investment income that has been earned but not yet received in cash. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 13 4 us-gaap_IncreaseDecreaseInOtherReceivables us-gaap true credit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false -93300000 -93.3 false false false 2 false true false false -256900000 -256.9 false false false The net change during the reporting period in other amounts due to the reporting entity, which are not otherwise defined in the taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 14 4 us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable us-gaap true debit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false 235600000 235.6 false false false 2 false true false false 216700000 216.7 false false false The net change during the period in the amount of cash payments due to taxing authorities for taxes that are based on the reporting entity's earnings. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 15 4 us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet us-gaap true credit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false -66100000 -66.1 false false false 2 false true false false -68700000 -68.7 false false false For entities with classified balance sheets, the net change during the reporting period in the value of other assets or liabilities used in operating activities, that are not otherwise defined in the taxonomy. For entities with unclassified balance sheets, the net change during the reporting period in the value of all other assets or liabilities used in operating activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 16 4 aet_HealthCareAndInsuranceLiabilities aet false debit duration monetary The net change during the reporting period of Health Care and Other Insurance Liabilities balances; shall be classified as... false false false false false false false false false false false label false 1 false true false false 174700000 174.7 false false false 2 false true false false 361700000 361.7 false false false The net change during the reporting period of Health Care and Other Insurance Liabilities balances; shall be classified as cash flows from operating activities. No authoritative reference available. false 17 3 us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther us-gaap true debit duration monetary No definition available. false false false false false false false false false false false terselabel false 1 false true false false 400000 0.4 false false false 2 false true false false -1000000 -1.0 false false false Transactions that do not result in cash inflows or outflows in the period in which they occur, but affect net income and thus are removed when calculating net cash flow from operating activities using the indirect cash flow method. This element is used when there is not a more specific and appropriate element. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 18 2 us-gaap_NetCashProvidedByUsedInOperatingActivities us-gaap true na duration monetary No definition available. false false false false false false false false false false false totallabel false 1 false true false false 837300000 837.3 false false false 2 false true false false 826300000 826.3 false false false The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 true 19 1 us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract us-gaap true na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false No definition available. false 20 2 us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities us-gaap true debit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false 2462200000 2462.2 false false false 2 false true false false 2490700000 2490.7 false false false The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (trading, held-to-maturity, or available-for-sale) during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 16 -Subparagraph b Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 16 -Subparagraph a false 21 2 us-gaap_PaymentsToAcquireInvestments us-gaap true credit duration monetary No definition available. false false false false false false false false false false true negated false 1 false true false false -2686400000 -2686.4 false false false 2 false true false false -2287300000 -2287.3 false false false The cash outflow associated with the purchase of all investments (debt, security, other) during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15, 17 false 22 2 us-gaap_PaymentsToAcquirePropertyPlantAndEquipment us-gaap true credit duration monetary No definition available. false false false false false false false false false false true negated false 1 false true false false -74500000 -74.5 false false false 2 false true false false -88600000 -88.6 false false false The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 17 -Subparagraph c false 23 2 us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired us-gaap true credit duration monetary No definition available. false false false false false false false false false false true negated false 1 false true false false -100000 -0.1 false false false 2 false true false false 0 0 false false false The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15, 17 false 24 2 us-gaap_NetCashProvidedByUsedInInvestingActivities us-gaap true debit duration monetary No definition available. false false false false false false false false false false false totallabel false 1 false true false false -298800000 -298.8 false false false 2 false true false false 114800000 114.8 false false false The net cash inflow (outflow) from investing activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 true 25 1 us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract us-gaap true na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false No definition available. false 26 2 us-gaap_ProceedsFromRepaymentsOfShortTermDebt us-gaap true debit duration monetary No definition available. false false false false false false false false false false false label false 1 false true false false -1300000 -1.3 false false false 2 false true false false -114800000 -114.8 false false false The net cash inflow (outflow) for borrowing having initial term of repayment within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 18 false 27 2 us-gaap_AdditionsToContractHoldersFunds us-gaap true debit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false 1600000 1.6 false false false 2 false true false false 1900000 1.9 false false false The cash inflow from a segregated fund account during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26, 31 false 28 2 us-gaap_WithdrawalFromContractHoldersFunds us-gaap true credit duration monetary No definition available. false false false false false false false false false false true negated false 1 false true false false -3700000 -3.7 false false false 2 false true false false -3900000 -3.9 false false false The cash outflow for a segregated fund account during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26, 31 false 29 2 us-gaap_ProceedsFromIssuanceOfCommonStock us-gaap true debit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false 3600000 3.6 false false false 2 false true false false 3700000 3.7 false false false The cash inflow from the additional capital contribution to the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 18 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 19 -Subparagraph a false 30 2 us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities us-gaap true debit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false -1000000 -1.0 false false false 2 false true false false 3600000 3.6 false false false Reductions in the entity's income taxes that arise when compensation cost (from non-qualified share-based compensation) recognized on the entity's tax return exceeds compensation cost from share-based compensation recognized in financial statements. This element represents the cash inflow reported in the enterprise's financing activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph i Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 00-15 -Paragraph 3 false 31 2 us-gaap_PaymentsForRepurchaseOfCommonStock us-gaap true credit duration monetary No definition available. false false false false false false false false false false true negated false 1 false true false false -162000000 -162.0 false false false 2 false true false false -263800000 -263.8 false false false The cash outflow to reacquire common stock during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 18 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 20 -Subparagraph a false 32 2 aet_CollateralOnInterestRateSwaps aet false na duration monetary This item represents the change in cash that serves as collateral for our interest rate swaps. false false false false false false false false false false false terselabel false 1 false true false false -8900000 -8.9 false false false 2 false true false false 0 0 false false false This item represents the change in cash that serves as collateral for our interest rate swaps. No authoritative reference available. false 33 2 us-gaap_NetCashProvidedByUsedInFinancingActivities us-gaap true debit duration monetary No definition available. false false false false false false false false false false false totallabel false 1 false true false false -171700000 -171.7 false false false 2 false true false false -373300000 -373.3 false false false The net cash inflow (outflow) from financing activity for the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 true 34 1 us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease us-gaap true na duration monetary No definition available. false false false false false false false false false false false label false 1 false true false false 366800000 366.8 false false false 2 false true false false 567800000 567.8 false false false The net change between the beginning and ending balance of cash and cash equivalents. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 false 35 1 us-gaap_CashAndCashEquivalentsAtCarryingValue us-gaap true debit instant monetary No definition available. false false false false false false false false true false false periodstartlabel false 1 false true false false 1203600000 1203.6 false false false 2 false true false false 1179500000 1179.5 false false false Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased th ree years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits should not be reported as cash and cash equivalents. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7, 26 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 8, 9 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7 -Footnote 1 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 false 36 1 us-gaap_CashAndCashEquivalentsAtCarryingValue us-gaap true debit instant monetary No definition available. false false false false false false false false false true false periodendlabel false 1 false true false false 1570400000 1570.4 false false false 2 false true false false 1747300000 1747.3 false false false Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased th ree years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits should not be reported as cash and cash equivalents. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7, 26 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 8, 9 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7 -Footnote 1 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 false 37 1 us-gaap_SupplementalCashFlowInformationAbstract us-gaap true na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false No definition available. false 38 2 us-gaap_InterestPaid us-gaap true credit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false 35000000 35.0 false false false 2 false true false false 36800000 36.8 false false false The amount of cash paid during the current period for interest owed on money borrowed; includes amount of interest capitalized Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 29 false 39 2 us-gaap_IncomeTaxesPaid us-gaap true credit duration monetary No definition available. false false false false false false false false false false false false 1 true true false false 3700000 3.7 false false false 2 true true false false 10900000 10.9 false false false The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 29 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 27 -Subparagraph f false false 2 37 false HundredThousands UnKnown UnKnown false true XML 36 defnref.xml IDEA: XBRL DOCUMENT No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The sum of the known and estimated amounts currently payable as of the balance sheet date to policyholders pertaining to insured events for long-duration contracts, which can be viewed as either (a) the present value of future benefits to be paid to or on behalf of policyholders and expenses less the present value of future net premiums payable under the insurance contracts or (b) the accumulated amount of net premiums already collected less the accumulated amount of benefits and expenses already paid to or on behalf of policyholders. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This item represents the adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into functional currency of the reporting entity and also the accumulated pretax change in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Disclosure of statutory restrictions on the payment of dividends as prescribed by the National Association of Insurance Commissioners or state regulatory authorities, amounts not available for future dividend payments, and amount of dividends paid. Amount of statutory capital and surplus computed using prescribed or permitted statutory accounting practice. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Current liability as of the balance sheet date for the estimated ultimate cost of settling claims and claim adjustment expense relating to insured events that have occurred on or before the balance sheet date for those liabilities owed to another party as a result of assuming another insurer's primary obligation. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Total amount of benefit and other expenses incurred during the period. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The total liability as of the balance sheet date of current amounts due to policy holders, excluding future policy benefits and claims, including unpaid policy dividends, retrospective refunds, and undistributed earnings on participating business. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This item represents the complete disclosure regarding the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments, assets, and liabilities. Also, provides general information items required or determined to be disclosed with respect to the Companys fair value estimates for financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined). No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Value of stock issued during the period as a result of stock-based compensation plans and employee stock purchase plans. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This item represents the entire disclosure related to Investments in Certain Debt and Equity Securities (and certain other trading assets) which include all debt and equity securities (other than those equity securities accounted for under the equity or cost methods of accounting) with readily determinable fair values. Other trading assets include assets that are carried on the balance sheet at fair value and held for trading purposes. A debt security represents a creditor relationship with an enterprise that is in the form of a security. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferr ed stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities (and other trading assets). Secondly, contains a description of noncontrolling interest which might include background information, terms of the ownership arrangement, and type and terms of equity interest owned by the noncontrolling interest holders. Thirdly, a description of the variable interest entity. In general, a VIE is a corporation, partnership, trust, or any other legal structure used for business purposes that either (a) does not have equity investors with voting rights or (b) has equity investors that do not provide sufficient financial resources for the entity to support its activities. A VIE often holds financial assets, including loans or receivables, real estate or other property. A VIE may be essentially passive or it may engage in research and developme nt or other activities on behalf of another company. Fourth, credit default swaps are also included. These are a type of swap transaction used as a credit derivative in which one party makes periodic payments to the other and receives the promise of a pay-off if a third party defaults. Finally, net investment income is also disclosed. This is the income earned from investments in securities and property, equipment and other capital assets. It includes rent from property and equipment, dividends from shares in corporations, and interest from bonds, loans, mortgages, derivatives, commercial paper, bank accounts, certificates of deposits, treasuries, and other financial securities. It does not include realized gains and losses on investments. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This item represents the change in cash that serves as collateral for our interest rate swaps. No authoritative reference available. Sum of income before income taxes. No authoritative reference available. No authoritative reference available. No authoritative reference available. The total liability as of the balance sheet date of noncurrent amounts due policy holders, excluding future policy benefits and claims, including unpaid policy dividends, retrospective refunds, and undistributed earnings on participating business. No authoritative reference available. Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancings and noncompliance with debt covenants. Also contains a description of forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period. No authoritative reference available. The net change during the reporting period of Health Care and Other Insurance Liabilities balances; shall be classified as cash flows from operating activities. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Health Care Costs Payable represents the company's estimated obligation for health care services that have been rendered on behalf of insured customers but for which claims have not yet been received or processed as of the balance sheet date, and for liabilities for physician, hospital and other medical cost disputes as of the balance sheet date. No authoritative reference available. Noncurrent liability as of the balance sheet date for the estimated ultimate cost of settling claims and claim adjustment expense relating to insured events that have occurred on or before the balance sheet date for those liabilities owed to another party as a result of assuming another insurer's primary obligation. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The sum of the known and estimated noncurrent amounts payable as of the balance sheet date to policyholders pertaining to insured events for long-duration contracts, which can be viewed as either (a) the present value of future benefits to be paid to or on behalf of policyholders and expenses less the present value of future net premiums payable under the insurance contracts or (b) the accumulated amount of net premiums already collected less the accumulated amount of benefits and expenses already paid to or on behalf of policyholders. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Prior to 1993, we sold single-premium annuities ("SPAs") and guaranteed investment contracts ("GICs"), primarily to employer sponsored pension plans. In 1993, we discontinued selling these products, and now we refer to these products as discontinued products. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This element may be used to describe all significant accounting policies of the reporting entity. For a new accounting pronouncement that has been issued but not yet adopted, an entity's disclosure should (1) describe the new pronouncement, the date that adoption is required and the date that the entity plans to adopt, if earlier; (2) discuss the methods of adoption allowed by the pronouncement and the method expected to be utilized by the entity, if determined; (3) discuss the impact that adoption of the pronouncement is expected to have on the financial statements of the entity, unless such impact is not known or reasonably estimable (in which case, a statement to that effect should be made) and; (4) disclose the potential impact of other significant matters that the entity believes might result from the adoption of the pronouncement (for example, technical violations of debt covenant agreements and planned or intended changes in business practices.) No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Number of stock issued during the period as a result of stock-based compensation plans and employee stock purchase plans. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury; and Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Excludes common shares repurchased by the entity and held as Treasury shares. Shares outstanding equals shares issued minus shares held in treasury. Does not include common shares that have been repurchased. No authoritative reference available. XML 37 R21.xml IDEA: Entity Information 2.0.0.10 false Entity Information (USD $) 995400 - Document - Entity Information true false false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 2 0 dei_EntityTextBlock dei false na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false Container to serve as parent of six Entity related Table concepts. false 3 1 dei_EntityRegistrantName dei false na duration normalizedstring No definition available. false false false false false false false false false false false false 1 false false false false 0 0 AETNA INC /PA/ AETNA INC /PA/ false false false The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false 4 1 dei_EntityCentralIndexKey dei false na duration na No definition available. false false false false false false false false false false false false 1 false false false false 0 0 0001122304 0001122304 false false false A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false 5 1 dei_CurrentFiscalYearEndDate dei false na duration monthday No definition available. false false false false false false false false false false false false 1 false false false false 0 0 --12-31 --12-31 false false false End date of current fiscal year in the format --MM-DD. No authoritative reference available. false 6 1 dei_EntityWellKnownSeasonedIssuer dei false na duration na No definition available. false false false false false false false false false false false false 1 false false false false 0 0 Yes Yes false false false Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A. No authoritative reference available. false 7 1 dei_EntityVoluntaryFilers dei false na duration na No definition available. false false false false false false false false false false false false 1 false false false false 0 0 No No false false false Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. No authoritative reference available. false 8 1 dei_EntityCurrentReportingStatus dei false na duration na No definition available. false false false false false false false false false false false false 1 false false false false 0 0 No No false false false Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure. No authoritative reference available. false 9 1 dei_EntityFilerCategory dei false na duration na No definition available. false false false false false false false false false false false false 1 false false false false 0 0 Large Accelerated Filer Large Accelerated Filer false false false Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, or (4) Smaller Reporting Company. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure. No authoritative reference available. false 10 1 dei_EntityPublicFloat dei false credit instant monetary No definition available. false false false false false false false false false false false false 1 true true false false 14900000000 14900000000 false false false State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K. No authoritative reference available. false 11 1 dei_EntityCommonStockSharesOutstanding dei false na instant shares No definition available. false false false false false false false false false false false false 1 false true false false 424900000 424900000 false false false Indicate number of shares outstanding of each of registrant's classes of common stock, as of latest practicable date. Where multiple classes exist define each class by adding class of stock items such as Common Class A [Member], Common Class B [Member] onto the Instrument [Domain] of the Entity Listings, Instrument No authoritative reference available. false 12 1 dei_DocumentFiscalYearFocus dei false na duration positiveinteger No definition available. false false false false false false false false false false false false 1 false true false false 2010 2010 false false false This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006. No authoritative reference available. false 13 1 dei_DocumentFiscalPeriodFocus dei false na duration na No definition available. false false false false false false false false false false false false 1 false false false false 0 0 Q1 Q1 false false false This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY. No authoritative reference available. false false 1 12 false NoRounding NoRounding UnKnown false true XML 38 R13.xml IDEA: Defined Benefit Retirement Plans 2.0.0.10 false Defined Benefit Retirement Plans 006080 - Disclosure - Defined Benefit Retirement Plans true false false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 2 0 aet_NotesToFinancialStatementsAbstract aet false na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false No definition available. false 3 1 us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock us-gaap true na duration string No definition available. false false false false false false false false false false false terselabel false 1 false false false false 0 0 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="2%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">8.</font></div></td><td valign="top" align="left" width="83%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -1.8pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Defined Benefit Retirement Plans</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 3.6pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Components of the net periodic benefit cost of our noncontributory defined benefit pension plans and other postretirement benefit (&#8220;OPEB&#8221;) plans for the three months ended March 31, 2010 and 2009 were as follows:</font><br /></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="bottom" width="59%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="20%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Pension Plans</font></div></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZ E: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="17%" colspan="3"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">OPEB Plans</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">(Millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; F ONT-SIZE: 9pt; FONT-FAMILY: times new roman">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right" ><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">2009</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Operating component:</font></div></td><td valign="bottom" wid th="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">& #160; </font></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;Service cost</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 15.3</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY : inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 12.0</font></div></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160;&#160; .1</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&am p;#160;$&#160;&#160;&#160;&#160;&#160; .1</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;Amortization of prior service cost</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(.5)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font>< /td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(.5)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(.9)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman" >&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(1.0)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total operating component<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"> (1)</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font styl e="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;14.8</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;11.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDE NT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(.8)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(.9)</font></div></td></tr><tr><td valign="bottom" width="59%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"> &#160; </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width=" 59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Financing component:</font></div></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td>< td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;Interest cost</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;76.6</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZ E: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;79.1</font></div></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;4.5</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="7%"&g t;<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.5</font></div></td></tr><tr><td valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;Expected return on plan assets</font></div></td><td valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(88.3)</font></div></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#16 0; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(79.7)</font></div></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(.9)</font></div></td><td valign="bottom" align="right" width="2%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman"></font> &#160;</div></td><td valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;(1.0)</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;&#160;&#160;Recognized net actuarial loss</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;50.3< /font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;54.1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE : 9pt; FONT-FAMILY: times new roman">&#160;1.1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;.8</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Total financing component<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"> (1)< ;/font></font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;38.6</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;53.5</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="4%"><font sty le="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;4.7</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;5.3</font></div></td></tr><tr><td valign="bottom" w idth="59%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&a mp;#160; </font></td><td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td></tr><tr><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="59%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">Net periodic benefit cost</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 53.4</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="2%"><font style="DISPL AY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 65.0</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="8%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160; 3.9</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="left" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="7%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">&#160;$&#160;&#160;&#160; 4.4</font></div></td></tr></table></div><div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td style="TEXT-ALIGN: center" valign="top" width="3%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div></td><td valign="top" align="left" width="82%"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: times new roman">The operating component of this expense is allocated to our business segments and the financing component is allocated to our Corporate Financing segment.&#160;&#160;Our Corporate Financing segment is not a business segment.&#160;&#160;It is added to our business segments to reconcile to our consolidated results.&#160;&#160;Refer to Note 13 beginning on page&#160;19 for additional information on our business segments.</font></div></td></tr></table></div> 8.Defined Benefit Retirement PlansComponents of the net periodic benefit cost of our noncontributory defined benefit pension plans and other postretirement false false false Description containing the entire pension and other postretirement benefits disclosure as a single block of text. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Staff Position (FSP) -Number FAS106-2 -Paragraph 20, 21, 22 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 132R -Paragraph 5, 6, 7, 8 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 87 -Paragraph 264 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Implementation Guide (Q and A) -Number FAS88 -Paragraph 63 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 158 -Paragraph 7, 21, 22 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 132R -Paragraph 5 -Subparagraph b Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 30 -Paragraph 26 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 106 -Paragraph 518 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 03-2 -Paragraph 8 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 132R -Paragraph 8 -Subparagraph m Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 132R -Paragraph 5 -Subparagraph h Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 132R -Paragraph 5 -Subparagraph a Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 132R -Paragraph 5 -Subparagraph q false false 1 2 false UnKnown UnKnown UnKnown false true XML 39 R1.xml IDEA: Consolidated Statements of Income (Unaudited) 2.0.0.10 false Consolidated Statements of Income (Unaudited) (USD $) 001000 - Statement - Consolidated Statements of Income (Unaudited) true false In Millions, except Per Share data false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 false 2 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 3 1 us-gaap_RevenuesAbstract us-gaap true na duration string No definition available. false false false false false true false false false false false label false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false No definition available. false 4 2 us-gaap_PremiumsEarnedNetAccidentAndHealth us-gaap true credit duration monetary No definition available. false false false false false false false false false false false false 1 true true false false 6895100000 6895.1 false false false 2 true true false false 6992200000 6992.2 false false false Premiums recognized as revenue in the period earned on all accident and health insurance and reinsurance contracts after subtracting any amounts ceded to another insurer. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 113 -Paragraph 27 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 17 -Article 12 false 5 2 us-gaap_OtherPremiumRevenueNet us-gaap true credit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false 474700000 474.7 false false false 2 false true false false 485100000 485.1 false false false Premiums recognized as revenue in the period earned on all types of insurance and reinsurance contracts not otherwise specified in the taxonomy after subtracting any amounts ceded to another insurer. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 113 -Paragraph 27 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 17 -Article 12 false 6 2 us-gaap_OtherIncome us-gaap true credit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false 899800000 899.8 [1] false false false 2 false true false false 893000000 893.0 [1] false false false Reflects the sum of all other revenue and income recognized by the entity in the period not otherwise specified in the income statement. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 4 -Article 7 false 7 2 us-gaap_NetInvestmentIncome us-gaap true credit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false 275200000 275.2 false false false 2 false true false false 249200000 249.2 false false false The income earned from investments in securities and property, equipment and other capital assets. It includes rent from property and equipment, dividends from shares in corporations, and interest from bonds, loans, mortgages, derivatives, commercial paper, bank accounts, certificates of deposits, treasuries, and other financial securities. It does not include realized gains and losses on investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 16 -Article 12 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 2 -Article 7 false 8 2 us-gaap_RealizedInvestmentGainsLosses us-gaap true credit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false 76700000 76.7 false false false 2 false true false false -4800000 -4.8 false false false The net realized gains or losses on investments during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 3 -Subparagraph a -Article 7 false 9 2 us-gaap_Revenues us-gaap true credit duration monetary No definition available. false false false false false false false false false false false totallabel false 1 false true false false 8621500000 8621.5 false false false 2 false true false false 8614700000 8614.7 false false false Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 true 10 1 aet_BenefitsAndExpenses aet false na duration string No definition available. false false false false false true false false false false false label false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false No definition available. false 11 2 us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare us-gaap true debit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false 5691000000 5691.0 [2] false false false 2 false true false false 5804200000 5804.2 [2] false false false Provision for benefits, claims and claims settlement expenses incurred during the period for health care insurance contracts net of the effects of contracts assumed and ceded. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 5 -Article 7 false 12 2 us-gaap_PolicyholderBenefitsAndClaimsIncurredNet us-gaap true debit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false 527000000 527.0 false false false 2 false true false false 503300000 503.3 false false false Provision for benefits, claims and claims settlement expenses incurred during the period net of the effects of contracts assumed and ceded. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 5 -Article 7 false 13 2 us-gaap_OperatingExpensesAbstract us-gaap true na duration string No definition available. false false false false false true false false false false false terselabel false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false No definition available. false 14 3 us-gaap_SellingExpense us-gaap true debit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false 321500000 321.5 false false false 2 false true false false 322500000 322.5 false false false Expenses recognized in the period that are directly related to the selling and distribution of products or services. No authoritative reference available. false 15 3 us-gaap_GeneralAndAdministrativeExpense us-gaap true debit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false 1195700000 1195.7 false false false 2 false true false false 1229800000 1229.8 false false false The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. No authoritative reference available. false 16 3 us-gaap_OperatingExpenses us-gaap true debit duration monetary No definition available. false false false false false false false false false false false totallabel false 1 false true false false 1517200000 1517.2 false false false 2 false true false false 1552300000 1552.3 false false false Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No authoritative reference available. true 17 2 us-gaap_InterestExpense us-gaap true debit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false 60900000 60.9 false false false 2 false true false false 61500000 61.5 false false false The cost of borrowed funds accounted for as interest that was charged against earnings during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 34 -Paragraph 21 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher OTS -Name Federal Regulation (FR) -Number Title 12 -Chapter V -Section 563c.102 -Paragraph 9 -Subsection II Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 9 -Article 9 false 18 2 us-gaap_AmortizationOfIntangibleAssets us-gaap true debit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false 24400000 24.4 false false false 2 false true false false 24500000 24.5 false false false The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by (used in) operations using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 142 -Paragraph 45 -Subparagraph a(2) false 19 2 aet_TotalBenefitsAndExpenses aet false debit duration monetary Total amount of benefit and other expenses incurred during the period. false false false false false false false false false false false totallabel false 1 false true false false 7820500000 7820.5 false false false 2 false true false false 7945800000 7945.8 false false false Total amount of benefit and other expenses incurred during the period. No authoritative reference available. true 20 1 aet_IncomeBeforeIncomeTax aet false credit duration monetary Sum of income before income taxes. false false false false false false false false false false false totallabel false 1 false true false false 801000000 801.0 false false false 2 false true false false 668900000 668.9 false false false Sum of income before income taxes. No authoritative reference available. true 21 1 us-gaap_IncomeTaxExpenseBenefitAbstract us-gaap true na duration string No definition available. false false false false false true false false false false false terselabel false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false No definition available. false 22 2 us-gaap_CurrentIncomeTaxExpenseBenefit us-gaap true debit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false 216100000 216.1 false false false 2 false true false false 208300000 208.3 false false false The component of income tax expense for the period representing amounts of income taxes paid or payable (or refundable) for the period for all income tax obligations as determined by applying the provisions of relevant enacted tax laws to relevant amounts of taxable income (loss) from continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 6 -Section I -Subsection 7 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 289 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 45 -Subparagraph a false 23 2 us-gaap_DeferredIncomeTaxExpenseBenefit us-gaap true debit duration monetary No definition available. false false false false false false false false false false false false 1 false true false false 22300000 22.3 false false false 2 false true false false 22800000 22.8 false false false The component of income tax expense for the period representing the net change in the entity's deferred tax assets and liabilities pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 6 -Section I -Subsection 7 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 45 -Subparagraph b Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 289 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 false 24 2 us-gaap_IncomeTaxExpenseBenefit us-gaap true debit duration monetary No definition available. false false false false false false false false false false false totallabel false 1 false true false false 238400000 238.4 false false false 2 false true false false 231100000 231.1 false false false The sum of the current income tax expense (benefit) and the deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 45 -Subparagraph a, b true 25 1 us-gaap_NetIncomeLoss us-gaap true credit duration monetary No definition available. false false false false false false false false false false false totallabel false 1 true true false false 562600000 562.6 false false false 2 true true false false 437800000 437.8 false false false The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph d Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A7 -Appendix A Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 10, 15 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 87-21 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28, 29, 30 true 26 1 us-gaap_EarningsPerShareAbstract us-gaap true na duration string No definition available. false false false false false true false false false false false label false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false No definition available. false 27 2 us-gaap_EarningsPerShareBasic us-gaap true na duration decimal No definition available. false false false false false false false false false false false totallabel true 1 true true false false 1.3 1.3 false false false 2 true true false false 0.97 0.97 false false false The amount of net income or loss for the period per each share of common stock outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 36, 37, 38 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 true 28 2 us-gaap_EarningsPerShareDiluted us-gaap true na duration decimal No definition available. false false false false false false false false false false false totallabel true 1 true true false false 1.28 1.28 false false false 2 true true false false 0.95 0.95 false false false The amount of net income or loss for the period per each share of common stock and dilutive common stock equivalents outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 11, 12, 36 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 true 1 Fees and other revenue include administrative services contract member co-payments and plan sponsor reimbursements related to our mail order and specialty pharmacy operations of $20.4 million and $14.8 million (net of pharmaceutical and processing costs of $353.6 million and $397.9 million) for the three months ended March 31, 2010 and 2009, respectively. 2 Health care costs have been reduced by Insured member co-payments related to our mail order and specialty pharmacy operations of $31.2 million and $30.0 million for the three months ended March 31, 2010 and 2009, respectively. false 2 26 false HundredThousands UnKnown Hundreds false true XML 40 R2.xml IDEA: Consolidated Balance Sheets 2.0.0.10 false Consolidated Balance Sheets (USD $) 002000 - Statement - Consolidated Balance Sheets true false In Millions false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 false 2 usd $ false false 4 2 us-gaap_AssetsCurrentAbstract us-gaap true na duration string No definition available. false false false false false true false false false false false label false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false No definition available. false 5 3 us-gaap_CashAndCashEquivalentsAtCarryingValue us-gaap true debit instant monetary No definition available. false false false false false false false false false false false false 1 true true false false 1570400000 1570.4 false false false 2 true true false false 1203600000 1203.6 false false false Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased th ree years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits should not be reported as cash and cash equivalents. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7, 26 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 8, 9 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7 -Footnote 1 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 false 6 3 us-gaap_ShortTermInvestments us-gaap true debit instant monetary No definition available. false false false false false false false false false false false terselabel false 1 false true false false 2851900000 2851.9 false false false 2 false true false false 2922700000 2922.7 false false false Investments which are intended to be sold in the short term (usually less than one year or the normal operating cycle, whichever is longer) including trading securities, available-for-sale securities, held-to-maturity securities, and other short-term investments not otherwise listed in the existing taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Subparagraph g -Article 7 false 7 3 us-gaap_PremiumsReceivableAtCarryingValue us-gaap true debit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 758800000 758.8 false false false 2 false true false false 630400000 630.4 false false false The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 5 -Article 7 false 8 3 us-gaap_OtherReceivables us-gaap true debit instant monetary No definition available. false false false false false false false false false false false label false 1 false true false false 634000000 634.0 false false false 2 false true false false 626700000 626.7 false false false Carrying amounts due as of the balance sheet date from parties or arising from transactions not otherwise specified in the taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 8 -Article 5 false 9 3 us-gaap_AccruedInvestmentIncomeReceivable us-gaap true debit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 216000000 216.0 false false false 2 false true false false 209200000 209.2 false false false Interest, dividends, rents, ancillary and other revenues earned but not yet received by the entity on its investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 3 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 4 -Article 7 false 10 3 us-gaap_CashCollateralForBorrowedSecurities us-gaap true debit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 422400000 422.4 false false false 2 false true false false 210000000 210.0 false false false Carrying amount as of the balance sheet date of cash collateral held for borrowed securities, for which the cash is restricted as to withdrawal or usage. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 2 -Article 7 false 11 3 us-gaap_IncomeTaxesReceivable us-gaap true debit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 0 0 false false false 2 false true false false 89500000 89.5 false false false Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 5 -Subparagraph c -Article 7 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 3 -Subparagraph a -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Section Appendix E -Paragraph 289 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 10 -Article 9 false 12 3 us-gaap_DeferredTaxAssetsNetCurrent us-gaap true debit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 284700000 284.7 false false false 2 false true false false 383400000 383.4 false false false The current portion of the aggregate tax effects as of the balance sheet date of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after deducting the allocated valuation allowance, if any, to reduce such amount to net realizable value. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference. An unrecognized tax benefit that is directly related to a position taken in a tax year that results in a net operating los s carryforward should be presented as a reduction of the related deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 41, 42, 43 false 13 3 us-gaap_OtherAssetsCurrent us-gaap true debit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 688200000 688.2 false false false 2 false true false false 551400000 551.4 false false false Aggregate carrying amount, as of the balance sheet date, of current assets not separately presented elsewhere in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 8 -Article 5 false 14 3 us-gaap_AssetsCurrent us-gaap true debit instant monetary No definition available. false false false false false false false false false false false totallabel false 1 false true false false 7426400000 7426.4 false false false 2 false true false false 6826900000 6826.9 false false false Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 9 -Article 5 true 15 2 us-gaap_LongTermInvestments us-gaap true debit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 17809500000 17809.5 false false false 2 false true false false 17051100000 17051.1 false false false The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle). No authoritative reference available. false 16 2 us-gaap_ReinsuranceRecoverables us-gaap true debit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 978000000 978.0 false false false 2 false true false false 986900000 986.9 false false false The known and estimated amount recoverable as of the balance sheet date from reinsurers for claims paid or incurred by the ceding insurer and associated claims settlement expenses, including estimated amounts for claims incurred but not reported, and policy benefits, net of any related valuation allowance. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 6 -Article 7 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 113 -Paragraph 14, 16, 27, 113 false 17 2 us-gaap_Goodwill us-gaap true debit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 5145700000 5145.7 false false false 2 false true false false 5146200000 5146.2 false false false Carrying amount as of the balance sheet date, which is the cumulative amount paid, adjusted for any amortization recognized prior to adoption of FAS 142 and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 142 -Paragraph 43 false 18 2 us-gaap_IntangibleAssetsNetExcludingGoodwill us-gaap true debit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 566300000 566.3 false false false 2 false true false false 590700000 590.7 false false false Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 142 -Paragraph 42, 45 false 19 2 us-gaap_PropertyPlantAndEquipmentNet us-gaap true debit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 556300000 556.3 false false false 2 false true false false 551000000 551.0 false false false Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, and production equipment. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 13 -Subparagraph a -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 12 -Paragraph 5 -Subparagraph b, c Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 8 -Article 7 false 20 2 us-gaap_DeferredTaxAssetsNetNoncurrent us-gaap true debit instant monetary No definition available. false false false false false false false false false false false terselabel false 1 false true false false 350500000 350.5 false false false 2 false true false false 333400000 333.4 false false false The noncurrent portion as of the balance sheet date of the aggregate carrying amount of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after the valuation allowance, if any, to reduce such amount to net realizable value. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 41, 42, 43 false 21 2 us-gaap_OtherAssetsNoncurrent us-gaap true debit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 770600000 770.6 false false false 2 false true false false 781100000 781.1 false false false Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet due to materiality considerations. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 17 -Article 5 false 22 2 us-gaap_SeparateAccountAssets us-gaap true debit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 5369500000 5369.5 false false false 2 false true false false 6283100000 6283.1 false false false The fair value of the assets held by the Entity for the benefit of separate account policyholders. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 11 -Article 7 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 10 -Article 9 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Statement of Position (SOP) -Number 03-1 -Paragraph 10-18 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 113 -Paragraph 53, 54 false 23 2 us-gaap_Assets us-gaap true debit instant monetary No definition available. false false false false false false false false false false false totallabel false 1 false true false false 38972800000 38972.8 false false false 2 false true false false 38550400000 38550.4 false false false Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Concepts (CON) -Number 6 -Paragraph 25 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 true 25 2 us-gaap_LiabilitiesCurrentAbstract us-gaap true na duration string No definition available. false false false false false true false false false false false label false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false No definition available. false 26 3 aet_ShortTermHealthCareCostsPayable aet false credit instant monetary Health Care Costs Payable represents the company's estimated obligation for health care services that have been rendered on... false false false false false false false false false false false terselabel false 1 false true false false 2965400000 2965.4 false false false 2 false true false false 2895300000 2895.3 false false false Health Care Costs Payable represents the company's estimated obligation for health care services that have been rendered on behalf of insured customers but for which claims have not yet been received or processed as of the balance sheet date, and for liabilities for physician, hospital and other medical cost disputes as of the balance sheet date. No authoritative reference available. false 27 3 aet_ShortTermFuturePolicyBenefits aet false credit instant monetary The sum of the known and estimated amounts currently payable as of the balance sheet date to policyholders pertaining to... false false false false false false false false false false false terselabel false 1 false true false false 736000000 736.0 false false false 2 false true false false 739600000 739.6 false false false The sum of the known and estimated amounts currently payable as of the balance sheet date to policyholders pertaining to insured events for long-duration contracts, which can be viewed as either (a) the present value of future benefits to be paid to or on behalf of policyholders and expenses less the present value of future net premiums payable under the insurance contracts or (b) the accumulated amount of net premiums already collected less the accumulated amount of benefits and expenses already paid to or on behalf of policyholders. No authoritative reference available. false 28 3 aet_ShortTermUnpaidClaims aet false credit instant monetary Current liability as of the balance sheet date for the estimated ultimate cost of settling claims and claim adjustment... false false false false false false false false false false false terselabel false 1 false true false false 579000000 579.0 false false false 2 false true false false 559500000 559.5 false false false Current liability as of the balance sheet date for the estimated ultimate cost of settling claims and claim adjustment expense relating to insured events that have occurred on or before the balance sheet date for those liabilities owed to another party as a result of assuming another insurer's primary obligation. No authoritative reference available. false 29 3 us-gaap_UnearnedPremiums us-gaap true credit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 411200000 411.2 false false false 2 false true false false 306400000 306.4 false false false Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 13 -Subparagraph a(2) -Article 7 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 16 -Article 12 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 60 -Paragraph 13 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 97 -Paragraph 16, 17, 20 false 30 3 aet_PolicyholdersFunds aet false credit instant monetary The total liability as of the balance sheet date of current amounts due to policy holders, excluding future policy benefits... false false false false false false false false false false false label false 1 false true false false 831900000 831.9 false false false 2 false true false false 788300000 788.3 false false false The total liability as of the balance sheet date of current amounts due to policy holders, excluding future policy benefits and claims, including unpaid policy dividends, retrospective refunds, and undistributed earnings on participating business. No authoritative reference available. false 31 3 us-gaap_DepositsReceivedForSecuritiesLoanedAtCarryingValue us-gaap true credit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 422400000 422.4 false false false 2 false true false false 210000000 210.0 false false false The amount of cash received as security in return for loaning securities to another party. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 16 -Article 9 false 32 3 us-gaap_ShortTermBorrowings us-gaap true credit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 479600000 479.6 false false false 2 false true false false 480800000 480.8 false false false Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Subparagraph a -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 13 -Subparagraph 2, 3 -Article 9 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 16 -Subparagraph a(1) -Article 7 false 33 3 us-gaap_OtherLongTermDebtCurrent us-gaap true credit instant monetary No definition available. false false false false false false false false false false false label false 1 false true false false 449700000 449.7 false false false 2 false true false false 0 0 false false false Carrying value as of the balance sheet date of the portion of long-term debt not otherwise specified in the taxonomy that is scheduled to be repaid within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 20 -Article 5 false 34 3 us-gaap_TaxesPayableCurrent us-gaap true credit instant monetary No definition available. false false false false false false false false false false false label false 1 false true false false 117300000 117.3 false false false 2 false true false false 0 0 false false false Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 20 -Article 5 false 35 3 us-gaap_OtherLiabilitiesCurrent us-gaap true credit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 2851900000 2851.9 false false false 2 false true false false 2484300000 2484.3 false false false Aggregate carrying amount, as of the balance sheet date, of current obligations not separately disclosed in the balance sheet due to materiality considerations. Current liabilities are expected to be paid within one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 43 -Chapter 3 -Section A -Paragraph 8 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 6 -Paragraph 15 false 36 3 us-gaap_LiabilitiesCurrent us-gaap true credit instant monetary No definition available. false false false false false false false false false false false totallabel false 1 false true false false 9844400000 9844.4 false false false 2 false true false false 8464200000 8464.2 false false false Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 21 -Article 5 true 37 2 aet_LongTermFurturePolicyBenefits aet false credit instant monetary The sum of the known and estimated noncurrent amounts payable as of the balance sheet date to policyholders pertaining to... false false false false false false false false false false false terselabel false 1 false true false false 6433200000 6433.2 false false false 2 false true false false 6470100000 6470.1 false false false The sum of the known and estimated noncurrent amounts payable as of the balance sheet date to policyholders pertaining to insured events for long-duration contracts, which can be viewed as either (a) the present value of future benefits to be paid to or on behalf of policyholders and expenses less the present value of future net premiums payable under the insurance contracts or (b) the accumulated amount of net premiums already collected less the accumulated amount of benefits and expenses already paid to or on behalf of policyholders. No authoritative reference available. false 38 2 aet_LongTermUnpaidClaims aet false credit instant monetary Noncurrent liability as of the balance sheet date for the estimated ultimate cost of settling claims and claim adjustment... false false false false false false false false false false false terselabel false 1 false true false false 1470800000 1470.8 false false false 2 false true false false 1453000000 1453.0 false false false Noncurrent liability as of the balance sheet date for the estimated ultimate cost of settling claims and claim adjustment expense relating to insured events that have occurred on or before the balance sheet date for those liabilities owed to another party as a result of assuming another insurer's primary obligation. No authoritative reference available. false 39 2 aet_LongTermPolicyholdersFunds aet false credit instant monetary The total liability as of the balance sheet date of noncurrent amounts due policy holders, excluding future policy benefits... false false false false false false false false false false false terselabel false 1 false true false false 1307100000 1307.1 false false false 2 false true false false 1294100000 1294.1 false false false The total liability as of the balance sheet date of noncurrent amounts due policy holders, excluding future policy benefits and claims, including unpaid policy dividends, retrospective refunds, and undistributed earnings on participating business. No authoritative reference available. false 40 2 us-gaap_LongTermDebtNoncurrent us-gaap true credit instant monetary No definition available. false false false false false false false false false false false terselabel false 1 false true false false 3190100000 3190.1 false false false 2 false true false false 3639500000 3639.5 false false false Sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year from the balance sheet date or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year (current maturities) or the normal operating cycle, if longer, and after deducting unamortized discount or premiums, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 22 -Article 5 false 41 2 us-gaap_OtherLiabilitiesNoncurrent us-gaap true credit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 1433800000 1433.8 false false false 2 false true false false 1442600000 1442.6 false false false Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet due to materiality considerations. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 24 -Article 5 false 42 2 us-gaap_SeparateAccountsLiability us-gaap true credit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 5369500000 5369.5 false false false 2 false true false false 6283100000 6283.1 false false false The equivalent summary total of separate account assets representing contract holder funds that are carried at fair value. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Statement of Position (SOP) -Number 03-1 -Section Summary Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 18 -Article 7 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 60 -Paragraph 53, 54 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Statement of Position (SOP) -Number 03-1 -Paragraph 10-18 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Statement of Position (SOP) -Number 03-1 -Paragraph 19-23, 38 false 43 2 us-gaap_Liabilities us-gaap true credit instant monetary No definition available. false false false false false false false false false false false totallabel false 1 false true false false 29048900000 29048.9 false false false 2 false true false false 29046600000 29046.6 false false false Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. No authoritative reference available. true 44 2 us-gaap_CommitmentsAndContingencies2009 us-gaap true na duration string No definition available. false false false false false false false false false false false label false 1 false false false false 0 0 -- -- false false false 2 false false false false 0 0 -- -- false false false Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. This caption alerts the reader that one or more notes to the financial statements disclose pertinent information about the entity's commitments and contingencies. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 7 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 5 -Paragraph 8, 9 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 25 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 17 -Article 9 false 45 2 us-gaap_StockholdersEquityAbstract us-gaap true na duration string No definition available. false false false false false true false false false false false label false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false No definition available. false 46 3 us-gaap_CommonStockIncludingAdditionalPaidInCapital us-gaap true credit instant monetary No definition available. false false false false false false false false false false false label false 1 false true false false 499200000 499.2 false false false 2 false true false false 470100000 470.1 false false false Aggregate of par value plus amounts in excess of par value or issuance value (in cases of no-par value stock) for common stock held by shareholders. Aggregate value for common stock issued and outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30, 31 -Article 5 false 47 3 us-gaap_RetainedEarningsAccumulatedDeficit us-gaap true credit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false 10567400000 10567.4 false false false 2 false true false false 10256700000 10256.7 false false false The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 false 48 3 us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax us-gaap true credit instant monetary No definition available. false false false false false false false false false false false false 1 false true false false -1142700000 -1142.7 false false false 2 false true false false -1223000000 -1223.0 false false false Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at fiscal year-end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, and unrealized gains and losses on certain investments in debt and equity securities as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 14, 17, 26 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 false 49 3 us-gaap_StockholdersEquity us-gaap true credit instant monetary No definition available. false false false false false false false false false false false totallabel false 1 false true false false 9923900000 9923.9 false false false 2 false true false false 9503800000 9503.8 false false false Total of all Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A3 -Appendix A Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section E Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 true 50 2 us-gaap_LiabilitiesAndStockholdersEquity us-gaap true credit instant monetary No definition available. false false false false false false false false false false false totallabel false 1 true true false false 38972800000 38972.8 false false false 2 true true false false 38550400000 38550.4 false false false Total of all Liabilities and Stockholders' Equity items. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 32 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 25 -Article 7 true false 2 46 false HundredThousands UnKnown UnKnown false true XML 41 FilingSummary.xml IDEA: XBRL DOCUMENT 2.0.0.10 true Sheet 001000 - Statement - Consolidated Statements of Income (Unaudited) Consolidated Statements of Income (Unaudited) http://aetna.com/role/ConsolidatedStatementsOfIncome false R1.xml false Sheet 002000 - Statement - Consolidated Balance Sheets Consolidated Balance Sheets http://aetna.com/role/ConsolidatedBalanceSheets false R2.xml false Sheet 002010 - Statement - Parenthetical to Consolidated Balance Sheets Parenthetical to Consolidated Balance Sheets http://aetna.com/role/ParentheticalDataForConsolidatedBalanceSheets false R3.xml false Sheet 003000 - Statement - Consolidated Statements of Shareholders' Equity (Unaudited) Consolidated Statements of Shareholders' Equity (Unaudited) http://aetna.com/role/ConsolidatedStatementsOfShareholdersEquity false R4.xml false Sheet 004000 - Statement - Consolidated Statements of Cash Flows (Unaudited) Consolidated Statements of Cash Flows (Unaudited) http://aetna.com/role/ConsolidatedStatementsOfCashFlows false R5.xml false Sheet 006010 - Disclosure - Organization Organization http://aetna.com/role/Organization false R6.xml false Sheet 006020 - Disclosure - Summary of Significant Accounting Policies Summary of Significant Accounting Policies http://aetna.com/role/SummaryOfSignificantAccountingPolicies false R7.xml false Sheet 006030 - Disclosure - Earnings Per Common Share Earnings Per Common Share http://aetna.com/role/EarningsPerCommonShare false R8.xml false Sheet 006040 - Disclosure - Operating Expenses Operating Expenses http://aetna.com/role/OperatingExpenses false R9.xml false Sheet 006050 - Disclosure - Investments Investments http://aetna.com/role/Investments false R10.xml false Sheet 006060 - Disclosure - Other Comprehensive (Loss) Income Other Comprehensive (Loss) Income http://aetna.com/role/OtherComprehensiveLossIncome false R11.xml false Sheet 006070 - Disclosure - Financial Instruments Financial Instruments http://aetna.com/role/FairValueMeasurements false R12.xml false Sheet 006080 - Disclosure - Defined Benefit Retirement Plans Defined Benefit Retirement Plans http://aetna.com/role/EmployeeBenefitPlans false R13.xml false Sheet 006090 - Disclosure - Debt Debt http://aetna.com/role/Debt false R14.xml false Sheet 006100 - Disclosure - Capital Stock Capital Stock http://aetna.com/role/CapitalStock false R15.xml false Sheet 006110 - Disclosure - Dividend Restrictions and Statutory Surplus Dividend Restrictions and Statutory Surplus http://aetna.com/role/DividendRestrictionsAndStatutorySurplus false R16.xml false Sheet 006120 - Disclosure - Commitments and Contingencies Commitments and Contingencies http://aetna.com/role/CommitmentsAndContingencies false R17.xml false Sheet 006130 - Disclosure - Segment Information Segment Information http://aetna.com/role/SegmentInformation false R18.xml false Sheet 006140 - Disclosure - Discontinued Products Discontinued Products http://aetna.com/role/DiscontinuedProducts false R19.xml false Sheet 995200 - Document - Document Information Document Information http://xbrl.us/us-gaap/role/document/DocumentInformation false R20.xml false Sheet 995400 - Document - Entity Information Entity Information http://xbrl.us/us-gaap/role/document/EntityInformation false R21.xml false Book All Reports All Reports false 1 33 5 0 3 133 true false c00006 45 c00009 1 c00016 2 c00029 1 c00032 1 c00003 1 c00022 82 c00005 2 c00021 2 c00017 1 c00020 1 c00010 1 c00008 1 c00019 1 c00000 1 c00031 1 c00011 55 c00001 1 c00014 4 c00024 3 c00026 2 c00015 2 c00004 1 c00030 1 c00027 2 c00028 47 c00013 3 c00002 1 c00018 1 c00025 4 c00007 1 c00023 2 c00012 2 true true EXCEL 42 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls MT,\1X*&Q&N$`````````````````````/@`#`/[_"0`&```````````````" M`````0``````````$```Q0````$```#^____```````````"````________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M_______________________]_____O____W___\$````!0````8````'```` M"`````D````*````"P````P````-````#@````\````0````$0```!(````3 M````%````!4````6````%P```!@````9````&@```!L````<````'0```!X` M```?````(````"$````B````(P```"0````E````)@```"<````H````*0`` M`"H````K````+````"T````N````+P```#`````Q````,@```#,````T```` M-0```#8````W````.````#D````Z````.P```#P````]````/@```#\```!` M````00```$(```!#````1````$4```!&````1P```$@```!)````2@```$L` M``!,````30```$X```!/````4````%$```!2````4P```%0```!5````5@`` M`%<```!8````60```%H```!;````7````%T```!>````7P```&````!A```` M8@```&,```!D````90```&8```!G````:````&D```!J````:P```&P```!M M````;@```&\```!P````<0```'(```!S````=````'4```!V````=P```'@` M``!Y````>@```'L```!\````?0```'X```!_````@````%(`;P!O`'0`(`!% M`&X`=`!R`'D````````````````````````````````````````````````` M```````````6``4`__________\"```````````````````````````````` M`````````%"+F-S7Y\H!Q@```$`!````````5P!O`'(`:P!B`&\`;P!K```` M```````````````````````````````````````````````````````````` M`!(``@#_______________\````````````````````````````````````` M```````````#````KH,!```````%`%,`=0!M`&T`80!R`'D`20!N`&8`;P!R M`&T`80!T`&D`;P!N````````````````````````````````````*``"`0$` M```#````_____P`````````````````````````````````````````````` M``````"```````````4`1`!O`&,`=0!M`&4`;@!T`%,`=0!M`&T`80!R`'D` M20!N`&8`;P!R`&T`80!T`&D`;P!N```````````````X``(`____________ M____`````````````````````````````````````````````````@```*`` M````````@0```((```"#````A````(4```"&````AP```(@```")````B@`` M`(L```",````C0```(X```"/````D````)$```"2````DP```)0```"5```` ME@```)<```"8````F0```)H```";````G````)T```">````GP```*````"A M````H@```*,```"D````I0```*8```"G````J````*D```"J````JP```*P` M``"M````K@```*\```"P````L0```+(```"S````M````+4```"V````MP`` M`+@```"Y````N@```+L```"\````O0```+X```"_````P````,$```#"```` MPP```,0```#^_____O____[_____________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M______________________________\)"!````8%`$88S0?!@```!@(``.$` M`@"P!,$``@```.(```!<`'``!P``&)R;```!@(````````````````` M```````````````````````````````````````````````````````````` M`````````````````````````````````````````````````````$(``@"P M!&$!`@```,`!```]`2H``0`"``,`!``%``8`!P`(``D`"@`+``P`#0`.``\` M$``1`!(`$P`4`!4`G``"``X`&0`"````$@`"````$P`"````KP$"````O`$" M````/0`2`/``6@!,+(L:.````````0!8`D```@```(T``@```"(``@````X` M`@`!`+!$$`!@`>``$B`"0`(@`C M`"P`(P`C`#``7P`I`#L`6P!2`&4`9`!=`%P`*``@`"(`)``B`",`+``C`",` M,`!<`"``*0`>!$,`!P`?``$B`"0`(@`C`"P`(P`C`#``+@`P`#``7P`I`#L` M7``H`"``(@`D`"(`(P`L`",`(P`P`"X`,``P`%P`(``I`!X$30`(`"0``2(` M)``B`",`+``C`",`,``N`#``,`!?`"D`.P!;`%(`90!D`%T`7``H`"``(@`D M`"(`(P`L`",`(P`P`"X`,``P`%P`(``I`!X$<0`J`#8``5\`*``B`"0`(@`J M`"``(P`L`",`(P`P`%\`*0`[`%\`*``B`"0`(@`J`"``7``H`"``(P`L`",` M(P`P`%P`(``I`#L`7P`H`"(`)``B`"H`(``B`"T`(@!?`"D`.P!?`"@`(`!` M`%\`(``I`!X$7P`I`"T``5\`*``J`"``(P`L`",`(P`P`%\`*0`[`%\`*``J M`"``7``H`"``(P`L`",`(P`P`%P`(``I`#L`7P`H`"H`(``B`"T`(@!?`"D` M.P!?`"@`(`!``%\`(``I`!X$@0`L`#X``5\`*``B`"0`(@`J`"``(P`L`",` M(P`P`"X`,``P`%\`*0`[`%\`*``B`"0`(@`J`"``7``H`"``(P`L`",`(P`P M`"X`,``P`%P`(``I`#L`7P`H`"(`)``B`"H`(``B`"T`(@`_`#\`7P`I`#L` M7P`H`"``0`!?`"``*0`>!&\`*P`U``%?`"@`*@`@`",`+``C`",`,``N`#`` M,`!?`"D`.P!?`"@`*@`@`%P`*``@`",`+``C`",`,``N`#``,`!<`"``*0`[ M`%\`*``J`"``(@`M`"(`/P`_`%\`*0`[`%\`*``@`$``7P`@`"D`'@0O`*0` M%0`!)``C`"P`(P`C`#``+@`C`",`.P`H`"0`(P`L`",`(P`P`"X`(P`C`"D` M'@0K`*4`$P`!(P`L`",`(P`P`"X`(P`C`#L`*``C`"P`(P`C`#``+@`C`",` M*0`>!!\`I@`-``$C`"P`(P`C`#``.P`H`",`+``C`",`,``I`!X$(P"G``\` M`20`(P`L`",`(P`P`#L`*``D`",`+``C`",`,``I`.``%```````]?\@```` M``````````#`(.``%``!````]?\@``#T``````````!!(.``%``!````]?\@ M``#T``````````!!(.``%``"````]?\@``#T``````````!!(.``%``"```` M]?\@``#T``````````!!(.``%```````]?\@``#T``````````!!(.``%``` M````]?\@``#T``````````!!(.``%```````]?\@``#T``````````!!(.`` M%```````]?\@``#T``````````!!(.``%```````]?\@``#T``````````!! M(.``%```````]?\@``#T``````````!!(.``%```````]?\@``#T```````` M``!!(.``%```````]?\@``#T``````````!!(.``%```````]?\@``#T```` M``````!!(.``%```````]?\@``#T``````````!!(.``%````````0`@```` M``````````#`(.``%``!`"L`]?\@``#X``````````!!(.``%``!`"D`]?\@ M``#X``````````!!(.``%``!`"P`]?\@``#X``````````!!(.``%``!`"H` M]?\@``#X``````````!!(.``%``!``D`]?\@``#X``````````!!(.``%``% M`````0`@```(``````````#`(.``%``%`````0`H```8``````````#`(.`` M%``%`````0`J```8``````````#`(.``%````````0`H```0``````````#` M(.``%``&`````0`@```(``````````#`(.``%````*0``0`@```$```````` M``#`(.``%````*4``0`@```$``````````#`(.``%````*8``0`@```$```` M``````#`(.``%``'`*4``0`@```,``````````#`(.``%``'`*8``0`@```, M``````````#`(.``%``'`*0``0`@```,``````````#`(.``%```````"0`@ M``````````````#`(.``%```````"0`H```0``````````#`(.``%``````` M"0`(```0``````````#`(.``%``'`````0`@```(``````````#`(.``%``` M`*<``0`@```$``````````#`(),"!```@`#_DP($`!"``_^3`@0`$8`&_Y," M!``2@`3_DP($`!.`!_^3`@0`%(`%_V`!`@```(4`1@#Y-`$````?`4,`;P!N M`',`;P!L`&D`9`!A`'0`90!D`"``4P!T`&$`=`!E`&T`90!N`'0`@!A`'0`:0!O`&X`A0!&`!5D`0```!\!4P!U`&T`;0!A`'(` M>0`@`&\`9@`@`%,`:0!G`&X`:0!F`&D`8P!A`&X`=``@`$$`8P!C`&\`=0!N M`'0`:0"%`#H`"&8!````&0%%`&$`<@!N`&D`;@!G`',`(`!0`&4`<@`@`$,` M;P!M`&T`;P!N`"``4P!H`&$`<@!E`(4`+`#[9P$````2`4\`<`!E`'(`80!T M`&D`;@!G`"``10!X`'``90!N`',`90!S`(4`'@#N:0$````+`4D`;@!V`&4` M0$````3 M`5,`90!G`&T`90!N`'0`(`!)`&X`9@!O`'(`;0!A`'0`:0!O`&X`A0`R`'E[ M`0```!4!1`!I`',`8P!O`&X`=`!I`&X`=0!E`&0`(`!0`'(`;P!D`'4`8P!T M`',`A0`P`&Q]`0```!0!1`!O`&,`=0!M`&4`;@!T`"``20!N`&8`;P!R`&T` M80!T`&D`;P!N`(4`+`##?P$````2`44`;@!T`&D`=`!Y`"``20!N`&8`;P!R M`&T`80!T`&D`;P!N`(P`!``!``$`P0$(`,$!``!4C0$`_``?(-0```#4```` M-0`!0P!O`&X``!P`&4`;@!S`&4``!P`&4`;@!S`&4`,``!00!M`&\`<@!T`&D`>@!A`'0`:0!O`&X`(`!O M`&8`(`!O`'0`:`!E`'(`(`!A`&,`<0!U`&D`<@!E`&0`(`!I`&X`=`!A`&X` M9P!I`&(`;`!E`"``80!S`',`90!T`',`&P`!5`!O`'0`80!L`"``8@!E`&X` M90!F`&D`=`!S`"``80!N`&0`(`!E`'@`<`!E`&X``!E`',`"@`!3@!E`'0`(`!I`&X`8P!O`&T`90`:``%%`&$` M<@!N`&D`;@!G`',`(`!P`&4`<@`@`&,`;P!M`&T`;P!N`"``0`@`'``:`!A`'(` M;0!A`&,`>0`@`&\`<`!E`'(`80!T`&D`;P!N`',`(`!O`&8`(``D`#(`,``N M`#0`(`!M`&D`;`!L`&D`;P!N`"``80!N`&0`(``D`#$`-``N`#@`(`!M`&D` M;`!L`&D`;P!N`"``*`!N`&4`=``@`&\`9@`@`'``:`!A`'(`;0!A`&,`90!U M`'0`:0!C`&$`;``@`&$`;@!D`"``<`!R`&\`8P!E`',``!E`',` M%``!3P!T`&@`90!R`"``8P!U`'(`<@!E`&X`=``@`&$`0!A`&(`;`!E`!8``48`=0!T`'4`<@!E`"``<`!O`&P`:0!C`'D` M(`!B`&4`;@!E`&8`:0!T`',`#0`!50!N`'``80!I`&0`(`!C`&P`80!I`&T` M0!A`&(`;`!E`"``=0!N`&0`90!R`"`` M0`Z`+D``4,`;P!M`&T` M;P!N`"``@!E M`&0`*P`!0P!O`&T`;0!O`&X`(`!3`'0`;P!C`&L`+``@`',`:`!A`'(`90!S M`"``:0!S`',`=0!E`&0`(`!A`&X`9``@`&\`=0!T`',`=`!A`&X`9`!I`&X` M9P!#``%#`&\`;@!S`&\`;`!I`&0`80!T`&4`9``@`%,`=`!A`'0`90!M`&4` M;@!T`',`(`!O`&8`(`!3`&@`80!R`&4`:`!O`&P`9`!E`'(`@!E`&0`(`!G`&$`:0!N`',`(``H`&P`;P!S`',` M90!S`"D`(`!O`&X`(`!S`&4`8P!U`'(`:0!T`&D`90!S`#(``4X`90!T`"`` M9@!O`'(`90!I`&<`;@`@`&,`=0!R`'(`90!N`&,`>0`@`&$`;@!D`"``9`!E M`'(`:0!V`&$`=`!I`'8`90`@`&<`80!I`&X```@`&(`90!N`&4`9@!I`'0`0`@`&D`;@`@`&4`80!R`&X`:0!N`&<`0`@`&\`<`!E`'(`80!T`&D`;@!G`"``80!C`'0`:0!V`&D`=`!I`&4` M`!E`',`(`!P`&$`:0!D``P``4\`<@!G`&$`;@!I`'H` M80!T`&D`;P!N`"@``4X`;P!T`&4`0`@`&(`90!N`&4`9@!I`'0`0!E`'(`+0!F`'4`;@!D`&4`9``@`&(`80!S`&D`0`@ M`&(`90!N`&4`9@!I`'0`(`!P`&P`80!N`',`+@!-`&4`9`!I`&,`80!L`"`` M<`!R`&\`9`!U`&,`=`!S`"``80!L`',`;P`@`&D`;@!C`&P`=0!D`&4`(`!H M`&4`80!L`'0`:``@`',`80!V`&D`;@!G`',`(`!A`&,`8P!O`'4`;@!T`',` M(``H`$@`4P!!`',`*0`@`&$`;@!D`"``00!E`'0`;@!A`"``2`!E`&$`;`!T M`&@`1@!U`&X`9``L`"``8P!O`&X`0`@`&(`90`@`&8`=0!N`&0`90!D M`"``8@!Y`"``=`!H`&4`(`!P`&P`80!N`"``0`@`'``<@!O M`&0`=0!C`'0`0`@`&D`;@!C M`&P`=0!D`&4`0!E`'(`0`@`&$` M9`!M`&D`;@!I`',`=`!R`&$`=`!I`&\`;@`@`&$`;@!D`"``;`!E`&$`=@!E M`"``;0!A`&X`80!G`&4`;0!E`&X`=``L`"``80!N`&0`(``H`&D`:0!I`"D` M(`!L`&\`;@!G`"T`=`!E`'(`;0`@`&,`80!R`&4`(`!P`'(`;P!D`'4`8P!T M`',`(`!T`&@`80!T`"``=P!E`'(`90`@`&\`9@!F`&4`<@!E`&0`(`!P`'(` M:0!M`&$`<@!I`&P`>0`@`&\`;@`@`&$`;@`@`$D`;@!S`'4`<@!E`&0`(`!B M`&$`0`@`&\`9@`@`'(` M90!T`&D`<@!E`&T`90!N`'0`(`!P`'(`;P!D`'4`8P!T`',`(``H`&D`;@!C M`&P`=0!D`&D`;@!G`"``<`!E`&X`0`@`'``<@!O`&0`=0!C`'0`0`@`&\`9@`@`%,`:0!G`&X`:0!F`&D`8P!A M`&X`=``@`$$`8P!C`&\`=0!N`'0`:0!N`&<`(`!0`&\`;`!I`&,`:0!E`',` M#0`-``T`20!N`'0`90!R`&D`;0`@`$8`:0!N`&$`;@!C`&D`80!L`"``4P!T M`&$`=`!E`&T`90!N`'0`0`@`'(`90!L`'D`(`!O`&X`(`!E`',` M=`!I`&T`80!T`&4`0`@`&,`:`!A`&X`9P!E`&0`(`!O`'(`(`!I`',`(`!R M`&4`<0!U`&D`<@!E`&0`(`!B`'D`(`!'`$$`00!0`"X`5P!E`"``:`!A`'8` M90`@`&4`=@!A`&P`=0!A`'0`90!D`"``0`@`&(`80!L M`&$`;@!C`&4`@!E`&0`(`!C`&$`<`!I`'0`80!L`"``;`!O`',``!I`&T`80!T`&4`;`!Y`"``,0`X`"X`.0`@ M`&$`;@!D`"``,0`Y`"X`-0`@`&T`:0!L`&P`:0!O`&X`(`!3`$$`4@!S`"`` M*`!W`&D`=`!H`"``90!X`&4`<@!C`&D``!P`&4`;@!S`&4``!P M`&4`;@!S`&4`,@,!#0`-`#0`+@`)``T`#0!/`'``90!R`&$`=`!I`&X`9P`@ M`$4`>`!P`&4`;@!S`&4``!P`&4`;@!S`&4``!P`&4` M;@!S`&4`0`@`',`90!C`'4`<@!I`'0`:0!E`',`(`!A`'8`80!I`&P` M80!B`&P`90`@`&8`;P!R`"``@!E`&0`"0`-``T`50!N`'(`90!A`&P`:0!Z`&4`9``)``D`#0`-`$8` M80!I`'(`#0`-``T`*`!-`&D`;`!L`&D`;P!N`',`*0`)``T`#0!#`&\`0`@`',`90!C`'4`<@!I`'0`:0!E M`',`(``H`#(`*0`)``T`#0`D`"``,0`V`"P`-``T`#(`+@`S``D`#0`-`"0` M(``@`#D`.``W`"X`,0`)``T`#0`D`"@`,@`V`#D`+@`W`"D`"0`)``T`#0`D M`#$`-P`L`#$`-0`Y`"X`-P`-``T`*``Q`"D`"0`-``T`00!T`"``30!A`'(` M8P!H`"``,P`Q`"P`(``R`#``,0`P`"``80!N`&0`(`!$`&4`8P!E`&T`8@!E M`'(`(``S`#$`+``@`#(`,``P`#D`+``@`'<`90`@`&@`90!L`&0`(`!S`&4` M8P!U`'(`:0!T`&D`90!S`"``9@!O`'(`(`!W`&@`:0!C`&@`(`!W`&4`(`!H M`&$`9``@`'(`90!C`&\`9P!N`&D`>@!E`&0`(`!A`"``8P!R`&4`9`!I`'0` M+0!R`&4`;`!A`'0`90!D`"``:0!M`'``80!I`'(`;0!E`&X`=``@`&D`;@`@ M`'0`:`!E`"``<`!A`',`=``N`$8`;P!R`"``=`!H`&4`(`!T`&@`<@!E`&4` M(`!M`&\`;@!T`&@`0`@`&0`;P`@`&X`;P!T`"``:0!M`'``80!C`'0` M(`!O`'4`<@`@`'(`90!S`'4`;`!T`',`(`!O`&8`(`!O`'``90!R`&$`=`!I M`&\`;@!S`"``*`!R`&4`9@!E`'(`(`!T`&\`(`!.`&\`=`!E`"``,0`T`"`` M8@!E`&<`:0!N`&X`:0!N`&<`(`!O`&X`(`!P`&$`9P!E`#(`,``@`&8`;P!R M`"``80!D`&0`:0!T`&D`;P!N`&$`;``@`&D`;@!F`&\`<@!M`&$`=`!I`&\` M;@`@`&\`;@`@`&\`=0!R`"``80!C`&,`;P!U`&X`=`!I`&X`9P`@`&8`;P!R M`"$``4\`=`!H`&4`<@`@`$,`;P!M`'``<@!E`&@`90!N`',`:0!V`&4`(``H M`$P`;P!S`',`*0`@`$D`;@!C`&\`;0!E`!H``4\`=`!H`&4`<@`@`$,`;P!M M`'``<@!E`&@`90!N`',`:0!V`&4`(`!)`&X`8P!O`&T`90#P!P$-``T`-@`N M``D`#0`-`$\`=`!H`&4`<@`@`$,`;P!M`'``<@!E`&@`90!N`',`:0!V`&4` M(``H`$P`;P!S`',`*0`@`$D`;@!C`&\`;0!E``T`#0`-`%,`:`!A`'(`90!H M`&\`;`!D`&4`<@!S`"``90!Q`'4`:0!T`'D`(`!I`&X`8P!L`'4`9`!E`&0` M(`!T`&@`90`@`&8`;P!L`&P`;P!W`&D`;@!G`"``80!C`#P`&R`!=`!I`'8` M:0!T`'D`(`!I`&X`(`!A`&,`8P!U`&T`=0!L`&$`=`!E`&0`(`!O`'0`:`!E M`'(`(`!C`&\`;0!P`'(`90!H`&4`;@!S`&D`=@!E`"``;`!O`',``!P`&4`<@!I`&4`;@!C`&4`+0!R`&$`=`!E`&0` M(`!C`&\`;@!T`'(`80!C`'0`(`!H`&\`;`!D`&4`<@!S`"``80!N`&0`(`!D M`&D`@!E M`&0`(`!'`&$`:0!N`',`(``H`$P`;P!S`',`90!S`"D`"0`)``T`#0!0`&4` M;@!S`&D`;P!N`"``80!N`&0`(`!/`%``10!"`"``4`!L`&$`;@!S``D`#0`- M`%0`;P!T`&$`;``-``T`#0!3`&4`8P!U`'(`:0!T`&D`90!S``D`#0`-`$8` M;P!R`&4`:0!G`&X`"0`)`"``"0`)``T`#0!!`&,`8P!U`&T`=0!L`&$`=`!E M`&0`#0`-``D`(``)``D`#0`-`$,`=0!R`'(`90!N`&,`>0`)``D`#0`-`%4` M;@!R`&4`8P!O`&<`;@!I`'H`90!D``D`#0`-`%4`;@!R`&4`8P!O`&<`;@!I M`'H`90!D``D`#0`-`$\`=`!H`&4`<@`-``T`#0!0`'(`90!V`&D`;P!U`',` M;`!Y``D`"0`-``T`80!N`&0`"0`)``T`#0!.`&4`=``@`$$`8P!T`'4`80!R M`&D`80!L``D`#0`-`%``<@!I`&\`<@`@`%,`90!R`'8`:0!C`&4`"0`-``T` M0P!O`&T`<`!R`&4`:`!E`&X`0`@`&$`;@!D``T`#0!$`&4`<@!I`'8`80!T`&D`=@!E`',`"0`)``T` M#0!5`&X`<@!E`&,`;P!G`&X`:0!Z`&4`9``-``T`3@!E`'0`(`!!`&,`=`!U M`&$`<@!I`&$`;``-``T`3`!O`',`0`@`&4`0`@`$<`00!!`%``+@!4 M`&@`90`@`&8`;P!L`&P`;P!W`&D`;@!G`"``80!R`&4`(`!T`&@`90`@`&P` M90!V`&4`;`!S`"``;P!F`"``=`!H`&4`(`!H`&D`90!R`&$`<@!C`&@`>0`@ M`&$`;@!D`"``80`@`&(`<@!I`&4`9@`@`&0`90!S`&,`<@!I`'``=`!I`&\` M;@`@`&\`9@`@`'0`:`!E`"``=`!Y`'``90`@`&\`9@`@`'8`80!L`'4`80!T M`&D`;P!N`"``:0!N`&8`;P!R`&T`80!T`&D`;P!N`"``*`!I`&X`<`!U`'0` M0`@`'4```@`'``<@!I`&,`:0!N`&<`(`!M`&\`9`!E M`&P`+@!4`&@`90!S`&4`(`!F`&D`;@!A`&X`8P!I`&$`;``@`&$`0`@`&$`=@!A`&D`;`!A`&(`;`!E`"X`#0`- M``T`5`!H`&4`(`!F`&\`;`!L`&\`=P!I`&X`9P`@`&D`0`N``T` M#0`-`$0`90!B`'0`(`!3`&4`8P!U`'(`:0!T`&D`90!S`%<`:`!E`'(`90`@ M`'$`=0!O`'0`90!D`"``<`!R`&D`8P!E`',`(`!A`'(`90`@`&$`=@!A`&D` M;`!A`&(`;`!E`"``:0!N`"``80!N`"``80!C`'0`:0!V`&4`(`!M`&$`<@!K M`&4`=``L`"``;P!U`'(`(`!D`&4`8@!T`"``0`N`$\`=0!R`"``3`!E`'8`90!L`"``,0`@ M`&0`90!B`'0`(`!S`&4`8P!U`'(`:0!T`&D`90!S`"``80!R`&4`(`!C`&\` M;0!P`'(`:0!S`&4`9``@`'``<@!I`&T`80!R`&D`;`!Y`"``;P!F`"``50`N M`%,`+@`@`%0`<@!E`&$`0`@`',`90!C`'4`<@!I`'0`:0!E`',` M+@!)`&8`(`!,`&4`=@!E`&P`(``Q`"``=@!A`&P`(``!1`!E`&8`:0!N`&4` M9``@`$(`90!N`&4`9@!I`'0`(`!2`&4`=`!I`'(`90!M`&4`;@!T`"``4`!L M`&$`;@!S`!4``44`;0!P`&P`;P!Y`&4`90`@`$(`90!N`&4`9@!I`'0`(`!0 M`&P`80!N``8%`0T`#0`X`"X`"0`-``T`1`!E`&8`:0!N`&4`9``@`$(`90!N M`&4`9@!I`'0`(`!2`&4`=`!I`'(`90!M`&4`;@!T`"``4`!L`&$`;@!S``T` M#0`-`$,`;P!M`'``;P!N`&4`;@!T`',`(`!O`&8`(`!T`&@`90`@`&X`90!T M`"``<`!E`'(`:0!O`&0`:0!C`"``8@!E`&X`90!F`&D`=``@`&,`;P!S`'0` M(`!O`&8`(`!O`'4`<@`@`&X`;P!N`&,`;P!N`'0`<@!I`&(`=0!T`&\`<@!Y M`"``9`!E`&8`:0!N`&4`9``@`&(`90!N`&4`9@!I`'0`(`!P`&4`;@!S`&D` M;P!N`"``<`!L`&$`;@!S`"``80!N`&0`(`!O`'0`:`!E`'(`(`!P`&\``!P`&4`;@!S`&4`(`!I`',`(`!A`&P`;`!O`&,`80!T`&4`9``@`'0`;P`@ M`&\`=0!R`"``8@!U`',`:0!N`&4`0!I`&X`9P`@`'8`80!L M`'4`90`@`&\`9@`@`&\`=0!R`"``;`!O`&X`9P`M`'0`90!R`&T`(`!D`&4` M8@!T`"``80!T`"``30!A`'(`8P!H`"``,P`Q`"P`(``R`#``,0`P`"``80!N M`&0`(`!$`&4`8P!E`&T`8@!E`'(`(``S`#$`+``@`#(`,``P`#D`(`!W`&$` M0!I M`&X`9P`@`&,`;P!N`',`;P!L`&D`9`!A`'0`90!D`"``8@!A`&P`80!N`&,` M90`@`',`:`!E`&4`=``@`&$`=``@`$T`80!R`&,`:``@`#,`,0`L`"``,@`P M`#$`,``N``T`#0!!`'0`(`!-`&$`<@!C`&@`(``S`#$`+``@`#(`,``Q`#`` M(`!A`&X`9``@`$0`90!C`&4`;0!B`&4`<@`@`#,`,0`L`"``,@`P`#``.0`L M`"``=P!E`"``:`!A`&0`(`!A`'``<`!R`&\`>`!I`&T`80!T`&4`;`!Y`"`` M)``T`#@`,``@`&T`:0!L`&P`:0!O`&X`(`!A`&X`9``@`"0`-``X`#$`(`!M M`&D`;`!L`&D`;P!N`"P`(`!R`&4`0`L`"`` M;P!F`"``8P!O`&T`;0!E`'(`8P!I`&$`;``@`'``80!P`&4`<@`@`&\`=0!T M`',`=`!A`&X`9`!I`&X`9P`@`'<`:0!T`&@`(`!A`"``=P!E`&D`9P!H`'0` M90!D`"``80!V`&4`<@!A`&<`90`@`&D`;@!T`&4`<@!E`',`=``@`'(`80!T M`&4`(`!O`&8`(``N`#,`,@`E`"``80!N`&0`(``N`#,`.``E`"P`(`!R`&4` M0`N``T`#0`-`$$`=``@`$T`80!R`&,`:``@ M`#,`,0`L`"``,@`P`#$`,``L`"``=P!E`"``:`!A`&0`(`!A`&X`(`!U`&X` M0`I`"``=P!I`'0`:``@ M`',`90!V`&4`<@!A`&P`(`!F`&D`;@!A`&X`8P!I`&$`;``@`&D`;@!S`'0` M:0!T`'4`=`!I`&\`;@!S`"``=P!H`&D`8P!H`"``=`!E`'(`;0!I`&X`80!T M`&4`0`@`'``<@!O`'8`:0!D`&4`0`@`'0`;P`@`&$`(`!M`&$`>`!I`&T`=0!M M`"``;P!F`"``)``R`"X`,``@`&(`:0!L`&P`:0!O`&X`+@!6`&$`<@!I`&\` M=0!S`"``:0!N`'0`90!R`&4`0`@`'(`90!V`&\`;`!V M`&D`;@!G`"``8@!O`'(`<@!O`'<`:0!N`&<`0`@`&8`80!C`&D`;`!I`'0`>0`@`&8`90!E`',`(`!O`&X`(`!T`&@`90`@ M`$8`80!C`&D`;`!I`'0`>0`@`'(`80!N`&<`:0!N`&<`(`!F`'(`;P!M`"`` M+@`P`#0`-0`E`"``=`!O`"``+@`Q`#<`-0`E`"``<`!E`'(`(`!A`&X`;@!U M`&T`+``@`&0`90`\`!L@`7``90!N`&0`:0!N`&<`(`!U`'``;P!N`"``;P!U M`'(`(`!L`&\`;@!G`"T`=`!E`'(`;0`@`',`90!N`&D`;P!R`"``=0!N`',` M90!C`'4`<@!E`&0`(`!D`&4`8@!T`"``<@!A`'0`:0!N`&<`+@!4`&@`90`@ M`&8`80!C`&D`;`!I`'0`>0`@`&8`90!E`"``=P!A`',`(``N`#``-@`E`"`` M80!T`"``30!A`'(`8P!H`"``,P`Q`"P`(``R`#``,0`P`"X`5`!H`&4`(`!& M`&$`8P!I`&P`:0!T`'D`(`!C`&\`;@!T`&$`:0!N`',`(`!A`"``9@!I`&X` M80!N`&,`:0!A`&P`(`!C`&\`=@!E`&X`80!N`'0`(`!T`&@`80!T`"``<@!E M`'$`=0!I`'(`90!S`"``=0!S`"``=`!O`"``;0!A`&D`;@!T`&$`:0!N`"`` M80`@`'(`80!T`&D`;P`@`&\`9@`@`'0`;P!T`&$`;``@`&0`90!B`'0`(`!T M`&\`(`!C`&\`;@!S`&\`;`!I`&0`80!T`&4`9``@`&,`80!P`&D`=`!A`&P` M:0!Z`&$`=`!I`&\`;@`@`&$`0`L`"``90!X`&,`;`!U`&0`:0!N`&<`(`!A M`&X`>0`@`&\`=@!E`'(`9@!U`&X`9`!E`&0`(`!O`'(`(`!U`&X`9`!E`'(` M9@!U`&X`9`!E`&0`(`!S`'0`80!T`'4`@!E`&0`(`!C M`&$`<`!I`'0`80!L`"``9P!A`&D`;@!S`"``80!N`&0`(`!L`&\`0`@`&$`=``@`$T`80!R`&,`:``@`#,`,0`L`"``,@`P M`#$`,``N``T`#0`-`$0`=0!R`&D`;@!G`"``,@`P`#$`,``@`&$`;@!D`"`` M,@`P`#``.0`L`"``=P!E`"``90!N`'0`90!R`&4`9``@`&D`;@!T`&\`(`!F M`&D`=@!E`"``:0!N`'0`90!R`&4`@!E`&0`(`!C`&$`<`!I`'0`80!L`"``;`!O`',`0`@`"0`.0`P`"``;0!I`&P`;`!I`&\` M;@`@`&\`9@`@`'0`:`!E`',`90`@`'(`90!P`'4`<@!C`&@`80!S`&4`0`@`"0`,P`S`#D`(`!M M`&D`;`!L`&D`;P!N`"``;P!F`"``8P!O`&T`;0!O`&X`(`!S`'0`;P!C`&L` M(`!U`&X`9`!E`'(`(`!T`&@`90`@`$8`90!B`'(`=0!A`'(`>0`@`#(`-P`L M`"``,@`P`#``.0`@`$(`;P!A`'(`9``@`&$`=0!T`&@`;P!R`&D`>@!A`'0` M:0!O`&X`+@`-``T`#0!/`&X`(`!&`&4`8@!R`'4`80!R`'D`(``X`"P`(``R M`#``,0`P`"P`(`!A`'``<`!R`&\`>`!I`&T`80!T`&4`;`!Y`"``+@`X`"`` M;0!I`&P`;`!I`&\`;@`@`'``90!R`&8`;P!R`&T`80!N`&,`90`@`',`=`!O M`&,`:P`@`'4`;@!I`'0`0!E`&4`@!A`'0`:0!O M`&X`+@`@`%0`:`!E`"``<`!E`'(`9@!O`'(`;0!A`&X`8P!E`"``<`!E`'(` M:0!O`&0`(`!F`&\`<@`@`'0`:`!E`"``4`!3`%4`0`@`'0`<@!A`&0`:0!N`&<`(`!D`&$`>0!S`"``<`!R M`&D`;P!R`"``=`!O`"``=`!H`&4`(`!V`&4``!E`',`+``@`&$`=``@`'0`:`!E`"``90!N`&0`(`!O`&8` M(`!T`&@`90`@`'8`90!S`'0`:0!N`&<`(`!P`&4`<@!I`&\`9``N`%0`:`!E M`"``4@!3`%4`0`@`%,`=0!R`'``;`!U M`',`%0`!1`!I`'8`:0!D`&4`;@!D`"``4@!E`',`=`!R`&D`8P!T`&D`;P!N M`',`,@(!#0`-`#$`,0`N``D`#0`-`$0`:0!V`&D`9`!E`&X`9``@`%(`90!S M`'0`<@!I`&,`=`!I`&\`;@!S`"``80!N`&0`(`!3`'0`80!T`'4`=`!O`'(` M>0`@`%,`=0!R`'``;`!U`',`#0`-``T`50!N`&0`90!R`"``<@!E`&<`=0!L M`&$`=`!O`'(`>0`@`'(`90!Q`'4`:0!R`&4`;0!E`&X`=`!S`"``80!T`"`` M30!A`'(`8P!H`"``,P`Q`"P`(``R`#``,0`P`"P`(`!T`&@`90`@`&$`;0!O M`'4`;@!T`"``;P!F`"``9`!I`'8`:0!D`&4`;@!D`',`(`!T`&@`80!T`"`` M;0!A`'D`(`!B`&4`(`!P`&$`:0!D`"``=`!O`"``00!E`'0`;@!A`"``=`!H M`'(`;P!U`&<`:``@`'0`:`!E`"``90!N`&0`(`!O`&8`(``R`#``,0`P`"`` M8@!Y`"``;P!U`'(`(`!I`&X`0`@`"0`,0`N`#$`(`!B`&D`;`!L M`&D`;P!N`"``:0!N`"``=`!H`&4`(`!A`&<`9P!R`&4`9P!A`'0`90`N`%0` M:`!E`'(`90`@`&$`<@!E`"``;@!O`"``0`@`&,`80!P`&D`=`!A`&P`(`!A M`&X`9``@`',`=0!R`'``;`!U`',`(`!O`&8`(`!O`'4`<@`@`&D`;@!S`'4` M<@!A`&X`8P!E`"``80!N`&0`(`!(`$T`3P`@`',`=0!B`',`:0!D`&D`80!R M`&D`90!S`"``=P!A`',`(``D`#<`+@`P`"``8@!I`&P`;`!I`&\`;@`@`&$` M;@!D`"``)``V`"X`.``@`&(`:0!L`&P`:0!O`&X`(`!A`'0`(`!-`&$`<@!C M`&@`(``S`#$`+``@`#(`,``Q`#``(`!A`&X`9``@`$0`90!C`&4`;0!B`&4` M<@`@`#,`,0`L`"``,@`P`#``.0`L`"``<@!E`',`<`!E`&,`=`!I`'8`90!L M`'D`+@`=``%#`&\`;0!M`&D`=`!M`&4`;@!T`',`(`!A`&X`9``@`$,`;P!N M`'0`:0!N`&<`90!N`&,`:0!E`',`'``!0P!O`&T`;0!I`'0`;0!E`&X`=``@ M`&$`;@!D`"``0P!O`&X`=`!I`&X`9P!E`&X`8P!I`&4`0!M`&4` M;@!T`"``;P!F`"``8P!L`&$`:0!M`',`(`!F`&\`<@`@`',`90!R`'8`:0!C M`&4`0`@`&@`90!A`&P`=`!H`"``8P!A`'(`90`@`'``<@!O M`'8`:0!D`&4`<@!S`"``=P!I`'0`:``@`'<`:`!O`&T`(`!W`&4`(`!D`&\` M(`!N`&\`=``@`&@`80!V`&4`(`!A`"``8P!O`&X`=`!R`&$`8P!T`"``*`!O M`'4`=``M`&\`9@`M`&X`90!T`'<`;P!R`&L`(`!P`'(`;P!V`&D`9`!E`'(` M``L`"``20!N`&,`+@`L M`"``80`@`',`=0!B`',`:0!D`&D`80!R`'D`(`!O`&8`(`!O`&X`90`@`&\` M9@`@`&\`=0!R`"``8P!O`&T`<`!E`'0`:0!T`&\`<@!S`"``*`!)`&X`9P!E M`&X`:0!X`"D`+@`-``T`#0!6`&$`<@!I`&\`=0!S`"``<`!L`&$`:0!N`'0` M:0!F`&8`0`@`$$`8P!T`"``;P!F M`"``,0`Y`#<`-``L`"``80!S`"``80!M`&4`;@!D`&4`9``@`"@`10!2`$D` M4P!!`"D`+``@`'0`:`!E`"``4@!A`&,`:P!E`'0`90!E`'(`(`!)`&X`9@!L M`'4`90!N`&,`90!D`"``80!N`&0`(`!#`&\`<@!R`'4`<`!T`"``3P!R`&<` M80!N`&D`>@!A`'0`:0!O`&X`0`@`&,`;P!N`'0`80!I`&X`(`!S`&D`;0!I`&P`80!R`"``80!L M`&P`90!G`&$`=`!I`&\`;@!S`"``80!N`&0`(`!S`&4`90!K`"``0`@`'4`;@!D`&4`<@`@`'0`:`!E`"``8P!A`'`` M=`!I`&\`;@`@`$D`;@`@`'(`90`Z`"``00!E`'0`;@!A`"``50!#`%(`(`!, M`&D`=`!I`&<`80!T`&D`;P!N`"P`(`!-`$0`3``@`$X`;P`N`"``,@`P`#(` M,``@`"@`30!$`$P`(``R`#``,@`P`"D`+@`@`$D`;@`@`&$`9`!D`&D`=`!I M`&\`;@`L`"``=`!H`&4`(`!-`$0`3``@`%``80!N`&4`;``@`&@`80!S`"`` M=`!R`&$`;@!S`&8`90!R`'(`90!D`"``=`!H`&4`(`!I`&X`9`!I`'8`:0!D M`'4`80!L`"``;`!A`'<`0`@`#$`-0`L`"`` M,@`P`#``.0`L`"``00!E`'0`;@!A`"``80!N`&0`(`!T`&@`90`@`$X`90!W M`"``60!O`'(`:P`@`$$`=`!T`&\`<@!N`&4`>0`@`$<`90!N`&4`<@!A`&P` M(`!A`&X`;@!O`'4`;@!C`&4`9``@`&$`;@`@`&$`9P!R`&4`90!M`&4`;@!T M`"``<@!E`&P`80!T`&D`;@!G`"``=`!O`"``80!N`"``:0!N`&0`=0!S`'0` M<@!Y`"T`=P!I`&0`90`@`&D`;@!V`&4```@ M`&$`;@!D`"``=P!I`&P`;``@`'4`0`@`&$`(`!R`&4`80!S`&\` M;@!A`&(`;`!E`"``80!N`&0`(`!C`'4`0`@`',`=`!A M`&X`9`!A`'(`9``@`&8`;P!R`"``;P!U`'0`+0!O`&8`+0!N`&4`=`!W`&\` M<@!K`"``<@`3``%3`&4`9P!M`&4`;@!T`"``20!N`&8`;P!R`&T`80!T`&D` M;P!N`!@)`0T`#0`Q`#,`+@`)``T`#0!3`&4`9P!M`&4`;@!T`"``20!N`&8` M;P!R`&T`80!T`&D`;P!N``T`#0`-`$\`=0!R`"``;P!P`&4`<@!A`'0`:0!O M`&X`0`-``T`#0`R`#``,0`P``D` M"0`@``D`"0`@``D`#0`-``T`4@!E`'8`90!N`'4`90`@`&8`<@!O`&T`(`!E M`'@`=`!E`'(`;@!A`&P`(`!C`'4``!C`&P`=0!D M`&4`9``@`&8`<@!O`&T`(`!F`&D`<@!S`'0`(`!Q`'4`80!R`'0`90!R`"`` M,@`P`#$`,``@`&\`<`!E`'(`80!T`&D`;@!G`"``90!A`'(`;@!I`&X`9P!S M`"``8@!E`&,`80!U`',`90`@`'<`90`@`&(`90!L`&D`90!V`&4`(`!I`'0` M(`!N`&4`:0!T`&@`90!R`"``<@!E`&P`80!T`&4`0`@`&D`;@!S`'4`<@!E`'(```@`&$`0`@`'<` M90!R`&4`(`!G`&4`;@!E`'(`80!T`&D`;@!G`"``;`!O`',`0`@`'<`;P!U`&P`9``@`&,`;P!N`'0`:0!N M`'4`90`@`'0`;P`@`&<`90!N`&4`<@!A`'0`90`@`&P`;P!S`',`90!S`"`` M;P!V`&4`<@`@`'0`:`!E`&D`<@`@`&P`:0!F`&4`(``H`'<`:`!I`&,`:``@ M`&D`0!E`&$` M<@!S`"D`.P`@`',`;P`@`'<`90`@`&4``!P`&4`8P!T`&4`9``@`&,`80!S`&@`(`!F M`&P`;P!W`',`(`!F`'(`;P!M`"``=`!H`&4`(`!A`',``!P`&4`8P!T`&4`9``@`'0`;P`@`&(`90`@`'(`90!Q`'4`:0!R`&4`9``@ M`'0`;P`@`&T`90!E`'0`(`!T`&@`90`@`&\`8@!L`&D`9P!A`'0`:0!O`&X` M0`@`&$`;@!D`"``<@!E`'0`:0!R`&4`;0!E`&X`=``@`'(`80!T`&4`0`@`&(`80!S M`&4`9``@`&\`;@`@`&$`8P!T`'4`80!L`"``90!X`'``90!R`&D`90!N`&,` M90`N`$$``!P`&4`8P!T M`&$`=`!I`&\`;@`@`&\`9@`@`&8`=0!T`'4`<@!E`"``;`!O`',`0`@`&@`80!V`&4`(`!T`&\`(`!I`&X`8P!R`&4`80!S M`&4`(`!T`&@`90`@`'(`90!S`&4`<@!V`&4`+``@`'<`:`!I`&,`:``@`&,` M;P!U`&P`9``@`&$`9`!V`&4`<@!S`&4`;`!Y`"``:0!M`'``80!C`'0`(`!N M`&4`=``@`&D`;@!C`&\`;0!E`"X`20!F`"``80!C`'0`=0!A`&P`(`!O`'(` M(`!E`'@`<`!E`&,`=`!E`&0`(`!F`'4`=`!U`'(`90`@`&P`;P!S`',`90!S M`"``80!R`&4`(`!L`&4`0`@ M`&@`80!V`&4`(`!T`&\`(`!D`&4`8P!R`&4`80!S`&4`(`!T`&@`90`@`'(` M90!S`&4`<@!V`&4`+``@`'<`:`!I`&,`:``@`&,`;P!U`&P`9``@`&8`80!V M`&\`<@!A`&(`;`!Y`"``:0!M`'``80!C`'0`(`!N`&4`=``@`&D`;@!C`&\` M;0!E`"X`5`!H`&4`(`!C`'4`<@!R`&4`;@!T`"``<@!E`',`90!R`'8`90`@ M`'(`90!F`&P`90!C`'0`0`@ M`&(`90!N`&4`9@!I`'0`@!E`&0`(`!C`&$`<`!I`'0`80!L M`"``9P!A`&D`;@!S`"P`(`!B`&\`=`!H`"``<`!R`&D`;0!A`'(`:0!L`'D` M(`!A`'0`=`!R`&D`8@!U`'0`80!B`&P`90`@`'0`;P`@`'0`:`!E`"``9@!A M`'8`;P!R`&$`8@!L`&4`(`!I`&X`=@!E`',`=`!M`&4`;@!T`"``8P!O`&X` M9`!I`'0`:0!O`&X```\`-T$`7``90!C`'0`80!T`&D`;P!N`',` M(`!O`&8`(`!F`'4`=`!U`'(`90`@`&,`80!S`&@`(`!F`&P`;P!W`',`(`!A M`',`0!P`&4`!``!,0`P`"T`40`8``%$`&\`8P!U`&T`90!N`'0`(`!0 M`&4`<@!I`&\`9``@`$4`;@!D`"``1`!A`'0`90`*``$R`#``,0`P`"T`,``S M`"T`,P`Q``X``4$`;0!E`&X`9`!M`&4`;@!T`"``1@!L`&$`9P`%``%F`&$` M;`!S`&4`&@`!10!N`'0`:0!T`'D`(`!)`&X`9@!O`'(`;0!A`'0`:0!O`&X` M(``H`%4`4P!$`"``)``I`!,``44`;@!T`&D`=`!Y`"``6P!4`&4`>`!T`"`` M0@!L`&\`8P!K`%T`%@`!10!N`'0`:0!T`'D`(`!2`&4`9P!I`',`=`!R`&$` M;@!T`"``3@!A`&T`90`.``%!`$4`5`!.`$$`(`!)`$X`0P`@`"\`4`!!`"\` M&``!10!N`'0`:0!T`'D`(`!#`&4`;@!T`'(`80!L`"``20!N`&0`90!X`"`` M2P!E`'D`"@`!,``P`#``,0`Q`#(`,@`S`#``-``<``%#`'4`<@!R`&4`;@!T M`"``1@!I`',`8P!A`&P`(`!9`&4`80!R`"``10!N`&0`(`!$`&$`=`!E``<` M`2T`+0`Q`#(`+0`S`#$`(0`!10!N`'0`:0!T`'D`(`!7`&4`;`!L`"``2P!N M`&\`=P!N`"``4P!E`&$`0`@`$8`:0!L M`&4`<@!S``(``4X`;P`?``%%`&X`=`!I`'0`>0`@`$,`=0!R`'(`90!N`'0` M(`!2`&4`<`!O`'(`=`!I`&X`9P`@`%,`=`!A`'0`=0!S`!4``44`;@!T`&D` M=`!Y`"``1@!I`&P`90!R`"``0P!A`'0`90!G`&\`<@!Y`!<``4P`80!R`&<` M90`@`$$`8P!C`&4`;`!E`'(`80!T`&4`9``@`$8`:0!L`&4`<@`3``%%`&X` M=`!I`'0`>0`@`%``=0!B`&P`:0!C`"``1@!L`&\`80!T`"8``44`;@!T`&D` M=`!Y`"``0P!O`&T`;0!O`&X`(`!3`'0`;P!C`&L`(`!3`&@`80!R`&4````&$```WA\` M`,01``#6(@``O!0``"(E```(%P``2"<``"X9``"T*0``FAL``%HL``!`'@`` M,2\``/@````C,0``Z@(``+$S``!X!0``*38``/`'``!-2P``%!T``/QM``"D M'P``1[<``)((```RY@``71<``*\O`0!]````O3`!`(L!```!,@$`SP(``$\S M`0`=!```"@````D($```!A``1AC-!\&````&`@``"P(4````````````'@`` M``````"M/@$`#0`"``$`#``"`&0`#P`"``$`$0`"````$``(`/RI\=)-8E`_ M7P`"``$`*@`"````*P`"````@@`"``$`@``(````````````)0($````_P"! M``(`P004````%0```(,``@```(0``@```*$`(@`)`&0``0`!``$`1@!8`E@" M````````X#\```````#@/P$`50`"``@`?0`,``````"V/`\````$`'T`#``! M``$`MA@/````!`!]``P``@`"`+8$#P````0`?0`,``,``P"V&`\````$`'T` M#``$``0`M@0/````!`!]``P`!0#_`"0)#P````0```(.```````>```````% M````"`(0`````````/\````````!#P`(`A```0````,`_P````````$/``@" M$``"````!`#_`````````0\`"`(0``,````$`/\````````!#P`(`A``!``` M``0`_P````````$/``@"$``%````!`#_`````````0\`"`(0``8````$`/\` M```````!#P`(`A``!P````0`_P````````$/``@"$``(````!`#_```````` M`0\`"`(0``D````$`/\````````!#P`(`A``"@````0`_P````````$/``@" M$``+````!`#_`````````0\`"`(0``P````$`/\````````!#P`(`A``#0`` M``0`_P````````$/``@"$``.````!`#_`````````0\`"`(0``\````$`/\` M```````!#P`(`A``$`````0`_P````````$/``@"$``1````!`#_```````` M`0\`"`(0`!(````$`/\````````!#P`(`A``$P````0`_P````````$/``@" M$``4````!`#_`````````0\`"`(0`!4````$`/\````````!#P`(`A``%@`` M``0`_P````````$/``@"$``7````!`#_`````````0\`"`(0`!@````$`/\` M```````!#P`(`A``&0````0`_P````````$/``@"$``:````!`#_```````` M`0\`"`(0`!L````$`/\````````!#P`(`A``'```````_P````````$/``@" M$``=``````#_`````````0\`_0`*```````7``````#]``H``0```!<``0`` M`/T`"@`!``$`%P`"````_0`*``$``P`7``,```#]``H``@```!8`!`````$" M!@`"``(`&0`!`@8``@`$`!D`_0`*``,````8``4```!^`@H``P`!`!H`S0HE M00$"!@`#``(`&0!^`@H``P`#`!H`J58E00$"!@`#``0`&0#]``H`!````!@` M!@```'X""@`$``$`&P#!+>=``0(&``0``@`9`'X""@`$``,`&P#!K^=``0(& M``0`!``9`/T`"@`%````&``'````?@(*``4``0`;`,'W]4#]``H`!0`"`!D` M"````'X""@`%``,`'```Z(M`_0`*``4`!``9``@```#]``H`!@```!@`"0`` M`'X""@`&``$`&P`!X-I``0(&``8``@`9`'X""@`&``,`&P`!5MA``0(&``8` M!``9`/T`"@`'````&``*````?@(*``<``0`;``'VO4`!`@8`!P`"`!D`?@(* M``<``P`;``$`?L`!`@8`!P`$`!D`_0`*``@````8``L```!^`@H`"``!`!T` MP-;`0`$"!@`(``(`&0`#`@X`"``#`!T`FIF9F5G3P$`!`@8`"``$`!D`_0`* M``D````6``P````!`@8`"0`"`!D``0(&``D`!``9`/T`"@`*````&``-```` M?@(*``H``0`<```[MD#]``H`"@`"`!D`#@```'X""@`*``,`&P")MB%!_0`* M``H`!``9``X```#]``H`"P```!@`#P```'X""@`+``$`'```>(!``0(&``L` M`@`9`'X""@`+``,`&P!!D^A``0(&``L`!``9`/T`"@`,````%@`0`````0(& M``P``@`9``$"!@`,``0`&0#]``H`#0```!@`$0```'X""@`-``$`&P``&'1` M`0(&``T``@`9`'X""@`-``,`&P``*'1``0(&``T`!``9`/T`"@`.````&``2 M````?@(*``X``0`;`"$Q_4`!`@8`#@`"`!D`?@(*``X``P`;`$$&_D`!`@8` M#@`$`!D`_0`*``\````8`!,```!^`@H`#P`!`!T`084"00$"!@`/``(`&0!^ M`@H`#P`#`!T`\?("00$"!@`/``0`&0#]``H`$````!@`%````'X""@`0``$` M&P`!RK=``0(&`!```@`9`'X""@`0``,`&P``P$Y``0(&`!``!``9`/T`"@`1 M````&``5````?@(*`!$``0`;``$0HT`!`@8`$0`"`!D`?@(*`!$``P`;``"` M.$`!`@8`$0`$`!D`_0`*`!(````8`!8```!^`@H`$@`!`!T`@(R^0`$"!@`2 M``(`&0!^`@H`$@`#`!T`J3\H00$"!@`2``0`&0#]``H`$P```!@`%P```'X" M"@`3``$`'@``"(E``0(&`!,``@`9`'X""@`3``,`'0"A5/!``0(&`!,`!``9 M`/T`"@`4````%@`8`````0(&`!0``@`9``$"!@`4``0`&0#]``H`%0```!@` M&0```'X""@`5``$`&P"!&M5``0(&`!4``@`9`'X""@`5``,`&P"!5]1``0(& M`!4`!``9`/T`"@`6````&``:````?@(*`!8``0`;``%LH4`!`@8`%@`"`!D` M?@(*`!8``P`;``'0H4`!`@8`%@`$`!D`_0`*`!<````8`!L```!^`@H`%P`! M`!T``4C70`$"!@`7``(`&0!^`@H`%P`#`!T`@9'60`$"!@`7``0`&0#]``H` M&````!@`'````'X""@`8``$`'P"!>.M``0(&`!@``@`9`'X""@`8``,`'P"! M8.5``0(&`!@`!``9`/T`"@`9````%@`=`````0(&`!D``@`9``$"!@`9``0` M&0#]``H`&@```!@`'@```'X""@`:``$`'P`!0&!``0(&`!H``@`9`'X""@`: M``,`'P`!0%A``0(&`!H`!``9`/T`"@`;````&``?````?@(*`!L``0`?``$` M8$`!`@8`&P`"`!D`?@(*`!L``P`?``'`5T`!`@8`&P`$`!D`_0`*`!P````8 M`"````#]``H`'0```!@`(0```-<`0`"`"```1`(.`"H`(@`^`#X`1@`^`#X` M0@`B`$8`/@`B`#X`/@`^`#X`/@`^`#X`(@`^`#X`/@`^`"(`/@`^``X`/@(2 M`+8&`````$```````````````*``!`!D`&0`'0`/``,````````!```````` M`.4`$@`"`!P`'````!,`'0`=````$P#O``8````W````"@````D($```!A`` M1AC-!\&````&`@``"P(8````````````,`````````!<1P$`8DL!``T``@`! M``P``@!D``\``@`!`!$``@```!``"`#\J?'236)0/U\``@`!`"H``@```"L` M`@```((``@`!`(``"````````````"4"!````/\`@0`"`,$$%````!4```"# M``(```"$``(```"A`"(`"0!D``$``0`!`$8`6`)8`@```````.`_```````` MX#\!`%4``@`(`'T`#```````MCP/````!`!]``P``0`"`+88#P````0`?0`, M``,`_P`D"0\````$```"#@``````,````````P````@"$`````````#_```` M`````0\`"`(0``$````"`/\````````!#P`(`A```@``````_P````````$/ M``@"$``#`````@#_`````````0\`"`(0``0````"`/\````````!#P`(`A`` M!0````(`_P````````$/``@"$``&`````@#_`````````0\`"`(0``<````" M`/\````````!#P`(`A``"`````(`_P````````$/``@"$``)`````@#_```` M`````0\`"`(0``H````"`/\````````!#P`(`A``"P````(`_P````````$/ M``@"$``,`````@#_`````````0\`"`(0``T````"`/\````````!#P`(`A`` M#@````(`_P````````$/``@"$``/`````@#_`````````0\`"`(0`!`````" M`/\````````!#P`(`A``$0````(`_P````````$/``@"$``2`````@#_```` M`````0\`"`(0`!,````"`/\````````!#P`(`A``%`````(`_P````````$/ M``@"$``5`````@#_`````````0\`"`(0`!8``````/\````````!#P`(`A`` M%P````(`_P````````$/``@"$``8`````@#_`````````0\`"`(0`!D````" M`/\````````!#P`(`A``&@````(`_P````````$/``@"$``;`````@#_```` M`````0\`"`(0`!P````"`/\````````!#P`(`A``'0````(`_P````````$/ M``@"$``>`````@#_`````````0\`"`(0`!\````"`/\````````!#P#]``H` M`````!<`(@```/T`"@`!````%P`C````_0`*``$``0`7``(```#]``H``0`" M`!<`)````/T`"@`"````%@`E````_0`*``,````8`"8```!^`@H``P`!`!H` M@2L#00,"#@`#``(`&@!F9F9F9LZ20/T`"@`$````&``G````O0`2``0``0`; M`!EH$4$;`+G6$4$"`/T`"@`%````&``H````O0`2``4``0`;`(&&\D`;``'( M[D`"`/T`"@`&````&``I````?@(*``8``0`<``#0@T`#`@X`!@`"`!L`FIF9 MF9F5@T#]``H`!P```!@`*@```+T`$@`'``$`'````&M`&P`!;M1``@#]``H` M"````!@`*P```+T`$@`(``$`&P`!H.1`'```0&I``@#]``H`"0```!@`+``` M`+T`$@`)``$`'```````&P``8%9``@#]``H`"@```!@`+0```+T`$@`*``$` M&P"!S=M`&P"!N.)``@#]``H`"P```!@`+@```+T`$@`+``$`&P!!S?!`&P"! M[.I``@#]``H`#````!@`+P```+T`$@`,``$`'0#AJ29!'0"%U21!`@#]``H` M#0```!@`,````'X""@`-``$`&P!@9-%``P(.``T``@`;`&9F9F;&IM!`_0`* M``X````8`#$```"]`!(`#@`!`!P``)".0!L`(1CX0`(`_0`*``\````8`#(` M``"]`!(`#P`!`!L`*6@?01L`\6@?00(`_0`*`!`````8`#,````#`@X`$``! M`!L`9F9F9F:R@4`#`@X`$``"`!L`FIF9F9EU@D#]``H`$0```!@`-`````," M#@`1``$`&P!F9F9F9F*!0'X""@`1``(`'```.(%`_0`*`!(````8`"T```"] M`!(`$@`!`!L``.AU0!L`@4?@0`(`_0`*`!,````8`#4```"]`!(`$P`!`!L` M0=#R0!L`X1'S0`(`_0`*`!0````8`#8```"]`!(`%``!`!L`@/FT0!L`K2PC M00(`_0`*`!4````8`#<````#`@X`%0`!`!T`FIF9F9D'XT!^`@H`%0`"`!T` M86E-0?T`"@`6````%@`X````_0`*`!<````8`#D```"]`!(`%P`!`!L`<1D2 M01L`Z:L100(`_0`*`!@````8`#H```"]`!(`&``!`!P```"'0!L`@0[R0`(` M_0`*`!D````8`#L```"]`!(`&0`!`!P``!B"0!L``'R!0`(`_0`*`!H````8 M`#P```!^`@H`&@`!`!L``13D0`,"#@`:``(`&P!F9F9F9B9S0/T`"@`;```` M&``]````O0`2`!L``0`;`&%/]$`;`.$^\T`"`/T`"@`<````&``^````O0`2 M`!P``0`;``&@Y$`<``!`:D`"`/T`"@`=````&``_````O0`2`!T``0`;``%K MYT`;``%ZYT`"`/T`"@`>````&`!`````O0`2`!X``0`;`$'UY4`<```````" M`/T`"@`?````&`!!````O0`2`!\``0`;``'IQD`<```````"`-<`1``.!P`` M;`(.`"H`#@`N`"0`)``N`"0`)``D`"0`)``D`"X`)``D`#(`+@`D`"0`)``N M``X`)``D`"0`+@`D`"0`)``D``@"$``@`````@#_`````````0\`"`(0`"$` M```"`/\````````!#P`(`A``(@````(`_P````````$/``@"$``C`````@#_ M`````````0\`"`(0`"0````"`/\````````!#P`(`A``)0````(`_P`````` M``$/``@"$``F`````@#_`````````0\`"`(0`"<````"`/\````````!#P`( M`A``*`````(`_P````````$/``@"$``I`````@#_`````````0\`"`(0`"H` M`````/\````````!#P`(`A``*P````(`_P````````$/``@"$``L`````@#_ M`````````0\`"`(0`"T````"`/\````````!#P`(`A``+@````(`_P`````` M``$/``@"$``O`````@#_`````````0\`_0`*`"`````8`$(```!^`@H`(``! M`!L`&6@100,"#@`@``(`&P":F9F9F6BC0/T`"@`A````&`!#````?@(*`"$` M`0`=`/$*+D$#`@X`(0`"`!T`FIF9F1F(P$#]``H`(@```!@`.@```+T`$@`B M``$`&P#QH2-!&P#%OB-!`@#]``H`(P```!@`.P```+T`$@`C``$`&P!!]`%! M'```M)9``@#]``H`)````!@`/0````,"#@`D``$`&P!F9F9F9FR40`,"#@`D M``(`&P!F9F9F9CB40/T`"@`E````&`!$````O0`2`"4``0`;`(EX$T$;``!O MK$`"`/T`"@`F````&`!%````O0`2`"8``0`;`*&``4$;`"&<`4$"`/T`"@`G M````&`!&````O0`2`"<``0`;`(#YM$`;`*TL(T$"`/T`"@`H````&`!'```` M`P(.`"@``0`=`)J9F9DY7MQ``P(.`"@``@`=`&9F9F:F7=Q`_0`*`"D````8 M`$@```#]``H`*0`!`"(`20```/T`"@`I``(`(@!)````_0`*`"H````6`$H` M``#]``H`*P```!@`2P```+T`$@`K``$`&P`!8.A`&P!!].9``@#]``H`+``` M`!@`3````'X""@`L``$`&P#E'S!!`P(.`"P``@`;`)J9F9E9",1`_0`*`"T` M```8`$T```"]`!(`+0`!`!L`X>7[P!P``!R3P`(`_0`*`"X````8`$X```!^ M`@H`+@`!`!T`#4DN00,"#@`N``(`'0!F9F9FYH_"0/T`"@`O````&`!/```` M`P(.`"\``0`?`)J9F9F9!^-`?@(*`"\``@`?`&%I34'7`"0`O@,``"P!+@`N M`"0`)``R`"0`)``D`#(`*@`.`"0`+@`D`"X`/@(2`+8``````$`````````` M`````*``!`!D`&0`'0`/``,````````!`````````.\`!@```#<````*```` M"0@0```&$`!&&,T'P8````8"```+`A0````````````&``````````%.`0`- M``(``0`,``(`9``/``(``0`1``(````0``@`_*GQTDUB4#]?``(``0`J``(` M```K``(```""``(``0"```@````````````E`@0```#_`($``@#!!!0````5 M````@P`"````A``"````H0`B``D`9``!``$``0!&`%@"6`(```````#@/P`` M`````.`_`0!5``(`"`!]``P``````+8\#P````0`?0`,``$``@"V&`\````$ M`'T`#``#`/\`)`D/````!````@X```````8```````,````(`A`````````` M_P````````$/``@"$``!`````@#_`````````0\`"`(0``(``````/\````` M```!#P`(`A```P````(`_P````````$/``@"$``$`````@#_`````````0\` M"`(0``4````"`/\````````!#P#]``H``````!<`4`````$"!@`!````%P#] M``H``0`!`!<`40```/T`"@`!``(`%P!2````_0`*``(````6`$H```#]``H` M`P```!@`4P```+T`$@`#``$`&@`!`/`_&@`!`/`_`@#]``H`!````!@`5``` M``,"#@`$``$`'`````!@UQWD00,"#@`$``(`'`````!@UQWD0?T`"@`%```` M&`!5````O0`2``4``0`<`(+6364<``+RM68"`-<`$``T`0``9``.`"8`#@`D M`#(`/@(2`+8``````$```````````````*``!`!D`&0`'0`/``,````````! M`````````.\`!@```#<````*````"0@0```&$`!&&,T'P8````8"```+`A@` M```````````B`````````!Q7`0#@5P$`#0`"``$`#``"`&0`#P`"``$`$0`" M````$``(`/RI\=)-8E`_7P`"``$`*@`"````*P`"````@@`"``$`@``(```` M````````)0($````_P"!``(`P004````%0```(,``@```(0``@```*$`(@`) M`&0``0`!``$`1@!8`E@"````````X#\```````#@/P$`50`"``@`?0`,```` M``"V/`\````$`'T`#``!``8`MA@/````!`!]``P`!P#_`"0)#P````0```(. M```````B```````'````"`(0`````````/\````````!#P`(`A```0````8` M_P````````$/``@"$``"`````0#_`````````0\`"`(0``,````&`/\````` M```!#P`(`A``!```````_P````````$/``@"$``%````!@#_`````````0\` M"`(0``8``````/\````````!#P`(`A``!P````8`_P````````$/``@"$``( M````!@#_`````````0\`"`(0``D````&`/\````````!#P`(`A``"@````8` M_P````````$/``@"$``+````!@#_`````````0\`"`(0``P````&`/\````` M```!#P`(`A``#0````$`_P````````$/``@"$``.````!@#_`````````0\` M"`(0``\````!`/\````````!#P`(`A``$`````8`_P````````$/``@"$``1 M`````0#_`````````0\`"`(0`!(````!`/\````````!#P`(`A``$P````8` M_P````````$/``@"$``4``````#_`````````0\`"`(0`!4````&`/\````` M```!#P`(`A``%@``````_P````````$/``@"$``7````!@#_`````````0\` M"`(0`!@````&`/\````````!#P`(`A``&0````8`_P````````$/``@"$``: M````!@#_`````````0\`"`(0`!L````&`/\````````!#P`(`A``'`````8` M_P````````$/``@"$``=`````0#_`````````0\`"`(0`!X````&`/\````` M```!#P`(`A``'P````$`_P````````$/`/T`"@``````%P!6````_0`*``$` M```7`",```#]``H``0`!`!<`5P```/T`"@`!``(`%P!8````_0`*``$``P`7 M`%D```#]``H``0`$`!<`6@```/T`"@`!``4`%P!;````_0`*``$`!@`7`%P` M``#]``H``@```!@`70```'X""@`"``$`&P#!1^9`_0`*``,````8`%X```"] M`!@``P`"`!H``2;A0!H`0/K"0!H`$?<&P00`?@(*``,`!@`:`*'[*$']``H` M!````!8`7P```/T`"@`%````&`!@````?@(*``4``P`;`(%@Y4"]`!(`!0`% M`!L`@6#E0!L`@6#E0`8`_0`*``8````6`&$```#]``H`!P```!@`8@```'X" M"@`'``0`&P`!@KG`?@(*``<`!@`;``&"N<#]``H`"````!@`8P```'X""@`( M``0`&P`!`&Y`?@(*``@`!@`;``$`;D#]``H`"0```!@`9`````,"#@`)``0` M&P":F9F9F5E!0`,"#@`)``8`&P":F9F9F5E!0/T`"@`*````&`!E````O@`, M``H``0`C`",`(P`#`+T`&``*``0`'0`!"*;`'0`!"*;`'0`!"*;`!@#]``H` M"P```!@`9@```+X`#@`+``$`(P`C`",`(P`$`'X""@`+``4`'0`!`.1``0(& M``L`!@`C`/T`"@`,````&`!G````?@(*``P``@`;``&*L4!^`@H`#``&`!L` M`8JQ0/T`"@`-````&`!H````?@(*``T``0`<````\#_]``H`#@```!@`:0`` M`'X""@`.``(`&P`!`"3``P(.``X``P`;`&9F9F9F3G'`?@(*``X`!@`<``!0 M<<#]``H`#P```!@`:@```'X""@`/``$`&P`!0)#`_0`*`!`````8`&L```"] M`!@`$``"`!P``,!X0!L`N20N01L``-:=P`0`?@(*`!``!@`;`$V&*4']``H` M$0```!@`;````'X""@`1``$`&P!!TN5`_0`*`!(````8`&T```!^`@H`$@`! M`!L``0GE0/T`"@`3````&`!N````?@(*`!,``@`;`$'TYD`#`@X`$P`#`!L` MFIF9F5D(Q$!^`@H`$P`$`!P``!R3P`,"#@`3``8`&P!F9F9FYH_"0/T`"@`4 M````%@!?````_0`*`!4````8`&````!^`@H`%0`#`!L`@7CK0+T`$@`5``4` M&P"!>.M`&P"!>.M`!@#]``H`%@```!8`80```/T`"@`7````&`!B````?@(* M`!<`!``;``%XM$!^`@H`%P`&`!L``7BT0/T`"@`8````&`!C`````P(.`!@` M!``;`&9F9F9F9A+``P(.`!@`!@`;`&9F9F9F9A+`_0`*`!D````8`&0```!^ M`@H`&0`$`!L``$!`0'X""@`9``8`&P``0$!`_0`*`!H````8`&4```"^``P` M&@`!`",`(P`C``,`O0`8`!H`!``=``%>OT`=``%>OT`=``%>OT`&`/T`"@`; M````&`!F````O@`.`!L``0`C`",`(P`C``0`?@(*`!L`!0`=`$%D[T`!`@8` M&P`&`",`_0`*`!P````8`&<```!^`@H`'``"`!L``="F0'X""@`<``8`&P`! MT*9`_0`*`!T````8`&@```!^`@H`'0`!`!L``4!@0/T`"@`>````&`!I```` MO0`2`!X``@`;``$`),`;`(&9V,`#`'X""@`>``8`'```@&_`_0`*`!\````8 M`&H```!^`@H`'P`!`!L``8"&P-<`1`#`!P``;`(.`&(`'``X``X`,@`.`"H` M*@`R`#H`.``J`!P`/``<`#@`'``<`$X`#@`R``X`*@`R`"H`.@`X`"H`'``R M``@"$``@````!@#_`````````0\`"`(0`"$````!`/\````````!#P#]``H` M(````!@`;P```+T`&``@``(`&@`!8.A`&@#E'S!!&@#AY?O`!`!^`@H`(``& M`!H`#4DN0?T`"@`A````&`!P````?@(*`"$``0`;`$&_Y$#7``@`?````!0` M.``^`A(`M@``````0```````````````H``$`&0`9``=``\``P````````$` M````````[P`&````-P````H````)"!````80`$88S0?!@```!@(```L"&``` M`````````"<`````````]5\!`,UA`0`-``(``0`,``(`9``/``(``0`1``(` M```0``@`_*GQTDUB4#]?``(``0`J``(````K``(```""``(``0"```@````` M```````E`@0```#_`($``@#!!!0````5````@P`"````A``"````H0`B``D` M9``!``$``0!&`%@"6`(```````#@/P```````.`_`0!5``(`"`!]``P````` M`+8\#P````0`?0`,``$``@"V&`\````$`'T`#``#`/\`)`D/````!````@X` M`````"<```````,````(`A``````````_P````````$/``@"$``!`````@#_ M`````````0\`"`(0``(``````/\````````!#P`(`A```P````(`_P`````` M``$/``@"$``$``````#_`````````0\`"`(0``4````"`/\````````!#P`( M`A``!@````(`_P````````$/``@"$``'`````@#_`````````0\`"`(0``@` M```"`/\````````!#P`(`A``"0````(`_P````````$/``@"$``*``````#_ M`````````0\`"`(0``L````"`/\````````!#P`(`A``#`````(`_P`````` M``$/``@"$``-`````@#_`````````0\`"`(0``X````"`/\````````!#P`( M`A``#P````(`_P````````$/``@"$``0`````@#_`````````0\`"`(0`!$` M```"`/\````````!#P`(`A``$@``````_P````````$/``@"$``3`````@#_ M`````````0\`"`(0`!0````"`/\````````!#P`(`A``%0````(`_P`````` M``$/``@"$``6`````@#_`````````0\`"`(0`!<````"`/\````````!#P`( M`A``&```````_P````````$/``@"$``9`````@#_`````````0\`"`(0`!H` M```"`/\````````!#P`(`A``&P````(`_P````````$/``@"$``<`````@#_ M`````````0\`"`(0`!T````"`/\````````!#P`(`A``'@````(`_P`````` M``$/``@"$``?`````@#_`````````0\`_0`*```````7`'$```#]``H``0`` M`!<`(P```/T`"@`!``$`%P`"````_0`*``$``@`7``,```#]``H``@```!8` M<@```/T`"@`#````&``<````O0`2``,``0`:`(%XZT`:`(%@Y4`"`/T`"@`$ M````%@!S````_0`*``4````8`'0```"]`!(`!0`!`!L``?:]P!L``0!^0`(` M_0`*``8````8`'4```"]`!(`!@`!`!L``?O#0!P``$!80`(`_0`*``<````8 M`'8```!^`@H`!P`!`!L``="1P`,"#@`'``(`&P!F9F9F9F8D0/T`"@`(```` M&`!W````?@(*``@``0`;``&0I4`#`@X`"``"`!L`FIF9F9F90D#]``H`"0`` M`!@`>````+T`$@`)``$`&P`!()+`&P``@##``@#]``H`"@```!8`>0```/T` M"@`+````&``J````O0`2``L``0`;``%`A<`<````$$`"`/T`"@`,````&`!Z M````?@(*``P``0`;``$YPL`#`@X`#``"`!L`9F9F9F8.<,#]``H`#0```!@` M>P```+T`$@`-``$`&P`!`M=`&P"!*=5``@#]``H`#@```!@`?`````,"#@`. M``$`&P!F9F9F9H90P'X""@`.``(`&P`!UKK`_0`*``\````8`'T```"]`!(` M#P`!`!L`@0_10!L`0:GA0`(`_0`*`!`````8`'X```"]`!(`$``!`!L``0!$ M0!P```#POP(`_0`*`!$````8`'\```"]`!(`$0`!`!T`(7'T0!T`82ST0`(` M_0`*`!(````6`(````#]``H`$P```!@`@0````,"#@`3``$`&P!F9F9F9CRC M0`,"#@`3``(`&P!F9F9F9G6C0/T`"@`4````&`""````?@(*`!0``0`;`(%E M$,$#`@X`%``"`!L`FIF9F9G>H<#]``H`%0```!@`@P```+T`$@`5``$`&P`` MH%+`&P`!3L'``@#]``H`%@```!@`A````+T`$@`6``$`&P`!`"3`'``````` M`@#]``H`%P```!@`A0```+T`$@`7``$`'0`!+MW`'0`!;,9``@#]``H`&``` M`!8`A@```/T`"@`9````&`"'````O0`2`!D``0`;``%`8,`;``%LQL`"`/T` M"@`:````&`"(````O0`2`!H``0`;``$`9$`;``'`9T`"`/T`"@`;````&`") M````O0`2`!L``0`;``$@=\`;``%@>,`"`/T`"@`<````&`"*````O0`2`!P` M`0`;``&`=D`;``$@=T`"`/T`"@`=````&`"+````O0`2`!T``0`<````\+\; M``&`=D`"`/T`"@`>````&`",````O0`2`!X``0`<``!`9,`;``'#V<`"`/T` M"@`?````&`"-````O0`2`!\``0`;``'0B\`<```````"`-<`1`#"!@``;`(. M`"H`#@`D``X`)``D`"X`+@`D``X`)``N`"0`+@`D`"0`)``.`#(`+@`D`"0` M)``.`"0`)``D`"0`)``D``@"$``@`````@#_`````````0\`"`(0`"$````" M`/\````````!#P`(`A``(@````(`_P````````$/``@"$``C`````@#_```` M`````0\`"`(0`"0``````/\````````!#P`(`A``)0````(`_P````````$/ M``@"$``F`````@#_`````````0\`_0`*`"`````8`(X```"]`!(`(``!`!T` M@<30P!T`03KBP`(`_0`*`"$````8`(\```!^`@H`(0`!`!L``>GA0`,"#@`A M``(`&P!F9F9F9KZ!0/T`"@`B````&`"0`````P(.`"(``0`;`&9F9F9FSI)` M?@(*`"(``@`;``!NDD#]``H`(P```!@`D0```+T`$@`C``$`&P"!*P-!&P!1 M5`5!`@#]``H`)````!8`D@```/T`"@`E````&`"3````?@(*`"4``0`<``"` M04`#`@X`)0`"`!L`9F9F9F9F0D#]``H`)@```!@`E````+T`$@`F``$`&@`! M('=`&@`!")%``@#7`!(`D`$``'@`)``N`"X`)``.`"X`/@(2`+8``````$`` M`````````````*``!`!D`&0`'0`/``,````````!`````````.\`!@```#<` M```*````"0@0```&$`!&&,T'P8````8"```+`A0````````````$```````` M`,9C`0`-``(``0`,``(`9``/``(``0`1``(````0``@`_*GQTDUB4#]?``(` M`0`J``(````K``(```""``(``0"```@````````````E`@0```#_`($``@#! M!!0````5````@P`"````A``"````H0`B``D`9``!``$``0!&`%@"6`(````` M``#@/P```````.`_`0!5``(`"`!]``P``````+8\#P````0`?0`,``$``0"V M&`\````$`'T`#``"`/\`)`D/````!````@X```````0```````(````(`A`` M````````_P````````$/``@"$``!`````0#_`````````0\`"`(0``(````` M`/\````````!#P`(`A```P````$`_P````````$/`/T`"@``````%P"5```` M`0(&``$````7`/T`"@`!``$`%P`"````_0`*``(````6`)8```#]``H``P`` M`!@`E0```/T`"@`#``$`(@"7````UP`,`*`````\``X`&``.`#X"$@"V```` M``!```````````````"@``0`9`!D`!T`#P`#`````````0````````#O``8` M```W````"@````D($```!A``1AC-!\&````&`@``"P(4````````````!``` M``````"Y90$`#0`"``$`#``"`&0`#P`"``$`$0`"````$``(`/RI\=)-8E`_ M7P`"``$`*@`"````*P`"````@@`"``$`@``(````````````)0($````_P"! M``(`P004````%0```(,``@```(0``@```*$`(@`)`&0``0`!``$`1@!8`E@" M````````X#\```````#@/P$`50`"``@`?0`,``````"V/`\````$`'T`#``! M``$`MA@/````!`!]``P``@#_`"0)#P````0```(.```````$```````"```` M"`(0`````````/\````````!#P`(`A```0````$`_P````````$/``@"$``" M``````#_`````````0\`"`(0``,````!`/\````````!#P#]``H``````!<` MF`````$"!@`!````%P#]``H``0`!`!<``@```/T`"@`"````%@"6````_0`* M``,````8`)D```#]``H``P`!`"(`F@```-<`#`"@````/``.`!@`#@`^`A(` MM@``````0```````````````H``$`&0`9``=``\``P````````$````````` M[P`&````-P````H````)"!````80`$88S0?!@```!@(```L"%``````````` M``0`````````K&`````0(&``$````7`/T`"@`!``$`%P`"````_0`*``(````6 M`)8```#]``H``P```!@`GP```/T`"@`#``$`(@"@````UP`,`*`````\``X` M&``.`#X"$@"V``````!```````````````"@``0`9`!D`!T`#P`#```````` M`0````````#O``8````W````"@````D($```!A``1AC-!\&````&`@``"P(4 M````````````!`````````"2:P$`#0`"``$`#``"`&0`#P`"``$`$0`"```` M$``(`/RI\=)-8E`_7P`"``$`*@`"````*P`"````@@`"``$`@``(```````` M````)0($````_P"!``(`P004````%0```(,``@```(0``@```*$`(@`)`&0` M`0`!``$`1@!8`E@"````````X#\```````#@/P$`50`"``@`?0`,``````"V M/`\````$`'T`#``!``$`MA@/````!`!]``P``@#_`"0)#P````0```(.```` M```$```````"````"`(0`````````/\````````!#P`(`A```0````$`_P`` M``````$/``@"$``"``````#_`````````0\`"`(0``,````!`/\````````! M#P#]``H``````!<`)P````$"!@`!````%P#]``H``0`!`!<``@```/T`"@`" M````%@"6````_0`*``,````8`"<```#]``H``P`!`"(`H0```-<`#`"@```` M/``.`!@`#@`^`A(`M@``````0```````````````H``$`&0`9``=``\``P`` M``````$`````````[P`&````-P````H````)"!````80`$88S0?!@```!@(` M``L"%`````````````0`````````A6T!``T``@`!``P``@!D``\``@`!`!$` M`@```!``"`#\J?'236)0/U\``@`!`"H``@```"L``@```((``@`!`(``"``` M`````````"4"!````/\`@0`"`,$$%````!4```"#``(```"$``(```"A`"(` M"0!D``$``0`!`$8`6`)8`@```````.`_````````X#\!`%4``@`(`'T`#``` M````MCP/````!`!]``P``0`!`+88#P````0`?0`,``(`_P`D"0\````$```" M#@``````!````````@````@"$`````````#_`````````0\`"`(0``$````! M`/\````````!#P`(`A```@``````_P````````$/``@"$``#`````0#_```` M`````0\`_0`*```````7`*(````!`@8``0```!<`_0`*``$``0`7``(```#] M``H``@```!8`E@```/T`"@`#````&`"C````_0`*``,``0`B`*0```#7``P` MH````#P`#@`8``X`/@(2`+8``````$```````````````*``!`!D`&0`'0`/ M``,````````!`````````.\`!@```#<````*````"0@0```&$`!&&,T'P8`` M``8"```+`A0````````````$`````````'AO`0`-``(``0`,``(`9``/``(` M`0`1``(````0``@`_*GQTDUB4#]?``(``0`J``(````K``(```""``(``0"` M``@````````````E`@0```#_`($``@#!!!0````5````@P`"````A``"```` MH0`B``D`9``!``$``0!&`%@"6`(```````#@/P```````.`_`0!5``(`"`!] M``P``````+8\#P````0`?0`,``$``0"V&`\````$`'T`#``"`/\`)`D/```` M!````@X```````0```````(````(`A``````````_P````````$/``@"$``! M`````0#_`````````0\`"`(0``(``````/\````````!#P`(`A```P````$` M_P````````$/`/T`"@``````%P"E`````0(&``$````7`/T`"@`!``$`%P`" M````_0`*``(````6`)8```#]``H``P```!@`I0```/T`"@`#``$`(@"F```` MUP`,`*`````\``X`&``.`#X"$@"V``````!```````````````"@``0`9`!D M`!T`#P`#`````````0````````#O``8````W````"@````D($```!A``1AC- M!\&````&`@``"P(4````````````!`````````!K<0$`#0`"``$`#``"`&0` M#P`"``$`$0`"````$``(`/RI\=)-8E`_7P`"``$`*@`"````*P`"````@@`" M``$`@``(````````````)0($````_P"!``(`P004````%0```(,``@```(0` M`@```*$`(@`)`&0``0`!``$`1@!8`E@"````````X#\```````#@/P$`50`" M``@`?0`,``````"V/`\````$`'T`#``!``$`MA@/````!`!]``P``@#_`"0) M#P````0```(.```````$```````"````"`(0`````````/\````````!#P`( M`A```0````$`_P````````$/``@"$``"``````#_`````````0\`"`(0``,` M```!`/\````````!#P#]``H``````!<`IP````$"!@`!````%P#]``H``0`! M`!<``@```/T`"@`"````%@"6````_0`*``,````8`*@```#]``H``P`!`"(` MJ0```-<`#`"@````/``.`!@`#@`^`A(`M@``````0```````````````H``$ M`&0`9``=``\``P````````$`````````[P`&````-P````H````)"!````80 M`$88S0?!@```!@(```L"%`````````````0`````````7G,!``T``@`!``P` M`@!D``\``@`!`!$``@```!``"`#\J?'236)0/U\``@`!`"H``@```"L``@`` M`((``@`!`(``"````````````"4"!````/\`@0`"`,$$%````!4```"#``(` M``"$``(```"A`"(`"0!D``$``0`!`$8`6`)8`@```````.`_````````X#\! M`%4``@`(`'T`#```````MCP/````!`!]``P``0`!`+88#P````0`?0`,``(` M_P`D"0\````$```"#@``````!````````@````@"$`````````#_```````` M`0\`"`(0``$````!`/\````````!#P`(`A```@``````_P````````$/``@" M$``#`````0#_`````````0\`_0`*```````7`*H````!`@8``0```!<`_0`* M``$``0`7``(```#]``H``@```!8`E@```/T`"@`#````&`"J````_0`*``,` M`0`B`*L```#7``P`H````#P`#@`8``X`/@(2`+8``````$`````````````` M`*``!`!D`&0`'0`/``,````````!`````````.\`!@```#<````*````"0@0 M```&$`!&&,T'P8````8"```+`A0````````````$`````````%%U`0`-``(` M`0`,``(`9``/``(``0`1``(````0``@`_*GQTDUB4#]?``(``0`J``(````K M``(```""``(``0"```@````````````E`@0```#_`($``@#!!!0````5```` M@P`"````A``"````H0`B``D`9``!``$``0!&`%@"6`(```````#@/P`````` M`.`_`0!5``(`"`!]``P``````+8\#P````0`?0`,``$``0"V&`\````$`'T` M#``"`/\`)`D/````!````@X```````0```````(````(`A``````````_P`` M``````$/``@"$``!`````0#_`````````0\`"`(0``(``````/\````````! M#P`(`A```P````$`_P````````$/`/T`"@``````%P"L`````0(&``$````7 M`/T`"@`!``$`%P`"````_0`*``(````6`)8```#]``H``P```!@`K````/T` M"@`#``$`(@"M````UP`,`*`````\``X`&``.`#X"$@"V``````!````````` M``````"@``0`9`!D`!T`#P`#`````````0````````#O``8````W````"@`` M``D($```!A``1AC-!\&````&`@``"P(4````````````!`````````!$=P$` M#0`"``$`#``"`&0`#P`"``$`$0`"````$``(`/RI\=)-8E`_7P`"``$`*@`" M````*P`"````@@`"``$`@``(````````````)0($````_P"!``(`P004```` M%0```(,``@```(0``@```*$`(@`)`&0``0`!``$`1@!8`E@"````````X#\` M``````#@/P$`50`"``@`?0`,``````"V/`\````$`'T`#``!``$`MA@/```` M!`!]``P``@#_`"0)#P````0```(.```````$```````"````"`(0```````` M`/\````````!#P`(`A```0````$`_P````````$/``@"$``"``````#_```` M`````0\`"`(0``,````!`/\````````!#P#]``H``````!<`K@````$"!@`! M````%P#]``H``0`!`!<``@```/T`"@`"````%@"6````_0`*``,````8`*\` M``#]``H``P`!`"(`L````-<`#`"@````/``.`!@`#@`^`A(`M@``````0``` M````````````H``$`&0`9``=``\``P````````$`````````[P`&````-P`` M``H````)"!````80`$88S0?!@```!@(```L"%`````````````0````````` M-WD!``T``@`!``P``@!D``\``@`!`!$``@```!``"`#\J?'236)0/U\``@`! M`"H``@```"L``@```((``@`!`(``"````````````"4"!````/\`@0`"`,$$ M%````!4```"#``(```"$``(```"A`"(`"0!D``$``0`!`$8`6`)8`@`````` M`.`_````````X#\!`%4``@`(`'T`#```````MCP/````!`!]``P``0`!`+88 M#P````0`?0`,``(`_P`D"0\````$```"#@``````!````````@````@"$``` M``````#_`````````0\`"`(0``$````!`/\````````!#P`(`A```@`````` M_P````````$/``@"$``#`````0#_`````````0\`_0`*```````7`+$````! M`@8``0```!<`_0`*``$``0`7``(```#]``H``@```!8`E@```/T`"@`#```` M&`"R````_0`*``,``0`B`+,```#7``P`H````#P`#@`8``X`/@(2`+8````` M`$```````````````*``!`!D`&0`'0`/``,````````!`````````.\`!@`` M`#<````*````"0@0```&$`!&&,T'P8````8"```+`A0````````````$```` M`````"I[`0`-``(``0`,``(`9``/``(``0`1``(````0``@`_*GQTDUB4#]? M``(``0`J``(````K``(```""``(``0"```@````````````E`@0```#_`($` M`@#!!!0````5````@P`"````A``"````H0`B``D`9``!``$``0!&`%@"6`(` M``````#@/P```````.`_`0!5``(`"`!]``P``````+8\#P````0`?0`,``$` M`0"V&`\````$`'T`#``"`/\`)`D/````!````@X```````0```````(````( M`A``````````_P````````$/``@"$``!`````0#_`````````0\`"`(0``(` M`````/\````````!#P`(`A```P````$`_P````````$/`/T`"@``````%P"T M`````0(&``$````7`/T`"@`!``$`%P`"````_0`*``(````6`)8```#]``H` M`P```!@`M````/T`"@`#``$`(@"U````UP`,`*`````\``X`&``.`#X"$@"V M``````!```````````````"@``0`9`!D`!T`#P`#`````````0````````#O M``8````W````"@````D($```!A``1AC-!\&````&`@``"P(4```````````` M!``````````=?0$`#0`"``$`#``"`&0`#P`"``$`$0`"````$``(`/RI\=)- M8E`_7P`"``$`*@`"````*P`"````@@`"``$`@``(````````````)0($```` M_P"!``(`P004````%0```(,``@```(0``@```*$`(@`)`&0``0`!``$`1@!8 M`E@"````````X#\```````#@/P$`50`"``@`?0`,``````"V/`\````$`'T` M#``!``$`MA@/````!`!]``P``@#_`"0)#P````0```(.```````$```````" M````"`(0`````````/\````````!#P`(`A```0````$`_P````````$/``@" M$``"``````#_`````````0\`"`(0``,````!`/\````````!#P#]``H````` M`!<`M@````$"!@`!````%P#]``H``0`!`!<``@```/T`"@`"````%@"6```` M_0`*``,````8`+8```#]``H``P`!`"(`MP```-<`#`"@````/``.`!@`#@`^ M`A(`M@``````0```````````````H``$`&0`9``=``\``P````````$````` M````[P`&````-P````H````)"!````80`$88S0?!@```!@(```L"%``````` M``````8`````````<'\!``T``@`!``P``@!D``\``@`!`!$``@```!``"`#\ MJ?'236)0/U\``@`!`"H``@```"L``@```((``@`!`(``"````````````"4" M!````/\`@0`"`,$$%````!4```"#``(```"$``(```"A`"(`"0!D``$``0`! M`$8`6`)8`@```````.`_````````X#\!`%4``@`(`'T`#```````MCP/```` M!`!]``P``0`!`+88#P````0`?0`,``(`_P`D"0\````$```"#@``````!@`` M`````@````@"$`````````#_`````````0\`"`(0``$````!`/\````````! M#P`(`A```@``````_P````````$/``@"$``#`````0#_`````````0\`"`(0 M``0````!`/\````````!#P`(`A``!0````$`_P````````$/`/T`"@`````` M%P"X`````0(&``$````7`/T`"@`!``$`%P`"````_0`*``(````6`+D```#] M``H``P```!@`N@```/T`"@`#``$`(@"[````_0`*``0````8`+P```#]``H` M!``!`"(`O0```/T`"@`%````&`"^````_0`*``4``0`B`+\```#7`!````$` M`&0`#@`8``X`'``<`#X"$@"V``````!```````````````"@``0`9`!D`!T` M#P`#`````````0````````#O``8````W````"@````D($```!A``1AC-!\&` M```&`@``"P(4````````````#@````````!+@P$`#0`"``$`#``"`&0`#P`" M``$`$0`"````$``(`/RI\=)-8E`_7P`"``$`*@`"````*P`"````@@`"``$` M@``(````````````)0($````_P"!``(`P004````%0```(,``@```(0``@`` M`*$`(@`)`&0``0`!``$`1@!8`E@"````````X#\```````#@/P$`50`"``@` M?0`,``````"V/`\````$`'T`#``!``$`MA@/````!`!]``P``@#_`"0)#P`` M``0```(.```````.```````"````"`(0`````````/\````````!#P`(`A`` M`0````$`_P````````$/``@"$``"``````#_`````````0\`"`(0``,````! M`/\````````!#P`(`A``!`````$`_P````````$/``@"$``%`````0#_```` M`````0\`"`(0``8````!`/\````````!#P`(`A``!P````$`_P````````$/ M``@"$``(`````0#_`````````0\`"`(0``D````!`/\````````!#P`(`A`` M"@````$`_P````````$/``@"$``+`````0#_`````````0\`"`(0``P````! M`/\````````!#P`(`A``#0````$`_P````````$/`/T`"@``````%P#````` M`0(&``$````7`/T`"@`!``$`%P`"````_0`*``(````6`,$```#]``H``P`` M`!@`P@```/T`"@`#``$`(@##````_0`*``0````8`,0```#]``H`!``!`"(` MQ0```/T`"@`%````&`#&````_0`*``4``0`B`,<```#]``H`!@```!@`R``` M`/T`"@`&``$`(@#)````_0`*``<````8`,H```#]``H`!P`!`"(`RP```/T` M"@`(````&`#,````_0`*``@``0`B`,L```#]``H`"0```!@`S0```/T`"@`) M``$`(@#.````_0`*``H````8`,\````#`@X`"@`!`"0`````J-_`"T+]``H` M"P```!@`T````'X""@`+``$`'`""UDUE_0`*``P````8`-$```!^`@H`#``! M`!P``&B?0/T`"@`-````&`#2````_0`*``T``0`B`-,```#7`"``A`(```0! M#@`8``X`'``<`!P`'``<`!P`'``@`!P`'``^`A(`M@``````0``````````` M````H``$`&0`9``=``\``P````````$`````````[P`&````-P````H````` M```````````````````````````````````````````````````````````` M`````````````````````````````````````````````````0```/[___\# M````!````/[_________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M___________^_P``!0("```````````````````````!````X(6?\OE/:!"K MD0@`*R>SV3````!0`````P````$````H````````@#`````$````.``````` M`````````@```+`$```3````"00``!\````(`````!B`'(`;``` M`/[_```%`@(```````````````````````(````"U XML 43 R7.xml IDEA: Summary of Significant Accounting Policies 2.0.0.10 false Summary of Significant Accounting Policies 006020 - Disclosure - Summary of Significant Accounting Policies true false false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 2 0 aet_NotesToFinancialStatementsAbstract aet false na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false No definition available. false 3 1 aet_SummaryOfSignificantAccountingPoliciesTextBlock aet false na duration string This element may be used to describe all significant accounting policies of the reporting entity. For a new accounting... false false false false false false false false false false false terselabel false 1 false false false false 0 0 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">2.</font></div></td><td valign="top" align="left" width="82%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Summary of Significant Accounting Policies</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Interim Financial Statements</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">These interim financial statements necessarily rely on estimates, including assumptions as to annualized tax rates.&#160;&#160;In the opinion of management, all adjustments necessary for a fair statement of results for the interim periods have been made.&#160;&#160;All such adjustments are of a normal, recurring nature.&#160;&#160;The accompanying unaudited consolidated financial statements and related notes should be read in conjunction with the consolidated financial statements and related notes presented in our 2009 Annual Report on Form 10-K (our &#8220;2009 Annual Report&#8221;).&#160;&#160;Certain financial information that is normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;), but that is not required for interi m reporting purposes, has been condensed or omitted.&#160;&#160;We have omitted certain footnote disclosures that would substantially duplicate the disclosures in our 2009 Annual Report, unless the information contained in those disclosures materially changed or is required by GAAP.&#160;&#160;We have evaluated subsequent events from the balance sheet date through the date the financials were issued and determined there were no other items to disclose.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Principles of Consolidation</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">These una udited consolidated financial statements have been prepared in accordance with GAAP and include the accounts of Aetna and the subsidiaries that we control.&#160;&#160;All significant intercompany balances have been eliminated in consolidation.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">New Accounting Standards</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Variable Interest Entities</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">In June 2009, the Financial Accounting Standards Board (&#8220;FASB&#8221;) released revised accounting guidance for variable interest entities (&#8220;VIEs&#8221;).&#160;&#160;This accounting guidance removes the quantitative-based risks-and-rewards calculation previously used to assess whether a company must consolidate a VIE and, instead, requires a variable interest holder to qualitatively assess whether it has a controlling financial interest in the VIE.&#160;&#160;This accounting guidance was effective on January 1, 2010.&#160;&#160;The adoption of this new accounting guidance did not impact our financial position or results of operations.&#160;&#160;Refer to Note 5 beginning on page 7 for additional information.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY : inline; FONT-SIZE: 11pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Recognition and Presentation of Other-Than-Temporary Impairments</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Effective April 1, 2009, we adopted new accounting guidance issued by the FASB for other-than-temporary impairments (&#8220;OTTI&#8221;) of debt securities. This guidance establishes new criteria for the recognition of OTTI on debt securities and also requires additional financial statement disclosure. The new criteria require OTTI to be recognized if either we determine a credit-related loss has occurred or we have the intention to sell a security that is in an unrealized capital loss position. Refer to Note 5 beginning on page&#160;7 for additional information.</font></div> 2.Summary of Significant Accounting PoliciesInterim Financial StatementsThese interim financial statements necessarily rely on estimates, including assumptions false false false This element may be used to describe all significant accounting policies of the reporting entity. For a new accounting pronouncement that has been issued but not yet adopted, an entity's disclosure should (1) describe the new pronouncement, the date that adoption is required and the date that the entity plans to adopt, if earlier; (2) discuss the methods of adoption allowed by the pronouncement and the method expected to be utilized by the entity, if determined; (3) discuss the impact that adoption of the pronouncement is expected to have on the financial statements of the entity, unless such impact is not known or reasonably estimable (in which case, a statement to that effect should be made) and; (4) disclose the potential impact of other significant matters that the entity believes might result from the adoption of the pronouncement (for example, technical violations of debt covenant agreements and planned or intended changes in business practices.) No authoritative reference available. false false 1 2 false UnKnown UnKnown UnKnown false true XML 44 R17.xml IDEA: Commitments and Contingencies 2.0.0.10 false Commitments and Contingencies 006120 - Disclosure - Commitments and Contingencies true false false false 1 usd $ false false u000 Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 u002 Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 2 0 aet_NotesToFinancialStatementsAbstract aet false na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false No definition available. false 3 1 us-gaap_CommitmentsAndContingenciesDisclosureTextBlock us-gaap true na duration string No definition available. false false false false false false false false false false false terselabel false 1 false false false false 0 0 <div><table style="FONT-SIZE: 9pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"><tr><td valign="top" align="left" width="3%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">12.</font></div></td><td valign="top" align="left" width="85%"><div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: times new roman">Commitments and Contingencies</font></div></td></tr></table></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Litigation and Regulatory Proceedings</font></div><div style="DISPLAY: block; MAR GIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Out-of-Network Benefit Proceedings</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We are named as a defendant in several purported class actions and individual lawsuits arising out of our practices related to the payment of claims for services rendered to our members by health care providers with whom we do not have a contract (&#8220;out-of-network providers&#8221;).&#160;&#160;Other major health insurers are also the subject of similar litigation or have settled similar litigation.&#160;&#160;Among other things, these lawsuits allege that we paid too little to our health plan members and/or providers for these services, among other reasons, because of our use of data provided by Ingenix, Inc., a subsidiary of one of our competitors (&#8220;Ingenix&#8221;).</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Various plaintiffs who are health care providers or medical associations seek to represent nationwide classes of out-of-network providers who provided services to our members during the period from 2001 to the present.&#160;&#160;Various plaintiffs who are members in our health plans seek to represent nationwide classes of our members who received services from out-of-network providers during the period from 2001 to the present.&#160;&#160;Taken together, these lawsuits allege that we violated state law, the Employee Retirement Income Security Act of 1974, as amended (&#8220;ERISA&#8221;), the Ra cketeer Influenced and Corrupt Organizations Act and federal antitrust laws, either acting alone or in concert with our competitors.&#160;&#160;The purported classes seek reimbursement of all unpaid benefits, recalculation and repayment of deductible and coinsurance amounts, unspecified damages and treble damages, statutory penalties, injunctive and declaratory relief, plus interest, costs and attorneys&#8217; fees, and seek to disqualify us from acting as a fiduciary of any benefit plan that is subject to ERISA.&#160;&#160;Individual lawsuits that generally contain similar allegations and seek similar relief have been brought by a health plan member and by out-of-network providers.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">The first class action cas e was commenced on July 30, 2007.&#160;&#160;The federal Judicial Panel on Multi-District Litigation (the &#8220;MDL Panel&#8221;) has consolidated these class action cases in federal district court in New Jersey under the caption <font style="DISPLAY: inline; FONT-STYLE: italic">In re: Aetna UCR Litigation, </font>MDL No. 2020 (&#8220;MDL 2020&#8221;).&#160;&#160; In addition, the MDL Panel has transferred the individual lawsuits to MDL 2020.&#160;&#160;Discovery has commenced in MDL 2020, and the court has not set a trial date.&#160;&#160;We intend to vigorously defend ourselves against the claims brought in these cases.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">On January 15, 2009, Aetna and the New York Att orney General announced an agreement relating to an industry-wide investigation into certain payment practices with respect to out-of-network providers.&#160;&#160;In October 2009, pursuant to that agreement, we contributed $20 million towards the establishment of an independent database system to provide fee information regarding out-of-network reimbursement rates.&#160;&#160;When the new database is operational, we will cease using databases owned by Ingenix and will use the new database for a period of at least five years in connection with out-of-network reimbursements in those benefit plans that employ a reasonable and customary standard for out-of-network reimbursements.&#160;&#160;During 2009, we also agreed to pay approximately $7.5 million in claims and administrative penalties in connection with our out-of-network benefit payment practices as a result of agreements with state attorneys general and a state insurance department.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We also have received subpoenas and/or requests for documents and other information from attorneys general and other state and/or federal regulators, legislators and agencies relating to our out-of-network benefit payment practices.&#160;&#160;It is reasonably possible that others could initiate additional litigation or additional regulatory action against us with respect to our out-of-network benefit payment practices.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">CMS Actions</font></div><div style ="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">In April 2010, CMS imposed intermediate sanctions on us suspending the enrollment of and marketing to new members of all Aetna Medicare Advantage and Standalone Prescription Drug Plan Contracts, effective April 21, 2010. The sanctions relate to compliance with certain Medicare Part D requirements, primarily those relating to changes in the drugs covered by certain plans from 2009 to 2010.&#160; The suspension does not affect our current Medicare enrollees who stay in their existing plans.&#160; Also in April 2010, CMS granted us a limited waiver of these sanctions to allow us to continue to enroll&#160;eligible members into existing, contracted group Aetna Medicare Advantage Plans and Standalone Prescription Drug Plans through July 21, 2010.</font></div><div style="DISPLAY: block; TEXT-INDENT: 0pt">&# 160;</div><div style="DISPLAY: block; TEXT-INDENT: 0pt"><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Securities Class Action Litigation</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">Two purported class action lawsuits were pending in the United States District Court for the Eastern District of Pennsylvania (the &#8220;Pennsylvania Federal Court&#8221;) against Aetna and certain of its current or former officers and/or directors.&#160;&#160;On October 24, 2007, the Southeastern Pennsylvania Transportation Authority filed suit on behalf of all </font><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">purchasers of Aetna common s tock between October 27, 2005 and April 27, 2006.&#160;&#160;The second lawsuit was filed on November 27, 2007, by the Plumbers and Pipefitters Local 51 Pension Fund on behalf of all purchasers of our common stock between July 28, 2005 and July 27, 2006.&#160;&#160;On June 3, 2008, plaintiffs in these two lawsuits filed a consolidated complaint in the Pennsylvania Federal Court on behalf of all purchasers of our common stock between October 27, 2005 and July 27, 2006.&#160;&#160;The consolidated complaint (the &#8220;Securities Class Action Litigation&#8221;) supersedes and replaces the two previous complaints.&#160;&#160;The plaintiffs allege that Aetna and four of its current or former officers and/or directors, John W. Rowe, M.D., Ronald A. Williams, Alan M. Bennett and Craig R. Callen (collectively, the &#8220;Defendants&#8221;), violated federal securities laws. The plaintiffs allege misrepresentations and omissions regarding, among other things, our medic al benefit ratios and health plan pricing practices, as well as insider trading by Dr. Rowe and Messrs. Bennett and Callen.&#160;&#160;The plaintiffs seek compensatory damages plus interest and attorneys&#8217; fees, among other remedies.&#160;&#160;On June 9, 2009, the Pennsylvania Federal Court granted Aetna&#8217;s motion to dismiss the consolidated complaint.&#160;&#160;On July 7, 2009, the plaintiffs filed a notice of appeal to the Pennsylvania Federal Court&#8217;s order dismissing the consolidated complaint.&#160;&#160;On February 11, 2010, the Third Circuit Court of Appeals conducted oral arguments on the plaintiff's appeal.&#160; The Defendants intend to vigorously defend themselves against the claims brought in the Securities Class Action Litigation.</font></div></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Tim es New Roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Other Litigation and Regulatory Proceedings</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We are involved in numerous other lawsuits arising, for the most part, in the ordinary course of our business operations, including employment litigation and claims of bad faith, medical malpractice, non-compliance with state and federal regulatory regimes, marketing misconduct, failure to timely or appropriately pay medical and/or group insurance claims (including post-payment audit and collection practices), rescission of insurance coverage, improper disclosure of personal information, patent infringement and other intellectual property litigation and other litigation in our Health Care and Group Insurance businesses. Some of these other lawsuits are or are purported to be class actions.&#160;&#160;We intend to vigorously defend ourselves against the claims brought in these matters.</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman"></font>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">In addition, our current and past business practices are subject to audit and review by, and from time to time we receive subpoenas and other requests for information from, various state insurance and health care regulatory authorities and attorneys general, the Office of the Inspector General, and othe r state and federal authorities.&#160;&#160;These audits, reviews, subpoenas, and other requests include inquiries by, and testimony before, certain members, committees and subcommittees of the U.S. Congress regarding certain of our business practices, including our overall claims processing and payment practices,&#160;our business practices with respect to our small business or individual customers (such as rating information, premium increases and medical benefit ratios), executive compensation matters and travel and entertainment expenses, in connection with their consideration of health care reform measures, as well as the investigations by, and subpoenas and requests from, attorneys general and others described above under &#8220;Out-of-Network Benefit Proceedings.&#8221;&#160;&#160;There also continues to be heightened review by regulatory authorities of and increased litigation regarding the health care benefits industry&#8217;s business and reporting practices, includi ng premium rate increases, utilization management, complaint and grievance processing, information privacy, provider network structure (including the use of performance-based networks), delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices and claim payment practices (including payments to out-of-network providers).&#160;&#160;As a leading national health care benefits company, we regularly are the subject of such reviews.&#160;&#160;These reviews may result, and have resulted, in changes to or clarifications of our business practices, as well as fines, penalties or other sanctions, including the actions taken by CMS that are described above under &#8220;CMS Actions.&#8221;</font></div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman"></fo nt>&#160;</div><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman">We are unable to predict at this time the ultimate outcome of the matters described above, and it is reasonably possible that their outcome could be material to us.</font><br /></div> 12.Commitments and ContingenciesLitigation and Regulatory ProceedingsOut-of-Network Benefit ProceedingsWe are named as a defendant in several purported class false false false Includes disclosure of commitments and contingencies. This element may be used as a single block of text to encapsulate the entire disclosure including data and tables. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Interpretation (FIN) -Number 14 -Paragraph 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 5 -Paragraph 9, 10, 11, 12 false false 1 2 false UnKnown UnKnown UnKnown false true -----END PRIVACY-ENHANCED MESSAGE-----